Citrus Sinensis ID: 017775

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360------
Protein Sequence
MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKLLSVVKSNLLPCLALVKSSGIIF
Secondary Structure (PSIPRED)
cccccccccccHHcccccccccccccccccccccccccccccccccccEEEEEEEccccEEEEEEEcccccEEEEEEccHHHHHHHHHHHHHHHHHHHHHHcccccEEcEEEEEcccccEEEEEEEcccccHHHHHHHcccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccHHHHcccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHcccccccccccccccccccccccccccccccccccccHHHEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEcccHccEEEcccccccccEEcccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccHHHHccHHHccccHHHHHHccccccccccccccccccHcccHHHccccccccccccccEcc
Coil and Loop (DISEMBL)
mlamekdfdsklriegnnnsstncptvqrsksfafrapqehfsiqdfelgkiygvgsyskvvrakkidtgTVYALKIMDKKFITKENKTAYVKLERIVLdqldhpgvvrlFFTFQDTFSLYMALesceggelfdqitskghlsedeARFYTAEVVDALEYIHSmglihrdikpenllltadghikiadfgsvkpmqdsritvlpnaasddkactfvgtaayvppevlnsspatfgndlwALGCTLyqmlsgtspfkdtsEWLIFQRIIArdirfpnyfSDAARDLIDRLldvdpsgrpgagpggyavlkmhpffkgidwknirgqtppklasepMVNFLLLIKLLSVVKSNLLPCLALVKSSGIIF
Flexible Loop (DISEMBL)
MLAMEKDFDSKlriegnnnsstncptVQRSKSFAFRAPQEHfsiqdfelgkiYGVGsyskvvrakkidtgtvyalkimdkkfitkenKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKLLSVVKSNLLPCLalvkssgiif
Low Complexity Region (SEG)
MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSdaardlidrlldvdPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFlllikllsvvksnllPCLALVKSSGIIF
Disordered region (IsUnstruct)
**********************************FRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDP****GAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKLLSVVKSNLLPCLALVKSSG***
Disordered Region (DISOPRED)
**********************************************FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR*******ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLL**********************IIF
Disordered Region (DISEMBL)
********DSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKLLSVVKSNLLPCLALVKSSGIIF
Disordered Region (DISPRO)
****************************************HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKLLSVVKSNLLPCLALVKSS*IIF
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKLLSVVKSNLLPCLALVKSSGIIF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	366	2.2.26 [Sep-21-2011]
Q4V3C8	486	3-phosphoinositide-depend	yes	no	0.907	0.683	0.862	1e-172
Q9XF67	491	3-phosphoinositide-depend	no	no	0.904	0.674	0.853	1e-172
Q9Z2A0	559	3-phosphoinositide-depend	yes	no	0.765	0.500	0.487	6e-75
O55173	559	3-phosphoinositide-depend	yes	no	0.765	0.500	0.487	1e-74
O15530	556	3-phosphoinositide-depend	yes	no	0.765	0.503	0.484	2e-74
Q6A1A2	396	Putative 3-phosphoinositi	no	no	0.765	0.707	0.480	3e-73
Q54PK9	908	3-phosphoinositide-depend	yes	no	0.767	0.309	0.416	3e-61
Q12701	592	Serine/threonine-protein	yes	no	0.765	0.472	0.424	6e-59
P34102	910	Protein kinase 3 OS=Dicty	no	no	0.770	0.309	0.390	4e-58
Q12236	1081	Serine/threonine-protein	yes	no	0.866	0.293	0.380	2e-57

>sp|Q4V3C8|PDPK2_ARATH 3-phosphoinositide-dependent protein kinase 2 OS=Arabidopsis thaliana GN=PDPK2 PE=1 SV=1

 Score =  605 bits (1559), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 288/334 (86%), Positives = 309/334 (92%), Gaps = 2/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDP 332

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9XF67|PDPK1_ARATH 3-phosphoinositide-dependent protein kinase 1 OS=Arabidopsis thaliana GN=PDPK1 PE=1 SV=1

 Score =  603 bits (1556), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 285/334 (85%), Positives = 308/334 (92%), Gaps = 3/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           MLAMEK+FDSKL ++GN   S+N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct: 1   MLAMEKEFDSKLVLQGN---SSNGANVSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct: 58  VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct: 118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD +PS RPGA
Sbjct: 238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GY  LK HPFF G+DWKN+R QTPPKLA +P
Sbjct: 298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDP 331

May couple lipid signals to the activation-loop phosphorylation of several protein kinases of the so-called AGC kinase family. Interacts via its pleckstrin homology domain with phosphatidic acid, PtdIns3P and PtdIns(3,4)P2 and to a lesser extent with PtdIns(4,5)P2 and PtdIns4P. May play a general role in signaling processes controlling the pathogen/stress response, polar auxin transport and development. Transphosphorylates the AGC protein kinases OXI1/AGC2-1, PK1/S6K1, PK19/S6K2 and PID resulting in their activation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z2A0|PDPK1_MOUSE 3-phosphoinositide-dependent protein kinase 1 OS=Mus musculus GN=Pdpk1 PE=1 SV=2

 Score =  281 bits (719), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 141/289 (48%), Positives = 186/289 (64%), Gaps = 9/289 (3%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 83  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 254

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYHFPEKFFPKARD 314

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           L+++LL +D + R G     GY  LK HPFF+ I W+N+  QTPPKL +
Sbjct: 315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFETITWENLHQQTPPKLTA 363

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus GN=Pdpk1 PE=1 SV=2

 Score =  280 bits (716), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 141/289 (48%), Positives = 186/289 (64%), Gaps = 9/289 (3%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 83  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           L+++LL +D + R G     GY  LK HPFF+ I W+N+  QTPPKL +
Sbjct: 315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTA 363

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O15530|PDPK1_HUMAN 3-phosphoinositide-dependent protein kinase 1 OS=Homo sapiens GN=PDPK1 PE=1 SV=1

 Score =  279 bits (714), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/289 (48%), Positives = 186/289 (64%), Gaps = 9/289 (3%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 80  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 139

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 140 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 199

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 200 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 251

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 252 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 311

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           L+++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 312 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 360

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6A1A2|PDPK2_HUMAN Putative 3-phosphoinositide-dependent protein kinase 2 OS=Homo sapiens GN=PDPK2 PE=5 SV=1

 Score =  275 bits (704), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 139/289 (48%), Positives = 186/289 (64%), Gaps = 9/289 (3%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 53  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 112

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 113 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 172

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D +I+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 173 GIIHRDLKPENILLNEDMYIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 224

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 225 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 284

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           L+++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 285 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 333

Phosphorylates and activates not only PKB/AKT, but also PKA, PKC-zeta, RPS6KA1 and RPS6KB1. May play a general role in signaling processes and in development.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54PK9|PDPKB_DICDI 3-phosphoinositide-dependent protein kinase B OS=Dictyostelium discoideum GN=pdkB PE=3 SV=1

 Score =  236 bits (601), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 123/295 (41%), Positives = 174/295 (58%), Gaps = 14/295 (4%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S  DF+  +  G G+Y KV    + +T  ++A KI++KK I KE K  YV  E+ +LD L
Sbjct: 267 SRSDFDFIRTIGKGAYGKVKLVIEKETQLIFASKILNKKLIIKEKKAKYVNTEKTILDSL 326

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P +V+LF+TFQD  +LY  LE C  G+L   +   G  S D  RFY AE++ ALEY+H
Sbjct: 327 DNPNIVKLFYTFQDENNLYFILEYCPNGDLLGALKKAGCFSIDVVRFYAAEILIALEYLH 386

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G+ HRD+KPEN+LL  + H+K++DFGS K +       + +     ++ +F GTA YV
Sbjct: 387 GKGIAHRDLKPENILLGKNQHLKLSDFGSAKQLS------IGSHHKGSRSGSFCGTAEYV 440

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 282
            PE+L    A    D+W+ GC LYQ++SG  PFK  +E+  F  I  R+  +P+ F    
Sbjct: 441 CPELLTEKSAGVEADIWSYGCLLYQLVSGKLPFKGFNEYQTFLLITKREFSYPDNFDKCC 500

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI-DWKNIRGQTPPKLASEPMV 336
            +LID+LLD+DP  RP       + +K H FF  I DW +I  QTPP +  E MV
Sbjct: 501 MNLIDQLLDLDPYKRPTI-----SEIKNHEFFSSIQDWSSIPSQTPPPI--EQMV 548

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12701|KSG1_SCHPO Serine/threonine-protein kinase ksg1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ksg1 PE=1 SV=2

 Score =  228 bits (580), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 123/290 (42%), Positives = 168/290 (57%), Gaps = 10/290 (3%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DF+ G+I G GSYS V+ A +  T   YA+K++DK+ I KE K  YV +E+  L  L 
Sbjct: 96  VSDFKFGEILGEGSYSTVLTATENSTKREYAIKVLDKRHIIKEKKEKYVNIEKEALCILS 155

Query: 104 -HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HPG ++LF+TFQD  +LY  L     GEL D I   G  +E  A++Y A +VD+++Y+H
Sbjct: 156 KHPGFIKLFYTFQDAHNLYFVLSLARNGELLDYINKLGRFNEICAQYYAALIVDSIDYMH 215

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK----ACTFVGT 218
             G+IHRD+KPEN+LL  +   KI DFGS K +  S  +   +    DK    + +FVGT
Sbjct: 216 GRGVIHRDLKPENILLDDNMRTKITDFGSAKILNSSHGSHEEDTHHADKPQAHSRSFVGT 275

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
           A YV PEVL+   A   +D+WA GC L+QML+G  PF   +E+L FQ I+      P   
Sbjct: 276 ARYVSPEVLSDKIAGTASDIWAFGCILFQMLAGKPPFVAGNEYLTFQSILHLSYEIPPDI 335

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           SD A DLI +LL +DP  R          +  HPFF GI + N   + PP
Sbjct: 336 SDVASDLIKKLLVLDPKDRLTVDE-----IHQHPFFNGIKFDNTLWELPP 380

Involved in the control of cell cycle arrest via a phosphoinositide signaling pathway.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P34102|PK3_DICDI Protein kinase 3 OS=Dictyostelium discoideum GN=pkgC PE=3 SV=2

 Score =  225 bits (574), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 114/292 (39%), Positives = 179/292 (61%), Gaps = 10/292 (3%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
            +I DFEL K+ GVGS+ +V   ++ DTG  YA+K+++KK + K+ + A+   E++VL  
Sbjct: 493 LTIDDFELLKVLGVGSFGRVYLVRRKDTGKFYAMKVLNKKDMLKKKQIAHTNTEKMVLST 552

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +DHP +VRL F FQ+   L+M ++   GGELF  +   G   E+ A+FY AEV+ +L Y+
Sbjct: 553 MDHPFIVRLHFAFQNEDFLFMCMDYVPGGELFHHLQKAGKFPEELAKFYIAEVICSLHYL 612

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL---PNAASDDKACTFVGT 218
           HS  +I+RDIKPEN+LL  +GHIK+ DFG    +  S IT +    N      A TF GT
Sbjct: 613 HSNNIIYRDIKPENILLDEEGHIKLTDFG----LSKSGITSVVGSKNGGEGGFATTFCGT 668

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++  +      D W++G  L++ML+G SPF  ++   +++ +I  ++R P + 
Sbjct: 669 PEYLAPEIITGAGHGKAADWWSVGILLFEMLTGRSPFLASNRNDMYKSMIQGNLRMPMFL 728

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           S  A+DL+++LL  DP+ R G+   G+  +  HPFF+ I W+ +  +  TPP
Sbjct: 729 SSDAQDLLEKLLVPDPNKRLGST-QGFEEISSHPFFELIPWRMLESKMITPP 779

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12236|PKH2_YEAST Serine/threonine-protein kinase PKH2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=PKH2 PE=1 SV=1

 Score =  223 bits (568), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 126/331 (38%), Positives = 199/331 (60%), Gaps = 14/331 (4%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 63
           MEK+ + K++IE  ++SS+  P  + S        ++   I+DF+ G + G G+YS V+ 
Sbjct: 141 MEKNRN-KVKIE--HDSSSQKPIAKESSKAQKNIIKK--GIKDFKFGSVIGDGAYSTVML 195

Query: 64  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYM 122
           A  IDT   YA K+++K+++ ++ K  YV +E+  L +L++ P VVRLF TFQD  SLY 
Sbjct: 196 ATSIDTKKRYAAKVLNKEYLIRQKKVKYVSIEKTALQKLNNSPSVVRLFSTFQDESSLYF 255

Query: 123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
            LE    G+    +   G L E  AR+Y A+++DA++Y+HS G+IHRDIKPEN+LL  + 
Sbjct: 256 LLEYAPNGDFLSLMKKYGSLDETCARYYAAQIIDAIDYLHSNGIIHRDIKPENILLDGEM 315

Query: 183 HIKIADFGSVKPMQDSRITV-LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWAL 241
            IK+ DFG+ K +  +  +V  P      ++ +FVGTA YV PE+LN S   +  D+WA 
Sbjct: 316 KIKLTDFGTAKLLNPTNNSVSKPEYDLSTRSKSFVGTAEYVSPELLNDSFTDYRCDIWAF 375

Query: 242 GCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
           GC L+QM++G  PFK T+E+L FQ+++     F   F    RDL+ ++L  +   R    
Sbjct: 376 GCILFQMIAGKPPFKATNEYLTFQKVMKVQYAFTPGFPLIIRDLVKKILVKNLDRR---- 431

Query: 302 PGGYAVLKMHPFFKGIDWKN--IRGQTPPKL 330
               + +K H FFK +++K+  +  +TPP++
Sbjct: 432 -LTISQIKEHHFFKDLNFKDGSVWSKTPPEI 461

Serine/threonine-protein kinase which is part sphingolipid-mediated signaling pathway that is required for the internalization step of endocytosis by regulating eisosome assembly and organization, and modulating the organization of the plasma membrane. Phosphorylates and activates PKC1. Activates YPK1 and YPK2, 2 components of signaling cascade required for maintenance of cell wall integrity. Required for stress-induced P-body assembly and regulates global mRNA decay at the deadenylation step.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	366
255586617	506	3-phosphoinositide-dependent protein kin	0.920	0.666	0.860	1e-174
297829596	486	hypothetical protein ARALYDRAFT_897238 [	0.907	0.683	0.868	1e-172
350539745	494	3-phosphoinositide-dependent protein kin	0.887	0.657	0.885	1e-172
224109900	496	predicted protein [Populus trichocarpa]	0.920	0.679	0.865	1e-172
225449645	502	PREDICTED: 3-phosphoinositide-dependent	0.901	0.657	0.849	1e-171
30681369	486	3-phosphoinositide-dependent protein kin	0.907	0.683	0.862	1e-170
110743925	486	3-phosphoinositide-dependent protein kin	0.907	0.683	0.862	1e-170
18414583	491	3'-phosphoinositide-dependent protein ki	0.904	0.674	0.853	1e-170
12322773	483	putative 3-phosphoinositide-dependent pr	0.898	0.681	0.864	1e-169
42573267	408	3'-phosphoinositide-dependent protein ki	0.904	0.811	0.853	1e-169

>gi|255586617|ref|XP_002533941.1| 3-phosphoinositide-dependent protein kinase-1, putative [Ricinus communis] gi|223526096|gb|EEF28448.1| 3-phosphoinositide-dependent protein kinase-1, putative [Ricinus communis]

 Score =  615 bits (1586), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 302/351 (86%), Positives = 317/351 (90%), Gaps = 14/351 (3%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTN--------------CPTVQRSKSFAFRAPQEHFSIQD 46
           MLAMEKDFDSKLRI+ +NNSS++                 VQRSKSFAFRAPQE+FSIQD
Sbjct: 1   MLAMEKDFDSKLRIQSSNNSSSSSSISSNHNNNNNNNIGNVQRSKSFAFRAPQENFSIQD 60

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FELGKIYGVGSYSKVVRAKK DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG
Sbjct: 61  FELGKIYGVGSYSKVVRAKKKDTGMVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 120

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VRLFFTFQD+FSLYMALESCEGGELFDQIT KG LSEDEARFY AEVVDALEYIH MGL
Sbjct: 121 IVRLFFTFQDSFSLYMALESCEGGELFDQITRKGRLSEDEARFYAAEVVDALEYIHGMGL 180

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRDIKPENLLLTADGHIK+ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV
Sbjct: 181 IHRDIKPENLLLTADGHIKVADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 240

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLI 286
           LNSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFS+ ARD+I
Sbjct: 241 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSEEARDII 300

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVN 337
           DRLLD+DPS RPGAGP GYA LK+HPFFKGI+WKN+R +TPPKLA E M  
Sbjct: 301 DRLLDIDPSRRPGAGPEGYAALKIHPFFKGINWKNLREETPPKLALEAMTQ 351

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297829596|ref|XP_002882680.1| hypothetical protein ARALYDRAFT_897238 [Arabidopsis lyrata subsp. lyrata] gi|297328520|gb|EFH58939.1| hypothetical protein ARALYDRAFT_897238 [Arabidopsis lyrata subsp. lyrata]

 Score =  611 bits (1576), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 290/334 (86%), Positives = 311/334 (93%), Gaps = 2/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML MEK+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMEKEFDSKLSLQGN--SSSNGATISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT+
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTS 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GYA LK HPFFKG+DWKN+R QTPPKLA +P
Sbjct: 299 GSEGYASLKRHPFFKGVDWKNLRSQTPPKLAPDP 332

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350539745|ref|NP_001234519.1| 3-phosphoinositide-dependent protein kinase-1 [Solanum lycopersicum] gi|57168305|gb|AAW38936.1| 3-phosphoinositide-dependent protein kinase-1 [Solanum lycopersicum]

 Score =  609 bits (1571), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 293/331 (88%), Positives = 310/331 (93%), Gaps = 6/331 (1%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 63
           ME++FD+KL+I+ NN+++T     QRSKSFAFRAPQE+F+IQDFELGKIYGVGSYSKVVR
Sbjct: 11  MEQEFDAKLKIQ-NNSANT-----QRSKSFAFRAPQENFTIQDFELGKIYGVGSYSKVVR 64

Query: 64  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
           AKK DT  VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA
Sbjct: 65  AKKKDTANVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 124

Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
           LESCEGGELFDQIT KG LSEDEARFY AEVVDALEYIHSMGLIHRDIKPENLLLT+DGH
Sbjct: 125 LESCEGGELFDQITRKGRLSEDEARFYAAEVVDALEYIHSMGLIHRDIKPENLLLTSDGH 184

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 243
           IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC
Sbjct: 185 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 244

Query: 244 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
           TLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFS+ ARD+ID+LLDVDPS RPGAGP 
Sbjct: 245 TLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSNEARDIIDQLLDVDPSRRPGAGPD 304

Query: 304 GYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           GYA LK HPFF GIDW+N+R QTPP+LA EP
Sbjct: 305 GYASLKNHPFFSGIDWENLRLQTPPRLAMEP 335

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224109900|ref|XP_002315349.1| predicted protein [Populus trichocarpa] gi|222864389|gb|EEF01520.1| predicted protein [Populus trichocarpa]

 Score =  608 bits (1569), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 295/341 (86%), Positives = 313/341 (91%), Gaps = 4/341 (1%)

Query: 1   MLAMEKDFDSKLRIEGNNN----SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVG 56
           ML ME++FDSKLRI+  ++    S+ N  +VQRSKSFAFRAPQE+F+I DFELGKIYGVG
Sbjct: 1   MLEMEREFDSKLRIQSGDHPSSSSNNNNGSVQRSKSFAFRAPQENFTIHDFELGKIYGVG 60

Query: 57  SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD 116
           SYSKVVRAKK DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+VRLFFTFQD
Sbjct: 61  SYSKVVRAKKKDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGIVRLFFTFQD 120

Query: 117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL 176
            +SLYMALESCEGGELFDQIT KG LSEDEA FY AEVVDALEYIHSMGLIHRDIKPENL
Sbjct: 121 NYSLYMALESCEGGELFDQITRKGRLSEDEACFYAAEVVDALEYIHSMGLIHRDIKPENL 180

Query: 177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 236
           LLTA+GHIKIADFGSVKPMQDS ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN
Sbjct: 181 LLTAEGHIKIADFGSVKPMQDSCITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 240

Query: 237 DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSG 296
           DLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFP+YFS  ARDLID LLD+DPS 
Sbjct: 241 DLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPDYFSGEARDLIDHLLDIDPSR 300

Query: 297 RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVN 337
           RPGAG GGYA LK HPFF+G+DWKN+RG+TPPKL SEPMV 
Sbjct: 301 RPGAGRGGYAELKNHPFFEGVDWKNLRGETPPKLVSEPMVQ 341

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449645|ref|XP_002262670.1| PREDICTED: 3-phosphoinositide-dependent protein kinase 1-like [Vitis vinifera]

 Score =  607 bits (1565), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 294/346 (84%), Positives = 307/346 (88%), Gaps = 16/346 (4%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPT----------------VQRSKSFAFRAPQEHFSIQDF 47
           MEKDFDSKLRI+ N+++                      VQRSKSFAFRAPQE+F+IQDF
Sbjct: 1   MEKDFDSKLRIQSNSSNGGTAGGGGGGGGGGGGGGGAGAVQRSKSFAFRAPQENFTIQDF 60

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           ELGKIYGVGSYSKVVRA+K DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+
Sbjct: 61  ELGKIYGVGSYSKVVRARKKDTGIVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGI 120

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           VRLFFTFQDTFSLYMALESCEGGELFDQIT KG LSE+EARFY AEVVDALEYIHS+GLI
Sbjct: 121 VRLFFTFQDTFSLYMALESCEGGELFDQITRKGRLSENEARFYAAEVVDALEYIHSLGLI 180

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HRDIKPENLLLTADGHIKIADFGSVKPMQDS ITVLPNAASDDKACTFVGTAAYVPPEVL
Sbjct: 181 HRDIKPENLLLTADGHIKIADFGSVKPMQDSLITVLPNAASDDKACTFVGTAAYVPPEVL 240

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
           NSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFSD ARDLID
Sbjct: 241 NSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSDEARDLID 300

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASE 333
           RLLD +PS RPGAG  GYA LKMHPFF G+DWKN+R QTPPKLA E
Sbjct: 301 RLLDTEPSRRPGAGRDGYASLKMHPFFNGVDWKNLRSQTPPKLAME 346

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30681369|ref|NP_187665.2| 3-phosphoinositide-dependent protein kinase [Arabidopsis thaliana] gi|75316154|sp|Q4V3C8.1|PDPK2_ARATH RecName: Full=3-phosphoinositide-dependent protein kinase 2; Short=AtPDK2 gi|66792634|gb|AAY56419.1| At3g10540 [Arabidopsis thaliana] gi|95147296|gb|ABF57283.1| At3g10540 [Arabidopsis thaliana] gi|332641402|gb|AEE74923.1| 3-phosphoinositide-dependent protein kinase [Arabidopsis thaliana]

 Score =  605 bits (1559), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 288/334 (86%), Positives = 309/334 (92%), Gaps = 2/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDP 332

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110743925|dbj|BAE99796.1| 3-phosphoinositide-dependent protein kinase-1 like [Arabidopsis thaliana]

 Score =  604 bits (1558), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 288/334 (86%), Positives = 308/334 (92%), Gaps = 2/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIEFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDP 332

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18414583|ref|NP_568138.1| 3'-phosphoinositide-dependent protein kinase 1 [Arabidopsis thaliana] gi|75267395|sp|Q9XF67.1|PDPK1_ARATH RecName: Full=3-phosphoinositide-dependent protein kinase 1; Short=AtPDK1 gi|5001828|gb|AAD37165.1|AF132742_1 3-phosphoinositide-dependent protein kinase-1 [Arabidopsis thaliana] gi|13430828|gb|AAK26036.1|AF360326_1 putative 3-phosphoinositide-dependent protein kinase-1 PDK1 [Arabidopsis thaliana] gi|15810595|gb|AAL07185.1| putative 3-phosphoinositide-dependent protein kinase-1 PDK1 [Arabidopsis thaliana] gi|332003372|gb|AED90755.1| 3'-phosphoinositide-dependent protein kinase 1 [Arabidopsis thaliana]

 Score =  603 bits (1556), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 285/334 (85%), Positives = 308/334 (92%), Gaps = 3/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           MLAMEK+FDSKL ++GN   S+N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct: 1   MLAMEKEFDSKLVLQGN---SSNGANVSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct: 58  VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct: 118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD +PS RPGA
Sbjct: 238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GY  LK HPFF G+DWKN+R QTPPKLA +P
Sbjct: 298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDP 331

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12322773|gb|AAG51370.1|AC011560_2 putative 3-phosphoinositide-dependent protein kinase-1; 57432-54928 [Arabidopsis thaliana] gi|8567784|gb|AAF76356.1| 3-phosphoinositide-dependent protein kinase-1, putative [Arabidopsis thaliana]

 Score =  601 bits (1550), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 286/331 (86%), Positives = 307/331 (92%), Gaps = 2/331 (0%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 63
           M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSKVVR
Sbjct: 1   MDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSKVVR 58

Query: 64  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
           AKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SLYMA
Sbjct: 59  AKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSLYMA 118

Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
           LESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT DGH
Sbjct: 119 LESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTLDGH 178

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 243
           IKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC
Sbjct: 179 IKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 238

Query: 244 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
           TLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGAG  
Sbjct: 239 TLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGAGSE 298

Query: 304 GYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           GY  LK HPFFKG+DWKN+R QTPPKLA +P
Sbjct: 299 GYDSLKRHPFFKGVDWKNLRSQTPPKLAPDP 329

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42573267|ref|NP_974730.1| 3'-phosphoinositide-dependent protein kinase 1 [Arabidopsis thaliana] gi|332003371|gb|AED90754.1| 3'-phosphoinositide-dependent protein kinase 1 [Arabidopsis thaliana]

 Score =  601 bits (1549), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 285/334 (85%), Positives = 308/334 (92%), Gaps = 3/334 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           MLAMEK+FDSKL ++GN   S+N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct: 1   MLAMEKEFDSKLVLQGN---SSNGANVSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct: 58  VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct: 118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD +PS RPGA
Sbjct: 238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           G  GY  LK HPFF G+DWKN+R QTPPKLA +P
Sbjct: 298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDP 331

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	366
TAIR|locus:2075740	486	AT3G10540 [Arabidopsis thalian	0.907	0.683	0.826	1.9e-147
TAIR|locus:2184357	491	PDK1 "3'-phosphoinositide-depe	0.904	0.674	0.817	6.4e-147
ZFIN|ZDB-GENE-061013-109	536	pdpk1a "3-phosphoinositide dep	0.797	0.544	0.453	4.7e-64
UNIPROTKB|F1Q2Y3	558	PDPK1 "Uncharacterized protein	0.765	0.501	0.463	6e-64
UNIPROTKB|Q5F3U4	556	PDPK1 "Uncharacterized protein	0.844	0.555	0.44	2e-63
MGI|MGI:1338068	559	Pdpk1 "3-phosphoinositide depe	0.765	0.500	0.463	2e-63
UNIPROTKB|E9PER6	529	PDPK1 "3-phosphoinositide-depe	0.765	0.529	0.460	2.6e-63
UNIPROTKB|O15530	556	PDPK1 "3-phosphoinositide-depe	0.765	0.503	0.460	2.6e-63
RGD|620307	559	Pdpk1 "3-phosphoinositide depe	0.765	0.500	0.463	2.6e-63
UNIPROTKB|O55173	559	Pdpk1 "3-phosphoinositide-depe	0.765	0.500	0.463	2.6e-63

TAIR|locus:2075740 AT3G10540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
 Identities = 276/334 (82%), Positives = 296/334 (88%)

Query:     1 MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
             ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct:     1 MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query:    61 VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
             VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct:    59 VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query:   121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
             YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct:   119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query:   181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
             DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct:   179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query:   241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 300
             LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS              PS RPGA
Sbjct:   239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query:   301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
             G  GY  LK HPFFKG+DWKN+R QTPPKLA +P
Sbjct:   299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDP 332

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2184357 PDK1 "3'-phosphoinositide-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1435 (510.2 bits), Expect = 6.4e-147, P = 6.4e-147
 Identities = 273/334 (81%), Positives = 296/334 (88%)

Query:     1 MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
             MLAMEK+FDSKL ++GN+++  N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct:     1 MLAMEKEFDSKLVLQGNSSNGAN---VSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query:    61 VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
             VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct:    58 VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query:   121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
             YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct:   118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query:   181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
             DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct:   178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query:   241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 300
             LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS              PS RPGA
Sbjct:   238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query:   301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
             G  GY  LK HPFF G+DWKN+R QTPPKLA +P
Sbjct:   298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDP 331

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IGI

GO:0035091 "phosphatidylinositol binding" evidence=IDA

GO:0070300 "phosphatidic acid binding" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045860 "positive regulation of protein kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

ZFIN|ZDB-GENE-061013-109 pdpk1a "3-phosphoinositide dependent protein kinase-1a" [Danio rerio (taxid:7955)]

 Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
 Identities = 137/302 (45%), Positives = 183/302 (60%)

Query:    30 SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT 89
             S + A + PQ  F  +DF  GKI G GS+S VV AK++ TG  YA+KI++K  I KENK 
Sbjct:    61 SSTPALKPPQS-FKKEDFSFGKILGEGSFSTVVLAKELATGKEYAMKILEKNHIRKENKA 119

Query:    90 AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF 149
              YV  E+ +L  +DHP  V+LFFTFQD+  LY AL   + GEL   I   G   E   RF
Sbjct:   120 HYVIREKDILSCIDHPFFVKLFFTFQDSQKLYFALSYAKNGELLRYIRKIGSFDETCTRF 179

Query:   150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
             YTAE+V ALEY+H++G+IHRD+KPEN+LL  D HI+I DFG+ K +           ++ 
Sbjct:   180 YTAEIVCALEYLHTVGIIHRDLKPENILLCEDMHIQITDFGTAKQLSSD--------SAQ 231

Query:   210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
              +A +FVGTA YV PE+L    A   +DLWA+GC +YQ+++G  PF+  +E+LIFQ+II 
Sbjct:   232 TRANSFVGTAQYVSPELLTEKSACKSSDLWAMGCIIYQLVAGLPPFRAGNEYLIFQKIIK 291

Query:   270 RDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPP 328
              +  FP  F               P  R G    GG+  LK H FF+ + W+N+  QTPP
Sbjct:   292 LEYEFPEKFFPKAKDLVQRLLSLDPRKRLGCEEMGGFGPLKGHMFFETVSWENLPLQTPP 351

Query:   329 KL 330
             KL
Sbjct:   352 KL 353

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|F1Q2Y3 PDPK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
 Identities = 134/289 (46%), Positives = 178/289 (61%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    82 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 141

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   142 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEMVSALEYLHGK 201

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   202 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 253

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   254 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 313

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                       + R G    GGY+ L+ HPFF+ I W+N++ QTPPKL +
Sbjct:   314 LVEKLLVLDATKRLGCEEMGGYSPLRAHPFFESITWENLQHQTPPKLTA 362

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0032869 "cellular response to insulin stimulus" evidence=IEA

GO:0032148 "activation of protein kinase B activity" evidence=IEA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0006469 "negative regulation of protein kinase activity" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q5F3U4 PDPK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 647 (232.8 bits), Expect = 2.0e-63, P = 2.0e-63
 Identities = 143/325 (44%), Positives = 188/325 (57%)

Query:    15 EGNNNSSTNCPTVQRSKSF----AFRAPQEHFSI-QDFELGKIYGVGSYSKVVRAKKIDT 69
             +G+N  ST   +   S S       + PQ       DF+ GKI G GS+S VV A+++ +
Sbjct:    48 QGSNMESTAAESRSSSNSLPQHTGQQPPQPRKKRPDDFKFGKILGEGSFSTVVLARELTS 107

Query:    70 GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 129
                YA+KI++K+ I KENK  YV  ER V+ +LDHP  V+L+FTFQD   LY  L   + 
Sbjct:   108 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 167

Query:   130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
             GEL   I   G   E   RFYTAE+V ALEY+H  G+IHRD+KPEN+LL  D HI+I DF
Sbjct:   168 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 227

Query:   190 GSVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
             G+ K +  DSR           +A +FVGTA YV PE+L    A   +DLWALGC +YQ+
Sbjct:   228 GTAKVLSADSR---------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 278

Query:   249 LSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAV 307
             ++G  PF+  +E+LIFQ+II  +  FP  F                + R G    GGY  
Sbjct:   279 VAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAKDLVEKLLVLDATKRLGCEEMGGYGP 338

Query:   308 LKMHPFFKGIDWKNIRGQTPPKLAS 332
             LK HPFF+ I W+N+  QTPPKL +
Sbjct:   339 LKAHPFFESIVWENLHLQTPPKLTA 363

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1338068 Pdpk1 "3-phosphoinositide dependent protein kinase 1" [Mus musculus (taxid:10090)]

 Score = 647 (232.8 bits), Expect = 2.0e-63, P = 2.0e-63
 Identities = 134/289 (46%), Positives = 175/289 (60%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 254

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYHFPEKFFPKARD 314

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFETITWENLHQQTPPKLTA 363

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=ISO;IDA

GO:0005158 "insulin receptor binding" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0005829 "cytosol" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0006469 "negative regulation of protein kinase activity" evidence=ISO

GO:0006972 "hyperosmotic response" evidence=IDA

GO:0007165 "signal transduction" evidence=TAS

GO:0010594 "regulation of endothelial cell migration" evidence=IMP

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IMP

GO:0016020 "membrane" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IDA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030054 "cell junction" evidence=IEA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=ISO

GO:0032148 "activation of protein kinase B activity" evidence=ISO

GO:0032869 "cellular response to insulin stimulus" evidence=ISO

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IMP

GO:0042981 "regulation of apoptotic process" evidence=ISO

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=ISO

GO:0043304 "regulation of mast cell degranulation" evidence=IMP

GO:0048041 "focal adhesion assembly" evidence=ISO

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=ISO

UNIPROTKB|E9PER6 PDPK1 "3-phosphoinositide-dependent protein kinase 1" [Homo sapiens (taxid:9606)]

 Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
 Identities = 133/289 (46%), Positives = 175/289 (60%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    53 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 112

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   113 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 172

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   173 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 224

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   225 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 284

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                       + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct:   285 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 333

GO:0005524 "ATP binding" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IEA

GO:0005158 "insulin receptor binding" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0048041 "focal adhesion assembly" evidence=IEA

UNIPROTKB|O15530 PDPK1 "3-phosphoinositide-dependent protein kinase 1" [Homo sapiens (taxid:9606)]

 Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
 Identities = 133/289 (46%), Positives = 175/289 (60%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    80 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 139

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   140 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 199

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   200 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 251

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   252 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 311

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                       + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct:   312 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 360

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0005158 "insulin receptor binding" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0048041 "focal adhesion assembly" evidence=IEA

GO:0005925 "focal adhesion" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IDA

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IMP

GO:0042981 "regulation of apoptotic process" evidence=IMP

GO:0030036 "actin cytoskeleton organization" evidence=TAS

GO:0035556 "intracellular signal transduction" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007268 "synaptic transmission" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0016301 "kinase activity" evidence=EXP

GO:0030168 "platelet activation" evidence=TAS

GO:0031295 "T cell costimulation" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0050852 "T cell receptor signaling pathway" evidence=TAS

GO:0032869 "cellular response to insulin stimulus" evidence=IMP

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IMP

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IDA

GO:0032148 "activation of protein kinase B activity" evidence=IDA

GO:0006469 "negative regulation of protein kinase activity" evidence=IDA

RGD|620307 Pdpk1 "3-phosphoinositide dependent protein kinase-1" [Rattus norvegicus (taxid:10116)]

 Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
 Identities = 134/289 (46%), Positives = 175/289 (60%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTA 363

GO:0003323 "type B pancreatic cell development" evidence=IEA;ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=ISO;IDA;TAS

GO:0005158 "insulin receptor binding" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0005886 "plasma membrane" evidence=ISO;IDA;TAS

GO:0005925 "focal adhesion" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006469 "negative regulation of protein kinase activity" evidence=IEA;ISO

GO:0006972 "hyperosmotic response" evidence=IEA;ISO

GO:0010594 "regulation of endothelial cell migration" evidence=IEA;ISO

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA;ISO

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA;ISO

GO:0016301 "kinase activity" evidence=ISO

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA;ISO

GO:0019901 "protein kinase binding" evidence=IDA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IEA;ISO

GO:0032148 "activation of protein kinase B activity" evidence=IEA;ISO

GO:0032869 "cellular response to insulin stimulus" evidence=IEA;ISO

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA;ISO

GO:0035556 "intracellular signal transduction" evidence=IEA;ISO

GO:0042981 "regulation of apoptotic process" evidence=ISO

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA;ISO

GO:0043304 "regulation of mast cell degranulation" evidence=IEA;ISO

GO:0048041 "focal adhesion assembly" evidence=IMP

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IEA;ISO

UNIPROTKB|O55173 Pdpk1 "3-phosphoinositide-dependent protein kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
 Identities = 134/289 (46%), Positives = 175/289 (60%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTA 363

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q4V3C8	PDPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.8622	0.9071	0.6831	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: scaffold_301208.1 annotation not avaliable (486 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	366
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-133
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-105
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-95
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-87
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-84
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-84
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-80
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-77
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-74
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-73
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-71
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-69
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-69
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-67
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-67
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-66
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-65
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-65
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-65
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-65
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-64
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-63
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-62
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-62
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-61
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-60
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-60
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-60
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-58
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-57
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-57
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-57
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-57
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-57
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-56
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-56
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-56
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-55
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-55
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-55
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-54
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-54
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-54
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-54
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-53
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-52
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-52
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-52
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-52
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-52
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-52
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-51
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-51
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-51
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-50
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-50
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-50
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-49
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-49
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-47
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-47
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-47
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-46
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-46
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-46
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-45
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-44
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-44
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-42
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-42
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-40
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-40
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-40
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-39
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-39
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-38
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-38
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-38
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-37
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-37
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-37
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-36
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-36
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-36
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-36
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-35
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-35
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-35
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-33
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-33
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-33
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-31
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-30
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-29
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-29
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-29
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-29
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-29
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-29
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-28
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-28
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-28
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-27
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-26
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-26
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-26
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-26
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-26
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-25
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-24
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-24
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-23
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-22
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-20
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-18
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-18
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-18
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.001

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  382 bits (984), Expect = e-133
 Identities = 134/281 (47%), Positives = 179/281 (63%), Gaps = 12/281 (4%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 103
            DF+ GKI G GS+S VV AK+ +T   YA+KI+DK+ + KE K  YVK+E+ VL +L+ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HPG+++L++TFQD  +LY  LE    GEL   I   G L E   RFY AE++ ALEY+HS
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPM----------QDSRITVLPNAASDDKAC 213
            G+IHRD+KPEN+LL  D HIKI DFG+ K +           D+         +  +  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +FVGTA YV PE+LN  PA   +DLWALGC +YQML+G  PF+ ++E+L FQ+I+  +  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           FP  F   A+DLI++LL +DP  R G    GY  LK HPFF
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  309 bits (793), Expect = e-105
 Identities = 113/261 (43%), Positives = 158/261 (60%), Gaps = 12/261 (4%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ KV+  +K DTG +YA+K++ KK I K  +  +   ER +L +++HP +V+L + 
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           FQ    LY+ LE   GGELF  ++ +G  SE+ ARFY AE+V ALEY+HS+G+I+RD+KP
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           EN+LL ADGHIK+ DFG  K            ++   +  TF GT  Y+ PEVL      
Sbjct: 122 ENILLDADGHIKLTDFGLAK----------ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVD 293
              D W+LG  LY+ML+G  PF       I+++I+   +RFP + S  ARDLI  LL  D
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231

Query: 294 PSGRPGAGPGGYAVLKMHPFF 314
           P+ R G+G      +K HPFF
Sbjct: 232 PTKRLGSGG--AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  295 bits (759), Expect = 2e-99
 Identities = 114/278 (41%), Positives = 162/278 (58%), Gaps = 13/278 (4%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE  K  G GS+ +V+  +   +G  YALKI+ K  I K  +  +V  E+ +L  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V L+ +FQD  +LY+ +E   GGELF  +   G   E  ARFY A+VV ALEY+HS+
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPENLLL +DG+IKI DFG  K     R+          +  T  GT  Y+ P
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-----RV--------KGRTYTLCGTPEYLAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E++ S       D WALG  +Y+ML+G  PF D +   I+++I+   +RFP++FS  A+D
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD 227

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
           LI  LL VD + R G    G   +K HP+F GIDW  +
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  284 bits (730), Expect = 1e-95
 Identities = 110/272 (40%), Positives = 155/272 (56%), Gaps = 22/272 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  G GS+ KV  A+   TG + A+K++ KK I K+ +      E  +L +L HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR--EIKILKKLKHPN 58

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VRL+  F+D   LY+ +E CEGG+LFD +  +G LSEDEARFY  +++ ALEY+HS G+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           +HRD+KPEN+LL  DGH+K+ADFG  + +              +K  TFVGT  Y+ PEV
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDP-----------GEKLTTFVGTPEYMAPEV 167

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIRFPNY---FSDAA 282
           L         D+W+LG  LY++L+G  PF  D     +F++I      FP      S  A
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +DLI +LL  DP  R  A          HPFF
Sbjct: 228 KDLIRKLLVKDPEKRLTAEE-----ALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  264 bits (678), Expect = 1e-87
 Identities = 113/266 (42%), Positives = 157/266 (59%), Gaps = 6/266 (2%)

Query: 56  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ 115
           G+Y +V  AKK  TG +YA+K++ K  + ++N+   V  ER +L Q   P VV+L+++FQ
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN 175
              +LY+ +E   GG+L   + + G L ED AR Y AE+V ALEY+HS G+IHRD+KP+N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           +L+ ++GH+K+ DFG  K     R   L +   +DK    VGT  Y+ PEV+     +  
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK--RIVGTPDYIAPEVILGQGHSKT 181

Query: 236 NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF--SDAARDLIDRLLDVD 293
            D W+LGC LY+ L G  PF   +   IFQ I+   I +P     SD A DLI +LL  D
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPD 241

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGIDW 319
           P  R GA       +K HPFFKGIDW
Sbjct: 242 PEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  260 bits (666), Expect = 1e-84
 Identities = 123/306 (40%), Positives = 172/306 (56%), Gaps = 28/306 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE+ K+ G G++ +V   +  DTG VYA+K++ K  + K N+ A+V+ ER +L   D P
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+L+++FQD   LY+ +E   GG+L + +  K    E+ ARFY AE+V AL+ +H +G
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---------RITVL----PNAASDDK- 211
            IHRDIKP+N+L+ ADGHIK+ADFG  K M  +            +L          D  
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 212 -----ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
                A + VGT  Y+ PEVL  +P     D W+LG  LY+ML G  PF   +    + +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 267 IIA--RDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
           II     +RFP     S  A DLI RLL  DP  R G+    +  +K HPFFKGIDW+N+
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGS----FEEIKSHPFFKGIDWENL 296

Query: 323 RGQTPP 328
           R   PP
Sbjct: 297 RETKPP 302

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  258 bits (661), Expect = 2e-84
 Identities = 118/309 (38%), Positives = 172/309 (55%), Gaps = 24/309 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F+  K+ G G   +V   +   TG ++ALK++DKK + K NK   V  E+ +L  LDH
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 162
           P +  L+ +FQ    L + ++ C GGELF   Q      LSE+ ARFY AEV+ ALEY+H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADF-----GSVKP-------------MQDSRITVLP 204
            +G+++RD+KPEN+LL   GHI ++DF       V+P                + I    
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 205 NAASDD-KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
            +     ++ +FVGT  Y+ PEV++        D W LG  LY+ML GT+PFK ++    
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 264 FQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 321
           F  I+ +++ FP     S +ARDLI +LL  DPS R G+   G A +K HPFF+G++W  
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWAL 299

Query: 322 IRGQTPPKL 330
           IR  TPP +
Sbjct: 300 IRHTTPPII 308

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  245 bits (627), Expect = 5e-80
 Identities = 102/270 (37%), Positives = 154/270 (57%), Gaps = 15/270 (5%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           GVG + +V   K       +ALK + K+ I +  +  ++  E+ +L++ +HP +V+L+ T
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +YM +E C GGEL+  +  +G   E  ARFY A VV A EY+H+ G+I+RD+KP
Sbjct: 62  FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           ENLLL ++G++K+ DFG  K ++  +           K  TF GT  YV PE++ +    
Sbjct: 122 ENLLLDSNGYVKLVDFGFAKKLKSGQ-----------KTWTFCGTPEYVAPEIILNKGYD 170

Query: 234 FGNDLWALGCTLYQMLSGTSPFK--DTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRL 289
           F  D W+LG  LY++L+G  PF   D     I+  I+  +  + FPNY   AA+DLI +L
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           L  +P  R G   GG   +K H +F G DW
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  239 bits (611), Expect = 1e-77
 Identities = 106/276 (38%), Positives = 153/276 (55%), Gaps = 24/276 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL +  G GS+  V +AK   TG + A+KI+ K+   K  K    + E  +L +L HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VRL   F+D   LY+ +E CEGG+LFD ++  G LSEDEA+    +++  LEY+HS G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+KPEN+LL  +G +KIADFG  K +            S     TFVGT  Y+ PEV
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL----------LKSSSSLTTFVGTPWYMAPEV 169

Query: 227 LN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRIIARDIRFPNYF---- 278
           L   +      D+W+LG  LY++L+G  PF   +      + +RI+   + F        
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG 229

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           S+ A+DLI + L+ DPS RP A       +  HP+F
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTA-----EEILQHPWF 260

Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  233 bits (597), Expect = 1e-74
 Identities = 111/287 (38%), Positives = 161/287 (56%), Gaps = 15/287 (5%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DFE+G+  G GS+ +V  AK   TG  YA+K + K+ I K  +  +V  E+ +L +L 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V +  +FQD   +Y  LE   GGELF  +   G    D A+FY AE+V A EY+HS
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +I+RD+KPENLLL   GH+K+ DFG  K     ++         D+  T  GT  Y+ 
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVP--------DRTFTLCGTPEYLA 183

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PEV+ S       D W +G  LY+ ++G  PF D + + I+++I+A  ++FPN+F   AR
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR 243

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           DL+  LL  D + R G   GG A +K HP+F G +W  +  R    P
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAP 290

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  230 bits (587), Expect = 1e-73
 Identities = 105/286 (36%), Positives = 157/286 (54%), Gaps = 15/286 (5%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            D E  K  G G++ +V   +   +   YALK+M    + +  +  +V  E+ VL ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RLF+T  D   LYM +E   GGELF  + + G  S     FY +E+V ALEY+HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPEN+LL  +GHIK+ DFG  K ++             D+  T  GT  Y+ P
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------------DRTWTLCGTPEYLAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           EV+ S       D WALG  +Y+ML G  PF D + + I+++I+A  + FP +    A+D
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD 227

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           LI +LL VD + R G    G   +K H +FK +DW ++  R   PP
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPP 273

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  224 bits (574), Expect = 9e-71
 Identities = 116/317 (36%), Positives = 174/317 (54%), Gaps = 39/317 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE  K+ G G++ +V   +K DTG +YA+K + K  + ++ + A+V+ ER +L + D+P
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            VV+L+++FQD   LY+ +E   GG++   +  K   +E+E RFY AE + A++ IH +G
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------VLPNAASD-------- 209
            IHRDIKP+NLLL A GHIK++DFG    ++ S  T         LP+   D        
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 210 -DKACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-- 255
             KA T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF  
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 256 KDTSEWLIFQRII--ARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
            +  E   +++II     ++FP+    S  A+DLI RL   +   R G    G   +K H
Sbjct: 242 DNPQE--TYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGN--NGVNEIKSH 296

Query: 312 PFFKGIDWKNIRGQTPP 328
           PFFKG+DW++IR +  P
Sbjct: 297 PFFKGVDWEHIRERPAP 313

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  219 bits (560), Expect = 1e-69
 Identities = 109/294 (37%), Positives = 167/294 (56%), Gaps = 22/294 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 101
           +FEL ++ G G+Y KV   +K+   D G +YA+K++ K  I ++ KTA + + ER VL+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 102 LDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +   P +V L + FQ    L++ L+   GGELF  +  + H +E E R Y AE+V AL++
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H +G+I+RDIK EN+LL ++GH+ + DFG  K            A  +++A +F GT  
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL---------AEEEERAYSFCGTIE 171

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 274
           Y+ PEV+           D W+LG   +++L+G SPF    +  S+  I +RI+     F
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF 231

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           P   S  ARD I +LL+ DP  R GA   G   +K HPFF+GIDW ++  +  P
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIP 283

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  218 bits (557), Expect = 2e-69
 Identities = 104/269 (38%), Positives = 150/269 (55%), Gaps = 21/269 (7%)

Query: 56  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTF 114
           G++  V  AKK  TG  +A+K++ K  +  +N+   VK ER I++ Q + P V +L+++F
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 115 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE 174
           Q    LY+ +E   GG+    I + G L ED A+ Y AEVV  +E +H  G+IHRDIKPE
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF 234
           NLL+   GH+K+ DFG       SR  +            FVGT  Y+ PE +       
Sbjct: 127 NLLIDQTGHLKLTDFGL------SRNGLENK--------KFVGTPDYLAPETILGVGDDK 172

Query: 235 GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLL 290
            +D W+LGC +++ L G  PF   +   +F  I++R I +P     + S  A DLI+RLL
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
            +DP+ R GA   GY  +K HPFFK I+W
Sbjct: 233 CMDPAKRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  214 bits (547), Expect = 3e-67
 Identities = 113/293 (38%), Positives = 167/293 (56%), Gaps = 21/293 (7%)

Query: 51  KIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAYVKLERIVLDQLDHPG 106
           K+ G G Y KV + +K+   DTG ++A+K++ K  I +  K TA+ K ER +L+ + HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L + FQ    LY+ LE   GGELF  +  +G   ED A FY +E+  ALE++H  G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVK-PMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           I+RD+KPEN+LL A GH+K+ DFG  K  + +  +T            TF GT  Y+ PE
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT-----------HTFCGTIEYMAPE 170

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL 285
           +L  S      D W+LG  +Y ML+G  PF   +      +I+   +  P Y +  ARDL
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL 230

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI---RGQTP--PKLASE 333
           + +LL  +PS R GAGPG  A ++ HPFF+ ++W ++   + + P  P L SE
Sbjct: 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSE 283

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  213 bits (545), Expect = 5e-67
 Identities = 100/270 (37%), Positives = 146/270 (54%), Gaps = 11/270 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 109
           K+ G GS+ KV+ A+   T  +YA+K++ K  I +++       E+ VL     HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L   I   G   E  ARFY AE+V  L+++H  G+I+R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL ++GHIKIADFG  K                    TF GT  Y+ PE+L+ 
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKE----------GILGGVTTSTFCGTPDYIAPEILSY 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
            P     D WALG  LY+ML+G SPF+   E  +FQ I+  ++R+P + S  A+ ++   
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           L  +P  R G  P G   +K HPFF+ IDW
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  213 bits (545), Expect = 1e-66
 Identities = 117/293 (39%), Positives = 155/293 (52%), Gaps = 30/293 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF++    G G Y +V  AKK DTG + ALK M K  + K N+  +V  ER +L      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+L + FQD   LY+A+E   GG+    + + G LSED ARFY AE+ +A++ +H +G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
            IHRD+KPEN L+ A GHIK+ DFG  K                  A + VG+  Y+ PE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-------------GIVTYANSVVGSPDYMAPE 168

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPF-----KDTSEWL-----IFQRIIARDIRFP 275
           VL      F  D W+LGC LY+ L G  PF      +T E L       QR +  D RF 
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF- 227

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
              SD A DLI +L++ DPS R     G    +K HPFFK +DW  +R   PP
Sbjct: 228 -NLSDEAWDLITKLIN-DPSRR----FGSLEDIKNHPFFKEVDWNELRELKPP 274

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  210 bits (537), Expect = 1e-65
 Identities = 106/283 (37%), Positives = 152/283 (53%), Gaps = 18/283 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVR 109
           K+ G GS+ KV+ AK    G  YA+K++ KK I K+ +  ++  ER VL   + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L ++FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +I+R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GH+ + DFG  K                    TF GT  Y+ PEVL  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
            P     D W LG  LY+ML G  PF  +DT+E  ++  I+ + +R     S +AR L++
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYDNILNKPLRLKPNISVSARHLLE 228

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            LL  D + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 229 GLLQKDRTKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  207 bits (530), Expect = 2e-65
 Identities = 94/271 (34%), Positives = 148/271 (54%), Gaps = 17/271 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G++ KV   +K DT  ++A+K M+K+   ++     V  ER +L +L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L+++FQD  ++Y+ ++   GG+L   ++ K   SE++ +F+  E+V ALEY+HS G+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRDIKP+N+LL   GH+ I DF     +    +T            +  GT  Y+ PEV
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-----------STSGTPGYMAPEV 170

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFK---DTSEWLIFQRIIARDIRFPNYFSDAAR 283
           L     +   D W+LG T Y+ L G  P++    T    I  +    D+ +P  +S  A 
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI 230

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           D I++LL+ DP  R G        LK HP+F
Sbjct: 231 DAINKLLERDPQKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 5e-65
 Identities = 111/277 (40%), Positives = 154/277 (55%), Gaps = 14/277 (5%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ KV++ +K DT  +YALK + K  I   ++  +   ER VL Q++ P +V L F+
Sbjct: 2   GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFS 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           FQ    LY+ L    GGELF  +  +G      ARFYTAE++ ALE +H   +I+RD+KP
Sbjct: 62  FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKP 121

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           EN+LL   GHI + DFG  K           N   DDK  TF GT  Y+ PE+L     T
Sbjct: 122 ENILLDYQGHIALCDFGLCK----------LNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVD 293
              D W LG  LY+ML+G  PF D +   ++++I+   +RFP+ F   A+DL+  LL  D
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           P+ R G    G   +K HPFF  + WK +  +G  PP
Sbjct: 232 PTRRLGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPP 266

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  206 bits (526), Expect = 7e-65
 Identities = 75/258 (29%), Positives = 140/258 (54%), Gaps = 16/258 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +E+ K  G GS+ KV   ++   G +Y LK +D   ++++ +   +  E  +L +L+HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYI 161
            +++ + +F++   L + +E  +GG+L  +I  +        E++   +  ++  AL+Y+
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  ++HRDIKP+N+ LT++G +K+ DFG  K +            + D A T VGT  Y
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS----------TVDLAKTVVGTPYY 169

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSD 280
           + PE+  + P  + +D+W+LGC LY++ +   PF+  +   +  +I+       P+ +S 
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS 229

Query: 281 AARDLIDRLLDVDPSGRP 298
             R+L+  LL  DP  RP
Sbjct: 230 ELRNLVSSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  206 bits (526), Expect = 4e-64
 Identities = 101/272 (37%), Positives = 146/272 (53%), Gaps = 10/272 (3%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL Y+HS  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +K ENL+L  DGHIKI DFG  K             +      TF GT  Y+ PEVL  +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK----------EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
                 D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL 230

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
             DP  R G GP     +  H FF  I+W+++
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  203 bits (519), Expect = 9e-64
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 21/275 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++  G++ G GS+  V  A   DTG + A+K ++    ++E   A  + E  +L  L HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 106 GVVRLFFTFQDTF--SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            +VR + + +D    +L + LE   GG L   +   G L E   R YT ++++ L Y+HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G++HRDIK  N+L+ +DG +K+ADFG  K + D                +  GT  ++ 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG--------SVRGTPYWMA 171

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARDI--RFPNYFS 279
           PEV+         D+W+LGCT+ +M +G  P+ +       ++ +I +       P + S
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSGEPPEIPEHLS 230

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           + A+D + + L  DP  RP A       L  HPF 
Sbjct: 231 EEAKDFLRKCLRRDPKKRPTA-----DELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  205 bits (522), Expect = 2e-63
 Identities = 110/310 (35%), Positives = 180/310 (58%), Gaps = 27/310 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 101
           +FEL K+ G G+Y KV   +K+   DTG +YA+K++ K  + ++ KT  + + ER VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +   P +V L + FQ    L++ L+   GGE+F  +  + + SEDE RFY+ E++ ALE+
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H +G+++RDIK EN+LL ++GH+ + DFG  K                ++  +F GT  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE---------KERTYSFCGTIE 171

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 274
           Y+ PE++       G   D W+LG  ++++L+G SPF    +  ++  + +RI+  D  F
Sbjct: 172 YMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI---RGQTP--PK 329
           P++    A+DL+ +LL  DP  R GAGP G + +K HPFFKG+DW+ +   +   P  P 
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290

Query: 330 LASEPMV-NF 338
           + +E  V NF
Sbjct: 291 IRNELDVGNF 300

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  204 bits (521), Expect = 1e-62
 Identities = 107/318 (33%), Positives = 156/318 (49%), Gaps = 40/318 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   K  G+G++ +V   +K+DT  +YA+K + K  +   N+ A+VK ER +L + D+  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           VV+L+++FQD  +LY  ++   GG++   +   G   ED ARFY AE+  A+E +H MG 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 167 IHRDIKPENLLLTADGHIKIADFG----------------SVKPMQDS------------ 198
           IHRDIKP+N+L+  DGHIK+ DFG                     QDS            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 199 -RITVLPNAASDD----KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 253
            R+  L            A + VGT  Y+ PEVL  +  T   D W++G  LY+ML G  
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 254 PFKDTSEWLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK 309
           PF   +      ++I     +  P+    S  A DLI RL       R   G  G   +K
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR--LGKNGADEIK 299

Query: 310 MHPFFKGIDWKNIRGQTP 327
            HPFFKGID+ ++  +  
Sbjct: 300 AHPFFKGIDFASLIRRQK 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  202 bits (516), Expect = 5e-62
 Identities = 120/363 (33%), Positives = 183/363 (50%), Gaps = 47/363 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF   K+ G G++ +V   +K DTG +YA+K + K  + K+++ A+VK ER VL + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV L+++FQD   LY+ +E   GG+L   +      SED  RFY AE V A+E +H +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG---------------------SVKPMQDSRITVL 203
           G IHRDIKP+N+L+   GHIK++DFG                     S K   D+R +V 
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 204 PNA-----ASDDKACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
            ++     +S D+  T+           VGT  Y+ PE+          D W+LG  +++
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 248 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPG 303
            L G  PF   +    +++II     + FP+  + S  A DLI RL+  +   R   G G
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENR--LGRG 297

Query: 304 GYAVLKMHPFFKGIDWKNIRG-QTP--PKLASEPMVNFLLLIKLLSVVKSNLLPCLALVK 360
           G   +K HPFF+G+DW  IR  + P  P+L S    ++    +L  V ++  L   A  +
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQ 357

Query: 361 SSG 363
              
Sbjct: 358 QEE 360

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  200 bits (510), Expect = 1e-61
 Identities = 104/282 (36%), Positives = 161/282 (57%), Gaps = 15/282 (5%)

Query: 51  KIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           K+ G GS+ KV   +KI   D G +YA+K++ KK   K       K+ER +L +++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS+G+I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ PEV+
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMAPEVV 170

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
           N    T   D W+ G  +++ML+G+ PF+          I+   +  P + S  A+ L+ 
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW-KNIRGQTPP 328
            L   +P+ R GAGP G   +K HPFF  IDW K  R +  P
Sbjct: 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  197 bits (503), Expect = 1e-60
 Identities = 103/295 (34%), Positives = 152/295 (51%), Gaps = 26/295 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF++  + G G + +V   ++  TG +YA+K+M K  +  +   ++ + ER +L   + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 163
           P + +L + FQD  +LY+ +E   GG+L   +   +    ED A+FY AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           MG +HRDIKPEN+L+   GHIK+ADFGS   +  +   V             VGT  Y+ 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLP--------VGTPDYIA 171

Query: 224 PEVLNS----SPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFP 275
           PEVL +       T+G   D W+LG   Y+M+ G SPF + +    +  I+   R ++FP
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231

Query: 276 N--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
                S    DLI  LL      R      GY  L  HPFF  IDW NIR   PP
Sbjct: 232 EDPKVSSDFLDLIQSLL-CGQKERL-----GYEGLCCHPFFSKIDWNNIRNSLPP 280

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  196 bits (500), Expect = 3e-60
 Identities = 104/280 (37%), Positives = 150/280 (53%), Gaps = 12/280 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+HS  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           IK ENL+L  DGHIKI DFG  K       T+           TF GT  Y+ PEVL  +
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------TFCGTPEYLAPEVLEDN 170

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
                 D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 230

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
             DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  195 bits (497), Expect = 3e-60
 Identities = 101/294 (34%), Positives = 165/294 (56%), Gaps = 20/294 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 101
           +FEL K+ G G+Y KV   +K+   D+G +YA+K++ K  I ++ KT  + + ER VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 102 LDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +   P +V L + FQ    L++ L+   GGELF  ++ +    E E + Y+ E+V ALE+
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H +G+I+RDIK EN+LL ++GH+ + DFG  K                ++A +F GT  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH---------EDEVERAYSFCGTIE 171

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 274
           Y+ P+++           D W++G  +Y++L+G SPF    +  S+  I +RI+  +  +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           P   S  A+D+I RLL  DP  R G GP     +K HPFF+ I+W ++  +  P
Sbjct: 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  192 bits (490), Expect = 1e-58
 Identities = 115/296 (38%), Positives = 165/296 (55%), Gaps = 25/296 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE+ K+ G G++ +V   K  +TG VYA+KI++K  + K  +TA  + ER VL   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHS 163
             +  L + FQD  +LY+ ++   GG+L   ++     L ED ARFY AE+V A++ +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +G +HRDIKP+N+LL  +GHI++ADFGS ++ + D   TV  N A        VGT  Y+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--------VGTPDYI 170

Query: 223 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP 275
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+      +FP
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230

Query: 276 NY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
                 S+ A+DLI RL+   P  R   G  G    K HPFF+GIDW NIR  T P
Sbjct: 231 PDVTDVSEEAKDLIRRLI-CSPETR--LGRNGLQDFKDHPFFEGIDWDNIRNSTAP 283

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  189 bits (482), Expect = 1e-57
 Identities = 106/281 (37%), Positives = 151/281 (53%), Gaps = 13/281 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHR 169
            ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+HS   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K ENL+L  DGHIKI DFG  K       T+           TF GT  Y+ PEVL  
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFCGTPEYLAPEVLED 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
           +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  L
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           L  DP  R G GP     +  H FF GI W+++  +   PP
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPP 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  189 bits (482), Expect = 2e-57
 Identities = 99/292 (33%), Positives = 156/292 (53%), Gaps = 25/292 (8%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 109
           ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +   +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL ++H  G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL A+GHIK+ D+G  K                D   TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----------EGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIARDIRFPNYFS 279
               F  D WALG  +++M++G SPF          ++T ++L FQ I+ + IR P   S
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL-FQVILEKQIRIPRSLS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQTPP 328
             A  ++   L+ DP  R G  P  G+  +K HPFF+ IDW  +  +   PP
Sbjct: 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  189 bits (481), Expect = 2e-57
 Identities = 104/281 (37%), Positives = 151/281 (53%), Gaps = 18/281 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           K+ G GS+ KV+ A+   T   +A+K + K  + +++      +ER VL    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           LF TFQ    L+  +E   GG+L   I S G   E  ARFY AE++  L+++H  G+I+R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL  DGHIKIADFG  K           N   + KA TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK----------ENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D W+ G  LY+ML G SPF    E  +F  I+     FP + S  A+D + +L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230

Query: 290 LDVDPSGRPG-AGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
            + DP+ R G  G      ++ HPFF+GIDW+ + + + PP
Sbjct: 231 FERDPTKRLGVDGD-----IRQHPFFRGIDWERLEKREIPP 266

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  189 bits (481), Expect = 2e-57
 Identities = 101/286 (35%), Positives = 145/286 (50%), Gaps = 13/286 (4%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  I +++      +E+ VL     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   L ++HS 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+I+RD+K +N++L A+GHIKIADFG  K           N        TF GT  Y+ P
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKE----------NIFGGKTTRTFCGTPDYIAP 170

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S  A  
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           +   LL   P+ R G GP G   ++ H FF+ IDW+ +  R   PP
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPP 276

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  189 bits (480), Expect = 3e-57
 Identities = 103/280 (36%), Positives = 155/280 (55%), Gaps = 12/280 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  ++  +G  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            ++FQ    L   +E   GGELF  ++ +   SED  RFY AE+V AL+Y+HS  +++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +K ENL+L  DGHIKI DFG  K         + +AA+     TF GT  Y+ PEVL  +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEG-------ITDAATMK---TFCGTPEYLAPEVLEDN 170

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
                 D W LG  +Y+M+ G  PF +     +F+ I+  DI+FP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL 230

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
             DP+ R G GP     +  H FF G++W+++  +   PP
Sbjct: 231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  187 bits (476), Expect = 1e-56
 Identities = 107/284 (37%), Positives = 156/284 (54%), Gaps = 22/284 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ---LDHPGVVRL 110
           G G++ +V + +K DT  +YA+K++ KK I  + + A+   ER +L +    + P +V L
Sbjct: 2   GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGL 61

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            F+FQ    LY+  +   GGELF  +  +G  SED A+FY AE+V ALE++H   +++RD
Sbjct: 62  KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNS 229
           +KPEN+LL A GHI + DFG  K           N   +    TF GT  Y+ PEV L+ 
Sbjct: 122 LKPENILLDATGHIALCDFGLSK----------ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFP-NYFSDAARDLI 286
              T   D W+LG  +++M  G SPF  +DT +  +++ I    +RFP N  SD  R  +
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNIAFGKVRFPKNVLSDEGRQFV 229

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
             LL+ +P  R GA       LK HPFF  IDW  +  +  TPP
Sbjct: 230 KGLLNRNPQHRLGAHRDAVE-LKEHPFFADIDWDLLSKKQITPP 272

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  183 bits (466), Expect = 2e-56
 Identities = 83/250 (33%), Positives = 124/250 (49%), Gaps = 46/250 (18%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G +  V  A+   TG   A+KI+ K+  +   +    ++E  +L +L+HP +V+L+  
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE--ILKKLNHPNIVKLYGV 59

Query: 114 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           F+D   LY+ +E CEGG L D +    G LSEDE      ++++ LEY+HS G+IHRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 173 PENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NSS 230
           PEN+LL +D G +K+ADFG  K +                  T VGT AY+ PEVL    
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTS----------DKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
             +  +D+W+LG  LY++                                  +DLI ++L
Sbjct: 170 YYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKML 198

Query: 291 DVDPSGRPGA 300
             DP  RP A
Sbjct: 199 QKDPEKRPSA 208

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  185 bits (472), Expect = 3e-56
 Identities = 103/281 (36%), Positives = 151/281 (53%), Gaps = 14/281 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 109
           K+ G GS+ KV+ AK+   G+ YA+K++ KK I K+ +  ++  ER ++L  L HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L ++FQ    LY  L+   GGELF  +  +    E  ARFY AEV  A+ Y+HS+ +I+R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GH+ + DFG  K               ++   TF GT  Y+ PEVL  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
            P     D W LG  LY+ML G  PF       ++  I+ + ++ P   + AA DL+  L
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           L  D   R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 231 LHKDQRRRLGA-KADFLEIKNHVFFSPINWDDLYHKRITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  185 bits (471), Expect = 7e-56
 Identities = 96/287 (33%), Positives = 144/287 (50%), Gaps = 16/287 (5%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           F    + G G + KV+ A+   TG +YA+K + K  I   ++   +  E+ + +  +   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V LF  FQ    +   +E   GG+L   I      SE  A FY A VV  L+Y+H 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +++RD+K +NLLL  +G +KIADFG  K                D+  TF GT  ++ 
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKE----------GMGFGDRTSTFCGTPEFLA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PEVL  +  T   D W LG  +Y+ML G SPF    E  +F  I+  ++R+P + S  A 
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            ++ RLL  +P  R G+G      +K  PFF+ I+W ++  R   PP
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPP 276

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  181 bits (462), Expect = 4e-55
 Identities = 87/283 (30%), Positives = 143/283 (50%), Gaps = 19/283 (6%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V   +   TG +YA K +DKK + K         E+ +L+++    +V L + 
Sbjct: 2   GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F+    L + +    GG+L   I + G     E  A FY A+++  LE++H   +++RD+
Sbjct: 62  FETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDL 121

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
           KPEN+LL   G+++I+D G    ++  +           K     GT  Y+ PEVL    
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGK-----------KIKGRAGTPGYMAPEVLQGEV 170

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAARDLID 287
             F  D +ALGCTLY+M++G SPF+   E +    + +R +   + +P+ FS  A+DL +
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCE 230

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
            LL  DP  R G   G    ++ HP FK ++W+ +      PP
Sbjct: 231 ALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  182 bits (464), Expect = 7e-55
 Identities = 94/282 (33%), Positives = 151/282 (53%), Gaps = 14/282 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           ++ G GS+ KV+ A+  ++G +YA+K++ K  I +++       E+ +L    +HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L+  FQ    L+  +E   GG+L   I       E  ARFY AE+  AL ++H  G+I+R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL  +GH K+ADFG  K    +  T            TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT----------TSTFCGTPDYIAPEILQE 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P + S  A D++   
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230

Query: 290 LDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPP 328
           +  +P+ R G+   GG   +  HPFFK +DW+  N R   PP
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPP 272

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  183 bits (467), Expect = 9e-55
 Identities = 107/297 (36%), Positives = 156/297 (52%), Gaps = 25/297 (8%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
             +DF++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +   +V+L + FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IH
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           SMG IHRD+KP+N+LL   GH+K+ADFG+   M  + +     A         VGT  Y+
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA---------VGTPDYI 210

Query: 223 PPEVLNSSPAT--FGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFP- 275
            PEVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP 
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPP 328
               S  A+DLI   L    + R    G  G   +K HPFFK   W   NIR    P
Sbjct: 271 DIEISKQAKDLICAFL----TDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAP 323

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  181 bits (461), Expect = 1e-54
 Identities = 112/300 (37%), Positives = 159/300 (53%), Gaps = 15/300 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE  K+   G+Y  V   +  +T   +A+K ++K+ +   N+   V +ER +L   ++P
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            VV +F +F+    L M +E  EGG+    + + G L  D AR Y AE V ALEY+H+ G
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV-----GTAA 220
           ++HRD+KP+NLL+T+ GHIK+ DFG  K    S  T L     +     F+     GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFP---N 276
           Y+ PEV+         D WA+G  LY+ L G  PF  DT E L F ++I+ DI +P    
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWPEGDE 240

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP---PKLASE 333
                A+DLI RLL  +P  R G   GG   +K H FF G+DW  +  Q     P+L SE
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESE 298

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  182 bits (464), Expect = 2e-54
 Identities = 108/307 (35%), Positives = 167/307 (54%), Gaps = 32/307 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE  K+ G G++ +V   +K DTG +YA+KI+ K  + ++ + A+++ ER +L + D  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            VV++F++FQD  +LY+ +E   GG++   +  K  LSE+  +FY AE V A++ IH +G
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------------VLPNAASDDK 211
            IHRDIKP+NLLL A GH+K++DFG    ++ +  T                 N  S  K
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 212 ACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           A T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF   + 
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 261 WLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              +++++     + FP     S+ A+DLI R    D   R G+   G   +K HPFF+G
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS--NGVEEIKSHPFFEG 298

Query: 317 IDWKNIR 323
           +DW +IR
Sbjct: 299 VDWGHIR 305

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  181 bits (461), Expect = 2e-54
 Identities = 100/295 (33%), Positives = 151/295 (51%), Gaps = 18/295 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVR 109
           K+ G GS+ KV+ A+   T  VYA+K++ K  I +++       E RI+     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L  QI       E  +RFY AEV  AL ++H  G+I+R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL A+GH K+ADFG  K              +     TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK----------EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D WALG  +Y+M++G  PF+  +E  +F+ I+  D+ +P + S  A  ++   
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230

Query: 290 LDVDPSGRPGAGP--GGYAVLKMHPFFKGIDW-----KNIRGQTPPKLASEPMVN 337
           +  +P+ R G     GG   +K HPFFK IDW     + I+    PK+ ++  VN
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVN 285

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  180 bits (458), Expect = 5e-54
 Identities = 100/281 (35%), Positives = 153/281 (54%), Gaps = 14/281 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 109
           K+ G GS+ KV+ A+       YA+K++ KK I K+ +  ++  ER ++L  + HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L F+FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GHI + DFG  K        +  N  +     TF GT  Y+ PEVL+ 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKE------NIEHNGTTS----TFCGTPEYLAPEVLHK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
            P     D W LG  LY+ML G  PF   +   ++  I+ + ++     +++AR L++ L
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           L  D + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 231 LQKDRTKRLGA-KDDFMEIKNHIFFSPINWDDLINKKITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  178 bits (453), Expect = 3e-53
 Identities = 109/296 (36%), Positives = 161/296 (54%), Gaps = 25/296 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE+ K+ G G++ +V   K   T  +YA+KI++K  + K  +TA  + ER VL   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 163
             +  L + FQD   LY+ ++   GG+L   ++  +  L ED ARFY AE+V A+  IH 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +HRDIKP+N+LL  +GHI++ADFGS +K  QD  +          ++   VGT  Y+
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV----------QSSVAVGTPDYI 170

Query: 223 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FP 275
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+  + R  FP
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Query: 276 NYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           ++ +D    A+DLI RL+    S     G  G    K H FF+GIDW+NIR    P
Sbjct: 231 SHITDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAP 283

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  177 bits (449), Expect = 1e-52
 Identities = 105/292 (35%), Positives = 160/292 (54%), Gaps = 27/292 (9%)

Query: 51  KIYGVGSYSKV--VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV 107
           ++ G GSY+KV  VR KK D   +YA+K++ K+ +  +    +V+ E+ V +Q   +P +
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL 58

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V L   FQ T  L++ +E   GG+L   +  +  L E+ ARFY AE+  AL ++H  G+I
Sbjct: 59  VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +RD+K +N+LL ADGHIK+ D+G  K                D   TF GT  Y+ PE+L
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK----------EGLGPGDTTSTFCGTPNYIAPEIL 168

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFK--------DTSEWLIFQRIIARDIRFPNYFS 279
                 F  D WALG  +++M++G SPF         +T ++L FQ I+ + IR P + S
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL-FQVILEKPIRIPRFLS 227

Query: 280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
             A  ++   L+ DP  R G  P  G++ +K H FF+ IDW  +  +  TPP
Sbjct: 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPP 279

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  176 bits (447), Expect = 2e-52
 Identities = 98/282 (34%), Positives = 152/282 (53%), Gaps = 17/282 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 109
           K+ G GS+ KV+ AK+   G  YA+K++ KK +    +  ++  ER ++L  + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L ++FQ T  LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GH+ + DFG  K             A  D   TF GT  Y+ PEV+  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGIAQSDTTTTFCGTPEYLAPEVIRK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
            P     D W LG  LY+ML G  PF  +D +E  ++  I+ + +      S  A  +++
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYDNILHKPLVLRPGASLTAWSILE 228

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
            LL+ D   R GA    +  ++ HPFF+ + W ++ + + PP
Sbjct: 229 ELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  173 bits (442), Expect = 2e-52
 Identities = 86/274 (31%), Positives = 140/274 (51%), Gaps = 27/274 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            FE+ +  G G + +V +A+   TG   A+K++  K  +KE K   +  E  +L +  HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIIN-EIQILKKCKHP 57

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            +V+ + ++     L++ +E C GG L D + S    L+E +  +   E++  LEY+HS 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRDIK  N+LLT+DG +K+ DFG    + D++              T VGT  ++ P
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-----------TMVGTPYWMAP 166

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD----IRFPNYFS 279
           EV+N  P  +  D+W+LG T  ++  G  P+ +      +F   IA +    +R P  +S
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIATNGPPGLRNPEKWS 224

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           D  +D + + L  +P  RP A       L  HPF
Sbjct: 225 DEFKDFLKKCLQKNPEKRPTA-----EQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  176 bits (446), Expect = 3e-52
 Identities = 99/292 (33%), Positives = 158/292 (54%), Gaps = 25/292 (8%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 109
           ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q  +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y+H  G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL ++GHIK+ D+G  K                D   TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIARDIRFPNYFS 279
               F  D WALG  +++M++G SPF          ++T ++L FQ I+ + IR P   S
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEKQIRIPRSLS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
             A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  +   PP
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  175 bits (444), Expect = 5e-52
 Identities = 97/281 (34%), Positives = 150/281 (53%), Gaps = 17/281 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           K+ G GS+ KV+ A+    G  +A+K + K  +  ++      +E+ VL    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L+ TFQ    L+  +E   GG+L   I  KG      A FY AE+V  L+++HS G+I+R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N++L  DGHIKIADFG  K           N   D++A TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK----------ENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
              TF  D W+ G  LY+ML G SPF    E  +F+ I      +P + +  ++D++++L
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
            + DP+ R G        ++ HPFFK I+W  +  +   PP
Sbjct: 231 FERDPTRRLGV----VGNIRGHPFFKTINWTALEKRELDPP 267

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  176 bits (446), Expect = 9e-52
 Identities = 102/318 (32%), Positives = 150/318 (47%), Gaps = 28/318 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            + + +  G GS+ +V  A+        ALK++ KK  +K  +      E  +L  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYI 161
             +V+L+  FQD  SLY+ +E  +GG L D +   G    LSE EA F  A+++ ALEY+
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 162 HSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           HS G+IHRDIKPEN+LL  DG  +K+ DFG  K + D   T    A       T VGT  
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA----LPSTSVGTPG 173

Query: 221 YVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--------- 268
           Y+ PEVL   + + A+  +D+W+LG TLY++L+G  PF+         + +         
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 269 ----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 324
                     P   S AA DL+ +LL  DP  R  +       L  H   K  D  ++  
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293

Query: 325 QTPPKLASEPMVNFLLLI 342
                     +   L  +
Sbjct: 294 PDDSAPLRLSLPPSLEAL 311

Length = 384

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  174 bits (442), Expect = 9e-52
 Identities = 104/300 (34%), Positives = 152/300 (50%), Gaps = 18/300 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  + +++      +E+ VL   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             + +L   FQ    LY  +E   GG+L   I   G   E +A FY AE+   L ++H  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVP 223
           G+I+RD+K +N++L ++GHIKIADFG  K  M D   T            TF GT  Y+ 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR-----------TFCGTPDYIA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PE++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S  A 
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 229

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG---QTP--PKLASEPMVNF 338
            +   L+   PS R G GP G   ++ H FF+ IDW  +     Q P  PK+  +   NF
Sbjct: 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGAENF 289

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  175 bits (446), Expect = 1e-51
 Identities = 114/324 (35%), Positives = 163/324 (50%), Gaps = 45/324 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   K  G+G++ +V  A+K+DT  +YA+K + KK +   N+ A+VK ER +L + D+  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           VVRL+++FQD  +LY  ++   GG++   +   G   ED ARFY AE+  A+E +H MG 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVK----------------PMQDS------------ 198
           IHRDIKP+N+L+  DGHIK+ DFG                     QDS            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 199 -----RITVLP-NAASDDKAC---TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
                R+  L   AA   + C   + VGT  Y+ PEVL  +  T   D W++G  LY+ML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 250 SGTSPFKDTSEWLIFQRII----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGY 305
            G  PF   +      ++I    +  I      S  A DLI +L    P  R   G  G 
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDR--LGKNGA 299

Query: 306 AVLKMHPFFKGIDW-KNIRGQTPP 328
             +K HPFFK ID+  ++R Q+ P
Sbjct: 300 DEIKAHPFFKTIDFSSDLRQQSAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  173 bits (439), Expect = 4e-51
 Identities = 107/296 (36%), Positives = 162/296 (54%), Gaps = 25/296 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K  +TA  + ER VL   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 163
             +  L + FQD  +LY+ ++   GG+L   ++  +  L ED ARFY AE+V A++ +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +HRDIKP+N+L+  +GHI++ADFGS +K M+D  +          ++   VGT  Y+
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------QSSVAVGTPDYI 170

Query: 223 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FP 275
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+    R  FP
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230

Query: 276 NYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
              +D    A+DLI RL+    S     G  G    K HPFF GIDW NIR    P
Sbjct: 231 AQVTDVSEDAKDLIRRLI---CSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAP 283

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  173 bits (440), Expect = 5e-51
 Identities = 106/308 (34%), Positives = 168/308 (54%), Gaps = 32/308 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DFE  K+ G G++ +V   +K DTG VYA+KI+ K  + ++ +  +++ ER +L + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             VV++F++FQD  +LY+ +E   GG++   +  K  L+E+E +FY AE V A++ IH +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------VLP------NAASDD 210
           G IHRDIKP+NLLL + GH+K++DFG    ++ +  T         LP      N  S  
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 211 KACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           KA T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF   +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 260 EWLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
               +++++     + FP     S+ A+DLI R            G  G   +K +PFF+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC---CEWEHRIGAPGVEEIKTNPFFE 297

Query: 316 GIDWKNIR 323
           G+DW++IR
Sbjct: 298 GVDWEHIR 305

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  171 bits (435), Expect = 1e-50
 Identities = 97/281 (34%), Positives = 144/281 (51%), Gaps = 17/281 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ VL    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L+ TFQ   +L+  +E   GG+L   I S        A FY AE++  L+++HS G+++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL  DGHIKIADFG  K           N   D K CTF GT  Y+ PE+L  
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK----------ENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D W+ G  LY+ML G SPF    E  +FQ I   +  +P + +  A+D++ +L
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
              +P  R G        ++ HPFF+ IDW  +  R   PP
Sbjct: 231 FVREPERRLGVK----GDIRQHPFFREIDWSALEEREIEPP 267

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 1e-50
 Identities = 95/296 (32%), Positives = 150/296 (50%), Gaps = 20/296 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I + G+   DE R  FY AE+   LE +H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            +++RD+KPEN+LL   GHI+I+D G +V+  +   I               VGT  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR------------GRVGTVGYMA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS 279
           PEV+ +   TF  D W LGC +Y+M+ G SPF+   E +    + +R+      +   FS
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 334
           +AAR +  +LL  DP  R G    G   +K HPFF+  ++K +  G   P    +P
Sbjct: 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  170 bits (432), Expect = 4e-50
 Identities = 104/300 (34%), Positives = 151/300 (50%), Gaps = 18/300 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  + +++      +E+ VL     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             + +L   FQ    LY  +E   GG+L  QI   G   E  A FY AE+   L ++HS 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVP 223
           G+I+RD+K +N++L ++GHIKIADFG  K  M D   T            TF GT  Y+ 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-----------TFCGTPDYIA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P   S  A 
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 229

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW-----KNIRGQTPPKLASEPMVNF 338
            +   L+   P  R G GP G   +K H FF+ IDW     K ++    PK       NF
Sbjct: 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDAENF 289

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  169 bits (430), Expect = 3e-49
 Identities = 109/331 (32%), Positives = 161/331 (48%), Gaps = 51/331 (15%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G+G++ +V  A K+DT  +YA+K + KK +   N+ A+VK ER +L + D+  VV+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +++FQD  +LY  ++   GG++   +       E  ARFY AE+  A+E +H MG IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 171 IKPENLLLTADGHIKIADFG-----------------------SVKPMQ----------- 196
           IKP+N+L+  DGHIK+ DFG                       S++P             
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 197 DSRITVLPNAASDDKAC---TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 253
           D   T+   A    + C   + VGT  Y+ PEVL     T   D W++G  L++ML G  
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 254 PFKDTSEWLIFQRII--ARDIRFPNY--FSDAARDLIDRLL--DVDPSGRPGAGPGGYAV 307
           PF   +      ++I     +  P     S  A DLI +L     +  GR GA       
Sbjct: 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD----- 301

Query: 308 LKMHPFFKGIDWK-NIRGQTPPKLA--SEPM 335
           +K HPFF  +D+  +IR Q  P +   S PM
Sbjct: 302 IKAHPFFSEVDFSSDIRTQPAPYVPKISHPM 332

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  165 bits (419), Expect = 6e-49
 Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 17/270 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +++LG + G G++  V +   ++TG   A+K +  + I +E   + +  E  +L  L HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+   + + + SLY+ LE  E G L   I   G   E     Y  +V+  L Y+H  G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +IHRDIK  N+L T DG +K+ADFG    + D                + VGT  ++ PE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLND----------VSKDDASVVGTPYWMAPE 169

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARD 284
           V+  S A+  +D+W+LGCT+ ++L+G  P+ D +      RI+  D    P   S   +D
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
            + +    DP+ RP A      +LK HP+ 
Sbjct: 230 FLMQCFQKDPNLRPTAK----QLLK-HPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  168 bits (426), Expect = 8e-49
 Identities = 109/294 (37%), Positives = 158/294 (53%), Gaps = 23/294 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 212

Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFP--N 276
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP  N
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
             S  A++LI   L  D   R   G  G   +K H FFK     W+ +R    P
Sbjct: 273 DISKEAKNLICAFL-TDREVR--LGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 323

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  164 bits (416), Expect = 1e-47
 Identities = 94/279 (33%), Positives = 144/279 (51%), Gaps = 14/279 (5%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +DF   +  G GS+ +V+ A  K +     A+K  +K  I K+ +  +V  ER +L+ ++
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP  V L+ +F+D   LY+ LE   GGE F  +        D   FY A++V   EY+ S
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + +++RD+KPENLLL  DG IK+ DFG  K +             D +  T  GT  Y+ 
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-------------DTRTYTLCGTPEYIA 196

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PE+L +       D W LG  +Y++L G  PF      LI+Q+I+   I FP +  +  +
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            L+ +LL  D + R G    G   +K HP+F  IDW ++
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295

Length = 340

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  163 bits (414), Expect = 5e-47
 Identities = 110/302 (36%), Positives = 166/302 (54%), Gaps = 26/302 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF  FQD   LYM +E   GG+L + + S   + E  A+FYTAEVV AL+ IHSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           GLIHRD+KP+N+LL   GH+K+ADFG+   M ++ +          +  T VGT  Y+ P
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISP 212

Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPN-- 276
           EVL S      +G   D W++G  L++ML G +PF   S    + +I+     + FP   
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG--IDWKNIR---GQTPPKLA 331
             S  A++LI   L  D   R   G  G   +K HPFFK    +W NIR       P+L+
Sbjct: 273 EISKHAKNLICAFL-TDREVR--LGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELS 329

Query: 332 SE 333
           S+
Sbjct: 330 SD 331

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  160 bits (407), Expect = 6e-47
 Identities = 98/287 (34%), Positives = 147/287 (51%), Gaps = 20/287 (6%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVV 108
           I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L  +   D P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            + + F     L   L+   GG+L   ++  G  SE E RFY AE++  LE++H+  +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RD+KP N+LL   GH++I+D G            L    S  K    VGT  Y+ PEVL 
Sbjct: 121 RDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTHGYMAPEVLQ 168

Query: 229 SSPATFGN-DLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFPNYFSDAARD 284
              A   + D ++LGC L+++L G SPF   K   +  I +  +   +  P+ FS   R 
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 330
           L++ LL  D + R G    G   +K HPFF+ +DW+ +  Q  PP L
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  159 bits (403), Expect = 2e-46
 Identities = 100/292 (34%), Positives = 146/292 (50%), Gaps = 23/292 (7%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVV 108
           I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L  +   D P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            + + F     L   L+   GG+L   ++  G  SE E RFY  E++  LE++H+  +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RD+KP N+LL   GH++I+D G            L    S  K    VGT  Y+ PEVL 
Sbjct: 121 RDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTHGYMAPEVLQ 168

Query: 229 SSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARDIRFPNYFSDAA 282
              A   +  W +LGC L+++L G SPF     KD  E  I +  +  ++  P+ FS   
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTVNVELPDSFSPEL 226

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           + L++ LL  D S R G    G   +K H FFKGIDW+ +  Q  P     P
Sbjct: 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  158 bits (401), Expect = 4e-46
 Identities = 90/280 (32%), Positives = 128/280 (45%), Gaps = 25/280 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDH 104
           D E  K+ G GS   V + +   TG +YALK +       E     +  E + +    + 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSC-ES 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+ +  F     + + LE  +GG L D +   G + E    +   +++  L+Y+H+ 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 165 -GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +IHRDIKP NLL+ + G +KIADFG  K        VL N  + D+  TFVGT  Y+ 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLEN--TLDQCNTFVGTVTYMS 168

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRF--PNYF 278
           PE +     ++  D+W+LG TL +   G  PF      S + + Q I            F
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
           S   RD I   L  DP  RP A     A L  HPF K  D
Sbjct: 229 SPEFRDFISACLQKDPKKRPSA-----AELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  157 bits (399), Expect = 7e-46
 Identities = 85/276 (30%), Positives = 135/276 (48%), Gaps = 25/276 (9%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 104
           + G   G G++ KV  A  +DTG + A+K +      ++N    +K    E  VL+ L H
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR----IQDNDPKTIKEIADEMKVLELLKH 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V+ +        +Y+ +E C GG L + +     L E   R YT ++++ L Y+HS 
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G++HRDIKP N+ L  +G IK+ DFG    ++++  T+     S        GT AY+ P
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAYMAP 172

Query: 225 EVLNSSPAT--FGN-DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD---IRFPNY 277
           EV+            D+W+LGC + +M +G  P+ +  +E+ I   + A     I     
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            S   +D +DR L+ DP  RP A     + L  HPF
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTA-----SELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  157 bits (399), Expect = 1e-45
 Identities = 93/296 (31%), Positives = 152/296 (51%), Gaps = 20/296 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    +    E+ +L++++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I + G+    E+ A FY AE++  LE +H  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++RD+KPEN+LL   GHI+I+D G +VK         +P     +     VGT  Y+ 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVK---------IPEG---ESIRGRVGTVGYMA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS 279
           PEVLN+   T   D W LGC +Y+M+ G SPF+   E +    + +R++  +  +   FS
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 334
           + A+ +   LL  DP  R G    G   +K HPFF+ +++K +  G   P    +P
Sbjct: 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  155 bits (392), Expect = 1e-44
 Identities = 91/287 (31%), Positives = 146/287 (50%), Gaps = 21/287 (7%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSMGLIH 168
            + ++   +L + L    GG+L   I + G+   DE R  FY AE+   LE +    +++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 169 RDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           RD+KPEN+LL   GHI+I+D G +V+  +   +               VGT  Y+ PEV+
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVR------------GRVGTVGYMAPEVI 173

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAAR 283
           N+   TF  D W LGC +Y+M+ G SPF+   E +    + +R+      +   FS+ A+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
            +   LL  +P  R G    G A +K HP FK I++K +      PP
Sbjct: 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  152 bits (386), Expect = 8e-44
 Identities = 95/296 (32%), Positives = 150/296 (50%), Gaps = 20/296 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    +    E+ +L++++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I   G    +E R  FY AE+   LE +H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            +++RD+KPEN+LL   GHI+I+D G +V   +   I               VGT  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK------------GRVGTVGYMA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDIR--FPNYFS 279
           PEV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + ++++  +   FS
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 334
             AR L   LL  DP  R G   GG   +K HP FK I++K +  G   P    +P
Sbjct: 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  148 bits (375), Expect = 3e-42
 Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 23/267 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D+E+ +  G GS+  V + ++   G +   K +D   +T++ K   V  E  +L +L HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELKHP 59

Query: 106 GVVRLFFTFQDTFS--LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALE 159
            +VR +    D  +  LY+ +E CEGG+L   I      + ++ E+       +++ AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 160 YIH-----SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
             H        ++HRD+KP N+ L A+ ++K+ DFG  K +                A T
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS----------SFAKT 169

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI-IARDIR 273
           +VGT  Y+ PE LN       +D+W+LGC +Y++ + + PF   ++  +  +I   +  R
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGA 300
            P  +S    ++I  +L+VDP  RP  
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRPST 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  148 bits (375), Expect = 3e-42
 Identities = 84/283 (29%), Positives = 142/283 (50%), Gaps = 18/283 (6%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L + 
Sbjct: 2   GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGLIHR 169
           FQ    L + +    GG+L   I +         E  A FYTA+++  LE++H   +I+R
Sbjct: 62  FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR 121

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL  DG+++I+D G    ++D +           K   + GT  ++ PE+L  
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQ----------SKTKGYAGTPGFMAPELLQG 171

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAARDL 285
               F  D +ALG TLY+M++   PF+   E +    + QRI+   + +P+ FS A++  
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF 231

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
            + LL  DP  R G   G    L+ HP F+ ++W+ +     P
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  142 bits (361), Expect = 2e-40
 Identities = 83/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLDHPGV 107
           G++ G GS+  V     +D G  +A+K +      +  + A  +LE+ +  L +L HP +
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V+   T ++  +LY+ LE   GG L   +   G   E   R YT +++  LEY+H    +
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HRDIK  N+L+  +G +K+ADFG  K     ++     A S      F G+  ++ PEV+
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKS------FKGSPYWMAPEVI 173

Query: 228 NSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDAARD 284
                     D+W+LGCT+ +M +G  P+          +I         P++ SD A+D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            I + L  DPS RP A     A L  HPF
Sbjct: 234 FILKCLQRDPSLRPTA-----AELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  142 bits (360), Expect = 3e-40
 Identities = 72/259 (27%), Positives = 123/259 (47%), Gaps = 18/259 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF++ K  G GSY  V + K++     YALK +D   ++++ +   V   RI L  ++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRI-LASVNHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYI 161
            ++     F D   L + +E    G+L   I+     +  + E E      +++  L+ +
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H   ++HRD+K  N+LL A+  +KI D G  K                + A T +GT  Y
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISK------------VLKKNMAKTQIGTPHY 167

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSD 280
           + PEV    P ++ +D+W+LGC LY+M +   PF+  S   +  ++   +    P  +S 
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227

Query: 281 AARDLIDRLLDVDPSGRPG 299
             ++ I  +L V P  RP 
Sbjct: 228 DLQNFIRSMLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  142 bits (361), Expect = 4e-40
 Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 38/287 (13%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E +  ++ E  KI G G+  +V +A    TG   A+K M    + K+NK   +  E +
Sbjct: 17  PRELY--KNLE--KI-GEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIIN-EIL 67

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVD 156
           ++    HP +V  + ++     L++ +E  +GG L D IT +   ++E +  +   EV+ 
Sbjct: 68  IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKAC 213
            LEY+HS  +IHRDIK +N+LL+ DG +K+ADFG    +   +  R +V           
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV----------- 176

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIAR-- 270
             VGT  ++ PEV+         D+W+LG    +M  G  P  ++     +F   I    
Sbjct: 177 --VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL--ITTKG 232

Query: 271 --DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              ++ P  +S   +D +++ L  DP  RP A       L  HPF K
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA-----EELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 2e-39
 Identities = 84/273 (30%), Positives = 127/273 (46%), Gaps = 20/273 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F L +  G GS+ +V +A    T  V A+K++D +    E++   ++ E   L Q   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRS 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P + + + +F     L++ +E C GG   D +   G L E    F   EV+  LEY+H  
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEE 117

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRDIK  N+LL+ +G +K+ADFG    +  +            K  TFVGT  ++ P
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS----------KRNTFVGTPFWMAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAA 282
           EV+  S      D+W+LG T  ++  G  P  D     +   I   +      N FS   
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +D +   L+ DP  RP A      +LK H F K
Sbjct: 228 KDFVSLCLNKDPKERPSA----KELLK-HKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 3e-39
 Identities = 86/279 (30%), Positives = 131/279 (46%), Gaps = 29/279 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+EL +  G G+Y  V +A+ I TG + A+K++    +   +    ++ E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 162
           P +V  F ++     L++ +E C GG L D  Q+T +G LSE +  +   E +  L Y+H
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH 118

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G IHRDIK  N+LLT DG +K+ADFG       +++T     A+  K  +F+GT  ++
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGV-----SAQLT-----ATIAKRKSFIGTPYWM 168

Query: 223 PPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 275
            PEV             D+WALG T  ++     P  D         I   +   P    
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
              +S    D I + L  DP  RP A       L  HPF
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTA-----TKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  138 bits (349), Expect = 1e-38
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 16/259 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE+    G GS+  V +  +     VYA+K +D   + +  +   +   R VL +LD  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEA-RFYTAEVVDALEYIH 162
            ++R + +F D   L + +E  E G+L   +       L ED+  RF+  +++  L ++H
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRDIK  NL L A  ++KI D G  K + D+  T   N        T VGT  Y+
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFAN--------TIVGTPYYL 168

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 281
            PE+    P    +D+WALG  LY+  +G  PF   ++  +  +II          +S  
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228

Query: 282 ARDLIDRLLDVDPSGRPGA 300
              LID+ L  D   RP  
Sbjct: 229 LAQLIDQCLTKDYRQRPDT 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 7e-38
 Identities = 81/271 (29%), Positives = 136/271 (50%), Gaps = 29/271 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +TG   A KI+    I  E +     +E  +L +  HP +V L+  
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           +     L++ +E C+GG L   +      L+E + R+   ++++AL ++HS  +IHRD+K
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 173 PENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--- 228
             N+LLT DG +K+ADFG S K           N ++  K  TF+GT  ++ PEV+    
Sbjct: 131 AGNILLTLDGDVKLADFGVSAK-----------NKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 229 --SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAAR 283
              +P  +  D+W+LG TL ++     P  + +   +  +I+  +   +  P+ +S +  
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           D +   L  DP  RP A     A L  HPF 
Sbjct: 240 DFLKSCLVKDPDDRPTA-----AELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  136 bits (344), Expect = 7e-38
 Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 49/292 (16%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-------KFITKENKTAYVKLERIV 98
           D+EL ++ GVG+ + V  A  +      A+K +D          + KE +          
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA--------- 52

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK---GHLSEDEARFYTAEVV 155
           + Q +HP VV+ + +F     L++ +    GG L D + S    G L E        EV+
Sbjct: 53  MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS----VKPMQDSRITVLPNAASDDK 211
             LEY+HS G IHRDIK  N+LL  DG +KIADFG           +R            
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR----------KV 162

Query: 212 ACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
             TFVGT  ++ PEV+       F  D+W+ G T  ++ +G +P+       +    +  
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222

Query: 271 DIRFPNY--------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           D   P+         +S + R +I   L  DPS RP A       L  H FF
Sbjct: 223 D--PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTA-----EELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  135 bits (340), Expect = 2e-37
 Identities = 79/261 (30%), Positives = 139/261 (53%), Gaps = 21/261 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLD 103
            + + ++ G GS+ + +  + +++   YA+K   + K     E+     + E ++L ++ 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS----RKEAVLLAKMK 56

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYI 161
           HP +V    +F+    LY+ +E C+GG+L  +I   +G L  ED    +  ++   +++I
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H   ++HRDIK +N+ LT +G +K+ DFGS      +R+   P A     ACT+VGT  Y
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGS------ARLLTSPGAY----ACTYVGTPYY 166

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LIFQRIIARDIRFPNYFS 279
           VPPE+  + P    +D+W+LGC LY++ +   PF+  S W  LI +         P+++S
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQGSYKPLPSHYS 225

Query: 280 DAARDLIDRLLDVDPSGRPGA 300
              R LI ++   +P  RP A
Sbjct: 226 YELRSLIKQMFKRNPRSRPSA 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  135 bits (341), Expect = 2e-37
 Identities = 80/283 (28%), Positives = 151/283 (53%), Gaps = 20/283 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V   +  +TG +YA K +DKK + K++      LE+ +L++++ P +V L + 
Sbjct: 2   GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSMGLIHRDI 171
           F+    L + +    GG+L   I + G    +  R   Y+A++   + ++HSM +++RD+
Sbjct: 62  FESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDM 121

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
           KPEN+LL   G+ +++D G    ++D +           +A    GT  Y+ PE+L   P
Sbjct: 122 KPENVLLDDQGNCRLSDLGLAVELKDGKTIT-------QRA----GTNGYMAPEILKEEP 170

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNY-FSDAARDLI 286
            ++  D +A+GC++Y+M++G +PFKD  E +    + +R +  +++F +  F++ ++D+ 
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPP 328
              L   P  R G+        K H FFK I++  +  G  PP
Sbjct: 231 RLFLAKKPEDRLGSREKNDDPRK-HEFFKTINFPRLEAGLIPP 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 9e-37
 Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 65/308 (21%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQL-DH 104
           +++ K  G G++  V  A+  +TG + A+K M KKF + E     + L  +  L +L +H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNEH 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIH 162
           P +V+L   F++   LY   E  EG  L+  +        SE   R    +++  L +IH
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR-ITVLPNAASDDKACTFVGTAAY 221
             G  HRD+KPENLL++    +KIADFG  + ++     T             +V T  Y
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT------------DYVSTRWY 164

Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI----- 267
             PE+L      SSP     D+WALGC + ++ +    F  +SE    + I   +     
Sbjct: 165 RAPEILLRSTSYSSP----VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220

Query: 268 --------IARD--IRFPNY--------FSDAARDLID---RLLDVDPSGRPGAGPGGYA 306
                   +A     RFP +          +A+ + ID    +L  DP  RP A      
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS----Q 276

Query: 307 VLKMHPFF 314
            L+ HP+F
Sbjct: 277 ALQ-HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 2e-36
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 56/301 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGV 107
           LGKI G G+Y  V +A+   TG + A+K +  +F ++   KTA  +++  +L +L+HP +
Sbjct: 4   LGKI-GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK--LLKELNHPNI 60

Query: 108 VRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
           ++L   F+    LY+  E  +    +L      +  L E   + Y  +++  L + HS G
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 224
           ++HRD+KPENLL+  +G +K+ADFG  +           +  S  +  T +V T  Y  P
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR-----------SFGSPVRPYTHYVVTRWYRAP 167

Query: 225 EVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI------------ 267
           E+L      +   D+W++GC   ++LS    F   SE    + IF+ +            
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 268 -IARD--IRFPNY--------FSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            +AR+    FP          F +A   A DL+ ++L  DP  R  A       L  HP+
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA----EQALA-HPY 282

Query: 314 F 314
           F
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 2e-36
 Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 57/301 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---KTAYVKLERI-VLDQLDH 104
           L K+ G G+Y  V +A+   TG + ALK +  +   +E     TA   L  I +L +L H
Sbjct: 4   LEKL-GEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTA---LREISLLKELKH 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHS 163
           P +V+L         LY+  E C+  +L   +    G LS +  +    +++  L Y HS
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KP+N+L+  DG +K+ADFG       +R   +P      +    V T  Y  
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGL------ARAFGIPLRTYTHE----VVTLWYRA 166

Query: 224 PEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ------------- 265
           PE+L  S   +   D+W++GC   +M++G   F   SE    + IFQ             
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226

Query: 266 -RIIARDIRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            ++      FP +                 DL+ ++L  +P+ R  A       LK HP+
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA----KEALK-HPY 281

Query: 314 F 314
           F
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 3e-36
 Identities = 85/303 (28%), Positives = 126/303 (41%), Gaps = 57/303 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 105
           LG + G G+Y  V++ +   TG + A+K    KF   E+     K    E  VL QL H 
Sbjct: 6   LGVV-GEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V L   F+    LY+  E  E   L     S G L  D  R Y  +++ A+ Y HS  
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 224
           +IHRDIKPEN+L++  G +K+ DFG  + ++          A      T +V T  Y  P
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALR----------ARPASPLTDYVATRWYRAP 170

Query: 225 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ-------------- 265
           E+L          D+WA+GC + ++L G   F   S+    +LI +              
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Query: 266 --------------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
                         +  + + R+P   S  A D +   L +DP  R          L  H
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQH 285

Query: 312 PFF 314
           P+F
Sbjct: 286 PYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  131 bits (332), Expect = 4e-36
 Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 50/279 (17%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKTAYVKLERI 97
           + +F++ K  G G +S V +A  +  G V ALK      +MD K   +++    + L   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDL--- 55

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------Y 150
            L QLDHP V++   +F +   L + LE  + G+L   I    H  + +          Y
Sbjct: 56  -LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK---HFKKQKRLIPERTIWKY 111

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-----SVKPMQDSRITVLPN 205
             ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G     S K            
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--------- 162

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--I 263
                 A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF      L  +
Sbjct: 163 ------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216

Query: 264 FQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRP 298
            ++I   D  +P    +++S+  RDL+ R ++ DP  RP
Sbjct: 217 CKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  130 bits (330), Expect = 7e-36
 Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 26/275 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F++ +  G GSY  V +A   +TG V A+K++    + ++ +   +  E  +L Q D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQE--IIKEISILKQCDS 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 162
           P +V+ + ++     L++ +E C  G + D  +IT+K  L+E+E      + +  LEY+H
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   IHRDIK  N+LL  +G  K+ADFG    + D+            K  T +GT  ++
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM----------AKRNTVIGTPFWM 166

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS 279
            PEV+         D+W+LG T  +M  G  P+ D         I  +    +  P  +S
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS 226

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
               D + + L  DP  RP A       L  HPF 
Sbjct: 227 PEFNDFVKKCLVKDPEERPSA-----IQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 3e-35
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 19/252 (7%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH---PGVV 108
           + G G+Y  V R K + TG V ALKI++    T ++  + ++ E  +L QL     P + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIIN--LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
           + + ++     L++ +E  EGG +   +   G ++E        EV+ AL+YIH +G+IH
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RDIK  N+L+T  G++K+ DFG    +  +            K  TFVGT  ++ PEV+ 
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAALLNQNS----------SKRSTFVGTPYWMAPEVIT 174

Query: 229 SSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFP-NYFSDAARDL 285
                    D+W+LG T+Y+M +G  P+ D   +     I  ++  R   N +S   R+ 
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234

Query: 286 IDRLLDVDPSGR 297
           +   LD +P  R
Sbjct: 235 VAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 4e-35
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 74/303 (24%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-------VKLERIVL 99
           +E     G G+Y +V +A+   TG + ALK    K   +  K  +       +KL    L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKL----L 52

Query: 100 DQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQ---ITSKG-HLSEDEARFYTAE 153
            +L HP +VRL    T +   S+YM  E  +     D    + S     +E + + Y  +
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQ 108

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +++ L+Y+HS G++HRDIK  N+L+  DG +K+ADFG  +P          N        
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR------- 161

Query: 214 TFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQ 265
             V T  Y PPE+L       P     D+W++GC L ++  G   F+ ++E      IF+
Sbjct: 162 --VITLWYRPPELLLGATRYGPEV---DMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 266 ----------------------------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGR 297
                                       +   R+  F +    +A DL+D+LL +DP  R
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE-FFKHLIDPSALDLLDKLLTLDPKKR 275

Query: 298 PGA 300
             A
Sbjct: 276 ISA 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 6e-35
 Identities = 75/273 (27%), Positives = 134/273 (49%), Gaps = 16/273 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 103
           ++  GK+ G G++ +V     +DTG   A+K +     + E K     LE  +  L  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +V+ +   +D  +L + +E   GG + DQ+ + G L+E   R YT ++++ +EY+HS
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRDIK  N+L  + G++K+ DFG+ K +Q          +S     +  GT  ++ 
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-------SSGTGMKSVTGTPYWMS 175

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDA 281
           PEV++        D+W++GCT+ +ML+   P+ +        +I  +    + P++ S  
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           AR+ + R    +   RP A       L  H F 
Sbjct: 236 ARNFLRRTFVENAKKRPSA-----EELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  128 bits (323), Expect = 6e-35
 Identities = 82/257 (31%), Positives = 133/257 (51%), Gaps = 17/257 (6%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +E+ K  G GS+ K+  AK K D+      +I   K   KE + +  K E I+L ++ HP
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYIHS 163
            +V  F +FQ+   L++ +E C+GG+L  +I   +G L SED+   +  ++   L++IH 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 164 MGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             ++HRDIK +N+ L+ +G + K+ DFG  + + DS           + A T VGT  Y+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM----------ELAYTCVGTPYYL 169

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDIRFPNYFSDA 281
            PE+  + P     D+W+LGC LY++ +   PF+  +   L+ +            FS  
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD 229

Query: 282 ARDLIDRLLDVDPSGRP 298
            R LI +L  V P  RP
Sbjct: 230 LRSLISQLFKVSPRDRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  127 bits (320), Expect = 2e-34
 Identities = 79/258 (30%), Positives = 138/258 (53%), Gaps = 25/258 (9%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           + KI G GS+ K +  K  + G  Y +K I   K   KE + +  + E  VL  + HP +
Sbjct: 5   VKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES--RKEVAVLSNMKHPNI 61

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHL-SEDEARFYTAEVVDALEYIHSMG 165
           V+   +F++  +LY+ ++ CEGG+L+ +I + +G L  ED+   +  ++  AL+++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRDIK +N+ LT DG IK+ DFG  +        VL +     + C  +GT  Y+ PE
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIAR--------VLNSTVELARTC--IGTPYYLSPE 171

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----FPNYFSD 280
           +  + P    +D+WALGC LY+M +    F+  +     + ++ + IR       +++S 
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIRGSYPPVSSHYSY 227

Query: 281 AARDLIDRLLDVDPSGRP 298
             R+L+ +L   +P  RP
Sbjct: 228 DLRNLVSQLFKRNPRDRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  127 bits (320), Expect = 2e-34
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 13/209 (6%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E ++L  L HP ++  +  F D  +L + +E   GG L+D+I         E+   +Y  
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++V A+ YIH  G++HRDIK  N+ LT  G IK+ DFG  K +                A
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM----------A 158

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD- 271
            T VGT  Y+ PE+       F +D+WALGC LY++L+    F  T+   +  +I+  + 
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218

Query: 272 IRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
               + +S     L+  LL  DP  RP A
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTA 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  125 bits (316), Expect = 2e-33
 Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    TG   A+K MD   + K+ +   +  E +++    HP +V ++ +
Sbjct: 28  GEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL ++H+ G+IHRDIK 
Sbjct: 85  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT+DG +K++DFG    +       +P   S       VGT  ++ PEV++  P  
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKE----VPRRKS------LVGTPYWMAPEVISRLPYG 193

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+ +       +RI  RD     ++  +  S   R  +DR
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDR 251

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +L  DP+ R  A     A L  HPF  
Sbjct: 252 MLVRDPAQRATA-----AELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  124 bits (313), Expect = 2e-33
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 24/277 (8%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAY--VKLERIVLDQLDHPG 106
           G+  G G++S   +A+ + TGT+ A+K +   +  + E +     ++ E  ++ +L+HP 
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           ++R+     +     + +E   GG +   ++  G   E     YT +++  L Y+H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 167 IHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           IHRD+K  NLL+ + G  ++IADFG+   +  ++ T      + +     +GT A++ PE
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARL-AAKGT-----GAGEFQGQLLGTIAFMAPE 178

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDI---RFPNYF 278
           VL         D+W++GC + +M +   P+          LIF+  IA        P + 
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--IASATTAPSIPEHL 236

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           S   RD+  R L++ P  RP +       L  HP F+
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPS-----RELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  124 bits (313), Expect = 2e-33
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 30/284 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            D E     G G+   V +     TG + A+K +  +      K    +L+  +L + + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD--ILHKCNS 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIH 162
           P +V  +  F +   + + +E  +GG L D+I    +G + E         V+  L Y+H
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               +IHRD+KP N+L+ + G IK+ DFG    + +S             A TFVGT++Y
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS------------LAKTFVGTSSY 165

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWLIF---QRIIARDI-RFP 275
           + PE +  +  +  +D+W+LG +L ++ +G  P+   +     IF   Q I+     R P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225

Query: 276 N-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
           +  FS   +D ++  L  DP  RP      Y  L  HPF K  +
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERP-----SYKELLEHPFIKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  123 bits (311), Expect = 7e-33
 Identities = 87/276 (31%), Positives = 143/276 (51%), Gaps = 33/276 (11%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   +HP +V+L   
Sbjct: 21  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYM-VEIEILATCNHPYIVKLLGA 77

Query: 114 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           F     L++ +E C GG + D I     +G L+E + +    ++++AL+Y+HSM +IHRD
Sbjct: 78  FYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 171 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 226
           +K  N+LLT DG IK+ADFG S K           N  +  +  +F+GT  ++ PEV   
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAK-----------NVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 227 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA 281
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   +   +  P+ +S  
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
            RD +   LD  P  RP A     A L  HPF   +
Sbjct: 245 FRDFLKTALDKHPETRPSA-----AQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 1e-31
 Identities = 85/293 (29%), Positives = 134/293 (45%), Gaps = 50/293 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDH 104
            FEL ++ G G+Y KV +A+   TG + A+KIMD   I ++ +   +K E  I+    +H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSNH 62

Query: 105 PGVVRLFFTFQDTF----------SLYMALESCEGGELFDQI----TSKGHLSEDEARFY 150
           P +     TF   F           L++ +E C GG + D +         L E+   + 
Sbjct: 63  PNIA----TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
             E +  L Y+H   +IHRDIK +N+LLT +  +K+ DFG V    DS +          
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG-VSAQLDSTLG--------- 168

Query: 211 KACTFVGTAAYVPPEVL--NSSP-ATFGN--DLWALGCTLYQMLSGTSPFKDTSEW-LIF 264
           +  TF+GT  ++ PEV+  +  P A++    D+W+LG T  ++  G  P  D      +F
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228

Query: 265 QRIIARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           +  I R+    ++ P  +S    D I   L  +   RP         L  HPF
Sbjct: 229 K--IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE-----LLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 32/281 (11%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALK-------IMDKKFITKENKTAYVKLERIVLDQL 102
           G++ G G+Y +V  A  + TG + A+K       I  +    +++    ++ E   L  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 103 DHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           DH  +V+   F T ++  S++  LE   GG +   + + G   E   RF+T +V++ L Y
Sbjct: 66  DHLNIVQYLGFETTEEYLSIF--LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +HS G++HRD+K +NLL+ ADG  KI+DFG  K   D           +D+  +  G+  
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD--------IYDNDQNMSMQGSVF 175

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--- 275
           ++ PEV++S    +    D+W+LGC + +M +G  P+ D        ++  +    P   
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
                 S  A D ++    ++P  RP A       L  HPF
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTA-----RELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  119 bits (300), Expect = 3e-31
 Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 55/302 (18%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPG 106
            LG+I G G++  V +AK  +TG   ALK +  +    E       L  I  L    HP 
Sbjct: 4   ILGRI-GEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQHPY 60

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMG 165
           VV+L   F       + +E     +L + +  +   L E + + Y   ++  + Y+H+ G
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+KP NLL++ADG +KIADFG  +         L +          V T  Y  PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQ--------VATRWYRAPE 170

Query: 226 VLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ--RII-------------- 268
           +L  +     G DLWA+GC   ++L+G+  F   ++  I Q   +               
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGL 228

Query: 269 -----ARDIRFPN--------YFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
                   I FP          F DA   A DL+  LL  DPS R  A     A    HP
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHP 283

Query: 313 FF 314
           +F
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 2e-30
 Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 61/308 (19%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV----LDQL 102
           +E     G G+Y  V +A+ ++TG   ALK +  +    E       L  I     L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESF 58

Query: 103 DHPGVVRLF--FTFQDT---FSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVV 155
           +HP +VRL        T     L +  E  +        +    G L  +  +    +++
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLL 117

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ-DSRITVLPNAASDDKACT 214
             ++++HS  ++HRD+KP+N+L+T+DG +KIADFG  +    +  +T            +
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT------------S 165

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRI--- 267
            V T  Y  PEVL  S      D+W++GC   ++      F+ TSE      IF  I   
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225

Query: 268 ----------IARDIRFPNYF-----------SDAARDLIDRLLDVDPSGRPGAGPGGYA 306
                     + R   FP+Y             +   DL+ ++L  +P  R  A    + 
Sbjct: 226 SEEEWPRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA----FE 280

Query: 307 VLKMHPFF 314
            L+ HP+F
Sbjct: 281 ALQ-HPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  115 bits (289), Expect = 5e-30
 Identities = 75/257 (29%), Positives = 133/257 (51%), Gaps = 25/257 (9%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GSY +V   +    G  Y +K ++ +  ++  + A  + E  +L QL HP +V  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPNIV-- 62

Query: 111 FFTFQDTFS-----LYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYIHS 163
              +++++      LY+ +  CEGG+L+ ++   KG L  E++   +  ++  AL+Y+H 
Sbjct: 63  --AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+K +N+ LT    IK+ D G  +        VL N    D A T +GT  Y+ 
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--------VLEN--QCDMASTLIGTPYYMS 170

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDA 281
           PE+ ++ P  + +D+WALGC +Y+M +    F  KD +  L+++ I  +    P  +S  
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKLPPMPKDYSPE 229

Query: 282 ARDLIDRLLDVDPSGRP 298
             +LI  +L   P  RP
Sbjct: 230 LGELIATMLSKRPEKRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  114 bits (287), Expect = 1e-29
 Identities = 86/286 (30%), Positives = 135/286 (47%), Gaps = 31/286 (10%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           R PQE     DFEL +  G G+Y  V +A+ ++TG + A+K++    +      A V+ E
Sbjct: 5   RNPQE-----DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQE 56

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            I++    H  +V  F ++     L++ +E C GG L D     G LSE +  + + E +
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L Y+HS G +HRDIK  N+LLT +GH+K+ADFG       ++IT     A+  K  +F
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV-----SAQIT-----ATIAKRKSF 166

Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           +GT  ++ PEV         N   D+WA+G T  ++     P  D         +   + 
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226

Query: 273 RFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           + P       +S++    +   L  +P  RP A       L  HPF
Sbjct: 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK-----LLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  114 bits (286), Expect = 1e-29
 Identities = 75/259 (28%), Positives = 131/259 (50%), Gaps = 22/259 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E  ++ G G++  V   ++     +  +K +  + +TK+ + A  + E  VL  L HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPN 60

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSM 164
           ++  +  F +  +L + +E   GG L + I  + +  L ED    +  +++ AL ++H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 165 GLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++HRD+K +N+LL  D H   +KI DFG  K +           +S  KA T VGT  Y
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKIL-----------SSKSKAYTVVGTPCY 167

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--NYFS 279
           + PE+    P    +D+WALGC LY++ S    F+  +   +  +I+      P  + +S
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYS 226

Query: 280 DAARDLIDRLLDVDPSGRP 298
              R LI  +L++DPS RP
Sbjct: 227 PDLRQLILSMLNLDPSKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  114 bits (286), Expect = 2e-29
 Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 20/273 (7%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIVLDQLD 103
           G + G GS+  V       +G + A+K ++   ++  +K     +      E  +L +L 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +V+   +  D   L + LE   GG +   + + G   E   R +  +++  L Y+H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRDIK  N+L+   G IKI+DFG  K ++ +      +  ++    +  G+  ++ 
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN----SLSTKTNGARPSLQGSVFWMA 180

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIR--FPNYFSD 280
           PEV+  +  T   D+W+LGC + +ML+G  PF D ++   IF+  I  +     P+  S 
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENASPEIPSNISS 238

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            A D +++  ++D + RP A     A L  HPF
Sbjct: 239 EAIDFLEKTFEIDHNKRPTA-----AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  113 bits (285), Expect = 2e-29
 Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 34/271 (12%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKTAYVKLERI 97
           + +F + K  G G +S+V RA  +  G   ALK      +MD K   + +    + L   
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDL--- 55

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAE 153
            L QL+HP V++ + +F +   L + LE  + G+L   I      K  + E     Y  +
Sbjct: 56  -LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  ALE++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ T          A 
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKTTA---------AH 164

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARD 271
           + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF     + + + ++I   D
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 224

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRP 298
             +P    +++S+  R L++  ++ DP  RP
Sbjct: 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  113 bits (283), Expect = 4e-29
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 23/272 (8%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVKLERIVLDQLDHPGV 107
           GK+ G G++ +V     +DTG   A K +  D +      + + ++ E  +L  L H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 108 VRLFFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           V+ +   +D    T +++M  E   GG + DQ+ + G L+E   R YT ++++ + Y+HS
Sbjct: 67  VQYYGCLRDRAEKTLTIFM--EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRDIK  N+L  + G++K+ DFG+ K     R+  +  + +  ++ T  GT  ++ 
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICMSGTGIRSVT--GTPYWMS 177

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDA 281
           PEV++        D+W+LGCT+ +ML+   P+ +        +I  +  + + P++ S+ 
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           ARD +  +  V+   RP A       L  HPF
Sbjct: 238 ARDFLGCIF-VEARHRPSAEE-----LLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  113 bits (283), Expect = 5e-29
 Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 19/264 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P + R + ++     L++ +E   GG   D +   G L E        E++  
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKG 113

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN 276
           T  ++ PEV+  S   F  D+W+LG T  ++  G  P  D     +   I          
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 223

Query: 277 YFSDAARDLIDRLLDVDPSGRPGA 300
            +S   ++ ++  L+ DP  RP A
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTA 247

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (284), Expect = 5e-29
 Identities = 79/266 (29%), Positives = 135/266 (50%), Gaps = 26/266 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A++  +G   A+K+MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 30  GEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  +GG L D I S+  L+E++       V+ AL Y+HS G+IHRDIK 
Sbjct: 87  YLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P      K  + VGT  ++ PEV++ +P  
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKD----VP------KRKSLVGTPYWMAPEVISRTPYG 195

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+   S     +R+  RD     ++  +  S   RD ++R
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNAHKISPVLRDFLER 253

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +L  +P  R  A       L  HPF 
Sbjct: 254 MLTREPQERATAQE-----LLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  112 bits (281), Expect = 7e-29
 Identities = 76/263 (28%), Positives = 137/263 (52%), Gaps = 18/263 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVKLERIVLDQLD 103
           ++ LGK+ G G++ +V      DTG   A+K +  D +      +   ++ E  +L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 104 HPGVVRLFFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
           H  +V+ +   +D    T S++M  E   GG + DQ+ S G L+E+  R YT ++++ + 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM--EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  ++HRDIK  N+L  + G++K+ DFG+ K     R+  +  + +  K+ T  GT 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK-----RLQTICLSGTGMKSVT--GTP 173

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNY 277
            ++ PEV++        D+W++GCT+ +ML+   P+ +        +I  +  +   P +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233

Query: 278 FSDAARDLIDRLLDVDPSGRPGA 300
            SD  RD + R+  V+   RP A
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSA 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  113 bits (286), Expect = 8e-29
 Identities = 84/299 (28%), Positives = 129/299 (43%), Gaps = 59/299 (19%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQL 102
           + +E+ +  G G+Y  V +A    T  V ALK   K F    N T   +  R  + L +L
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63

Query: 103 -DHPGVVRLFFTF-----QDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEV 154
            DHP +V+L         +D   +Y+  E  E     D   +     L +   R+   ++
Sbjct: 64  GDHPNIVKLLNVIKAENDKD---IYLVFEYMET----DLHAVIRANILEDVHKRYIMYQL 116

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           + AL+YIHS  +IHRD+KP N+LL +D  +K+ADFG  + + +          +D     
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD----- 171

Query: 215 FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE------------- 260
           +V T  Y  PE+L  S   T G D+W++GC L +ML G   F  TS              
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 261 --------------WLIFQRIIARDIR-----FPNYFSDAARDLIDRLLDVDPSGRPGA 300
                           +   + +R  +      P   SD A DL+ +LL  +P+ R  A
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-SDDALDLLKKLLVFNPNKRLTA 289

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  112 bits (282), Expect = 8e-29
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTA 152
           I+ +QL HP +VR + TF +   LY+ ++  EG  L +   S    K   +E+       
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 153 EVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           ++V AL Y+H    ++HRD+ P N++L  D  + I DFG  K  Q       P +    K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-------PES----K 169

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--A 269
             + VGT  Y  PE++ + P     D+WA GC LYQM +   PF  T+   +  +I+   
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229

Query: 270 RDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            +      +S+   D+I   L  D   RP
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  116 bits (293), Expect = 1e-28
 Identities = 51/148 (34%), Positives = 89/148 (60%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           SI++F + K    G++ KV   +K +   +YA+K++ K  +  +N    V+ ER  L   
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
             P +V L+++ Q   ++Y+ +E   GG++   +   G+  E+ A  Y +EV  AL+Y+H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG 190
             G+IHRD+KP+N+L++ +GHIK+ DFG
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  115 bits (288), Expect = 2e-28
 Identities = 85/270 (31%), Positives = 129/270 (47%), Gaps = 23/270 (8%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVK 93
             P+EH  +    L  + G    +    A +   G+    K++  KF+    E + AY +
Sbjct: 62  NNPREHMYV----LTTLVGRNPTTAAFVATR---GSDPKEKVV-AKFVMLNDERQAAYAR 113

Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHL--SEDEARF 149
            E   L   DH G+V+ F  F+    L + +E   GG+L  QI    K HL   E E   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              ++V AL+ +HS  ++HRD+K  N+ L   G IK+ DFG  K   DS         S 
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS--------VSL 225

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII- 268
           D A +F GT  Y+ PE+      +   D+W+LG  LY++L+   PFK  S+  I Q+++ 
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            +   FP   S   + L+D LL  +P+ RP
Sbjct: 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRP 315

Length = 478

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  110 bits (276), Expect = 2e-28
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 22/245 (8%)

Query: 75  LKIMDKK----FITKE-NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 129
           L +MD +    FI K   K++    ER+ +     P +V L        S+++ L+  EG
Sbjct: 10  LLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69

Query: 130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
           G+L+  I+   ++ E+  + + AE+V AL+ +H  G++ RD+ P N+LL   GHI++  F
Sbjct: 70  GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYF 129

Query: 190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
                ++DS          D +A   +    Y  PEV   S  T   D W+LG  L+++L
Sbjct: 130 SRWSEVEDS---------CDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 250 SGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK 309
           +G +  +     +        +I  P + S+ AR L+ +LL  +P+ R GAG  G   +K
Sbjct: 177 TGKTLVECHPSGI--NTHTTLNI--PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232

Query: 310 MHPFF 314
            HPFF
Sbjct: 233 SHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  110 bits (275), Expect = 6e-28
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 27/268 (10%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D + + G   E +      E++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKG 113

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-- 275
           T  ++ PEV+  S      D+W+LG T  ++  G  P  D        R++    +    
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNNPP 219

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRPGA 300
                FS   ++ ID  L+ DPS RP A
Sbjct: 220 TLTGEFSKPFKEFIDACLNKDPSFRPTA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  109 bits (273), Expect = 1e-27
 Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 34/274 (12%)

Query: 44  IQDFELGKIYGVGSYSKVVRA------KKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           + +F++ K  G G +S+V RA      K +    V   ++MD K   +++    + L   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDL--- 55

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAE 153
            L QL+HP V++   +F +   L + LE  + G+L   I      K  + E     Y  +
Sbjct: 56  -LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  A+E++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ T          A 
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKTTA---------AH 164

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQRIIARD 271
           + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF      L  + Q+I   D
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAG 301
             +P     ++S+  R+L+   +  DP  RP  G
Sbjct: 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 82/292 (28%), Positives = 134/292 (45%), Gaps = 48/292 (16%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 104
           EL ++ G G+   V + +  +TG ++ALK      IT +      K    E  +      
Sbjct: 5   ELSRL-GEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKSCKS 58

Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGEL---FDQITSKGHLSEDEARFYTAE-VVDAL 158
           P +V+ +  F D  + S+ +A+E CEGG L   + ++  +G    ++     AE V+  L
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+HS  +IHRDIKP N+LLT  G +K+ DFG            +     +  A TF GT
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG------------VSGELVNSLAGTFTGT 166

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFPN- 276
           + Y+ PE +   P +  +D+W+LG TL ++     PF  +    L    +++  +  PN 
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226

Query: 277 ----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKG 316
                      +S+  +D I + L+ DP+ RP           M  HP+ K 
Sbjct: 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW-------DMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  108 bits (270), Expect = 4e-27
 Identities = 85/297 (28%), Positives = 146/297 (49%), Gaps = 36/297 (12%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E + I    +G++ G G++ KV +A+  +TG + A K++D K  ++E    Y+ +E  
Sbjct: 3   PEEFWEI----IGEL-GDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYM-VEID 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 155
           +L   DHP +V+L   F    +L++ +E C GG + D +  +    L+E + R    + +
Sbjct: 55  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTL 113

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACT 214
           +AL Y+H   +IHRD+K  N+L T DG IK+ADFG S K           N  +  +  +
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-----------NTRTIQRRDS 162

Query: 215 FVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
           F+GT  ++ PEV+        P  +  D+W+LG TL +M     P  + +   +  +I  
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222

Query: 270 RD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
            +   +  P+ +S   +D + + L+ +   R          L  HPF      K IR
Sbjct: 223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT-----TQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  107 bits (270), Expect = 5e-27
 Identities = 88/302 (29%), Positives = 136/302 (45%), Gaps = 59/302 (19%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGV 107
           LGKI G G++S+V++A+   TG  YA+K M K F + E        E   L +L  HP +
Sbjct: 4   LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR--EIQALRRLSPHPNI 60

Query: 108 VRLFFTFQD--TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSM 164
           +RL     D  T  L +  E  +   L++ I   K  L E   + Y  +++ +L+++H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+ HRDIKPEN+L+  D  +K+ADFGS + +  S+    P          ++ T  Y  P
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSK---PPYTE-------YISTRWYRAP 167

Query: 225 E-VLNSSPATFGNDLWALGCTLYQMLS------GT--------------SPFKDTSEWLI 263
           E +L         D+WA+GC  +++LS      GT              +P  D      
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP--DAEVLKK 225

Query: 264 FQRIIARDIRFPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
           F++    +  FP+             S    DL+ +LL  DP  R  A       L+ HP
Sbjct: 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA----KQALR-HP 280

Query: 313 FF 314
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  107 bits (268), Expect = 1e-26
 Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 28/268 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A+K M+   + ++ K   +  E +V+ +  HP +V    +
Sbjct: 28  GQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T +  + E +      E + ALE++HS  +IHRDIK 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143

Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 190

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 287
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R L++D   R  A       L  HPF K
Sbjct: 251 RCLEMDVEKRGSAKE-----LLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (266), Expect = 1e-26
 Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 22/257 (8%)

Query: 54  GVGSYSKV--VRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVR 109
           G GS+  V  V+ KK        LK++ +  +     N+T     E  +L +LDHP +V+
Sbjct: 9   GKGSFGTVYLVKDKKAVAEE--RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMG 165
              +F +  +  +  E CEG +L  ++    H    LSE++   +  +++  + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+K +N+ L  +  +KI DFG       SR+ +     S D A TF GT  Y+ PE
Sbjct: 127 ILHRDLKAKNIFLK-NNLLKIGDFGV------SRLLM----GSCDLATTFTGTPYYMSPE 175

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAARD 284
            L        +D+W+LGC LY+M      F+  +   +  RI+       P  +S     
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 285 LIDRLLDVDPSGRPGAG 301
           ++  +L+ DPS RP A 
Sbjct: 236 IMQSMLNKDPSLRPSAA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  106 bits (266), Expect = 1e-26
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 19/264 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 113

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN 276
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +     +   I   +      
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG 223

Query: 277 YFSDAARDLIDRLLDVDPSGRPGA 300
            +S   ++ ++  L+ +PS RP A
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  107 bits (270), Expect = 1e-26
 Identities = 81/323 (25%), Positives = 131/323 (40%), Gaps = 81/323 (25%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--------IMDKKFITKENKTAYVKLERIV 98
           +EL K  G G+Y  V  A    TG   A+K        ++D K I +E     +KL    
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKL---- 52

Query: 99  LDQLDHPGVVRLFFTF----QDTFS-LYMALESCEGGELFDQ-----ITSKGHLSEDEAR 148
           L  L H  ++ L         + F+ +Y+  E      L +      I S   L++D  +
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQ 106

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           ++  +++  L+Y+HS  +IHRD+KP N+L+ ++  +KI DFG       +R         
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL------ARGVDPDEDEK 160

Query: 209 DDKACT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----L 262
                T +V T  Y  PE+ L+SS  T   D+W++GC   ++L+    F          L
Sbjct: 161 GFL--TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Query: 263 IF-----------QRII---------------ARDI--RFPNYFSDAARDLIDRLLDVDP 294
           I            + I                 + +   FP   S  A DL++++L  DP
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEKMLVFDP 277

Query: 295 SGRPGAGPGGYAVLKMHPFFKGI 317
             R  A       L  HP+   +
Sbjct: 278 KKRITAD----EALA-HPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 28/261 (10%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRL 110
           + G G+Y  V  A+ + T     ++I  K+   ++++      E I L   L H  +V+ 
Sbjct: 15  VLGKGTYGIVYAARDLST----QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70

Query: 111 F--FTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEA--RFYTAEVVDALEYIHSMG 165
               +    F ++M  E   GG L   + SK G L ++E    FYT ++++ L+Y+H   
Sbjct: 71  LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 166 LIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           ++HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ P
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----------AGINPCTETFTGTLQYMAP 178

Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARD-IRFPNYFS 279
           EV++  P  +G   D+W+LGCT+ +M +G  PF +  E    +F+  + +     P   S
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238

Query: 280 DAARDLIDRLLDVDPSGRPGA 300
             A++ I R  + DP  R  A
Sbjct: 239 AEAKNFILRCFEPDPDKRASA 259

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 37/282 (13%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           ELGK    G+Y  V +     TG   A+K  + +    E+K   + +E  +L +   P +
Sbjct: 8   ELGK----GNYGSVYKVLHRPTGVTMAMK--EIRLELDESKFNQIIMELDILHKAVSPYI 61

Query: 108 VRLFFTFQDTFSLYMALESCEGG---ELFDQITSKGHLSEDEARFYTAEVVDALEYI-HS 163
           V  +  F    ++YM +E  + G   +L+    +   + ED  R  T  VV  L+++   
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +IHRD+KP N+L+  +G +K+ DFG    +  S             A T +G  +Y+ 
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL------------AKTNIGCQSYMA 169

Query: 224 PEVLNSSPA------TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA----RDIR 273
           PE + S         T  +D+W+LG ++ +M  G  P+   +   IF ++ A        
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            P+ +SD A+D + + L+  P+ RP      YA L  HP+  
Sbjct: 230 LPSGYSDDAQDFVAKCLNKIPNRRP-----TYAQLLEHPWLV 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  106 bits (265), Expect = 2e-26
 Identities = 80/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A +  TG   A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 31  GEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 88  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT+DG IK++DFG    +       +P      K  + VGT  ++ PEV++  P  
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKE----VP------KRKSLVGTPYWMAPEVISRLPYG 196

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+ +       +RI  RD     ++  +  S   R  +D 
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDL 254

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +L  +PS R  A       L  HPF K
Sbjct: 255 MLVREPSQRATA-----QELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  105 bits (265), Expect = 3e-26
 Identities = 89/304 (29%), Positives = 133/304 (43%), Gaps = 61/304 (20%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 105
           LG + G GSY  V++ K  +TG + A+K    KF+  E+     K+   E  +L QL H 
Sbjct: 6   LGLV-GEGSYGMVMKCKHKETGQIVAIK----KFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V L   F+    LY+  E  +   L D       L E   R Y  +++  +E+ HS  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 224
           +IHRDIKPEN+L++  G +K+ DFG  + +           A+  +  T +V T  Y  P
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL-----------AAPGEVYTDYVATRWYRAP 169

Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE------------------WLIF 264
           E+L      +G   D+WA+GC + +ML+G   F   S+                    IF
Sbjct: 170 ELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228

Query: 265 QR--------------IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
           Q+              I   + RFP   S    DL  + L +DP  RP +     + L  
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSS-----SQLLH 282

Query: 311 HPFF 314
           H FF
Sbjct: 283 HEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  105 bits (262), Expect = 4e-26
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 21/225 (9%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           R PQ      D+EL +  G G+Y  V +A+ + TG + A+KI+    +   +  + ++ E
Sbjct: 5   RNPQ-----HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQE 56

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ +  H  +V  F ++     L++ +E C GG L D     G LSE +  +   E +
Sbjct: 57  IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL 116

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L Y+HS G +HRDIK  N+LLT +G +K+ADFG       ++IT     A+  K  +F
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA-----AKIT-----ATIAKRKSF 166

Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
           +GT  ++ PEV         N   D+WA+G T  ++     P  D
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (262), Expect = 4e-26
 Identities = 77/276 (27%), Positives = 138/276 (50%), Gaps = 23/276 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM----DKKFITKENKTAYVKLERIVLDQ 101
           ++ LGK+ G G++ +V      DTG   A+K +    D +  +KE      +++  +L  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ--LLKN 60

Query: 102 LDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
           L H  +V+ +   +D     L + +E   GG + DQ+ + G L+E+  R YT +++  + 
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  ++HRDIK  N+L  + G++K+ DFG+ K     RI  +  + +  K+ T  GT 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVT--GTP 173

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNY 277
            ++ PEV++        D+W++ CT+ +ML+   P+ +        +I  +      P+ 
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            SDA RD + ++  V+   RP         L  HPF
Sbjct: 234 VSDACRDFLKQIF-VEEKRRP-----TAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  105 bits (263), Expect = 7e-26
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 40/290 (13%)

Query: 42  FSIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
             + D E LG+I G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL 
Sbjct: 12  ADLNDLENLGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-VVLK 69

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALE---SCEGGELFDQIT--SKGHLSEDEARFYTAEVV 155
             D P +V+ +  F     +++ +E   +C      D++    +G + ED     T  +V
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKMTVAIV 124

Query: 156 DALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
            AL Y+    G+IHRD+KP N+LL A G++K+ DFG    + DS+      A +    C 
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK------AKTRSAGC- 177

Query: 215 FVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRII 268
               AAY+ PE +   P          D+W+LG +L ++ +G  P+K+  +E+ +  +I+
Sbjct: 178 ----AAYMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 269 ARDIRFPNY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
             +         FS      +D  L  D   RP      Y  L  HPF +
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP-----KYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  103 bits (260), Expect = 1e-25
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 36/268 (13%)

Query: 56  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF 114
           G + KV   K   T  ++  KI+  K         +  +E +V   + D+P  ++L+++ 
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAK--------NFNAIEPMVHQLMKDNPNFIKLYYSV 78

Query: 115 Q--DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                  L M  +  + G+LFD +  +G LSE E +    ++V+AL  +H   +IH DIK
Sbjct: 79  TTLKGHVLIM--DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136

Query: 173 PENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
            EN+L   A   I + D+G  K +                   + GT  Y  PE +    
Sbjct: 137 LENVLYDRAKDRIYLCDYGLCKII--------------GTPSCYDGTLDYFSPEKIKGHN 182

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRIIARDIRFPNYFSDAARDLID 287
                D WA+G   Y++L+G  PFK+  +  +      +   + + F    S  A D + 
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +L  + + R       Y  +  HPF K
Sbjct: 243 SMLKYNINYRLTN----YNEIIKHPFLK 266

Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (254), Expect = 6e-25
 Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 44/271 (16%)

Query: 48  ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKL----ERIVL 99
            LGK  G G++ +V + K            A+K +      KE+ +         E  ++
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL------KEDASEQQIEEFLREARIM 55

Query: 100 DQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDA 157
            +LDHP VV+L     ++   LY+ +E  EGG+L   +  ++  LS  +   +  ++   
Sbjct: 56  RKLDHPNVVKLLGVCTEEE-PLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG--------SVKPMQDSRITVLPNAASD 209
           +EY+ S   IHRD+   N L+  +  +KI+DFG             +  ++ +       
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI------- 167

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII 268
                      ++ PE L     T  +D+W+ G  L+++ + G  P+   S   + + + 
Sbjct: 168 ----------RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217

Query: 269 ARD-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
               +  P        DL+ +    DP  RP
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  100 bits (252), Expect = 2e-24
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 105
           L KI G GSY  V + +  +TG + A+K    KF+  E+     K+   E  +L QL HP
Sbjct: 6   LSKI-GEGSYGVVFKCRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V L   F+    L++  E C+   L +   +   + E   +    + + A+ + H   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
            IHRD+KPEN+L+T  G IK+ DFG       +RI   P     D    +V T  Y  PE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGF------ARILTGPGDDYTD----YVATRWYRAPE 170

Query: 226 VL-----NSSPATFGNDLWALGCTLYQMLSG 251
           +L        P     D+WA+GC   ++L+G
Sbjct: 171 LLVGDTQYGPPV----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 99.5 bits (249), Expect = 3e-24
 Identities = 55/268 (20%), Positives = 110/268 (41%), Gaps = 37/268 (13%)

Query: 48  ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            LGK  G G++ +V +              A+K + K+  +++    +++ E  ++ +LD
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLR-EARIMRKLD 59

Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEY 160
           HP +V+L     ++   L + +E   GG+L D +       LS  +   +  ++   +EY
Sbjct: 60  HPNIVKLLGVCTEEE-PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG--------SVKPMQDSRITVLPNAASDDKA 212
           + S   IHRD+   N L+  +  +KI+DFG            ++  ++ +          
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI---------- 168

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD 271
                   ++ PE L     T  +D+W+ G  L+++ + G  P+   S   + + +    
Sbjct: 169 -------RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY 221

Query: 272 IR-FPNYFSDAARDLIDRLLDVDPSGRP 298
               P         L+ +    DP  RP
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  100 bits (252), Expect = 3e-24
 Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 61/312 (19%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKI--MDKKFITKENKTAYVKLERIVL 99
           S+ +FE L +I G G+Y  V RA+   +G + ALK   MD +   ++        E  +L
Sbjct: 5   SVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNE---RDGIPISSLREITLL 60

Query: 100 DQLDHPGVVRL--FFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVV 155
             L HP +V L      +   S+++ +E CE     L D + +    SE + +    +++
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLL 118

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L+Y+H   +IHRD+K  NLLLT  G +KIADFG  +        + P           
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---------- 168

Query: 216 VGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-------------- 260
           V T  Y  PE+L   +  T   D+WA+GC L ++L+        SE              
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 261 ----WLIF------QRIIARD-------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
               W  F       +             +FP + S+A   L++ LL  DP  R  A   
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAE-- 285

Query: 304 GYAVLKMHPFFK 315
               L+   +FK
Sbjct: 286 --EALE-SSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  100 bits (249), Expect = 4e-24
 Identities = 68/228 (29%), Positives = 116/228 (50%), Gaps = 34/228 (14%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G+Y +V + + + TG + A+K+MD      E++   +KLE  +L +  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHH- 72

Query: 107 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 154
             R   T+   F           L++ +E C  G + D +  +KG+ L ED   +   E+
Sbjct: 73  --RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L ++H+  +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 180

Query: 215 FVGTAAYVPPEVL--NSSPAT---FGNDLWALGCTLYQMLSGTSPFKD 257
           F+GT  ++ PEV+  + +P     + +D+W+LG T  +M  G  P  D
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 99.8 bits (248), Expect = 6e-24
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 28/268 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  I TG   A+K M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + AL+++HS  +IHRDIK 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143

Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 190

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 287
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R L++D   R     G    L  HPF K
Sbjct: 251 RCLEMDVDRR-----GSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 99.4 bits (247), Expect = 7e-24
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 32/270 (11%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A+K ++   + K+ K   +  E +V+ +L +P +V    +
Sbjct: 28  GQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--EVVDALEYIHSMGLIHRDI 171
           F     L++ +E   GG L D +T       DEA+      E + ALE++H+  +IHRDI
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDI 141

Query: 172 KPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           K +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+ 
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVT 188

Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDL 285
                   D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           ++R L++D   R     G    L  HPF K
Sbjct: 249 LNRCLEMDVEKR-----GSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  101 bits (254), Expect = 8e-24
 Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 22/266 (8%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           + ++ G G+   V+ AK++  G  +A+K++D + +++ +K    + E   L   D   +V
Sbjct: 36  ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNR-AQAEVCCLLNCDFFSIV 94

Query: 109 RLF--FTFQD------TFSLYMALESCEGGELFDQITSKGHLS----EDEARFYTAEVVD 156
           +    F  +D         + + L+    G+L  +I S+   +    E EA     +V+ 
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A+ ++HS  +IHRDIK  N+LL ++G +K+ DFG  K        +     SDD   TF 
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK--------MYAATVSDDVGRTFC 206

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDIRFP 275
           GT  YV PE+    P +   D+++LG  LY++L+   PF   +   +  + +A R    P
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAG 301
              S   ++++  LL  DP  RP + 
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 88/305 (28%), Positives = 134/305 (43%), Gaps = 69/305 (22%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF- 111
           G G+Y +V  A    TG   A+K + + F +  + K  Y +L   +L  +DH  V+ L  
Sbjct: 24  GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR--LLKHMDHENVIGLLD 81

Query: 112 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            FT       FQD   L   L    G +L + I     LS+D  +F   +++  L+YIHS
Sbjct: 82  VFTPASSLEDFQD-VYLVTHLM---GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP N+ +  D  +KI DFG       +R T       DD+   +V T  Y  
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGL------ARHT-------DDEMTGYVATRWYRA 183

Query: 224 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----------------SEWLIFQR 266
           PE+ LN        D+W++GC + ++L+G + F  +                 E L+ Q+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL-QK 242

Query: 267 IIARDIR-------------FPNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
           I +   R             F   FS A   A DL++++L +DP  R  A          
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA-----LA 297

Query: 311 HPFFK 315
           HP+  
Sbjct: 298 HPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 26/266 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 29  GEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P   S       VGT  ++ PE+++  P  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKE----VPRRKS------LVGTPYWMAPELISRLPYG 194

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+ +       + I  RD     ++  +  S + +  +DR
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPKLKNLHKVSPSLKGFLDR 252

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFF 314
           LL  DP+ R  A     A L  HPF 
Sbjct: 253 LLVRDPAQRATA-----AELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.1 bits (239), Expect = 6e-23
 Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 17/260 (6%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA----YVKLERIV--LDQLD 103
           G++ G G+Y  V      + G + A+K ++   +   N  A    Y KL+  V  L  L 
Sbjct: 5   GEVLGKGAYGTVY-CGLTNQGQLIAVKQVE---LDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +V+   T  D  ++ + +E   GG +   +   G L E     YT +++D + Y+H+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRDIK  N++L  +G IK+ DFG  + +      V  +    +   +  GT  ++ 
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL----AWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDI--RFPNYFSD 280
           PEV+N S     +D+W++GCT+++M +G  P         +F     R +  R P+ FS 
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236

Query: 281 AARDLIDRLLDVDPSGRPGA 300
           AA D +   L  D   RP A
Sbjct: 237 AAIDFVTSCLTRDQHERPSA 256

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 96.4 bits (240), Expect = 8e-23
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 40/296 (13%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQ 101
           +D E     G G+   V + K I TGTV     M KK +    K++  K    E  ++ +
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTV-----MAKKVVHIGAKSSVRKQILRELQIMHE 59

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEY 160
              P +V  +  F +  ++ M +E  + G L D+I  K G +  +        VV+ L Y
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 161 IHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           ++++  ++HRDIKP N+L+ + G IK+ DFG            L N+ +D    TFVGT+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE--------LINSIAD----TFVGTS 166

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-----------IFQRII 268
            Y+ PE +     T  +D+W+LG ++ ++  G  PF  ++              + Q+I+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 269 ARDI-RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                R P + F +  RD +D  L  DP+ RP        +  M PF + +   N+
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ----QLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 96.3 bits (239), Expect = 9e-23
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144

Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 191

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 287
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R LD+D   R     G    L  H F K
Sbjct: 252 RCLDMDVEKR-----GSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 95.2 bits (236), Expect = 2e-22
 Identities = 71/228 (31%), Positives = 117/228 (51%), Gaps = 34/228 (14%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G+Y +V + + + TG + A+K+MD   +T + +   +K E  +L +  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSHH- 62

Query: 107 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 154
             R   T+   F           L++ +E C  G + D I  +KG+ L E+   +   E+
Sbjct: 63  --RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L ++H   +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 170

Query: 215 FVGTAAYVPPEVL--NSSP-AT--FGNDLWALGCTLYQMLSGTSPFKD 257
           F+GT  ++ PEV+  + +P AT  F +DLW+LG T  +M  G  P  D
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 82/310 (26%), Positives = 121/310 (39%), Gaps = 80/310 (25%)

Query: 39  QEHFSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
            E FS  D E  K++      G GS+  V  A+ + T  V A+K M     +   K +  
Sbjct: 5   AELFSKDDPE--KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-----SYSGKQSNE 57

Query: 93  KLERIV-----LDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSED 145
           K + I+     L QL HP  +     +    + ++ +E C G   ++ +    K  L E 
Sbjct: 58  KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEV 115

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           E        +  L Y+HS   IHRDIK  N+LLT  G +K+ADFGS              
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGS-------------- 161

Query: 206 AASDDKACTFVGTAAYVPPEV---LNSSPATFGNDLWALGCT------------------ 244
           A+    A +FVGT  ++ PEV   ++        D+W+LG T                  
Sbjct: 162 ASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221

Query: 245 -LYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
            LY +    SP   +++W                 SD  R+ +D  L   P  RP +   
Sbjct: 222 ALYHIAQNDSPTLSSNDW-----------------SDYFRNFVDSCLQKIPQDRPSS--- 261

Query: 304 GYAVLKMHPF 313
               L  H F
Sbjct: 262 --EELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 63/298 (21%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDT--GTVYALK----IMDKKFITKENKTAYVKLERIVLD 100
           +EL K  G G+Y  V  A+  +T      A+K    +  KK + K        L  + L 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR------ALRELKLL 55

Query: 101 QL--DHPGVVRLF---FTFQDTFS---LYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
           +    H  +  L+     F   F+   LY  L   +   L   I S   L++   + +  
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD---LHQIIRSGQPLTDAHFQSFIY 112

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++  L+YIHS  ++HRD+KP NLL+ AD  +KI DFG  +           N   +   
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS-------ENPGENAGF 165

Query: 213 CT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWL------ 262
            T +V T  Y  PE+ L+    T   D+W++GC L ++L     FK  D  + L      
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 263 -------IFQRI-------------IARDIRFPNYFSDA---ARDLIDRLLDVDPSGR 297
                     RI                   F + F +A   A DL+++LL  DP+ R
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 97.6 bits (243), Expect = 4e-22
 Identities = 46/116 (39%), Positives = 65/116 (56%), Gaps = 8/116 (6%)

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
           +GT  Y+ PE+L   P     D WALG  L++ L+G  PF D +   +FQ I+ RDI +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 276 N---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
                 S  A++ I+ LL +DP+ R G        LK HP F G+DW+N++ QT P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKE-----LKQHPLFHGVDWENLQNQTMP 651

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 63/191 (32%), Positives = 88/191 (46%), Gaps = 41/191 (21%)

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D  +++  +++  L+YIHS  ++HRD+KP NLLL  +  +KI DFG       +RI
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL------ARI 155

Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF--KD 257
              P          +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F  KD
Sbjct: 156 AD-PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214

Query: 258 TSE--WLIFQ-----------RII---ARD-IR-------------FPNYFSDAARDLID 287
                 LI              II   AR+ I+             FPN     A DL+D
Sbjct: 215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA-DPKALDLLD 273

Query: 288 RLLDVDPSGRP 298
           ++L  +P  R 
Sbjct: 274 KMLTFNPHKRI 284

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 65/317 (20%)

Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VL 99
           F++G  Y      G G+Y  V  A    +G   A+K +   F       A   L  + +L
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKIL 58

Query: 100 DQLDHPGVVRL---FFTFQDTF-SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
               H  ++ +          F  +Y+ ++  E  +L   I S   L+E+  R++  +++
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL 117

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L+YIHS  +IHRD+KP NLL+  D  ++I DFG  + +          ++S  +   F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL----------SSSPTEHKYF 167

Query: 216 ----VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTS--PFKDTSEWL------ 262
               V T  Y  PE+L S P  T   D+W++GC   +ML      P K+    L      
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 263 -------IFQRIIARDIR-----FPN--------YFSDA---ARDLIDRLLDVDPSGRPG 299
                  +  RI +  +R      P          F  A   A DL+ ++L  DP  R  
Sbjct: 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287

Query: 300 AGPGGYAVLKMHPFFKG 316
                 A+   HPF   
Sbjct: 288 VEQ---ALQ--HPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 93.0 bits (231), Expect = 3e-21
 Identities = 84/313 (26%), Positives = 139/313 (44%), Gaps = 49/313 (15%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
            +SS++  +   +   A  A +   S+ + E     G G+   V +     TG +YALK+
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAK---SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 78  MD-------KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 130
           +        ++ I +E +         +L  ++HP VV+    F     + + LE  +GG
Sbjct: 107 IYGNHEDTVRRQICREIE---------ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157

Query: 131 ELFD-QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
            L    I  +  L+ D AR    +++  + Y+H   ++HRDIKP NLL+ +  ++KIADF
Sbjct: 158 SLEGTHIADEQFLA-DVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212

Query: 190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-----FGNDLWALGCT 244
           G       SRI     A + D   + VGT AY+ PE +N+         +  D+W+LG +
Sbjct: 213 GV------SRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262

Query: 245 LYQMLSGTSPFK--DTSEW--LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           + +   G  PF      +W  L+    +++    P   S   R  I   L  +P+ R  A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSA 322

Query: 301 GPGGYAVLKMHPF 313
                  L  HPF
Sbjct: 323 -----MQLLQHPF 330

Length = 353

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 91.1 bits (227), Expect = 7e-21
 Identities = 85/320 (26%), Positives = 131/320 (40%), Gaps = 77/320 (24%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKK---F-ITKENKTAYVKLE 95
           S+ ++E L +I   G+Y  V RA+   TG + ALK   M+K+   F IT         L 
Sbjct: 3   SVDEYEKLNRIEE-GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--------LR 53

Query: 96  RI-VLDQLDHPGVVRL----FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARF 149
            I +L +L HP +V +      +  D   +YM +E  E  +L   + T K    + E + 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +++  + ++H   ++HRD+K  NLLL   G +KI DFG  +                
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL---- 166

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE------- 260
                 V T  Y  PE+L  +   +    D+W++GC   ++L+    F   SE       
Sbjct: 167 ------VVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219

Query: 261 -----------WLIFQRIIA--------------RDIRFPNYF-SDAARDLIDRLLDVDP 294
                      W  F  +                R  +FP    SD   DL++RLL  DP
Sbjct: 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDP 278

Query: 295 SGRPGAGPGGYAVLKMHPFF 314
           + R  A       LK HP+F
Sbjct: 279 AKRISA----EDALK-HPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 74/326 (22%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-----TAYVKLERI 97
            ++D+E+    G G++ +V +A++I TG V ALK    K +    K     TA   L  I
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK----KILMHNEKDGFPITA---LREI 58

Query: 98  -VLDQLDHPGVVRLFFTFQD-------------TFSLYMALESCEGGELFDQITSKGHLS 143
            +L +L HP VV L     +               + YM  +    G L +       L+
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENP---SVKLT 113

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV- 202
           E + + Y  ++++ + Y+H   ++HRDIK  N+L+   G +KIADFG  +P         
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Query: 203 LPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
                   K    V T  Y PPE+L      + A    D+W +GC   +M +     +  
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV---DIWGIGCVFAEMFTRRPILQGK 230

Query: 259 SEW----LIFQRI-IARDIRFPNY-----------FSDAAR--------------DLIDR 288
           S+     LIF+      +  +P +           F++  R              DL+ +
Sbjct: 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK 290

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFF 314
           LL +DP  R  A          HP+F
Sbjct: 291 LLSLDPYKRLTASDA-----LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 89/307 (28%), Positives = 136/307 (44%), Gaps = 60/307 (19%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKE--NKTAYVKLERI-VLDQ 101
           +E GK  G G+Y+ V +A+  +TG + A+K +   ++   K+  N TA   L  I +L +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA---LREIKLLQE 58

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEY 160
           L HP ++ L   F    ++ +  E  E  +L   I  K   L+  + + Y    +  LEY
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +HS  ++HRD+KP NLL+ +DG +K+ADFG       +R    PN     K    V T  
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGL------ARSFGSPN----RKMTHQVVTRW 167

Query: 221 YVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF------------------------ 255
           Y  PE+L  +     G D+W++GC   ++L    PF                        
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEEN 226

Query: 256 -------KDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 308
                   D  E+  F     + I FP   SD A DL+ RLL ++P+ R  A        
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQI-FPAA-SDDALDLLQRLLTLNPNKRITA-----RQA 279

Query: 309 KMHPFFK 315
             HP+F 
Sbjct: 280 LEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 44/269 (16%)

Query: 54  GVGSYSKVVRAK---KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           G G++ +V + K   K    T  A+K + K+  ++E +  ++K E  V+ +L HP VVRL
Sbjct: 4   GEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLK-EARVMKKLGHPNVVRL 61

Query: 111 F-FTFQDTFSLYMALESCEGGEL---------FDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++   LY+ LE  EGG+L               K  LS  +   +  ++   +EY
Sbjct: 62  LGVCTEEE-PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           + S   +HRD+   N L+  D  +KI+DFG    +  SR     +   DD      G   
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFG----L--SR-----DVYDDDYYRKKTGGKL 169

Query: 221 YV---PPEVLNS---SPATFGNDLWALGCTLYQMLS-GTSPF--KDTSEWLIFQRIIA-- 269
            +    PE L     +  +   D+W+ G  L+++ + G +P+      E  + + +    
Sbjct: 170 PIRWMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKGY 224

Query: 270 RDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           R +  P Y  D   +L+     +DP  RP
Sbjct: 225 R-LPKPEYCPDELYELMLSCWQLDPEDRP 252

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 14/216 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FE+  + G G+Y  V++ +  +T  + A+K        +E K   ++ E  +L  L    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           +V L   F+    LY+  E  E    EL +++ +   +  ++ R Y  +++ A+ + H  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKN 119

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRDIKPENLL++ +  +K+ DFG  + + +          S+     +V T  Y  P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE---------GSNANYTEYVATRWYRSP 170

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           E+L  +P     D+W++GC L ++  G   F   SE
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.1 bits (221), Expect = 3e-20
 Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 57/297 (19%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y  V +A+   TG V ALK +  +  T+        +  I +L +L+HP +V+L  
Sbjct: 9   GEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 113 TFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                  LY+  E   +  + F   +    +     + Y  +++  L + HS  ++HRD+
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 172 KPENLLLTADGHIKIADFGSVK----PMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           KP+NLL+  +G IK+ADFG  +    P++     V+              T  Y  PE+ 
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--------------TLWYRAPEIL 172

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD-------IRFP 275
           L     +   D+W+LGC   +M++  + F   SE    + IF+ +   D          P
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 276 NY------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +Y                    +  RDL+ ++L  DP+ R  A     A L  HPFF
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK----AALA-HPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 84/324 (25%), Positives = 139/324 (42%), Gaps = 82/324 (25%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--------IMDKKFITKENKTAYVKLERIV 98
           +++ ++ G GSY  V  A    TG   A+K        + D   I +E     +KL R+ 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE-----IKLLRL- 55

Query: 99  LDQLDHPGVVRLFF--------TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
              L HP +V +           F+D + ++  +ES    +L   I +   L+ +  +F+
Sbjct: 56  ---LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFF 108

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAASD 209
             +++ AL+YIH+  + HRD+KP+N+L  AD  +KI DFG  +    D+   +     +D
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTD 165

Query: 210 DKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTS--PFKD----- 257
                +V T  Y  PE+  S     +PA    D+W++GC   ++L+G    P K+     
Sbjct: 166 -----YVATRWYRAPELCGSFFSKYTPAI---DIWSIGCIFAEVLTGKPLFPGKNVVHQL 217

Query: 258 --------TSEWLIFQRI-------------IARDIRFPNYFSDA---ARDLIDRLLDVD 293
                   T       R+               + + F   F +A   A  L++RLL  D
Sbjct: 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGI 317
           P  RP A           P+FKG+
Sbjct: 278 PKDRPTA-----EEALADPYFKGL 296

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 86.8 bits (216), Expect = 1e-19
 Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 37/269 (13%)

Query: 47  FELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            ELGK  G G++ +V +         T T  A+K + K+  ++E +  +++ E  ++ +L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLE-EASIMKKL 58

Query: 103 DHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
            HP +VRL    T  +   LY+  E   GG+L D +      L+  +      ++   +E
Sbjct: 59  SHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFV 216
           Y+ S   +HRD+   N L+T +  +KI+DFG    +      R                 
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----------------K 160

Query: 217 GTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
                +P     PE L     T  +D+W+ G  L+++ + G  P+   S   + + +   
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220

Query: 271 D-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
             +  P    D   +L+ +    DP  RP
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRP 249

Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 81/302 (26%), Positives = 125/302 (41%), Gaps = 67/302 (22%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           L KI G G++ +V +A+   T  + ALK  +M+ +   KE        E  +L  L H  
Sbjct: 17  LAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHEN 72

Query: 107 VVRL----------FFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
           VV L          +  ++ +F  Y+  E CE     L      K  LSE +       +
Sbjct: 73  VVNLIEICRTKATPYNRYKGSF--YLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKML 128

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL------ARAFSLSKNSKPNRYTN 182

Query: 215 FVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--- 267
            V T  Y PPE+L    +  P     D+W  GC + +M + +   +  +E      I   
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPI---DMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 268 ---IARDI-------------------------RFPNYFSDA-ARDLIDRLLDVDPSGRP 298
              I  ++                         R   Y  D  A DLID+LL +DP+ R 
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 299 GA 300
            A
Sbjct: 300 DA 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 83/308 (26%), Positives = 131/308 (42%), Gaps = 69/308 (22%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK----TAYVKLERIV 98
            +  F++    G G+Y +V +A+  DTG + ALK   K  +  E +    TA  +++  +
Sbjct: 5   CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIK--I 59

Query: 99  LDQLDHPGVVRLFFTF----------QDTFSLYMALESCEGGELFDQITSK-GHLSEDEA 147
           L QL+H  +V L              +D  + Y+  E  +  +L   + S   H SED  
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
           + +  ++++ L Y H    +HRDIK  N+LL   G IK+ADFG  +         L N+ 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR---------LYNSE 169

Query: 208 SDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
                   V T  Y PPE+L       PA    D+W+ GC L ++ +    F+   E   
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKKPIFQANQELAQ 226

Query: 264 FQRIIAR------------DIRFPNY----------------FS---DAARDLIDRLLDV 292
            + +I+R             I+ P +                FS     A DL+D +L +
Sbjct: 227 LE-LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285

Query: 293 DPSGRPGA 300
           DPS R  A
Sbjct: 286 DPSKRCTA 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 36/272 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
           +E+ +  G G+Y KV +      G+  A+KI+D      E     ++ E  +L  L DHP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILKALSDHP 75

Query: 106 GVVRLFFTF-----QDTFSLYMALESCEGGELFDQITSKGHLSEDE------ARFYTAEV 154
            VV+ +  +     ++   L++ LE C GG + D +  KG L   E        +   E 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L+++H    IHRD+K  N+LLT +G +K+ DFG    +  +R+          +  T
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----------RRNT 183

Query: 215 FVGTAAYVPPEVLNSSP---ATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
            VGT  ++ PEV+       +T+    D+W+LG T  ++  G  P  D        +I  
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243

Query: 270 R---DIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                +  P  +S+   D I + L  D   RP
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLF- 111
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR--LLKHMKHENVIGLLD 81

Query: 112 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            FT       F D F L M     + G+L         LSED  +F   +++  L+YIH+
Sbjct: 82  VFTPDLSLDRFHD-FYLVMPFMGTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP NL +  D  +KI DFG  +              +D +   +V T  Y  
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------QTDSEMTGYVVTRWYRA 183

Query: 224 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           PEV LN    T   D+W++GC + +ML+G   FK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 19/194 (9%)

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMALE 125
            TG   A+K++      +E++ A  + E  +  +L HP +V L  + +      L+   E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59

Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--- 182
              G  L + + + G L   E      +V+DAL   H+ G++HRD+KP+N++++  G   
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDD-----KACTFVGTAAYVPPEVLNSSPATFGND 237
           H K+ DFG          T+LP     D     +    +GT  Y  PE L   P T  +D
Sbjct: 120 HAKVLDFGIG--------TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 238 LWALGCTLYQMLSG 251
           L+A G    + L+G
Sbjct: 172 LYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 58/303 (19%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALK---IMDKKFITKENKTAYVKLERIVLDQLDH 104
           +L KI G G+Y  V +AK  +T  + ALK   + D      E   +    E  +L +L H
Sbjct: 4   KLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDD----EGVPSSALREICLLKELKH 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
             +VRL+        L +  E C+    + FD  +  G +  +  + +  +++  L + H
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G +K+ADFG  +      I V   +A        V T  Y 
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAE-------VVTLWYR 166

Query: 223 PPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWL--IFQRI--------- 267
           PP+VL  +   +   D+W+ GC   ++ +   P     D  + L  IF+ +         
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226

Query: 268 ----IARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
               +     +P Y             +   RDL+  LL  +P  R  A       L+ H
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE----EALQ-H 281

Query: 312 PFF 314
           P+F
Sbjct: 282 PYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 87.9 bits (217), Expect = 7e-19
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 52/303 (17%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + ++E+ K  G G + +V   K   T   +  K +  + + +  K+  V +E  V+ +L 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70

Query: 104 HPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDA 157
           H  +VR    F +  +  LY+ +E C+ G+L   I       G + E      T +++ A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 158 LEYIHSMG-------LIHRDIKPENLLL-TADGHI----------------KIADFGSVK 193
           L Y H++        ++HRD+KP+N+ L T   HI                KI DFG  K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSG 251
                      N   +  A + VGT  Y  PE+L     ++ +  D+WALGC +Y++ SG
Sbjct: 191 -----------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 252 TSPFKDTSEWLIFQRIIARDIRFPNY----FSDAARDLIDRLLDVDPSGRPGAGPG-GYA 306
            +PF   +    F ++I+   R P+      S     LI  LL++    RP A    GY 
Sbjct: 240 KTPFHKANN---FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296

Query: 307 VLK 309
           ++K
Sbjct: 297 IIK 299

Length = 1021

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 84/295 (28%), Positives = 130/295 (44%), Gaps = 40/295 (13%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G      IM +K I  E K A    +  E  VL + 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 162 HSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 167

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEW-LIFQRIIARDIRFPNY 277
           Y+ PE L  +  +  +D+W++G +L +M  G  P    D  E  L+F   +  D      
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD------ 221

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
              A  +   R     P GRP +  G  +   M   F+ +D+  I  + PPKL S
Sbjct: 222 --PAESETSPR---PRPPGRPLSSYGPDSRPPM-AIFELLDY--IVNEPPPKLPS 268

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.6 bits (212), Expect = 8e-19
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G      IM +K I  E K A    +  E  VL + 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGL-----IMARKLIHLEIKPAIRNQIIRELKVLHEC 56

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E+     +  V+  L Y+
Sbjct: 57  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYL 115

Query: 162 ---HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
              H   ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGT 161

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
            +Y+ PE L  +  T  +D+W+LG +L +M  G  P
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 86.1 bits (213), Expect = 8e-19
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLF- 111
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYREL--TLLKHMQHENVIGLLD 81

Query: 112 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            FT       FQD F L M     +  ++         LSED+ ++   +++  L+YIHS
Sbjct: 82  VFTSAVSGDEFQD-FYLVMPYMQTDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHS 135

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP NL +  D  +KI DFG  +              +D +   +V T  Y  
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMTGYVVTRWYRA 182

Query: 224 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           PEV LN        D+W++GC + +ML+G + FK
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 75/294 (25%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT-AYVKLERI-VLDQLDHPGVVRL- 110
           G G+Y  V  AK  +T    A+K +   F   +N+  A   L  I +L  LDH  V+ + 
Sbjct: 14  GRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 111 -------FFTFQDTFSLYMALESCEGGELFDQ-----ITSKGHLSEDEARFYTAEVVDAL 158
                     F D + +Y         EL D      I S   LS+D  +++  +++  L
Sbjct: 71  DIMPPPHREAFNDVYIVY---------ELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           +YIHS  ++HRD+KP NLLL A+  +KI DFG  +            +   D    +V T
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----------TTSEKGDFMTEYVVT 171

Query: 219 AAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIAR----- 270
             Y  PE+ LN S  T   D+W++GC   ++L     F  KD    L   ++I       
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSP 228

Query: 271 ---DIRF-------------PNY--------FSDA---ARDLIDRLLDVDPSGR 297
              D+ F             P          F  A   A DL++++L  DPS R
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 71/252 (28%), Positives = 103/252 (40%), Gaps = 19/252 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A    T  V A+K M         K   +  E   L QL HP  +     
Sbjct: 30  GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGC 89

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRDIK 
Sbjct: 90  YLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LLT  G +K+ADFGS              A+    A +FVGT  ++ PEV   ++  
Sbjct: 150 GNILLTEPGQVKLADFGS--------------ASKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 288
                 D+W+LG T  ++     P  + +       I   D      N ++D+ R  +D 
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255

Query: 289 LLDVDPSGRPGA 300
            L   P  RP +
Sbjct: 256 CLQKIPQERPAS 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFF 112
           G G+Y+ V + +   TG + ALK +    +  E  T    +  I L  +L H  +VRL  
Sbjct: 9   GEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 113 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
                  L +  E  +    +  D    +G L  +  + +T +++  + + H   ++HRD
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLP-NAASDDKACTFVGTAAYVPPEVL-N 228
           +KP+NLL+   G +K+ADFG       +R   +P N  S++     V T  Y  P+VL  
Sbjct: 126 LKPQNLLINKRGELKLADFGL------ARAFGIPVNTFSNE-----VVTLWYRAPDVLLG 174

Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIF-------QRIIARDIRFPNY 277
           S   +   D+W++GC + +M++G   F  T+       IF       +       + P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 278 FSDAAR------------------DLIDRLLDVDPSGRPGA 300
                R                  DL+ RLL ++P  R  A
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 36/281 (12%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           ELG+    G+Y  V + + + TGT+ A+K +     ++E K   + L+ I +  +D P  
Sbjct: 8   ELGR----GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD-ISMRSVDCPYT 62

Query: 108 VRLF---FTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHS 163
           V  +   F   D + + M +      + + ++  KG  + ED        +V ALEY+HS
Sbjct: 63  VTFYGALFREGDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 164 -MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            + +IHRD+KP N+L+  +G +K+ DFG    + DS        A    A    G   Y+
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-------VAKTIDA----GCKPYM 170

Query: 223 PPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFP 275
            PE +N      G    +D+W+LG T+ ++ +G  P+   K   + L  Q +     + P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-QVVEEPSPQLP 229

Query: 276 N-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              FS   +D +++ L  +   RP      Y  L  HPFF+
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERP-----NYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 63/315 (20%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
              +GK +       + + K   T T+ A+K   K  +   +K     L  E I   QL 
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKP--TNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQ 57

Query: 104 HPGVVRLFFTFQDTFSLY-----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           HP ++    +F     LY     MA  SCE  +L      +G L E    F   +V++AL
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCE--DLLKTHFPEG-LPELAIAFILKDVLNAL 114

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--QDSRITVLPNAASDDKACTFV 216
           +YIHS G IHR +K  ++LL+ DG + ++       M     R  V+      D   + V
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV-----HDFPKSSV 169

Query: 217 GTAAYVPPEVL--NSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRI------ 267
               ++ PEVL  N       +D++++G T  ++ +G  PFKD  +  ++ +++      
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229

Query: 268 ---------------------------IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
                                       + D  +   FS+     ++  L  DP  RP A
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289

Query: 301 GPGGYAVLKMHPFFK 315
                + L  H FFK
Sbjct: 290 -----SQLLNHSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 40/285 (14%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQL 102
           +Q +++ ++ G G   +V  A         ALK + +        K  +++  +I  D L
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD-L 59

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEG---GELFDQITSKGHLSEDEAR----------F 149
            HPG+V ++    D   +Y  +   EG     L   +  K  LS++ A           F
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           +   +   +EY+HS G++HRD+KP+N+LL   G + I D+G+    +     +L     +
Sbjct: 120 HK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 210 DKAC--------TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTS 259
              C          VGT  Y+ PE L   PA+   D++ALG  LYQML+ + P+  K   
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 260 EWLIFQRIIA-------RDIRFPNYFSDAARDLIDRLLDVDPSGR 297
           +      I++       R+I  P + S  A     + L VDP+ R
Sbjct: 238 KISYRDVILSPIEVAPYREI--PPFLSQIAM----KALAVDPAER 276

Length = 932

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.6 bits (206), Expect = 4e-18
 Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 19/250 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 189

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 288
                 D+W+LG T  ++     P  + +       I   +       ++S+  R+ +D 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 289 LLDVDPSGRP 298
            L   P  RP
Sbjct: 250 CLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLDQLDHPGVVRL-- 110
           G GSY+ V + K    G + ALK++    + +E  T +  + E  +L  L H  +V L  
Sbjct: 14  GEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
               ++T +L       +  +  D+    G L  +  + +  +++  L YIH   ++HRD
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRD 128

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNS 229
           +KP+NLL++  G +K+ADFG       +R   +P+    ++  T      Y PP+V L S
Sbjct: 129 LKPQNLLISDTGELKLADFGL------ARAKSVPSHTYSNEVVTL----WYRPPDVLLGS 178

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF 255
           +  +   D+W +GC   +M+ G + F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.7 bits (204), Expect = 7e-18
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 37/287 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
           +E+ +  G G+Y KV +      G++ A+KI+D      E     ++ E  +L  L +HP
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQSLPNHP 79

Query: 106 GVVRLFFTF--QDTFS---LYMALESCEGG---ELFDQITSKGH-LSEDEARFYTAEVVD 156
            VV+ +  F   D      L++ LE C GG   EL   +   G  L E    +     + 
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            L+++H+  +IHRD+K  N+LLT +G +K+ DFG    +  +R+          +  T V
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----------RRNTSV 189

Query: 217 GTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRII 268
           GT  ++ PEV+              D+W+LG T  ++  G  P  D           R  
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              +  P  +  +    I + L  D   RP         L  HPF K
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 83.2 bits (205), Expect = 8e-18
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 26  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 83

Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 143

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 190

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 69/250 (27%), Positives = 104/250 (41%), Gaps = 19/250 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ + T  V A+K M         K   +  E   L ++ HP  +     
Sbjct: 34  GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRDIK 
Sbjct: 94  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 153

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LLT  G +K+ADFGS              A+    A +FVGT  ++ PEV   ++  
Sbjct: 154 GNILLTEPGQVKLADFGS--------------ASIASPANSFVGTPYWMAPEVILAMDEG 199

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 288
                 D+W+LG T  ++     P  + +       I   +      N +SD  R+ +D 
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 259

Query: 289 LLDVDPSGRP 298
            L   P  RP
Sbjct: 260 CLQKIPQDRP 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 81/303 (26%), Positives = 129/303 (42%), Gaps = 60/303 (19%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDH 104
           + KI G G+Y  V +A+   TG + ALK      I  E +   V    I    +L +L+H
Sbjct: 4   VEKI-GEGTYGVVYKARDKLTGEIVALKK-----IRLETEDEGVPSTAIREISLLKELNH 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
           P +VRL         LY+  E  +  +L   + S      D      Y  +++  + Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF-VGTAAY 221
           S  ++HRD+KP+NLL+  +G +K+ADFG       +R   +P      +  T  V T  Y
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGL------ARAFGVPV-----RTYTHEVVTLWY 165

Query: 222 VPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD----- 271
             PE+L  S   +   D+W++GC   +M++    F   SE    + IF+ +   D     
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225

Query: 272 ---------IRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
                      FP +             +   DL+ ++L  DP+ R  A     A+   H
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA---KAALQ--H 280

Query: 312 PFF 314
           P+F
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 61/286 (21%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFF 112
           G+G++  V  A+   TG   A+K + K F T    K  Y +L+  +L  L H  ++ L  
Sbjct: 19  GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK--LLKHLRHENIISL-- 74

Query: 113 TFQDTF-----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
              D F      +Y   E   G +L   +TS+  L +   +++  +++  L+Y+HS G++
Sbjct: 75  --SDIFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVV 130

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+L+  +  +KI DFG  +  QD ++T             +V T  Y  PE+ 
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI-QDPQMT------------GYVSTRYYRAPEIM 177

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTS--PFKD-------TSEWL------IFQRIIARD 271
           L         D+W+ GC   +ML G    P KD        ++ L      +   I + +
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237

Query: 272 I-----------------RFPNYFSDAARDLIDRLLDVDPSGRPGA 300
                             +F N    +A DL++++L  DP  R  A
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISA 282

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 32/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           QD +  +I G G+   V +A  + T  + A+K++      +  K    +LE  +L + D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE--ILYKCDS 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++  +  F     + +  E  +GG L         + E         VV  L Y+ S+
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP N+L+   G +K+ DFG    + +S             A T+VGT AY+ P
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------IAKTYVGTNAYMAP 162

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSP----FKDTSEWL---IFQRIIARDI-RFP- 275
           E ++       +D+W+LG +  ++  G  P     K+    +   + Q I+  D    P 
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
             FS+     I + +   P  RP         L  HPF    +  N 
Sbjct: 223 GQFSEKFVHFITQCMRKQPKERPAP-----ENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 69/238 (28%), Positives = 101/238 (42%), Gaps = 55/238 (23%)

Query: 49  LGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIVLD 100
            G I G G+Y +V +A  K    G  YA+K    KF  K +K  Y  +      E  +L 
Sbjct: 5   EGCI-GRGTYGRVYKAKRKNGKDGKEYAIK----KF--KGDKEQYTGISQSACREIALLR 57

Query: 101 QLDHPGVVRL---FFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEV- 154
           +L H  VV L   F    D  S+Y+  +  E     D  QI  K H          + V 
Sbjct: 58  ELKHENVVSLVEVFLEHADK-SVYLLFDYAE----HDLWQII-KFHRQAKRVSIPPSMVK 111

Query: 155 ------VDALEYIHSMGLIHRDIKPENLLLTADGH----IKIADFGSVKPMQDSRITVLP 204
                 ++ + Y+HS  ++HRD+KP N+L+  +G     +KI D G       +R+   P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL------ARLFNAP 165

Query: 205 NA--ASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFK 256
               A  D     V T  Y  PE+L  +     A    D+WA+GC   ++L+    FK
Sbjct: 166 LKPLADLDPV---VVTIWYRAPELLLGARHYTKAI---DIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDHPG 106
           KI G G+Y  V + +   TG + A+K      I  E++   V    I    +L +L HP 
Sbjct: 7   KI-GEGTYGVVYKGRNKKTGQIVAMKK-----IRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 107 VVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           +V L         LY+  E  S +  +  D +    ++  +  + Y  +++  + + HS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP+NLL+   G IK+ADFG       +R   +P      +    V T  Y  P
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGL------ARAFGIPVRVYTHE----VVTLWYRAP 170

Query: 225 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           EVL  SP  +   D+W++G    +M +    F   SE
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 49/295 (16%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMD----KKFITKENKTA------YVKLERI- 97
            G   G G+Y KV +A    TG + A+K +        +TK+ +        +  L  + 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 98  VLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           +++++ H  ++ L   +   D  +L M + +    +L   +  K  L+E + +    +++
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMA---SDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG----SVKPMQDSRITVLPNAASDDK 211
           + L  +H    +HRD+ P N+ + + G  KIADFG       P     ++        ++
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 212 ACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE---------- 260
             + V T  Y  PE+L  +    F  D+W++GC   ++L+G   F   +E          
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Query: 261 --------W-------LIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGR 297
                   W       L  +    +       F   SD A DL+  LL ++P  R
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHMKHENVIGLLD 81

Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + F+    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +DD+   +V T  Y  PE+ 
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLAR-------------QADDEMTGYVATRWYRAPEIM 187

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           +L K+ G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +
Sbjct: 9   KLDKL-GEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSMGL 166
           V L         L +  E  +  +L   + + G+L S    + +  +++  L Y H   +
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           +HRD+KP+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP+V
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGL------ARAKSVPTKTYSNE----VVTLWYRPPDV 174

Query: 227 -LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            L S+  +   D+W +GC LY+M +G   F
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 46/232 (19%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLDQLDHPGVVRL-- 110
           G GSY+ V + +   TG + ALK +    +  E    +  + E  +L  L H  +V L  
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 111 ----------FFTFQDT-FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
                      F + DT    YM  + C GG           LS    R +  +++  L 
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYM--DDCGGG-----------LSMHNVRLFLFQLLRGLA 117

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y H   ++HRD+KP+NLL++  G +K+ADFG       +R   +P+    ++    V T 
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGL------ARAKSVPSKTYSNE----VVTL 167

Query: 220 AYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWL--IFQ 265
            Y PP+VL  S+  +   D+W +GC  Y+M +G   F    D  + L  IF+
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALE 159
           LDH  ++RL+        L M  E    G L D++   + GH        Y  ++ + + 
Sbjct: 53  LDHENLIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   N+LL +D  +KI DFG ++  P  +    +  +         F  
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH-----LKVPF-- 164

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF-- 274
             A+  PE L +   +  +D+W  G TL++M + G  P+   S   I ++I     R   
Sbjct: 165 --AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
           P        +++ +    +P+ RP
Sbjct: 223 PEACPQDIYNVMLQCWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 44/297 (14%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           +LG+I G G++  V +     +GT+ A+K +      KE K   + L+ ++    D P +
Sbjct: 8   DLGEI-GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYI 65

Query: 108 VRLF---FTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYI- 161
           V+ +   F   D + + M L      + +  +    K  + E+         V AL Y+ 
Sbjct: 66  VKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             + +IHRD+KP N+LL  +G+IK+ DFG    + DS       A + D  C       Y
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI------AKTRDAGCR-----PY 173

Query: 222 VPPEVLNSSPAT---FGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQR----------I 267
           + PE ++ S        +D+W+LG TLY++ +G  P+    +W  +F +          I
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY---PKWNSVFDQLTQVVKGDPPI 230

Query: 268 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 324
           ++        FS +  + I+  L  D S RP      Y  L  HPF K  + +N+  
Sbjct: 231 LSNSEER--EFSPSFVNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVDV 280

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 38/294 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQ 101
            DFE     G G+   V + +   +G      IM +K I  E K A    +  E  VL +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHE 59

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            + P +V  +  F     + + +E  +GG L   +     + E+     +  V+  L Y+
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 162 HSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRS 167

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEW-LIFQR-IIARDIRFPN 276
           Y+ PE L  +  +  +D+W++G +L ++  G  P    D  E   IF R ++  +   P+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
             S   R          P GRP +G G  +   M   F+ +D+  I  + PPKL
Sbjct: 228 SISPRPR----------PPGRPVSGHGMDSRPAM-AIFELLDY--IVNEPPPKL 268

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 75/296 (25%), Positives = 116/296 (39%), Gaps = 53/296 (17%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GSY+ V +      G + ALK++  K  T+E        E  +L  L H  +V L   
Sbjct: 14  GEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
                +L    E          I   G L     R +  +++  L YIH   ++HRD+KP
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP 131

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPA 232
           +NLL++  G +K+ADFG       +R   +P+     +    V T  Y PP+VL  ++  
Sbjct: 132 QNLLISYLGELKLADFGL------ARAKSIPSQTYSSE----VVTLWYRPPDVLLGATDY 181

Query: 233 TFGNDLWALGCTLYQMLSGTSPFKDTSE--------WLIFQRIIARDI-----RFPNYFS 279
           +   D+W  GC   +ML G   F   S+        W +   +   D      + PNY  
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG-VPTEDTWPGVSKLPNYKP 240

Query: 280 D---------------------AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +                      A DL  ++L + P  R  A         +HP+F
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA-----LLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 15/252 (5%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ +V   +     T  A+K   ++ +  + K  +++  RI L Q  HP +VRL   
Sbjct: 4   GRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIGV 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                 +Y+ +E  +GG+    + ++G  L   E           +EY+ S   IHRD+ 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
             N L+T    +KI+DFG  +  +D     +  +    K      TA    PE LN    
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDG----VYASTGGMKQIPVKWTA----PEALNYGRY 173

Query: 233 TFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRL 289
           +  +D+W+ G  L++  S G  P+ + S     +  I + +R   P    DA   L++R 
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQGVRLPCPELCPDAVYRLMERC 232

Query: 290 LDVDPSGRPGAG 301
            + DP  RP   
Sbjct: 233 WEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL----DQLDHPGVVR 109
           GVG+Y  V +A+   +G   ALK +  +  T E+      +  + L    +  DHP +VR
Sbjct: 9   GVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 110 LF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L        T ++T  + +  E  +       D++   G L  +  +    + +  L+++
Sbjct: 67  LMDVCATSRTDRET-KVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFL 124

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTP----------VVVTLWY 173

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             PEVL  S      D+W++GC   +M      F   SE
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAE 153
           E  V+ +L HP +V+L+        LY+  E  E G L + +  + G LS+D       +
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V + +EY+     IHRD+   N L+++ G +K++DFG  + + D   T    A    K  
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI 272
                    PPEV N S  +  +D+W+ G  ++++ + G  PF+  S + +   +I+R  
Sbjct: 169 ---------PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218

Query: 273 RF--PNYFSDAARDLIDRLLDVDPSGRP 298
           R   P   S    +++       P GRP
Sbjct: 219 RLYRPKLASMTVYEVMYSCWHEKPEGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 58

Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 116

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 167

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 168 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 25/270 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F   +   GK  G G++ KVV A      K D     A+K++     + E +    +L+ 
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK- 90

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAE 153
            ++  L +H  +V L         + +  E C  G+L + +  K    L+ ++   ++ +
Sbjct: 91  -IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPNAASDDK 211
           V   + ++ S   IHRD+   N+LLT  G I KI DFG  +  M DS   V  NA    K
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
                    ++ PE + +   TF +D+W+ G  L+++ S G++P+        F ++I  
Sbjct: 209 ---------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259

Query: 271 DIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
             R   P +      D++    D DP  RP
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRP 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 32/230 (13%)

Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           F+LG  Y      G GS   V  A   D     A+K   K  +T      +   E  ++ 
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIR 57

Query: 101 QLDHPGVVRLFFTF-------QDTFSLYMALES-CEGGELFD----QITSKGHLSEDEAR 148
           +LDH  +V+++           +       L S     E  +     +  +G LSE+ AR
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAA 207
            +  +++  L+YIHS  ++HRD+KP N+ + T D  +KI DFG       +RI V P+ +
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL------ARI-VDPHYS 170

Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF 255
                   + T  Y  P +L  SP  +    D+WA GC   +ML+G   F
Sbjct: 171 HKGYLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN----KTAYVKLERI---- 97
           D E  +  G G++  V        G   ALK M   F   +N    K  + +L+ +    
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFK 57

Query: 98  ---VLDQLD--HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
              VL  LD   P  +  F   ++ + +   ++S    +L   I S   LS D  + +  
Sbjct: 58  HDNVLSALDILQPPHIDPF---EEIYVVTELMQS----DLHKIIVSPQPLSSDHVKVFLY 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++  L+Y+HS G++HRDIKP NLL+ ++  +KI DFG            L      D++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG------------LARVEEPDES 158

Query: 213 CTF---VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSG 251
                 V T  Y  PE+L  S   T   D+W++GC   ++L  
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 15  GEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                SL +  E  +  +L   +   G+ +S    + +  +++  L Y H   ++HRD+K
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131

Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 231
           P+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP+V L SS 
Sbjct: 132 PQNLLINERGELKLADFGL------ARAKSVPTKTYSNE----VVTLWYRPPDVLLGSSE 181

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTS 259
            +   D+W +GC  ++M SG   F  ++
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 73/297 (24%)

Query: 55  VGSYSKVVRAKKIDT--GTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF 111
           +GS ++ +     DT  G   A+K + + F  + + K AY +L  ++L  ++H  ++ L 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCVNHKNIISLL 86

Query: 112 --FTFQDTFS----LYMALESCEGGELFD-QITSKGHLSEDEAR--FYTAEVVDALEYIH 162
             FT Q +      +Y+ +E      L D  +    H+  D  R  +   +++  ++++H
Sbjct: 87  NVFTPQKSLEEFQDVYLVME------LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S G+IHRD+KP N+++ +D  +KI DFG  +            A ++     +V T  Y 
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMTPYVVTRYYR 189

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEW-----------LIFQRII 268
            PEV+         D+W++GC + +++ G+  F+ T    +W             F   +
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249

Query: 269 ARDIR-----------------FPNYF-----------SDAARDLIDRLLDVDPSGR 297
              +R                 FP++            +  ARDL+ ++L +DP  R
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 28/255 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++  V +   +   T  A+K   +  +  + K  +++   I L Q DHP +V+L   
Sbjct: 4   GKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEI-LKQYDHPNIVKLIGV 60

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE----VVDA---LEYIHSMGL 166
                 +Y+ +E   GG L         L + + R    +     +DA   +EY+ S   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLT------FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+   N L+  +  +KI+DFG  +  +    TV    +   K      TA    PE 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SDGLKQIPIKWTA----PEA 166

Query: 227 LNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAAR 283
           LN    T  +D+W+ G  L++  S G +P+   S     +R I    R   P    +   
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIY 225

Query: 284 DLIDRLLDVDPSGRP 298
            L+ +    DP  RP
Sbjct: 226 RLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 72/301 (23%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQL 102
           + ++LG I G GS+  V  A  IDT    A+K  + D +         Y   E +++  L
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNL 116

Query: 103 DHPGVVRLF-FTFQDTF-----SLYMALESCEGGELFDQITSK--GHLSEDE-------A 147
           +H  ++ L  + + + F     ++++ +      E   Q   K   H + +         
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVM----EFIPQTVHKYMKHYARNNHALPLFLV 172

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNA 206
           + Y+ ++  AL YIHS  + HRD+KP+NLL+  + H +K+ DFGS K           N 
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----------NL 221

Query: 207 ASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ 265
            +  ++ +++ +  Y  PE+ L ++  T   DLW+LGC + +M+ G   F   S      
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 266 RIIA-----------------RDIRFPNYFS------------DAARDLIDRLLDVDPSG 296
           RII                   DI+FP+               D A + I + L  +P  
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK 341

Query: 297 R 297
           R
Sbjct: 342 R 342

Length = 440

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 28/265 (10%)

Query: 45  QDFELGKIYGVGSYSKV---VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +D  LG+  G G +  V   V     +     A+K   K   +   +  +++ E  ++ Q
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQ-EAYIMRQ 63

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALE 159
            DHP +V+L     +   +++ +E    GEL  + Q  +K  L       Y+ ++  AL 
Sbjct: 64  FDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALA 121

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ S   +HRDI   N+L+++   +K+ DFG  + ++D          S  KA       
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE---------SYYKASKGKLPI 172

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-----DIR 273
            ++ PE +N    T  +D+W  G  ++++L  G  PF    + +    +I R      + 
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF----QGVKNNDVIGRIENGERLP 228

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRP 298
            P         L+ +    DPS RP
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRP 253

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 15  GEGTYATVYKGRSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 114 FQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                SL +  E  +    +  D   +  ++     + +  +++  L Y H   ++HRD+
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLHRDL 130

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSS 230
           KP+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP++ L S+
Sbjct: 131 KPQNLLINERGELKLADFGL------ARAKSIPTKTYSNE----VVTLWYRPPDILLGST 180

Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
             +   D+W +GC  Y+M +G   F
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 81/316 (25%), Positives = 127/316 (40%), Gaps = 72/316 (22%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DH 104
           +E  +  G G+Y KV +A+  +TG + ALK    +    E       L  I L Q+  + 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 105 PGVVRLF---FTFQDT--FSLYMALESCEGGELFDQITSKGH-----LSEDEARFYTAEV 154
             +VRL       +     SLY+  E  +  +L   + S G      L     + +  ++
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  + + H  G++HRD+KP+NLL+    G +KIAD G        R   +P      K+ 
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL------GRAFSIPV-----KSY 168

Query: 214 TF-VGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE------- 260
           T  + T  Y  PEVL      S+P     D+W++GC   +M      F   SE       
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224

Query: 261 --------------------WLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
                               W  F +   +D+    P+  S    DL+ ++L  DP+ R 
Sbjct: 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRI 283

Query: 299 GAGPGGYAVLKMHPFF 314
            A     A L  HP+F
Sbjct: 284 SA----KAALT-HPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAK---KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +    K  G G +  V   K   KID     A+K++ +  +++++     K    V+ +L
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKIDV----AIKMIREGAMSEDDFIEEAK----VMMKL 56

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA-------EVV 155
            HP +V+L+        +++  E    G L +      +L E + +  T        +V 
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN------YLRERKGKLGTEWLLDMCSDVC 110

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +A+EY+ S G IHRD+   N L+  D  +K++DFG       +R  +      DD+  + 
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL------ARYVL------DDQYTSS 158

Query: 216 VGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            GT     + PPEV + S  +  +D+W+ G  ++++ S G  P+
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 82/305 (26%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVR 109
           K  G G+   V  A    TG   A+K + + F      K AY +L  +++  ++H  ++ 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL--VLMKLVNHKNIIG 79

Query: 110 LF--FTFQDTFS----LYMALESCEGGELFD----QITSKGHLSEDEAR--FYTAEVVDA 157
           L   FT Q +      +Y+ +E      L D    Q+     +  D  R  +   +++  
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVME------LMDANLCQVI---QMDLDHERMSYLLYQMLCG 130

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FV 216
           ++++HS G+IHRD+KP N+++ +D  +KI DFG            L   A      T +V
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------LARTAGTSFMMTPYV 178

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEW------------ 261
            T  Y  PEV+         D+W++GC + +M+ GT  F  T    +W            
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238

Query: 262 ----------------------LIFQRIIARDIRFPNYFSDA-------ARDLIDRLLDV 292
                                   F+ +   D+ FP             ARDL+ ++L +
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFP-DVLFPPDSESHNKLKASQARDLLSKMLVI 297

Query: 293 DPSGR 297
           DP  R
Sbjct: 298 DPEKR 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 9/105 (8%)

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           + R    +++ A+EYIH   LIHRDIK EN+ L  DG I + DFG+  P +  R      
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA---- 323

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
                    +VGT A   PE+L         D+W+ G  L  MLS
Sbjct: 324 -----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 42/226 (18%)

Query: 43  SIQDFELGKIYGVGSYSKVV----RAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ER 96
           + ++ +LG   G G +  V+    R +K+      A+K +      K++ TA      E 
Sbjct: 4   NSKELKLGATIGKGEFGDVMLGDYRGQKV------AVKCL------KDDSTAAQAFLAEA 51

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEV 154
            V+  L HP +V+L         LY+  E    G L D + S+G   ++  +   +  +V
Sbjct: 52  SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV----LPNAASDD 210
            + +EY+     +HRD+   N+L++ D   K++DFG  K   ++        LP      
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLP------ 162

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 163 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++Q   LG+I G G +  V++ +   TG   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNI------KCDVTAQAFLEETAVMT 54

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDAL 158
           +L H  +VRL         LY+ +E    G L + + ++G       +   ++ +V + +
Sbjct: 55  KLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG--SVKPMQ-DSRITVLPNAASDDKACTF 215
           EY+ S  L+HRD+   N+L++ DG  K++DFG   V  M  D+  + LP           
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLP----------- 160

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                +  PE L     +  +D+W+ G  L+++ S G +P+   S
Sbjct: 161 ---VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 29/264 (10%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++++ +L +  G G +  V+       G   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMT 54

Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDA 157
           QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-LPNAASDDKACTFV 216
           +EY+ +   +HRD+   N+L++ D   K++DFG  K    ++ T  LP            
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------------ 162

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI-IARDIRF 274
               +  PE L     +  +D+W+ G  L+++ S G  P+       +  R+     +  
Sbjct: 163 --VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 220

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
           P+       D++ +   +D + RP
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRP 244

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 54  GVGSYSKVV----RAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           G G++  VV      K      V A+K + ++ I    K  +++ E  V+ QLDHP +VR
Sbjct: 4   GHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L    +    L + +E    G L   +  +  +   + +    +V   + Y+ S   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----P 224
           D+   N+LL      KI+DFG  + +          A SD    T   TA   P     P
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL---------GAGSDYYRAT---TAGRWPLKWYAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
           E +N    +  +D+W+ G TL++  S G  P+ +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 29/112 (25%), Positives = 55/112 (49%), Gaps = 17/112 (15%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           +++++   ++Y+ S   IHRD+   N+L+ ++  +KI+DFG            L     +
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG------------LAKVLPE 161

Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           DK   +V      P     PE L +S  +  +D+W+ G TLY++ +   P +
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 12/168 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 169

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                   +  PE +N    T  +D+W+ G  LY++++ G  P+   S
Sbjct: 170 --------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 46/191 (24%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 74  ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF 133
           A+K + +  +++E+       E  V+ +L HP +V+L+    +   + +  E  E G L 
Sbjct: 32  AIKTIREGAMSEED----FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87

Query: 134 DQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
           D +   +G  S++       +V + + Y+ S  +IHRD+   N L+  +  +K++DFG  
Sbjct: 88  DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM- 146

Query: 193 KPMQDSRITVLPNAASDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
                +R  +      DD+  +  GT     +  PEV + S  +  +D+W+ G  ++++ 
Sbjct: 147 -----TRFVL------DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195

Query: 250 S-GTSPFKDTS 259
           S G +P+++ S
Sbjct: 196 SEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 13/164 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTA 152
           E  ++ QL HP +VRL+        +Y+  E  E G L D + T +G  L+ ++     A
Sbjct: 51  EANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 169 --------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  +L  ++HP +++L  TF       + L   +  +L+  + +K +++  +       V
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           + A++Y+H   +IHRDIK EN+ +   G + + DFG+            P   + +K   
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA---------ACFPVDINANKYYG 242

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KD------TSEWLIFQR 266
           + GT A   PE+L   P     D+W+ G  L++M +       KD       S+  I + 
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KL 301

Query: 267 IIARDIRFPNYFSDAARDLIDRL---LDVDPSGRPGAGP 302
           II R    PN F   A+  +D +   L    S +PG+ P
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP 340

Length = 391

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 29/173 (16%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+ +L H  +V+L+        +Y+  E    G L + +   G       RF  ++ 
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQL 102

Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V + + Y+ S   IHRD+   N L+   G +K++DFG            L    
Sbjct: 103 LEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG------------LSRYV 150

Query: 208 SDDKACTFVGTAAYV---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+   V   PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 21/259 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A++  E  V+  L H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE---AFLA-EANVMKTLQH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 61  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 170

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPNYFS-- 279
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P   +  
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPRPENCP 229

Query: 280 DAARDLIDRLLDVDPSGRP 298
           +   +++ R     P  RP
Sbjct: 230 EELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
            TG + A+K + K+   ++N + + K E  +L  L H  +V+     + Q    L + +E
Sbjct: 31  GTGEMVAVKTL-KRECGQQNTSGWKK-EINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88

Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
               G L D +  K  L+  +   +  ++ + + Y+HS   IHRD+   N+LL  D  +K
Sbjct: 89  YVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147

Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  K + +           D  +  F     +   E L  +  ++ +D+W+ G TL
Sbjct: 148 IGDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAVECLKENKFSYASDVWSFGVTL 200

Query: 246 YQMLSGTSPFK 256
           Y++L+     +
Sbjct: 201 YELLTHCDSKQ 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 17/252 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G++ +V +    D   V A+K   K+ + +E K  ++   RI L Q DHP +V+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTC-KEDLPQELKIKFLSEARI-LKQYDHPNIVKL 57

Query: 111 FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                    +Y+ +E   GG+    +   K  L   +   +  +    + Y+ S   IHR
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+   N L+  +  +KI+DFG  +   D   +     +S  K      TA    PE LN 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SSGLKQIPIKWTA----PEALNY 168

Query: 230 SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLI 286
              +  +D+W+ G  L++  S G  P+   +     ++ + +  R   P    D    ++
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVM 227

Query: 287 DRLLDVDPSGRP 298
            R  D  P  RP
Sbjct: 228 QRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 22/205 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           + + K    GS  +V  A K        LKI  K             +E ++L  ++HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMG 165
           V+R+  T        M L      +L+  +T +   L  D+A     ++++ L Y+H+  
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +IHRD+K EN+ +     + I D G+ +          P  A         GT     PE
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQ---------FPVVAPAFLG--LAGTVETNAPE 226

Query: 226 VLNSSPATFGNDLWALGCTLYQMLS 250
           VL         D+W+ G  L++ML+
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 13/160 (8%)

Query: 98  VLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           +L  + H  ++ L   + ++ T  + M    C+   LF  +   G L  ++A      ++
Sbjct: 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAITIQRRLL 195

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +AL Y+H  G+IHRD+K EN+ L    +  + DFG+   +     T         +   +
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--------PQCYGW 247

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            GT     PE+L   P     D+W+ G  L++M       
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.3 bits (148), Expect = 2e-10
 Identities = 62/273 (22%), Positives = 120/273 (43%), Gaps = 65/273 (23%)

Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q +      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160

Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209

Query: 247 QMLSGTS--PFKD-TSEW--LI---------FQRIIARDIR-------------FPNYFS 279
           +M+      P +D   +W  +I         F + +   +R             FP  F 
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269

Query: 280 DA---------------ARDLIDRLLDVDPSGR 297
           D+               ARDL+ ++L +DP+ R
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 18/234 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++F L +  G G + +V      +   V A+KI+  K      +  + K E   L +L H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKIL--KSDDLLKQQDFQK-EVQALKRLRH 61

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             ++ LF        +Y+  E  E G L   + S        A       +V + + Y+ 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD+   N+L+  D   K+ADFG  + +++          S DK   +  TA   
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL------SSDKKIPYKWTA--- 172

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFP 275
            PE  +    +  +D+W+ G  LY+M + G  P+   +   ++ + I    R P
Sbjct: 173 -PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-ITAGYRMP 224

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 32/171 (18%)

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 149
           ++ +L H  +V+L+    +   +Y+  E    G L D       L   E +         
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVD 107

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAAS 208
             A++ + + Y+ S   IHRD+   N+L+  +  + KIADFG            L     
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILV-GENLVCKIADFG------------LARLIE 154

Query: 209 DDKACTFVGTA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           DD+     G      +  PE  N    T  +D+W+ G  L ++++ G  P+
Sbjct: 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 47/192 (24%), Positives = 93/192 (48%), Gaps = 23/192 (11%)

Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q +      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167

Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216

Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG   A+K +  +  +  N  A +K E  +L  L H  +V+     T      + + +E
Sbjct: 31  NTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 126 SCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L + +  +K  ++  +   Y  ++   ++Y+ S   +HRD+   N+L+ ++  +
Sbjct: 89  FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 148

Query: 185 KIADFGSVKPMQDSR--ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
           KI DFG  K ++  +   TV      DD        A    PE L  S     +D+W+ G
Sbjct: 149 KIGDFGLTKAIETDKEYYTV-----KDDLDSPVFWYA----PECLIQSKFYIASDVWSFG 199

Query: 243 CTLYQMLS 250
            TLY++L+
Sbjct: 200 VTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++ A++YIH  G+IHRDIK EN+L+     I + DFG+    + S  T      +    
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA---- 323

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
               GT     PEVL   P T   D+W+ G  +++
Sbjct: 324 ----GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 32/267 (11%)

Query: 51  KIYGVGSYSKVV--RAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPG 106
              G G + +V   +AK I+      L ++ K       EN  +  + E  +  +L H  
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETL-VLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 107 VVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVD-------A 157
           VVRL    ++    YM LE  + G+L  F + T             T + V         
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++++ +   +HRD+   N L+++   +K++               L     + +      
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLS------------LSKDVYNSEYYKLRN 177

Query: 218 TAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR 273
                 ++ PE +     +  +D+W+ G  ++++ + G  PF   S+  +  R+ A  + 
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237

Query: 274 F--PNYFSDAARDLIDRLLDVDPSGRP 298
              P         L+ R   V+P  RP
Sbjct: 238 LPVPEGCPSRLYKLMTRCWAVNPKDRP 264

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 46/258 (17%)

Query: 54  GVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL- 110
           G G+Y  V +AK+ D      YALK ++   I+          E  +L +L HP V+ L 
Sbjct: 10  GRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-----ACREIALLRELKHPNVISLQ 64

Query: 111 --FFTFQDTFSLYMALESCEGGELFDQI----TSKGH-----LSEDEARFYTAEVVDALE 159
             F +  D   +++  +  E  +L+  I     SK +     L     +    +++D + 
Sbjct: 65  KVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 160 YIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  D    TF
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPVVVTF 179

Query: 216 VGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
                Y  PE +L +   T   D+WA+GC   ++L+    F    E          DI+ 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------DIKT 225

Query: 275 PNYFSDAARDLIDRLLDV 292
            N +     D +DR+ +V
Sbjct: 226 SNPYH---HDQLDRIFNV 240

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 50/232 (21%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER-------IVLD 100
           K+ G G + +V   +         LK+  K+ I    K  K  Y + +R        ++ 
Sbjct: 10  KVIGAGEFGEVCSGR---------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 158
           Q DHP ++ L      +  + +  E  E G L         L + + +F   ++V  L  
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRG 114

Query: 159 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
                +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA      
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEAA------ 163

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +      +P     PE +     T  +D+W+ G  +++++S G  P+ + S
Sbjct: 164 -YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 46/258 (17%)

Query: 54  GVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV--- 108
           G G+Y  V +AK+ D      YALK ++   I+          E  +L +L HP V+   
Sbjct: 10  GRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-----ACREIALLRELKHPNVIALQ 64

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQI----TSKGH-----LSEDEARFYTAEVVDALE 159
           ++F +  D   +++  +  E  +L+  I     SK +     L     +    +++D + 
Sbjct: 65  KVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 160 YIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  D    TF
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPVVVTF 179

Query: 216 VGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
                Y  PE +L +   T   D+WA+GC   ++L+    F    E          DI+ 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------DIKT 225

Query: 275 PNYFSDAARDLIDRLLDV 292
            N F     D +DR+  V
Sbjct: 226 SNPFH---HDQLDRIFSV 240

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 23/43 (53%), Positives = 32/43 (74%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
           +V+  L  +H +G++HRDIKPENLL+T DG +KI DFG+   M
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359

Length = 507

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 24/201 (11%)

Query: 62  VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY 121
           +R K+ID   +  LK  ++K +  E        E  ++ QLD+P +VR+    +   +L 
Sbjct: 18  MRKKQIDVA-IKVLKNENEKSVRDEMMR-----EAEIMHQLDNPYIVRMIGVCEAE-ALM 70

Query: 122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           + +E   GG L   ++ K   ++         +V   ++Y+     +HRD+   N+LL  
Sbjct: 71  LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDD---KACTFVG-TAAYVPPEVLNSSPATFGN 236
             + KI+DFG  K +            +DD   KA +       +  PE +N    +  +
Sbjct: 131 QHYAKISDFGLSKAL-----------GADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 237 DLWALGCTLYQMLS-GTSPFK 256
           D+W+ G T+++  S G  P+K
Sbjct: 180 DVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 66/305 (21%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK----TAYVKLERIVLDQLDHPGVVR 109
           G G+Y  V +A+   T    ALK   K  + +E++    TA  ++   +L ++ H  +VR
Sbjct: 11  GEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREIS--LLKEMQHGNIVR 65

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE--ARFYTAEVVDALEYIHSMGLI 167
           L         LY+  E  +  +L   + S    +++    + Y  +++  + Y HS  ++
Sbjct: 66  LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 168 HRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           HRD+KP+NLL+      +K+ADFG       +R   +P      +    V T  Y  PE+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGL------ARAFGIPVRTFTHE----VVTLWYRAPEI 174

Query: 227 L-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD------ 271
           L      S+P     D+W++GC   +M++    F   SE    + IF+ +   +      
Sbjct: 175 LLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 272 -IRFPNYFS------------------DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
               P+Y S                   A  DL+ ++L +DPS R  A     A L+ H 
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR----AALE-HE 285

Query: 313 FFKGI 317
           +FK +
Sbjct: 286 YFKDL 290

Length = 294

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 51/289 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKL--ERIV 98
           +  LGK  G G + KVV+A           T  A+K++ +      + +    L  E  +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNL 56

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSEDEARFYTA- 152
           L Q++HP V++L+        L + +E  + G L  F + + K    +L  D  R  +  
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 153 ------------------EVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVK 193
                             ++   ++Y+  M L+HRD+   N+L+ A+G   KI+DFG  +
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 194 PM--QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
            +  +DS +       S  +         ++  E L     T  +D+W+ G  L+++++ 
Sbjct: 176 DVYEEDSYVK-----RSKGRI-----PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225

Query: 251 GTSPFKDTSEWLIFQRI-IARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           G +P+   +   +F  +     +  P   S+   +L+      +P  RP
Sbjct: 226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 12/164 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE-ARFYTA- 152
           E  V+ ++ HP +V+L          Y+  E    G L D +        +     Y A 
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 170

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 171 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 37/233 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +D +   + G G++ +V+RA  K D   + A   M K+F ++ +   +     ++     
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEA---------------- 147
           HP ++ L    ++   LY+A+E    G L D +     L  D A                
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 148 -RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVL 203
            +F  ++V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  L
Sbjct: 122 LQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 181 P--------------VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 45/246 (18%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER-------IVLD 100
           ++ G G + +V R +         LK+  K+ I    K  K+ Y + +R        ++ 
Sbjct: 10  EVIGAGEFGEVCRGR---------LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 60

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 158
           Q DHP ++ L      +  + +  E  E G L         L +++ +F   ++V  L  
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRG 114

Query: 159 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
                +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D          SD    
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD--------TSDPTYT 166

Query: 214 TFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA 269
           + +G      +  PE +     T  +D+W+ G  +++++S G  P+ D S   +    I 
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIE 225

Query: 270 RDIRFP 275
           +D R P
Sbjct: 226 QDYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 36/230 (15%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK--KFITKENKTAYVKLERIVL- 99
           S Q F++  + G G++ KVV A         A+KI+    K+ T++ K     +E++   
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKIEIQFMEKVRQA 185

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGE-LFDQITSKGHLSEDEARFYTAEVVDAL 158
           D  D   ++++   FQ+  + +M +   + G  L D I   G  S         +   AL
Sbjct: 186 DPADRFPLMKIQRYFQNE-TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 159 EYIHS-MGLIHRDIKPENLLL-TADG---------------HIKIADFGSVKPMQDSRIT 201
           +Y H+ + L+H D+KPEN+L+ T+D                 ++I D G     + SR  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
           +             V T  Y  PEV+      +  D+W++GC +Y++ +G
Sbjct: 305 I-------------VSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 66

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 147
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 204
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 187 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 54  GVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDHPGV 107
           G G++  V +   K   +    A+KI+       +N    +K E +    V+ QLD+P +
Sbjct: 4   GSGNFGTVKKGMYKMKKSEKTVAVKIL-----KNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           VR+     +  S  + +E  E G L   +    H++E        +V   ++Y+     +
Sbjct: 59  VRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP---- 223
           HRD+   N+LL    + KI+DFG            L  A   D+      T    P    
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFG------------LSKALGADENYYKAKTHGKWPVKWY 165

Query: 224 -PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            PE +N    +  +D+W+ G  +++  S G  P+K
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 16/209 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 152
           E  ++ +L H  +V L+    +   +Y+  E    G L D +      +L   +     A
Sbjct: 51  EAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ D + YI  M  IHRD++  N+L+  +   KIADFG  + ++D+  T    A    K 
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD 271
                   +  PE       T  +D+W+ G  L ++++ G  P+       + ++ + R 
Sbjct: 169 --------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERG 219

Query: 272 IRF--PNYFSDAARDLIDRLLDVDPSGRP 298
            R   P    ++  +L+      DP  RP
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 26/145 (17%)

Query: 139 KGHLSEDEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
           + +L +   R        Y +++   +EY+ S   +HRD+   N+L+ ++  +KI DFG 
Sbjct: 95  RDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLY 246
            K        VLP     DK    V      P     PE L  S  +  +D+W+ G  LY
Sbjct: 155 TK--------VLPQ----DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARD 271
           ++ + +   K  S    F R++  D
Sbjct: 203 ELFTYSD--KSCSPPAEFMRMMGND 225

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 52  IYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           + G G++ +V++A+ K D   + A     K++ +K++   +     ++     HP ++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEA-----------------RFYTAE 153
               +    LY+A+E    G L D +     L  D A                  F  A+
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AAD 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLPNAASDD 210
           V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP      
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP------ 174

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 175 --------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 50/240 (20%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLERI-------VLD 100
           K+ G G + +V R           LK+  +K +    K  K  Y + +R        ++ 
Sbjct: 11  KVIGAGEFGEVFRG---------ILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 158
           Q  H  ++RL           +  E  E G L D+     +L + +  F + ++V  L  
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DK-----YLRDHDGEFSSYQLVGMLRG 115

Query: 159 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
                +Y+  M  +HRD+   N+L+ ++   K++DFG            L     DD   
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG------------LSRVLEDDPEG 163

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           T+  +   +P     PE +     T  +D+W+ G  +++++S G  P+ D S   + + I
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 20/184 (10%)

Query: 126 SCEGGELFDQITSKGHLSEDEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLL 178
           S   G   DQ  +   L EDE          ++ +V   + ++ S   IHRD+   N+LL
Sbjct: 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247

Query: 179 TADGHIKIADFGSVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGND 237
           T     KI DFG  + ++ DS   V  NA    K         ++ PE + +   TF +D
Sbjct: 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESD 298

Query: 238 LWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDP 294
           +W+ G  L+++ S G+SP+        F ++I    R   P        D++    D DP
Sbjct: 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP 358

Query: 295 SGRP 298
             RP
Sbjct: 359 LKRP 362

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 43/203 (21%)

Query: 74  ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF 133
           A+KI+ +    K  +  ++K E  +L +L  P ++RL     D   L M  E  E G+L 
Sbjct: 50  AVKIL-RPDANKNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL- 106

Query: 134 DQITSKGHLSEDEAR--------------------FYTAEVVDALEYIHSMGLIHRDIKP 173
           +Q  S  HL + E                          ++   ++Y+ S+  +HRD+  
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166

Query: 174 ENLLLTADGHIKIADFGSVKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVL 227
            N L+  +  IKIADFG  + +      RI    VLP                ++  E +
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP--------------IRWMAWECI 212

Query: 228 NSSPATFGNDLWALGCTLYQMLS 250
                T  +D+WA G TL+++L 
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 12/195 (6%)

Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE 128
           TG    ++ ++ +  T E  T +++ E  V    +HP +V    TF     L++      
Sbjct: 24  TGEYVTVRRINLEACTNEMVT-FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 129 GGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            G   D I +     +SE    +    V+ AL+YIH MG +HR +K  ++L++ DG + +
Sbjct: 83  YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 142

Query: 187 ADFGSVKPM--QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDLWALG 242
           +   S   M     R+ V+      D     V    ++ PEVL  +   +   +D++++G
Sbjct: 143 SGLRSNLSMINHGQRLRVV-----HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197

Query: 243 CTLYQMLSGTSPFKD 257
            T  ++ +G  PFKD
Sbjct: 198 ITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 33/242 (13%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTA 90
           P+  FS     LGK  G G + +VV A+       K       A+K++      K+    
Sbjct: 8   PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 67

Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 68  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126

Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + +++  F      T +V   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 187 VN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 254 PF 255
           P+
Sbjct: 239 PY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 63/299 (21%), Positives = 106/299 (35%), Gaps = 65/299 (21%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            +LGKI G G +  V+  +   D G+    A+K M     T      ++  E   +   D
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFD 59

Query: 104 HPGVVRL---------------------FFTFQD--TFSLYMALESCEGGELFDQITSKG 140
           HP V++L                     F    D  +F LY  L                
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-----------GLPE 108

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----- 195
            L       +  ++   +EY+ +   IHRD+   N +L  D  + +ADFG  K +     
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Query: 196 -QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
            +  RI  +P                ++  E L     T  +D+WA G T++++ + G +
Sbjct: 169 YRQGRIAKMP--------------VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214

Query: 254 PFKDTSEWLIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
           P+       I+  +     ++ P    D   DL+      DP  RP      +  L+  
Sbjct: 215 PYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRP-----TFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 13/175 (7%)

Query: 128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA 187
           E       I     LS  +   ++ +V + +E++ S   +HRD+   N+L+     +KI 
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281

Query: 188 DFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
           DFG  +  M+DS      N  S  K  TF+      P  + N+   T  +D+W+ G  L+
Sbjct: 282 DFGLARDIMRDS------NYIS--KGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLW 332

Query: 247 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
           ++ + G +P+ +      F   I R  R   P + SD   +++ +  +     RP
Sbjct: 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 48/235 (20%)

Query: 48  ELGKIYGVGSYSKV----VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            L +  G G++ +V     R +  D      + +        E   +   +E +++ + +
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDA-VELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR-------------FY 150
           H  +VRL     +    ++ LE   GG+L      K  L E+  R             F 
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFC 121

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDS---RI---T 201
             +V    +Y+     IHRDI   N LLT  G     KIADFG  + +  +   R     
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           +LP                ++PPE       T   D+W+ G  L+++ S G  P+
Sbjct: 182 MLP--------------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 33/242 (13%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+   S     LGK  G G + +VV A+ I       +     A+K++      K+    
Sbjct: 5   PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64

Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG---------- 140
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 65  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123

Query: 141 -HLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             L E++  F        +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + 
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  L+++ + G S
Sbjct: 184 VH--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235

Query: 254 PF 255
           P+
Sbjct: 236 PY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 45/244 (18%)

Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK 139
           +K  T + K  ++K E  ++   +HP +V+L          Y+ +E  EGG+L   +   
Sbjct: 35  RKGATDQEKKEFLK-EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA 93

Query: 140 GHLSEDEARFYTA------------EVVDALEYIHSMGLIHRDIKPENLLLTADGH---- 183
                   RF               +V     Y+  M  IHRD+   N L++  G+    
Sbjct: 94  -----RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148

Query: 184 -IKIADFGSVKPMQDSRI------TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 236
            +KI DFG  + +  S         +LP                ++ PE L     T  +
Sbjct: 149 VVKIGDFGLARDIYKSDYYRKEGEGLLP--------------VRWMAPESLLDGKFTTQS 194

Query: 237 DLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDP 294
           D+W+ G  ++++L+ G  P+   +   + Q + A   ++ P    D    L+      DP
Sbjct: 195 DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254

Query: 295 SGRP 298
           S RP
Sbjct: 255 SERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 9e-08
 Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 108
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 109 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           RL       T  L   L     G L D +   K ++       +  ++   + Y+    L
Sbjct: 73  RLLGVCLSPTIQLVTQL--MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA---AYVP 223
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 179

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 23/223 (10%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVL 99
               +    K+ G G +  V +   I  G    + +  K    +  +  + ++    + +
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 158
             LDH  +VRL        SL +  +    G L D +   +  L       +  ++   +
Sbjct: 64  GSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+    ++HR++   N+LL +D  ++IADFG           +L     DDK   +  +
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD--------LLY---PDDK--KYFYS 169

Query: 219 AAYVPPEVLNSSPATFG-----NDLWALGCTLYQMLS-GTSPF 255
               P + +      FG     +D+W+ G T+++M+S G  P+
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 34/221 (15%)

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARF----YTAEVVD 156
           L+HP V++      ++    + LE C  G+L + + S +G +++   +        EV  
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV--KPMQDSRITVLPNAASDDKACT 214
            L ++H    IH D+   N  LTAD  +KI D+G    +  +D  IT       D  A  
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT------KDCHAVP 165

Query: 215 FVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTS-EWLIFQ 265
               A    PE++            T  +++W+LG T++++ +    P+ D S E ++ Q
Sbjct: 166 LRWLA----PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221

Query: 266 RIIARDIRFPNYFSDAARDLIDRLLDV------DPSGRPGA 300
            +  +DI+ P           DR  +V      DP  RP A
Sbjct: 222 VVREQDIKLPK--PQLDLKYSDRWYEVMQFCWLDPETRPTA 260

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 54/259 (20%), Positives = 101/259 (38%), Gaps = 69/259 (26%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+         LGK  G G++ +VV+A+ +        +  A+K++      K++ T   
Sbjct: 5   PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML------KDDAT--- 55

Query: 93  KLERIVLDQL----------DHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------- 134
             E+ + D +           H  ++ L         LY+ +E    G L D        
Sbjct: 56  --EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP 113

Query: 135 --------QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
                       +  L++ +   +  +V   +E++ S   IHRD+   N+L+T D  +KI
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173

Query: 187 ADFGSVKPMQ---------DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGND 237
           ADFG  + +          + R+ V                  ++ PE L     T  +D
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPV-----------------KWMAPEALFDRVYTHQSD 216

Query: 238 LWALGCTLYQMLS-GTSPF 255
           +W+ G  L+++ + G SP+
Sbjct: 217 VWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 37/185 (20%)

Query: 87  NKTA---YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
           NK A   ++K  +I + +L  P ++RL      +  L M  E  E G+L +Q  S+    
Sbjct: 59  NKNARNDFLKEIKI-MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQ 116

Query: 144 EDEA------------RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
           E                F   ++   ++Y+ S+  +HRD+   N L+  +  IKIADFG 
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 192 VKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
            + +      RI    VLP                ++  E +     T  +D+WA G TL
Sbjct: 177 SRNLYSGDYYRIQGRAVLP--------------IRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 246 YQMLS 250
           +++L+
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 39/273 (14%)

Query: 49  LGKIYGVGSYSKVVRAK--KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           LGK  G G +  V+  +  + D+    A+K M     T+     ++  E + + + DHP 
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDHPN 61

Query: 107 VVRLF-FTFQDTFSL----------YMALESCEGGELFDQITSKG-HLSEDEARFYTAEV 154
           V+RL     Q   S           +M         L+ ++     +L       +  ++
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM------QDSRITVLPNAAS 208
              +EY+ S   IHRD+   N +L  + ++ +ADFG  K +      +  RI  +P    
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP---- 177

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK--DTSEWLIFQ 265
                       ++  E L     T  +D+W+ G T++++ + G +P+   + SE   + 
Sbjct: 178 ----------VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Query: 266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           R   R ++ P    D    L+     ++P  RP
Sbjct: 228 RQGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF----- 149
           E  ++ +L H  +V+L+    +   +Y+  E    G L D       L + E R      
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLD------FLKDGEGRALKLPN 103

Query: 150 ---YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPN 205
                A+V   + YI  M  IHRD++  N+L+  DG + KIADFG  + ++D+  T    
Sbjct: 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF 264
           A    K         +  PE       T  +D+W+ G  L ++++ G  P+   +   + 
Sbjct: 163 AKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213

Query: 265 QRIIARDIRFP 275
           ++ + R  R P
Sbjct: 214 EQ-VERGYRMP 223

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 39/245 (15%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VVRA+       + D     A+K++      K+    
Sbjct: 5   PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64

Query: 91  YVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK---------- 139
             ++E + ++ +  H  ++ L         LY+ +E    G L + + ++          
Sbjct: 65  ISEMELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 140 -GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 193
              + E++  F        +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  +
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 194 PMQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
            + D           D    T  G     ++ PE L     T  +D+W+ G  ++++ + 
Sbjct: 183 GVHD----------IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232

Query: 251 GTSPF 255
           G SP+
Sbjct: 233 GGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 70  GTVY--ALKIMDKKFIT---KENKTAYVKLERI-------VLDQLDHPGVVRLFFTFQDT 117
           G V    LK+  KK I    K  K      +R+       ++ Q DHP ++RL      +
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-------EYIHSMGLIHRD 170
             + +  E  E G L         L E++ +F   ++V  L       +Y+  M  +HRD
Sbjct: 78  RPVMIITEYMENGSL------DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +   N+L+ ++   K++DFG       SR      A    K         +  PE +   
Sbjct: 132 LAARNILVNSNLVCKVSDFGL------SRRLEDSEATYTTKGGKI--PIRWTAPEAIAYR 183

Query: 231 PATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             T  +D+W+ G  +++++S G  P+ D S
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG---------ELF 133
           +TK  +  ++K E  ++ +L +P ++RL         L M  E  E G         E+ 
Sbjct: 56  VTKTARNDFLK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114

Query: 134 DQITSKGHL---SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
              T   ++   S     +   ++   ++Y+ S+  +HRD+   N L+     IKIADFG
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 191 SVKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 244
             + +      RI    VLP                ++  E +     T  +D+WA G T
Sbjct: 175 MSRNLYSGDYYRIQGRAVLP--------------IRWMAWESILLGKFTTASDVWAFGVT 220

Query: 245 LYQMLS 250
           L++M +
Sbjct: 221 LWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 18/205 (8%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V       T  V A+K +    ++ E   A+++ E  V+ +L H  +V+L+  
Sbjct: 15  GQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAV 69

Query: 114 FQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
             +   +Y+  E    G L D +  +   +L   +     A++   + Y+  M  +HRD+
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
           +  N+L+  +   K+ADFG  + ++D+  T    A    K         +  PE      
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---------WTAPEAALYGR 179

Query: 232 ATFGNDLWALGCTLYQMLS-GTSPF 255
            T  +D+W+ G  L ++ + G  P+
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 53/252 (21%), Positives = 99/252 (39%), Gaps = 39/252 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI--V 98
           H   +D  L +  G G++ KV  A+  +        ++  K +      A    +R   +
Sbjct: 1   HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 60

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF----------------DQITSKGHL 142
           L  L H  +V+ +    D   L M  E  + G+L                     +KG L
Sbjct: 61  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---R 199
              +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  +   R
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180

Query: 200 I---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           +   T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P+
Sbjct: 181 VGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 256 KDTSEWLIFQRI 267
              S   + + I
Sbjct: 227 FQLSNTEVIECI 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 16/160 (10%)

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 201
           +D  RF +++V   ++++ S   IHRD+   N+LLT DG + KI DFG  +  M DS   
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYV 269

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE 260
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G SP+     
Sbjct: 270 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320

Query: 261 WLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
              F +++ R  +   P++       ++    +++P+ RP
Sbjct: 321 NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 38/202 (18%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-----------------T 137
           E  ++ +L HP +V L         + M  E    G+L + +                 T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
            K  L   +      ++   +EY+ S   +H+D+   N+L+    H+KI+D G  + +  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 198 S---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
           +   R+   ++LP                ++PPE +     +  +D+W+ G  L+++ S 
Sbjct: 177 ADYYRVQPKSLLP--------------IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222

Query: 251 GTSPFKDTSEWLIFQRIIARDI 272
           G  P+   S   + + +  R +
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 50/281 (17%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           F LG++ G G +  V  A+ K + G+    A+K++     +  +   +++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 104 HPGVVRL---------------------FFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
           HP V++L                     F    D  +  +   S  G E F        L
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM--SRIGEEPFT-------L 110

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
                  +  ++   +EY+ S   IHRD+   N +L  +  + +ADFG  K +       
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY------ 164

Query: 203 LPNAASDD---KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT 258
                S D   + C       ++  E L  +  T  +D+WA G T++++++ G +P+   
Sbjct: 165 -----SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219

Query: 259 SEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
               I+  +I  + ++ P    +   +L+ +    +P  RP
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 31/224 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDH 104
            E  K+ G G++  V +   I  G    + +  K    + +  A  ++  E  V+  +DH
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 105 PGVVRLF-FTFQDTFSL---YMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           P VVRL          L    M L     G L D +   K ++       +  ++   + 
Sbjct: 69  PHVVRLLGICLSSQVQLITQLMPL-----GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+    L+HRD+   N+L+    H+KI DFG  K        +L     D+K   +    
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK--------LLD---VDEK--EYHAEG 170

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
             VP      E +     T  +D+W+ G T++++++ G  P++ 
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 53/283 (18%)

Query: 46  DFELGKIYGVGSYSKVVR--AKKIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLD 100
              L +  G GS+  V    AK +  G      A+K +++    +E    ++  E  V+ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLN-EASVMK 64

Query: 101 QLDHPGVVRLF---FTFQDTFSL--YMALESCEGGELFDQITSKGHLSEDEA-------- 147
           + +   VVRL     T Q T  +   MA      G+L   +  +    E E         
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAK-----GDLKSYL--RSRRPEAENNPGLGPPT 117

Query: 148 --RFY--TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---RI 200
             +F    AE+ D + Y+ +   +HRD+   N ++  D  +KI DFG  + + ++   R 
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 201 T---VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
               +LP                ++ PE L     T  +D+W+ G  L++M +    P++
Sbjct: 178 GGKGLLP--------------VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223

Query: 257 DTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRP 298
             S   + + +I       P    D   +L+      +P  RP
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 35/164 (21%), Positives = 72/164 (43%), Gaps = 12/164 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTA 152
           E  ++ +L HP +++L+        +Y+  E  + G L +  Q  +   L   +     A
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +V   + Y+ +   IHRD+   N+L+  +   K+ADFG  + +++        A    K 
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK- 169

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE    +  +  +D+W+ G  L ++++ G  P+
Sbjct: 170 --------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 29/222 (13%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +F+  K+ G G++  V +   I  G       A+K + +    K NK   +  E  V+  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMAS 65

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           +D+P V RL       T  L   L     G L D +   K ++       +  ++   + 
Sbjct: 66  VDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+    L+HRD+   N+L+    H+KI DFG  K +            +D+K   +    
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GADEKE--YHAEG 170

Query: 220 AYVPP-----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             VP      E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           E+G+  G  + + V  A+   TGT+  ++I D +  T+E+  A    E ++     HP +
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQN-EVVLSHFFRHPNI 61

Query: 108 VRLFFTFQD-----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +  +  F         S +MA  S     L      +G +SE          +  L Y+H
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSAN--SLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGS----VKPMQDSRITV-LPNAASDDKACTFVG 217
             G IHR+IK  ++L++ DG + ++        V+  Q +++    P  ++         
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST--------S 170

Query: 218 TAAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 257
              ++ PE+L      +   +D++++G T  ++ +G  PF+D
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 13/168 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E + L Q DH  +VRL        ++ +  E    G L D    K  G L   +      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLP 114

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
            +   ++Y+  MG +H+ +    +L+ +D   KI+ F     +Q+ +   +    S    
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS- 170

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                   +  PE +     +  +D+W+ G  +++++S G  P+ D S
Sbjct: 171 -----PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAAS 208
           +T +V   +E++ S   +HRD+   N+LL     +KI DFG  +  M DS      N  S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS------NYVS 295

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
             K  TF+    ++ PE +  +  T  +D+W+ G  L+++ S G +P+        F   
Sbjct: 296 --KGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352

Query: 268 IARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
           I    R   P++ +    D++ +  + +P  RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 38/195 (19%), Positives = 83/195 (42%), Gaps = 37/195 (18%)

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------- 152
           L HP +++      +     +  E CE G+L      K +LS+++     +         
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQRMA 105

Query: 153 -EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP--MQDSRITVLPNAASD 209
            E+   + ++H    +H D+   N  LT+D  +K+ D+G + P   ++  I       ++
Sbjct: 106 CEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG-IGPSRYKEDYIE------TE 158

Query: 210 DKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQML-SGTSPFKDTSEW 261
           D  C       ++ PE++         +  T  +++WALG TL+++  +   P+   S+ 
Sbjct: 159 DDKCV---PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215

Query: 262 LIFQRIIA-RDIRFP 275
            +   +I  + ++  
Sbjct: 216 EVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 18/153 (11%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +V   +EY+ S   +HRD+   N +L     +K+ADFG  + + D     + N       
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH------ 159

Query: 213 CTFVGTAAYVPP-----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR 266
                T A +P      E L +   T  +D+W+ G  L+++++ G  P+ D   + I   
Sbjct: 160 -----TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214

Query: 267 II-ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           ++  R +  P Y  D   +++       P  RP
Sbjct: 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRP 247

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 51/240 (21%)

Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G + +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-----------GHLSEDEARFY 150
             H  ++ L         LY+ +E    G L + + ++             + E++  F 
Sbjct: 82  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 151 -----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV---------KPMQ 196
                  +V   +EY+ S   IHRD+   N+L+T D  +KIADFG           K   
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           + R+ V                  ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 201 NGRLPV-----------------KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 17/155 (10%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           Y+ +V   +E++ S   IHRD+   N+LL+ +  +KI DFG  + +        P+    
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-----PDYVRK 238

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII 268
             A        ++ PE +     T  +D+W+ G  L+++ S G SP+        F R +
Sbjct: 239 GDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Query: 269 ARDIRF--PNYFSDAARDLIDRLLDV---DPSGRP 298
               R   P+Y +    ++   +LD    +PS RP
Sbjct: 296 KEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRP 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 17/155 (10%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAAS 208
           Y+ +V   +E++ S   IHRD+   N+LL+ +  +KI DFG  + + +D       +A  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF-QR 266
             K         ++ PE +     T  +D+W+ G  L+++ S G SP+        F QR
Sbjct: 239 PLK---------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289

Query: 267 IIARD---IRFPNYFSDAARDLIDRLLDVDPSGRP 298
           +  +D   +R P   +     ++      DP  RP
Sbjct: 290 L--KDGTRMRAPENATPEIYRIMLACWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 31/159 (19%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGH-------IKIADFGSVKPMQDSRITVLPN 205
           ++  AL Y+    L+H ++  +N+L+   G        IK++D G         ITVL  
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-------IPITVLSR 161

Query: 206 AASDDKACTFVGTAAYVPPE---VLNSSPATFGNDLWALGCTLYQMLS-GTSPFK--DTS 259
               ++         ++ PE      +S      D W+ G TL ++ S G  P     +S
Sbjct: 162 EERVER-------IPWIAPECIRNGQASLTIAA-DKWSFGTTLLEICSNGEEPLSTLSSS 213

Query: 260 EWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           E   F +      R P        +LI++    DP+ RP
Sbjct: 214 EKERFYQ---DQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 38/243 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI--V 98
           H   +D  L    G G++ KV  A+  +        ++  K + + +++A    +R   +
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF---------------DQITSKGHLS 143
           L  L H  +VR +    +   L M  E    G+L                 +  + G L+
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---RI 200
             +     +++   + Y+ S+  +HRD+   N L+     +KI DFG  + +  +   R+
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 201 ---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
              T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P+ 
Sbjct: 181 GGRTMLP--------------IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Query: 257 DTS 259
             S
Sbjct: 227 QLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 40/185 (21%), Positives = 77/185 (41%), Gaps = 34/185 (18%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-------------H 141
           E  +L  L H  +V+ +    +   L M  E  + G+L   + + G              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--- 198
           L++ +      ++   + Y+ S   +HRD+   N L+  +  +KI DFG  + +  +   
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 199 RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 254
           R+   T+LP                ++PPE +     T  +D+W+LG  L+++ + G  P
Sbjct: 177 RVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Query: 255 FKDTS 259
           +   S
Sbjct: 223 WYQLS 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 29/116 (25%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS---- 208
           ++   + Y+H  G+IH+DI   N ++  +  +KI D                NA S    
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD----------------NALSRDLF 168

Query: 209 -DDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
             D  C  +G     P      E L +   +  +D+W+ G  L+++++ G +P+ +
Sbjct: 169 PMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 51/260 (19%), Positives = 98/260 (37%), Gaps = 44/260 (16%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
              +      +  G G++ KV + +     +  + T  A+K + +    K  +    + E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------------FDQITSK 139
             ++  L HP +V L           M  E    G+L                    T K
Sbjct: 61  --LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS- 198
             L   +      ++   +EY+ S   +HRD+   N L+     +KI+DFG  + +  + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 199 --RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GT 252
             R+   ++LP                ++PPE +     T  +D+W+ G  L+++ S G 
Sbjct: 179 YYRVQSKSLLP--------------VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224

Query: 253 SPFKDTSEWLIFQRIIARDI 272
            P+   S   + + I +R +
Sbjct: 225 QPYYGFSNQEVIEMIRSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 50/245 (20%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKL- 94
           H       L +  G G++ KV        G  Y L+  + K +      KE  +   +  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFL------GECYHLEPENDKELVAVKTLKETASNDARKD 54

Query: 95  ---ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS------------- 138
              E  +L    H  +V+ +    +     M  E  E G+L   + S             
Sbjct: 55  FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 139 -KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
             G L+  +      ++   + Y+ S   +HRD+   N L+  D  +KI DFG  + +  
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174

Query: 198 S---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
           +   R+   T+LP                ++PPE +     T  +D+W+ G  L+++ + 
Sbjct: 175 TDYYRVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220

Query: 251 GTSPF 255
           G  P+
Sbjct: 221 GKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 29/217 (13%)

Query: 51  KIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           K+ G G++  V +   I  G       A+K++ +    K NK   +  E  V+  +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 70

Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
           V RL       T  L   L     G L D +  +K  +   +   +  ++   + Y+  +
Sbjct: 71  VCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            L+HRD+   N+L+ +  H+KI DFG  + +             D     +      VP 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------------DIDETEYHADGGKVPI 175

Query: 225 -----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                E +     T  +D+W+ G T++++++ G  P+
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 30/149 (20%), Positives = 65/149 (43%), Gaps = 10/149 (6%)

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++            K
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RK 177

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
               +    ++ PE L     T  +D+W+ G  L+++ +    P++  S   + + ++  
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237

Query: 271 D-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
             +  P+   D   +L+      +P  RP
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 28/201 (13%)

Query: 61  VVRAKKIDTGTVYALKIM--DKKFITKE-NKTAYVKLERIV-LDQLDHPGVVRLFFTFQD 116
           + R KK   G  Y  K +    +F+ KE N    +    I  + +L HP +V+L    + 
Sbjct: 698 ISRGKK---GASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS 754

Query: 117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH---SMGLIHRDIKP 173
               Y+  E  EG  L + + +   LS +  R     +  AL ++H   S  ++  ++ P
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           E ++      I   D       +      LP     D  C    ++AYV PE   +   T
Sbjct: 812 EKII------IDGKD-------EPHLRLSLPGLLCTDTKCFI--SSAYVAPETRETKDIT 856

Query: 234 FGNDLWALGCTLYQMLSGTSP 254
             +D++  G  L ++L+G SP
Sbjct: 857 EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 42.4 bits (100), Expect = 8e-05
 Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 23/113 (20%)

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 201
           L+E+E     A  +  L  +     +HR  K  N+LLT DG +K+   GSV         
Sbjct: 14  LNEEEI---WAVCLQCLGALRE---LHRQAKSGNILLTWDGLLKL--DGSV--------A 57

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
                 S            ++ PEV+     T   D+++LG TLY+ L    P
Sbjct: 58  FKTPEQSR-------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 26/110 (23%), Positives = 51/110 (46%), Gaps = 9/110 (8%)

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
            AE+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++            
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------R 176

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           K    +    ++ PE L     T  +D+W+ G  L+++ S    P++  S
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 60/283 (21%), Positives = 109/283 (38%), Gaps = 53/283 (18%)

Query: 54  GVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKL----ERIVLDQLDH 104
           G G++ +V +A+       +  T+ A+K++      KE  +A ++     E  ++ + DH
Sbjct: 14  GQGAFGRVFQARAPGLLPYEPFTMVAVKML------KEEASADMQADFQREAALMAEFDH 67

Query: 105 PGVVRLF------------FTFQDTFSLYMALESC----------EGGELFDQITSKGHL 142
           P +V+L             F +     L   L                       +   L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           S  E      +V   + Y+     +HRD+   N L+  +  +KIADFG  + +  +    
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 186

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP-FKDTSE 260
               AS++ A        ++PPE +  +  T  +D+WA G  L+++ S G  P +    E
Sbjct: 187 ---KASENDAIPI----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239

Query: 261 WLIFQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
            +I+     RD   +  P+       +L+       PS RP  
Sbjct: 240 EVIYY---VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 37/158 (23%)

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAAS 208
           AL ++   GL H ++  +N+LL  +          IK++D G         ITVLP    
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG-------ISITVLPKEIL 164

Query: 209 DDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSG-TSPFK--DTSEWLIF 264
            ++         +VPPE + N    +   D W+ G TL+++ SG   P    D+ + L F
Sbjct: 165 LER-------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217

Query: 265 ----QRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                ++ A     P +   A   LI++ +D +P  RP
Sbjct: 218 YEDRHQLPA-----PKWTELAN--LINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 16/42 (38%), Positives = 25/42 (59%)

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
             +++  LEYIH  G+ H DIKPEN+++  +    I D+G  
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 34/136 (25%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG--SVKPMQDSRITVLPNAASDD 210
           E+   L ++H    IH D+   N LLTAD  +KI D+G    K  +D  +T       D 
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT------PDQ 161

Query: 211 KACTFVGTAAYVP-----PEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKD 257
                     +VP     PE+++           T  +++W+LG T++++   G+ P++ 
Sbjct: 162 L---------WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Query: 258 TSEWLIFQRIIARDIR 273
            S+    ++++   +R
Sbjct: 213 LSD----EQVLTYTVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 16/40 (40%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGS 191
           +++ AL+ +HS G++HRD+KP+N++ +   G  KI D G+
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302

Length = 566

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 34/197 (17%)

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F +  SL    E  EG EL+ +  +   L       Y+ +V   +E++ S   IHRD+  
Sbjct: 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLIS-----YSFQVARGMEFLASRKCIHRDLAA 201

Query: 174 ENLLLTADGHIKIADFGSVKPMQ---------DSRITVLPNAASDDKACTFVGTAAYVPP 224
            N+LL+ +  +KI DFG  + +          D+R   LP                ++ P
Sbjct: 202 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR---LP--------------LKWMAP 244

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDA 281
           E +     T  +D+W+ G  L+++ S G SP+        F R +    R   P Y +  
Sbjct: 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304

Query: 282 ARDLIDRLLDVDPSGRP 298
              ++      +P  RP
Sbjct: 305 IYSIMLDCWHNNPEDRP 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 39/203 (19%), Positives = 78/203 (38%), Gaps = 37/203 (18%)

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF----------------DQI 136
           K E ++  +L HP +V L         L M    C   +L                 D  
Sbjct: 56  KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
           T K  L   +      ++   +E++ S  ++H+D+   N+L+    ++KI+D G  + + 
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 197 DSRI------TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
            +        ++LP                ++ PE +     +  +D+W+ G  L+++ S
Sbjct: 176 AADYYKLMGNSLLP--------------IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Query: 251 -GTSPFKDTSEWLIFQRIIARDI 272
            G  P+   S   + + I  R +
Sbjct: 222 YGLQPYCGYSNQDVIEMIRNRQV 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 15/107 (14%)

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT------ 151
           +L +L  P + RL         L M +E  E G+L +Q   K H++E             
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQK-HVAETSGLACNSKSLSF 129

Query: 152 -------AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
                   ++   + Y+ S+  +HRD+   N L+  +  IKIADFG 
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 27/212 (12%)

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA-EVVD 156
           ++ Q+ H  +V L+          M  E  E G L   +  K  +     +F  A ++  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADG-------HIKIADFGSVKPMQDSRITVLPNAASD 209
           AL Y+    L+H ++  +N+LL  +G        IK++D G         ITVL      
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG-------IPITVLSRQECV 169

Query: 210 DKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQM-LSGTSPFKDTSEWLI-FQR 266
           ++         ++ PE V +S   +   D W+ G TL+++  +G  P KD +  L   +R
Sbjct: 170 ER-------IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--LAEKER 220

Query: 267 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                            DL+   ++ DP+ RP
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	366
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
smart00090	237	RIO RIO-like kinase.	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG1243	690	consensus Protein kinase [General function predict	99.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.52
KOG3087	229	consensus Serine/threonine protein kinase [General	99.46
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.45
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.44
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.19
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.12
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.05
PRK09902	216	hypothetical protein; Provisional	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.95
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.92
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.75
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.64
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.6
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.58
PF01636	239	APH: Phosphotransferase enzyme family This family	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.39
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.27
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.21
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.97
PRK10593	297	hypothetical protein; Provisional	97.9
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.87
KOG2270	520	consensus Serine/threonine protein kinase involved	97.84
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.83
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.76
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.71
PRK05231	319	homoserine kinase; Provisional	97.67
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.66
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.56
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.36
PLN02236	344	choline kinase	97.33
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.33
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.2
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.18
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.02
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.97
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.96
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.93
PRK12396	409	5-methylribose kinase; Reviewed	96.8
PLN02756	418	S-methyl-5-thioribose kinase	96.8
PTZ00384	383	choline kinase; Provisional	96.72
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.45
PTZ00296	442	choline kinase; Provisional	96.18
PRK11768	325	serine/threonine protein kinase; Provisional	96.18
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.15
PRK06148	1013	hypothetical protein; Provisional	95.75
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.4
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.37
PRK10271	188	thiK thiamine kinase; Provisional	95.15

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-65  Score=449.96  Aligned_cols=284  Identities=42%  Similarity=0.751  Sum_probs=260.6

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      +....++|+++++||+|+||.|++++.++|++.||+|++++..+........+..|..+|..++||+||+++..|++...
T Consensus        20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             ccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            45778999999999999999999999999999999999999888777778889999999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+|+||+.||+|...+++++.++|..++.++..|+.||.|||++||+||||||+|||+|.+|+++|+|||+++..-.. 
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-  178 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-  178 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999854332 


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYF  278 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~  278 (366)
                               .....+++||+.|||||++.+..|+.++|+||||+++|+|++|.+||.+.+...+.++|..++.. .|..+
T Consensus       179 ---------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~l  249 (357)
T KOG0598|consen  179 ---------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYL  249 (357)
T ss_pred             ---------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccC
Confidence                     33455789999999999999999999999999999999999999999999999999999999944 55569


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~  334 (366)
                      +.++++||+++|..||++|..+ ....+++.+||||..++|+.+.+. ..|++.|..
T Consensus       250 s~~ardll~~LL~rdp~~RLg~-~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~  305 (357)
T KOG0598|consen  250 SEEARDLLKKLLKRDPRQRLGG-PGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV  305 (357)
T ss_pred             CHHHHHHHHHHhccCHHHhcCC-CCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence            9999999999999999999873 335689999999999999998754 567776654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-65  Score=463.51  Aligned_cols=288  Identities=53%  Similarity=0.903  Sum_probs=268.7

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  119 (366)
                      .....||.+++.||.|+|++|++|+++.++..||||++.+..+.++.....+..|...|.+| +||.|++++..|+|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            67889999999999999999999999999999999999999999999999999999999999 89999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+|+||+++|+|.+++.+.|.+++..++.++.||+.||+|||++|||||||||+|||++.+|+++|+|||.|+.+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999887664


Q ss_pred             cccc---CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 017775          200 ITVL---PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (366)
Q Consensus       200 ~~~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  276 (366)
                      ....   ..........+++||..|.+||++.....+..+|||+||||+|+|+.|.+||.+.++...+++|+...+.+|+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence            3311   1111222346799999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASE  333 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~~~~~~~~  333 (366)
                      ++++.+++||+++|..||++|+|+     ++|..||||.+++|+++..++||++.+-
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~-----~qIk~HpFF~~Vdw~nlw~~~PP~l~py  360 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTS-----QQIKAHPFFEGVDWENLWQQTPPKLQPY  360 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccH-----HHHhhCcccccCChhhhhhcCCCcccCC
Confidence            999999999999999999999999     8999999999999999988888877663

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-64  Score=426.61  Aligned_cols=282  Identities=42%  Similarity=0.760  Sum_probs=263.5

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ++.+..+++|+.++.||.|+||.|.+++.+.+|..||+|++++..+-+-...+...+|..+|+.+.||+++++++.+.+.
T Consensus        37 ~~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~  116 (355)
T KOG0616|consen   37 PQNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN  116 (355)
T ss_pred             CCCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence            34448999999999999999999999999999999999999988777777788899999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+|+||||++||.|..++.+.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+|++|||+|+....
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999997754


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                                   ...+.+|||.|+|||++...+|+.++|+||||+++|||+.|.+||...++..++++|+.+++.+|..
T Consensus       197 -------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~  263 (355)
T KOG0616|consen  197 -------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY  263 (355)
T ss_pred             -------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc
Confidence                         3457899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      +++++++||.++|+.|-.+|.+--..+.++|.+||||++++|..+..+ ..||..|
T Consensus       264 fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p  319 (355)
T KOG0616|consen  264 FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP  319 (355)
T ss_pred             cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence            999999999999999999997766667799999999999999988754 3455544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6e-62  Score=444.22  Aligned_cols=293  Identities=41%  Similarity=0.725  Sum_probs=258.8

Q ss_pred             cCCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           36 RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        36 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      ...+..++.+||+++++||+|+||.||+|+.+.||..||+|++++...........++.|..+|...++|+||++|..|+
T Consensus       132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            34566789999999999999999999999999999999999999988888888889999999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +..++|+||||.+||++..++.+.+.|+++.++.++.+++.|++.+|+.|+|||||||+|+|||..|++||+|||++.-+
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999654


Q ss_pred             CCcccc---------------ccCCCCCC----------------------CCccccccCCCCCCceeecCCCCCCCCCc
Q 017775          196 QDSRIT---------------VLPNAASD----------------------DKACTFVGTAAYVPPEVLNSSPATFGNDL  238 (366)
Q Consensus       196 ~~~~~~---------------~~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  238 (366)
                      ......               ..+.....                      ..+.+.+|||.|+|||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            331110               01111110                      02245689999999999999999999999


Q ss_pred             ccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       239 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ||||||+||||.|.+||.+.++.+.+.+|..-.  +.+|.  .++++++|||.+||+ ||++|..+  .++++|+.||||
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~HPfF  448 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKKHPFF  448 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhcCCcc
Confidence            999999999999999999999999999998754  56664  578999999999999 99999984  477999999999


Q ss_pred             CCCCccccccCCCCCCCC
Q 017775          315 KGIDWKNIRGQTPPKLAS  332 (366)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~  332 (366)
                      ++++|+.+.... |++.|
T Consensus       449 ~~v~W~~l~~~~-apfvP  465 (550)
T KOG0605|consen  449 KGVDWDHLREMP-APFVP  465 (550)
T ss_pred             ccCCcchhhcCC-CCCCC
Confidence            999999998654 44443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-61  Score=448.62  Aligned_cols=256  Identities=35%  Similarity=0.706  Sum_probs=246.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      .+|..++.||+|+|+.+|.+++..+|+.||+|++.+..+.+....+.+.+|+++.+.++|||||+++++|+|.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            67999999999999999999999999999999999988888888899999999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |+|..++|.+++++++.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+...      
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~------  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD------  171 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc------
Confidence            99999999999999999999999999999999999999999999999999999999999999999999987643      


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                          ..+..+.+|||.|.|||++....++..+||||+||++|.||.|++||+..+-.+.+.+|...+..+|..+|.++++
T Consensus       172 ----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~d  247 (592)
T KOG0575|consen  172 ----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKD  247 (592)
T ss_pred             ----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHH
Confidence                2455688999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ||++||++||.+|||+     ++++.|+||+
T Consensus       248 LI~~lL~~~P~~Rpsl-----~~vL~h~Ff~  273 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSL-----DEVLDHPFFK  273 (592)
T ss_pred             HHHHHhcCCcccCCCH-----HHHhcCHhhh
Confidence            9999999999999999     8999999993

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-61  Score=427.48  Aligned_cols=260  Identities=38%  Similarity=0.580  Sum_probs=232.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc----hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ....|.+.+.||+|+||.|-+|..+.||+.||||++++.....    ......+++|+++|++++|||||+++++|+...
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4678999999999999999999999999999999999865444    223445679999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCCcccc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPM  195 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~a~~~  195 (366)
                      ..||||||++||+|.+.+..++.+.|..-+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999877   68999999999987


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCC---CCCCCCcccchhhhhhhhcCCCCCCCCCHHH-HHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~  271 (366)
                      ++..           ...+.+||+.|.|||++.+..   +..++|||||||++|-+++|.+||.+..... ..++|..+.
T Consensus       330 g~~s-----------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  330 GEGS-----------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             ccce-----------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence            6543           445889999999999997655   4457899999999999999999998765555 778888887


Q ss_pred             CCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       272 ~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +.+-    ..+++++.+||.+||..||++|||+     .++|+||||+.+.
T Consensus       399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~-----~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSA-----DEALNHPWFKDAP  444 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHHhhEeCcccCcCH-----HHHhcChhhhccc
Confidence            7654    4589999999999999999999999     8899999999765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-60  Score=417.11  Aligned_cols=263  Identities=31%  Similarity=0.505  Sum_probs=239.2

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-  118 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-  118 (366)
                      ..++..+.+.++.||+|..|+||+|+++.|+..+|+|++...  ........+.+|+++++..+||+||++|+.|..+. 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            456677999999999999999999999999999999999543  35666777888999999999999999999999999 


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .++|+||||+||+|.+++...+.++|..+..++.++++||.|||+ ++|+||||||+|||++..|.|||+|||.+..+..
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            499999999999999999988999999999999999999999995 9999999999999999999999999999987754


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC-----CHHHHHHHHhcC-C
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIAR-D  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~-~  271 (366)
                      .            .+.+++||..|||||.+.+..|+.++||||||++++|+++|+.||...     ...+++..|..+ .
T Consensus       232 S------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  232 S------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP  299 (364)
T ss_pred             h------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence            3            445889999999999999999999999999999999999999999774     667888888874 5


Q ss_pred             CCCCCC-CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          272 IRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       272 ~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      +.+|.. +|+++++||..||++||.+|||+     .+++.|||++.....+
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~-----~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSA-----KQLLQHPFIKKFEDPN  345 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCHHHhhccccc
Confidence            667886 99999999999999999999999     8999999998765433

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-60  Score=442.26  Aligned_cols=284  Identities=36%  Similarity=0.654  Sum_probs=262.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  119 (366)
                      .+++++|.++++||+|+||.|+++..+.+++.||||++++..+-..+..+....|..++.... ||.++.++..|++...
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            889999999999999999999999999999999999999998888888888888999988875 9999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+||||+.||++.. +.+.+.+++..++.++..++.||.|||++||||||||.+|||+|.+|++||+|||+++....  
T Consensus       444 l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--  520 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--  520 (694)
T ss_pred             EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC--
Confidence            999999999999543 33446799999999999999999999999999999999999999999999999999985432  


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s  279 (366)
                              ....+.+++|||.|+|||++.+..|+.++|+|||||+||||+.|+.||.++++++++..|+..++.+|..+|
T Consensus       521 --------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls  592 (694)
T KOG0694|consen  521 --------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS  592 (694)
T ss_pred             --------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence                    234667899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCCc
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEPM  335 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~~  335 (366)
                      .++.++++++|.+||++|..+.+...++|+.||||+.++|+.+... ..|++.|...
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~  649 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIK  649 (694)
T ss_pred             HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccC
Confidence            9999999999999999999998878899999999999999998754 5666666543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-58  Score=406.87  Aligned_cols=292  Identities=36%  Similarity=0.635  Sum_probs=259.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ....+.+++|++++.||.|.-|+||+|..+.++..+|+|++.+..+.........+.|.+||+.++||.+..+|..|+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            45678899999999999999999999999999999999999998877777777888899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      ...|++||||+||+|..+.+++  +.++++.++.++.+++.||+|||..|||+|||||+||||.++|++.|+||.++...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999999999876  46999999999999999999999999999999999999999999999999998655


Q ss_pred             CCcccccc---------------------------C-------------------CCCCCCCccccccCCCCCCceeecC
Q 017775          196 QDSRITVL---------------------------P-------------------NAASDDKACTFVGTAAYVPPEVLNS  229 (366)
Q Consensus       196 ~~~~~~~~---------------------------~-------------------~~~~~~~~~~~~gt~~y~aPE~~~~  229 (366)
                      .....-..                           .                   ......+..+++||-.|.|||++.|
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            32110000                           0                   0111234567799999999999999


Q ss_pred             CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHh
Q 017775          230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAV  307 (366)
Q Consensus       230 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~  307 (366)
                      ...+.++|||+||+.+|||+.|..||.+.+..+.+.+|+.+.+.+|.  .++.+++|||+++|.+||++|..... ++++
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r-GA~e  388 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR-GAAE  388 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc-chHH
Confidence            99999999999999999999999999999999999999999999986  47899999999999999999998543 5599


Q ss_pred             hhcCCCCCCCCccccccCCCCCC
Q 017775          308 LKMHPFFKGIDWKNIRGQTPPKL  330 (366)
Q Consensus       308 ~l~hp~f~~~~~~~~~~~~~~~~  330 (366)
                      |+.||||++++|..++...||..
T Consensus       389 IK~HpFF~gVnWaLir~~~PP~i  411 (459)
T KOG0610|consen  389 IKRHPFFEGVNWALIRCARPPEI  411 (459)
T ss_pred             hhcCccccCCChhheeccCCCcC
Confidence            99999999999997776665554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-57  Score=421.25  Aligned_cols=266  Identities=34%  Similarity=0.592  Sum_probs=245.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      -+.+-|++++.||.|+-|.|.+|++..||+..|||++.+...........+.+|+-+|+.+.|||++++|++|++..++|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            34677999999999999999999999999999999998875445555667889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|+||++||.|++++-++|++++.++.++++||+.|+.|||..+|+||||||+|+|++..+++||+|||+|..-.++.  
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--  166 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--  166 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998544332  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                               ...+.+|++.|.|||++.|.+| +.++||||.|||||.||+|..||.+++...++.++..+.++.|..+++
T Consensus       167 ---------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~  237 (786)
T KOG0588|consen  167 ---------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISS  237 (786)
T ss_pred             ---------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCH
Confidence                     3457799999999999999885 689999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ++++||++||..||.+|+|.     ++|++|||+.+.......
T Consensus       238 eaQdLLr~ml~VDp~~RiT~-----~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  238 EAQDLLRRMLDVDPSTRITT-----EEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHHHHHHhccCccccccH-----HHHhhCchhhcCCCCChh
Confidence            99999999999999999999     999999999987654433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-57  Score=386.64  Aligned_cols=257  Identities=28%  Similarity=0.495  Sum_probs=223.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ++.|+.+.++|+|+||+||+|++++||+.||||++.... ..+.......+|+.+|++++|+|+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            468999999999999999999999999999999986542 2233444566799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      +|||+. ++.+.+++. ..++.+.++.+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+..+    
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p----  154 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP----  154 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC----
Confidence            999987 777777665 45999999999999999999999999999999999999999999999999999977532    


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------  270 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-----------  270 (366)
                            ......++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+.++.+++..|...           
T Consensus       155 ------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  155 ------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             ------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence                  234457899999999999887 67999999999999999999999999999998887776431           


Q ss_pred             ---C-----CCCC------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 ---D-----IRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 ---~-----~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                         +     +.+|            ..++.-+.||+++||+.||.+|++.     ++++.||||.++
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc-----~qll~H~yFd~~  290 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC-----EQLLHHPYFDGF  290 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH-----HHHhcChHHHHH
Confidence               1     1112            1357789999999999999999999     899999999654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-55  Score=408.83  Aligned_cols=261  Identities=39%  Similarity=0.701  Sum_probs=238.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhCC-CCCcceeEEEEeeC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  117 (366)
                      ....+.|++++.||+|+||.|+.|.+..+|+.||+|++++......  .....+.+|+.+++.+. ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4567899999999999999999999999999999998877533212  34456778999999998 99999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~~  196 (366)
                      ..+|+||||+.||+|.+++.+.++++|.+++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++....
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999 999999999998763


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCC-C-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-A-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  274 (366)
                      .          ......+.+||+.|+|||++.+.. | +.++||||+|+++|.|++|..||...+...++..|..+.+.+
T Consensus       173 ~----------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~  242 (370)
T KOG0583|consen  173 G----------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI  242 (370)
T ss_pred             C----------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence            1          123445779999999999999876 6 488999999999999999999999999999999999999999


Q ss_pred             CCCC-CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          275 PNYF-SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       275 ~~~~-s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      |..+ |+++++|+.+||..||.+|+++     .+++.||||+.
T Consensus       243 p~~~~S~~~~~Li~~mL~~~P~~R~t~-----~~i~~h~w~~~  280 (370)
T KOG0583|consen  243 PSYLLSPEARSLIEKMLVPDPSTRITL-----LEILEHPWFQK  280 (370)
T ss_pred             CCCcCCHHHHHHHHHHcCCCcccCCCH-----HHHhhChhhcc
Confidence            9999 9999999999999999999999     89999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-56  Score=392.54  Aligned_cols=257  Identities=33%  Similarity=0.581  Sum_probs=232.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+. ....+.+..|+.+|+.++|||||.+++++++.+.+|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            478999999999999999999999999999999999887653 3445567779999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC------CCEEEEecCCccccC
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD------GHIKIADFGSVKPMQ  196 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~------~~vkL~Dfg~a~~~~  196 (366)
                      |||||+||+|.+++.+++.++|..++.++.||+.||++||+++|+||||||+|||++..      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      469999999999886


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC---
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  273 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---  273 (366)
                      ..           ....+.+|++.|||||++....|+.|+|+||+|+|+|+|++|+.||...+..+.+..+..+...   
T Consensus       167 ~~-----------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~  235 (429)
T KOG0595|consen  167 PG-----------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV  235 (429)
T ss_pred             ch-----------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence            54           3455889999999999999999999999999999999999999999999999988877665433   


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++..+++.+.+|+...|+.+|.+|.+.     .+-..|++...
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~-----~~~~~~~~l~~  273 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISF-----EDFFDHPFLAA  273 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCch-----HHhhhhhhccc
Confidence            345678888899999999999999988     77788888753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-54  Score=401.12  Aligned_cols=274  Identities=40%  Similarity=0.735  Sum_probs=248.5

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ....+..++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            44556789999999999999999999999999999999999765443444455677899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+|+||||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999876533


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .             .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....+.+..+...+|..
T Consensus       171 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~  237 (329)
T PTZ00263        171 R-------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW  237 (329)
T ss_pred             C-------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC
Confidence            2             123468999999999999889999999999999999999999999999888889999998899999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      ++..+++||.+||+.||.+|+++.+.+++++++||||++.+|+.+..
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~  284 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYA  284 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence            99999999999999999999997666779999999999999987653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-57  Score=381.88  Aligned_cols=250  Identities=31%  Similarity=0.543  Sum_probs=223.1

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE-EEeeCC
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF-TFQDTF  118 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~  118 (366)
                      ...++.+|+++++||+|+||.||++++..+|..+|.|.+.-.... .........|+.+|++++|||||++++ .+.+++
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            445688999999999999999999999999999999999855443 334455667999999999999999988 455544


Q ss_pred             e-EEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCeEeCCCCCEEEEec
Q 017775          119 S-LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHS--MG--LIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       119 ~-~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~--~~--i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      . ++||||||.+|+|...++.    ++.++|..+|.++.|++.||..+|+  ..  |.||||||.||+++.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 9999999999999998864    3469999999999999999999998  45  999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      |+++.+....          ..+.+++|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-.+..++|..
T Consensus       173 GL~r~l~s~~----------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q  242 (375)
T KOG0591|consen  173 GLGRFLSSKT----------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ  242 (375)
T ss_pred             hhHhHhcchh----------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence            9999876542          234578999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCC-CC-CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          270 RDIR-FP-NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       270 ~~~~-~~-~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ++.+ .| ..+|.++..+|..|++.||..||+.
T Consensus       243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            9875 67 6799999999999999999999985

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-56  Score=381.85  Aligned_cols=288  Identities=36%  Similarity=0.643  Sum_probs=265.4

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ....+++++|.++++||+|.||.|.+|+.+.+|+.||+|+++++.+-..+.......|-.+|+..+||.+..+...|+..
T Consensus       161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            45567899999999999999999999999999999999999998877777677777799999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+++||||.+||.|+-.+.+...++|...+.+-..|+.||.|||+++|++||||.+|.|+|.+|++|+.|||+++.--.
T Consensus       241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999984322


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .          .....+++|||.|+|||++....|+.++|+|.+||++|||++|+.||...+...+++-|+...+.||..
T Consensus       321 ~----------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~  390 (516)
T KOG0690|consen  321 Y----------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT  390 (516)
T ss_pred             c----------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc
Confidence            1          345568899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc-cCCCCCCCCCCc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEPM  335 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~-~~~~~~~~~~~~  335 (366)
                      ++++++.|+..+|.+||.+|.......+.++..|+||..++|+..- +...|+++|...
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt  449 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT  449 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence            9999999999999999999999877778999999999999998764 456777776543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-54  Score=392.44  Aligned_cols=267  Identities=38%  Similarity=0.662  Sum_probs=242.0

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997654333344556788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||++......      
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------  154 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------  154 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence            99999999999998888999999999999999999999999999999999999999999999999998765321      


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                             .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++.+++
T Consensus       155 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  227 (291)
T cd05612         155 -------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD  227 (291)
T ss_pred             -------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHH
Confidence                   1234689999999999998899999999999999999999999999999888999999889999999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      ||++||+.||.+|++....++++++.||||+.++|.....
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  267 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ  267 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhc
Confidence            9999999999999986555669999999999999987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-53  Score=391.83  Aligned_cols=264  Identities=38%  Similarity=0.661  Sum_probs=235.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      +.||+|+||.||+|.++.+|+.||+|++.+.............+|+.+++.++||||+++++++.+.+.+|+||||+.|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998754434444455667999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 017775          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (366)
Q Consensus       131 ~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~  210 (366)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~----------~~  150 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD----------GA  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------CC
Confidence            99999998888999999999999999999999999999999999999999999999999998743221          11


Q ss_pred             CccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 017775          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  290 (366)
Q Consensus       211 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  290 (366)
                      ......||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            22345799999999999999999999999999999999999999999888888888888888999999999999999999


Q ss_pred             cCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       291 ~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      +.||++||+....++.++++||||.+++|+.+..
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~  264 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ  264 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999965444559999999999999988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-53  Score=393.01  Aligned_cols=272  Identities=34%  Similarity=0.611  Sum_probs=243.1

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ..+..++|++.+.||+|+||.||+|.+..++ ..||+|.+.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            4467889999999999999999999876654 689999997654434444556778999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999765321


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  278 (366)
                                   .....||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+..+...+|..+
T Consensus       185 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~  251 (340)
T PTZ00426        185 -------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL  251 (340)
T ss_pred             -------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence                         1245789999999999988899999999999999999999999999998888889998888899999


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      +++++++|++||+.||++|++....+++++++||||.+++|..+..
T Consensus       252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~  297 (340)
T PTZ00426        252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLH  297 (340)
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999999999999999754444569999999999999987653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-55  Score=394.90  Aligned_cols=257  Identities=33%  Similarity=0.512  Sum_probs=227.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCC-
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF-  118 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-  118 (366)
                      ...+++|.++++||.|+||.||+|+.+.+|+.||||.+++++...+  ...-.+|+..|++++ ||||+++.+++.+.+ 
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            3457899999999999999999999999999999999988765533  233456999999998 999999999999988 


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .+|+|||||+. +|+++++.+ ..++++.++.|+.||++||+|+|.+|++|||+||+|||+..+..+||+|||+|+....
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999999987 999999876 5699999999999999999999999999999999999999889999999999998765


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  270 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------  270 (366)
                      .           .....++.|.+|+|||++. ...|+.+.|+|++|||++|+++-++.|.|.++.+.+.+|..-      
T Consensus       163 k-----------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  163 K-----------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             C-----------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            4           3445889999999999975 556999999999999999999999999999999888887541      


Q ss_pred             -------------CCCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          271 -------------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       271 -------------~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                                   ++.+|           ...+.++.+||.+||..||.+||||     .++++||||+.
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-----~~al~~pffq~  296 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-----SQALQHPFFQV  296 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-----HHHhcCccccc
Confidence                         12222           2368999999999999999999999     88999999974

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.5e-55  Score=400.07  Aligned_cols=256  Identities=30%  Similarity=0.575  Sum_probs=239.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+..... .....+.+|+++++.++||||+.++++|++..++++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            578999999999999999999999999999999998865433 3445688899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +|||.| +|..++...+.++|+.++.++.|++.||.|||+++|.|||+||.|||+...|.+|++|||+|+.+..+.    
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----  154 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----  154 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc----
Confidence            999988 999999999999999999999999999999999999999999999999999999999999999887653    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR  283 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~  283 (366)
                            .....+.|||.|||||.+.+.+|+..+|+||||||+||+++|++||...+..+..+.|.......|...+..++
T Consensus       155 ------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~  228 (808)
T KOG0597|consen  155 ------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFV  228 (808)
T ss_pred             ------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHH
Confidence                  23346789999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +|++.+|.+||.+|.+-     .+++.|||.++
T Consensus       229 nfl~gLL~kdP~~RltW-----~~Ll~HpF~k~  256 (808)
T KOG0597|consen  229 NFLQGLLIKDPAQRLTW-----TDLLGHPFWKG  256 (808)
T ss_pred             HHHHHHhhcChhhcccH-----HHHhcChHHhh
Confidence            99999999999999988     88999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.3e-53  Score=383.57  Aligned_cols=277  Identities=32%  Similarity=0.563  Sum_probs=238.2

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|+..+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999876544433444456779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+++|+|...+...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence            99999998887643  358999999999999999999999999999999999999999999999999987653221    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH----HHHHHHhcCCCCCCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRIIARDIRFPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~s  279 (366)
                             ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||.+....    .....+......++..++
T Consensus       157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (285)
T cd05631         157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS  229 (285)
T ss_pred             -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCC
Confidence                   112346899999999999999999999999999999999999999875542    233344455566778899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      +++.+||++||+.||++||++.+.+++++++||||.+++|+.+... ..|++.|.
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD  284 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence            9999999999999999999987777899999999999999998765 46777664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-53  Score=377.40  Aligned_cols=260  Identities=33%  Similarity=0.571  Sum_probs=221.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC--eEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~  121 (366)
                      ..+|..++.||+|+||.||++.++.+|+..|+|.+....  .. ....+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            556899999999999999999999999999999887651  11 1566888999999999999999999754444  699


Q ss_pred             EEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +.|||++||+|.+++.+.+ .++|..++.+++|+++||.|||++||+||||||+|||++. +|.+||+|||+++......
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999987 7999999999999999999999999999999999999999 7999999999998776411


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR--DIRFP  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~--~~~~~  275 (366)
                             ..........||+.|||||++... ..+.++|||||||++.||+||..||.. .........+...  .+.+|
T Consensus       173 -------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  173 -------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             -------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCC
Confidence                   011223357899999999999853 344599999999999999999999987 3443433444433  35788


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..+|+++++||.+|+..||++||||     +++|.|||.++..
T Consensus       246 ~~ls~~a~~Fl~~C~~~~p~~Rpta-----~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  246 DSLSDEAKDFLRKCFKRDPEKRPTA-----EELLEHPFLKQNS  283 (313)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCH-----HHHhhChhhhccc
Confidence            9999999999999999999999999     8999999997543

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-54  Score=384.44  Aligned_cols=302  Identities=32%  Similarity=0.586  Sum_probs=271.4

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +..+++.+.|..-++||+|+||.||-|+.+.||..||+|.+.++.+..........+|.++|.+++.+.||.+-..|++.
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            45778899999999999999999999999999999999999998888887788888999999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          118 FSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +.+++|+..|+||+|...+.+.+  .+++..++.++.+|+.||++||+.+|++|||||+|||+|+.|+++|+|+|+|..+
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999999998876  6999999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~  271 (366)
                      ....           .....+||.+|||||++.+..|+...|+|||||++|+|+.|+.||....+    +++-+.+++..
T Consensus       338 ~~g~-----------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~  406 (591)
T KOG0986|consen  338 PEGK-----------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP  406 (591)
T ss_pred             CCCC-----------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch
Confidence            6543           22345899999999999999999999999999999999999999975433    45666778888


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCCchhh---HHhhhhccc
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEPMVNF---LLLIKLLSV  347 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~  347 (366)
                      ..+++.+|++++++++.+|++||++|......+.+++..||||+.++|+.+.+. ..||+.|.|-..+   ...|.-++-
T Consensus       407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~  486 (591)
T KOG0986|consen  407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFST  486 (591)
T ss_pred             hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhccc
Confidence            899999999999999999999999999998778899999999999999999854 6899999887655   344555555


Q ss_pred             ccc
Q 017775          348 VKS  350 (366)
Q Consensus       348 ~~~  350 (366)
                      +|+
T Consensus       487 VKG  489 (591)
T KOG0986|consen  487 VKG  489 (591)
T ss_pred             ccc
Confidence            544

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-55  Score=364.92  Aligned_cols=258  Identities=33%  Similarity=0.581  Sum_probs=235.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ..-+.|++-++||+|.|+.|++|.+..+|+.+|+|+++....... ..+.+.+|+.+.+.++||||+++++.+.+....|
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            345789999999999999999999999999999999987655444 5677889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCCccccCCc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDS  198 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~a~~~~~~  198 (366)
                      +|+|.+.|++|..-+-++...+|..+-.+++||++||.|+|.+||+|||+||+|+++-..   .-+||+|||+|..+...
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            999999999998887777678999999999999999999999999999999999999643   46999999999977632


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN--  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  276 (366)
                                 .....+.|||.|||||++...+|+..+|||+.|||+|-|+.|.+||.+.+...+++.|..+...+|.  
T Consensus       167 -----------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~  235 (355)
T KOG0033|consen  167 -----------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE  235 (355)
T ss_pred             -----------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence                       2444678999999999999999999999999999999999999999999999999999999887764  


Q ss_pred             --CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 --YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 --~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                        .+++++++|+++||..||.+|+|+     .+.|+|||+.+
T Consensus       236 w~~is~~Ak~LvrrML~~dP~kRIta-----~EAL~HpWi~~  272 (355)
T KOG0033|consen  236 WDTVTPEAKSLIRRMLTVNPKKRITA-----DEALKHPWICN  272 (355)
T ss_pred             cCcCCHHHHHHHHHHhccChhhhccH-----HHHhCCchhcc
Confidence              689999999999999999999999     78999999974

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-53  Score=384.45  Aligned_cols=258  Identities=30%  Similarity=0.489  Sum_probs=226.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--Ce
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FS  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~  119 (366)
                      ...+.|+.+++||+|.||.||+|++..||+.||+|.+..+.. .+.......+|+.+|++++||||+++.+...+.  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            456789999999999999999999999999999999988743 344455667799999999999999999988776  68


Q ss_pred             EEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      +|+|+|||+. +|.-++...+ .|++.+++.++.||+.||+|||.+||.|||||.+|||||.+|.+||+|||+|+.+...
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999987 9999888753 6999999999999999999999999999999999999999999999999999977654


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  271 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------  271 (366)
                      ..         ......+.|++|+|||.+.|.. |+.++|+||+|||+.||++|++.|.+.++.+++..|.+..      
T Consensus       272 ~~---------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~  342 (560)
T KOG0600|consen  272 GS---------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED  342 (560)
T ss_pred             CC---------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence            31         2244678899999999988765 9999999999999999999999999999999988886411      


Q ss_pred             ----CCCC-------------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          272 ----IRFP-------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       272 ----~~~~-------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                          ..+|                   ..++..+.+|+..||+.||.+|.||     .++|+|+||.
T Consensus       343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA-----~~aL~seyF~  404 (560)
T KOG0600|consen  343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA-----SSALQSEYFT  404 (560)
T ss_pred             ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH-----HHHhcCcccc
Confidence                0111                   2478899999999999999999999     8899999995

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-53  Score=381.71  Aligned_cols=268  Identities=40%  Similarity=0.645  Sum_probs=229.5

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHHhCCCCCc
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------NKTAYVKLERIVLDQLDHPGV  107 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i  107 (366)
                      .....+++|++++.||+|.||.|.+|++..+|+.||||++.+......           ...+.+++|+.+|++++||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            345568899999999999999999999999999999999987543221           123468889999999999999


Q ss_pred             ceeEEEEee--CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          108 VRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       108 v~~~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                      |+++++..+  .+.+|||+|||..|.+...-.....+++.+++.+++.++.||+|||.+||+||||||+|+|++.+|+||
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            999999986  456999999999888754333332399999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC----CCCCCCCcccchhhhhhhhcCCCCCCCCCHH
Q 017775          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFKDTSEW  261 (366)
Q Consensus       186 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  261 (366)
                      |+|||.+..+......     .........+|||.|+|||.+.+.    ..+.+.||||+||+||.|+.|+.||-+....
T Consensus       251 IsDFGVs~~~~~~~~~-----~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDE-----GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             eeccceeeecccCCcc-----ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            9999999876443111     111222346899999999998762    2577899999999999999999999999999


Q ss_pred             HHHHHHhcCCCCCCCC--CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          262 LIFQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       262 ~~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +.+.+|.+..+.+|..  +.++++|||.+||++||++|.+.     .++..|||...
T Consensus       326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l-----~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL-----PDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh-----hhheecceecc
Confidence            9999999999999976  79999999999999999999999     88999999864

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.3e-52  Score=384.31  Aligned_cols=263  Identities=38%  Similarity=0.668  Sum_probs=234.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998764444444556777999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 017775          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (366)
Q Consensus       131 ~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~  210 (366)
                      +|...+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......          .
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------~  150 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------A  150 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----------c
Confidence            999999888889999999999999999999999999999999999999999999999999987532211          1


Q ss_pred             CccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 017775          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  290 (366)
Q Consensus       211 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  290 (366)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHc
Confidence            12245689999999999988899999999999999999999999999888888888888888899999999999999999


Q ss_pred             cCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       291 ~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      +.||++|++....++.++++||||.+++|..+.
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  263 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY  263 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            999999996555566999999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5e-52  Score=383.42  Aligned_cols=269  Identities=36%  Similarity=0.644  Sum_probs=238.8

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEeeCCeEEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.| ++|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999987644344445556678888888876 56888999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......      
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------  154 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------
Confidence            99999999999988888999999999999999999999999999999999999999999999999998643211      


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                          ........|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+......+|..+++++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T cd05587         155 ----GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (324)
T ss_pred             ----CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence                1122345789999999999999999999999999999999999999999999999999998888899999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      ++.+||+.||.+|+++.....+++++||||..++|..+..
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~  270 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER  270 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            9999999999999998655668999999999999987653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.7e-53  Score=354.83  Aligned_cols=257  Identities=30%  Similarity=0.429  Sum_probs=223.0

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      .+|...+.||+|.||.||+|++..||+.||||+++....... ......+|+..|+.++|+||+.++++|.....+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            579999999999999999999999999999999987643333 3344566999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||++. +|...++.. ..++..+++.++.+++.||+|||++.|.||||||.|+||+.+|.+||+|||+|+.+.....   
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~---  156 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR---  156 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---
Confidence            99987 999988765 4699999999999999999999999999999999999999999999999999998865431   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----------  272 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------  272 (366)
                             .....+-|.+|+|||.+.|.. |+..+|+||+|||+.||+.|.+.|.|.++.+++..|...--          
T Consensus       157 -------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  157 -------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             -------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence                   222337899999999987765 99999999999999999999999999999998887754100          


Q ss_pred             -C---------CC--------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 -R---------FP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 -~---------~~--------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                       .         +|        ...++++.||+.+||..||.+|+++     .+++.|+||++..
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita-----~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA-----SQALKHPYFKSLP  288 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccH-----HHHhcchhhhcCC
Confidence             0         11        1247888999999999999999999     8899999999643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-52  Score=383.60  Aligned_cols=264  Identities=38%  Similarity=0.658  Sum_probs=235.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      +.||+|+||.||+|++..+|..||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998754433444455667999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 017775          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (366)
Q Consensus       131 ~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~  210 (366)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......          .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----------~  150 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----------A  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----------C
Confidence            999999888889999999999999999999999999999999999999999999999999987432211          1


Q ss_pred             CccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 017775          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  290 (366)
Q Consensus       211 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  290 (366)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            12245689999999999988899999999999999999999999999888888888888888899999999999999999


Q ss_pred             cCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       291 ~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      +.||++|++....++.++++||||.+++|.....
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  264 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ  264 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999976666779999999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6e-52  Score=382.74  Aligned_cols=270  Identities=36%  Similarity=0.630  Sum_probs=239.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++..+ +|++|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999876443344444455677777766 5899999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-----  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-----  155 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----
Confidence            999999999999888889999999999999999999999999999999999999999999999999987432211     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                           .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.+
T Consensus       156 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  230 (323)
T cd05616         156 -----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  230 (323)
T ss_pred             -----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence                 122345689999999999999999999999999999999999999999999999999999888899999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      ++.+||+.||.+|+++.+....++++||||..++|+.+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~  271 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK  271 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence            99999999999999986666789999999999999987643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-52  Score=382.01  Aligned_cols=259  Identities=41%  Similarity=0.697  Sum_probs=231.8

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++||||+++++++.+.+..|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999999765433444445667799999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 017775          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (366)
Q Consensus       133 ~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~  212 (366)
                      .+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......          ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----------~~~  150 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----------DKT  150 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----------Ccc
Confidence            9999888889999999999999999999999999999999999999999999999999987532211          122


Q ss_pred             cccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcC
Q 017775          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  292 (366)
Q Consensus       213 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  292 (366)
                      ....||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+......+|..+++++++||.+||+.
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence            34578999999999999899999999999999999999999999988888888999888899999999999999999999


Q ss_pred             CCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          293 DPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       293 dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ||++||++.  ++.++++||||...+|....
T Consensus       231 dp~~R~~~~--~~~e~l~hp~~~~~~~~~~~  259 (312)
T cd05585         231 DPTRRLGYN--GAQEIKNHPFFSQLSWKKLL  259 (312)
T ss_pred             CHHHcCCCC--CHHHHHcCCCcCCCCHHHHH
Confidence            999999764  34899999999999887654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-53  Score=375.38  Aligned_cols=257  Identities=32%  Similarity=0.538  Sum_probs=240.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ....+|++.+.||+|.||.|-+|.....|+.||||.++++.+..+.+...+++|+++|..++||||+++|++|+..+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            34679999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |||||..+|.|++++..++.++|.+++.+++||+.|+.|||.++++|||||.+|||+|.++++||+|||++..+....  
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--  207 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--  207 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998776543  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                               ...+++|++-|.+||+..|.+| +..+|.||||+++|.|..|..||++.+...+..+|..+.+.-|.. +.
T Consensus       208 ---------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PS  277 (668)
T KOG0611|consen  208 ---------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PS  277 (668)
T ss_pred             ---------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-Cc
Confidence                     3347899999999999999997 578999999999999999999999999999999999887766654 66


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ++.-||++||-.||++|.|+     +++..|-|.+
T Consensus       278 dA~gLIRwmLmVNP~RRATi-----eDiAsHWWvN  307 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATI-----EDIASHWWVN  307 (668)
T ss_pred             hHHHHHHHHHhcCcccchhH-----HHHhhhheee
Confidence            78899999999999999998     8999999875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-52  Score=389.08  Aligned_cols=279  Identities=39%  Similarity=0.688  Sum_probs=234.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998654333444556778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.........
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998765432111000


Q ss_pred             CCC----------------------------CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCC
Q 017775          205 NAA----------------------------SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  256 (366)
Q Consensus       205 ~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  256 (366)
                      ...                            ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence            000                            0001123469999999999998889999999999999999999999999


Q ss_pred             CCCHHHHHHHHhcCC--CCCCC--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC
Q 017775          257 DTSEWLIFQRIIARD--IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (366)
Q Consensus       257 ~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~  326 (366)
                      +.+.......+....  ..+|.  .+++++++||.+||. +|.+|++.  .++++++.||||++++|+.+....
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~~~~  311 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIRERP  311 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHhhcC
Confidence            988887777776533  33443  479999999999997 99999983  133999999999999998765443

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.2e-52  Score=388.60  Aligned_cols=275  Identities=37%  Similarity=0.679  Sum_probs=233.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+++.++|++|+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999998754444445566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc-
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~-  203 (366)
                      ||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+........ 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999986543211000 


Q ss_pred             -------CCC-----------------CCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC
Q 017775          204 -------PNA-----------------ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (366)
Q Consensus       204 -------~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  259 (366)
                             +..                 .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                   000                 00011234579999999999999899999999999999999999999999988


Q ss_pred             HHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHhhcCCCCCC---CCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          260 EWLIFQRIIAR--DIRFPN--YFSDAARDLIDRLLDVDPSGR---PGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       260 ~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R---ps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      ..+...++...  ...+|.  .+++++++||.+|++ +|.+|   |++     +++++||||++++|+.+...
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~-----~ei~~hp~f~~~~~~~~~~~  307 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV-----EEIKTNPFFEGVDWEHIRER  307 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH-----HHHhCCCCCCCCCHHHHHhC
Confidence            88888877653  344554  478999999999886 56655   555     99999999999999988643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1e-51  Score=381.46  Aligned_cols=263  Identities=39%  Similarity=0.673  Sum_probs=233.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      +.||+|+||.||+|.+..+|..||+|++.+..............|..+++.++||||+++++++.+.+.+|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998764444444455667899999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       131 ~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      +|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.......          
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----------  150 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----------  150 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----------
Confidence            999999888889999999999999999999997 799999999999999999999999999987432211          


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            11224568999999999998889999999999999999999999999988888888888888889999999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      |+.||++|++....++.++++||||.++.|....
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  264 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY  264 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            9999999986555566999999999999998664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-54  Score=354.06  Aligned_cols=261  Identities=34%  Similarity=0.573  Sum_probs=245.0

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++++.||+|.||.||+|+.+.++..||+|++-++.+........+.+|+++-..++||||+++|++|-+..
T Consensus        16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            45688999999999999999999999999999999999999887777777788999999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          119 SLYMALESCEGGELFDQIT--SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      .+|+++||..+|+|+..+.  ..+.+++...+.++.|++.||.|+|.++++||||||+|+|++.+|.+|++|||.+....
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999999998  55779999999999999999999999999999999999999999999999999876432


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  276 (366)
                                  ..+..+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+.+++|...+..+|.
T Consensus       176 ------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~  243 (281)
T KOG0580|consen  176 ------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS  243 (281)
T ss_pred             ------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc
Confidence                        23455789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .++.++.|||.+||.++|.+|.+.     .+++.|||+..
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l-----~~v~~hpwI~a  278 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLAL-----TEVMDHPWIVA  278 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccH-----HHHhhhHHHHh
Confidence            999999999999999999999988     89999999863

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.7e-52  Score=381.49  Aligned_cols=266  Identities=35%  Similarity=0.620  Sum_probs=234.6

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHH---HhCCCCCcceeEEEEeeCCeEEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL---DQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      |++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|..++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999865433333344556666554   466899999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||++|++|...+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......     
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-----  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-----  154 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence            999999999888754 46999999999999999999999999999999999999999999999999998643221     


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR  283 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~  283 (366)
                           ........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+......+|..+++++.
T Consensus       155 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  229 (324)
T cd05589         155 -----GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI  229 (324)
T ss_pred             -----CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence                 112234678999999999999889999999999999999999999999999988888888888889999999999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ++|.+||+.||.+||++.+.++.+++.||||++++|+...
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~  269 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLL  269 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHH
Confidence            9999999999999999888788999999999999988754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.9e-52  Score=380.68  Aligned_cols=264  Identities=34%  Similarity=0.657  Sum_probs=232.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.++.+++.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999875443344445556677777765 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......          .
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~----------~  150 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----------G  150 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            12234578999999999998889999999999999999999999999999999999998888888999999999999999


Q ss_pred             hcCCCCCCCCCCC-CChHhhhcCCCCCCCCcccccc
Q 017775          290 LDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       290 L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |+.||++||++.+ ...+++++||||..++|+.+..
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~  266 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNR  266 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999999843 3458899999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-51  Score=379.54  Aligned_cols=264  Identities=35%  Similarity=0.618  Sum_probs=233.4

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.+..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999875443444445566688888765 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|...+.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......          
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----------  150 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----------  150 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999987532211          


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            11224568999999999998899999999999999999999999999999999999999888888999999999999999


Q ss_pred             hcCCCCCCCCCCCC--ChHhhhcCCCCCCCCcccccc
Q 017775          290 LDVDPSGRPGAGPG--GYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       290 L~~dP~~Rps~~~~--~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |+.||++|+++.+.  +++++++||||..++|..+..
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~  267 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ  267 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence            99999999966442  569999999999999987754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-51  Score=388.35  Aligned_cols=275  Identities=38%  Similarity=0.659  Sum_probs=231.0

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|.+++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999987654333444556778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc--
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  202 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~--  202 (366)
                      ||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999997443211000  


Q ss_pred             ---cC--CCCC------------------------------CCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhh
Q 017775          203 ---LP--NAAS------------------------------DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (366)
Q Consensus       203 ---~~--~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  247 (366)
                         ..  ....                              .......+||+.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence               00  0000                              000113579999999999998889999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHhhcCCCCCCC---CCCCCChHhhhcCCCCCCCCcc
Q 017775          248 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRP---GAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       248 ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L~~dP~~Rp---s~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      |++|..||.+.+..+.+..+..  ....+|.  .++.++++||.+||+ +|.+|+   ++     .+++.||||++++|+
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~-----~~~l~hp~~~~~~~~  314 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA-----HEIKSHPFFRGVDWD  314 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH-----HHHhcCCCcCCCCHH
Confidence            9999999998888777777664  3344554  479999999999998 777765   55     899999999999998


Q ss_pred             ccccC
Q 017775          321 NIRGQ  325 (366)
Q Consensus       321 ~~~~~  325 (366)
                      .+...
T Consensus       315 ~~~~~  319 (377)
T cd05629         315 TIRQI  319 (377)
T ss_pred             HHccC
Confidence            87644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-51  Score=379.53  Aligned_cols=270  Identities=35%  Similarity=0.641  Sum_probs=239.5

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++.+..............|..+++.+. |++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999998754433444455666888887775 578888999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++|++|.+++.+.+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......     
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-----  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-----  155 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-----
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532211     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                           .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+
T Consensus       156 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (323)
T cd05615         156 -----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (323)
T ss_pred             -----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence                 112245689999999999988899999999999999999999999999999888899988888899999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      ++.+||++||.+|+++.+...++++.||||..++|..+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  271 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENR  271 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence            99999999999999987777799999999999999887643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=369.11  Aligned_cols=269  Identities=32%  Similarity=0.501  Sum_probs=233.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      +.+.++|++.++||.|..++||+|+...+++.||||+++.+.....  ...+++|+..++.++||||++++..|..+..+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            4678899999999999999999999999999999999998765444  56788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      |+||.+|.+|++.+++...  ..+.|..+..+++++++||.|||++|-||||||+.||||+.+|.|||+|||.+..+...
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999999874  34999999999999999999999999999999999999999999999999998766543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeec--CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  275 (366)
                      ...      ...+..+++||+.|||||++.  ...|+.|+||||+|++..||++|..||....+..++-.-+.+.++.+ 
T Consensus       180 G~R------~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  180 GDR------QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             Cce------eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            200      011125779999999999953  34599999999999999999999999998888777666555555422 


Q ss_pred             ---------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          276 ---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       276 ---------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                               ..++..++.+|..||++||++||||     +++++|+||+.......
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptA-----skLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTA-----SKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCH-----HHHhccHHHhhccchhh
Confidence                     2367889999999999999999999     89999999997765443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-51  Score=387.00  Aligned_cols=280  Identities=35%  Similarity=0.565  Sum_probs=231.3

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|++++.||+|+||+||+|++..+++.||+|++.+...........+..|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999987654444555668889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc---
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV---  202 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~---  202 (366)
                      |++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..+.......   
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            99999999999888889999999999999999999999999999999999999999999999999986442110000   


Q ss_pred             c----------------------------------CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhh
Q 017775          203 L----------------------------------PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM  248 (366)
Q Consensus       203 ~----------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  248 (366)
                      .                                  ............+||+.|+|||++.+..++.++|||||||++|+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence            0                                  000001112346799999999999988899999999999999999


Q ss_pred             hcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHhhcC--CCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          249 LSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDV--DPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       249 l~g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L~~--dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                      ++|..||...+..+....+..  ....+|.  .+++++++||.+|++.  +|..|+++     +++++||||++++|...
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~-----~~~l~hp~f~~~~~~~~  316 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA-----DDIKAHPFFSEVDFSSD  316 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCcccCCCChhHH
Confidence            999999998887766666553  2334443  5899999999996654  44459988     89999999999999765


Q ss_pred             ccCCCCCC
Q 017775          323 RGQTPPKL  330 (366)
Q Consensus       323 ~~~~~~~~  330 (366)
                      ....+++.
T Consensus       317 ~~~~~~~~  324 (381)
T cd05626         317 IRTQPAPY  324 (381)
T ss_pred             hhcCCCCc
Confidence            43333333

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-51  Score=380.55  Aligned_cols=262  Identities=39%  Similarity=0.667  Sum_probs=231.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998764444444556778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....       
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-------  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence            9999999999999888899999999999999999999999999999999999999999999999999875433       


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCC------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN------  276 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~------  276 (366)
                            ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....  ...|.      
T Consensus       154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  227 (333)
T cd05600         154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF  227 (333)
T ss_pred             ------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccc
Confidence                  1224578999999999998899999999999999999999999999988877766665422  12221      


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      .+++++.+||.+||..+|.+||++     ++++.||||..++|..+..
T Consensus       228 ~~s~~~~~li~~~l~~~~~rr~s~-----~~ll~h~~~~~~~~~~~~~  270 (333)
T cd05600         228 NLSDEAWDLITKLINDPSRRFGSL-----EDIKNHPFFKEVDWNELRE  270 (333)
T ss_pred             ccCHHHHHHHHHHhhChhhhcCCH-----HHHHhCcccCCCCHHHHhh
Confidence            468999999999999999999998     8999999999999987763

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-53  Score=372.92  Aligned_cols=286  Identities=35%  Similarity=0.624  Sum_probs=263.5

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      ...+...||.++.+||+|+||.|.++..+.+.+.||||+++++.+-..++.+....|..+|... +-|.+++++..|++-
T Consensus       343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            3367788999999999999999999999999999999999999887777776666688888877 468899999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+|.||||++||+|-..+++-|++.|..+..++..|+-||-|||++||++||||.+||+++.+|++||+|||+++.-- 
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-  501 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-  501 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998532 


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                               .......+++||+.|+|||++...+|+..+|+||+||++|||+.|++||.+.++.++++.|.+.+..+|..
T Consensus       502 ---------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs  572 (683)
T KOG0696|consen  502 ---------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS  572 (683)
T ss_pred             ---------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc
Confidence                     22345668899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~  334 (366)
                      +|.++.+++...|.+.|.+|..+...+-.++..||||+.++|+.++.. .+|++.|..
T Consensus       573 lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~  630 (683)
T KOG0696|consen  573 LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI  630 (683)
T ss_pred             ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence            999999999999999999999987777799999999999999998854 577777766

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-51  Score=384.67  Aligned_cols=275  Identities=43%  Similarity=0.745  Sum_probs=237.4

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765444455566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc-
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~-  203 (366)
                      ||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........... 
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999986654320000 


Q ss_pred             ------------------CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH
Q 017775          204 ------------------PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (366)
Q Consensus       204 ------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  265 (366)
                                        .............||+.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                              00000112334578999999999999999999999999999999999999999988888777


Q ss_pred             HHhc--CCCCCCCC--CCHHHHHHHHHhhcCCCCCCCC-CCCCChHhhhcCCCCCCCCccccccC
Q 017775          266 RIIA--RDIRFPNY--FSDAARDLIDRLLDVDPSGRPG-AGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       266 ~i~~--~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps-~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      .+..  ....+|..  +++++.+||.+||. ||.+|++ +     ++++.||||++++|......
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~-----~~ll~hp~~~~~~~~~~~~~  299 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF-----EEIKSHPFFKGIDWENLRET  299 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH-----HHHhcCCCcCCCCHHHHhhC
Confidence            7776  44455543  59999999999997 9999999 7     89999999999999877633

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=386.37  Aligned_cols=254  Identities=32%  Similarity=0.527  Sum_probs=230.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ...|.....||+|+.|.||.|....+++.||+|.+...   .....+.+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~---~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR---KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec---cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            34788999999999999999999999999999999876   344456688899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||++||+|.+.+... .++|.++..+++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+....    
T Consensus       349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~----  423 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ----  423 (550)
T ss_pred             EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc----
Confidence            9999999999998775 49999999999999999999999999999999999999999999999999998775542    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~  280 (366)
                            ....+.+||+.|||||+.....|+.++||||||++++||.-|++||-..++..-+..|-..   .+..|+.+|+
T Consensus       424 ------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~  497 (550)
T KOG0578|consen  424 ------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP  497 (550)
T ss_pred             ------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence                  3556889999999999999999999999999999999999999999988887766666443   4556788999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++++|+.+||+.|+++|++|     .+||.||||+.
T Consensus       498 ~~kdFL~~cL~~dv~~RasA-----~eLL~HpFl~~  528 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASA-----KELLEHPFLKM  528 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCH-----HHHhcChhhhh
Confidence            99999999999999999999     89999999953

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-51  Score=382.97  Aligned_cols=278  Identities=38%  Similarity=0.680  Sum_probs=235.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+..|+.++..++|++|+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444445566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc-
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~-  203 (366)
                      ||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.+|+++|+|||++........... 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999876533211000 


Q ss_pred             -------CC-----------------CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC
Q 017775          204 -------PN-----------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (366)
Q Consensus       204 -------~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  259 (366)
                             +.                 ..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                   00                 000111224579999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          260 EWLIFQRIIAR--DIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       260 ~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      .......+...  ...+|.  .+++++++||.+|+ .||.+|+++.  ++++++.||||.+++|..+...
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~--~~~ei~~hp~f~~~~~~~~~~~  307 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN--GVEEIKSHPFFEGVDWGHIRER  307 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCC--CHHHHhcCCCCCCCCHHHHhcC
Confidence            88877777653  344444  47999999999987 5999999753  4589999999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.3e-51  Score=376.39  Aligned_cols=263  Identities=37%  Similarity=0.678  Sum_probs=229.5

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHH-HHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||+||+|.++.+|+.||+|++.+...........+..| ..+++.++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999999999999999976533322222333334 3456789999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------~  150 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------S  150 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743221          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+..+++++.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            12224568999999999999889999999999999999999999999998888888888888888888999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |+.||.+||++.+ .+.++++||||..++|..+..
T Consensus       231 l~~~p~~R~~~~~-~~~~il~~~~~~~~~~~~~~~  264 (323)
T cd05575         231 LQKDRTKRLGAKD-DFLEIKNHVFFSSINWDDLVN  264 (323)
T ss_pred             hhcCHHhCCCCCC-CHHHHHcCCCcCCCCHHHHhh
Confidence            9999999999864 557999999999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.8e-51  Score=376.12  Aligned_cols=261  Identities=38%  Similarity=0.714  Sum_probs=228.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.+..+++.||+|+++...............|..++.. .+||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999987543333333344446666654 4899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......          
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----------  150 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----------  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999987543221          


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            12234578999999999998889999999999999999999999999999888888888888888899999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      |+.||++||++.    .+++.||||..++|......
T Consensus       231 l~~~P~~R~~~~----~~l~~h~~~~~~~~~~~~~~  262 (316)
T cd05592         231 FERDPTKRLGVD----GDIRQHPFFRGIDWERLEKR  262 (316)
T ss_pred             ccCCHHHcCCCh----HHHHcCcccCCCCHHHHHhC
Confidence            999999999873    57999999999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.8e-51  Score=376.47  Aligned_cols=264  Identities=36%  Similarity=0.707  Sum_probs=227.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544444555677788887766 899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----------~  150 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----------G  150 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743221          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC---------CCHHHHHHHHhcCCCCCCCCCCH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||..         .......+.+......+|..++.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~  230 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH
Confidence            122345789999999999999999999999999999999999999952         12233455667777888999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCcccccc
Q 017775          281 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      ++.+||.+||+.||++||++.. .+++++++||||++++|+....
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~  275 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ  275 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence            9999999999999999999732 3468999999999999986653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.7e-51  Score=383.84  Aligned_cols=276  Identities=38%  Similarity=0.603  Sum_probs=230.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999997654434445566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc---
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT---  201 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~---  201 (366)
                      ||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998643211000   


Q ss_pred             -cc---------------------------------CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhh
Q 017775          202 -VL---------------------------------PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (366)
Q Consensus       202 -~~---------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  247 (366)
                       ..                                 ............+||+.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence             00                                 00000011234579999999999999899999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          248 MLSGTSPFKDTSEWLIFQRIIAR--DIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       248 ll~g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      |++|+.||.+.+..+....+...  ...+|  ..+++++.++|.+|+ .+|.+|++..  +++++++||||+.++|....
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~--~~~ei~~hp~f~~~~~~~~~  317 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN--GADEIKAHPFFKTIDFSSDL  317 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC--CHHHHhcCCCcCCcChHHHH
Confidence            99999999988887766666542  23333  458999999999986 5999999832  34899999999999987643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.1e-51  Score=375.26  Aligned_cols=259  Identities=36%  Similarity=0.679  Sum_probs=227.5

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.++.+|+.||+|++++..............|..++.. .+||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999987543323334445557777765 4899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++...+.+++.++..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......          .
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----------~  150 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----------D  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998643211          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+.....+.+......+|..++.++++||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL  230 (316)
T ss_pred             CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            12234578999999999999999999999999999999999999999998888888888888888889999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      |+.||++||++.    +++++||||+.++|..+.
T Consensus       231 l~~dP~~R~~~~----~~~~~h~~f~~~~~~~~~  260 (316)
T cd05620         231 FERDPTRRLGVV----GNIRGHPFFKTINWTALE  260 (316)
T ss_pred             ccCCHHHcCCCh----HHHHcCCCcCCCCHHHHH
Confidence            999999999983    579999999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-52  Score=363.11  Aligned_cols=263  Identities=31%  Similarity=0.454  Sum_probs=223.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-----CC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----TF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~  118 (366)
                      ...|...+.||+|+||.|+.+.++.+|+.||+|++...+.... ......+|+.+|+.++|+||+.+.+++..     -+
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~-~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI-DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH-HHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455557999999999999999999999999999987654444 34445669999999999999999999865     45


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+|+|+|+. +|...++.+..++++.++.+++||+.||+|+|+.+|+||||||.|++++.++.+|++|||+|+.....
T Consensus       100 DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             eeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence            69999999965 99999998878999999999999999999999999999999999999999999999999999977543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------  270 (366)
                              ......+.++.|.+|+|||++. ...|+.+.||||+|||+.||++|++.|.|.+...+++.|..-       
T Consensus       179 --------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  179 --------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             --------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence                    1123445788999999999864 556999999999999999999999999998877666655431       


Q ss_pred             ----------------CCCCC--------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          271 ----------------DIRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       271 ----------------~~~~~--------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                      ....|        .+.++.+.+|+.+||..||.+|+|+     +++|.||||....-..
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita-----~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA-----EEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH-----HHHhcChhhhhhcCCc
Confidence                            11111        3578999999999999999999999     8999999999876443

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6e-51  Score=376.92  Aligned_cols=264  Identities=36%  Similarity=0.700  Sum_probs=229.3

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      ++||+|+||.||+|.+..+++.||+|++++...........+..|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544455556677899998888 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----------~  150 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----------G  150 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998642111          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC---------CHHHHHHHHhcCCCCCCCCCCH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---------SEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                      .......||+.|+|||++.+..++.++|+||+||++|+|++|..||...         ......+.+......+|..++.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  230 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            1223457899999999999989999999999999999999999999631         2233455677777888999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCcccccc
Q 017775          281 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      ++.++|.+||+.||.+|+++.. .+++++++||||..++|.....
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~  275 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ  275 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence            9999999999999999998643 3568999999999999987653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-50  Score=374.86  Aligned_cols=270  Identities=38%  Similarity=0.734  Sum_probs=231.0

Q ss_pred             CeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  120 (366)
                      +|++++.||+|+||.||+|++.   .+|..||+|++.+.... ..........|+.+++.+ +|++|+++++++.+.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   57899999999764322 223344567789999999 599999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++||||++|++|.+++.+++.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCC----CHHHHHHHHhcCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDIRFP  275 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~  275 (366)
                              ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...    ........+......+|
T Consensus       160 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         160 --------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             --------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                    11222457899999999987654 788999999999999999999999642    33455566677777888


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      ..+++.+.+||.+||+.||++||++...+++++++||||+..+|.....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  280 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL  280 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            8899999999999999999999988666779999999999999887654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.1e-51  Score=383.79  Aligned_cols=273  Identities=37%  Similarity=0.614  Sum_probs=229.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654333444556778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc--
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  202 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~--  202 (366)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+.......  
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999986432110000  


Q ss_pred             ------------cCC-------------------CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcC
Q 017775          203 ------------LPN-------------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG  251 (366)
Q Consensus       203 ------------~~~-------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  251 (366)
                                  ...                   ..........+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                        000                   0000112245799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcCC--CCCC--CCCCHHHHHHHHHhhcCCCCCCC---CCCCCChHhhhcCCCCCCCCccccc
Q 017775          252 TSPFKDTSEWLIFQRIIARD--IRFP--NYFSDAARDLIDRLLDVDPSGRP---GAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       252 ~~pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~~L~~dP~~Rp---s~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ..||.+.+..+....+....  ..+|  ..+++++.++|.+|+ .+|.+|+   ++     .++++||||++++|....
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~-----~ell~h~~~~~~~~~~~~  313 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA-----DEIKAHPFFKGIDFASLI  313 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH-----HHHhCCCCcCCCCHHHHh
Confidence            99999888777666655432  2233  368999999999977 5999999   66     899999999999988764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7e-51  Score=376.75  Aligned_cols=266  Identities=36%  Similarity=0.659  Sum_probs=231.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|+++............+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765444445566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||++|++|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+......  
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence            999999999999876 67999999999999999999999999999999999999999999999999999865433211  


Q ss_pred             CCCCCCCCccccccCCCCCCceeec------CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP  275 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~  275 (366)
                             ......||+.|+|||++.      +..++.++|||||||++|+|++|..||...+....+..+....  ..+|
T Consensus       159 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (330)
T cd05601         159 -------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP  231 (330)
T ss_pred             -------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC
Confidence                   112346899999999986      4557889999999999999999999999888877777766532  3334


Q ss_pred             C--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          276 N--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       276 ~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      .  .+++++.+||.+||+ ||++||++     ++++.||||..++|..+...
T Consensus       232 ~~~~~~~~~~~li~~ll~-~p~~R~t~-----~~l~~h~~~~~~~~~~~~~~  277 (330)
T cd05601         232 EDPKVSSDFLDLIQSLLC-GQKERLGY-----EGLCCHPFFSKIDWNNIRNS  277 (330)
T ss_pred             CCCCCCHHHHHHHHHHcc-ChhhCCCH-----HHHhCCCCcCCCCHHHHhhC
Confidence            3  579999999999998 99999999     89999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-50  Score=373.03  Aligned_cols=265  Identities=40%  Similarity=0.733  Sum_probs=232.9

Q ss_pred             eeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           50 GKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      ++.||+|+||.||+|++.   .+++.||+|++.+.... .......+..|+.+++.++||||+++++++.+++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   57899999999764322 22233456779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......      
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------  154 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------  154 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------
Confidence            99999999999988889999999999999999999999999999999999999999999999999987432211      


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL  285 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  285 (366)
                          .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+|
T Consensus       155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (323)
T cd05584         155 ----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL  230 (323)
T ss_pred             ----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence                1122456899999999999888999999999999999999999999999988888888888888999999999999


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |.+||+.||++||+....++++++.||||...+|..+..
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~  269 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLA  269 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhc
Confidence            999999999999966556669999999999999877653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-51  Score=374.45  Aligned_cols=263  Identities=37%  Similarity=0.721  Sum_probs=233.3

Q ss_pred             eeeeeecCceEEEEEEE---CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           50 GKIYGVGSYSKVVRAKK---IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      ++.||+|+||.||++.+   ..+|+.||+|++.+..... ........|+.+++.++||||+++++++.+.+.+|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            36799999999999986   3678999999997653322 2233456789999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCC
Q 017775          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~  206 (366)
                      +.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......       
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------  152 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-------  152 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence            9999999999888889999999999999999999999999999999999999999999999999987543221       


Q ss_pred             CCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 017775          207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLI  286 (366)
Q Consensus       207 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li  286 (366)
                         .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||
T Consensus       153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  229 (318)
T cd05582         153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  229 (318)
T ss_pred             ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence               12224568999999999998889999999999999999999999999999888888888888888999999999999


Q ss_pred             HHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ++||+.||++||++.+..+++++.||||..++|..+.
T Consensus       230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T cd05582         230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY  266 (318)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence            9999999999999987778999999999999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-52  Score=358.66  Aligned_cols=258  Identities=27%  Similarity=0.388  Sum_probs=223.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSL  120 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  120 (366)
                      +.+.|+.+..|++|+||.||+|+++.|++.||+|.++.+.- .+..--.-.+|+.+|.+++|||||.+.++...  -+.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            46789999999999999999999999999999999987642 22222234569999999999999999888763  4569


Q ss_pred             EEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |||||||+. +|..++.+.+ ++++.+++.++.|++.||+|||.+.|+|||||++|+|++..|.+|++|||+|+.++...
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999987 9999999875 89999999999999999999999999999999999999999999999999999887652


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--------
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  270 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------  270 (366)
                                ......+.|.+|+|||.+.+.. |+.++|+||+|||+.||+++.+.|.+.++.+++.+|...        
T Consensus       232 ----------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  232 ----------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             ----------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence                      2334568899999999988766 999999999999999999999999999999888887541        


Q ss_pred             -----------CCCCC------------CC-CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 -----------DIRFP------------NY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 -----------~~~~~------------~~-~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                 ...++            .. +++...+|+..+|..||.+|.||     ++.|+|+||...
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA-----~~~L~h~~F~e~  367 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA-----EDGLKHEYFRET  367 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH-----HHhhcccccccC
Confidence                       11111            11 56899999999999999999999     889999999863

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.2e-51  Score=368.07  Aligned_cols=268  Identities=32%  Similarity=0.603  Sum_probs=228.0

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||+|+||+||+|.++.+|+.||+|.+.............+..|+.+++.++|+||+++++++.+....++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999998765433333344566799999999999999999999999999999999999999


Q ss_pred             HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCC
Q 017775          133 FDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (366)
Q Consensus       133 ~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~  208 (366)
                      ...+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......         
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---------  151 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---------  151 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence            887743    3468999999999999999999999999999999999999999999999999987654321         


Q ss_pred             CCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       209 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                       .......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.....    ......+......++..++.++.+
T Consensus       152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (280)
T cd05608         152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS  230 (280)
T ss_pred             -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHH
Confidence             112234689999999999999999999999999999999999999976533    233444555566677889999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKL  330 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~  330 (366)
                      ++.+||+.||++||++.+.+++++++||||++++|+.+... .++++
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~  277 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPF  277 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCC
Confidence            99999999999999888878899999999999999987543 34444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-50  Score=373.82  Aligned_cols=264  Identities=35%  Similarity=0.657  Sum_probs=229.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHH-HHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+..|. .+++.++||||+++++++...+..|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999999999999999999765333333333334444 457789999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----------~  150 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----------S  150 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+...+..+.++|++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL  230 (325)
T ss_pred             CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHH
Confidence            12234578999999999999899999999999999999999999999998888888888888878888999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      |+.||.+||++.+ .+.+++.||||+.++|..+...
T Consensus       231 l~~~p~~R~~~~~-~~~~i~~h~~f~~~~~~~~~~~  265 (325)
T cd05604         231 LEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQK  265 (325)
T ss_pred             hccCHHhcCCCCC-CHHHHhcCCCcCCCCHHHHHhC
Confidence            9999999999854 4679999999999999877643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-51  Score=376.65  Aligned_cols=261  Identities=39%  Similarity=0.685  Sum_probs=239.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  119 (366)
                      ......|++.+.||+|.||.||.|+++.||+.+|+|++.+...........+.+|+.+|+++. ||||+.++++|++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            344678999999999999999999999999999999999887766666778999999999998 9999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC----CCEEEEecCCcccc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPM  195 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~----~~vkL~Dfg~a~~~  195 (366)
                      +++|||+|.||+|.+.+... .++|..+..++.|++.|+.|||+.||+||||||+|+|+...    +.+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999999887 49999999999999999999999999999999999999743    47999999999977


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ...           ......+||+.|+|||++...+|+..+||||+|+++|.|++|.+||.+.+......++..+++.++
T Consensus       190 ~~~-----------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~  258 (382)
T KOG0032|consen  190 KPG-----------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT  258 (382)
T ss_pred             cCC-----------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC
Confidence            552           234477999999999999999999999999999999999999999999999999999999987765


Q ss_pred             ----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          276 ----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       276 ----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                          +.++..+++||++||..||.+|+|+     .++|.|||+++..
T Consensus       259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta-----~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  259 SEPWDDISESAKDFIRKLLEFDPRKRLTA-----AQALQHPWIKSIG  300 (382)
T ss_pred             CCCccccCHHHHHHHHHhcccCcccCCCH-----HHHhcCccccCCc
Confidence                4689999999999999999999999     8999999998653

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-50  Score=373.07  Aligned_cols=264  Identities=38%  Similarity=0.680  Sum_probs=234.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.++.+++.||+|++.+..............|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876443444445566788888877 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......          
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----------  150 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----------  150 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999986432111          


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+......+|..++.++.+||++|
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence            11224568999999999999999999999999999999999999999999888888888888888999999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |+.||++||++......+++.||||+.++|.....
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~  265 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLER  265 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999999666678999999999999976543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-50  Score=372.22  Aligned_cols=263  Identities=36%  Similarity=0.664  Sum_probs=229.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHH-HHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|++..+++.||+|++.+........... ..++..+++.++|+||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999997653322222223 33334457888999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......          .
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----------~  150 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----------N  150 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++..+++.+.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  230 (325)
T ss_pred             CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHH
Confidence            12234578999999999999899999999999999999999999999999888888888887788888999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |+.||.+|+++.+ .+.++++|+||..++|+.+..
T Consensus       231 l~~~p~~R~~~~~-~~~~i~~~~~~~~~~~~~~~~  264 (325)
T cd05602         231 LQKDRTKRLGAKD-DFMEIKNHIFFSPINWDDLIN  264 (325)
T ss_pred             cccCHHHCCCCCC-CHHHHhcCcccCCCCHHHHHh
Confidence            9999999999965 456899999999999987753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-50  Score=364.90  Aligned_cols=277  Identities=32%  Similarity=0.564  Sum_probs=234.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999976544333444456679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+.|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence            99999999887654  458999999999999999999999999999999999999999999999999987653221    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRIIARDIRFPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~s  279 (366)
                             ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||.+......    ...+......++..++
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05605         157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS  229 (285)
T ss_pred             -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccC
Confidence                   11234688999999999888899999999999999999999999987665432    2334444556677899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      +.+.+||.+||+.||.+||+..+.+++++++||||...+|+..... .+|++.|.
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD  284 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence            9999999999999999999665555699999999999999987643 34565553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-50  Score=371.12  Aligned_cols=260  Identities=35%  Similarity=0.652  Sum_probs=226.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.+..+++.||+|++................|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999987543223333444556677765 5899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      |+|.+++.+...+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......          
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----------  150 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----------  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----------
Confidence            9999999887789999999999999999999999999999999999999999999999999987432211          


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......||..|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+......+|..++.++++||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            12234568999999999998889999999999999999999999999988888888887777778888999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |+.||++||++.    .+++.||||..++|..+..
T Consensus       231 l~~~P~~R~~~~----~~l~~h~~~~~~~~~~~~~  261 (316)
T cd05619         231 FVREPERRLGVK----GDIRQHPFFREIDWSALEE  261 (316)
T ss_pred             hccCHhhcCCCh----HHHHcCcccCCCCHHHHHh
Confidence            999999999993    4899999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=410.00  Aligned_cols=276  Identities=41%  Similarity=0.683  Sum_probs=247.7

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..+||+++++||+|+||.|.+++.+.|++.||+|++++....+......+.+|..+|..-+.+=|+.++..|+|++++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            46788999999999999999999999999999999999885555555667788899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||++||+|..++.+.+++++..++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.+-.+.....
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999988864421


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeec----C-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLN----S-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIR  273 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~  273 (366)
                               ......+|||.|.|||++.    + ..|+..+|+||+||++|||+.|..||...+--+.+.+|..-  .+.
T Consensus       231 ---------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  231 ---------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             ---------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence                     2333568999999999984    3 45899999999999999999999999999999999998875  677


Q ss_pred             CC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCCCC
Q 017775          274 FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (366)
Q Consensus       274 ~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~~~  328 (366)
                      ||  ..+|.++++||.++++ +|+.|.+-  .+++++.+||||.+++|++++...||
T Consensus       302 FP~~~~VSeeakdLI~~ll~-~~e~RLgr--ngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALLC-DREVRLGR--NGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             CCcccccCHHHHHHHHHHhc-Chhhhccc--ccHHHHHhCccccCCChhhhhhcCCC
Confidence            88  4689999999999996 88899863  35699999999999999999876554

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-50  Score=371.97  Aligned_cols=265  Identities=36%  Similarity=0.705  Sum_probs=229.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||+|+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544445556677888888887 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------~  150 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP----------G  150 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC-------CCHHHHHHHHhcCCCCCCCCCCHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-------TSEWLIFQRIIARDIRFPNYFSDAA  282 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~s~~~  282 (366)
                      .......||+.|+|||.+.+..++.++|||||||++|+|++|..||..       .........+......+|..++..+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  230 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA  230 (327)
T ss_pred             CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence            122345789999999999999999999999999999999999999953       2233455666677778889999999


Q ss_pred             HHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCccccccC
Q 017775          283 RDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      .++|.+||+.||++|+++.+ .++++++.||||+.++|+.+...
T Consensus       231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~  274 (327)
T cd05617         231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK  274 (327)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence            99999999999999999742 45689999999999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.3e-50  Score=370.05  Aligned_cols=262  Identities=38%  Similarity=0.682  Sum_probs=228.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHH-HHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+..|. .+++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999765433333333343444 467889999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----------~  150 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----------E  150 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743221          1


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+|...+.++.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            12234578999999999998889999999999999999999999999998888888888888888889999999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      |+.||.+|+++.. .+.++++|+||..++|..+.
T Consensus       231 l~~~p~~R~~~~~-~~~~~~~~~~~~~~~~~~~~  263 (321)
T cd05603         231 LHKDQRRRLGAKA-DFLEIKNHVFFSPINWDDLY  263 (321)
T ss_pred             ccCCHhhcCCCCC-CHHHHhCCCCcCCCCHHHHh
Confidence            9999999998743 45789999999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.4e-50  Score=377.38  Aligned_cols=269  Identities=37%  Similarity=0.625  Sum_probs=231.9

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34567889999999999999999999999999999999997654333344455678999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||++||+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999999988664 5899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCC----CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--C
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--I  272 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~  272 (366)
                      ..         .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.+.+....+..+....  .
T Consensus       196 ~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  266 (370)
T cd05596         196 GM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL  266 (370)
T ss_pred             Cc---------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence            11         112245789999999998653    37889999999999999999999999998888888887643  4


Q ss_pred             CCCC--CCCHHHHHHHHHhhcCCCCC--CCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          273 RFPN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       273 ~~~~--~~s~~~~~li~~~L~~dP~~--Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                      .+|.  .++.++++||.+||+.+|.+  |+++     +++++||||++.+|...
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~-----~ell~h~~~~~~~~~~~  315 (370)
T cd05596         267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGV-----DEIKSHPFFKNDQWTFD  315 (370)
T ss_pred             CCCCcCCCCHHHHHHHHHHccChhhccCCCCH-----HHHhcCcccCCCChhhH
Confidence            4555  57999999999999999988  9988     89999999999887643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-50  Score=369.77  Aligned_cols=261  Identities=38%  Similarity=0.647  Sum_probs=223.0

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      ||+|+||+||+|+++.+|+.||+|++.+..............|..++...   +||+|+++++++.+...+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999999764333333333334455555544   799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......          
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----------  150 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN----------  150 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999987532211          


Q ss_pred             CCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCHHHHHHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-YFSDAARDLID  287 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~  287 (366)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+..+...+|. .+++++.+||+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  230 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVK  230 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            122345789999999998754 4889999999999999999999999998888888888877777775 47999999999


Q ss_pred             HhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       288 ~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      +||+.||.+||++.+ +++++++||||..++|+.+..
T Consensus       231 ~~L~~~P~~R~~~~~-~~~~ll~h~~~~~~~~~~~~~  266 (330)
T cd05586         231 GLLNRNPQHRLGAHR-DAVELKEHPFFADIDWDLLSK  266 (330)
T ss_pred             HHcCCCHHHCCCCCC-CHHHHhcCccccCCCHHHHHh
Confidence            999999999997643 458999999999999887653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-49  Score=372.02  Aligned_cols=266  Identities=39%  Similarity=0.642  Sum_probs=225.9

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|..+++.++||||+++++++.+..
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34556789999999999999999999999999999999997643333444456778999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            999999999999999998764 5899999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC----CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--C
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--I  272 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~  272 (366)
                      .         ........||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+....  .
T Consensus       196 ~---------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  266 (371)
T cd05622         196 G---------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL  266 (371)
T ss_pred             C---------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence            1         11123457999999999986543    7889999999999999999999999998888888877643  3


Q ss_pred             CCCC--CCCHHHHHHHHHhhcCCCCC---CCCCCCCChHhhhcCCCCCCCCcc
Q 017775          273 RFPN--YFSDAARDLIDRLLDVDPSG---RPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       273 ~~~~--~~s~~~~~li~~~L~~dP~~---Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      .+|.  .++.++++||.+||. +|.+   |+++     +++++||||++..|.
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~-----~ei~~h~~~~~~~~~  313 (371)
T cd05622         267 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGV-----EEIKRHLFFKNDQWA  313 (371)
T ss_pred             cCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCH-----HHHhcCcccCCCChh
Confidence            4443  589999999999998 5555   5555     999999999886553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-49  Score=372.93  Aligned_cols=265  Identities=38%  Similarity=0.651  Sum_probs=226.9

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            45568999999999999999999999999999999999764433444455677899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            9999999999999998764 589999999999999999999999999999999999999999999999999986543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC----CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRF  274 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~  274 (366)
                               .......||+.|+|||++.+..    ++.++||||+||++|+|++|..||.+.+.......+....  ..+
T Consensus       198 ---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (370)
T cd05621         198 ---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF  268 (370)
T ss_pred             ---------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC
Confidence                     1123557999999999986543    7789999999999999999999999988888777776543  445


Q ss_pred             CC--CCCHHHHHHHHHhhcCCCCC--CCCCCCCChHhhhcCCCCCCCCcc
Q 017775          275 PN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       275 ~~--~~s~~~~~li~~~L~~dP~~--Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      |.  .++..+++++.+||..++.+  |+++     +++++||||+...|+
T Consensus       269 p~~~~~s~~~~~li~~~L~~~~~r~~R~~~-----~e~l~hp~~~~~~~~  313 (370)
T cd05621         269 PEDVEISKHAKNLICAFLTDREVRLGRNGV-----EEIKQHPFFKNDQWN  313 (370)
T ss_pred             CCcccCCHHHHHHHHHHccCchhccCCCCH-----HHHhcCcccCCCCcC
Confidence            54  47999999999999865544  7777     899999999986654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-51  Score=370.14  Aligned_cols=260  Identities=31%  Similarity=0.526  Sum_probs=237.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      -+=|.+.+.||+|-|.+|-+|++.-||+.||||++++..+.... ...+.+|+..|+.++|||||++|++..+...+|+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            34589999999999999999999999999999999988654433 44566699999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-CCCCEEEEecCCccccCCcccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|.-++|+|++++.++ ..+.|+.+++++.||+.|+.|||+..++||||||+|+.+- .-|-|||.|||++..+....  
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--  173 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--  173 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence            9999999999999876 4599999999999999999999999999999999998765 56999999999998776543  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCC-CCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                               ...+.+|++.|.|||++.|..|+ +++||||||||+|.|.+|++||...++.+.+..|+.+++..|..++.
T Consensus       174 ---------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~  244 (864)
T KOG4717|consen  174 ---------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSK  244 (864)
T ss_pred             ---------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhH
Confidence                     44578999999999999998875 57899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      ++++||..||..||++|.+.     ++|..|+|++.++..
T Consensus       245 eCrdLI~sMLvRdPkkRAsl-----EeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASL-----EEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHHHHhcCchhhccH-----HHHhccccccCCCCC
Confidence            99999999999999999988     999999999988743

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-49  Score=365.71  Aligned_cols=268  Identities=40%  Similarity=0.681  Sum_probs=225.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||.||++.++.+++.||+|++.+...........+.+|..+++.++|+||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999997643333444455778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+.|++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT---  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC---
Confidence            99999999999976 45799999999999999999999999999999999999999999999999999876543211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCC-
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP-  275 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~-  275 (366)
                            .......||+.|+|||++.+     ..++.++||||+||++|+|++|+.||.+.+..+....+....  ..++ 
T Consensus       158 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  231 (331)
T cd05597         158 ------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP  231 (331)
T ss_pred             ------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence                  11123468999999999863     347889999999999999999999999888777777765432  2333 


Q ss_pred             --CCCCHHHHHHHHHhhcCCCCC--CCCCCCCChHhhhcCCCCCCCCccccccCC
Q 017775          276 --NYFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (366)
Q Consensus       276 --~~~s~~~~~li~~~L~~dP~~--Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~  326 (366)
                        ..+++++++||++||+.++++  |+++     +++++||||.+++|..+....
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~~r~~r~~~-----~~~l~hp~~~~~~~~~~~~~~  281 (331)
T cd05597         232 DVTDVSEEAKDLIRRLICSPETRLGRNGL-----QDFKDHPFFEGIDWDNIRNST  281 (331)
T ss_pred             ccCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCCCCCCCCHHHHhhCC
Confidence              347999999999999864443  6666     899999999999998876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-49  Score=361.21  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=213.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999999765322 233445677999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++++.+..+....+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........    
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----  155 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN----  155 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence            9999877765555556799999999999999999999999999999999999999999999999999986543211    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-------------  271 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-------------  271 (366)
                           .......|++.|+|||++.+..++.++|+||+||++|+|++|++||.+.+.......+....             
T Consensus       156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         156 -----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             -----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence                 11224568999999999988889999999999999999999999998876654433322110             


Q ss_pred             ------CCC-------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 ------IRF-------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 ------~~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                            ...             ...++.++.+||.+||+.||++|||+     +++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-----~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-----EQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence                  001             12368889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-51  Score=347.21  Aligned_cols=259  Identities=33%  Similarity=0.551  Sum_probs=231.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cchh---hHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKEN---KTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      .+.|+-.++||+|..++|.+|.++.+|..+|+|++.....  ..+.   ..+....|+.+|+++ .||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            5678889999999999999999999999999999875321  1222   233455699999988 699999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+++|+|.|+.|.|++++...-.++|.+.+.+++|+++|++|||.++|+||||||+|||++++-++||+|||+|+.+..
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeec------CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      +           ......+|||+|+|||.+.      ...|+..+|+|++|+|+|.|+.|.+||.......++..|..++
T Consensus       176 G-----------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  176 G-----------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             c-----------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            4           3455789999999999874      3448889999999999999999999999988889999999998


Q ss_pred             CCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       272 ~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ++|.    .++|.+.+|||.+||+.||.+|.|+     ++.|.||||.++-
T Consensus       245 yqF~speWadis~~~KdLIsrlLqVdp~~Rita-----ke~LaHpff~q~~  290 (411)
T KOG0599|consen  245 YQFRSPEWADISATVKDLISRLLQVDPTKRITA-----KEALAHPFFIQIA  290 (411)
T ss_pred             cccCCcchhhccccHHHHHHHHHeeCchhcccH-----HHHhcChHHHHHH
Confidence            8875    4689999999999999999999999     8999999997553

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.7e-49  Score=364.73  Aligned_cols=267  Identities=37%  Similarity=0.657  Sum_probs=226.8

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..++|++|+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997643333444455778899999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........   
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~---  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT---  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---
Confidence            99999999999987 46799999999999999999999999999999999999999999999999999875432210   


Q ss_pred             CCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCC-
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP-  275 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~-  275 (366)
                            .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||...+..+....+....  ..+| 
T Consensus       158 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  231 (332)
T cd05623         158 ------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA  231 (332)
T ss_pred             ------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC
Confidence                  1112346899999999985     3457889999999999999999999999988888888776643  2333 


Q ss_pred             --CCCCHHHHHHHHHhhcCCCCC--CCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          276 --NYFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       276 --~~~s~~~~~li~~~L~~dP~~--Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                        ..+++++++||++||+.++.+  |+++     ++++.||||.+++|+.+...
T Consensus       232 ~~~~~s~~~~~li~~ll~~~~~r~~r~~~-----~~~~~h~~f~~~~~~~~~~~  280 (332)
T cd05623         232 QVTDVSEDAKDLIRRLICSREHRLGQNGI-----EDFKQHPFFTGIDWDNIRNC  280 (332)
T ss_pred             ccccCCHHHHHHHHHHccChhhhcCCCCH-----HHHhCCCCcCCCCHHHHhhC
Confidence              357999999999999876555  4555     99999999999999887643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.4e-49  Score=364.78  Aligned_cols=270  Identities=38%  Similarity=0.651  Sum_probs=226.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|..++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997643333344455777899999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+.||+|.+++.+ .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........   
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT---  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence            99999999999987 46799999999999999999999999999999999999999999999999999876543211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  276 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~  276 (366)
                            .......|++.|+|||++.+     ..++.++||||+||++|+|++|+.||...+..+....+....  ..+|.
T Consensus       158 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  231 (331)
T cd05624         158 ------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS  231 (331)
T ss_pred             ------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCC
Confidence                  11123468999999999865     457889999999999999999999999888877777776543  33443


Q ss_pred             ---CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC
Q 017775          277 ---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (366)
Q Consensus       277 ---~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~  326 (366)
                         .++.+++++|.+||+.++++ +..  .+++++++||||..++|..+....
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~~~-~~~--~~~~~~~~h~~f~~~~~~~~~~~~  281 (331)
T cd05624         232 HITDVSEEAKDLIQRLICSRERR-LGQ--NGIEDFKKHAFFEGIDWENIRNLE  281 (331)
T ss_pred             ccccCCHHHHHHHHHHccCchhh-cCC--CCHHHHhcCCCcCCCCHHHHhhCC
Confidence               46899999999999976544 321  134999999999999998876433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-49  Score=356.90  Aligned_cols=278  Identities=33%  Similarity=0.572  Sum_probs=231.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.............+..|+.+++.++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999876544334444456679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+.|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence            99999999988654  358999999999999999999999999999999999999999999999999987543221    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH---HHHHHHh-cCCCCCCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRII-ARDIRFPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~-~~~~~~~~~~s  279 (366)
                             ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||......   .....+. .....++..++
T Consensus       157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05630         157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS  229 (285)
T ss_pred             -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCC
Confidence                   112346899999999999888999999999999999999999999865432   2222222 22334567789


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc-CCCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEP  334 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~-~~~~~~~~~~  334 (366)
                      +++.+|+++||+.||++|||+...+++++++||||+.++|..+.. +.+|++.|.|
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~  285 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP  285 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence            999999999999999999996544559999999999999987764 3456666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-49  Score=349.90  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=222.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEeeCC----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTF----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----  118 (366)
                      +..|+.+++||+|+||+||+|+++.+|+.||+|+++.+... +.......+|+.+++.++|+| |+.+++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            67799999999999999999999999999999999876432 233345567999999999999 999999998877    


Q ss_pred             --eEEEEEeecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          119 --SLYMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       119 --~~~iv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                        .+++|+||++. +|..++...+    .++...++.+++||+.||+|||+++|+||||||.||+|+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999986 9999998765    4788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-  270 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-  270 (366)
                      +.+.-+.          .....-++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.++.+++..|... 
T Consensus       168 ra~~ip~----------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l  237 (323)
T KOG0594|consen  168 RAFSIPM----------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL  237 (323)
T ss_pred             HHhcCCc----------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence            9654332          223355789999999998877 5999999999999999999999999999998888877541 


Q ss_pred             -----------------CCCCC------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          271 -----------------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       271 -----------------~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                       +..++            +..+++..+++.+||+.+|.+|.||     +.++.||||.....
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa-----~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA-----KGALTHPYFSELPE  310 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH-----HHHhcChhhccccc
Confidence                             11111            1234589999999999999999999     88999999998753

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-50  Score=351.71  Aligned_cols=252  Identities=31%  Similarity=0.524  Sum_probs=216.3

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----Ce
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FS  119 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  119 (366)
                      =.|...+++|+|+||.||+|...++++.||||.+-.+.       +.-.+|+++|+.++|||||++..+|...     -+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            35899999999999999999999999999999875432       1234599999999999999998888632     24


Q ss_pred             EEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCccc
Q 017775          120 LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKP  194 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~  194 (366)
                      ..+||||++. +|.+.+..    +..++.-.++-+++||+.||.|||+.||+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            6789999986 99998874    4579999999999999999999999999999999999999976 9999999999998


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  270 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---  270 (366)
                      +..+.           ...++..|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.|.+..+++..|.+-   
T Consensus       176 L~~~e-----------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  176 LVKGE-----------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             eccCC-----------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            86653           33478899999999998765 4999999999999999999999999999988887777541   


Q ss_pred             --------------CCC------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          271 --------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       271 --------------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                    ...            +....++++.+|+.++|..+|.+|.++     .+++.||||..+.-+
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~-----~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA-----LEALAHPFFDELRDP  315 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH-----HHHhcchhhHHhhCc
Confidence                          111            123468999999999999999999999     899999999876544

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.7e-49  Score=354.66  Aligned_cols=261  Identities=29%  Similarity=0.576  Sum_probs=219.6

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||+|+||.||++.++.+|+.||+|.+................|+.+++.++||||+++++++.+....++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999999765443333344455699999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 017775          133 FDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (366)
Q Consensus       133 ~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~  210 (366)
                      .+++...+  .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......           
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----------  149 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----------  149 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence            98886543  48899999999999999999999999999999999999999999999999987654321           


Q ss_pred             CccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCCC-CCCCHHHHHH
Q 017775          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFP-NYFSDAARDL  285 (366)
Q Consensus       211 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~l  285 (366)
                      ......|+..|+|||++.+..++.++|+||+||++|+|++|..||.....    .+....+.......+ ..+++++++|
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI  229 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence            11133588899999999888899999999999999999999999976433    333444444443333 4689999999


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      +.+||++||++||++.+. .+++++||||+.++|+.+...
T Consensus       230 i~~~L~~~P~~R~~~~~~-~~~~~~h~~f~~~~~~~~~~~  268 (277)
T cd05607         230 CRLFLAKKPEDRLGSREK-NDDPRKHEFFKTINFPRLEAG  268 (277)
T ss_pred             HHHHhccCHhhCCCCccc-hhhhhcChhhcCCCHHHHhcC
Confidence            999999999999999653 367889999999999888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-50  Score=367.46  Aligned_cols=258  Identities=28%  Similarity=0.495  Sum_probs=237.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe-EE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS-LY  121 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~  121 (366)
                      .+++|.+++++|+|+||.+++++++.++..|++|.+........... ....|..++++++|||||.+.+.|.+++. ++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            36789999999999999999999999999999999998766555544 56669999999999999999999998888 99


Q ss_pred             EEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |||+||+||+|.+.+.+.+  .++|+.+..|+.|++.||.|||+++|.|||||+.||+++.++.|||+|||+|+.+....
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999998764  59999999999999999999999999999999999999999999999999999887653


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYF  278 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~  278 (366)
                                ....+.+||+.|++||++.+.+|+.++|||||||++|||++-+++|.+.+......+|.... .+.|..+
T Consensus       161 ----------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y  230 (426)
T KOG0589|consen  161 ----------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY  230 (426)
T ss_pred             ----------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc
Confidence                      24457899999999999999999999999999999999999999999999999999988877 6788899


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +.+++.+|..||..+|..||++     .+++.+|....
T Consensus       231 s~el~~lv~~~l~~~P~~RPsa-----~~LL~~P~l~~  263 (426)
T KOG0589|consen  231 SSELRSLVKSMLRKNPEHRPSA-----LELLRRPHLLR  263 (426)
T ss_pred             cHHHHHHHHHHhhcCCccCCCH-----HHHhhChhhhh
Confidence            9999999999999999999999     88999988763

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-48  Score=353.94  Aligned_cols=268  Identities=42%  Similarity=0.730  Sum_probs=240.3

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987654434444556778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++......      
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------  154 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------  154 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence            99999999999988888999999999999999999999999999999999999999999999999998765432      


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                             .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+.+......+|..++..+++
T Consensus       155 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  227 (290)
T cd05580         155 -------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD  227 (290)
T ss_pred             -------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHH
Confidence                   1234578899999999888888999999999999999999999998888777888888888888999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      +|.+||+.||.+|++....+++++++||||..++|..+...
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~  268 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQR  268 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhc
Confidence            99999999999999665556699999999999999877543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.9e-49  Score=357.54  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=213.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+++|++.+.||.|+||.||+|.+..+++.||+|+++....  ......+.+|+.+++.++||||+++++++.+....++
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            46889999999999999999999999999999999875432  2223345679999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9999986 9999887654 47999999999999999999999999999999999999999999999999987543221  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---------  271 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------  271 (366)
                              .......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+....         
T Consensus       158 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07871         158 --------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP  229 (288)
T ss_pred             --------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence                    11123467889999999865 558899999999999999999999998877665554432110         


Q ss_pred             ----------CCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 ----------IRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 ----------~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                ..+|           ..+++++++||.+||+.||.+|||+     +++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~-----~~~l~hp~f  288 (288)
T cd07871         230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA-----EAALRHSYF  288 (288)
T ss_pred             ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCCCC
Confidence                      0011           2468899999999999999999999     899999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-48  Score=352.36  Aligned_cols=278  Identities=32%  Similarity=0.577  Sum_probs=235.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|+..+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++|++++++++.+.+++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999876544444444556779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence            99999999888654  359999999999999999999999999999999999999999999999999987543221    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHH----HHHhcCCCCCCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRIIARDIRFPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~s  279 (366)
                             ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.......    ..+......++..++
T Consensus       157 -------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05632         157 -------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS  229 (285)
T ss_pred             -------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCC
Confidence                   112346899999999998888999999999999999999999999877654333    333444445667789


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc-CCCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEP  334 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~-~~~~~~~~~~  334 (366)
                      .++.+|+.+||+.||++||++.+..+.+++.|+||+.+.|+.+.. +..|++.+.|
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (285)
T cd05632         230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP  285 (285)
T ss_pred             HHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence            999999999999999999998777779999999999999987653 3456665543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.8e-49  Score=369.32  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=215.8

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCcceeEEEEeeCCe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQDTFS  119 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~  119 (366)
                      +|.+.+.||+|+||+|.+|.+..|++.||||+++..    .........|+.+|..++      .-|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            789999999999999999999999999999999774    334445566888998885      3579999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC--CCEEEEecCCcccc
Q 017775          120 LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPM  195 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~--~~vkL~Dfg~a~~~  195 (366)
                      +|||+|.+.- +|+++++.++  .++...++.++.||+.||.+||++||||+||||+|||+...  ..||++|||+|+..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999975 9999999874  58999999999999999999999999999999999999754  47999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-----
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----  270 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-----  270 (366)
                      ..             ...+++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.|.++.+++..|.+-     
T Consensus       342 ~q-------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  342 SQ-------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             CC-------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            43             233778899999999999999999999999999999999999999999998888777540     


Q ss_pred             ---------------C--------------------------------CCCCC-----------CCCHHHHHHHHHhhcC
Q 017775          271 ---------------D--------------------------------IRFPN-----------YFSDAARDLIDRLLDV  292 (366)
Q Consensus       271 ---------------~--------------------------------~~~~~-----------~~s~~~~~li~~~L~~  292 (366)
                                     .                                ...|.           .-...+.|||.+||+.
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence                           0                                00110           1134589999999999


Q ss_pred             CCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          293 DPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       293 dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ||.+|+|+     .++++||||+...
T Consensus       489 dP~~R~tp-----~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  489 DPAERITP-----AQALNHPFLTGTS  509 (586)
T ss_pred             CchhcCCH-----HHHhcCccccccc
Confidence            99999999     8899999998543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=367.08  Aligned_cols=257  Identities=31%  Similarity=0.493  Sum_probs=229.4

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..|...+.||+|+||.||+|.+..+++.||+|+++.+.  .+...+.+++|+.++.+++++||.++|+.|..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            35777799999999999999999999999999998864  3444567888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |||.||++.+.++..+.+.|.++.-++++++.||.|||.++.+|||||+.||++..+|.+||+|||++..+....     
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-----  165 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-----  165 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh-----
Confidence            999999999999988777999999999999999999999999999999999999999999999999998765542     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAAR  283 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~  283 (366)
                           ....+++||+.|||||++....|+.++||||||++.+||++|.+|+....+...+..|.+..+ .+...+|+.++
T Consensus       166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHH
Confidence                 223588999999999999998999999999999999999999999988877655555554433 34457899999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +|+..||++||+.||+|     .++++|+|++...
T Consensus       241 EFV~~CL~k~P~~RpsA-----~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSA-----KELLKHKFIKRAK  270 (467)
T ss_pred             HHHHHHhhcCcccCcCH-----HHHhhhHHHHhcC
Confidence            99999999999999999     8999999998643

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-48  Score=358.06  Aligned_cols=285  Identities=41%  Similarity=0.692  Sum_probs=241.3

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.............+..|+.+++.++|+||+++++.+.+....|++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998764444345556788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          125 ESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       125 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||+.|++|.+++.+.  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764  468999999999999999999999999999999999999999999999999987654332111


Q ss_pred             cCC-------------------CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH
Q 017775          203 LPN-------------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI  263 (366)
Q Consensus       203 ~~~-------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  263 (366)
                      ...                   ...........|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence            000                   0011122345788999999999988899999999999999999999999998888887


Q ss_pred             HHHHhcCCCCCCCC--CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCCCCCC
Q 017775          264 FQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL  330 (366)
Q Consensus       264 ~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~~~~~  330 (366)
                      +..+......++..  +++++.++|.+||+.||++||+... .+++++.||||++++|..+....+|..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~-~~~~ll~~~~~~~~~~~~~~~~~~~~~  308 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR-GAAEIKQHPFFRGVNWALIRHTTPPII  308 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchh-hHHHHHcCchhhcCChhhcccCCCCCC
Confidence            77777766666654  6999999999999999999999211 128999999999999999988666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.8e-49  Score=359.64  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=210.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.....  ........+|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            5789999999999999999999999999999999875422  12223456799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+.+ +|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......   
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  157 (303)
T cd07869          82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---  157 (303)
T ss_pred             EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence            999975 888777654 568999999999999999999999999999999999999999999999999987543221   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcC--C-------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIAR--D-------  271 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~--~-------  271 (366)
                             .......+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.... .....+...  .       
T Consensus       158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         158 -------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             -------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence                   11123467899999999865 45788999999999999999999999875432 222222110  0       


Q ss_pred             ------------CC--CC---------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          272 ------------IR--FP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       272 ------------~~--~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                  ..  .+         ..+++++.+|+.+||+.||++|||+     ++++.||||+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~-----~~~l~h~~f~~~~~  296 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA-----QAALSHEYFSDLPP  296 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH-----HHHhcCcccccCCh
Confidence                        00  00         1245789999999999999999999     89999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-48  Score=358.46  Aligned_cols=259  Identities=24%  Similarity=0.411  Sum_probs=220.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|+||.||+|++..+|..+|+|++....  .......+.+|+.+++.++||||+++++++.+.+.++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            45689999999999999999999999999999999987642  2334456788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            9999999999999998888899999999999999999999986 6999999999999999999999999998755322  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHh------------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII------------  268 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------------  268 (366)
                                ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......+....+.            
T Consensus       158 ----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         158 ----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             ----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence                      1124468999999999998889999999999999999999999997665543322111            


Q ss_pred             ----------------------------------cC-CCCC-CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCC
Q 017775          269 ----------------------------------AR-DIRF-PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (366)
Q Consensus       269 ----------------------------------~~-~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp  312 (366)
                                                        .. .... ...+++++++||.+||+.||++|||+     .+++.||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~-----~ell~h~  302 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL-----KMLMNHT  302 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH-----HHHhcCh
Confidence                                              00 0111 12478899999999999999999999     8999999


Q ss_pred             CCCCCCc
Q 017775          313 FFKGIDW  319 (366)
Q Consensus       313 ~f~~~~~  319 (366)
                      ||+....
T Consensus       303 ~~~~~~~  309 (331)
T cd06649         303 FIKRSEV  309 (331)
T ss_pred             HHhhccc
Confidence            9986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-48  Score=361.05  Aligned_cols=261  Identities=28%  Similarity=0.464  Sum_probs=212.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----CeE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FSL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  120 (366)
                      +|++.+.||+|+||.||+|+++.+|..||+|.+...... ......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            599999999999999999999999999999998754322 22334567799999999999999999987543     358


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999996 59999998888899999999999999999999999999999999999999999999999999875432211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc---------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---------  269 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---------  269 (366)
                      .       ........|++.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+.......+..         
T Consensus       159 ~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         159 T-------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             c-------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            0       111234578999999999865  5688899999999999999999999987665332221110         


Q ss_pred             -----------------CCCCC-----CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          270 -----------------RDIRF-----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       270 -----------------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                       .....     ...+++++.++|.+||+.||++|||+     ++++.||||+++...
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~e~l~hp~f~~~~~~  299 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA-----EEALADPYFKGLAKV  299 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH-----HHHhcCchhhhcCcc
Confidence                             00000     12467889999999999999999999     899999999977653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-47  Score=358.44  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=214.4

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ........+|+.++.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus        67 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             CCCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            344556789999999999999999999999999999999986542  233345677899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+++||||+++++|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus       145 ~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999999999998642    3467888999999999999999999999999999999999999999999999886543


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCCHH---HHHHHH-h
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRI-I  268 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i-~  268 (366)
                      ..          .......|+..|+|||++..     ...+.++|||||||++|+|++|+.||......   .....+ .
T Consensus       221 ~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  290 (353)
T PLN00034        221 TM----------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM  290 (353)
T ss_pred             cc----------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc
Confidence            21          11124578999999998743     33456899999999999999999999743322   222222 2


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       269 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ......+..++.++++||.+||+.||++||++     .+++.||||..-
T Consensus       291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~ell~hp~~~~~  334 (353)
T PLN00034        291 SQPPEAPATASREFRHFISCCLQREPAKRWSA-----MQLLQHPFILRA  334 (353)
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCcCH-----HHHhcCcccccC
Confidence            23445567789999999999999999999999     899999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-48  Score=363.05  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=209.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+...+|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++.++||||+++++++......
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            4567789999999999999999999999999999996432         2356799999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++|+|++. ++|..++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            99999996 5899999888889999999999999999999999999999999999999999999999999987532211 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-------HHHHHHHHhc----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-------EWLIFQRIIA----  269 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~----  269 (366)
                              ........||+.|+|||++.+..++.++|||||||++|+|++|..||....       ....+..+..    
T Consensus       237 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        237 --------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             --------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence                    112234579999999999998889999999999999999999998764321       1111111111    


Q ss_pred             ----------------------CCCCCC---------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          270 ----------------------RDIRFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       270 ----------------------~~~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                            .....+         ..++.++.+||.+||+.||++|||+     ++++.||||+.+
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~  382 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA-----EALLDFAAFQDI  382 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH-----HHHhcChhhccC
Confidence                                  000000         1246789999999999999999999     899999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-49  Score=340.32  Aligned_cols=286  Identities=35%  Similarity=0.681  Sum_probs=256.3

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      ...+.+++|.++++||+|+|..|.+++.+.|.+.||+|+++++..+..++..-++.|..+..+- +||.+|.++..|+++
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            4457899999999999999999999999999999999999999888888888888898888765 799999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+++|.||++||+|--.++++.+++|+.++.+...|+.||.|||++||++||||.+|+|++..|++||.|+|.++.-- 
T Consensus       324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987432 


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC--------CCHHHHHHHHhc
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD--------TSEWLIFQRIIA  269 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~  269 (366)
                               .+.....+++||+.|.|||++.+..|+..+|+|+||++++||+.|+.||.-        .++.-.++-|++
T Consensus       403 ---------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile  473 (593)
T KOG0695|consen  403 ---------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE  473 (593)
T ss_pred             ---------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence                     223456689999999999999999999999999999999999999999952        223345667888


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCcccccc-CCCCCCCCCC
Q 017775          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEP  334 (366)
Q Consensus       270 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~-~~~~~~~~~~  334 (366)
                      ....+|..+|-.+..+++..|++||.+|..... .+..++..|+||+.++|+.+.. +..|++.|..
T Consensus       474 kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i  540 (593)
T KOG0695|consen  474 KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQI  540 (593)
T ss_pred             hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCcc
Confidence            899999999999999999999999999987643 4778999999999999999874 4566666644

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-50  Score=364.26  Aligned_cols=287  Identities=36%  Similarity=0.657  Sum_probs=264.6

Q ss_pred             ccCCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           35 FRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        35 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      +..+...+.+.+.+.+..||-|+||.|-++........+|+|++++..+-.....+.+..|..+|...+.|.||++|..|
T Consensus       410 ~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  410 FAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             HHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            34455667788999999999999999999998777667999999998877777888889999999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      .+..++|++||-|-||.|+..+..++.+.+..++.++..+++|++|||++||++|||||+|.+++.+|-+||.|||+|++
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DI  272 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~  272 (366)
                      +....           +..+++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++...+..|+.+  ..
T Consensus       570 i~~g~-----------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i  638 (732)
T KOG0614|consen  570 IGSGR-----------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI  638 (732)
T ss_pred             hccCC-----------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh
Confidence            87654           556899999999999999999999999999999999999999999999999999999886  46


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC-CCCCCC
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKLAS  332 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~-~~~~~~  332 (366)
                      .+|..++..+.+||+++...+|.+|..-...++.+|.+|.||.+++|+.+.... +||+.+
T Consensus       639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~  699 (732)
T KOG0614|consen  639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP  699 (732)
T ss_pred             hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence            789999999999999999999999999877889999999999999999988653 555544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=351.74  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=219.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcE-EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV-YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +...+...+..+.+.||+|+||+||++.+.  |+. ||+|++......... ...+.+|+.+|.+++|||||++++++.+
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            445566677788888999999999999984  455 999999876544444 6788999999999999999999999999


Q ss_pred             CC-eEEEEEeecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCeEeCCCC-CEEEEecCC
Q 017775          117 TF-SLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTADG-HIKIADFGS  191 (366)
Q Consensus       117 ~~-~~~iv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qil~aL~~LH~~~-i~H~dlkp~NIli~~~~-~vkL~Dfg~  191 (366)
                      .. .++|||||+++|+|.+++..  .+.++...+..++.||+.||+|||+++ |+||||||+|||++.++ ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999988  578999999999999999999999999 99999999999999998 999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeec--CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      ++......          .......||+.|||||++.  ...|+.++||||+|+++|||+||..||.+.........+..
T Consensus       191 sr~~~~~~----------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~  260 (362)
T KOG0192|consen  191 SREKVISK----------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV  260 (362)
T ss_pred             ceeecccc----------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            98765432          1122357999999999999  56899999999999999999999999999988666666643


Q ss_pred             --CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          270 --RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       270 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                        ..+.+|...++.+..|+.+||..||.+||+..+
T Consensus       261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e  295 (362)
T KOG0192|consen  261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLE  295 (362)
T ss_pred             cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence              345567779999999999999999999999843

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-47  Score=367.25  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=209.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC----
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT----  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----  117 (366)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++...    
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            34568999999999999999999999999999999885431       1234699999999999999998877432    


Q ss_pred             ----CeEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEe
Q 017775          118 ----FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIAD  188 (366)
Q Consensus       118 ----~~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~D  188 (366)
                          ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence                257899999986 77776642    45699999999999999999999999999999999999999665 799999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      ||+++.+....           ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+
T Consensus       215 FGla~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  283 (440)
T PTZ00036        215 FGSAKNLLAGQ-----------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI  283 (440)
T ss_pred             cccchhccCCC-----------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99998654321           12245789999999997664 6899999999999999999999999988766555444


Q ss_pred             hcC-----------------CC------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          268 IAR-----------------DI------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       268 ~~~-----------------~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ...                 ..            .+|...++++++||.+||++||.+|||+     .+++.||||..+.
T Consensus       284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta-----~e~l~hp~f~~~~  358 (440)
T PTZ00036        284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP-----IEALADPFFDDLR  358 (440)
T ss_pred             HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhCChhHHhhh
Confidence            321                 01            1344578899999999999999999999     8999999998765


Q ss_pred             c
Q 017775          319 W  319 (366)
Q Consensus       319 ~  319 (366)
                      .
T Consensus       359 ~  359 (440)
T PTZ00036        359 D  359 (440)
T ss_pred             c
Confidence            4

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.9e-47  Score=355.71  Aligned_cols=254  Identities=23%  Similarity=0.415  Sum_probs=209.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            46899999999999999999999999999999999876532 233344566799999999999999999998654     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ..+|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence             357999999976 67666643  48999999999999999999999999999999999999999999999999987543


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc-------
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-------  269 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------  269 (366)
                      ...           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..       
T Consensus       175 ~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         175 TNF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             cCc-----------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            221           12245688999999999998999999999999999999999999987765443322211       


Q ss_pred             ---------------CCCC--------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          270 ---------------RDIR--------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       270 ---------------~~~~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                     ....                    .+...++++++||.+||+.||++|||+     .++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~  318 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV-----DEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH-----HHHhcCchh
Confidence                           1100                    111246789999999999999999999     899999999


Q ss_pred             CC
Q 017775          315 KG  316 (366)
Q Consensus       315 ~~  316 (366)
                      ..
T Consensus       319 ~~  320 (359)
T cd07876         319 TV  320 (359)
T ss_pred             hh
Confidence            74

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.5e-47  Score=343.37  Aligned_cols=262  Identities=32%  Similarity=0.601  Sum_probs=224.7

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||+|+||.||+|.+..+|+.||+|.+.............+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999765443344444556799999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCC
Q 017775          133 FDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (366)
Q Consensus       133 ~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~  210 (366)
                      .+++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......           
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----------  149 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----------  149 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence            99998765  69999999999999999999999999999999999999999999999999987553311           


Q ss_pred             CccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCHHHHHHH
Q 017775          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFPNYFSDAARDLI  286 (366)
Q Consensus       211 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li  286 (366)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....    ......+.......+..+++++.++|
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC  229 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence            11133577889999999888899999999999999999999999976544    23333344445566778899999999


Q ss_pred             HHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      .+||+.||.+||+..+.++.+++.||||..++|+.....
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~  268 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAG  268 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcC
Confidence            999999999999887777799999999999999887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.9e-47  Score=345.22  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=206.8

Q ss_pred             CCeeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEe-----
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ-----  115 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----  115 (366)
                      ++|++.+.||+|+||.||+|.+.. +|..||+|.++....... ......+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 578899999876432222 222344566666655   6999999999875     


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          116 DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ....+++||||+.+ +|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            34569999999975 899988764  358999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-  272 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-  272 (366)
                      .....           .......|++.|+|||.+.+..++.++||||+||++|+|++|.+||.+.+..+....+..... 
T Consensus       159 ~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         159 IYSFQ-----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             eccCC-----------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            65332           112245689999999999888899999999999999999999999998887776666543110 


Q ss_pred             ----C----------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          273 ----R----------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       273 ----~----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                          .                      ....+++.+++|+.+||+.||++|||+     .++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~hp~f  290 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYF  290 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH-----HHHhcCCCC
Confidence                0                      112467889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-46  Score=340.68  Aligned_cols=260  Identities=35%  Similarity=0.613  Sum_probs=214.7

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD---QLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      .||+|+||.||++.+..+|+.+|+|.+.+.............+|..+++   ..+|++++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997754433332333334444433   3479999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCC
Q 017775          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (366)
Q Consensus       129 g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~  208 (366)
                      +++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......         
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---------  151 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------  151 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999987543221         


Q ss_pred             CCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          209 DDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       209 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                         .....|+..|+|||.+. +..++.++|+||+||++|+|++|..||....   ..............+|..+++++.+
T Consensus       152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd05633         152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS  228 (279)
T ss_pred             ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHH
Confidence               11335889999999986 4568899999999999999999999996532   2222233334455677889999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      +|.+||+.||++||+....++.++++||||++++|....
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~  267 (279)
T cd05633         229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY  267 (279)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence            999999999999997444455999999999999988764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3e-47  Score=358.11  Aligned_cols=257  Identities=28%  Similarity=0.390  Sum_probs=215.1

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----eE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~  120 (366)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++.+..     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            58899999999999999999999999999999865422 2223345677999999999999999999998776     79


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||+.+ +|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            999999975 8988888878899999999999999999999999999999999999999999999999999876533211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc----------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA----------  269 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----------  269 (366)
                               .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.......+..          
T Consensus       159 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         159 ---------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             ---------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence                     111234678899999998774 478899999999999999999999988877655544422          


Q ss_pred             -------------CCC---------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          270 -------------RDI---------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       270 -------------~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                   ...         ......++++.+||.+||+.||++|||+     .++++||||.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~~~~  295 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA-----ADALAHPYLDEGR  295 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH-----HHHhcCHhhCCCc
Confidence                         000         1223468899999999999999999999     8999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-46  Score=337.33  Aligned_cols=257  Identities=39%  Similarity=0.738  Sum_probs=227.2

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||.|++|.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876544444556788899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 017775          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (366)
Q Consensus       133 ~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~  212 (366)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......           ..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----------~~  149 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----------KT  149 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------cc
Confidence            9999888789999999999999999999999999999999999999999999999999988664331           11


Q ss_pred             cccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC--HHHHHHHHh--cCCCCCCCCCCHHHHHHHHH
Q 017775          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRII--ARDIRFPNYFSDAARDLIDR  288 (366)
Q Consensus       213 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~  288 (366)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....  .......+.  .....+|...++++.++|.+
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  229 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ  229 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHH
Confidence            23467889999999988888999999999999999999999998776  666666666  45666777789999999999


Q ss_pred             hhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          289 LLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       289 ~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      ||+.||++||+..+.+++++++||||++++|+
T Consensus       230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             HccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99999999999555566999999999999886

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-46  Score=335.72  Aligned_cols=258  Identities=28%  Similarity=0.488  Sum_probs=221.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ++|++.+.||+|++|.||.|.+..+++.||+|.+........  .....+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            469999999999999999999999999999999875432222  223457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ++||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......... 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~-  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS-  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc-
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998765432111 


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSD  280 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~  280 (366)
                            ........++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+.......+...  ...+|..++.
T Consensus       161 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd06625         161 ------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP  234 (263)
T ss_pred             ------cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCH
Confidence                  01112345778999999999988999999999999999999999999876665554444333  4456778999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++.++|.+||..+|++||++     .++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSA-----EELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCH-----HHHhhCCCC
Confidence            99999999999999999998     899999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-47  Score=353.94  Aligned_cols=263  Identities=32%  Similarity=0.539  Sum_probs=242.7

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ........|.+.+.||+|.|+.|.++++..+|..||+|++++......... .+.+|+.+++.++|||||+++.+.+...
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~-k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQ-KLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHH-HHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            445567789999999999999999999999999999999999866555433 3778999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||+.+|.+++++.+++...+..++.++.|++.|++|||+++|+|||||++|||++.+.++||+|||++..+...
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987643


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                                 ....+++|++.|.|||++.+..| +..+|+||+|+++|.|+.|..||++.+-.+.....+.+++.+|..
T Consensus       209 -----------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~  277 (596)
T KOG0586|consen  209 -----------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY  277 (596)
T ss_pred             -----------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce
Confidence                       24457899999999999988774 678999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ++.++.++|+++|..+|.+|+++     ++++.|.|.....
T Consensus       278 ms~dce~lLrk~lvl~Pskr~~~-----dqim~~~W~n~~~  313 (596)
T KOG0586|consen  278 MSCDCEDLLRKFLVLNPSKRGPC-----DQIMKDRWRNDLL  313 (596)
T ss_pred             eechhHHHHHHhhccCccccCCH-----HHhhhhcccchhh
Confidence            99999999999999999999999     8899999997543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-46  Score=363.58  Aligned_cols=257  Identities=30%  Similarity=0.448  Sum_probs=224.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ...|.+.+.||+|++|.||+|.+..+ ++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            44599999999999999999998877 788999977543   33344567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          123 ALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ||||++||+|.+++.+    ..++++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999987754    346899999999999999999999999999999999999999999999999999866432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNY  277 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~  277 (366)
                      ..        .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+.. .+|..
T Consensus       223 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  294 (478)
T PTZ00267        223 VS--------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP  294 (478)
T ss_pred             cc--------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            11        1122355799999999999998899999999999999999999999999888888777766544 45678


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +++++.++|.+||+.||++||++     ++++.|+|++.
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~-----~~~l~~~~~~~  328 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTT-----QQLLHTEFLKY  328 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCH-----HHHHhCHHHHH
Confidence            89999999999999999999999     88999999864

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.7e-47  Score=365.74  Aligned_cols=268  Identities=27%  Similarity=0.447  Sum_probs=228.3

Q ss_pred             cCCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           36 RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        36 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      ..+......++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.++..++|+|+++++..+.
T Consensus        23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            3444455568999999999999999999999999999999999776443 333455677999999999999999987765


Q ss_pred             eCC--------eEEEEEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC
Q 017775          116 DTF--------SLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       116 ~~~--------~~~iv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~  183 (366)
                      ...        .+++||||+++|+|.+++...    ..+++..++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence            322        378999999999999988653    46899999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI  263 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  263 (366)
                      +||+|||+++.+.....        ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       182 vkL~DFGls~~~~~~~~--------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~  253 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVS--------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV  253 (496)
T ss_pred             EEEEecccCeecccccc--------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99999999986543211        1122356799999999999998899999999999999999999999999888877


Q ss_pred             HHHHhcCCC-CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          264 FQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       264 ~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ...+..... .+|..+++++.+++.+||+.||.+||++     .++++|||++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~-----~ell~~p~~~~~  303 (496)
T PTZ00283        254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS-----SKLLNMPICKLF  303 (496)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHhCHHHHHh
Confidence            777665543 4677899999999999999999999999     899999998754

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.7e-47  Score=354.01  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=211.5

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            468999999999999999999999999999999998765322 22334566799999999999999999887543     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             358999999976 78777754  48899999999999999999999999999999999999999999999999997653


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----  272 (366)
                      ...           ......++..|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....    
T Consensus       178 ~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         178 TSF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             CCC-----------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            321           11244689999999999999999999999999999999999999998877665554432100    


Q ss_pred             ------------------C--------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          273 ------------------R--------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       273 ------------------~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                        .                    .+...+.++++||.+||+.||.+|||+     .+++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~-----~e~L~hp~~  321 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYI  321 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH-----HHHhcCccc
Confidence                              0                    011235678999999999999999999     899999999


Q ss_pred             CC
Q 017775          315 KG  316 (366)
Q Consensus       315 ~~  316 (366)
                      ..
T Consensus       322 ~~  323 (364)
T cd07875         322 NV  323 (364)
T ss_pred             cc
Confidence            74

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-46  Score=349.20  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=217.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|+||.||+|.+..+|..+|+|.+....  .......+.+|+.+++.++|+||+++++++.+.+.++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            34689999999999999999999999999999999887642  2334456778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+.+++|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+||+++.+|.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            9999999999999999888899999999999999999999975 7999999999999999999999999998755321  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH-------------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI-------------  267 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------------  267 (366)
                                ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+             
T Consensus       158 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (333)
T cd06650         158 ----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET  227 (333)
T ss_pred             ----------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence                      112346889999999999888999999999999999999999999765543322111             


Q ss_pred             -------------------------------hcC-CCCCC-CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          268 -------------------------------IAR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       268 -------------------------------~~~-~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                                     ... ....+ ..++.++++||.+||+.||++|||+     .+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~-----~ell~h~~~  302 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL-----KQLMVHAFI  302 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH-----HHHhhCHHH
Confidence                                           000 01111 1367899999999999999999999     899999999


Q ss_pred             CCCC
Q 017775          315 KGID  318 (366)
Q Consensus       315 ~~~~  318 (366)
                      +...
T Consensus       303 ~~~~  306 (333)
T cd06650         303 KRSE  306 (333)
T ss_pred             hcCc
Confidence            8643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-46  Score=341.03  Aligned_cols=278  Identities=37%  Similarity=0.585  Sum_probs=232.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987653333334456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc-
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~-  203 (366)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999998864221110000 


Q ss_pred             C----CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC---
Q 017775          204 P----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---  276 (366)
Q Consensus       204 ~----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  276 (366)
                      .    ............++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+....+.......|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence            0    000001112345788899999998888999999999999999999999999988888777777665544433   


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      .++.++.++|.+||+.||++||++.  ++.+++.||||...+|.....
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~  286 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLR  286 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhh
Confidence            5789999999999999999999963  358999999999999887543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-46  Score=363.37  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCcceeEEEEeeC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQDT  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~  117 (366)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...    ........|+.+++.++      |.+++.+++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            478999999999999999999999999999999986431    12223445666666654      45688888888764


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCC-------------
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADG-------------  182 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~-------------  182 (366)
                       ..+++|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 66999999888889999999999999999999998 5999999999999998765             


Q ss_pred             ---CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC
Q 017775          183 ---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (366)
Q Consensus       183 ---~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  259 (366)
                         .+||+|||.+.....             .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       283 ~~~~vkl~DfG~~~~~~~-------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH-------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             CCceEEECCCCccccCcc-------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence               499999998753221             1234678999999999999999999999999999999999999998877


Q ss_pred             HHHHHHHHhcCCCCCC------------------------------------------CCCCHHHHHHHHHhhcCCCCCC
Q 017775          260 EWLIFQRIIARDIRFP------------------------------------------NYFSDAARDLIDRLLDVDPSGR  297 (366)
Q Consensus       260 ~~~~~~~i~~~~~~~~------------------------------------------~~~s~~~~~li~~~L~~dP~~R  297 (366)
                      ..+....+......+|                                          ...++.+.+||.+||++||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            6554433322110000                                          0114567899999999999999


Q ss_pred             CCCCCCChHhhhcCCCCCCC
Q 017775          298 PGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       298 ps~~~~~~~~~l~hp~f~~~  317 (366)
                      ||+     +++++||||...
T Consensus       430 ~ta-----~e~L~Hp~~~~~  444 (467)
T PTZ00284        430 LNA-----RQMTTHPYVLKY  444 (467)
T ss_pred             CCH-----HHHhcCcccccc
Confidence            999     899999999864

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-46  Score=352.06  Aligned_cols=255  Identities=22%  Similarity=0.392  Sum_probs=210.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ........+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            468999999999999999999999999999999998765322 22334566799999999999999999988643     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ...|+||||+++ +|.+.+..  .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             357999999976 77777654  48999999999999999999999999999999999999999999999999997553


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  270 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------  270 (366)
                      ...           ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...      
T Consensus       171 ~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         171 TSF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             Ccc-----------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            321           122456899999999999988999999999999999999999999887654443322110      


Q ss_pred             ----------------C--------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ----------------D--------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ----------------~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                      .                    ...+...+.++++||.+||+.||++|||+     .+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~-----~ell~hp~~  314 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DEALQHPYI  314 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH-----HHHhcCcch
Confidence                            0                    00112246788999999999999999999     899999999


Q ss_pred             CCC
Q 017775          315 KGI  317 (366)
Q Consensus       315 ~~~  317 (366)
                      +..
T Consensus       315 ~~~  317 (355)
T cd07874         315 NVW  317 (355)
T ss_pred             hcc
Confidence            744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-46  Score=340.25  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=205.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEee-----C
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD-----T  117 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~  117 (366)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+....... .......+|+.+++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999987643222 1122334566666554   79999999998864     3


Q ss_pred             CeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      ..++++|||+.+ +|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            458999999986 898888764  34899999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  271 (366)
                      ....           ......|+..|+|||++.+..++.++||||+||++|+|++|.+||.+........++....    
T Consensus       159 ~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07863         159 SCQM-----------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  227 (288)
T ss_pred             cCcc-----------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence            4321           1123467889999999988889999999999999999999999998877766555443210    


Q ss_pred             -------C----------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 -------I----------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 -------~----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                             .                .....++.++.+||.+||+.||++|||+     .+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~l~hp~f  288 (288)
T cd07863         228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA-----FRALQHPFF  288 (288)
T ss_pred             hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence                   0                0112467889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-46  Score=345.01  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=214.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ..+++|.+.+.||+|+||.||+|+++.+++.||+|.++....  ........+|+.+++.++||||+++++++.+++..+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            346889999999999999999999999999999999875432  222234567999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            99999986 888887665 358999999999999999999999999999999999999999999999999987543221 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  270 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---------  270 (366)
                               .......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...         
T Consensus       159 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07872         159 ---------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW  229 (309)
T ss_pred             ---------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence                     11123357889999998865 45888999999999999999999999887765544333210         


Q ss_pred             ----------CCCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          271 ----------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       271 ----------~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                ...++           ..+++++++||.+||+.||.+|||+     ++++.||||+.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~~  293 (309)
T cd07872         230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA-----EEAMKHAYFRSLG  293 (309)
T ss_pred             hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH-----HHHhcChhhhhcc
Confidence                      01111           2468899999999999999999999     8999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-47  Score=340.44  Aligned_cols=252  Identities=38%  Similarity=0.673  Sum_probs=212.7

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.+++.++||||+++++++.+....+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999876433322 22334589999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCC
Q 017775          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~  206 (366)
                      +.+++|.+++.+.+.+++..+..++.|+++||.+||++||+|+||||+||+++.++.++|+|||.+......        
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--------  151 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--------  151 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence            999999999997788999999999999999999999999999999999999999999999999998764111        


Q ss_pred             CCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCH---HHHHHHHhcCCCCCC----CCC
Q 017775          207 ASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP----NYF  278 (366)
Q Consensus       207 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~----~~~  278 (366)
                        ........++..|+|||.+. +..++.++|+||||+++|+|++|..||.....   ..............+    ...
T Consensus       152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T PF00069_consen  152 --NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREK  229 (260)
T ss_dssp             --TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred             --ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchh
Confidence              11223456788999999998 78899999999999999999999999988733   233333332221111    112


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +.++.++|.+||+.||++||++     .++++||||
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~-----~~l~~~~~~  260 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSA-----EELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTH-----HHHHTSGGG
T ss_pred             HHHHHHHHHHHccCChhHCcCH-----HHHhcCCCC
Confidence            4899999999999999999998     999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.2e-46  Score=334.67  Aligned_cols=263  Identities=34%  Similarity=0.585  Sum_probs=218.0

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHH---HHHHhCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER---IVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      .||+|+||.||+|.+..+|+.||+|.+.+..............|.   .+++...||+|+++++++.+....++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998775433222222223333   34445689999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCC
Q 017775          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (366)
Q Consensus       129 g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~  208 (366)
                      |++|.+++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+...          
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----------  150 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------  150 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----------
Confidence            9999999988888999999999999999999999999999999999999999999999999998754322          


Q ss_pred             CCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCHHHHH
Q 017775          209 DDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDIRFPNYFSDAARD  284 (366)
Q Consensus       209 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~  284 (366)
                        ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||...   ........+.......|..++.++.+
T Consensus       151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (278)
T cd05606         151 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  228 (278)
T ss_pred             --CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHH
Confidence              1123468899999999874 45888999999999999999999999765   33444444555566777888999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~  326 (366)
                      ++.+||..+|.+||.....++.+++.||||+.++|..+....
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~  270 (278)
T cd05606         229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQK  270 (278)
T ss_pred             HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcc
Confidence            999999999999994443444999999999999998876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.4e-46  Score=338.75  Aligned_cols=261  Identities=31%  Similarity=0.526  Sum_probs=221.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .+.|++++.||.|+||.||+|.+..++..+++|.+...   .......+.+|+.+++.++|+||+++++.+..++..++|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            46799999999999999999999999999999998654   333445567799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||++|++|..++.+ ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......   
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---  164 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL---  164 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc---
Confidence            999999999887765 3568999999999999999999999999999999999999999999999999886543221   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF  274 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~  274 (366)
                             .......++..|+|||.+.     ...++.++|+|||||++|+|++|..||...+......++....   ...
T Consensus       165 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T cd06644         165 -------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ  237 (292)
T ss_pred             -------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCC
Confidence                   1122446788999999984     3446789999999999999999999998877665555554332   233


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                      +..++.++.++|.+||+.||++||++     ++++.||||..+++...
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~~~~  280 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSA-----AQLLEHPFVSSVTSNRP  280 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccccccchh
Confidence            55688999999999999999999998     89999999998887654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-46  Score=333.59  Aligned_cols=254  Identities=40%  Similarity=0.691  Sum_probs=215.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      +.||.|++|.||+|.+..+|+.||+|++.+..............|..+ ....+|+|++++++++.+.+..|+++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            578999999999999999999999999876433222222233344443 4455899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....            
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------  149 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------  149 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence            99999998888899999999999999999999999999999999999999999999999998875332            


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF----PNYFSDAARDL  285 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~l  285 (366)
                        .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.......    +..+++++.++
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL  227 (260)
T ss_pred             --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHH
Confidence              113457788999999988888999999999999999999999999888877777665544333    33578999999


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      |.+||+.||++||++.  ++++++.||||+.++|+
T Consensus       228 i~~~l~~~p~~R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         228 INRLLCMDPAKRLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             HHHHccCCHHHccCCC--cHHHHHcChHhhcCCCC
Confidence            9999999999999885  34899999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=328.80  Aligned_cols=260  Identities=33%  Similarity=0.534  Sum_probs=224.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      .+.||+|+|+.|--|.+..+|..||||++.+.   .......+.+|++++.+. .|+||++++++|+++..+|+|||.+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            37899999999999999999999999999875   344456677899999988 59999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEEEecCCccccCCccccccCC
Q 017775          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       129 g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      ||+|...+.++..++|.++..++..|+.||.|||.+||.||||||+|||-....   -|||+||.+..-+....... + 
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s-p-  237 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS-P-  237 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC-C-
Confidence            999999999999999999999999999999999999999999999999987554   58999999876543332111 1 


Q ss_pred             CCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCC---------------HHHHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---------------EWLIFQ  265 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------~~~~~~  265 (366)
                       .......+.+|+..|||||+..     ...|+.++|.||||||+|-|++|++||.+.-               ...+++
T Consensus       238 -astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  238 -ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             -CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence             1123344678999999999852     3458999999999999999999999997532               256788


Q ss_pred             HHhcCCCCCCC----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          266 RIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       266 ~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      .|.++.++||+    .+|.++++||..+|..|+.+|.++     .++++|||++.+..+
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa-----~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA-----AQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh-----hhccCCccccccchh
Confidence            89999999996    489999999999999999999999     889999999876543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-46  Score=350.61  Aligned_cols=260  Identities=21%  Similarity=0.324  Sum_probs=213.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ....+|++++.||+|+||.||+|...  .++..||+|.+...        ....+|+.+++.++||||+++++++.....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            34567999999999999999999764  45678999987542        123569999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      .+++||++.+ +|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus       161 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9999999964 899999777889999999999999999999999999999999999999999999999999997654432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH---HHHHHHHhc----CC-
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIA----RD-  271 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~----~~-  271 (366)
                      ..        .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...   ...+..+..    .. 
T Consensus       240 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        240 DT--------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             cc--------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            11        122345789999999999998899999999999999999999999966432   111111111    00 


Q ss_pred             ------------------------CCCC-----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          272 ------------------------IRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       272 ------------------------~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                                              ...|     ..++.++.+||.+||..||++|||+     .+++.||||....|+.+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa-----~e~l~~p~f~~~~~~~~  386 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA-----QDILSLPLFTKEPINLL  386 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH-----HHHhhCchhhccchhhh
Confidence                                    0111     2356789999999999999999999     89999999998877765


Q ss_pred             c
Q 017775          323 R  323 (366)
Q Consensus       323 ~  323 (366)
                      .
T Consensus       387 ~  387 (392)
T PHA03207        387 N  387 (392)
T ss_pred             c
Confidence            4

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.5e-46  Score=339.14  Aligned_cols=258  Identities=24%  Similarity=0.411  Sum_probs=214.5

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+++|++.+.||+|+||.||+|.++.+++.||+|.+.....  ........+|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            47889999999999999999999999999999999875432  2223345679999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            9999975 898888764 468999999999999999999999999999999999999999999999999987543221  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC----------
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  270 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~----------  270 (366)
                              .......+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.+..+....+...          
T Consensus       159 --------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         159 --------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP  230 (301)
T ss_pred             --------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence                    111223568899999987654 4788999999999999999999999887765544332210          


Q ss_pred             ---------CCCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          271 ---------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       271 ---------~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                               ...+|           ..+++++++||.+||+.||.+|||+     +++++||||+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~eil~h~~f~~~~  293 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-----EEAMKHPYFHCLG  293 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccccc
Confidence                     01111           2478899999999999999999999     8999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-48  Score=357.41  Aligned_cols=258  Identities=31%  Similarity=0.521  Sum_probs=227.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +-|+++..||-|+||.||+|.++.++-..|.|++...   .++....+.-|+.+|..++||+|+++++.|..++.++|+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            3588999999999999999999999999999988654   3444445566999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+|.||-...++..- ..+++.++..+++|++.||.|||+++|||||||..|||++.+|.++|+|||.+......     
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-----  183 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-----  183 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence            999999998877654 46999999999999999999999999999999999999999999999999998755332     


Q ss_pred             CCCCCCCCccccccCCCCCCceee-----cCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC---CC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FP  275 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~  275 (366)
                           .....+++|||+|||||+.     ...+|+.++||||||+++.+|..+.+|....++..++-+|-...++   .|
T Consensus       184 -----~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  184 -----RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP  258 (1187)
T ss_pred             -----HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence                 1234478999999999975     5678999999999999999999999999999998888888766543   46


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      ..++..+.||+.+||.+||..||++     .+++.||||+++...
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~a-----aqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPA-----AQLLKHPFVQNAPSN  298 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCH-----HHHhhCcccccCCcc
Confidence            7899999999999999999999999     899999999977543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-45  Score=328.09  Aligned_cols=253  Identities=27%  Similarity=0.557  Sum_probs=218.2

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-CCeEEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLYMAL  124 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~  124 (366)
                      +|++.+.||+|++|.||.+.++.+++.||+|.+...... ......+.+|+.+++.++|+|++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            599999999999999999999999999999998764332 2234456779999999999999999988764 45689999


Q ss_pred             eecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          125 ESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       125 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||+++++|.+++...  ..+++.+++.++.|++.||.+||++|++||||+|+||+++.++.++|+|||++.......   
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence            999999999998763  458999999999999999999999999999999999999999999999999987654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDA  281 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~  281 (366)
                             .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+..+.. ..+..++++
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (257)
T cd08223         157 -------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPE  229 (257)
T ss_pred             -------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence                   112244678899999999988899999999999999999999999988877766666655544 456678999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +.+++.+||+.||++||++     .++++||||
T Consensus       230 ~~~li~~~l~~~p~~Rp~~-----~~~l~~~~~  257 (257)
T cd08223         230 LGELIATMLSKRPEKRPSV-----KSILRQPYI  257 (257)
T ss_pred             HHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence            9999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-47  Score=351.40  Aligned_cols=285  Identities=37%  Similarity=0.607  Sum_probs=240.7

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..+...-|..++.||-|+||+|.+++..+|...||+|.+++...-..+....++.|..||..-+++-||++|..|++.+
T Consensus       623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            44566677899999999999999999999999999999998877666777788899999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc--C
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--Q  196 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~--~  196 (366)
                      .+|+||||++||++-.++.+.+.|.|+.++.++..+..|+++.|..|+|||||||+|||||.+|++||.|||++.-+  .
T Consensus       703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998633  1


Q ss_pred             Cc-cccc------cCCC-----------------------CCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhh
Q 017775          197 DS-RITV------LPNA-----------------------ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY  246 (366)
Q Consensus       197 ~~-~~~~------~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  246 (366)
                      .+ +++.      .+..                       .........+||+.|+|||++....|+.-+|+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence            11 1111      0000                       0011235568999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHhc--C--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          247 QMLSGTSPFKDTSEWLIFQRIIA--R--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       247 ~ll~g~~pf~~~~~~~~~~~i~~--~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                      ||+.|++||...++.+...++++  .  .+.+...+|.++.+||.++.+ +++.|..-.  +.++++.||||++|||..+
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkn--g~d~vKaHpfFkgIDfssl  939 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKN--GADQVKAHPFFKGIDFSSL  939 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhccc--chhhhhcCccccccchHhh
Confidence            99999999988776554444432  1  233446799999999999775 888998653  4478999999999999998


Q ss_pred             ccCC
Q 017775          323 RGQT  326 (366)
Q Consensus       323 ~~~~  326 (366)
                      +++.
T Consensus       940 Rkq~  943 (1034)
T KOG0608|consen  940 RKQR  943 (1034)
T ss_pred             hhcc
Confidence            7653

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-46  Score=347.20  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=210.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  117 (366)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            47899999999999999999999999999999998764322 22234456799999999999999999887543      


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ...|+++|++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4579999998 5699887754 4699999999999999999999999999999999999999999999999999886532


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      .             .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....     
T Consensus       171 ~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         171 E-------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             C-------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            1             124568999999999876 568899999999999999999999998776655444332110     


Q ss_pred             ------------------CCC--------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          272 ------------------IRF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       272 ------------------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                        ...        ....++.+.+||.+||+.||.+|||+     .+++.||||.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~-----~ell~hp~~~~~~~  306 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA-----SEALAHPYFSQYHD  306 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhccCC
Confidence                              000        12356778999999999999999999     89999999987643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.9e-46  Score=331.26  Aligned_cols=255  Identities=36%  Similarity=0.644  Sum_probs=223.7

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|+.++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987644443445667889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |+.|++|.+++.+...+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||.+.......      
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------  154 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------  154 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence            99999999999887789999999999999999999999999999999999999999999999999987654331      


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFPNYFSDAA  282 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~  282 (366)
                           ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+   ..............+|..++.++
T Consensus       155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd05578         155 -----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA  229 (258)
T ss_pred             -----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHH
Confidence                 1123457788999999988889999999999999999999999998776   34444444436667788899999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .++|.+||+.||.+||++.   +.++++||||
T Consensus       230 ~~~i~~~l~~~p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         230 IDAINKLLERDPQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHccCChhHcCCcc---HHHHhcCCCC
Confidence            9999999999999999983   4789999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-45  Score=337.72  Aligned_cols=254  Identities=28%  Similarity=0.465  Sum_probs=215.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||++.+..+|..+|+|.+..+.  .......+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999987542  2333445777999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......     
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----  153 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence            999999999999888889999999999999999999997 69999999999999999999999999998654321     


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------  270 (366)
                             ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+...             
T Consensus       154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence                   112456888999999998888999999999999999999999999765543332221110             


Q ss_pred             ------------------------CCCCC-CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 ------------------------DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 ------------------------~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                              ....| ..++.++++|+.+||..||++||++     .++++||||.+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~~  293 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL-----KELTKHPFIKRA  293 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhhc
Confidence                                    01111 2368899999999999999999999     899999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-45  Score=329.65  Aligned_cols=260  Identities=28%  Similarity=0.510  Sum_probs=221.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch------hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE------NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+........      .....+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47889999999999999999999999999998876533221      223457789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      .+++|||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998765322


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .....    ........|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+... ...+|..+
T Consensus       161 ~~~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06628         161 LSTKT----NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI  236 (267)
T ss_pred             ccCCc----cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence            11100    11112345788999999998888899999999999999999999999877665554444333 44567788


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +.++.++|++||+.||.+||++     .++++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~  267 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTA-----AELLKHPFL  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCH-----HHHhhCCCC
Confidence            9999999999999999999998     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.1e-46  Score=331.07  Aligned_cols=263  Identities=42%  Similarity=0.720  Sum_probs=227.0

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||.|+||.||+|.+..+|+.+++|.+.............+.+|+.+++.++|+||+++++.+.+....|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999766444445556678899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 017775          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (366)
Q Consensus       133 ~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~  212 (366)
                      .+++.+.+.+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++...........  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--NDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc--ccccccc
Confidence            99998878899999999999999999999999999999999999999999999999999875433221100  0001122


Q ss_pred             cccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHhh
Q 017775          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF--SDAARDLIDRLL  290 (366)
Q Consensus       213 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L  290 (366)
                      ....++..|+|||...+...+.++|+||||+++|++++|..||...........+..+....+...  +..+.+++.+||
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL  238 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHh
Confidence            344678899999999888889999999999999999999999998888888888877777776665  999999999999


Q ss_pred             cCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       291 ~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      +.+|.+|||+.  .+.++++||||+.++|
T Consensus       239 ~~~p~~Rpt~~--~~~~~l~~~~~~~~~~  265 (265)
T cd05579         239 VPDPEKRLGAK--SIEEIKNHPFFKGIDW  265 (265)
T ss_pred             cCCHhhcCCCc--cHHHHhcCccccCCCC
Confidence            99999999985  3478999999999987

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-47  Score=322.88  Aligned_cols=251  Identities=32%  Similarity=0.530  Sum_probs=216.5

Q ss_pred             CcCCeeee-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEee----
Q 017775           43 SIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD----  116 (366)
Q Consensus        43 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----  116 (366)
                      ..+||.+- ++||-|-.|.|..|.++.||+.+|+|++...        ...++|+++- ..-.|||||+++++|+.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            46677775 7899999999999999999999999987432        2244566653 34479999999999864    


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCC
Q 017775          117 TFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGS  191 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~  191 (366)
                      ...+.+|||.++||+|+..++.++.  ++|.++..+++||..|+.|||+.+|+||||||+|+|....   ..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            5568999999999999999998865  9999999999999999999999999999999999999754   5799999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHHHH
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI  267 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i  267 (366)
                      |+.-...           ....+.+.|+.|.|||++....|+..+|+||+||++|-|++|.+||.....    ..+..+|
T Consensus       211 AK~t~~~-----------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI  279 (400)
T KOG0604|consen  211 AKETQEP-----------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI  279 (400)
T ss_pred             ccccCCC-----------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence            9865432           233466789999999999999999999999999999999999999975432    4567788


Q ss_pred             hcCCCCCCC----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          268 IARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       268 ~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ..+.+.||.    .+|++++++|+++|..+|.+|.|+     ++++.|||+++.
T Consensus       280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI-----~~~m~hpwi~~~  328 (400)
T KOG0604|consen  280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTI-----EEVMDHPWINQY  328 (400)
T ss_pred             hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeH-----HHhhcCchhccc
Confidence            999999985    489999999999999999999999     889999999854

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9e-46  Score=332.19  Aligned_cols=254  Identities=31%  Similarity=0.513  Sum_probs=214.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.+++.++||||+++++.+.+.+..|
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999987542   223345677999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ++|||+++++|.+++...+.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            999999999999999888889999999999999999999999999999999999999999999999999987653221  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC---
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---  275 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  275 (366)
                              .......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||...................+   
T Consensus       161 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06645         161 --------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK  232 (267)
T ss_pred             --------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence                    1112346889999999874   44578899999999999999999999876554433333322222211   


Q ss_pred             --CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       276 --~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                        ..++..+.++|.+||+.||++||++     ++++.|||
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~R~~~-----~~ll~~~~  267 (267)
T cd06645         233 DKMKWSNSFHHFVKMALTKNPKKRPTA-----EKLLQHPF  267 (267)
T ss_pred             ccCCCCHHHHHHHHHHccCCchhCcCH-----HHHhcCCC
Confidence              2467899999999999999999998     89999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-45  Score=334.27  Aligned_cols=257  Identities=30%  Similarity=0.537  Sum_probs=220.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||.|++|.||+|.+..++..+|+|.+...   .......+..|+.+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            35699999999999999999999989999999998654   333345577799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+++++|.+++.+. +.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---  157 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---  157 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence            9999999999998764 569999999999999999999999999999999999999999999999999877543221   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF  274 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~  274 (366)
                             .......++..|+|||.+.     ...++.++|+||+|+++|+|++|..||...+.......+....   ...
T Consensus       158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (280)
T cd06611         158 -------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ  230 (280)
T ss_pred             -------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence                   1122446888999999874     3446789999999999999999999998887766666665543   234


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +..++.++.++|.+||+.+|.+||++     +++++||||....
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~~  269 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTA-----AELLKHPFVSDQS  269 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCH-----HHHhcChhhcccc
Confidence            56789999999999999999999999     8999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.9e-45  Score=325.09  Aligned_cols=253  Identities=30%  Similarity=0.468  Sum_probs=221.1

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|.+.+.||+|++|.||+|.+..+|+.|++|.+...... ......+..|+.+++.++|||++++++++.+.+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            589999999999999999999999999999998765333 2334457779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |++|++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........   
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence            99999999999774  5689999999999999999999999999999999999999999999999999886643211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  282 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~  282 (366)
                             ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..... .++..++.++
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08529         157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQL  229 (256)
T ss_pred             -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHH
Confidence                   11234578899999999988899999999999999999999999998887777766665543 3455789999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .+++.+||+.+|++||++     .+++.|||+
T Consensus       230 ~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  256 (256)
T cd08529         230 AQLIDQCLTKDYRQRPDT-----FQLLRNPSL  256 (256)
T ss_pred             HHHHHHHccCCcccCcCH-----HHHhhCCCC
Confidence            999999999999999999     899999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-45  Score=340.80  Aligned_cols=262  Identities=25%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             eeeeeeeec--CceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           48 ELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        48 ~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +++++||+|  +||+||++.++.+|+.||+|.++..... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            357889999  6789999999999999999998765332 3344567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+++++|.+++...  +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++++||+.+...........
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999999998753  4589999999999999999999999999999999999999999999999987654322110000


Q ss_pred             CCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  272 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------  272 (366)
                         ..........++..|+|||.+.+  ..++.++||||+||++|+|++|..||.................         
T Consensus       160 ---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         160 ---VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ---ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence               00011122356778999999875  4588999999999999999999999986555443322222111         


Q ss_pred             -------------------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          273 -------------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       273 -------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                                                           +....+++++.+||.+||+.||++|||+     +++++||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~ell~~p~f~  311 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA-----STLLNHSFFK  311 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH-----HHHhcChhhh
Confidence                                                 0112357889999999999999999999     8999999998


Q ss_pred             CCC
Q 017775          316 GID  318 (366)
Q Consensus       316 ~~~  318 (366)
                      ++.
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.9e-45  Score=330.97  Aligned_cols=270  Identities=37%  Similarity=0.720  Sum_probs=227.9

Q ss_pred             CeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccc-cchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  120 (366)
                      .|++.+.||.|+||.||.|.+.   .+|..||+|++..... ........+.+|+.+++.+ +|+||+++++.++.+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   4789999999876432 1223345567799999999 599999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999876543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCC--CCCCCCCcccchhhhhhhhcCCCCCCCC----CHHHHHHHHhcCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDIRF  274 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~  274 (366)
                               .......|+..|+|||.+.+.  .++.++|+||+|+++|+|++|..||...    ........+......+
T Consensus       161 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (290)
T cd05613         161 ---------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  231 (290)
T ss_pred             ---------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC
Confidence                     112234688899999998653  4678899999999999999999999643    2344455555566677


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |..+++.+.+++++||+.||++||+....++++++.||||+.++|+.+..
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  281 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA  281 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhh
Confidence            88899999999999999999999976666779999999999999988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4e-45  Score=330.33  Aligned_cols=251  Identities=26%  Similarity=0.448  Sum_probs=211.4

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.++++++||||+++++.+...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            47899999999999999999999999999999987542  2233445778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......      
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------  148 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------  148 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence            99999988654    35789999999999999999999999999999999999999999999999998765332      


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH-------HHHHHHHhcCC-CCC-C
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-------WLIFQRIIARD-IRF-P  275 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~-~~~-~  275 (366)
                            ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.....       ......+.... ... .
T Consensus       149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (279)
T cd06619         149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV  222 (279)
T ss_pred             ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence                  11234688899999999988899999999999999999999999964321       12222222222 122 2


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..+++++.+++.+||+.||++||++     ++++.||||...+
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~-----~eil~~~~~~~~~  260 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAP-----ENLMDHPFIVQYN  260 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCH-----HHHhcCccccccc
Confidence            3578999999999999999999998     8999999998765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.1e-45  Score=330.69  Aligned_cols=253  Identities=29%  Similarity=0.514  Sum_probs=215.9

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |++.+.||.|+||.||+|.+..++..+++|.+...   .......+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            78899999999999999999999999999998654   223344567799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +++++|..++.+ .+++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......      
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------  157 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------  157 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc------
Confidence            999999888765 4579999999999999999999999999999999999999999999999999987543221      


Q ss_pred             CCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCC
Q 017775          206 AASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNY  277 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~  277 (366)
                          .......++..|+|||.+.     +..++.++|+||+||++|+|++|..||...+.......+...   ....|..
T Consensus       158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd06643         158 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR  233 (282)
T ss_pred             ----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccc
Confidence                1112346888999999973     345778999999999999999999999887776665555433   2234567


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ++.++++||.+||+.||.+||++     +++++||||+..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~  268 (282)
T cd06643         234 WSSEFKDFLKKCLEKNVDARWTT-----TQLLQHPFVTVN  268 (282)
T ss_pred             cCHHHHHHHHHHccCChhhCcCH-----HHHhcCCCEecc
Confidence            89999999999999999999999     899999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-45  Score=342.41  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=202.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.+++.+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4567899999999999999999975     2456789999986532  223344577799999999 8999999999887


Q ss_pred             eC-CeEEEEEeecCCCchHHHHHhC-------------------------------------------------------
Q 017775          116 DT-FSLYMALESCEGGELFDQITSK-------------------------------------------------------  139 (366)
Q Consensus       116 ~~-~~~~iv~e~~~g~~L~~~l~~~-------------------------------------------------------  139 (366)
                      .. ..++++|||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 4589999999999999998653                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 017775          140 -------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (366)
Q Consensus       140 -------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~  212 (366)
                             .++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........        ...
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--------~~~  233 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--------VRK  233 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch--------hcc
Confidence                   23778889999999999999999999999999999999999999999999999865332111        111


Q ss_pred             cccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH-HHHHHhcC-CCCCCCCCCHHHHHHHHHh
Q 017775          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL-IFQRIIAR-DIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       213 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~  289 (366)
                      ....++..|+|||++.+..++.++||||+||++|+|++ |..||.+..... ....+..+ ....|...++++.+++.+|
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            22345678999999988889999999999999999997 999998755433 33333332 3445677899999999999


Q ss_pred             hcCCCCCCCCC
Q 017775          290 LDVDPSGRPGA  300 (366)
Q Consensus       290 L~~dP~~Rps~  300 (366)
                      |+.||.+|||+
T Consensus       314 l~~dp~~RPs~  324 (338)
T cd05102         314 WQGDPKERPTF  324 (338)
T ss_pred             ccCChhhCcCH
Confidence            99999999999

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.8e-45  Score=327.10  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=217.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      +|++++.||.|+||.||+|.+ .+|+.+|+|.+......   .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            589999999999999999986 57889999988754321   12233457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ++||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987653221110


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS  279 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s  279 (366)
                          ..........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...   ....+..++
T Consensus       160 ----~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         160 ----THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             ----cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence                0011122346888999999999888999999999999999999999999876655444333322   234667789


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .++.++|++||+.+|++||++     .+++.||||
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~-----~~~l~~~~~  265 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSA-----LQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence            999999999999999999999     899999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-45  Score=331.06  Aligned_cols=269  Identities=49%  Similarity=0.873  Sum_probs=234.3

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|++.+...........+.+|..+++.+. |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765545555566778999999998 99999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||++.+++|.+++.+.+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999887654332110


Q ss_pred             C----------CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 017775          204 P----------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  273 (366)
Q Consensus       204 ~----------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  273 (366)
                      .          ............++..|+|||...+..++.++|+||||++++++++|..||...+.......+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence            0          000112233456788999999998888899999999999999999999999988887777777777788


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +|..+++.+.+||++||+.||.+||++.+ .++++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~-~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCccc-CHHHHhcCCCC
Confidence            88899999999999999999999999954 45789999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-45  Score=328.95  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=213.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            34678999999999999999999999999999999987542   223345778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||||+++++|.+++.+.+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......  
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--  160 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence            999999999999999888889999999999999999999999999999999999999999999999999998653221  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-----
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----  273 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----  273 (366)
                              .......++..|+|||.+.   ...++.++|+||+||++|+|++|..||...........+......     
T Consensus       161 --------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06646         161 --------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK  232 (267)
T ss_pred             --------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCc
Confidence                    1112346788999999874   344778999999999999999999999765544333222222222     


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      .+..++..+.+||++||+.||++||++     ++++.|+|
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~l~  267 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTA-----ERLLTHLF  267 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCH-----HHHhcCCC
Confidence            123578999999999999999999999     89999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.4e-45  Score=331.43  Aligned_cols=249  Identities=16%  Similarity=0.232  Sum_probs=212.2

Q ss_pred             CCcCCeeee--eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee---
Q 017775           42 FSIQDFELG--KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD---  116 (366)
Q Consensus        42 ~~~~~y~~~--~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---  116 (366)
                      +..++++..  ..||+|++|.||+|..  +|+.||+|.+.............+.+|+.++++++||||+++++++.+   
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD   92 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence            344455555  6899999999999988  689999999987644344445667789999999999999999999876   


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          117 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       117 -~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                       ...+++||||++||+|.+++.+.+.++......++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence             45789999999999999999988889999999999999999999998 4999999999999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--  270 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--  270 (366)
                      .....             ....|+..|+|||++.+  ..++.++|||||||++|+|++|..||.+.+..+....+...  
T Consensus       173 ~~~~~-------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~  239 (283)
T PHA02988        173 LSSPP-------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN  239 (283)
T ss_pred             hcccc-------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence            53321             12357889999999876  67899999999999999999999999998888877777543  


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ...+|...++++++|+.+||+.||++|||+     .+++.
T Consensus       240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ell~  274 (283)
T PHA02988        240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI-----KEILY  274 (283)
T ss_pred             CCCCCCcCcHHHHHHHHHHhcCCcccCcCH-----HHHHH
Confidence            445565789999999999999999999999     66653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-46  Score=339.58  Aligned_cols=246  Identities=22%  Similarity=0.379  Sum_probs=215.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..+.+.+++.||+|.||.||.|.+.. ...||+|.++...    ...+.+.+|+++|++|+|++||++++++..+..+
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            3456677889999999999999999943 3489999987642    2234466899999999999999999999998899


Q ss_pred             EEEEeecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ||||||++.|+|.+++..  .+.+...+...++.||++|++||+++++|||||...||||+++..+|++|||+|+...+.
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999999999999987  356999999999999999999999999999999999999999999999999999965554


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      .+......         .-...|.|||.+....++.+|||||+|++|||++| |+.||.+.+..+..+.+..+ .++-|.
T Consensus       357 ~Y~~~~~~---------kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~  427 (468)
T KOG0197|consen  357 EYTASEGG---------KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE  427 (468)
T ss_pred             ceeecCCC---------CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC
Confidence            43332211         12346999999999999999999999999999999 99999999999999988776 577889


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..|+++-+++..||+.+|++|||.
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF  451 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTF  451 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCH
Confidence            999999999999999999999998

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.4e-45  Score=331.78  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=220.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+|++.+.||.|++|.||+|.+..+|+.|++|.+....   ......+.+|+.+++.++|+|++++++++.+...+|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            457999999999999999999999999999999986542   22345577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +||+++++|.+++... .+++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........   
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---  170 (296)
T cd06655          95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---  170 (296)
T ss_pred             EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence            9999999999988654 689999999999999999999999999999999999999999999999999876543211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~  280 (366)
                             ......++..|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+...   ....+..+++
T Consensus       171 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06655         171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP  243 (296)
T ss_pred             -------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence                   112345788999999998888999999999999999999999999887776554444332   2334567899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.++|.+||..||++||++     .+++.||||+..
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~-----~~il~~~~~~~~  275 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSA-----KELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCH-----HHHhhChHhhhc
Confidence            99999999999999999999     899999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.6e-45  Score=331.33  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=208.3

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            68999999999999999999999999999999876432 22233456779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          126 SCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       126 ~~~g~~L~~~l~~~---~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |+.+ +|.+++...   +.+++..++.++.||+.||.|||++|++|+||+|+||+++.+|.++|+|||++.......   
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  155 (285)
T cd07861          80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---  155 (285)
T ss_pred             cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence            9985 888887653   458999999999999999999999999999999999999999999999999987553221   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  271 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------  271 (366)
                             .......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||.+.........+....          
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         156 -------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             -------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence                   111123567899999988654 47889999999999999999999998776544332221100          


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 -------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                         ......+++++.++|++||+.||++|||+     .+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~ll~~~~~  285 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA-----KKALNHPYF  285 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH-----HHHhcCCCC
Confidence                               00123478999999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.7e-45  Score=329.61  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=212.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++..... .......+.+|+.+++.++|+|++++++++.+....++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            479999999999999999999999999999998865422 1222344677999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|..++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........    
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----  155 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD----  155 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence            9999988888777767799999999999999999999999999999999999999999999999999986643221    


Q ss_pred             CCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------  270 (366)
                            ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+...             
T Consensus       156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         156 ------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             ------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence                  1123456788999999876 45788999999999999999999999877665443332110             


Q ss_pred             ------CCCC------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ------DIRF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ------~~~~------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                            ....            ...++..+.+||.+||+.||++||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~eil~~~~f  286 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-----EELLEHPYF  286 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH-----HHHhcCCCC
Confidence                  0000            12468889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.3e-45  Score=331.06  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=217.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+|++.+.||+|++|.||+|.+..+++.|++|.+.....   .....+.+|+.+++.+.|+||+++++.+.+....|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            4689999999999999999999999999999999876432   2335577799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+++++|.+++.+ +.+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......    
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----  170 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc----
Confidence            999999999998865 468999999999999999999999999999999999999999999999999987543321    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~  280 (366)
                            .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.......+...   ....+..++.
T Consensus       171 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06654         171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (296)
T ss_pred             ------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence                  1112345788999999998888899999999999999999999999877664443333222   2234567889


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.+++.+||..||++||++     .+++.||||...
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~~  276 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSA-----KELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCH-----HHHhhChhhhcc
Confidence            99999999999999999999     899999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.5e-45  Score=327.64  Aligned_cols=259  Identities=26%  Similarity=0.486  Sum_probs=217.3

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc---hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK---ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      +|+..+.||+|++|.||++.+..+|+.||+|++.......   ......+..|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4888999999999999999999999999999987543221   2234567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |+||+.|++|.+++.+.+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 5999999998776443111


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH---HHh--cCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RII--ARDIRFPN  276 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~--~~~~~~~~  276 (366)
                      .      ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||..........   .+.  ......|.
T Consensus       161 ~------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06630         161 A------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE  234 (268)
T ss_pred             C------CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence            0      111223467889999999988889999999999999999999999996544322222   221  22345667


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      .+++++.+++.+||..+|.+||++     .++++||||+
T Consensus       235 ~~~~~~~~~i~~~l~~~p~~R~~~-----~~ll~~~~~~  268 (268)
T cd06630         235 HLSPGLRDVTLRCLELQPEDRPPS-----RELLKHPVFR  268 (268)
T ss_pred             hhCHHHHHHHHHHcCCCcccCcCH-----HHHhcCcccC
Confidence            789999999999999999999999     8999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-45  Score=342.01  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ....+|++++.||+|+||.||+|.+..++..||+|+.....         ...|..+++.++|+||+++++++.+....+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            44568999999999999999999999999999999754321         234888999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||++.+ +|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus       134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            99999975 888887654 569999999999999999999999999999999999999999999999999987432211 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCC-CCCCCHH---------HHHHHHhcC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEW---------LIFQRIIAR  270 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~---------~~~~~i~~~  270 (366)
                                ......||..|+|||++.+..++.++|||||||++|+|+++..+ |......         ..+..+...
T Consensus       212 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~  281 (357)
T PHA03209        212 ----------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST  281 (357)
T ss_pred             ----------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence                      11234689999999999998899999999999999999985444 4331110         011111110


Q ss_pred             ----CCCCC------------------------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          271 ----DIRFP------------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       271 ----~~~~~------------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                          ...++                              ..++.++.+||.+||+.||++|||+     .++++||||++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta-----~e~l~hp~f~~  356 (357)
T PHA03209        282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA-----EEILNYPMFAQ  356 (357)
T ss_pred             hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH-----HHHhcCchhcc
Confidence                00111                              1356778889999999999999999     89999999985


Q ss_pred             C
Q 017775          317 I  317 (366)
Q Consensus       317 ~  317 (366)
                      +
T Consensus       357 ~  357 (357)
T PHA03209        357 L  357 (357)
T ss_pred             C
Confidence            3

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=323.59  Aligned_cols=252  Identities=32%  Similarity=0.519  Sum_probs=216.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||.|++|.||+|.+..++..+++|++....   ......+.+|+.+++.++||||+++++++.+...+|++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999997652   22445677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+.+++|.+++... ..+++.++..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.......   
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---  155 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---  155 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence            9999999999998776 789999999999999999999999999999999999999999999999999987654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCC---CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-----CC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----RF  274 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~~  274 (366)
                             .......++..|+|||.+.+.   .++.++|+||+|+++|+|++|..||...+.......+.....     ..
T Consensus       156 -------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd06613         156 -------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD  228 (262)
T ss_pred             -------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccc
Confidence                   111234678889999998776   788899999999999999999999988776555444433322     22


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      +..++.++.+++.+||+.||.+|||+     .+++.|+|
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~  262 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTA-----TKLLQHPF  262 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCH-----HHHhcCCC
Confidence            33467889999999999999999999     89999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-44  Score=323.45  Aligned_cols=258  Identities=28%  Similarity=0.503  Sum_probs=217.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSL  120 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  120 (366)
                      .+|++.+.||+|+||.||.|.+..+|..||+|.+......  .......+.+|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5799999999999999999999999999999988653211  22334567789999999999999999998876  3568


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +++|||+++++|.+++.+.+.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999999998888899999999999999999999999999999999999999999999999999886543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~  278 (366)
                      .       ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...  ....|..+
T Consensus       162 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06652         162 S-------GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV  234 (265)
T ss_pred             c-------ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhh
Confidence            1       01112345788999999998888999999999999999999999999876655554444432  23456678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      +..+.++|++|+. +|++||++     ++++.|||+.
T Consensus       235 ~~~~~~~i~~~l~-~p~~Rp~~-----~~il~~~~~~  265 (265)
T cd06652         235 SDHCRDFLKRIFV-EAKLRPSA-----DELLRHTFVH  265 (265)
T ss_pred             CHHHHHHHHHHhc-ChhhCCCH-----HHHhcCcccC
Confidence            8999999999995 99999998     8999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-44  Score=324.63  Aligned_cols=258  Identities=28%  Similarity=0.510  Sum_probs=216.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSL  120 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  120 (366)
                      .+|++.+.||+|+||.||+|.+..+|..|++|.+.......  ......+.+|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36899999999999999999999999999999987543222  2234467789999999999999999998875  4678


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++++||+++++|.+++.+.+.+++..++.++.|++.||+|||+++|+||||+|+||+++.++.++|+|||++........
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998887899999999999999999999999999999999999999999999999999876533210


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~  278 (366)
                      .       ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||...........+...  ...+|..+
T Consensus       162 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd06651         162 S-------GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI  234 (266)
T ss_pred             c-------CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence            0       01112345788999999998888999999999999999999999999876655544443322  34556778


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ++.+++++ +||..+|++||++     +++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~-----~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSA-----EELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCH-----HHHhcCcccc
Confidence            99999999 6777899999999     8999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-45  Score=327.45  Aligned_cols=256  Identities=32%  Similarity=0.511  Sum_probs=221.4

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+..+.  .......+.+|+.+++.++|+||+++++++.+....|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            47999999999999999999999999999999987653  2233345678999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|.+++... ++++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......     
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-----  152 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-----  152 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence            999999999998875 79999999999999999999999999999999999999999999999999998765431     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCC-CCHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNY-FSDAA  282 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~~  282 (366)
                           .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.... ...+.. ++.++
T Consensus       153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (274)
T cd06609         153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF  227 (274)
T ss_pred             -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence                 11223467888999999998889999999999999999999999998776655555544432 233344 88999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .+++.+||..+|++|||+     +++++||||+...
T Consensus       228 ~~~l~~~l~~~p~~Rpt~-----~~il~~~~~~~~~  258 (274)
T cd06609         228 KDFVSLCLNKDPKERPSA-----KELLKHKFIKKAK  258 (274)
T ss_pred             HHHHHHHhhCChhhCcCH-----HHHhhChhhcCCC
Confidence            999999999999999998     8999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-44  Score=322.05  Aligned_cols=253  Identities=28%  Similarity=0.536  Sum_probs=221.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|+||.||.+.+..+|+.||+|.+........ ....+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            58999999999999999999999999999999876433222 33457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+.+++|.+.+....  .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence            999999999987643  578999999999999999999999999999999999999999999999999876543211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  282 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~  282 (366)
                             ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+..+.. ..+..++.++
T Consensus       157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08218         157 -------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDL  229 (256)
T ss_pred             -------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence                   11233578889999999888899999999999999999999999988887777776665543 4567789999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .++|.+||+.+|.+||++     .+++.||||
T Consensus       230 ~~li~~~l~~~p~~Rp~~-----~~vl~~~~~  256 (256)
T cd08218         230 RNLVSQLFKRNPRDRPSV-----NSILEKNFI  256 (256)
T ss_pred             HHHHHHHhhCChhhCcCH-----HHHhhCcCC
Confidence            999999999999999999     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-44  Score=328.48  Aligned_cols=269  Identities=38%  Similarity=0.713  Sum_probs=225.0

Q ss_pred             CeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  120 (366)
                      +|++.+.||+|++|.||++.+.   .++..||+|++.+.... .......+.+|+.++..+ +|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   46789999998754322 223344567799999999 599999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence            9999999999999999887789999999999999999999999999999999999999999999999999987653321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCC----HHHHHHHHhcCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIARDIRF  274 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~  274 (366)
                              ........|+..|+|||.+.+..  .+.++|+||+|+++|+|++|..||....    ..+....+.......
T Consensus       160 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         160 --------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF  231 (288)
T ss_pred             --------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC
Confidence                    11112345788999999987654  7789999999999999999999996432    234445555666677


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      |..++.++.+++.+||+.||++|||+.+  +.++++||||++++|+.+...
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~--~~~~l~~~~~~~~~~~~~~~~  280 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANG--ADEIKNHPFFQGIDWDDLAAK  280 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcch--HHHHhcCcccccCCHHHHhhh
Confidence            7889999999999999999999999864  488999999999999877543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=358.54  Aligned_cols=253  Identities=30%  Similarity=0.501  Sum_probs=209.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEE-Ee---e
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFT-FQ---D  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~---~  116 (366)
                      +...++++.+.|.+|||+.||+|++...|..||+|.+-..   .+...+.+.+|+.+|++|. |+|||.+++. ..   .
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            3455788999999999999999999998899999987654   6777788999999999996 9999999993 22   1


Q ss_pred             ---CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEEEec
Q 017775          117 ---TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       117 ---~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                         ...++|+||||.||.|.+++.++  ..|+|.++.+|++++++||.+||..+  |||||||-|||||+.+|++|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence               24589999999999999999864  45999999999999999999999998  999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceee---cCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHH
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR  266 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  266 (366)
                      |.|.-..........- .--...-....|+.|+|||++   .+.+.+.|+|||+|||+||-|+....||+....    ..
T Consensus       191 GSatt~~~~~~~~~e~-~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----la  265 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEV-NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LA  265 (738)
T ss_pred             cccccccCCCccHHHH-HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----ee
Confidence            9987432211000000 000000112468999999986   678899999999999999999999999987644    35


Q ss_pred             HhcCCCCCCC--CCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          267 IIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       267 i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      |+.+++.+|.  .+++.+++||+.||+.||.+||++.|
T Consensus       266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q  303 (738)
T KOG1989|consen  266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ  303 (738)
T ss_pred             EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence            7889999886  69999999999999999999999944

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-44  Score=323.27  Aligned_cols=257  Identities=32%  Similarity=0.517  Sum_probs=218.8

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||.|++|+||+|....++..+++|++.......  ....+.+|+..++.++|+|++++++.+...+..+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999999899999999987643322  4456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          125 ESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       125 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |+++|++|.+++.+.   +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++..+......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   45899999999999999999999999999999999999999999999999998766543211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-CC----
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FP----  275 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~----  275 (366)
                      .      ........|+..|+|||.+... .++.++|+||+|+++|+|++|..||...+......+....... ++    
T Consensus       159 ~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         159 T------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             c------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc
Confidence            0      0112344688899999998776 6889999999999999999999999887766655555443221 11    


Q ss_pred             -CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       276 -~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                       ..+++++.+++.+||+.||++||++     ++++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTA-----EELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCH-----HHHhhCCCC
Confidence             2578999999999999999999998     899999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-45  Score=332.11  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=217.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+|++++.||+|++|.||+|.+..+|+.||+|.+....   ......+.+|+.+++.++|+||+++++++......|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            478999999999999999999999999999999987542   22335577799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........   
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---  170 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---  170 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---
Confidence            999999999998865 4589999999999999999999999999999999999999999999999999876533211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~  280 (366)
                             ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||.+.+.......+...   ....+..++.
T Consensus       171 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (297)
T cd06656         171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA  243 (297)
T ss_pred             -------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCH
Confidence                   112345788999999999888999999999999999999999999876654332222221   2234566889


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.+|+.+||..||++||++     ++++.||||...
T Consensus       244 ~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~  275 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSA-----KELLQHPFLKLA  275 (297)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCchhccc
Confidence            99999999999999999999     899999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=362.93  Aligned_cols=263  Identities=27%  Similarity=0.461  Sum_probs=216.8

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--C
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  117 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~  117 (366)
                      .....++|++++.||+|+||.||+|.+..++..||+|++....... .....+..|+.+++.++||||++++++|.+  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3445789999999999999999999999999999999987654332 334557779999999999999999998854  4


Q ss_pred             CeEEEEEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCeEeCC------
Q 017775          118 FSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSM-------GLIHRDIKPENLLLTA------  180 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~-------~i~H~dlkp~NIli~~------  180 (366)
                      ..+|+||||+++++|.+++...    +.+++..++.++.||+.||.|||+.       +|+||||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5799999999999999998752    5699999999999999999999985       4999999999999964      


Q ss_pred             -----------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhh
Q 017775          181 -----------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQ  247 (366)
Q Consensus       181 -----------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~  247 (366)
                                 .+.+||+|||++..+....           ......||+.|+|||++.+  ..++.++||||||||+|+
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-----------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-----------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence                       2359999999997653321           1224578999999999854  448889999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          248 MLSGTSPFKDTSEWLIFQRIIARDIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       248 ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      |++|..||........+...+.....+| ...+.++.+||..||+.+|.+||++     .+++.|||+..+..
T Consensus       236 LLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa-----~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        236 LCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA-----LQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH-----HHHhccHHHhhcCC
Confidence            9999999976655443333333333333 4578999999999999999999999     89999999986654

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.7e-44  Score=319.51  Aligned_cols=249  Identities=28%  Similarity=0.573  Sum_probs=215.7

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||.|+||.||++.+..++..||+|.++....  ......+..|+.+++.++|+||+++++.+.+.+.+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999875422  2334556779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.......    
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~----  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG----  154 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence            99999999988653  358999999999999999999999999999999999999999999999999987654321    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  282 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~  282 (366)
                            .......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+.......+..... ..+..++..+
T Consensus       155 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (255)
T cd08219         155 ------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYEL  228 (255)
T ss_pred             ------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHH
Confidence                  111235688899999999888899999999999999999999999998887777666655543 3567789999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+||.+||+.||++||++     .++++-
T Consensus       229 ~~li~~~l~~~P~~Rp~~-----~~il~~  252 (255)
T cd08219         229 RSLIKQMFKRNPRSRPSA-----TTILSR  252 (255)
T ss_pred             HHHHHHHHhCCcccCCCH-----HHHhhc
Confidence            999999999999999999     677653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-44  Score=326.55  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=212.9

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            589999999999999999999999999999998765332 2334457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          126 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       126 ~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |+ +++|.+++... +.+++.+++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+........    
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~----  154 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP----  154 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence            99 89999998654 5699999999999999999999999999999999999999999999999999886643321    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------  270 (366)
                           .......++..|+|||++.+. .++.++||||+|+++|+|++|.+||.+.+.......+...             
T Consensus       155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence                 111234688899999998654 4688999999999999999999999877765554443321             


Q ss_pred             ------CCCC-----------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          271 ------DIRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       271 ------~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                            ...+           ....+.++.+||++||+.||++||++     +++++||||.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~-----~~~l~h~~~~  286 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHPYFT  286 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH-----HHHhhCcCcC
Confidence                  0000           12457899999999999999999999     8999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.7e-45  Score=332.01  Aligned_cols=252  Identities=27%  Similarity=0.436  Sum_probs=206.5

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++.+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            58999999999999999999999999999999876432 22223345679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       126 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |+.+ +|.+++.+ .+.+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||++.......     
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----  153 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-----  153 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence            9975 78887765 4679999999999999999999999999999999999999999999999999987553321     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCC-CCCCHHHHHHHHhcC------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIAR------------  270 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~------------  270 (366)
                           .......++..|+|||.+.+.. ++.++||||+||++|+|++|..|| .+.+....+..+...            
T Consensus       154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence                 1112335688999999986644 788999999999999999988875 444444443333210            


Q ss_pred             -----CC------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 -----DI------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 -----~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                           ..            .....+++++++||++||+.||.+|||+     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~il~h~~f  284 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-----EEALQHPYF  284 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH-----HHHhcCCCC
Confidence                 00            0112468899999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.7e-45  Score=328.82  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=214.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+....  .......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47999999999999999999999999999999886542  2233455777999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          125 ESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       125 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||++|++|..++...   +.+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||.+..+.... 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999999888763   369999999999999999999996 599999999999999999999999999987653221 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC------CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH---HHhcC-
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RIIAR-  270 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~-  270 (366)
                                 .....++..|+|||.+.+..      ++.++|+||+||++|+|++|..||..........   .+... 
T Consensus       158 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  226 (286)
T cd06622         158 -----------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD  226 (286)
T ss_pred             -----------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence                       11335778899999985433      4789999999999999999999997655443332   23332 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ....+..++.++.+||.+||+.+|++||++     .+++.||||....
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~l~~~~~~~~~~  269 (286)
T cd06622         227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTY-----AQLLEHPWLVKYK  269 (286)
T ss_pred             CCCCCcccCHHHHHHHHHHcccCcccCCCH-----HHHhcChhhhhcc
Confidence            345666799999999999999999999999     8999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-44  Score=333.40  Aligned_cols=247  Identities=27%  Similarity=0.406  Sum_probs=193.2

Q ss_pred             eeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEEEEEe
Q 017775           50 GKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYMALE  125 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e  125 (366)
                      +++||+|+||.||+|+++  .+++.||+|.+.....     .....+|+.+++.++||||+++++++.+  ...++++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            578999999999999975  4678999999865421     2235679999999999999999999854  556899999


Q ss_pred             ecCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----CCCCCEEEEecCCc
Q 017775          126 SCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSV  192 (366)
Q Consensus       126 ~~~g~~L~~~l~~~---------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli----~~~~~vkL~Dfg~a  192 (366)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9975 888887532         248999999999999999999999999999999999999    45679999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHH---------H
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW---------L  262 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~  262 (366)
                      .........       ........||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+....         .
T Consensus       160 ~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         160 RLFNSPLKP-------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             eccCCCCcc-------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            865432111       1122345789999999998764 5889999999999999999999999653321         1


Q ss_pred             HHHHHhcC----------------------------CCC----------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCC
Q 017775          263 IFQRIIAR----------------------------DIR----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGG  304 (366)
Q Consensus       263 ~~~~i~~~----------------------------~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~  304 (366)
                      ....+...                            ...          .....+.++.+||.+||+.||++|||+    
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~----  308 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS----  308 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH----
Confidence            11111100                            000          001235678999999999999999999    


Q ss_pred             hHhhhcCCCC
Q 017775          305 YAVLKMHPFF  314 (366)
Q Consensus       305 ~~~~l~hp~f  314 (366)
                       +++++||||
T Consensus       309 -~e~l~hp~f  317 (317)
T cd07868         309 -EQAMQDPYF  317 (317)
T ss_pred             -HHHhcCCCC
Confidence             899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.5e-44  Score=318.51  Aligned_cols=253  Identities=28%  Similarity=0.529  Sum_probs=221.8

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||.|+||.||.+++..+++.+++|.+........ ....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            58999999999999999999999999999999876543333 33456679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+++++|.+++.+.  ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence            99999999999875  4589999999999999999999999999999999999999999999999999876543321   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSDAA  282 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~  282 (366)
                             ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+..+... .+..++.++
T Consensus       157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08221         157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL  229 (256)
T ss_pred             -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHH
Confidence                   112446889999999998888889999999999999999999999988887777777665443 345679999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .+++.+||+.+|.+||++     .+++.|||+
T Consensus       230 ~~~i~~~l~~~p~~R~s~-----~~ll~~~~l  256 (256)
T cd08221         230 ISLVHSLLQQDPEKRPTA-----DEVLDQPLL  256 (256)
T ss_pred             HHHHHHHcccCcccCCCH-----HHHhhCcCC
Confidence            999999999999999999     899999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.2e-44  Score=325.89  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=216.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45789999999999999999997642     35589999876542  122233466799999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEE
Q 017775          118 FSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                      ...++||||+++|+|.+++.+.          ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999999753          234667889999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHH
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  266 (366)
                      |||+++.........        ......++..|+|||.+.+..++.++|+||+||++|+|++ |..||.+....+....
T Consensus       162 Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         162 DFGMTRDIYETDYYR--------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             cCCcccccccccccc--------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999987654322110        0112234667999999988889999999999999999998 8999988887777766


Q ss_pred             HhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc------CCCCCCCCc
Q 017775          267 IIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM------HPFFKGIDW  319 (366)
Q Consensus       267 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~------hp~f~~~~~  319 (366)
                      +..+ ....+...++.+.+++.+||+.||++|||+     .+++.      ||||.+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF-----LEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHHHHHhhcCCCCCCCCC
Confidence            6554 344566788999999999999999999999     45543      999999987

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.4e-44  Score=318.36  Aligned_cols=252  Identities=28%  Similarity=0.493  Sum_probs=219.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++|||++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5899999999999999999999999999999998754433 334567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence            99999999999764  3489999999999999999999999999999999999998654 68999999998664321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDA  281 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  281 (366)
                              ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+... ...++..++++
T Consensus       157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd08220         157 --------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD  228 (256)
T ss_pred             --------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHH
Confidence                    112346788999999999888899999999999999999999999887776666665544 33466778999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +.+++.+||+.||++|||+     .+++.||||
T Consensus       229 l~~li~~~l~~~p~~Rpt~-----~~ll~~p~~  256 (256)
T cd08220         229 LRQLILSMLNLDPSKRPQL-----SQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhhCCCC
Confidence            9999999999999999999     899999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-44  Score=323.39  Aligned_cols=251  Identities=29%  Similarity=0.492  Sum_probs=208.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC------
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT------  117 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------  117 (366)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+..|+.+++.+ +|+||+++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            56889999999999999999999999999999987542    2234566788888888 799999999998753      


Q ss_pred             CeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      ..+|++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998864  35899999999999999999999999999999999999999999999999998755


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ....          .......|+..|+|||.+.     +..++.++|+||+||++|+|++|..||...........+...
T Consensus       162 ~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~  231 (272)
T cd06637         162 DRTV----------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  231 (272)
T ss_pred             cccc----------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence            3221          1122456888999999985     335788999999999999999999999776655444433332


Q ss_pred             CC--CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 DI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ..  ..+..++.++.+|+.+||..||.+|||+     .+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~~  272 (272)
T cd06637         232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT-----EQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH-----HHHhhCCCC
Confidence            21  1234578999999999999999999999     899999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=343.86  Aligned_cols=249  Identities=31%  Similarity=0.554  Sum_probs=216.5

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      -+||+|.||+||.|++..|....|||.+...   .....+.+.+|+.+-+.++|.|||++++.+.+++.+-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            4799999999999999999999999988654   3334456888999999999999999999999999999999999999


Q ss_pred             chHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-CCCCEEEEecCCccccCCccccccCCC
Q 017775          131 ELFDQITSK-GHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNA  206 (366)
Q Consensus       131 ~L~~~l~~~-~~l--~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~  206 (366)
                      +|.+++... |++  .|..+..+.+||++||.|||++.|+|||||.+|+||+ ..|.+||+|||-++++..-        
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--------  729 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--------  729 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--------
Confidence            999999765 788  8999999999999999999999999999999999997 4699999999999877543        


Q ss_pred             CCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCC-HHH-HHH-HHhcCCCCCCCCCCHH
Q 017775          207 ASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWL-IFQ-RIIARDIRFPNYFSDA  281 (366)
Q Consensus       207 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~-~~~-~i~~~~~~~~~~~s~~  281 (366)
                        ..-..++.||..|||||++...+  |+.++|||||||++.||.||++||.... +.. +++ -+.+..+++|..++.+
T Consensus       730 --nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae  807 (1226)
T KOG4279|consen  730 --NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE  807 (1226)
T ss_pred             --CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence              23345788999999999996544  9999999999999999999999996433 222 222 2345567889999999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +++||.+|+.+||.+||+|     .++|..||++.-
T Consensus       808 ak~FilrcFepd~~~R~sA-----~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  808 AKNFILRCFEPDPCDRPSA-----KDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHcCCCcccCccH-----HHhccCcccccC
Confidence            9999999999999999999     889999999754

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-44  Score=322.06  Aligned_cols=248  Identities=17%  Similarity=0.311  Sum_probs=209.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +...+|++.+.||+|+||.||+|.++   ..+..||+|.++...  .......+.+|+..++.++||||+++++++...+
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            45678999999999999999999865   456789999987642  2233445778999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||+++++|.+++... +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999998774 5789999999999999999999999999999999999999999999999998764322


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      ....         ......++..|+|||.+.+..++.++||||+||++|++++ |..||.+.+..+....+... ..+.|
T Consensus       160 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  230 (266)
T cd05064         160 EAIY---------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP  230 (266)
T ss_pred             cchh---------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence            1100         1112234568999999988889999999999999999775 99999988888777776554 34556


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..++..+.+++.+||+.+|.+||++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~  255 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRF  255 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCH
Confidence            7789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-46  Score=340.76  Aligned_cols=250  Identities=29%  Similarity=0.408  Sum_probs=219.7

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |.-++.||.|+||.||-|++..+.+.||||.+........+.-..+..|+..|++++|||++.+.++|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            56789999999999999999999999999999877655555555677799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |-| +-.+++.-. +++.+.+|..++.+.++||.|||+++.||||||..|||+++.|.|||+|||.|..+.         
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---------  177 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---------  177 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---------
Confidence            976 888887654 579999999999999999999999999999999999999999999999999987653         


Q ss_pred             CCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCC-CCCCH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFP-NYFSD  280 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~-~~~s~  280 (366)
                           .+.+++|||.|||||++.   ...|+-++||||||++..||.-.++|+.+.+...-+..|-... +.++ ..+|.
T Consensus       178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~  252 (948)
T KOG0577|consen  178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD  252 (948)
T ss_pred             -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence                 345889999999999874   4568889999999999999999999988777766666654433 3333 45899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+++|+..||++-|.+|||.     +++++|+|...
T Consensus       253 ~F~~Fvd~CLqKipqeRpts-----e~ll~H~fv~R  283 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTS-----EELLKHRFVLR  283 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcH-----HHHhhcchhcc
Confidence            99999999999999999999     89999999863

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.4e-44  Score=323.23  Aligned_cols=253  Identities=28%  Similarity=0.494  Sum_probs=211.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----  117 (366)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|++...    ......+..|+.+++.+ +|||++++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            67899999999999999999999999999999998653    12234566788888888 899999999998753     


Q ss_pred             CeEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          118 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ...++||||++|++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            358999999999999998763    3568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCC-----CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHh
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  268 (366)
                      .......          ......|+..|+|||.+...     .++.++||||+||++|+|++|+.||...........+.
T Consensus       177 ~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~  246 (291)
T cd06639         177 QLTSTRL----------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP  246 (291)
T ss_pred             hcccccc----------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence            6543221          11133578899999987543     36789999999999999999999998877655555544


Q ss_pred             cCC---CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          269 ARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       269 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ...   ...+..++..+.+||.+||+.||++||++     .+++.||||+
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il~~~~~~  291 (291)
T cd06639         247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK  291 (291)
T ss_pred             cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCH-----HHHhcCcccC
Confidence            332   22355678899999999999999999999     8999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5e-44  Score=318.82  Aligned_cols=253  Identities=32%  Similarity=0.540  Sum_probs=217.9

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +|+..+.||+|++|.||+|.+..+++.|++|.+.....  ........+.+|+.+++.++|+||+++++++.+...++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            57888999999999999999998999999999865422  1233445677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.......    
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence            9999999999999888789999999999999999999999999999999999999999999999999987654322    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~s~  280 (366)
                             ......++..|+|||.+.... ++.++|+||+|+++|+|++|..||...........+..  ....++..+++
T Consensus       157 -------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd06632         157 -------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD  229 (258)
T ss_pred             -------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence                   112345788999999987766 88999999999999999999999987765554444433  23345677899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++.+++.+||+.+|.+||++     .+++.|||+
T Consensus       230 ~~~~li~~~l~~~p~~Rp~~-----~~~l~~~~~  258 (258)
T cd06632         230 EAKDFILKCLQRDPSLRPTA-----AELLEHPFV  258 (258)
T ss_pred             HHHHHHHHHhhcCcccCcCH-----HHHhcCCCC
Confidence            99999999999999999998     899999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-44  Score=326.18  Aligned_cols=255  Identities=20%  Similarity=0.340  Sum_probs=215.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|++.+.||+|+||.||+|.....+     ..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            45779999999999999999999876555     679999886542  23334557789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          117 TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      ....+++|||+++++|.+++...                ..+++.++..++.|++.||.|||++|++|+||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999764                45788999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      ++.++|+|||++.........        .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             CCcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999998755332111        11123346788999999988889999999999999999998 999999888


Q ss_pred             HHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          260 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       260 ~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..+....+.... ...|..+++++.+|+.+||+.||.+||++     .+++++
T Consensus       232 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-----~~i~~~  279 (283)
T cd05048         232 NQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRF-----KDIHTR  279 (283)
T ss_pred             HHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            888777766543 34567889999999999999999999999     666653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-44  Score=320.51  Aligned_cols=250  Identities=31%  Similarity=0.498  Sum_probs=216.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||.|++|.||+|.+..++..|++|.+.....     ...+.+|+.+++.++|+||+++++.+.+....|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            679999999999999999999999999999999865421     456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........   
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---  154 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---  154 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc---
Confidence            999999999998763 5689999999999999999999999999999999999999999999999999886643211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~  280 (366)
                             ......++..|+|||.+.+..++.++||||+|+++|+|++|..||...........+...   ....+..++.
T Consensus       155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd06612         155 -------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSP  227 (256)
T ss_pred             -------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCH
Confidence                   112345788999999998888999999999999999999999999877665544433322   2234456789


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++.++|.+||+.||++|||+     .+++.||||
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~-----~~il~~~~~  256 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSA-----IQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCH-----HHHhcCCCC
Confidence            99999999999999999999     899999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-44  Score=327.64  Aligned_cols=254  Identities=31%  Similarity=0.469  Sum_probs=212.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999999999999886643222 23445677999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|..+....+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-----  154 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-----  154 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence            999998888877766679999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------  270 (366)
                           .......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||......+....+...             
T Consensus       155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 -----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             -----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence                 111234578899999998653 4778999999999999999999999876654433332210             


Q ss_pred             ------CCC------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                            ...            ....++..+.+|+.+||+.+|++||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  286 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-----SQLLHHEFF  286 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH-----HHHhcCCCC
Confidence                  000            123568899999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-45  Score=333.65  Aligned_cols=258  Identities=28%  Similarity=0.452  Sum_probs=211.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  121 (366)
                      .-..|++++.||+||.+.||++...+. +.||+|.+.... .......-+.+|+.+|.+++ |.+|+++++|-..++.+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            456899999999999999999988544 556666554332 23344456778999999995 999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||=+. +|..++.+.+. ++...++.+..||+.|+.++|++||||.||||.|+|+ -.|.+||+|||.|..+.....
T Consensus       437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence            99999765 99999988754 4446899999999999999999999999999999999 678999999999998876543


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC-----------CCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHh
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----------ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRII  268 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~  268 (366)
                      ...        ..+-+||..|||||.+....           .++++||||||||||+|+.|++||.... .+.-+..|.
T Consensus       515 sI~--------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~  586 (677)
T KOG0596|consen  515 SIV--------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT  586 (677)
T ss_pred             cee--------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence            332        22558999999999874322           4688999999999999999999997643 455566666


Q ss_pred             cCCC--CCCCCCCHH-HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          269 ARDI--RFPNYFSDA-ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       269 ~~~~--~~~~~~s~~-~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +.+.  +||..-+.. +.++++.||+.||++||++     .++|.|||++.+
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si-----~eLLqhpFl~~~  633 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSI-----PELLQHPFLQIQ  633 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCc-----HHHhcCcccccc
Confidence            6544  677655555 9999999999999999999     789999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=327.50  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=222.0

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |.++++||+|+||.||+|.++++|+.+|+|.+..+     .+.+.+..|+.++++++.+++|++|+.|.....+||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            68999999999999999999999999999987543     3445567799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |..|+..+.+..+ ++++|.++..+++..+.||+|||...-+|||||..|||++.+|+.||+|||.|-.+...-      
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM------  183 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM------  183 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH------
Confidence            9999999998754 679999999999999999999999999999999999999999999999999998665431      


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAA  282 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~  282 (366)
                          ....+..||+.|||||++..-.|+.++||||||++..||.-|++||....+..-...|....   +.-|+.+|+++
T Consensus       184 ----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  184 ----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             ----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHH
Confidence                23347789999999999999999999999999999999999999998766654433333332   23466789999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .||+++||-++|++|-||     .+++.|||+++..
T Consensus       260 ~DFi~~CLiK~PE~R~TA-----~~L~~H~FiknA~  290 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTA-----LRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHHHHhcCCHHHHHHH-----HHHhhhhhhcCCC
Confidence            999999999999999999     8899999998654

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.9e-44  Score=319.43  Aligned_cols=257  Identities=34%  Similarity=0.540  Sum_probs=223.0

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||+|.+..+|+.|++|.+......  .....+..|+..+..++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4789999999999999999999999999999998765322  34556778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~---  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence            999999999999888889999999999999999999999 9999999999999999999999999999886643321   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC---CHHHHHHHHhcC-CCCCCCC-C
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIAR-DIRFPNY-F  278 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~-~~~~~~~-~  278 (366)
                             ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...   ...+....+... ....+.. +
T Consensus       156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (264)
T cd06623         156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF  228 (264)
T ss_pred             -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccC
Confidence                   112345788999999998888999999999999999999999999776   444445554433 2334555 8


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +..+.++|.+||..+|++||++     .+++.||||+.++
T Consensus       229 ~~~l~~li~~~l~~~p~~R~~~-----~~ll~~~~~~~~~  263 (264)
T cd06623         229 SPEFRDFISACLQKDPKKRPSA-----AELLQHPFIKKAD  263 (264)
T ss_pred             CHHHHHHHHHHccCChhhCCCH-----HHHHhCHHHHhcc
Confidence            9999999999999999999999     8999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.8e-44  Score=322.75  Aligned_cols=246  Identities=27%  Similarity=0.456  Sum_probs=205.2

Q ss_pred             CCeeeeeee--eecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEeeCCeEE
Q 017775           45 QDFELGKIY--GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        45 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|.+........        |...... .+|+||+++++.+...+..|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            466776666  999999999999999999999999865422111        2222222 27999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++.+.+.+++.+++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||.+....... 
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-  164 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-  164 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence            9999999999999998887899999999999999999999999999999999999999998 99999999987553221 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH----HHHHHhcCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPN  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~  276 (366)
                                   ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......    ............+.
T Consensus       165 -------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T PHA03390        165 -------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK  231 (267)
T ss_pred             -------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc
Confidence                         2357889999999998889999999999999999999999997554332    12222244445666


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+++.+.+||.+||+.||.+||++    ++++++||||++
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~----~~~~l~h~~~~~  267 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTN----YNEIIKHPFLKI  267 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCch----HHHHhcCCcccC
Confidence            799999999999999999999963    278999999974

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-44  Score=328.54  Aligned_cols=258  Identities=30%  Similarity=0.422  Sum_probs=213.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  120 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  120 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .......+|+.+++.++|+||+++++++.+.  +.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4788999999999999999999999999999999987543222 2222345699999999999999999998754  568


Q ss_pred             EEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++||||+.+ +|.+++... ..+++.+++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||.+.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999976 888888763 679999999999999999999999999999999999999999999999999988664321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--------
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  270 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------  270 (366)
                      .          ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.+.+..+....+...        
T Consensus       163 ~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         163 K----------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             C----------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            0          1112245778999999865 45788999999999999999999999988877766554431        


Q ss_pred             -----------CCCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 -----------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 -----------~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                 ....+           ..+++++.+||.+||+.||++|||+     .+++.||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~~il~h~~f~~~  296 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA-----EEALESSYFKEK  296 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhccC
Confidence                       01111           1258899999999999999999999     899999999843

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.9e-44  Score=322.20  Aligned_cols=257  Identities=25%  Similarity=0.447  Sum_probs=207.3

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.++...... .....+ .|.. .++..+||||+++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~-~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLL-MDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHH-HHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47999999999999999999999999999999987653222 222333 3444 46777999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      |||++| +|.+++..    ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999975 88777754    24689999999999999999999997 9999999999999999999999999998765322


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC----CCCCCCCCcccchhhhhhhhcCCCCCCCC-CHHHHHHHHhc-CCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIA-RDI  272 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~-~~~  272 (366)
                      .           ......++..|+|||.+.+    ..++.++|+||+||++|+|++|+.||... ...+....+.. ...
T Consensus       158 ~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd06617         158 V-----------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP  226 (283)
T ss_pred             c-----------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC
Confidence            1           1112357888999998865    44688999999999999999999999643 22233333332 223


Q ss_pred             CCC-CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          273 RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       273 ~~~-~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      .+| ..++.++.++|.+||..+|++||++     .+++.||||.....+
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~~  270 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNY-----PELLQHPFFELHLSK  270 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCH-----HHHhcCchhhhcccc
Confidence            333 3579999999999999999999999     899999999876543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-44  Score=343.78  Aligned_cols=250  Identities=26%  Similarity=0.337  Sum_probs=203.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....         ....+|+.+++.++|+||+++++++......++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4579999999999999999999999999999995322         1245699999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||++. ++|..++... +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ 
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-  316 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST-  316 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence            99996 5888888764 56999999999999999999999999999999999999999999999999999765432111 


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC--------HHHHHHHHhcCCC--
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--------EWLIFQRIIARDI--  272 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~--  272 (366)
                             .......||..|+|||++.+..++.++|||||||++|||++|..|+....        .....+.+.....  
T Consensus       317 -------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        317 -------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             -------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence                   11124568999999999999889999999999999999999776542211        1222222221110  


Q ss_pred             -CCC-------------------------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          273 -RFP-------------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       273 -~~~-------------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                       .++                               ..++.++.+||.+||+.||++|||+     .++|+||||++
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa-----~elL~hp~f~~  460 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA-----AELLRLPLFQS  460 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH-----HHHhhCcccCC
Confidence             011                               0245689999999999999999999     89999999974

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=324.35  Aligned_cols=255  Identities=31%  Similarity=0.474  Sum_probs=214.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.++.... .......+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999998875432 2333456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++++.+..+..+...+++.++..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+........    
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----  155 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA----  155 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence            9999877766666666799999999999999999999999999999999999999999999999999886654321    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------  270 (366)
                           .......++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+..+....+...             
T Consensus       156 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         156 -----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             -----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence                 112235678899999999887 7899999999999999999999999876654433322110             


Q ss_pred             ------C-------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ------D-------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ------~-------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                            .             ..++..++.++.+||++||..+|++||++     ++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH-----HHHhcCCCC
Confidence                  0             01233458999999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.2e-44  Score=320.34  Aligned_cols=256  Identities=30%  Similarity=0.530  Sum_probs=213.1

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-------hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+.......       ......+..|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5889999999999999999999999999999886432111       112345677999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..++||||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998754322


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRF  274 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~  274 (366)
                      .        .........++..|+|||.+....  ++.++|+||||+++|++++|..||...........+...  ...+
T Consensus       162 ~--------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (272)
T cd06629         162 Y--------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI  233 (272)
T ss_pred             c--------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence            1        011122345788999999987654  788999999999999999999999766554444333222  2222


Q ss_pred             C----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          275 P----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       275 ~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +    ..++.++.++|.+||..+|++||++     .+++.||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~  272 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTA-----RELLQHPFI  272 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCH-----HHHhhCCCC
Confidence            3    2468999999999999999999998     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.9e-44  Score=326.81  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=213.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +|++.+.||+|++|.||+|.+..+|+.||+|.+......  .......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999999999999999765433  122334456799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+ +++|.+++.... .+++..+..++.||++||.|||++||+|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN---  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence            9999 889999998775 79999999999999999999999999999999999999999999999999988654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  271 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------  271 (366)
                             .......+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+....          
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         157 -------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             -------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence                   11112345778999998854 457889999999999999999988888777655544443210          


Q ss_pred             -------------C-----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          272 -------------I-----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       272 -------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                   .     ......+.++.++|.+||+.||++|||+     .+++.||||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~e~l~~~~~~~~  288 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-----RQALEHPYFSND  288 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH-----HHHhhCccccCC
Confidence                         0     0112357889999999999999999999     899999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.1e-44  Score=355.82  Aligned_cols=152  Identities=34%  Similarity=0.593  Sum_probs=140.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+++|.+++.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++|+||++++.++.....+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999987544444555677889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-44  Score=333.35  Aligned_cols=254  Identities=25%  Similarity=0.432  Sum_probs=210.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.... ......+.+|+.+++.++|+||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            368899999999999999999999999999999998754322 22334456799999999999999999988643     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ...|+||||+.+ +|.+.+...  +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             357999999975 888887654  8999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  270 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------  270 (366)
                      ...           ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+.......+...      
T Consensus       170 ~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (353)
T cd07850         170 TSF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD  238 (353)
T ss_pred             CCC-----------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            321           112345788999999999999999999999999999999999999877655444333210      


Q ss_pred             ----------------CC--------------CC-------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          271 ----------------DI--------------RF-------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       271 ----------------~~--------------~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                                      ..              .+       +...++.+++||.+||+.||++|||+     .+++.|||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~eiL~~~~  313 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV-----DDALQHPY  313 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH-----HHHhcChh
Confidence                            00              00       11346678999999999999999999     89999999


Q ss_pred             CCC
Q 017775          314 FKG  316 (366)
Q Consensus       314 f~~  316 (366)
                      |+.
T Consensus       314 ~~~  316 (353)
T cd07850         314 INV  316 (353)
T ss_pred             Hhh
Confidence            984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-44  Score=320.82  Aligned_cols=252  Identities=30%  Similarity=0.518  Sum_probs=211.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~----  118 (366)
                      .++|++.+.||+|++|.||+|.++.+++.+++|++....    .....+.+|+.+++.+ +|+||+++++++.+..    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            478999999999999999999999999999999987642    2234577899999998 7999999999997644    


Q ss_pred             --eEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          119 --SLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       119 --~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                        .+++||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              48999999999999998865    347999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      .......          .......++..|+|||.+..     ..++.++||||||+++|+|++|..||...........+
T Consensus       161 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  230 (275)
T cd06608         161 AQLDSTL----------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI  230 (275)
T ss_pred             eecccch----------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence            7654321          11123457889999998753     34678899999999999999999999876655555555


Q ss_pred             hcCC---CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          268 IARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       268 ~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ....   ...+..++.++++||.+||..||++|||+     .+++.|||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~ll~~~~~  275 (275)
T cd06608         231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM-----EELLEHPFI  275 (275)
T ss_pred             hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCH-----HHHhcCCCC
Confidence            4432   22234478899999999999999999999     899999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.9e-44  Score=322.16  Aligned_cols=253  Identities=29%  Similarity=0.495  Sum_probs=209.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe-----e
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ-----D  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~  116 (366)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++...    ......+.+|..+++.+ +|+||+++++++.     +
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            467899999999999999999999999999999987542    12234466788889888 7999999999873     4


Q ss_pred             CCeEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          117 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      ....++||||++|++|.+++..    ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5679999999999999988753    346899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      ........          ......|++.|+|||.+..     ..++.++|+||+||++|+|++|..||...........+
T Consensus       172 ~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         172 AQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             eecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            76543211          1123458899999998753     44788999999999999999999999876654444333


Q ss_pred             hcC---CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          268 IAR---DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       268 ~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ...   ....|..++.++.+|+.+||+.||++|||+     .+++.|+||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~~~~  286 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTV-----SDLLQHVFI  286 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCH-----HHHhhcccC
Confidence            222   122345578899999999999999999999     899999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-44  Score=323.32  Aligned_cols=254  Identities=29%  Similarity=0.488  Sum_probs=217.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||.|++|.||+|.++.+++.+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+.+++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            478999999999999999999999999999999876532  234455677999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            999999999999876 789999999999999999999999 999999999999999999999999999987553221   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC-----CHHHHHHHHhcC-CCCCCC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~-~~~~~~  276 (366)
                               .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...     ......+.+... ....+.
T Consensus       156 ---------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (265)
T cd06605         156 ---------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS  226 (265)
T ss_pred             ---------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh
Confidence                     01145788999999998889999999999999999999999999654     233344444333 223344


Q ss_pred             C-CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          277 Y-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       277 ~-~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      . ++.++.++|.+||..||++|||+     .+++.||||+..
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~~~~  263 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSY-----KELLEHPFIKKY  263 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCH-----HHHhhCchhhcc
Confidence            4 89999999999999999999999     899999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.6e-44  Score=317.95  Aligned_cols=253  Identities=30%  Similarity=0.546  Sum_probs=219.2

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYMA  123 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv  123 (366)
                      +|++.+.||.|+||.||+|.+..+|..||+|.+...... ......+..|+.+++.++|+||+++++.+..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999998765433 3334557779999999999999999987753  4568999


Q ss_pred             EeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIH-----SMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH-----~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      |||+++++|.+++..    .+++++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999876    357899999999999999999999     89999999999999999999999999999887


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-C
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R  273 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~  273 (366)
                      ......          ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....+.+..... .
T Consensus       160 ~~~~~~----------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd08217         160 LGHDSS----------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR  229 (265)
T ss_pred             ccCCcc----------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC
Confidence            654321          11234688899999999888899999999999999999999999998887776666665543 4


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++..++.++.+++.+||+.+|++||++     .+++.|||+
T Consensus       230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~-----~~il~~~~~  265 (265)
T cd08217         230 IPYRYSSELNEVIKSMLNVDPDKRPST-----EELLQLPLI  265 (265)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCH-----HHHhhCCCC
Confidence            567889999999999999999999999     899999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-44  Score=324.57  Aligned_cols=256  Identities=29%  Similarity=0.457  Sum_probs=217.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|+||+||++.+..+|..||+|++....  .......+.+|+.+++.++||||+++++.+.+.+..+
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            34678999999999999999999999999999999886542  2334556778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++.+.+.+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999999999999888889999999999999999999997 699999999999999999999999999986542211 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-----------HHHHHHhc
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------LIFQRIIA  269 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~i~~  269 (366)
                                 .....|+..|+|||.+.+..++.++|+||+||++|++++|..||......           .....+..
T Consensus       159 -----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd06620         159 -----------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ  227 (284)
T ss_pred             -----------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence                       11346889999999998888999999999999999999999999765442           22333332


Q ss_pred             C-CCCCCC-CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          270 R-DIRFPN-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       270 ~-~~~~~~-~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      . ...++. .++.++.+|+.+||+.||++|||+     .++++|+||..
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~e~~~~~~~~~  271 (284)
T cd06620         228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTP-----QQLCAMPPFIQ  271 (284)
T ss_pred             ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccc
Confidence            2 222333 378899999999999999999999     89999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-43  Score=315.50  Aligned_cols=257  Identities=32%  Similarity=0.593  Sum_probs=217.3

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++|+||+++++.+.+.+.+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            689999999999999999999999999999998765432 3455678889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~--  157 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--  157 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--
Confidence            999999999998877799999999999999999999999999999999999999999999999999887654322110  


Q ss_pred             CCCCCCccccccCCCCCCceeecCCC---CCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHhc-CCCCCCCC--C
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIA-RDIRFPNY--F  278 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~--~  278 (366)
                          .......++..|+|||.+.+..   .+.++|+||+|+++|++++|..||.... .......+.. ....+|..  +
T Consensus       158 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         158 ----EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             ----ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence                0012345788999999988766   8889999999999999999999997653 3333333332 23344544  4


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++.+.++|.+||+.+|.+||++     .+++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~-----~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTA-----SELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence            8999999999999999999999     899999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=315.39  Aligned_cols=250  Identities=45%  Similarity=0.805  Sum_probs=223.7

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||.|++|.||++.+..+++.|++|.+.............+..|+.+++.++|+||+++++.+.+....+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999876554444566778899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCc
Q 017775          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (366)
Q Consensus       133 ~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~  212 (366)
                      .+++.+.+.+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.++|+|||.+.......          ...
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------~~~  150 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------SRT  150 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC----------Ccc
Confidence            9999988789999999999999999999999999999999999999999999999999987654432          112


Q ss_pred             cccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcC
Q 017775          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  292 (366)
Q Consensus       213 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  292 (366)
                      ....++..|+|||...+...+.++|+||||+++|++++|..||...+.......+......+|...+.++.+++++||..
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcC
Confidence            23457889999999988888899999999999999999999998888777777887778888899999999999999999


Q ss_pred             CCCCCCCCCCCChHhhhcCCCC
Q 017775          293 DPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       293 dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ||++||++..  ++++++||||
T Consensus       231 ~p~~R~~~~~--~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGG--AEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCccc--HHHHHhCCCC
Confidence            9999999854  4689999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.2e-44  Score=323.13  Aligned_cols=252  Identities=29%  Similarity=0.442  Sum_probs=208.8

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|+..+.||.|++|.||+|.+..+|+.||+|.+..+.. .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            48999999999999999999999999999998875432 22233457779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+.+ +|..++...  +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        80 ~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~----  154 (284)
T cd07860          80 FLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----  154 (284)
T ss_pred             cccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence            9974 888888653  468999999999999999999999999999999999999999999999999987553321    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------  271 (366)
                            .......++..|+|||.+.+.. ++.++|+||||+++|+|+||..||.+.+......++....           
T Consensus       155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         155 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence                  1111234678899999887644 6888999999999999999999998877654443322100           


Q ss_pred             -------CC-----------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 -------IR-----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 -------~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                             ..           ....++++++++|.+||+.||++||++     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~f  284 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-----KAALAHPFF  284 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH-----HHHhcCCCC
Confidence                   00           113468899999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-43  Score=321.33  Aligned_cols=252  Identities=29%  Similarity=0.498  Sum_probs=208.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe------e
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ------D  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~  116 (366)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|++...    ......+..|+.+++.+ +|+||+++++++.      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            46899999999999999999999999999999998653    22234567788888888 7999999999985      3


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          117 TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ....|++|||+.+++|.+++...  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            46789999999999999998764  3588999999999999999999999999999999999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      .....          .......|+..|+|||.+.     +..++.++|+|||||++|+|++|..||...........+..
T Consensus       171 ~~~~~----------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  240 (282)
T cd06636         171 LDRTV----------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  240 (282)
T ss_pred             hhccc----------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence            53221          1122456888999999875     34578899999999999999999999977655443333332


Q ss_pred             CCC--CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          270 RDI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       270 ~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ...  ..+..++.++.+||++||..||.+||++     .++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~ell~~~~~  282 (282)
T cd06636         241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST-----EQLLKHPFI  282 (282)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhCCChhhCcCH-----HHHhcCCCC
Confidence            211  1224578999999999999999999999     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.7e-44  Score=325.11  Aligned_cols=253  Identities=24%  Similarity=0.382  Sum_probs=209.1

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      .+..++|++.+.||+|+||.||+|.+..+|..  +++|.+...  ........+.+|+.++.++ +|+||+++++++.+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            45678999999999999999999999887765  466665432  2233445677799999999 899999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC
Q 017775          118 FSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~  181 (366)
                      +..|+||||+++++|.+++.+.+                .+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999997542                47899999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCH
Q 017775          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (366)
Q Consensus       182 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  260 (366)
                      +.+||+|||++.......           ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             CcEEeCccccCcccchhh-----------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence            999999999986322110           0011123567999999988889999999999999999998 9999988777


Q ss_pred             HHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       261 ~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+....+... ....+..+++++.+|+.+||+.+|++||++     ++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~  276 (303)
T cd05088         230 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  276 (303)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            7766665443 234566788999999999999999999999     566654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-44  Score=337.44  Aligned_cols=249  Identities=22%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|++..+     +..||+|++....  .......+.+|+.+++.+ +|+||+++++++.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            5567899999999999999999986543     3579999987642  222345577899999999 8999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC--------------------------------------------------------
Q 017775          116 DTFSLYMALESCEGGELFDQITSK--------------------------------------------------------  139 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------  139 (366)
                      +....++||||+++|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999988542                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          140 --------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       140 --------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                                    .++++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........    
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----  268 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----  268 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----
Confidence                          23788899999999999999999999999999999999999999999999998765432110    


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAA  282 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~  282 (366)
                          .......++..|+|||++.+..++.++||||+||++|+|++ |..||...........+...  ....|..+++++
T Consensus       269 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (374)
T cd05106         269 ----VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEI  344 (374)
T ss_pred             ----eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHH
Confidence                01112234567999999988889999999999999999997 99999876554444343333  334556789999


Q ss_pred             HHHHHHhhcCCCCCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~  300 (366)
                      .+++.+||+.||++|||+
T Consensus       345 ~~li~~cl~~dp~~RPs~  362 (374)
T cd05106         345 YSIMKMCWNLEPTERPTF  362 (374)
T ss_pred             HHHHHHHcCCChhhCcCH
Confidence            999999999999999999

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=330.88  Aligned_cols=249  Identities=31%  Similarity=0.544  Sum_probs=220.4

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      .++||+|.||+||-|.++.+|+.||||++++....... ...+++|+.+|+.+.||.||.+-..|++.+.+++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            48999999999999999999999999999987554433 46789999999999999999999999999999999999987


Q ss_pred             CchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCCccccCCccccccC
Q 017775          130 GELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       130 ~~L~~~l~~--~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                       ++.+.+..  .+++++...+.++.||+.||.|||-++|+|+||||+|||+...   ..+||+|||+|+.+++..+    
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----  722 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----  722 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh----
Confidence             66665543  3789999999999999999999999999999999999999754   4899999999999877642    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----YFSD  280 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~  280 (366)
                             ..+.+||+.|+|||++.+..|...-|+||+|||+|--+.|..||..+  +++..+|.+..+.+|.    .+++
T Consensus       723 -------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  723 -------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             -------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCH
Confidence                   23679999999999999999999999999999999999999999654  3455677777777764    5899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ++.|||..+|+..-++|-|.     ...+.|||+++..
T Consensus       794 ~AidlIn~LLqVkm~kRysv-----dk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSV-----DKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcch-----Hhhccchhhhcch
Confidence            99999999999999999999     7789999998753

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.2e-44  Score=322.66  Aligned_cols=256  Identities=32%  Similarity=0.481  Sum_probs=219.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +.|+..+.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.+.|+||+++++.+.+....++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468889999999999999999999999999999875422  233456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++|++|.+++.. +++++.++..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........    
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----  156 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----  156 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence            99999999998865 5689999999999999999999999999999999999999999999999999876543221    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  283 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  283 (366)
                            ......++..|+|||.+.+...+.++|+||||+++|+|++|..||...........+... ....+..++..+.
T Consensus       157 ------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06640         157 ------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK  230 (277)
T ss_pred             ------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH
Confidence                  112335778899999998888999999999999999999999999877766555544333 2334556788999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +++.+||+.+|++||++     .+++.|+||....
T Consensus       231 ~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~  260 (277)
T cd06640         231 EFIDACLNKDPSFRPTA-----KELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHHcccCcccCcCH-----HHHHhChHhhhcc
Confidence            99999999999999999     8999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-43  Score=314.88  Aligned_cols=257  Identities=28%  Similarity=0.500  Sum_probs=218.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  120 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  120 (366)
                      .+|++.+.||+|++|.||+|.+..+|..||+|.+....  .........+.+|+.+++.++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875432  11233445677899999999999999999998764  568


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++++||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999999999999999999986543210


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~  278 (366)
                      .       ........++..|+|||.+.+..++.++|+|||||++|+|++|..||..........++...  ...+|..+
T Consensus       162 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~  234 (264)
T cd06653         162 S-------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV  234 (264)
T ss_pred             c-------CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCccc
Confidence            0       11112356888999999998888899999999999999999999999877666555554433  34568889


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++++.++|.+||. +|.+||++     .+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~-----~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTA-----EFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccH-----HHHhcCCCC
Confidence            9999999999999 67999999     899999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-43  Score=324.51  Aligned_cols=249  Identities=21%  Similarity=0.309  Sum_probs=203.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID----------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP  105 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~  105 (366)
                      +..++|++.+.||+|+||.||+|.+..                ++..||+|.+....  .......+.+|+.+++.++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            346789999999999999999997532                34579999987542  233345677899999999999


Q ss_pred             CcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 017775          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-------------------HLSEDEARFYTAEVVDALEYIHSMGL  166 (366)
Q Consensus       106 ~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-------------------~l~~~~~~~~~~qil~aL~~LH~~~i  166 (366)
                      ||+++++++.+.+..++||||+.+++|.+++....                   .++...+..++.||+.||.|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999986532                   35778899999999999999999999


Q ss_pred             eeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhh
Q 017775          167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY  246 (366)
Q Consensus       167 ~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  246 (366)
                      +||||||+||+++.++.+||+|||++.........        .......++..|+|||.+.+..++.++||||||+++|
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  231 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY--------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW  231 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCcee--------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence            99999999999999999999999999865432211        0112334577899999998888999999999999999


Q ss_pred             hhhc--CCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          247 QMLS--GTSPFKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       247 ~ll~--g~~pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +|++  +..||...+..+....+..        .....|...+..+.+|+.+||+.||++|||+
T Consensus       232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            9986  6788887766655443321        1122355678999999999999999999999

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=322.43  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=206.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|++|.||+|.++.+|+.||+|.+......  .......+|+.+++.++|+||+++++++.+.+..++
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            367899999999999999999999999999999998764322  122235569999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+.+ +|.+++... +.+++..++.++.|+++||.|||++||+||||+|+||+++.++.+||+|||++.......  
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9999986 999988764 468999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHhcC---------
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIAR---------  270 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~---------  270 (366)
                              .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.+.. ..+....+...         
T Consensus       158 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (291)
T cd07844         158 --------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW  229 (291)
T ss_pred             --------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence                    01112245778999999865 457889999999999999999999997655 22222221110         


Q ss_pred             ------------CCCC---------CCCCC--HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ------------DIRF---------PNYFS--DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ------------~~~~---------~~~~s--~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                  ....         ...++  .++.+++.+||+.||++|||+     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~-----~e~l~~~~f  291 (291)
T cd07844         230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-----AEAMKHPYF  291 (291)
T ss_pred             hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH-----HHHhcCCCC
Confidence                        0000         01234  889999999999999999999     899999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-43  Score=319.34  Aligned_cols=253  Identities=30%  Similarity=0.485  Sum_probs=216.7

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|...+.||+|++|.||++.+..+++.+++|.+...   .......+.+|+.+++.++|+||+++++++...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            456678999999999999999999999999988643   22334456779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+.......      
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~------  169 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------  169 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC------
Confidence            9999999999887 579999999999999999999999999999999999999999999999999876543221      


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPNYFSDAA  282 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~  282 (366)
                          .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+......   .+..++..+
T Consensus       170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (285)
T cd06648         170 ----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRL  245 (285)
T ss_pred             ----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHH
Confidence                1112345788999999998888999999999999999999999999887776666665544322   233478999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+++++||+.+|++||++     .+++.||||+..
T Consensus       246 ~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~~  275 (285)
T cd06648         246 RSFLDRMLVRDPAQRATA-----AELLNHPFLAKA  275 (285)
T ss_pred             HHHHHHHcccChhhCcCH-----HHHccCcccccC
Confidence            999999999999999999     899999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.7e-43  Score=322.81  Aligned_cols=252  Identities=29%  Similarity=0.408  Sum_probs=213.5

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..|+..+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45999999999999999999999999999999987554334444456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+.| ++.+++.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......     
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----  168 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----  168 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence            99975 77777654 456999999999999999999999999999999999999999999999999988654321     


Q ss_pred             CCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCC-CCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRF-PNYF  278 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~-~~~~  278 (366)
                               ....++..|+|||.+.   ...++.++||||+|+++|+|++|..||.+.+.......+.... ... +..+
T Consensus       169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (307)
T cd06607         169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW  239 (307)
T ss_pred             ---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence                     1345778899999874   3457889999999999999999999998877666555444332 222 2357


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +.++.++|.+||+.||++||++     .+++.||||..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  272 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSS-----EELLKHRFVLR  272 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhcc
Confidence            8899999999999999999998     89999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-44  Score=326.71  Aligned_cols=254  Identities=30%  Similarity=0.490  Sum_probs=216.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +.|.....||+|+||.||++.+..++..||+|.+...   .......+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            4566678899999999999999999999999988653   2333455778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......     
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-----  172 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-----  172 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence            99999999988754 468999999999999999999999999999999999999999999999999987543221     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  281 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~~  281 (366)
                           .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+...   .......++..
T Consensus       173 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06658         173 -----PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSV  247 (292)
T ss_pred             -----ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHH
Confidence                 1112346888999999998888999999999999999999999999887776655544332   22223457899


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +.+++.+||+.||.+|||+     ++++.||||...
T Consensus       248 ~~~li~~~l~~~P~~Rpt~-----~~il~~~~~~~~  278 (292)
T cd06658         248 LRGFLDLMLVREPSQRATA-----QELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhhChhhhcc
Confidence            9999999999999999999     899999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-43  Score=316.25  Aligned_cols=247  Identities=21%  Similarity=0.348  Sum_probs=212.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +...+|.+.+.||+|++|.||+|.++.++..||+|.+..+    ......+.+|+.+++.++|+||+++++++.....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            4467899999999999999999999999999999998653    222345677999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999998764  358999999999999999999999999999999999999999999999999998664432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ...         .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+... ....+..
T Consensus       159 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (263)
T cd05052         159 YTA---------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG  229 (263)
T ss_pred             eec---------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence            111         011233567999999988889999999999999999998 99999888877776666543 4556778


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ++.++.+++.+||+.||++||++.
T Consensus       230 ~~~~~~~li~~cl~~~p~~Rp~~~  253 (263)
T cd05052         230 CPPKVYELMRACWQWNPSDRPSFA  253 (263)
T ss_pred             CCHHHHHHHHHHccCCcccCCCHH
Confidence            999999999999999999999993

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.6e-44  Score=323.79  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=211.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~  121 (366)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.++..... ......+.+|+.+++.++||||+++++++...  ...|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            56899999999999999999999999999999999765332 22233455799999999999999999998877  8899


Q ss_pred             EEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+.+ +|.+++.... .+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  160 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-  160 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence            99999985 9999887653 58999999999999999999999999999999999999999999999999988664431 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  270 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---------  270 (366)
                               .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+......++...         
T Consensus       161 ---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
T cd07843         161 ---------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW  231 (293)
T ss_pred             ---------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence                     1112335678899999987644 688999999999999999999999877665554443210         


Q ss_pred             ----------------------CCCCCCC-CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ----------------------DIRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ----------------------~~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                            ...++.. +++.+.++|++||+.||++|||+     .+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~ell~~~~f  293 (293)
T cd07843         232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-----EDALKHPYF  293 (293)
T ss_pred             HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH-----HHHhcCCCC
Confidence                                  0112333 68899999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-44  Score=335.49  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=206.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|.+     ..++..||+|+++....  ......+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            4456899999999999999999974     35677899999865422  22334567799999999 8999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCC-------------------------------------------------------
Q 017775          116 DTFSLYMALESCEGGELFDQITSKG-------------------------------------------------------  140 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~-------------------------------------------------------  140 (366)
                      +....++||||+++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999886431                                                       


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          141 --------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       141 --------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                                          .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                                367888999999999999999999999999999999999999999999999986543221


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC--CCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNY  277 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~  277 (366)
                      .        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||..........+....  ....|..
T Consensus       270 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (375)
T cd05104         270 Y--------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC  341 (375)
T ss_pred             c--------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence            1        01112234567999999999899999999999999999997 99999776544333333332  2334566


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+.++.+|+.+||+.||++|||+     .+++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~-----~eil~  369 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTF-----KQIVQ  369 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCH-----HHHHH
Confidence            78999999999999999999999     66654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-43  Score=320.77  Aligned_cols=249  Identities=20%  Similarity=0.345  Sum_probs=211.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|.+.+.||+|+||.||++...     .++..+|+|.+...   .......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45678999999999999999999852     34567999988653   23344567789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC
Q 017775          117 TFSLYMALESCEGGELFDQITSKG-------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~-------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~  183 (366)
                      .+..+++|||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999997543             3899999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  262 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  262 (366)
                      ++|+|||++.........        .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus       159 ~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~  230 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE  230 (288)
T ss_pred             EEeccCCccccccCCcee--------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999998865432211        01112335678999999998889999999999999999998 999998888877


Q ss_pred             HHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          263 IFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       263 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ....+..+. ...+..++.++.+|+.+||+.||.+|||+.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  270 (288)
T cd05093         231 VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK  270 (288)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            777776654 345667899999999999999999999993

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=311.30  Aligned_cols=253  Identities=32%  Similarity=0.582  Sum_probs=221.9

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+.+++.++|+|++++++++.+.+..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999876433 2344567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |+++++|.+++.+.+.+++..++.++.|++.||.+||++||+||||+|+||+++.++.++|+|||.+.........    
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~----  155 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----  155 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence            9999999999988888999999999999999999999999999999999999999999999999999876543211    


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSDAARD  284 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~s~~~~~  284 (366)
                            .....++..|+|||...+..++.++|+||+|+++|+|++|..||...........+. .....++..++..+.+
T Consensus       156 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (254)
T cd06627         156 ------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD  229 (254)
T ss_pred             ------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence                  123457889999999988888999999999999999999999998766554444433 4445567788999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++.+||..+|++||++     .+++.||||
T Consensus       230 ~i~~~l~~~p~~R~~~-----~~~l~~~~~  254 (254)
T cd06627         230 FLMQCFQKDPNLRPTA-----KQLLKHPWI  254 (254)
T ss_pred             HHHHHHhCChhhCcCH-----HHHhcCCCC
Confidence            9999999999999999     899999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.5e-44  Score=329.92  Aligned_cols=264  Identities=26%  Similarity=0.415  Sum_probs=213.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe----eCCeE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFSL  120 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~  120 (366)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            6899999999999999999999999999999998765322 223344567999999999999999998875    34568


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus        84 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            999999964 8999998877899999999999999999999999999999999999999999999999999876543221


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc----------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA----------  269 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----------  269 (366)
                      .      .........++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+.......+..          
T Consensus       163 ~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         163 E------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             C------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            1      0111124468889999999765 4588999999999999999999999977654332222111          


Q ss_pred             ----------------CCCCC-----CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          270 ----------------RDIRF-----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       270 ----------------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                      .....     ....+.++.++|.+||+.+|++||++     .+++.||||.+..-+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~~~~~~~~~  304 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-----EQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhChhhhhccCCc
Confidence                            00011     13468999999999999999999999     8999999998655433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-44  Score=346.93  Aligned_cols=263  Identities=25%  Similarity=0.356  Sum_probs=199.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCC-CcEEEEEEe--------------ecccccchhhHHHHHHHHHHHHhCCCCCcc
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIM--------------DKKFITKENKTAYVKLERIVLDQLDHPGVV  108 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~--------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv  108 (366)
                      .++|++++.||+|+||.||+|..+.. +...+.|.+              .+...........+.+|+.+++.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            57899999999999999999876432 222222211              111111222344577899999999999999


Q ss_pred             eeEEEEeeCCeEEEEEeecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC
Q 017775          109 RLFFTFQDTFSLYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       109 ~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~  183 (366)
                      ++++++.+.+..|+++|++.+ +|.+++...     ......+++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999965 787776543     22456778899999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCC-CCCC--CH
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDT--SE  260 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~--~~  260 (366)
                      +||+|||++..+.....         .......|+..|+|||++.+..++.++|||||||++|+|++|..+ |...  ..
T Consensus       306 vkL~DFGla~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        306 IVLGDFGTAMPFEKERE---------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EEEEeCCCceecCcccc---------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            99999999986643221         112245789999999999998999999999999999999998754 4322  22


Q ss_pred             HHHHHHHhcC----CCCCC----------------------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhh
Q 017775          261 WLIFQRIIAR----DIRFP----------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL  308 (366)
Q Consensus       261 ~~~~~~i~~~----~~~~~----------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~  308 (366)
                      ...+.+++..    ...+|                            ..++.++.++|.+||+.||++|||+     .++
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa-----~el  451 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-----AEL  451 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH-----HHH
Confidence            2222221110    00011                            1356778899999999999999999     899


Q ss_pred             hcCCCCCCCCccc
Q 017775          309 KMHPFFKGIDWKN  321 (366)
Q Consensus       309 l~hp~f~~~~~~~  321 (366)
                      +.||||+....+.
T Consensus       452 L~hp~f~~~~~~~  464 (501)
T PHA03210        452 LALPLFSAEEEEE  464 (501)
T ss_pred             hhChhhhcCCchH
Confidence            9999998765443

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4e-43  Score=315.26  Aligned_cols=252  Identities=29%  Similarity=0.513  Sum_probs=208.5

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +.......||+|+||.||+|.+..++..|++|.+...   .......+.+|+.+++.++|+||+++++++.+.+..++++
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3444456899999999999999999999999988654   2233456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEecCCccccCCccc
Q 017775          125 ESCEGGELFDQITSK-GHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l--~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||+++++|.+++... +.+  ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            999999999998764 455  88899999999999999999999999999999999986 67999999999876533211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCCHH-H-HHH-HHhcCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEW-L-IFQ-RIIARDIRFP  275 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~-~~~-~i~~~~~~~~  275 (366)
                                ......++..|+|||.+.+..  ++.++|+||+|+++|+|++|..||...... . ... ........+|
T Consensus       165 ----------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06624         165 ----------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP  234 (268)
T ss_pred             ----------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC
Confidence                      111235788999999986543  788999999999999999999999754322 1 111 1223344567


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ..+++++++++.+||+.+|.+|||+     .+++.||||
T Consensus       235 ~~~~~~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~  268 (268)
T cd06624         235 ESLSAEAKNFILRCFEPDPDKRASA-----HDLLQDPFL  268 (268)
T ss_pred             cccCHHHHHHHHHHcCCCchhCCCH-----HHHHhCCCC
Confidence            7899999999999999999999999     899999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.2e-43  Score=323.39  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=206.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ........+|+.+++.++||||+++++++....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            56899999999999999999999999999999998654322 222233456899999999999999999886543     


Q ss_pred             ---eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          119 ---SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       119 ---~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                         ..++||||+.+ +|.+.+.+. ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence               46999999975 888877665 3689999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--  271 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--  271 (366)
                      ........      ........++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+.......+....  
T Consensus       169 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         169 FSLSKNSK------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             ccCCcccC------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            64432111      11122345788899999886644 7889999999999999999999998776544332221100  


Q ss_pred             -----------------CCCCC-------------CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 -----------------IRFPN-------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 -----------------~~~~~-------------~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                       ..++.             ..+..+.+||.+||+.||.+|||+     ++++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~-----~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA-----DTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH-----HHHhcCCCC
Confidence                             01111             135678899999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.2e-43  Score=318.99  Aligned_cols=248  Identities=31%  Similarity=0.512  Sum_probs=203.6

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeC--CeEEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT--FSLYMA  123 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~iv  123 (366)
                      |++.+.||+|+||.||+|.+..++..||+|.++....... . .....|+..++++. |+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999876532222 1 22335777888774 99999999999987  889999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+.+ +|.+.+... +.+++.+++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++.......   
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence            999975 888877764 56899999999999999999999999999999999999999 999999999987654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc------------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA------------  269 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------------  269 (366)
                              ......++..|+|||.+. +..++.++|+||+||++|+|++|..||.+.+..+....+..            
T Consensus       154 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
T cd07831         154 --------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK  225 (282)
T ss_pred             --------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence                    111345788999999764 45578899999999999999999999988776554443321            


Q ss_pred             ------CCCCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          270 ------RDIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       270 ------~~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                            ....+|           ..++.++.++|.+||++||++||++     ++++.||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-----~~~l~~~~~  282 (282)
T cd07831         226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA-----KQALRHPYF  282 (282)
T ss_pred             hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH-----HHHhhCCCC
Confidence                  011111           2468999999999999999999999     899999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-43  Score=320.40  Aligned_cols=254  Identities=27%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCe----
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS----  119 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~----  119 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.+. |+||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            4799999999999999999999999999999988764322 222345667999999995 6999999999887665    


Q ss_pred             -EEEEEeecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEecCCc
Q 017775          120 -LYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSV  192 (366)
Q Consensus       120 -~~iv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a  192 (366)
                       .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||.+
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 888887653     34799999999999999999999999999999999999998 889999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      .......          .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+....
T Consensus       159 ~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  228 (295)
T cd07837         159 RAFSIPV----------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL  228 (295)
T ss_pred             eecCCCc----------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            7553321          01112246788999998765 457889999999999999999999998876655444332210


Q ss_pred             -----C------------CC-----------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          272 -----I------------RF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       272 -----~------------~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                           .            .+           ...+++++.+||.+||..||.+||++     .+++.||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~-----~eil~~~~~~  295 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-----KAALTHPYFD  295 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH-----HHHhcCCCcC
Confidence                 0            00           12478899999999999999999999     8999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-43  Score=328.47  Aligned_cols=262  Identities=27%  Similarity=0.402  Sum_probs=219.5

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----eE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~  120 (366)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++.+..     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            58999999999999999999999999999999876432 2333455777999999999999999999988765     79


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |++|||+.+ +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+........
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999985 8999998877899999999999999999999999999999999999999999999999999987654321


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-------  272 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------  272 (366)
                      .       ........++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||.+.+..+....+.....       
T Consensus       159 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         159 E-------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             c-------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            0       0112234678899999999887 789999999999999999999999988877665554433110       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          273 ------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       273 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                              .....++.++.++|.+||+.+|.+||++     ++++.||||+++.-+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~~~~~~  299 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA-----DEALAHPYLAQLHDPE  299 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH-----HHHHhCccHHhhcccc
Confidence                                    0112368899999999999999999999     8999999999765433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-43  Score=328.78  Aligned_cols=259  Identities=28%  Similarity=0.418  Sum_probs=211.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----C
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  118 (366)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|.+......... .....+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45799999999999999999999999999999998764322222 33456799999999999999999887644     3


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+++||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999996 589999988888999999999999999999999999999999999999999999999999998765332


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc--------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  269 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------  269 (366)
                      .          .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+..        
T Consensus       162 ~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         162 G----------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             c----------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            1          11123467889999998764 4588999999999999999999999987654332221110        


Q ss_pred             ------------------C--CC---CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          270 ------------------R--DI---RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       270 ------------------~--~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                        .  ..   .....+++++.+||++||+.||++|||+     +++++||||..+.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~-----~ell~h~~~~~~~~  299 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV-----EEALAHPYLASLHD  299 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH-----HHHHcCcchhhhcC
Confidence                              0  00   0123578999999999999999999998     89999999987643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.3e-43  Score=310.86  Aligned_cols=255  Identities=32%  Similarity=0.564  Sum_probs=220.7

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMA  123 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~iv  123 (366)
                      +|...+.||+|++|.||+|.+..++..|++|++...... ......+.+|+..+++++|+||+++++.+.+.  ..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999998765332 34456678899999999999999999999988  899999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  157 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--  157 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence            999999999999988878999999999999999999999999999999999999999999999999998876554211  


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHh--cCCCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRII--ARDIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~--~~~~~~~~~~s~  280 (366)
                            .......++..|+|||.+.+...+.++|+||||+++|+|++|..||.... .......+.  ......|..++.
T Consensus       158 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd06606         158 ------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE  231 (260)
T ss_pred             ------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCH
Confidence                  01123457889999999988889999999999999999999999998765 333333333  234456778899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .+.++|.+||+.||++||++     .+++.||||
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  260 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTA-----DELLQHPFL  260 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCH-----HHHhhCCCC
Confidence            99999999999999999999     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.3e-43  Score=317.43  Aligned_cols=254  Identities=30%  Similarity=0.495  Sum_probs=218.2

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      -|++.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++||||+++++.+.+....++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47889999999999999999999999999998865422  2234557789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |+++++|.+++.+ +.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++........     
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-----  156 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-----  156 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence            9999999998865 4689999999999999999999999999999999999999999999999999876543211     


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARD  284 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~  284 (366)
                           ......++..|+|||.+.+...+.++|+||+||++|+|++|..||...........+.... ..++..++.++.+
T Consensus       157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06641         157 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE  231 (277)
T ss_pred             -----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence                 1123457888999999988888899999999999999999999998877666555554432 3355678999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ++.+||+.+|.+||++     .++++||||...
T Consensus       232 ~i~~~l~~~p~~Rp~~-----~~~l~~~~~~~~  259 (277)
T cd06641         232 FVEACLNKEPSFRPTA-----KELLKHKFIVRF  259 (277)
T ss_pred             HHHHHccCChhhCcCH-----HHHHhCHHHhhh
Confidence            9999999999999998     899999999854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-43  Score=321.92  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=210.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++.+.||+|++|.||+|.++.+|+.||+|.+...... ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            46899999999999999999999999999999998664322 22334566799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+++ +|.+.+.....  +++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++....... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-  157 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-  157 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence            999975 88888766533  578899999999999999999999999999999999985 4679999999987553321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--------  271 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------  271 (366)
                               .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||...+..+...++....        
T Consensus       158 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        158 ---------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             ---------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence                     011123567899999988664 57889999999999999999999998776655444432100        


Q ss_pred             -------------CC--------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          272 -------------IR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       272 -------------~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                   ..        ....+++++.+++.+||+.||++||++     .+++.||||.+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----~~~l~~~~~~~~~  291 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-----RAALEHEYFKDLG  291 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH-----HHHhcCchHhHHh
Confidence                         00        123478899999999999999999998     8999999998754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-43  Score=313.17  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=210.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      +..+|++.+.||+|+||.||++..+. +..+|+|.+.....    ....+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            45789999999999999999998754 56899998764322    23446779999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|||+++++|.+++... +.+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||.+.........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999998754 56899999999999999999999999999999999999999999999999998765332211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s  279 (366)
                      .         .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+....+..+. ...|...+
T Consensus       157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  227 (256)
T cd05114         157 S---------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS  227 (256)
T ss_pred             c---------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence            0         112234567999999988889999999999999999999 999999888877777776653 33466788


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .++.+++.+||+.||++||++     ++++.
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~-----~~l~~  253 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTF-----AELLR  253 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            999999999999999999999     66653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.1e-43  Score=310.92  Aligned_cols=253  Identities=31%  Similarity=0.603  Sum_probs=221.9

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||++.+..++..|++|++...... ......+.+|+++++.++|+|++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999999999999998765332 2344557779999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          126 SCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       126 ~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ++++++|.+++.+.    ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999999764    679999999999999999999999999999999999999999999999999987654432  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSD  280 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~  280 (366)
                              .......|++.|+|||...+..++.++|+||+|+++++|++|..||...+.......+.... ...|..++.
T Consensus       158 --------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd08215         158 --------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS  229 (258)
T ss_pred             --------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCH
Confidence                    11223467889999999988889999999999999999999999998887777666665543 345667899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++.+++.+||..+|++||++     .+++.||||
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  258 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSI-----AQILQSPFI  258 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCH-----HHHhcCCCC
Confidence            99999999999999999999     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.3e-43  Score=318.31  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+|.+.+.||+|+||.||+|.+..+|..||+|.+.....  ........+|+.+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999865432  12223456789999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+.+ +|.+.+.. .+.+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  157 (291)
T cd07870          82 FEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---  157 (291)
T ss_pred             EecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence            999964 77766654 3568899999999999999999999999999999999999999999999999987543221   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcC----------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIAR----------  270 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~----------  270 (366)
                             .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... +....+...          
T Consensus       158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence                   111233568899999998754 4788999999999999999999999765432 222211100          


Q ss_pred             ----C---------CCCC---------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ----D---------IRFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ----~---------~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                          .         ...+         ...+.++.+++.+||+.||++|||+     .+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~-----~~~l~h~~~  291 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA-----QDALLHPYF  291 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH-----HHHhcCCCC
Confidence                0         0000         0135789999999999999999999     899999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.1e-43  Score=314.86  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=210.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||+|++..+|+.||+|.+.............+.+|+.+++.++||||+++++++.+.+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            36899999999999999999999999999999988764333444455677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3458999999999999999999999999999999999999999999999999988654321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC--HHHHHHHHhcCCC-CC-C
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIARDI-RF-P  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~-~~-~  275 (366)
                      .          ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....  .......+..... .. +
T Consensus       161 ~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd08228         161 T----------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT  230 (267)
T ss_pred             H----------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCCh
Confidence            1          1113457889999999988888999999999999999999999996543  2334444333221 11 2


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..++..+.+++.+||+.+|++||++     .+++.
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~-----~~vl~  260 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDI-----GYVHQ  260 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCH-----HHHHH
Confidence            3578899999999999999999999     66664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-43  Score=350.89  Aligned_cols=258  Identities=26%  Similarity=0.339  Sum_probs=208.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999999999765444444455677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          124 LESCEGGELFDQITSK-----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-----------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      |||++|++|.+++.+.           ..++...+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23456778899999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCC--------CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHH
Q 017775          193 KPMQDSRITVLPN--------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF  264 (366)
Q Consensus       193 ~~~~~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  264 (366)
                      .............        ..........+||+.|+|||.+.+..++.++||||+||++|+|++|..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            8763221110000        00111223457999999999999999999999999999999999999999875544332


Q ss_pred             HHH-hcCCCC--CCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          265 QRI-IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       265 ~~i-~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ... ......  ....+++.+.+++.+||+.||++|++..
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~  280 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSV  280 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence            221 111111  1235789999999999999999998763

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-43  Score=319.17  Aligned_cols=253  Identities=19%  Similarity=0.313  Sum_probs=213.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            4678999999999999999999874     346789999986542  222345678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC
Q 017775          118 FSLYMALESCEGGELFDQITSKG--------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~--------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~  183 (366)
                      ...+++|||+++++|.+++...+              .+++.++..++.|++.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              3788999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  262 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  262 (366)
                      ++|+|||++.........        .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EEECCcccceecccCcce--------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999998754332111        01112345678999999999899999999999999999998 999998888877


Q ss_pred             HHHHHhcCCCC-CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          263 IFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       263 ~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ....+..+... .+..++.++.+++++||+.||++||++     .+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~eil~  276 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI-----KDIHE  276 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            77777665443 456789999999999999999999999     56653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=365.31  Aligned_cols=259  Identities=32%  Similarity=0.568  Sum_probs=226.1

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      -+|+-+..||.|.||.||-|.+.++|+..|+|-++..... ......+.+|..++..++|||+|++|++-.+.+.++|.|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4788899999999999999999999999999988754333 333345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |||.||+|.+.+...+..+|...+.+..|++.|+.|||++||+||||||.||+++.+|.+|++|||.|..+..+....  
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~-- 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM-- 1391 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC--
Confidence            999999999999887778888899999999999999999999999999999999999999999999999887663221  


Q ss_pred             CCCCCCCccccccCCCCCCceeecCC---CCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhcC-CCCCCCCCC
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                          +.....+.||+.|||||++.+.   ....+.||||||||+.||+||+.||.. ++++.++..+-.+ .+++|..+|
T Consensus      1392 ----~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1392 ----PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred             ----CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhh
Confidence                1234477899999999998754   467799999999999999999999964 5666777666554 567899999


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ++.++||.+||+.||++|+++     .|++.|.|=+
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~-----~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTA-----SQLLEHAFGK 1498 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHH-----HHHHHhhccc
Confidence            999999999999999999988     7899998855

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4e-43  Score=317.85  Aligned_cols=254  Identities=18%  Similarity=0.327  Sum_probs=211.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +.+.+|++.+.||+|+||.||+|...    .++..+++|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            45678999999999999999999853    456789999986532  233345577899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          118 FSLYMALESCEGGELFDQITSK-----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      ...|++|||+++++|.+++...                 ..+++.++..++.|++.||.|||++|++||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998532                 23788899999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      ++.+||+|||++..........        ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYR--------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             CCcEEeccccccccccCCccee--------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999998664332111        1122345677999999988889999999999999999998 999998877


Q ss_pred             HHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          260 EWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       260 ~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .....+.+... ....+..+++++.+++.+||+.||.+||++     .+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~~i~~  278 (283)
T cd05090         232 NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF-----KDIHT  278 (283)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHH
Confidence            76666655443 344567789999999999999999999998     56654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-43  Score=323.42  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=216.8

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..|+....||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.++|||++++++.+...+..|+++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            34556778999999999999999999999999986542   223345677999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|..++.. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......     
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-----  171 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-----  171 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-----
Confidence            99999999987755 468999999999999999999999999999999999999999999999999987543321     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA  281 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~s~~  281 (366)
                           .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+....   ...+..++.+
T Consensus       172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (297)
T cd06659         172 -----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV  246 (297)
T ss_pred             -----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHH
Confidence                 11123568889999999988889999999999999999999999998877766665554332   2233467899


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +.++|++||+.+|.+||++     .+++.||||....
T Consensus       247 l~~~i~~~l~~~P~~Rps~-----~~ll~~~~~~~~~  278 (297)
T cd06659         247 LRDFLERMLTREPQERATA-----QELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHHHhcCCcccCcCH-----HHHhhChhhccCC
Confidence            9999999999999999998     8999999998554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-43  Score=325.57  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=192.1

Q ss_pred             eeeeeecCceEEEEEEECC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe--eCCeEEEEEe
Q 017775           50 GKIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMALE  125 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~iv~e  125 (366)
                      +..||+|+||.||+|.++.  ++..||+|.+....     ....+.+|+.+++.++||||+++++++.  ....+++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999999754  66889999886532     1233567999999999999999999885  3567899999


Q ss_pred             ecCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----CCCCCEEEEecCCc
Q 017775          126 SCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSV  192 (366)
Q Consensus       126 ~~~g~~L~~~l~~~---------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli----~~~~~vkL~Dfg~a  192 (366)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9976 888777531         248899999999999999999999999999999999999    45679999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHH---------
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL---------  262 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------  262 (366)
                      +........       ........||+.|+|||.+.+. .++.++||||+||++|+|++|.+||.......         
T Consensus       160 ~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07867         160 RLFNSPLKP-------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD  232 (317)
T ss_pred             eccCCCccc-------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHH
Confidence            866433211       1122345689999999998764 47889999999999999999999997543210         


Q ss_pred             HHHHHhc----------------------------CCC----------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCC
Q 017775          263 IFQRIIA----------------------------RDI----------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGG  304 (366)
Q Consensus       263 ~~~~i~~----------------------------~~~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~  304 (366)
                      ....+..                            ...          ......+..+.+||.+||+.||.+|||+    
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~----  308 (317)
T cd07867         233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS----  308 (317)
T ss_pred             HHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH----
Confidence            0000000                            000          0011235678999999999999999999    


Q ss_pred             hHhhhcCCCC
Q 017775          305 YAVLKMHPFF  314 (366)
Q Consensus       305 ~~~~l~hp~f  314 (366)
                       ++++.||||
T Consensus       309 -~e~l~hp~f  317 (317)
T cd07867         309 -EQALQDPYF  317 (317)
T ss_pred             -HHHhcCCCC
Confidence             899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=326.04  Aligned_cols=259  Identities=25%  Similarity=0.410  Sum_probs=208.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----C
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  118 (366)
                      .++|++.+.||+|++|.||+|.+..+|+.||+|.+....  .......+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            468999999999999999999999999999999986421  222334466799999999999999999876543     3


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+++||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999975 88887754 46999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc--------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  269 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------  269 (366)
                      ...       ........|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+.......+..        
T Consensus       160 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         160 HDH-------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             ccc-------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            111       011223568899999998654 5688899999999999999999999977654332222110        


Q ss_pred             -------C-----------CCC-----CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          270 -------R-----------DIR-----FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       270 -------~-----------~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                             .           ...     ....+++++.+|+.+||+.||++|||+     .+++.||||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~e~l~hp~~~~~~  299 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV-----EEALAHPYLEQYH  299 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH-----HHHhcCccccccC
Confidence                   0           000     012467889999999999999999999     8999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.7e-43  Score=313.13  Aligned_cols=253  Identities=31%  Similarity=0.569  Sum_probs=216.8

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|.+.+.||+|+||.||+|.++.+|..+|+|.+....... .....+.+|+.+++.++|+||+++++.+.+....++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999987653322 233456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCccccc
Q 017775          126 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |+++++|.+++.+..  .+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence            999999999987653  479999999999999999999999999999999999999886 46999999987654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDA  281 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~  281 (366)
                             .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+..... ..+..++.+
T Consensus       157 -------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (257)
T cd08225         157 -------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD  229 (257)
T ss_pred             -------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHH
Confidence                   111233578899999999888899999999999999999999999988777666655554433 345568899


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +.++|.+||+.+|++|||+     .+++.||||
T Consensus       230 ~~~~i~~~l~~~p~~Rpt~-----~~ll~~~~~  257 (257)
T cd08225         230 LRSLISQLFKVSPRDRPSI-----TSILKRPFL  257 (257)
T ss_pred             HHHHHHHHhccChhhCcCH-----HHHhhCCCC
Confidence            9999999999999999999     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=286.88  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=218.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..|.-.++||+|.||+|+++++.++++.||+|.++.+... +.......+|+-+++.++|.|||+++++...+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            4678889999999999999999999999999999876432 333345667999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+. +|..++..- |.++.+.++.++.|++.||.|+|++++.|||+||.|.+|+.+|.+||+|||+++.++-.-... 
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy-  158 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY-  158 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence            99976 999988764 779999999999999999999999999999999999999999999999999999776542111 


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC----------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD----------  271 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~----------  271 (366)
                               ...+.|.+|++|.++.+.. |+...|+||.|||+.|+.. |.+.|.+.+-.+++.+|...-          
T Consensus       159 ---------saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  159 ---------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             ---------eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence                     1236789999999988766 8999999999999999997 888899999888888875410          


Q ss_pred             ----------CCCC---------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          272 ----------IRFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       272 ----------~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                +.+|         +.++..-++|++++|.-+|.+|++|     +..++||||...
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa-----eaalqhpyf~d~  289 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA-----EAALQHPYFSDF  289 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH-----HHHhcCcccccc
Confidence                      0011         1245668999999999999999999     889999999864

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.2e-43  Score=318.42  Aligned_cols=251  Identities=26%  Similarity=0.425  Sum_probs=208.8

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||.|++|.||+|.+..+|..||+|.++....  ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            58999999999999999999999999999999876532  2223445679999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          126 SCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       126 ~~~g~~L~~~l~~~---~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |+.+ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......   
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence            9986 888888754   358999999999999999999999999999999999999999999999999987553321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  271 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------  271 (366)
                             .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+..+....+....          
T Consensus       155 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         155 -------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             -------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence                   011123567889999988654 47889999999999999999999998877655444432110          


Q ss_pred             --------CC-----------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 --------IR-----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 --------~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                              ..           .....++++++++.+||+.||.+||++     .++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-----~~~l~~~~f  284 (284)
T cd07836         228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-----HDALQHPWF  284 (284)
T ss_pred             HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence                    00           112457889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2e-43  Score=321.52  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=216.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||++.+..++..|++|.+...   .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            47899999999999999999999989999999998643   222345567799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +||+++++|.+++.+. .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........   
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---  170 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---  170 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence            9999999999998764 588999999999999999999999999999999999999999999999998875533211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc-CC--CCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RD--IRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~--~~~~~~~s~  280 (366)
                             ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+.......+.. ..  ...+..++.
T Consensus       171 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd06647         171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  243 (293)
T ss_pred             -------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence                   11234578889999999888889999999999999999999999987665443332221 11  223445788


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.++|++||+.+|++||++     .+++.|+||+..
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~-----~~il~h~~~~~~  275 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSA-----KELLQHPFLKIA  275 (293)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCHHHhcC
Confidence            99999999999999999998     899999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.5e-44  Score=323.74  Aligned_cols=256  Identities=31%  Similarity=0.492  Sum_probs=217.8

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.++|+||+++++.+.+.+..|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            45788899999999999999999999999999987542  2233456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........    
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----  156 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----  156 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch----
Confidence            99999999998865 4689999999999999999999999999999999999999999999999999876543211    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  283 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  283 (366)
                            ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+... ....+..++.++.
T Consensus       157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06642         157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK  230 (277)
T ss_pred             ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH
Confidence                  112335788999999999888999999999999999999999999876665554444332 2234456788999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ++|.+||+.+|++||++     .+++.||||....
T Consensus       231 ~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~  260 (277)
T cd06642         231 EFVEACLNKDPRFRPTA-----KELLKHKFITRYT  260 (277)
T ss_pred             HHHHHHccCCcccCcCH-----HHHHHhHHHHHHh
Confidence            99999999999999999     8999999997543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.2e-43  Score=312.16  Aligned_cols=240  Identities=25%  Similarity=0.414  Sum_probs=202.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      +.||+|+||.||+|.++.+|+.||+|.+....  .......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46899999999999999999999999876532  2334456778999999999999999999999999999999999999


Q ss_pred             chHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          131 ELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       131 ~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      +|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........       
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-------  151 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-------  151 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence            9999987654 58999999999999999999999999999999999999999999999999987544321110       


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  287 (366)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... ....+..++..+.+|+.
T Consensus       152 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (252)
T cd05084         152 -TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME  230 (252)
T ss_pred             -cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHH
Confidence             0001123456999999988889999999999999999997 99999877766655554432 34566778999999999


Q ss_pred             HhhcCCCCCCCCC
Q 017775          288 RLLDVDPSGRPGA  300 (366)
Q Consensus       288 ~~L~~dP~~Rps~  300 (366)
                      +||+.||++|||+
T Consensus       231 ~~l~~~p~~Rps~  243 (252)
T cd05084         231 RCWEYDPGQRPSF  243 (252)
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999999

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=316.77  Aligned_cols=255  Identities=30%  Similarity=0.538  Sum_probs=214.1

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEeeCCeEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~i  122 (366)
                      .|++.+.||+|+||.||+|.+..+|..||+|.++...  .......+.+|+.+++.++   |||++++++++.+....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4888999999999999999999999999999987542  2223345677888888886   9999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      +|||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence            9999999999998866 479999999999999999999999999999999999999999999999999988664432   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCC-CCC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN-YFS  279 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~-~~s  279 (366)
                             .......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+.... ..++. .++
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T cd06917         156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS  228 (277)
T ss_pred             -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCC
Confidence                   11123468889999998764 457889999999999999999999998776654443332221 22233 378


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .++.+++.+||+.||++||++     .+++.|+||+...
T Consensus       229 ~~~~~~i~~~l~~~p~~R~~~-----~~il~~~~~~~~~  262 (277)
T cd06917         229 KLLREFVAACLDEEPKERLSA-----EELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHHHHcCCCcccCcCH-----HHHhhChHhhccc
Confidence            899999999999999999998     8999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=312.03  Aligned_cols=253  Identities=20%  Similarity=0.314  Sum_probs=212.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..++|++.+.||+|+||.||+|.++.+   ...||+|.+....  .......+..|+.+++.++|+||+++++.+.+.+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            457899999999999999999998654   4579999886542  23334456779999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+++|||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999998764 46899999999999999999999999999999999999999999999999999877522


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....        ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... ..+.+.
T Consensus       160 ~~~~--------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd05033         160 EATY--------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM  231 (266)
T ss_pred             ccce--------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            1110        1111234568999999998889999999999999999998 99999887777776666554 334566


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+..+.+++.+||+.+|++||++     .++++
T Consensus       232 ~~~~~l~~li~~cl~~~p~~Rp~~-----~ei~~  260 (266)
T cd05033         232 DCPSALYQLMLDCWQKDRNERPTF-----SQIVS  260 (266)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            789999999999999999999999     66654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.9e-43  Score=316.77  Aligned_cols=259  Identities=29%  Similarity=0.478  Sum_probs=222.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..+.|++.+.||.|++|.||+|.+..++..|++|++.....    ....+..|+.+++.++|+|++++++.+......|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            35568999999999999999999998999999999876422    34556779999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ++||++|++|.+++...+ .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            999999999999998876 799999999999999999999999999999999999999999999999998765433210 


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYF  278 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~  278 (366)
                               ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.....   ..+..+
T Consensus       172 ---------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (286)
T cd06614         172 ---------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW  242 (286)
T ss_pred             ---------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence                     11233467889999999888899999999999999999999999988777655555443322   223347


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      +.++.++|.+||+.+|.+||++     .+++.|+||....|+
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~~~~~  279 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSA-----EELLQHPFLKKACPK  279 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCH-----HHHhhChHhhccCch
Confidence            8999999999999999999999     899999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-43  Score=316.89  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=208.7

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |++.+.||.|++|.||+|.++.+|..||+|++...... ......+.+|+.+++.++|+|++++++++.+.+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67889999999999999999999999999998765322 22234466799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          127 CEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       127 ~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ++ ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||.+........    
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----  154 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR----  154 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence            96 58999988765  689999999999999999999999999999999999999999999999999875533211    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC------------
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  271 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------  271 (366)
                            ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+....            
T Consensus       155 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         155 ------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             ------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence                  11122457889999987654 47889999999999999999999998776654433322110            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 -----------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                       ......++.++.++|.+||+.||.+||++     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~il~~~~~  283 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-----KAALQHPYF  283 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHhcCCCC
Confidence                             01124578899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-43  Score=320.15  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=211.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  121 (366)
                      ..++|+..+.||+|+||.||++.+..+|+.||+|.+......  .....+..|+.++.++. |+||+++++++......+
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            356788899999999999999999999999999998764322  33445677888888885 999999999999999999


Q ss_pred             EEEeecCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          122 MALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      ++|||+.+ ++.++..     ..+.+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99999865 5544332     235699999999999999999999974 9999999999999999999999999998755


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCC---CCCCCCCcccchhhhhhhhcCCCCCCCCCH-HHHHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~  271 (366)
                      ....           ......|+..|+|||.+.+.   .++.++||||+|+++|+|++|..||..... .+...++....
T Consensus       159 ~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  227 (288)
T cd06616         159 VDSI-----------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD  227 (288)
T ss_pred             ccCC-----------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC
Confidence            3321           11223578899999998766   688899999999999999999999976542 12223332221


Q ss_pred             -CCC----CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          272 -IRF----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       272 -~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                       ...    +..++.++.+|+.+||+.||++|||+     ++++.||||+...+++.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~i~~~~~~~~~~~~~~  278 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKY-----KELLEHPFIKDYEERNV  278 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhchhhcch
Confidence             111    23478999999999999999999999     89999999998776554

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=335.37  Aligned_cols=251  Identities=22%  Similarity=0.395  Sum_probs=220.0

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe--EEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF-ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS--LYMAL  124 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~iv~  124 (366)
                      ++..+||+|+|-+||+|.|..+|-.||.-.++... .......+.+..|+.+|+.|+|+||+++|++|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            66789999999999999999999999976555432 2344455678889999999999999999999987655  89999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCC-CCEEEEecCCccccCCcccc
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |.+..|+|..|.++.+.++...++.|++||++||.|||++.  |+|||||.+||+|+.+ |.|||+|+|+|..+...   
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---  199 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence            99999999999999999999999999999999999999996  9999999999999965 99999999999876543   


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCC-CCCHHHHHHHHhcCCCC--CCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIR--FPNYF  278 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~--~~~~~  278 (366)
                               .+...+|||.|||||++. ..|+..+||||+|+.+.||+|+.+||. ..+..++++++..+..+  +...-
T Consensus       200 ---------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  200 ---------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             ---------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence                     333578999999999998 679999999999999999999999995 57788899998877543  33345


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+++++||.+||.. .++|+|+     .++|.||||..-
T Consensus       270 dPevr~fIekCl~~-~~~R~sa-----~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  270 DPEVREFIEKCLAT-KSERLSA-----KELLKDPFFDED  302 (632)
T ss_pred             CHHHHHHHHHHhcC-chhccCH-----HHHhhChhhccc
Confidence            78999999999998 9999999     899999999863

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.6e-43  Score=325.42  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=208.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  117 (366)
                      ..+|++.+.||.|+||.||+|.++.+|..||+|.+....   ......+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            478999999999999999999999999999999986653   23345577799999999999999998776543      


Q ss_pred             --------CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEe
Q 017775          118 --------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIAD  188 (366)
Q Consensus       118 --------~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~D  188 (366)
                              ...|+||||+.+ +|.+++.. +.+++..++.++.||++||.|||++||+||||||+||+++. ++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    358999999975 89888764 46999999999999999999999999999999999999984 56789999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      ||.+..........       .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus       159 fg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         159 FGLARIVDPHYSHK-------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             cccceecCCccccc-------cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99987653321110       01112357889999998654 55888999999999999999999999877665544443


Q ss_pred             hcCC-------------------------C-----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          268 IARD-------------------------I-----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       268 ~~~~-------------------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ....                         .     .....++.++.+||.+||+.||.+|||+     .+++.||||+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~h~~~~~~  306 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-----EEALMHPYMSCY  306 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH-----HHHhCCCccccc
Confidence            2210                         0     0123578899999999999999999999     899999999865


Q ss_pred             Cc
Q 017775          318 DW  319 (366)
Q Consensus       318 ~~  319 (366)
                      .+
T Consensus       307 ~~  308 (342)
T cd07854         307 SC  308 (342)
T ss_pred             cC
Confidence            43

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.3e-45  Score=312.05  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=208.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-CC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~  118 (366)
                      +..|+..+.||+|.||.||+|..++++.    .+|+|.++.+........ ..-+|+.+++.++|||++.+..++.. +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~-SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISM-SACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCH-HHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            6689999999999999999997765543    689999876532222222 34459999999999999999999887 78


Q ss_pred             eEEEEEeecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC----CCEEEEec
Q 017775          119 SLYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADF  189 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~----~~vkL~Df  189 (366)
                      .+++++||.+. +|+..+.-+     +.++...++.+++||+.|+.|||++=|+||||||.|||+..+    |.|||+|+
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999987 999998643     358999999999999999999999999999999999999987    89999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHH-------
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEW-------  261 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------  261 (366)
                      |+++.+...-....       .....+.|.+|+|||.+.|.. |+.+.|+|++|||+.||+|-++.|.+....       
T Consensus       181 GlaR~~~~plkpl~-------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  181 GLARLFNNPLKPLA-------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             cHHHHhhccccccc-------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            99998866532211       122457899999999988765 999999999999999999999999764331       


Q ss_pred             --HHHHHHhcC-------C----CCCC--------------------------CCCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          262 --LIFQRIIAR-------D----IRFP--------------------------NYFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       262 --~~~~~i~~~-------~----~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                        +.+.+|.+-       .    ..+|                          ..-++...+|+.+||+.||.+|+|+  
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta--  331 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA--  331 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH--
Confidence              233333220       0    0011                          1125558899999999999999999  


Q ss_pred             CChHhhhcCCCCCCC
Q 017775          303 GGYAVLKMHPFFKGI  317 (366)
Q Consensus       303 ~~~~~~l~hp~f~~~  317 (366)
                         +++++|+||..-
T Consensus       332 ---~qAleh~yF~~d  343 (438)
T KOG0666|consen  332 ---EQALEHPYFTED  343 (438)
T ss_pred             ---HHHhcccccccC
Confidence               889999999854

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=313.61  Aligned_cols=254  Identities=20%  Similarity=0.317  Sum_probs=212.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|++.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4578999999999999999999988643     4789999986542  22233456779999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEE
Q 017775          117 TFSLYMALESCEGGELFDQITSKG----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  186 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~----------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL  186 (366)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+++++||||||+||+++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999986532          3678899999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHH
Q 017775          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ  265 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  265 (366)
                      +|||+++........        .......++..|+|||.+.+..++.++||||||+++|++++ |..||.+.+..+..+
T Consensus       161 ~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         161 GDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             CCcccchhhccCccc--------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            999998765433211        01122345778999999988889999999999999999998 999998888777776


Q ss_pred             HHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          266 RIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       266 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+... ....|...+.++.+++.+||+.+|++|||+     .+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~l~~  273 (277)
T cd05032         233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTF-----LEIVS  273 (277)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence            66644 345677789999999999999999999998     66653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.6e-43  Score=314.66  Aligned_cols=253  Identities=19%  Similarity=0.304  Sum_probs=209.8

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999999864     245679999885432  122234466799999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEE
Q 017775          118 FSLYMALESCEGGELFDQITSKG----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~----------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                      ...++||||+++++|.+++.+.+          .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999987532          25678899999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHH
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  266 (366)
                      |||++..........        ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.......
T Consensus       162 dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         162 DFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCCccccCCcceee--------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999987654332111        0112245678999999988889999999999999999999 7999998888777766


Q ss_pred             HhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          267 IIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       267 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +.... ...+...++.+.+++.+||+.||++|||+     .+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~  273 (277)
T cd05062         234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIIS  273 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            65543 35567789999999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-42  Score=314.09  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=210.8

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYM  122 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i  122 (366)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++.++||||+++++++.+  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            479999999999999999999999999999999875422  2334557789999999999999999998864  447899


Q ss_pred             EEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          123 ALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    345899999999999999999999999999999999999999999999999998754322


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC-----CHHHHHHHHhcCCC-
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIARDI-  272 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~-  272 (366)
                      .            .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...     ...+....+..... 
T Consensus       159 ~------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd06621         159 L------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP  226 (287)
T ss_pred             c------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence            1            11234678899999999888999999999999999999999999765     22333333333211 


Q ss_pred             CCC------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 RFP------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 ~~~------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..+      ..+++++.++|.+||..||++|||+     .+++.||||++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~~~  273 (287)
T cd06621         227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP-----WDMLEHPWIKAQM  273 (287)
T ss_pred             hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCH-----HHHHhCccccccc
Confidence            111      2356789999999999999999999     8999999997654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.8e-43  Score=324.21  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=210.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      .++|++++.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++|+||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            6689999999999999999999999999999999865422 2223345667999999999999999999987643     


Q ss_pred             -eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 -~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                       .+++||||+ |++|.+++.. +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             468999999 6689888764 4699999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----  272 (366)
                      .             .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||.+.+.......+.....    
T Consensus       171 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         171 E-------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             C-------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            1             113356889999999876 4578899999999999999999999987765544433322110    


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                                 .....+++++.++|.+||+.||++|||+     .+++.||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~-----~~~l~~~~~~~~~  305 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA-----AEALAHPYFEEFH  305 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH-----HHHhcCccHhhhc
Confidence                                       1123578889999999999999999999     8999999998764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-43  Score=311.43  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=209.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ...+|++.+.||+|+||.||+|.++ ++..+|+|++.....    ....+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            3467999999999999999999885 467899999865322    22345669999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++........
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999999998764 46899999999999999999999999999999999999999999999999998765332111


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                      .         .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+... ....|...+
T Consensus       157 ~---------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05059         157 S---------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP  227 (256)
T ss_pred             c---------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence            0         001123457999999998889999999999999999999 89999887777766666544 345567789


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .++.+++.+||+.+|++|||+     .+++.
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~-----~~~l~  253 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAF-----KKLLS  253 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            999999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-45  Score=302.08  Aligned_cols=263  Identities=28%  Similarity=0.407  Sum_probs=209.0

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--  116 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--  116 (366)
                      .-.++-++|++.+.||+|||+-||+++...++..||+|.+.+..   .+..+...+|+...++++|||+++++++...  
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            33567889999999999999999999999999999999998863   4555667789999999999999999866543  


Q ss_pred             ---CCeEEEEEeecCCCchHHHHHhC---C-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEEE
Q 017775          117 ---TFSLYMALESCEGGELFDQITSK---G-HLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       117 ---~~~~~iv~e~~~g~~L~~~l~~~---~-~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL~  187 (366)
                         ....|++++|...|+|.+.+.+.   + .++|.++..++.+++.||++||+..  ++||||||.||++++.+..+|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence               34499999999999999998764   3 6999999999999999999999999  9999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH--H
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--L  262 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~  262 (366)
                      |||.+....-.-...... ..-.....-.+|..|+|||.+.   +...+.++|||||||++|.|+.|..||+..-..  .
T Consensus       172 D~GS~~~a~i~i~~~~~a-~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQA-LRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             eccCccccceEeechHHH-HHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            999987553221000000 0000111224688999999985   444788999999999999999999999542110  1


Q ss_pred             HHHHHhcCCCCCCC--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          263 IFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       263 ~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +.-.+..+...+|.  .+|+.+.+||..||+.||.+||++     .+++.
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i-----~~ll~  295 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI-----PELLS  295 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH-----HHHHH
Confidence            11223445556664  489999999999999999999999     56664

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1e-42  Score=314.25  Aligned_cols=255  Identities=21%  Similarity=0.366  Sum_probs=212.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|.+.+.||+|++|.||+|.+..     ++..|++|.+....  .......+..|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            345789999999999999999999977     77889999876532  22233456779999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEE
Q 017775          117 TFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKI  186 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~-------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL  186 (366)
                      ....++||||++|++|.+++.+.+       .+++..+..++.||+.||.|||+++++||||||+||+++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999999997653       488999999999999999999999999999999999998765   6999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHH
Q 017775          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ  265 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  265 (366)
                      +|||+++.........        .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+......
T Consensus       161 ~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~  232 (277)
T cd05036         161 ADFGMARDIYRASYYR--------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME  232 (277)
T ss_pred             ccCccccccCCcccee--------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999998663322110        0112223457999999988889999999999999999997 999999887776665


Q ss_pred             HHhc-CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          266 RIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       266 ~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+.. .....|..++..+.+++.+||+.||++||++     .+++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~-----~~vl~~  274 (277)
T cd05036         233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF-----ATILER  274 (277)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence            5543 3455677889999999999999999999999     777765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-42  Score=310.29  Aligned_cols=245  Identities=22%  Similarity=0.347  Sum_probs=207.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|++|.||+|.+. ++..||+|.+....    .....+.+|+.+++.++|+||+++++.+.+.+..+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45789999999999999999999864 56789999876532    22456778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++|||+.+++|.+++.+.  ..++...+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999998763  458899999999999999999999999999999999999999999999999998664332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ..         ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ..+.+..
T Consensus       158 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05072         158 YT---------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN  228 (261)
T ss_pred             ee---------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            11         0112235668999999988889999999999999999998 99999888777766666543 2334456


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ++.++.+++.+||+.+|++||++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~  251 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTF  251 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCH
Confidence            88999999999999999999999

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-42  Score=310.71  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|++|.||.|.+.. +..+|+|.+.....    ....+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            46789999999999999999998754 45699998865422    22446779999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|||+.+++|.+++... ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+.........
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999998764 46899999999999999999999999999999999999999999999999998765332111


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI-RFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s  279 (366)
                               ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+..... ..+...+
T Consensus       157 ---------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05113         157 ---------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLAS  227 (256)
T ss_pred             ---------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence                     1111234567999999988889999999999999999998 9999988887777666665433 3456678


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..+.+++.+||+.||.+||++     .+++.+
T Consensus       228 ~~~~~li~~cl~~~p~~Rp~~-----~~ll~~  254 (256)
T cd05113         228 EKVYAIMYSCWHEKAEERPTF-----QQLLSS  254 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCH-----HHHHHh
Confidence            999999999999999999999     677653

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-42  Score=309.07  Aligned_cols=245  Identities=19%  Similarity=0.313  Sum_probs=208.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|++|.||+|.+. ++..||+|.+.....    ....+.+|+.+++.++|+||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            45678999999999999999999875 457899999865422    2344677999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++|||+.+++|.+++....  .+++..+..++.|++.||.+||++|++||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997654  68999999999999999999999999999999999999999999999999998765321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ...         ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.......+... ....+..
T Consensus       158 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05068         158 YEA---------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG  228 (261)
T ss_pred             ccc---------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            110         011123457999999998889999999999999999999 99999988877766666543 3345667


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .+..+.+++.+||+.+|++||++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~  251 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTF  251 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCH
Confidence            89999999999999999999999

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-43  Score=320.51  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=205.7

Q ss_pred             CeeeeeeeeecCceEEEEEEECC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLY  121 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~  121 (366)
                      +|++.+.||+|++|.||+|.+..  ++..||+|.+...............+|+.+++.++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8999999999874322233334566799999999999999999999988  8899


Q ss_pred             EEEeecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC----CCCEEEEecCCc
Q 017775          122 MALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA----DGHIKIADFGSV  192 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~----~~~vkL~Dfg~a  192 (366)
                      +||||+.+ +|.+.+...     ..+++..++.++.|++.||.|||+++|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999976 777766532     26899999999999999999999999999999999999999    899999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHH---------
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL---------  262 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------  262 (366)
                      .........       ........++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.....         
T Consensus       160 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd07842         160 RLFNAPLKP-------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD  232 (316)
T ss_pred             cccCCCccc-------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence            866443211       1112234678899999987664 57889999999999999999999997654321         


Q ss_pred             HHHHHh--------------------------cCCCCCC-----------CCCCHHHHHHHHHhhcCCCCCCCCCCCCCh
Q 017775          263 IFQRII--------------------------ARDIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGY  305 (366)
Q Consensus       263 ~~~~i~--------------------------~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~  305 (366)
                      ....+.                          .....++           ...+.++.+++.+||+.||++|||+     
T Consensus       233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----  307 (316)
T cd07842         233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA-----  307 (316)
T ss_pred             HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH-----
Confidence            111110                          0011111           1567889999999999999999999     


Q ss_pred             HhhhcCCCC
Q 017775          306 AVLKMHPFF  314 (366)
Q Consensus       306 ~~~l~hp~f  314 (366)
                      .+++.||||
T Consensus       308 ~eil~~~~f  316 (316)
T cd07842         308 EEALEHPYF  316 (316)
T ss_pred             HHHhcCCCC
Confidence            899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=309.48  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=213.0

Q ss_pred             eeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeec
Q 017775           51 KIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  127 (366)
                      +.||+|+||.||+|.+...   +..|++|.+.......  ....+..|+..++.++|+|++++++++.+...++++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4789999999999999866   8999999987653322  3566778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          128 EGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       128 ~g~~L~~~l~~~---------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ++++|.+++...         ..+++.+++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         67999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ...        .......++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+... ....|.
T Consensus       159 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd00192         159 DYY--------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE  230 (262)
T ss_pred             ccc--------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            210        11223456788999999988889999999999999999999 69999998888777777643 345677


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .++.++.+++.+||+.||++|||+     .+++++
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~-----~~l~~~  260 (262)
T cd00192         231 YCPDELYELMLSCWQLDPEDRPTF-----SELVER  260 (262)
T ss_pred             cCChHHHHHHHHHccCCcccCcCH-----HHHHHh
Confidence            889999999999999999999999     777654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-42  Score=315.35  Aligned_cols=249  Identities=20%  Similarity=0.335  Sum_probs=209.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|.+.+.||+|+||.||+|.+.     .++..+++|.+...   .......+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            45678999999999999999999854     34566899987653   22333457789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          117 TFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      ....++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997643                3789999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      ++.++|+|||++.........        .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             CCcEEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999998765432211        11123346788999999998889999999999999999998 999998888


Q ss_pred             HHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          260 EWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       260 ~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ..+....+..+.. ..+...+.++.+++.+||+.||++||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  273 (291)
T cd05094         231 NTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK  273 (291)
T ss_pred             HHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHH
Confidence            7777766665543 34566789999999999999999999993

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=298.55  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=212.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceeEEEEeeCCe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~  119 (366)
                      +...++.++++.||.|+.|+|++++.+.+|...|||.+.+.....  ....+...+.++.. -.+|+||+.+++|..+..
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            445667788899999999999999999999999999998864322  22234444554443 459999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          120 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ++|.||.|.. .+..++.+ .++++|.-+-++...++.||.||.+ +||+|||+||+|||+|..|++||+|||.+-++..
T Consensus       166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            9999999854 55555554 3679999999999999999999975 5899999999999999999999999999987765


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC---CCCCCCCCcccchhhhhhhhcCCCCCCCC-CHHHHHHHHhcCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIARDIR  273 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~  273 (366)
                      ..-.           ....|-+.|||||.+.-   ..|+.++||||||++++||.||++||.+. .+.+++.++++..++
T Consensus       245 SkAh-----------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP  313 (391)
T KOG0983|consen  245 SKAH-----------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP  313 (391)
T ss_pred             cccc-----------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC
Confidence            4322           23357889999999853   35899999999999999999999999874 456777777775433


Q ss_pred             -CC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          274 -FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       274 -~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                       +|  ..+|+++.+|+..||.+|+.+||.-     .+++.|||+...+
T Consensus       314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y-----~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKY-----NKLLEHPFIKRYE  356 (391)
T ss_pred             CCCcccCcCHHHHHHHHHHhhcCcccCcch-----HHHhcCcceeecc
Confidence             22  3589999999999999999999977     8899999997544

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8e-43  Score=312.97  Aligned_cols=246  Identities=31%  Similarity=0.513  Sum_probs=207.0

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||+|.+..+|..+|+|.+.............+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            67999999999999999999999999999999887644334444456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          125 ESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       125 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999998864    34589999999999999999999999999999999999999999999999999876543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH--HHHHHHHhcCCCC--CCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARDIR--FPN  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~--~~~  276 (366)
                                ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+...  ......+......  .+.
T Consensus       162 ----------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd08229         162 ----------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD  231 (267)
T ss_pred             ----------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcc
Confidence                      11234578899999999888899999999999999999999999975443  2333333332211  224


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .++.++.+++.+||+.||++|||+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~Rpt~  255 (267)
T cd08229         232 HYSEELRQLVNMCINPDPEKRPDI  255 (267)
T ss_pred             cccHHHHHHHHHhcCCCcccCCCH
Confidence            588999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-42  Score=314.25  Aligned_cols=259  Identities=23%  Similarity=0.378  Sum_probs=214.4

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  111 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  111 (366)
                      +.-.+..++|++.+.||+|+||.||++.+...     ...+|+|.+....  .......+.+|+.+++.+ +|+||++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34456778999999999999999999987643     3689999887542  222334577799999999 799999999


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  175 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~N  175 (366)
                      +++.....++++|||+.+++|..++...                +.+++..+..++.|++.||.|||++||+||||||+|
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            9999999999999999999999998642                358899999999999999999999999999999999


Q ss_pred             eEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCC
Q 017775          176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  254 (366)
Q Consensus       176 Ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  254 (366)
                      |+++.++.+||+|||+++.+.......        ......++..|+|||.+.+..++.++||||+||++|++++ |..|
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYR--------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             EEEcCCCeEEeCcccccccccccccee--------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence            999999999999999998664432110        0111224567999999988889999999999999999997 9999


Q ss_pred             CCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          255 FKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       255 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      |.+....+....+.... ...+...+.++.+|+.+||..||++|||+     .+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~eil~~  287 (293)
T cd05053         235 YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-----KQLVED  287 (293)
T ss_pred             CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHHH
Confidence            99888777766655442 34566788999999999999999999999     666653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-42  Score=317.70  Aligned_cols=251  Identities=29%  Similarity=0.405  Sum_probs=213.3

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |...+.||+|+||.||++.+..+|..||+|.+.............+..|+.+++.++|+|++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            78899999999999999999999999999998765433444445677799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +.| +|.+.+.. ..++++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......       
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-------  178 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-------  178 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-------
Confidence            986 77777754 456899999999999999999999999999999999999999999999999987643321       


Q ss_pred             CCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYFSD  280 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~s~  280 (366)
                             ....++..|+|||.+.   ...++.++|+||+||++|+|++|..||...+.......+......  .+..+++
T Consensus       179 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (317)
T cd06635         179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD  251 (317)
T ss_pred             -------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccH
Confidence                   1335788999999873   445788999999999999999999999887766655555544322  2345788


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.+++.+||+.+|.+||++     .++++|+|+...
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~~  283 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTS-----EELLKHMFVLRE  283 (317)
T ss_pred             HHHHHHHHHccCCcccCcCH-----HHHHhChhhhcc
Confidence            99999999999999999998     899999999643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7e-43  Score=316.16  Aligned_cols=254  Identities=18%  Similarity=0.319  Sum_probs=213.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +...+|++.+.||+|+||.||+|.+..     ++..||+|+++...  .......+..|..+++.++||||+++++++.+
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            456789999999999999999998754     35789999987542  22334557789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          117 TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      ....++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||++++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999999999998532                24788889999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      ++.+||+|||+++........        .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             CCceEecccccccccccchhe--------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999998865433211        11122345678999999988889999999999999999998 899999888


Q ss_pred             HHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          260 EWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       260 ~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+....+..... ..+..++.++.+|+.+||+.+|.+||++     .+++.
T Consensus       232 ~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-----~~i~~  278 (283)
T cd05091         232 NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-----KDIHS  278 (283)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-----HHHHH
Confidence            8888877766553 4577899999999999999999999999     66654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.4e-43  Score=308.86  Aligned_cols=234  Identities=30%  Similarity=0.483  Sum_probs=198.8

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCchHHH
Q 017775           56 GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ  135 (366)
Q Consensus        56 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~  135 (366)
                      |.+|.||+|+++.+|+.||+|.+....        ....|...+....||||+++++++.+.+..+++|||++|++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999986642        122244444555799999999999999999999999999999999


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCcccc
Q 017775          136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  215 (366)
Q Consensus       136 l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~  215 (366)
                      +.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.......             ...
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------------~~~  142 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------------DGE  142 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------------ccC
Confidence            9887789999999999999999999999999999999999999999999999999876553321             122


Q ss_pred             ccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCC
Q 017775          216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPS  295 (366)
Q Consensus       216 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~  295 (366)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||........    ......+|..+++.+.++|.+||+.||+
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHH
Confidence            346679999999888889999999999999999999988765332110    1123456778999999999999999999


Q ss_pred             CCCCCCCCChHhhhcCCCC
Q 017775          296 GRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       296 ~Rps~~~~~~~~~l~hp~f  314 (366)
                      +||++.+.+++++++||||
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            9999988889999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.7e-42  Score=315.36  Aligned_cols=252  Identities=30%  Similarity=0.405  Sum_probs=212.2

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |...+.||+|+||.||+|.+..+|..|++|.+.............+.+|+.+++.++|+|++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            67788899999999999999999999999998765433444445677799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +.| +|.+++... .++++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....        
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--------  173 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--------  173 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence            975 777777653 5689999999999999999999999999999999999999999999999998763221        


Q ss_pred             CCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYFSD  280 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~s~  280 (366)
                            .....|+..|+|||.+.   +..++.++|+||+|+++|+|++|..||...+.......+......  ....++.
T Consensus       174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (313)
T cd06633         174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD  247 (313)
T ss_pred             ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence                  11346788999999974   355788999999999999999999999877765555554433221  2245788


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .+++|+.+||+.+|.+||++     .+++.||||....
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~-----~~~l~~~~~~~~~  280 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPAS-----AELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCcccCCCc
Confidence            99999999999999999999     8999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-42  Score=318.66  Aligned_cols=254  Identities=19%  Similarity=0.312  Sum_probs=208.3

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +...+|++.+.||+|+||.||+|.+..+|..    ||+|.+...  ........+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            5567899999999999999999998766654    899988643  1233345577799999999999999999998764


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ..++++||+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999999875 458899999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      ......        ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.+....+....+... ....
T Consensus       161 ~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd05108         161 ADEKEY--------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  232 (316)
T ss_pred             CCCcce--------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            332111        1111234567999999998899999999999999999997 99999887766554433322 3344


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      +...+.++.+++.+||..||.+||++     .+++.+
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~-----~~l~~~  264 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  264 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            56788999999999999999999999     556654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6e-43  Score=324.32  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee-
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD-  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-  116 (366)
                      .++|++++.||+|+||.||+|.+.     .+++.||+|++....  .......+..|+.+++.+ +|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            458999999999999999999754     345789999987542  122234466799999999 79999999998764 


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC---------------------------------------------------------
Q 017775          117 TFSLYMALESCEGGELFDQITSK---------------------------------------------------------  139 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~---------------------------------------------------------  139 (366)
                      ...++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45689999999999999988542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCcccc
Q 017775          140 ----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  215 (366)
Q Consensus       140 ----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~  215 (366)
                          ..++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+......        ......
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--------~~~~~~  235 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--------VRKGDA  235 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--------hhccCC
Confidence                25788999999999999999999999999999999999999999999999999866432211        111233


Q ss_pred             ccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHh-cC-CCCCCCCCCHHHHHHHHHhhcC
Q 017775          216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-AR-DIRFPNYFSDAARDLIDRLLDV  292 (366)
Q Consensus       216 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~-~~-~~~~~~~~s~~~~~li~~~L~~  292 (366)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+...... .. ....|...++++.+++.+||+.
T Consensus       236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence            45678999999999999999999999999999997 999998755433333322 22 2344667899999999999999


Q ss_pred             CCCCCCCCCCCChHhhhcC
Q 017775          293 DPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       293 dP~~Rps~~~~~~~~~l~h  311 (366)
                      +|++||++     .++++|
T Consensus       316 ~p~~RPs~-----~ell~~  329 (337)
T cd05054         316 NPEDRPTF-----SELVEI  329 (337)
T ss_pred             ChhhCcCH-----HHHHHH
Confidence            99999999     667654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-42  Score=317.23  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=210.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  112 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  112 (366)
                      ....++|.+++.||+|+||.||+|.+..       ++..+|+|.+....  .......+..|+.+++.+ +|+||+++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            3445789999999999999999998643       33579999987542  223344566799999998 7999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      ++.+.+..|+||||+.+++|.+++...+                .++..++..++.|++.||+|||++|++||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999999999999997642                378899999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  255 (366)
                      +++.++.+||+|||.+..........        ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhh--------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999987654321110        0011123467999999988889999999999999999998 89999


Q ss_pred             CCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          256 KDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       256 ~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+.+..+....+.... ...|...+.++.+|+.+||..+|++||++     .+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~  294 (307)
T cd05098         244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  294 (307)
T ss_pred             CcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCH-----HHHHH
Confidence            8888777666655443 35667789999999999999999999999     56654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.2e-42  Score=308.61  Aligned_cols=240  Identities=22%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             eeeecCceEEEEEEE--CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           52 IYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      .||+|+||.||+|.+  +.++..+|+|+++... ........+.+|+.+++.++|+||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            689999999999964  4678899999987543 223344567789999999999999999998764 467899999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       130 ~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      ++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++..........       
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-------  152 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-------  152 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence            9999999888889999999999999999999999999999999999999999999999999998664332110       


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  287 (366)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+..+ ..+.|..+++++.++|.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            00111234578999999988888999999999999999998 99999888777776666554 34567789999999999


Q ss_pred             HhhcCCCCCCCCC
Q 017775          288 RLLDVDPSGRPGA  300 (366)
Q Consensus       288 ~~L~~dP~~Rps~  300 (366)
                      +||+.||++||++
T Consensus       233 ~~~~~~p~~Rp~~  245 (257)
T cd05116         233 LCWTYGVDERPGF  245 (257)
T ss_pred             HHhccCchhCcCH
Confidence            9999999999999

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4e-42  Score=308.20  Aligned_cols=246  Identities=32%  Similarity=0.529  Sum_probs=207.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|.++............+.+|+.+++.++|++++++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999987543334444566778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          125 ESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       125 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||+++++|..++.+    ...+++.++..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999998864    24589999999999999999999999999999999999999999999999999876543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC--HHHHHHHHhcCC-CCCCC-
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIARD-IRFPN-  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~-~~~~~-  276 (366)
                                ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....  .......+..+. ...|. 
T Consensus       162 ----------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd08224         162 ----------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD  231 (267)
T ss_pred             ----------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChh
Confidence                      1123457888999999988889999999999999999999999996543  223333433332 22333 


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .++.++.++|.+||..+|++|||+
T Consensus       232 ~~~~~~~~~i~~cl~~~p~~Rp~~  255 (267)
T cd08224         232 HYSEELRDLVSRCINPDPEKRPDI  255 (267)
T ss_pred             hcCHHHHHHHHHHcCCCcccCCCH
Confidence            688899999999999999999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.1e-43  Score=312.24  Aligned_cols=243  Identities=21%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+|++++.||.|+||.||+|.+.. +..+++|++....   ......+..|+.+++.++|+||+++++++.+....++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            5679999999999999999999987 8999999987642   22344577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          124 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |||+++++|.+++.+.  ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999999764  45899999999999999999999999999999999999999999999999999765432111


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                                .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+... ..+.+...+
T Consensus       161 ----------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05148         161 ----------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP  230 (261)
T ss_pred             ----------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCC
Confidence                      112234567999999988889999999999999999998 89999888877776666543 345567789


Q ss_pred             HHHHHHHHHhhcCCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +++.+++.+||+.||++|||+
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~  251 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSF  251 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCH
Confidence            999999999999999999999

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.8e-42  Score=304.32  Aligned_cols=249  Identities=32%  Similarity=0.592  Sum_probs=214.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|.+.+.||+|++|.||++.+..+|+.+++|++.....   .....+.+|+.+++.++|++++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            68999999999999999999999999999999876532   344567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          126 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       126 ~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |++|++|.+++... +.+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........    
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----  153 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----  153 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence            99999999999876 5799999999999999999999999999999999999999999999999999876544321    


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCC--CCCCHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFP--NYFSDA  281 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~--~~~s~~  281 (366)
                             .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+........... ....+  ..++..
T Consensus       154 -------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (253)
T cd05122         154 -------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE  226 (253)
T ss_pred             -------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHH
Confidence                   22446788999999998888899999999999999999999999877544433333222 22222  234899


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      +.++|.+||+.||++|||+     .+++.|||
T Consensus       227 ~~~~i~~~l~~~p~~R~t~-----~~~l~~~~  253 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTA-----EQLLKHPF  253 (253)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhcCCC
Confidence            9999999999999999999     89999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.9e-42  Score=314.46  Aligned_cols=243  Identities=24%  Similarity=0.390  Sum_probs=203.5

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGT--VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  121 (366)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..  ........+.+|+.+++++ +||||+++++++.+.+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999877765  4688877532  1223344567799999888 7999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          122 MALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                      ++|||+++++|.+++.+.+                .+++..++.++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997532                478899999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHH
Q 017775          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  264 (366)
Q Consensus       186 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  264 (366)
                      |+|||++.......           .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus       160 l~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~  228 (297)
T cd05089         160 IADFGLSRGEEVYV-----------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY  228 (297)
T ss_pred             ECCcCCCcccccee-----------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999986332110           0001122456999999988889999999999999999997 99999988887777


Q ss_pred             HHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          265 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       265 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..+... ....+..++.++.+|+.+||+.+|.+||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  265 (297)
T cd05089         229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF  265 (297)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            766554 334566789999999999999999999999

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-42  Score=315.70  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=213.3

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |.....||+|+||.||++....+|+.||+|.+...   .......+.+|+.+++.++|+|++++++.+...+..+++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            44457899999999999999999999999987543   233445577899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCC
Q 017775          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~  206 (366)
                      +++++|.+++.. +.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......       
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------  170 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------  170 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-------
Confidence            999999987754 468999999999999999999999999999999999999999999999999876543221       


Q ss_pred             CCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHHHH
Q 017775          207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAAR  283 (366)
Q Consensus       207 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~  283 (366)
                         .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.........+...   .......++..+.
T Consensus       171 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (292)
T cd06657         171 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK  247 (292)
T ss_pred             ---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHH
Confidence               1112345788999999998888899999999999999999999999887766555444322   2223345789999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +++.+||+.||.+||++     .+++.||||...
T Consensus       248 ~li~~~l~~~P~~R~~~-----~~ll~~~~~~~~  276 (292)
T cd06657         248 GFLDRLLVRDPAQRATA-----AELLKHPFLAKA  276 (292)
T ss_pred             HHHHHHHhCCcccCcCH-----HHHhcChHHhcc
Confidence            99999999999999999     899999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-42  Score=314.77  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=210.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC----------------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG----------------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP  105 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~  105 (366)
                      +..++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ......+.+|+.+++.++||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCC
Confidence            45679999999999999999999876544                4589998876422  23445677899999999999


Q ss_pred             CcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 017775          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  174 (366)
Q Consensus       106 ~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~  174 (366)
                      ||+++++++.++...+++||++.+++|.+++.+..           .+++..++.++.|++.||.|||++||+|+||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999997765           6899999999999999999999999999999999


Q ss_pred             CeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc--CC
Q 017775          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GT  252 (366)
Q Consensus       175 NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~  252 (366)
                      ||+++.++.++|+|||++.........        .......++..|+|||.+.+..++.++||||||+++|+|++  |.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  231 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE  231 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence            999999999999999998765433211        11123345678999999988889999999999999999998  78


Q ss_pred             CCCCCCCHHHHHHHHhcC--------CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhh
Q 017775          253 SPFKDTSEWLIFQRIIAR--------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (366)
Q Consensus       253 ~pf~~~~~~~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l  309 (366)
                      .||...+.......+...        ....+..++.++.+++.+||+.||++|||+     .+++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~el~  291 (296)
T cd05051         232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF-----REIH  291 (296)
T ss_pred             CCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH-----HHHH
Confidence            899877766665554322        123345678999999999999999999999     6664

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=328.69  Aligned_cols=244  Identities=35%  Similarity=0.552  Sum_probs=210.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceeEEEEeeCCeEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ..++|++...+|.|+|+.|-.|.+..+++.+++|++.+..       ....+|+.++. .-+||||+++++++.+....|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            4789999999999999999999999999999999997751       11233554444 447999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe-CCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli-~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||.+.|+.+.+.+...+.+. .++..|+++|+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999888887765555 8888999999999999999999999999999999 58899999999999865443  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCCCCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFPNYFS  279 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~s  279 (366)
                                 ..+.+-|..|.|||++....|+.++||||||++||+|++|+.||...... +...++..+..  ...+|
T Consensus       470 -----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--s~~vS  536 (612)
T KOG0603|consen  470 -----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--SECVS  536 (612)
T ss_pred             -----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc--ccccC
Confidence                       12335688999999999999999999999999999999999999766555 55555554433  38899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +++++||++||+.||.+|+++     .+++.||||
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~-----~~i~~h~w~  566 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGA-----DEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHhccCChhhCcCh-----hhhccCcch
Confidence            999999999999999999999     789999999

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-42  Score=312.20  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=208.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +...+|++.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            45678999999999999999999742     35678999987653   23344567889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC
Q 017775          117 TFSLYMALESCEGGELFDQITSKG---------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~---------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~  181 (366)
                      ....+++|||+++++|.+++...+               .+++..+..++.|++.||+|||++|++||||||+||+++++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999987643               37889999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCH
Q 017775          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (366)
Q Consensus       182 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  260 (366)
                      +.++|+|||++.........        .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.....
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCEEECCCCceeEcCCCcee--------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            99999999998755432211        01112335678999999998889999999999999999998 9999988777


Q ss_pred             HHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       261 ~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ......+... ....+..+++.+.+++.+||+.||.+||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~  271 (280)
T cd05092         231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI  271 (280)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            7666666554 345567789999999999999999999999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-42  Score=323.73  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=212.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe---
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS---  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---  119 (366)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+|++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            367899999999999999999999999999999998754322 2233445679999999999999999988766544   


Q ss_pred             ---EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          120 ---LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       120 ---~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                         .++|+||+ +++|.+++.. +.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               89999999 5599998876 469999999999999999999999999999999999999999999999999987653


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---  272 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---  272 (366)
                      ..             .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+.....   
T Consensus       170 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~  236 (343)
T cd07851         170 DE-------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD  236 (343)
T ss_pred             cc-------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence            22             123457888999998765 3578899999999999999999999988776655554433110   


Q ss_pred             ----------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 ----------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 ----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                                  .....+++++.+||.+||+.||++|||+     .+++.||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~-----~ell~h~~~~~~~  305 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-----AEALAHPYLAEYH  305 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH-----HHHhcCCCccccC
Confidence                                        0112368999999999999999999999     8999999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=327.40  Aligned_cols=237  Identities=24%  Similarity=0.461  Sum_probs=207.7

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeec
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  127 (366)
                      .-++-||.|+.|.||+|+.  .++.||||+++.          .-+.++..|++|+|+||+.+.+++...-.++||||||
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            3457789999999999987  578999997632          1233778899999999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       128 ~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                      ..|.|+..++....++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++......        
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--------  266 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--------  266 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--------
Confidence            999999999999999999999999999999999999999999999999999999999999999998765432        


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDL  285 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~l  285 (366)
                         +...+.||..|||||++.+.+.+.|+||||+|||||||+||..||...+...++.-+-..  .++.|...++.++-|
T Consensus       267 ---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL  343 (904)
T KOG4721|consen  267 ---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL  343 (904)
T ss_pred             ---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence               334678999999999999999999999999999999999999999876654433322222  356678899999999


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCC
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp  312 (366)
                      +++||+-.|..||+.     .+++.|-
T Consensus       344 ~Kqcw~sKpRNRPSF-----rqil~Hl  365 (904)
T KOG4721|consen  344 LKQCWNSKPRNRPSF-----RQILLHL  365 (904)
T ss_pred             HHHHHhcCCCCCccH-----HHHHHHH
Confidence            999999999999999     8888883

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=312.55  Aligned_cols=252  Identities=31%  Similarity=0.497  Sum_probs=210.0

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEEEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMAL  124 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~iv~  124 (366)
                      |++.+.||.|++|.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|+|++++++++.+.  ...++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            788999999999999999999999999999998764 2233334566799999999999999999999988  8999999


Q ss_pred             eecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+++ +|.+++.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~---  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS---  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence            99986 898888765 5799999999999999999999999999999999999999999999999999886644321   


Q ss_pred             CCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----------  272 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------  272 (366)
                            .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....          
T Consensus       156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence                  01112346778999998765 4578899999999999999999999988776555444432100          


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          273 ---------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       273 ---------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                           .+....+.++.+++++||+.||.+||++     ++++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~~~~  287 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-----DQALQHEYF  287 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH-----HHHhhCcCC
Confidence                                 0011138899999999999999999999     899999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-42  Score=320.04  Aligned_cols=268  Identities=24%  Similarity=0.358  Sum_probs=214.5

Q ss_pred             cCCee-eeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh-----------hHHHHHHHHHHHHhCCCCCcceeE
Q 017775           44 IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-----------KTAYVKLERIVLDQLDHPGVVRLF  111 (366)
Q Consensus        44 ~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~  111 (366)
                      .++|. +.+.||.|+||+||+|.+..+|+.||+|++.........           ....+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            45665 457899999999999999999999999998764322211           011356799999999999999999


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      +++...+..+++|||+.| +|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            999999999999999975 9999998888899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCC----CCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHH
Q 017775          192 VKPMQDSRITVLPNA----ASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR  266 (366)
Q Consensus       192 a~~~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  266 (366)
                      +..............    ..........++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||.+.+..+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            987653221100000    0011112334678899999987644 68899999999999999999999998877665554


Q ss_pred             HhcCC-----C-----------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          267 IIARD-----I-----------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       267 i~~~~-----~-----------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +....     .                       ......+.++.++|.+||+.+|++||++     ++++.||||+..
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~~~~~~~~  319 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA-----KEALKHEYFKSD  319 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH-----HHHhcCcccCCC
Confidence            43210     0                       0012357889999999999999999999     899999999854

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.3e-42  Score=306.71  Aligned_cols=251  Identities=28%  Similarity=0.493  Sum_probs=218.6

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +|++.+.||+|++|.||++.+..+|+.+++|.+....... .....+.+|+.+++.++|+||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999987654333 233455678999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          126 SCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       126 ~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |+++++|.+++.+    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999998876    346899999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSD  280 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~  280 (366)
                               ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+..... ..+..++.
T Consensus       157 ---------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd08530         157 ---------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ  227 (256)
T ss_pred             ---------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCH
Confidence                     11123477899999999988899999999999999999999999998887776666655443 35567899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ++++++.+||+.+|++||++     .+++.||++
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~-----~~~l~~p~~  256 (256)
T cd08530         228 DLQNFIRSMLQVKPKLRPNC-----DKILASPAV  256 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCH-----HHHhcCCCC
Confidence            99999999999999999999     899999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-42  Score=309.25  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=206.8

Q ss_pred             eeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe----
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  119 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  119 (366)
                      |++++.||+|+||.||.|....+   +..||+|.+..+... ......+..|+..++.++|+||+++++++.+...    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67889999999999999987653   478999998764322 2334557779999999999999999998765443    


Q ss_pred             --EEEEEeecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          120 --LYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       120 --~~iv~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                        .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              89999999999999888542      3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ++.........        ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.+....+....+...
T Consensus       160 ~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05035         160 SKKIYSGDYYR--------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG  231 (273)
T ss_pred             eeecccccccc--------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            98664332110        1111234567999999988889999999999999999999 99999888877777666544


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       271 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                       ....|..++.++.+++.+||+.||++||++     .+++.
T Consensus       232 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~e~~~  267 (273)
T cd05035         232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTF-----TKLRE  267 (273)
T ss_pred             CCCCCCcCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence             445677899999999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-42  Score=326.50  Aligned_cols=250  Identities=21%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|.+..     ++..||+|++....  .......+.+|+.+++.+. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            447789999999999999999998743     34579999986542  2333456778999999996 999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC--------------------------------------------------------
Q 017775          116 DTFSLYMALESCEGGELFDQITSK--------------------------------------------------------  139 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------  139 (366)
                      +....|+||||+++|+|.+++.+.                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999887642                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC
Q 017775          140 ----------------------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (366)
Q Consensus       140 ----------------------------------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~  179 (366)
                                                              ..+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367888899999999999999999999999999999999


Q ss_pred             CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCC
Q 017775          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (366)
Q Consensus       180 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  258 (366)
                      .++.+||+|||++.........        .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             CCCEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999998765332111        11123346778999999988889999999999999999997 99999765


Q ss_pred             CHHH-HHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          259 SEWL-IFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       259 ~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      .... ....+... ....+..++.++.+++.+||+.||++||++.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            4433 33333332 3445667899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=311.29  Aligned_cols=250  Identities=28%  Similarity=0.455  Sum_probs=206.8

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEeeCCe----
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFS----  119 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----  119 (366)
                      |++.+.||+|++|.||+|.++.+++.||+|.++.... .......+.+|+.+++.+   +|+|++++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7889999999999999999998999999999976532 222223445577666555   69999999999988776    


Q ss_pred             -EEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          120 -LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       120 -~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       .+++|||+.+ +|.+++.+..  .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999986 8988887643  48999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      ...           ......++..|+|||.+.+..++.++|+||+|+++|+|++|.+||.+.+..+...++....     
T Consensus       159 ~~~-----------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07838         159 FEM-----------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE  227 (287)
T ss_pred             CCc-----------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence            321           1112346788999999998889999999999999999999999999888776665554310     


Q ss_pred             CC-----------C-----------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 IR-----------F-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 ~~-----------~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ..           +           ...+++.+.++|++||+.||++||++     .+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~il~~~~~  287 (287)
T cd07838         228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-----FEALQHPYF  287 (287)
T ss_pred             HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH-----HHHhcCcCC
Confidence            00           0           01346788999999999999999999     899999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.1e-42  Score=308.08  Aligned_cols=243  Identities=22%  Similarity=0.338  Sum_probs=205.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|++|.||+|.+. ++..+|+|.+......    ...+.+|+.+++.++|++++++++++.+ ...++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            4678999999999999999999775 5677999998764322    2347789999999999999999998754 56899


Q ss_pred             EEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999998764  3589999999999999999999999999999999999999999999999999976543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .         ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+... ..+.+...
T Consensus       158 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05070         158 T---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC  228 (260)
T ss_pred             c---------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            1         1112234567999999988889999999999999999999 99999888777777666543 44556778


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +.++.+|+.+||+.||++|||+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~  250 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTF  250 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.5e-42  Score=320.49  Aligned_cols=263  Identities=31%  Similarity=0.476  Sum_probs=213.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee--CCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD--TFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~  119 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.+|+|.+........ ....+..|+.+++.+ +|+||+++++++..  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            46789999999999999999999999999999998865432222 233455799999999 99999999998864  346


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      .|+||||+.+ +|..++.+. .+++..++.++.|++.||.|||++||+||||+|+||+++.+|.+||+|||.+.......
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            8999999975 999888765 78999999999999999999999999999999999999999999999999988664332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC------
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------  272 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------  272 (366)
                      ...     .........|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.........+.....      
T Consensus       162 ~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         162 ENP-----ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             ccc-----cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            110     0112234568899999998755 4578899999999999999999999987665544333221100      


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 -------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 -------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                               .....++.++.++|.+||+.||++|||+     .++++||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~-----~~il~~~~~~~~~  302 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA-----EEALEHPYVAQFH  302 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH-----HHHhhChhhhhhc
Confidence                                     0112368999999999999999999999     8999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5e-42  Score=310.01  Aligned_cols=254  Identities=18%  Similarity=0.301  Sum_probs=209.6

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      .+...+|++.+.||+|+||+||+|.+..+|+    .||+|++....  .......+.+|..+++.++|+||+++++++..
T Consensus         3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            3567899999999999999999999877776    48999886542  23334557778999999999999999998875


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      . ..++++||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            4 578999999999999999764 56899999999999999999999999999999999999999999999999999866


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  273 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~  273 (366)
                      .......        ......++..|+|||...+..++.++|||||||++|||++ |..||...........+... ...
T Consensus       160 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd05109         160 DIDETEY--------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP  231 (279)
T ss_pred             cccccee--------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC
Confidence            4322110        0111234567999999988889999999999999999998 99999887766655544443 334


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+...+.++.+++.+||+.||++||++     .+++.
T Consensus       232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~l~~  263 (279)
T cd05109         232 QPPICTIDVYMIMVKCWMIDSECRPRF-----RELVD  263 (279)
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            556789999999999999999999999     66663

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.5e-42  Score=316.48  Aligned_cols=264  Identities=28%  Similarity=0.446  Sum_probs=209.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------  116 (366)
                      .++|++.+.||.|++|.||+|.++.+++.+|+|.+........ ......+|+.+++.++|+||+++++++.+       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            6899999999999999999999999999999999876432221 22345679999999999999999988754       


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          117 -TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       117 -~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                       ...+++|+||+.+ +|...+... ..+++.+++.++.|+++||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence             3357999999976 777776653 5799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCC-CCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          195 MQDSRITVLPN-AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       195 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      ........... ...........+++.|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            65432211110 0011222345678899999987654 478899999999999999999999988777655444332100


Q ss_pred             -----------------------CCC-------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          273 -----------------------RFP-------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       273 -----------------------~~~-------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                             ..+       ..+++++.++|.+||+.||.+|||+     .+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~-----~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA-----SDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH-----HHHhcCCCC
Confidence                                   000       2345789999999999999999998     899999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=311.27  Aligned_cols=252  Identities=26%  Similarity=0.460  Sum_probs=207.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-C-CC----cceeEEEEee
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H-PG----VVRLFFTFQD  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~~----iv~~~~~~~~  116 (366)
                      ..++|.+++.+|+|.||.|..|.+..++..||+|+++.-    ....+...-|+.++.++. + |+    ++++.++|.-
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            478999999999999999999999999999999998653    233344555888998883 2 22    5677788999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--------------
Q 017775          117 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--------------  180 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--------------  180 (366)
                      .+..+||+|.+ |.++++++.+++  +++..+++.+++||+++++|||+.+++|-||||+|||+.+              
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999999 559999998764  6899999999999999999999999999999999999853              


Q ss_pred             ------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCC
Q 017775          181 ------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP  254 (366)
Q Consensus       181 ------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  254 (366)
                            +..|+++|||.|..-...             ..+.+.|..|+|||++.+.+++.++||||+||||+|+++|...
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-------------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-------------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-------------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                  225899999999854332             2467889999999999999999999999999999999999999


Q ss_pred             CCCCCHHH---HHHHHhcC------------------CCCCCCC-------------------------CCHHHHHHHHH
Q 017775          255 FKDTSEWL---IFQRIIAR------------------DIRFPNY-------------------------FSDAARDLIDR  288 (366)
Q Consensus       255 f~~~~~~~---~~~~i~~~------------------~~~~~~~-------------------------~s~~~~~li~~  288 (366)
                      |...+..+   +++.|+..                  .++.|+.                         -..++.|||++
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            98777555   44444321                  1111110                         12348899999


Q ss_pred             hhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          289 LLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       289 ~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ||..||.+|+|+     .+++.||||+..
T Consensus       389 mL~fDP~~RiTl-----~EAL~HpFF~~~  412 (415)
T KOG0671|consen  389 MLEFDPARRITL-----REALSHPFFARL  412 (415)
T ss_pred             HHccCccccccH-----HHHhcCHHhhcC
Confidence            999999999999     889999999854

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-42  Score=305.58  Aligned_cols=245  Identities=22%  Similarity=0.388  Sum_probs=210.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||.|++|.||+|..  .|+.||+|.+.....    ....+.+|+.+++.++|+||+++++++.+....+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            3567899999999999999999987  478999999876522    3455777999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999998765  69999999999999999999999999999999999999999999999999998653221


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      .             ....+..|+|||.+....++.++|+||+|+++|++++ |..||...+..+....+... ....+..
T Consensus       157 ~-------------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05039         157 D-------------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG  223 (256)
T ss_pred             c-------------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence            0             1223557999999988888999999999999999997 99999888877766655543 3345667


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +++++.++|.+||+.+|++||++     .+++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~-----~~l~~  251 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTF-----KQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCH-----HHHHH
Confidence            89999999999999999999999     55553

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.1e-42  Score=307.94  Aligned_cols=249  Identities=20%  Similarity=0.334  Sum_probs=207.8

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..++|++++.||+|+||.||+|.++.++.   .+|+|.++...  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            45789999999999999999998865543   79999886542  22334567789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+++|||+++++|.+++.+. +.++..++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999775 46899999999999999999999999999999999999999999999999999866432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....       .......++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+....+... ..+.+.
T Consensus       160 ~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd05066         160 PEAA-------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM  232 (267)
T ss_pred             ccee-------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCC
Confidence            2110       00111223467999999988889999999999999999886 99999887777666666554 233445


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .+++.+.+++.+||+.+|.+||++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~  256 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKF  256 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCH
Confidence            678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-42  Score=309.57  Aligned_cols=250  Identities=21%  Similarity=0.362  Sum_probs=205.0

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC------C
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------F  118 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~  118 (366)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.++.... .......+..|..+++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3578999999999999999887775  689998876532 233345667799999999999999999876432      2


Q ss_pred             eEEEEEeecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          119 SLYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      ..+++|||+.+++|.+++...      ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            478999999999999887421      34889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      ..+.......        ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+..+.
T Consensus       160 ~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  231 (272)
T cd05075         160 KKIYNGDYYR--------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN  231 (272)
T ss_pred             cccCccccee--------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            8764432110        0112235668999999998889999999999999999999 899998887777776666543


Q ss_pred             -CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          272 -IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       272 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                       ...+..++..+.++|.+||+.||++|||+     .++++
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~l~~  266 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSF-----ETLRC  266 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence             34566789999999999999999999999     66654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-42  Score=321.76  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             eeeeec--CceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      ..||+|  +||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  99999999999999999999987653322 334567889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCC
Q 017775          129 GGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (366)
Q Consensus       129 g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~  206 (366)
                      +++|.+++.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+...........   
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~---  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK---  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence            99999998864  3489999999999999999999999999999999999999999999999986543322110000   


Q ss_pred             CCCCCccccccCCCCCCceeecCC--CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC------------
Q 017775          207 ASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------------  272 (366)
Q Consensus       207 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------------  272 (366)
                      ..........++..|+|||.+.+.  .++.++||||+||++|+|++|..||.................            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence            000001112345679999998764  478899999999999999999999987665444333322111            


Q ss_pred             -----------------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          273 -----------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       273 -----------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                                         ..+..+++.+.+|+++||+.||++|||+     .++++||||.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta-----~e~l~~~~~~~~  314 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA-----SSLLSHAFFKQV  314 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH-----HHHhhCHHHHHH
Confidence                                               1122357789999999999999999999     899999999865


Q ss_pred             C
Q 017775          318 D  318 (366)
Q Consensus       318 ~  318 (366)
                      .
T Consensus       315 ~  315 (328)
T cd08226         315 K  315 (328)
T ss_pred             H
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-42  Score=320.04  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=207.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  117 (366)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++|+||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            57899999999999999999999999999999998764222 22234566799999999999999999988643      


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ...|++++++ |++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478888887 66998877654 699999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----  272 (366)
                      .             .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+.....    
T Consensus       173 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (345)
T cd07877         173 E-------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  239 (345)
T ss_pred             c-------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            1             123467889999998866 4588899999999999999999999987665544333221100    


Q ss_pred             -------------------CC--------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 -------------------RF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 -------------------~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                         ..        ....++++++||.+||+.||.+||++     .++++||||.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~f~~~~  307 (345)
T cd07877         240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQYH  307 (345)
T ss_pred             HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH-----HHHhcChhhhhcC
Confidence                               00        11357889999999999999999999     8999999998654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.8e-42  Score=307.33  Aligned_cols=244  Identities=20%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|+||.||+|.+..+ ..||+|.+.....    ....+.+|+.+++.++|+||+++++.+.+ ...++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            457899999999999999999988665 4699999875422    22356779999999999999999988754 56899


Q ss_pred             EEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||.+..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999764  3588999999999999999999999999999999999999999999999999976643321


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .         ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+.........+... ....+..+
T Consensus       158 ~---------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd05071         158 T---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC  228 (262)
T ss_pred             c---------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcccc
Confidence            1         1112345678999999988889999999999999999999 89999888777766665543 23445678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      +..+.+++.+||+.||++||++.
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~  251 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFE  251 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHH
Confidence            99999999999999999999983

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.6e-42  Score=314.74  Aligned_cols=253  Identities=27%  Similarity=0.391  Sum_probs=211.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..|...+.||+|++|.||+|+++.++..+|+|.+.............+.+|+.+++.++|+|++++++++.+....++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34888899999999999999999999999999987543333334445667999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+.| +|.+.+.. ...+++.++..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++......     
T Consensus        95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----  168 (308)
T cd06634          95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (308)
T ss_pred             EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence            99975 78777654 456899999999999999999999999999999999999999999999999998754321     


Q ss_pred             CCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYF  278 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~  278 (366)
                               ....++..|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+......  .+..+
T Consensus       169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (308)
T cd06634         169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW  239 (308)
T ss_pred             ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence                     1335788999999874   345788999999999999999999999876665544444433222  23468


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +..+.+||.+||+.+|++||++     +++++|||+...
T Consensus       240 ~~~~~~li~~cl~~~P~~Rp~~-----~~ll~~~~~~~~  273 (308)
T cd06634         240 SEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLRE  273 (308)
T ss_pred             cHHHHHHHHHHhhCCcccCCCH-----HHHhhCcccccc
Confidence            8999999999999999999999     899999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-42  Score=305.28  Aligned_cols=240  Identities=21%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             eeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeec
Q 017775           51 KIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  127 (366)
                      +.||+|+||.||+|....++   ..+|+|.+......  .....+.+|+.+++.+.|+||+++++++.. ...++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            47999999999999876554   78999998765332  334557779999999999999999998764 4689999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       128 ~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                      ++++|.+++.+.+.+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||.+..........     
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-----  152 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-----  152 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence            999999999888889999999999999999999999999999999999999999999999999988664332110     


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDL  285 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  285 (366)
                        .......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+... ....|..++..+.++
T Consensus       153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  230 (257)
T cd05060         153 --RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI  230 (257)
T ss_pred             --ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence              00011123467999999988889999999999999999998 99999887777666665444 335667789999999


Q ss_pred             HHHhhcCCCCCCCCC
Q 017775          286 IDRLLDVDPSGRPGA  300 (366)
Q Consensus       286 i~~~L~~dP~~Rps~  300 (366)
                      |.+||+.||++||++
T Consensus       231 i~~cl~~~p~~Rp~~  245 (257)
T cd05060         231 MLSCWKYRPEDRPTF  245 (257)
T ss_pred             HHHHhcCChhhCcCH
Confidence            999999999999999

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-42  Score=319.85  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=208.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  117 (366)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.... ......+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            36899999999999999999999999999999998764322 22234466799999999999999999988754      


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+++|+||+.. +|..+..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            346999999975 7776652  3589999999999999999999999999999999999999999999999999875422


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      .             .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+....     
T Consensus       170 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         170 E-------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP  236 (342)
T ss_pred             C-------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            1             113457888999999866 458889999999999999999999998877554444332210     


Q ss_pred             ------------------CCC--------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          272 ------------------IRF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       272 ------------------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                        ...        ....+.++.+||.+||+.||++||++     .+++.||||..+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~-----~e~l~h~~f~~~~~~  306 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA-----TEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcchhhcccc
Confidence                              000        12467889999999999999999999     899999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.9e-42  Score=312.71  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  112 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  112 (366)
                      .-.+..++|.+.+.||+|+||.||+|.+     ..++..||+|.++...  .......+.+|+.+++++ +|+||+++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            3457778999999999999999999975     3356689999886542  223345677899999999 7999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecC
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG  190 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg  190 (366)
                      ++...+..+++|||+.+++|.+++....  .+++.++..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999999997643  38999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhc
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  269 (366)
                      ++.........        .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||..............
T Consensus       187 ~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~  258 (302)
T cd05055         187 LARDIMNDSNY--------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK  258 (302)
T ss_pred             ccccccCCCce--------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence            98765432110        01112345678999999988889999999999999999998 9999987666554444443


Q ss_pred             CC--CCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          270 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       270 ~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..  ...+...++++.+++.+||+.+|++|||+
T Consensus       259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  291 (302)
T cd05055         259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTF  291 (302)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            32  23455678999999999999999999999

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.3e-42  Score=306.54  Aligned_cols=256  Identities=19%  Similarity=0.322  Sum_probs=211.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ...+|++.+.||+|+||.||+|.++.++.   .||+|.+....  .......+..|+.+++.++||||+++++++.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            45789999999999999999999887665   59999986542  23344567889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .++||||+++++|.+++... +.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999998764 56899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      .....     .........+..|+|||.+.+..++.++||||+|+++||+++ |..||...+.......+... ..+.+.
T Consensus       160 ~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  234 (269)
T cd05065         160 TSDPT-----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM  234 (269)
T ss_pred             ccccc-----cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcc
Confidence            21100     000001112457999999988889999999999999999886 99999888777766666433 334456


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .++..+.+++.+||+.+|++||++     .+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~-----~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKF-----GQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            789999999999999999999999     55553

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.8e-42  Score=314.19  Aligned_cols=256  Identities=29%  Similarity=0.436  Sum_probs=209.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  118 (366)
                      ..++|++.+.||+|++|.||+|.++.+|+.||+|.++.... .......+.+|+.+++.++||||+++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            46789999999999999999999999999999999876432 2222345667999999999999999999887654    


Q ss_pred             ------eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          119 ------SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       119 ------~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                            .+++++||+++ ++...+.+. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999987 777777654 4689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      +.........         ......++..|+|||.+.+. .++.++||||+||++|+|++|++||...+.......+...
T Consensus       163 ~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~  233 (302)
T cd07864         163 ARLYNSEESR---------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL  233 (302)
T ss_pred             cccccCCccc---------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            8865433210         11122457789999987653 4788999999999999999999999877665554443221


Q ss_pred             ---CC---------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ---DI---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ---~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                         ..                           .....++..+.+++.+||+.||.+||++     .+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  302 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA-----EEALNSPWL  302 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCC
Confidence               00                           0112468999999999999999999999     899999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-42  Score=305.41  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=209.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|.+.+.||+|++|.||+|.+. .+..||+|.+.....    ....+.+|+.+++.++|+||+++++++.+....+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            56789999999999999999999875 457899999875422    2345777999999999999999999999989999


Q ss_pred             EEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++|||+++++|.+++....  .++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997653  68999999999999999999999999999999999999999999999999988664321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ...         .....++..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+.+.......+... ....+..
T Consensus       158 ~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05034         158 YTA---------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN  228 (261)
T ss_pred             hhh---------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            110         011224568999999998889999999999999999998 99999988887777776554 3445667


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .+.++.+++.+||+.+|++||++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~  251 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTF  251 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCH
Confidence            79999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-41  Score=313.05  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=207.6

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  112 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  112 (366)
                      .+..++|.+++.||+|+||.||+|.+..       .+..+|+|.+....  .......+..|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            3456789999999999999999998632       34579999886542  222344567799999998 6999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      ++.+.+.++++|||+++++|.+++...                ..++..++..++.|++.||.|||++|++||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999999753                2478889999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  255 (366)
                      +++.++.+||+|||.++.........        ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYK--------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             EEcCCCcEEEcccccccccccccccc--------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            99999999999999998654322110        0011123457999999988889999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          256 KDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       256 ~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      .+.+..+....+.... ...+..++.++++++.+||..||++||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (314)
T cd05099         238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK  284 (314)
T ss_pred             CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            9888777777665543 345677899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-41  Score=304.34  Aligned_cols=243  Identities=23%  Similarity=0.363  Sum_probs=204.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|+++++||+|+||.||+|... +++.||+|.+.....    ....+.+|+.+++.++|+||+++++++. .+..++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            4678999999999999999999864 578899999875432    2345777999999999999999998874 457899


Q ss_pred             EEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||+.+++|.+++...  ..+++.++..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999998754  3589999999999999999999999999999999999999999999999999876543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .         ......++..|+|||.+.+..++.++||||+|+++|++++ |+.||.+.+.......+... ....+...
T Consensus       158 ~---------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05067         158 T---------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC  228 (260)
T ss_pred             c---------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Confidence            1         1112235678999999988889999999999999999998 99999888777666665443 34456778


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +.++.+++.+||+.+|++||++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTF  250 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCH
Confidence            8999999999999999999998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-42  Score=310.87  Aligned_cols=249  Identities=20%  Similarity=0.309  Sum_probs=203.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC--------------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG--------------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  107 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  107 (366)
                      +..++|++.+.||+|+||.||+|.+..++              ..||+|.++...  .......+.+|+.+++.++|+|+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i   79 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNI   79 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            34578999999999999999999875432              358999987542  23334567789999999999999


Q ss_pred             ceeEEEEeeCCeEEEEEeecCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 017775          108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKG------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  175 (366)
Q Consensus       108 v~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~N  175 (366)
                      +++++++...+..++||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            999999999999999999999999999986532            36788999999999999999999999999999999


Q ss_pred             eEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc--CCC
Q 017775          176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTS  253 (366)
Q Consensus       176 Ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~  253 (366)
                      |+++.++.+||+|||++.........        .......++..|+|||.+.+..++.++|+||||+++|+|++  |..
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~  231 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ  231 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcce--------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence            99999999999999998765332111        01112345678999999988889999999999999999987  778


Q ss_pred             CCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          254 PFKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       254 pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ||...+.......+..        .....+..+++.+.+|+.+||+.||++|||+
T Consensus       232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         232 PYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             CCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            9987766655444321        1122355678999999999999999999999

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-41  Score=315.31  Aligned_cols=260  Identities=28%  Similarity=0.399  Sum_probs=208.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee----CC
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDT--GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD----TF  118 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~  118 (366)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|.+..... .......+..|+.+++.+ +|+||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  99999999865432 222234456688899888 59999999986532    34


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+++|++. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5889999986 499999988888999999999999999999999999999999999999999999999999999866543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------  270 (366)
                      ...      .........|+..|+|||.+.+ ..++.++||||+|+++|+|++|.+||...+.......+...       
T Consensus       159 ~~~------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         159 PGE------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ccc------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            211      0111234578999999998765 46889999999999999999999999876654433322210       


Q ss_pred             ---------------------CCCC---CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          271 ---------------------DIRF---PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       271 ---------------------~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                           ...+   ....+.++.+|+.+||+.||++|||+     .+++.||||....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~ll~~~~~~~~~  299 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALEHPYLAIWH  299 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH-----HHHhcChhhhhhc
Confidence                                 0011   12357899999999999999999999     8999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-41  Score=303.79  Aligned_cols=239  Identities=23%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe-eCCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~  120 (366)
                      +...+|++.+.||+|+||.||++..  .|..+|+|.+....     ....+.+|+.+++.++|+|++++++++. +.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            4567999999999999999999976  47889999885431     2345677999999999999999998754 55679


Q ss_pred             EEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      +++|||+++++|.+++.+.+  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999997653  3889999999999999999999999999999999999999999999999998754322


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      .             ....++..|+|||++.+..++.++||||+|+++|+|++ |..||...+..+....+... ....+.
T Consensus       156 ~-------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05082         156 Q-------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  222 (256)
T ss_pred             C-------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            1             12234567999999988889999999999999999997 99999887777666665443 334566


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .+++.+.+++.+||+.+|++|||+
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~  246 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSF  246 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCH
Confidence            789999999999999999999999

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-42  Score=310.05  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=210.0

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |++.+.||+|++|.||+|.+..+++.||+|++.... ........+..|+.+++.++|+|++++++++.+....++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999998753 2223334566799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +.+ +|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+........     
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-----  153 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-----  153 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence            985 999999886 5799999999999999999999999999999999999999999999999999876543211     


Q ss_pred             CCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--------------
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------------  270 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------------  270 (366)
                           ......++..|+|||.+.+. .++.++|+||||+++|++++|.+||...+......++...              
T Consensus       154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence                 11122456789999998766 7889999999999999999999999887765544433210              


Q ss_pred             ----CCCC-----------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 ----DIRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 ----~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                          ...+           ...++..+.++|++||+.||++||++     +++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~p~~  282 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-----KEALKHPYF  282 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH-----HHHhhCcCC
Confidence                0001           11347889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-41  Score=306.60  Aligned_cols=253  Identities=19%  Similarity=0.306  Sum_probs=205.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +..++|++.+.||+|+||.||+|.+..+|+.    +++|.+...  ........+..|+..++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence            5678999999999999999999999887774    666666432  112223446667778899999999999998754 


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      ...++++||+++|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            4578899999999999999764 568999999999999999999999999999999999999999999999999997653


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~  274 (366)
                      .....        .......++..|+|||.+.+..++.++||||||+++||+++ |..||.+.........+..+. ...
T Consensus       161 ~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05111         161 PDDKK--------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ  232 (279)
T ss_pred             CCCcc--------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence            32111        11123346678999999988889999999999999999998 999998877665544444333 334


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +...+.++.+++.+||..||++|||+     .+++.
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rps~-----~el~~  263 (279)
T cd05111         233 PQICTIDVYMVMVKCWMIDENVRPTF-----KELAN  263 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            55678899999999999999999999     55554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.9e-43  Score=343.90  Aligned_cols=263  Identities=31%  Similarity=0.495  Sum_probs=208.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE--------
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF--------  114 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--------  114 (366)
                      ...+|+.++.||+||||.||+|+++-+|+.||||++....  .......+.+|+.++.+++|||||+++..|        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            3678999999999999999999999999999999998764  444556688899999999999999998000        


Q ss_pred             ----------------------------------------------------------e---------------------
Q 017775          115 ----------------------------------------------------------Q---------------------  115 (366)
Q Consensus       115 ----------------------------------------------------------~---------------------  115 (366)
                                                                                .                     
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                      0                     


Q ss_pred             -------------------------e-------CCeEEEEEeecCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHH
Q 017775          116 -------------------------D-------TFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIH  162 (366)
Q Consensus       116 -------------------------~-------~~~~~iv~e~~~g~~L~~~l~~~~~l-~~~~~~~~~~qil~aL~~LH  162 (366)
                                               +       ...+||.||||+.-+|.+++.++... .....|++++||++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                     0       03589999999986666666655433 47889999999999999999


Q ss_pred             HCCceeccCCCCCeEeCCCCCEEEEecCCccccC----Ccccccc----CCCCCCCCccccccCCCCCCceeecCCC---
Q 017775          163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ----DSRITVL----PNAASDDKACTFVGTAAYVPPEVLNSSP---  231 (366)
Q Consensus       163 ~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~----~~~~~~~----~~~~~~~~~~~~~gt~~y~aPE~~~~~~---  231 (366)
                      +.|||||||||.||+++.++.|||+|||+|+...    .......    -...+.......+||.-|+|||.+.+..   
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998722    1110000    1112223556779999999999997655   


Q ss_pred             CCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhcCCCCCCCC----CCHHHHHHHHHhhcCCCCCCCCCCCCChH
Q 017775          232 ATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDIRFPNY----FSDAARDLIDRLLDVDPSGRPGAGPGGYA  306 (366)
Q Consensus       232 ~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~----~s~~~~~li~~~L~~dP~~Rps~~~~~~~  306 (366)
                      |+.|+|+||||+|++||+   +||.. ......+.++..+.++.|..    --+.-..+|++||+.||.+||||     .
T Consensus       795 Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA-----~  866 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA-----T  866 (1351)
T ss_pred             ccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH-----H
Confidence            999999999999999999   45643 33445566666666666522    23446789999999999999999     8


Q ss_pred             hhhcCCCCC
Q 017775          307 VLKMHPFFK  315 (366)
Q Consensus       307 ~~l~hp~f~  315 (366)
                      ++|++.||-
T Consensus       867 eLL~s~llp  875 (1351)
T KOG1035|consen  867 ELLNSELLP  875 (1351)
T ss_pred             HHhhccCCC
Confidence            999999986

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-41  Score=310.85  Aligned_cols=257  Identities=22%  Similarity=0.363  Sum_probs=212.7

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCccee
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRL  110 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~  110 (366)
                      .-.+...+|.+.+.||+|+||.||+|+..       .++..||+|.+....  .......+.+|+.+++.+ +||||+++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence            34577889999999999999999999753       234579999886542  223345677899999999 89999999


Q ss_pred             EEEEeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 017775          111 FFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  174 (366)
Q Consensus       111 ~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~  174 (366)
                      ++++......|++|||+.+++|.+++.+..                .++..++..++.||+.||.|||++||+||||||+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            999999999999999999999999997642                3677889999999999999999999999999999


Q ss_pred             CeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCC
Q 017775          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS  253 (366)
Q Consensus       175 NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  253 (366)
                      ||+++.++.+||+|||+++.........        ......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  238 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  238 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccc--------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999998664332110        1112235568999999988889999999999999999998 889


Q ss_pred             CCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          254 PFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       254 pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ||.+.+..+....+.... ...+...+.++.+|+.+||..+|++||++     .+++.
T Consensus       239 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~l~  291 (304)
T cd05101         239 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF-----KQLVE  291 (304)
T ss_pred             CcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH-----HHHHH
Confidence            998888877777665443 34566789999999999999999999999     56654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-41  Score=303.74  Aligned_cols=243  Identities=22%  Similarity=0.341  Sum_probs=203.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|++|.||+|.+..+ ..+|+|.+....    .....+.+|+.+++.++|+|++++++++.. +..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence            356899999999999999999988654 469999876532    223446779999999999999999988754 56899


Q ss_pred             EEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||+.+++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999999999764  3478999999999999999999999999999999999999999999999999976543221


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .         ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+....+... ....+..+
T Consensus       158 ~---------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05069         158 T---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC  228 (260)
T ss_pred             c---------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            1         1112235678999999988889999999999999999999 99999888777766665544 33456678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +..+.+++.+||++||++||++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTF  250 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-41  Score=309.10  Aligned_cols=249  Identities=21%  Similarity=0.347  Sum_probs=208.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      ...++|++.+.||+|+||.||+|.+.     .++..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            34678999999999999999999874     367899999986542  22334557779999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 017775          117 TFSLYMALESCEGGELFDQITSKG----------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  174 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~----------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~  174 (366)
                      ....+++|||+++++|.+++....                      .+++..+..++.|++.||.|||++|++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            999999999999999999997432                      3678889999999999999999999999999999


Q ss_pred             CeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCC
Q 017775          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS  253 (366)
Q Consensus       175 NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  253 (366)
                      ||+++.++.++|+|||++..........        ......++..|+|||.+.+..++.++|+|||||++|+|++ |..
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYK--------ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             heEecCCCceEECccccceecccCcccc--------ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999987553322110        0111234567999999988889999999999999999997 889


Q ss_pred             CCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          254 PFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       254 pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ||.+.+..+....+..... ..+...+.++.+|+.+||+.||++|||+
T Consensus       232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  279 (288)
T cd05050         232 PYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF  279 (288)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            9988888777777665543 3466789999999999999999999999

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=310.43  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=210.8

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+..|+.+++.++|+||+++++++.+....++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998765332 23345567799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +.+ +|.+++... +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------  152 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------  152 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence            976 888888764 579999999999999999999999999999999999999999999999999987664432      


Q ss_pred             CCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-------------
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-------------  271 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-------------  271 (366)
                          .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+....             
T Consensus       153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence                011123577889999998776 68899999999999999999999998877665544432210             


Q ss_pred             ------CC-----------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 ------IR-----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 ------~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                            ..           ....++.++.++|.+||+.||.+||++     .++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~ll~~~~~  283 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA-----EQALAHPYF  283 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH-----HHHhhCCCC
Confidence                  00           112467899999999999999999999     899999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.5e-42  Score=305.92  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=212.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +|.+.+.||+|+||.||++.+..++..+++|+.+.....  ..........|..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            589999999999999999999888887877776543221  122233455688899999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +||+++++|.+++..    ...+++.+++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||.+.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988754    356899999999999999999999999999999999999964 679999999987653321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                                .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+... ....+..+
T Consensus       160 ----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd08222         160 ----------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY  229 (260)
T ss_pred             ----------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchh
Confidence                      1112345788999999998888888999999999999999999999877776666665544 33456678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +.++.++|.+||..||++||++     .+++.||||
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~  260 (260)
T cd08222         230 SRQLNSIMQSMLNKDPSLRPSA-----AEILRNPFI  260 (260)
T ss_pred             cHHHHHHHHHHhcCChhhCcCH-----HHHhhCCCC
Confidence            9999999999999999999999     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.5e-42  Score=314.51  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCchHHHH
Q 017775           57 SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI  136 (366)
Q Consensus        57 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l  136 (366)
                      ++|.||.++...+|+.||+|++..... .......+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            445667777777999999999976532 2334556888999999999999999999999999999999999999999999


Q ss_pred             HhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccc
Q 017775          137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT  214 (366)
Q Consensus       137 ~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~  214 (366)
                      .+.  ..+++..+..++.|++.||+|||+++|+||||||+||+++.+|.++|+|||.+...........   ........
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~---~~~~~~~~  167 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---VVHDFPKS  167 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc---cccccccc
Confidence            764  4589999999999999999999999999999999999999999999999998876543221100   00111123


Q ss_pred             cccCCCCCCceeecCC--CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------------------
Q 017775          215 FVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---------------------  271 (366)
Q Consensus       215 ~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------------------  271 (366)
                      ..++..|+|||++.+.  .++.++|+||+||++|+|++|..||..............+.                     
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR  247 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence            4567789999998663  47889999999999999999999998765543322211110                     


Q ss_pred             -------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          272 -------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       272 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                   ...+..++.++.+|+++||+.||++|||+     .++++||||+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~p~~~~~~  302 (314)
T cd08216         248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA-----SQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH-----HHHhcCchHhhhc
Confidence                         01112345789999999999999999999     8999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-41  Score=306.12  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=212.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|++.+.||+|+||.||+|+.+.     +...|++|.+....  .......+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            345789999999999999999999754     34679999876531  22244567889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEE
Q 017775          117 TFSLYMALESCEGGELFDQITSKG---------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                      ....++||||+++++|.+++....         .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence            999999999999999999998765         68999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHH
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  266 (366)
                      |||++........         .......++..|+|||.+.+...+.++||||||+++|++++ |..||...........
T Consensus       160 ~~~~~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~  230 (275)
T cd05046         160 LLSLSKDVYNSEY---------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR  230 (275)
T ss_pred             ccccccccCcccc---------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence            9999874432211         11122345677999999988888899999999999999998 8899987777777776


Q ss_pred             HhcCCCC--CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          267 IIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       267 i~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +..+...  .+..++..+.+++.+||+.||++||++     .+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~-----~~~l~  271 (275)
T cd05046         231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSF-----SELVS  271 (275)
T ss_pred             HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            6655433  456789999999999999999999999     66664

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-41  Score=308.07  Aligned_cols=262  Identities=27%  Similarity=0.454  Sum_probs=210.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  116 (366)
                      ....+..++|++.+.||+|++|.||+|.+..+|+.||+|.+......  .....+..|+.++... .|+||+++++++.+
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            34456789999999999999999999999999999999998764321  2223344455555555 59999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          117 TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ....|++|||+.+ +|..++.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            9999999999865 77777765 3578999999999999999999997 6999999999999999999999999999876


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCC----CCCCCCcccchhhhhhhhcCCCCCCCCCH-HHHHHHHhc
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIA  269 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~  269 (366)
                      +....           ......++..|+|||.+.+..    ++.++|+||+|+++|+|++|+.||..... .+....+..
T Consensus       165 ~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  233 (296)
T cd06618         165 LVDSK-----------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ  233 (296)
T ss_pred             ccCCC-----------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc
Confidence            53321           111224677899999987553    78899999999999999999999976433 344444443


Q ss_pred             CC-CCCC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          270 RD-IRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       270 ~~-~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .. ...+  ..++.++.+|+.+||+.||++||++     ++++.||||....
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~  280 (296)
T cd06618         234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY-----RELLQHPFIRRYE  280 (296)
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcChhhhccc
Confidence            32 2222  2478999999999999999999999     8999999998543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.7e-41  Score=312.22  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=208.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-CCeEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLY  121 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~  121 (366)
                      ..++|++.+.||.|+||.||+|.+..+|+.||+|.+.+.... ......+..|+.+++.++||||+++++++.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            467899999999999999999999999999999988764322 2233456679999999999999999999875 56789


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +++||+. ++|..++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+......   
T Consensus        87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---  161 (328)
T cd07856          87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---  161 (328)
T ss_pred             EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence            9999995 589887764 46889999999999999999999999999999999999999999999999998754321   


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc-----------
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-----------  269 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-----------  269 (366)
                                .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+.+           
T Consensus       162 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         162 ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence                      123456788999998765 5688999999999999999999999987655322111110           


Q ss_pred             ---------------CCCCC-----CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          270 ---------------RDIRF-----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       270 ---------------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                     .....     ...+++++.++|++||+.+|++||++     ++++.||||....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~ell~~~~~~~~~  295 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA-----AEALAHPYLAPYH  295 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCCcccccc
Confidence                           00011     13468899999999999999999999     8999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-41  Score=302.89  Aligned_cols=250  Identities=20%  Similarity=0.322  Sum_probs=207.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..++|...+.||+|+||.||+|.++.++.   .+|+|.+....  .......+..|+.+++.++|+|++++++++.+.+
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            345689999999999999999999876654   79999886542  2223445777999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||+++++|.+++... +.+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999998764 5789999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      .....       ........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.......+... ..+.+
T Consensus       160 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~  232 (268)
T cd05063         160 DPEGT-------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP  232 (268)
T ss_pred             ccccc-------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence            21110       00011122457999999988888999999999999999997 99999888777777766543 23344


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ...+.++.+++.+||+.+|++||++
T Consensus       233 ~~~~~~~~~li~~c~~~~p~~Rp~~  257 (268)
T cd05063         233 MDCPSAVYQLMLQCWQQDRARRPRF  257 (268)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCH
Confidence            5678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-41  Score=307.84  Aligned_cols=245  Identities=22%  Similarity=0.377  Sum_probs=203.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     23568888876542  122335577899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          121 YMALESCEGGELFDQITSK------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~------------------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      ++++||+.+++|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478899999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  255 (366)
                      ++++++.+||+|||++..........        ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYV--------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchh--------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            99999999999999987653322110        1112234668999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          256 KDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       256 ~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .+.......+.+... ....+..++.++.+++.+||+.||++||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~  276 (290)
T cd05045         231 PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF  276 (290)
T ss_pred             CCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence            988877766655432 344567789999999999999999999999

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=303.69  Aligned_cols=248  Identities=20%  Similarity=0.321  Sum_probs=209.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +...+|++.+.||+|+||.||+|.++.+|+    .+|+|......  .......+.+|+.+++.++|+||+++++++.. 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            456789999999999999999999877665    58999876542  23344567789999999999999999999887 


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      ...++||||+.+++|.+++.+. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999998874 469999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      ......        ......++..|+|||.+....++.++|+||+|+++|++++ |..||.+....+....+... ....
T Consensus       161 ~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05057         161 VDEKEY--------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ  232 (279)
T ss_pred             Ccccce--------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            332111        0011123567999999988889999999999999999998 99999988877776666554 3455


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      |...+.++.+++.+||..||++||++
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~  258 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTF  258 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCH
Confidence            66788999999999999999999999

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=306.07  Aligned_cols=249  Identities=32%  Similarity=0.513  Sum_probs=205.6

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEEe
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      |.+.+.||+|++|.||+|....+++.|++|.+......  .......+|+..++.++ |+|++++++++.+.+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            78899999999999999999999999999998765322  12223445888889998 9999999999999999999999


Q ss_pred             ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          126 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |+ +++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----  153 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----  153 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence            99 669999887764  68999999999999999999999999999999999999999999999999987654321    


Q ss_pred             CCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------------  270 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------  270 (366)
                             ......++..|+|||++. +..++.++|+||+|+++++|++|.+||...+..+....+...            
T Consensus       154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         154 -------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             -------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence                   112345788999999875 445788999999999999999999999877665444332210            


Q ss_pred             -------CCC-----------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          271 -------DIR-----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       271 -------~~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                             ...           .....+.++.++|++||+.||++||++     .+++.||||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~~~~~  283 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-----SQALQHPYF  283 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH-----HHHhhCCCC
Confidence                   000           011236889999999999999999999     899999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-42  Score=307.91  Aligned_cols=247  Identities=30%  Similarity=0.500  Sum_probs=203.0

Q ss_pred             eeeeeeeecCceEEEEEEEC----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .+.+.||.|+||.||+|...    ..+..|+||.++..  ........+.+|+..+++++||||+++++++......++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            56789999999999999987    45678999999543  2333456677899999999999999999999988889999


Q ss_pred             EeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          124 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||+++|+|.+++...  ..++..++..++.|++.||.|||+++++|+||+++||+++.++.+||+|||++.........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999887  67999999999999999999999999999999999999999999999999999876322111


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s  279 (366)
                      .        ......+...|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+.... ...+..++
T Consensus       160 ~--------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (259)
T PF07714_consen  160 K--------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCP  231 (259)
T ss_dssp             E--------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSB
T ss_pred             c--------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchh
Confidence            1        1112345678999999988889999999999999999999 789999988888777775543 34566789


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhh
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l  309 (366)
                      ..+.++|.+||+.||++|||+     ++++
T Consensus       232 ~~~~~li~~C~~~~p~~RPs~-----~~i~  256 (259)
T PF07714_consen  232 KDIYSLIQQCWSHDPEKRPSF-----QEIL  256 (259)
T ss_dssp             HHHHHHHHHHT-SSGGGS--H-----HHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence            999999999999999999998     6665

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-42  Score=306.71  Aligned_cols=237  Identities=20%  Similarity=0.312  Sum_probs=195.3

Q ss_pred             eeeeecCceEEEEEEECCCCcE-------EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTV-------YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~-------vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +.||+|+||.||+|.++.++..       +++|.+...   .......+.+|..+++.++||||+++++++......++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            4689999999999998765544       888877543   223334567788999999999999999999998999999


Q ss_pred             EeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC--------EEEEecCCccc
Q 017775          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKP  194 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~--------vkL~Dfg~a~~  194 (366)
                      |||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987764        69999998865


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcC-CCCCCCCCHHHHHHHHhcCCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      ....              ....++..|+|||.+.+. .++.++||||+|+++|+|++| ..||........ ........
T Consensus       158 ~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~  222 (258)
T cd05078         158 VLPK--------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRH  222 (258)
T ss_pred             cCCc--------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccc
Confidence            4321              134577889999998764 478899999999999999998 566666555433 23344556


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+|...+.++.+|+.+||+.||++|||+     ++++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~  255 (258)
T cd05078         223 QLPAPKWTELANLINQCMDYEPDFRPSF-----RAIIR  255 (258)
T ss_pred             cCCCCCcHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            6777788999999999999999999999     66664

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-41  Score=299.95  Aligned_cols=244  Identities=24%  Similarity=0.364  Sum_probs=205.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      +.||.|++|.||+|.+.. ++.||+|.+......  .....+..|+.+++.++|+||+++++++.+....++||||+.|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            478999999999999977 999999988765322  34456778999999999999999999999999999999999999


Q ss_pred             chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          131 ELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       131 ~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      +|.+++.+. ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||.+...........      
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------  151 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS------  151 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec------
Confidence            999998664 4689999999999999999999999999999999999999999999999999876543211110      


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  287 (366)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... ....|...+.++.+++.
T Consensus       152 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  229 (251)
T cd05041         152 --DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML  229 (251)
T ss_pred             --cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence              011123557999999988889999999999999999998 89999887776666655443 34456778999999999


Q ss_pred             HhhcCCCCCCCCCCCCChHhhhc
Q 017775          288 RLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       288 ~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +||+.+|++||++     .+++.
T Consensus       230 ~~l~~~p~~Rp~~-----~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSF-----SEIYN  247 (251)
T ss_pred             HHhccChhhCcCH-----HHHHH
Confidence            9999999999999     66664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-41  Score=313.28  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=211.0

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeE
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  111 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~  111 (366)
                      -.+...+|++++.||+|+||.||+|.+...       +..||+|.+....  .......+.+|+.+++++ +|+||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            345566899999999999999999986432       2368999876532  223345677799999999 799999999


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  175 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~N  175 (366)
                      +++...+..+++|||+++++|.+++.+..                .++..++..++.|++.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999987532                36778889999999999999999999999999999


Q ss_pred             eEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCC
Q 017775          176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  254 (366)
Q Consensus       176 Ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  254 (366)
                      |+++.++.+||+|||+++.........        ......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            999999999999999988654322110        0111233467999999998889999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          255 FKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       255 f~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      |.+.+..+....+... ....+...+.++.+++.+||+.+|.+||++     .+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~ell~~  289 (334)
T cd05100         237 YPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-----KQLVED  289 (334)
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHHH
Confidence            9988877777766554 334566789999999999999999999999     666654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.3e-41  Score=300.56  Aligned_cols=248  Identities=22%  Similarity=0.371  Sum_probs=209.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+|++.+.||.|+||.||+|.+. ++..+|+|.+......    ...+..|+.+++.++|||++++++++......+++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468999999999999999999885 4678999988654322    23466799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+.+++|.+++... +.++++.++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            9999999999998764 56899999999999999999999999999999999999999999999999998755332111 


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  280 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~  280 (366)
                              ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...........+... ....|...+.
T Consensus       157 --------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05112         157 --------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQ  228 (256)
T ss_pred             --------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCH
Confidence                    0111234568999999988889999999999999999998 99999888877777776554 3334566899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ++.+|+.+||+.+|++||++     .+++.
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~-----~~~l~  253 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSF-----SLLLH  253 (256)
T ss_pred             HHHHHHHHHcccChhhCCCH-----HHHHH
Confidence            99999999999999999999     66664

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-41  Score=301.37  Aligned_cols=240  Identities=24%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             eeeeecCceEEEEEEECC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeec
Q 017775           51 KIYGVGSYSKVVRAKKID-TGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  127 (366)
                      +.||+|++|.||+|.+.. .+.  .||+|.+......  .....+.+|+..++.++|+||+++++.+.+ ...+++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 333  6999999776433  445567789999999999999999999988 8999999999


Q ss_pred             CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          128 EGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       128 ~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      ++++|.+.+.+..  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..+.......   
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~---  154 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY---  154 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence            9999999998764  68999999999999999999999999999999999999999999999999998764422110   


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAA  282 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~  282 (366)
                          .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+...  ....+...+..+
T Consensus       155 ----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd05040         155 ----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI  230 (257)
T ss_pred             ----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHH
Confidence                01112346778999999998889999999999999999998 99999888777766665532  333456788999


Q ss_pred             HHHHHHhhcCCCCCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~  300 (366)
                      .+++.+||+.+|++||++
T Consensus       231 ~~li~~~l~~~p~~Rps~  248 (257)
T cd05040         231 YNVMLQCWAHNPADRPTF  248 (257)
T ss_pred             HHHHHHHCCCCcccCCCH
Confidence            999999999999999998

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-41  Score=304.52  Aligned_cols=250  Identities=21%  Similarity=0.331  Sum_probs=198.2

Q ss_pred             CCe-eeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--C
Q 017775           45 QDF-ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  117 (366)
Q Consensus        45 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~  117 (366)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 999999999999998865    34578899999987542  12234456779999999999999999998765  3


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++++|||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999998764 599999999999999999999999999999999999999999999999999886643


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH--------------H
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------I  263 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------------~  263 (366)
                      .....       .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......              .
T Consensus       160 ~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         160 GHEYY-------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             cchhh-------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            22110       00112234567999999988889999999999999999999999986433210              0


Q ss_pred             HHHHhc--CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhh
Q 017775          264 FQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (366)
Q Consensus       264 ~~~i~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l  309 (366)
                      ......  .....+..++.++.+++.+||+.||++|||+     ++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~~i~  275 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF-----RSLI  275 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH-----HHHH
Confidence            011111  1223456788999999999999999999999     5555

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-41  Score=300.93  Aligned_cols=240  Identities=20%  Similarity=0.300  Sum_probs=198.2

Q ss_pred             eeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           52 IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      .||+|+||.||+|.+.  .++..||+|++....  .......+.+|+.+++.++|+||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999765  456679999886542  23344567789999999999999999998764 578999999999


Q ss_pred             CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCC
Q 017775          130 GELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (366)
Q Consensus       130 ~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~  208 (366)
                      ++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........     
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-----  153 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-----  153 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-----
Confidence            999999875 45699999999999999999999999999999999999999999999999999875543221100     


Q ss_pred             CCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHH
Q 017775          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLI  286 (366)
Q Consensus       209 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  286 (366)
                        ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...........+..+ ....|...++++.+++
T Consensus       154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05115         154 --ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALM  231 (257)
T ss_pred             --ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence              0011123568999999988889999999999999999996 99999888877766655543 3456677899999999


Q ss_pred             HHhhcCCCCCCCCCC
Q 017775          287 DRLLDVDPSGRPGAG  301 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~  301 (366)
                      .+||..||++||++.
T Consensus       232 ~~c~~~~~~~Rp~~~  246 (257)
T cd05115         232 KDCWIYKWEDRPNFA  246 (257)
T ss_pred             HHHcCCChhhCcCHH
Confidence            999999999999993

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-41  Score=306.88  Aligned_cols=247  Identities=20%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKID----------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  107 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  107 (366)
                      .++|++.+.||+|+||.||+|.+..                ++..+|+|.+....  .......+.+|+.+++.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            4679999999999999999986432                34578999886542  23334567789999999999999


Q ss_pred             ceeEEEEeeCCeEEEEEeecCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKG-----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       108 v~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      +++++++.+.+..+++|||+++++|.+++.+..           .+++.++..++.|++.||+|||++|++|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987642           366778999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc--CCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSP  254 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p  254 (366)
                      +++.++.++|+|||++..+......        .......++..|+|||...+..++.++|+|||||++|+|++  |..|
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            9999999999999998865332111        01112234578999999888889999999999999999998  7899


Q ss_pred             CCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          255 FKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       255 f~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      |...+..+.......        ...+.+...++.+.+|+.+||+.||++||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            987666554433211        1223455678999999999999999999999

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.9e-41  Score=299.04  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=204.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|+||.||++.+. .+..+|+|.+...    ......+.+|+.+++.++|+||+++++.+.+ ...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            45789999999999999999999764 4567999987643    2233457779999999999999999999887 7789


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++|||+++++|.+++.+.  ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764  357888999999999999999999999999999999999999999999999987654321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ..         ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+.......+... ..+.+..
T Consensus       157 ~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05073         157 YT---------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN  227 (260)
T ss_pred             cc---------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCccc
Confidence            11         1112234567999999988889999999999999999998 99999988777666655443 2344567


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .+.++.+++.+||+.||++||++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~  250 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTF  250 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCH
Confidence            89999999999999999999998

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-41  Score=298.05  Aligned_cols=238  Identities=22%  Similarity=0.402  Sum_probs=200.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      ++||+|+||.||+|... ++..+|+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            47899999999999864 68899999987643  2233345777999999999999999999999999999999999999


Q ss_pred             chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCC
Q 017775          131 ELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (366)
Q Consensus       131 ~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~  209 (366)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.........        
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--------  149 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--------  149 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc--------
Confidence            999998764 45899999999999999999999999999999999999999999999999998754322111        


Q ss_pred             CCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 017775          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (366)
Q Consensus       210 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  287 (366)
                       ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+... ....+..++.++.+++.
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             0111233567999999988889999999999999999998 99999888777666665544 33456778999999999


Q ss_pred             HhhcCCCCCCCCC
Q 017775          288 RLLDVDPSGRPGA  300 (366)
Q Consensus       288 ~~L~~dP~~Rps~  300 (366)
                      +||+.+|++||++
T Consensus       229 ~~l~~~p~~Rp~~  241 (250)
T cd05085         229 RCWDYKPENRPKF  241 (250)
T ss_pred             HHcccCcccCCCH
Confidence            9999999999998

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=302.49  Aligned_cols=237  Identities=25%  Similarity=0.390  Sum_probs=197.0

Q ss_pred             eeeeecCceEEEEEEECCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeec
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~  127 (366)
                      +.||+|+||.||+|.+..+|..  +++|.+....  .......+.+|+.++.++ +||||+++++++...+..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            4689999999999999887764  6888775421  223344577899999999 7999999999999999999999999


Q ss_pred             CCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          128 EGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       128 ~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      ++++|.+++...+                .+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999987542                378899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  270 (366)
                      +.......           .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.......+...
T Consensus       159 ~~~~~~~~-----------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~  227 (270)
T cd05047         159 SRGQEVYV-----------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  227 (270)
T ss_pred             ccccchhh-----------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence            85322110           0001123557999999988889999999999999999997 99999887777766666543


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       271 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                       ....+...+.++.+++.+||+.||.+|||+
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence             334566788999999999999999999999

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.6e-41  Score=303.22  Aligned_cols=249  Identities=16%  Similarity=0.281  Sum_probs=206.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-  116 (366)
                      +..++|++.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|..+++.++|+||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            456789999999999999999999876    3578999987643  233345567789999999999999999998765 


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEe
Q 017775          117 TFSLYMALESCEGGELFDQITSK--------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~--------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~D  188 (366)
                      ....++++||+.+++|.+++...        ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            56789999999999999998763        3588999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHH
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  267 (366)
                      ||+++.+.........        ....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+
T Consensus       161 ~g~~~~~~~~~~~~~~--------~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  232 (280)
T cd05043         161 NALSRDLFPMDYHCLG--------DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL  232 (280)
T ss_pred             CCCcccccCCceEEeC--------CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            9999866443221110        12235667999999988889999999999999999998 99999888777666555


Q ss_pred             hcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          268 IAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       268 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ... ....+..+++++.+++.+||..||++|||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  266 (280)
T cd05043         233 KDGYRLAQPINCPDELFAVMACCWALDPEERPSF  266 (280)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence            443 223445678999999999999999999999

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.6e-41  Score=301.16  Aligned_cols=246  Identities=23%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..++|.+.+.||+|+||.||+|.+...   ...|++|.+....  .......+.+|+.+++.++|+||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            456799999999999999999987544   3468999886542  23344567789999999999999999998876 45


Q ss_pred             EEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .++||||+++++|.+++.+.+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999998753 5899999999999999999999999999999999999999999999999998765443


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....         .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+..+ ....+.
T Consensus       161 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (270)
T cd05056         161 SYYK---------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP  231 (270)
T ss_pred             ccee---------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            2110         111224567999999988889999999999999999886 99999888777666665543 345677


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .++.++.+++.+||..+|++|||+
T Consensus       232 ~~~~~~~~li~~~l~~~P~~Rpt~  255 (270)
T cd05056         232 NCPPTLYSLMTKCWAYDPSKRPRF  255 (270)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH
Confidence            889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=319.56  Aligned_cols=247  Identities=22%  Similarity=0.363  Sum_probs=207.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++..+++.||+|+||+||+|++-.   .||||+++.+....+ ..+.+++|+..+++-+|.||+=+.+++..... .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            345677889999999999999999954   599999988765554 67789999999999999999999999998877 9


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||+-+|+|.+|+.++.-. .+|.....+.|++|+++|+.|||.++|||||||..||++.++++|||+|||++..-..-. 
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~-  542 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS-  542 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec-
Confidence            999999999999999754 469999999999999999999999999999999999999999999999999987432211 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  273 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----  273 (366)
                             .........|...|||||++.   ..+|+..+||||+|+++|||++|..||...+.++++..+-.+.+.    
T Consensus       543 -------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  543 -------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             -------cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence                   112223445788999999875   456899999999999999999999999987777666555554222    


Q ss_pred             -CCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          274 -FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       274 -~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                       .....+.++++|+..||.+++++||...
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCcccCccHH
Confidence             1234577999999999999999999983

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-41  Score=318.81  Aligned_cols=255  Identities=21%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTF  114 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~  114 (366)
                      .+..++|.+++.||+|+||.||+|++.     .++..||+|+++...  .......+..|+.++..+. ||||+++++++
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            345668899999999999999999864     345689999997642  2222345677999999997 99999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCC------------------------------------------------------
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKG------------------------------------------------------  140 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~------------------------------------------------------  140 (366)
                      ......++||||+++|+|.+++.+.+                                                      
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999999999999986431                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          141 --------------------------------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       141 --------------------------------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                                                                  .++...+..++.||+.||.|||+.+++||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                        256677889999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  255 (366)
                      +++.++.+||+|||+++........        .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             EEeCCCEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999765322110        01112346778999999988889999999999999999998 89999


Q ss_pred             CCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          256 KDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       256 ~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ......+........  ....|..++.++.+|+.+||+.+|.+||++     .+++.
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~  394 (401)
T cd05107         343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-----SQLVH  394 (401)
T ss_pred             CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            876555544443332  344567789999999999999999999999     66654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-41  Score=314.63  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=203.3

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|.+     ..+++.||+|.++...  .......+.+|+.++..+ +|+||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            3467899999999999999999985     3567899999987542  222334566799999999 6899999998876


Q ss_pred             e-CCeEEEEEeecCCCchHHHHHhC-------------------------------------------------------
Q 017775          116 D-TFSLYMALESCEGGELFDQITSK-------------------------------------------------------  139 (366)
Q Consensus       116 ~-~~~~~iv~e~~~g~~L~~~l~~~-------------------------------------------------------  139 (366)
                      . ...++++|||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            5 45689999999999999988642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          140 ------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       140 ------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                                  ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------  235 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------  235 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence                        13677888899999999999999999999999999999999999999999998765332111      


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH-HHHHHhc-CCCCCCCCCCHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL-IFQRIIA-RDIRFPNYFSDAARD  284 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~-~~~~i~~-~~~~~~~~~s~~~~~  284 (366)
                        .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||....... ....+.. .....|...++++.+
T Consensus       236 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (343)
T cd05103         236 --VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  313 (343)
T ss_pred             --hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHH
Confidence              01112235667999999988889999999999999999996 999997654332 2222222 234456678899999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ++.+||+.||++|||+     .++++|
T Consensus       314 ~~~~cl~~~p~~Rps~-----~eil~~  335 (343)
T cd05103         314 TMLDCWHGEPSQRPTF-----SELVEH  335 (343)
T ss_pred             HHHHHccCChhhCcCH-----HHHHHH
Confidence            9999999999999999     777765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.2e-41  Score=298.30  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=210.9

Q ss_pred             eeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      +++.+.||.|+||.||+|.+..++    ..||+|.+....  .......+..|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            357889999999999999998766    899999986542  22244567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||+++++|.+++.....  +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999977544  99999999999999999999999999999999999999999999999999986654421


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~  278 (366)
                      ...         ....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.....+.+.... ...+..+
T Consensus       159 ~~~---------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T smart00219      159 YKK---------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC  229 (258)
T ss_pred             ccc---------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence            110         01226778999999988889999999999999999998 899998887777777665543 3456678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +.++.+++.+||+.||++|||+     .+++.
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~-----~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTF-----SELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCH-----HHHHh
Confidence            9999999999999999999998     66664

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-41  Score=302.77  Aligned_cols=253  Identities=20%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEE----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--  117 (366)
                      ..-|++++.||+|+||.||+|..    +.++..||+|.++...  .......+.+|+.+++.++|||++++++++.+.  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            45589999999999999999974    4578899999986542  233345678899999999999999999998775  


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      ...++||||++|++|.+++.+. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            6789999999999999998765 358999999999999999999999999999999999999999999999999988664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC---------------HH
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---------------EW  261 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------~~  261 (366)
                      ......       .......++..|+|||.+.+..++.++||||||+++|+|+++..|+....               ..
T Consensus       161 ~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         161 TDKEYY-------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cCccce-------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            332110       01113446678999999988889999999999999999999876643211               01


Q ss_pred             HHHHHHhc-CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          262 LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       262 ~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .....+.. ...+.+..++..+.+|+.+||+.||++||++     .+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~  278 (284)
T cd05079         234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-----QNLIE  278 (284)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            11111111 1233456789999999999999999999999     66664

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-41  Score=299.95  Aligned_cols=238  Identities=21%  Similarity=0.266  Sum_probs=192.2

Q ss_pred             eeeeecCceEEEEEEECCC------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           51 KIYGVGSYSKVVRAKKIDT------------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +.||+|+||.||+|.....            +..+++|++...   .......+.+|..+++.++||||+++++++.+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4689999999999985322            235888887553   2233445677888999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC-------EEEEecC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-------IKIADFG  190 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~-------vkL~Dfg  190 (366)
                      ..+++|||+++++|..++.+. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56999999999999999999999999999999999999987664       8999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhh-cCCCCCCCCCHHHHHHHHh
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII  268 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~  268 (366)
                      ++......              ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.. ...
T Consensus       158 ~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~  222 (262)
T cd05077         158 IPITVLSR--------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFY  222 (262)
T ss_pred             CCccccCc--------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHH
Confidence            98654321              1335778899999886 466889999999999999997 589998776544332 233


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       269 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..........++++.+|+.+||+.||.+||++     .+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~-----~~il~~  260 (262)
T cd05077         223 EGQCMLVTPSCKELADLMTHCMNYDPNQRPFF-----RAIMRD  260 (262)
T ss_pred             hcCccCCCCChHHHHHHHHHHcCCChhhCcCH-----HHHHHh
Confidence            33344444567889999999999999999999     777754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.3e-41  Score=297.51  Aligned_cols=237  Identities=24%  Similarity=0.418  Sum_probs=201.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|+||.||++..  +++.||+|.+..+.     ....+.+|+.+++.++|||++++++++... ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            467899999999999999999864  78899999986532     234567799999999999999999998765 4799


Q ss_pred             EEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... 
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999999999997653  48999999999999999999999999999999999999999999999999987543211 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                                  .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+... ....+..+
T Consensus       155 ------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         155 ------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC  222 (254)
T ss_pred             ------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcC
Confidence                        11223467999999988889999999999999999997 99999888877766665443 23345678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +.++.+++.+||+.+|++||++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~  244 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSF  244 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.6e-42  Score=328.14  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=221.4

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ..+...+.++.+.||+|+||+||+|...     .+...||||.++...  .......+++|++++..++|||||++++++
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            3466778899999999999999999754     344679999987652  344667799999999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKG--------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~--------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      .+++-+++|+|||..|||.+++..++              +++..+...++.||+.|+.||-++.++||||-..|+||.+
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence            99999999999999999999996532              3888999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      +-.|||+|||+++..-..+++-..        ....-..+|||||.+....++.+|||||+||++||+++ |..||.+.+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~--------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVR--------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             ceEEEecccccchhhhhhhhhccc--------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            999999999999977655544211        01123568999999999999999999999999999998 999999999


Q ss_pred             HHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          260 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       260 ~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      .+++.+.|..++ ++-|++.+.++-+|+..||+.+|++||++.+
T Consensus       711 n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  711 NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            999999998876 5678899999999999999999999999943

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.8e-41  Score=302.27  Aligned_cols=253  Identities=20%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             CcCCeeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--  116 (366)
                      ..++|++.+.||+|+||.||.|.    +..++..||+|.+...   .......+.+|+.+++.++||||+++++++..  
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            34689999999999999999997    4567889999998654   23334567789999999999999999987653  


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      ...+++||||+++++|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            45689999999999999999764 46899999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH-------------
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-------------  262 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------  262 (366)
                      ........       ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.......             
T Consensus       159 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05081         159 PQDKEYYK-------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI  231 (284)
T ss_pred             cCCCccee-------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence            43211100       0011123446999999988889999999999999999999877754322110             


Q ss_pred             --HHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          263 --IFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       263 --~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                        ....+...  ....+..++.++.+|+.+||+.+|++|||+     .+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~  278 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF-----SELAL  278 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHHH
Confidence              01111111  223456688999999999999999999999     55553

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.1e-41  Score=301.80  Aligned_cols=237  Identities=19%  Similarity=0.262  Sum_probs=191.8

Q ss_pred             eeeecCceEEEEEEECCC------------------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 017775           52 IYGVGSYSKVVRAKKIDT------------------------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  107 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  107 (366)
                      .||+|+||.||+|....+                        ...|++|++...   .......+.+|..+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            689999999999974321                        235888887543   22233456678889999999999


Q ss_pred             ceeEEEEeeCCeEEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC----
Q 017775          108 VRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----  182 (366)
Q Consensus       108 v~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~----  182 (366)
                      +++++++.+....++||||+++++|..++.+ .+.+++..+..++.|++.||+|||++||+||||||+||+++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999998865 46789999999999999999999999999999999999997643    


Q ss_pred             ---CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhh-cCCCCCCC
Q 017775          183 ---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQML-SGTSPFKD  257 (366)
Q Consensus       183 ---~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll-~g~~pf~~  257 (366)
                         .++++|||.+......              ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             ccceeeecCCccccccccc--------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence               4899999987643211              12246778999998865 55889999999999999985 69999987


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       258 ~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ....+... ........|...++++.++|.+||+.+|++|||+     .+++++
T Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~~il~~  272 (274)
T cd05076         225 RTPSEKER-FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF-----RTILRD  272 (274)
T ss_pred             cChHHHHH-HHHhccCCCCCCChHHHHHHHHHcccChhhCcCH-----HHHHHh
Confidence            76554432 3334445666678899999999999999999998     777653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=310.90  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=213.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCc---E-EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT---V-YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +.-++..+.++||+|+||.||+|..+..+.   . ||+|..+.+..........+..|.+++++++|||||++|++....
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            456677788999999999999998765422   3 899988764434455566677799999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      .-+++|||+|+||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+|++|||+++.-.
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999999999986 49999999999999999999999999999999999999999999999999987543


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC--CC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD--IR  273 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~--~~  273 (366)
                      .....          .....-...|+|||.+....++.++||||+||++||+++ |..||.+....+....+....  ..
T Consensus       314 ~~~~~----------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  314 QYVMK----------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP  383 (474)
T ss_pred             ceeec----------cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence            11100          001123468999999999999999999999999999999 899999999999999985543  44


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      .|..-+.++..++.+|+..||++||++.
T Consensus       384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  384 IPSKTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             CCCCCHHHHHHHHHHhccCChhhccCHH
Confidence            5667889999999999999999999994

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-42  Score=304.85  Aligned_cols=268  Identities=31%  Similarity=0.470  Sum_probs=220.1

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhH----HHHHHHHHHHHhCCCCCcceeEEEEe-
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AYVKLERIVLDQLDHPGVVRLFFTFQ-  115 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~-  115 (366)
                      +..-++|-++..||+|+|+.||+|.+...++.||+|+-.......++..    ...-+|..+-+.++||.||++|++|. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            3456789999999999999999999999999999998655433333322    23446899999999999999999996 


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCC---CCEEEEecC
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTAD---GHIKIADFG  190 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~---~~vkL~Dfg  190 (366)
                      +.+.++.|+|||+|.+|.-+++.++.++|.+++.|+.||+.||.||....  |||-||||.|||+...   |.+||.|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            56779999999999999999999999999999999999999999999875  9999999999999643   789999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeec-C---CCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHH
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-S---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQ  265 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~  265 (366)
                      +++.++.........   -.......||.+|++||.+. +   ...+.++||||+|||+|.++.|+-||...... ++++
T Consensus       619 LSKIMdddSy~~vdG---meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDG---MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             hhhhccCCccCcccc---eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999998776543222   22334557999999999874 2   23688999999999999999999999765432 2222


Q ss_pred             --HHhc-CCCCCC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          266 --RIIA-RDIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       266 --~i~~-~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                        .|++ ....||  +.+++++++||++||++.-++|...     .++.+||||..
T Consensus       696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV-----~qLA~dpyllP  746 (775)
T KOG1151|consen  696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV-----QQLACDPYLLP  746 (775)
T ss_pred             hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhH-----HHHccCccccc
Confidence              2333 345555  4689999999999999999999988     88999999975

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-40  Score=302.27  Aligned_cols=250  Identities=18%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      .+..++|+..+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            3567889999999999999999999987776    46888776532  22223346779999999999999999998876


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      . ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence            4 4678999999999999987753 5899999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  273 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~  273 (366)
                      ......        .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+... ...
T Consensus       160 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  231 (303)
T cd05110         160 EGDEKE--------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP  231 (303)
T ss_pred             cCcccc--------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence            432111        01112345678999999988889999999999999999997 99999877655544433322 233


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      .+...+.++.+++.+||..+|++||++.
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~  259 (303)
T cd05110         232 QPPICTIDVYMVMVKCWMIDADSRPKFK  259 (303)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            4556789999999999999999999994

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-40  Score=298.53  Aligned_cols=240  Identities=24%  Similarity=0.395  Sum_probs=199.6

Q ss_pred             eeeeecCceEEEEEEECCCC------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           51 KIYGVGSYSKVVRAKKIDTG------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +.||+|+||.||+|.++..+      ..+|+|.+....  .......+.+|+.+++.++||||+++++++.+....+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999886544      689999876532  1233445677999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-----CEEEEecCCc
Q 017775          125 ESCEGGELFDQITSK-------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----HIKIADFGSV  192 (366)
Q Consensus       125 e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-----~vkL~Dfg~a  192 (366)
                      ||+++++|.+++.+.       ..+++.++..++.|++.||.|||+.+++|+||+|+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998652       2378899999999999999999999999999999999999887     8999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-  270 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-  270 (366)
                      ..........        ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... 
T Consensus       159 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  230 (269)
T cd05044         159 RDIYKSDYYR--------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG  230 (269)
T ss_pred             cccccccccc--------cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC
Confidence            7654332110        1112345678999999988889999999999999999998 99999887776666655433 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ....+..++..+.++|.+||+.+|.+||++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         231 RLQKPENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             ccCCcccchHHHHHHHHHHcCCCcccCCCH
Confidence            345667789999999999999999999998

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-40  Score=294.24  Aligned_cols=247  Identities=21%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             eeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe-eCCeEEEEEee
Q 017775           51 KIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSLYMALES  126 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~iv~e~  126 (366)
                      +.||+|+||.||+|.+..   .+..+|+|.+...  ........+.+|..+++.++||||+++++++. .++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998653   3457999987542  12233445667889999999999999999765 45668999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +.+++|.+++.+. ..++...+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++...........  
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~--  156 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV--  156 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence            9999999999764 4467888899999999999999999999999999999999999999999999876543211100  


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  283 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  283 (366)
                          .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+... ....+..+++.+.
T Consensus       157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd05058         157 ----HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY  232 (262)
T ss_pred             ----cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence                01112235668999999988889999999999999999999 57778777776666655544 2344566789999


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +++.+||+.+|++||++     .+++.
T Consensus       233 ~li~~cl~~~p~~Rp~~-----~~il~  254 (262)
T cd05058         233 EVMLSCWHPKPEMRPTF-----SELVS  254 (262)
T ss_pred             HHHHHHcCCChhhCCCH-----HHHHH
Confidence            99999999999999999     56654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.3e-40  Score=295.69  Aligned_cols=239  Identities=22%  Similarity=0.367  Sum_probs=189.2

Q ss_pred             eeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      +.||+|+||.||+|...  .....+++|.+....  .......+.+|+..++.++|+||+++++.+.+....++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            36899999999999653  245578888775432  23334456679999999999999999999999999999999999


Q ss_pred             CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          129 GGELFDQITSKG-----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       129 g~~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +|+|.+++....     ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......... 
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI-  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence            999999997643     24677889999999999999999999999999999999999999999999986543221110 


Q ss_pred             CCCCCCCCccccccCCCCCCceeecC-------CCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCC-
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR-  273 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~-  273 (366)
                             ......++..|+|||++..       ..++.++||||+||++|+|++ |..||......+....+... ... 
T Consensus       158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05042         158 -------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL  230 (269)
T ss_pred             -------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence                   1112345677999998642       346789999999999999998 88999887766655554332 222 


Q ss_pred             ----CCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          274 ----FPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       274 ----~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                          .+..+++.+.+++..|+ .||++|||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~  260 (269)
T cd05042         231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTA  260 (269)
T ss_pred             CCCcccccCCHHHHHHHHHHh-cCcccccCH
Confidence                33468899999999999 599999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-40  Score=296.91  Aligned_cols=249  Identities=21%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEEC----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--  116 (366)
                      ..++|++.+.||+|+||.||+|...    .++..||+|.+......  .....+.+|+.+++.+.|+||+++++++..  
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            4568999999999999999999864    34889999998765322  345567889999999999999999999877  


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      ....+++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            667999999999999999997754 5899999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH-------------
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-------------  262 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------  262 (366)
                      ........       ......++..|+|||...+..++.++|+||||+++|+|++|..||.......             
T Consensus       160 ~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         160 PEDKDYYY-------VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             ccCCccee-------ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            53211100       0011234557999999988889999999999999999999999986532211             


Q ss_pred             -HHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          263 -IFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       263 -~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                       ........  ....+...+.++.+++.+||+.+|++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF  273 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCH
Confidence             11122222  233345678899999999999999999999

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-40  Score=294.61  Aligned_cols=235  Identities=20%  Similarity=0.268  Sum_probs=191.6

Q ss_pred             eeeeecCceEEEEEEECCCC----------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           51 KIYGVGSYSKVVRAKKIDTG----------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      +.||+|+||.||+|.+..++          ..+++|.+....    .....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998776          357778765432    114567779999999999999999999888 778


Q ss_pred             EEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-------CEEEEecCCc
Q 017775          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-------HIKIADFGSV  192 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-------~vkL~Dfg~a  192 (366)
                      ++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 789999999999999999999999999999999999999887       7999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCC--CCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhc
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  269 (366)
                      .......              ...++..|+|||.+.+.  .++.++|+||+|+++|+|++ |..||...+......... 
T Consensus       156 ~~~~~~~--------------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-  220 (259)
T cd05037         156 ITVLSRE--------------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-  220 (259)
T ss_pred             ccccccc--------------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-
Confidence            8653311              23456789999998876  68899999999999999999 688887664333222222 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       270 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .....+......+.+++.+||+.+|.+||++     .+++.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~  256 (259)
T cd05037         221 DQHRLPMPDCAELANLINQCWTYDPTKRPSF-----RAILR  256 (259)
T ss_pred             cCCCCCCCCchHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            2223333345889999999999999999998     56653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-43  Score=291.84  Aligned_cols=261  Identities=29%  Similarity=0.437  Sum_probs=214.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe-------
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-------  115 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-------  115 (366)
                      ..+.|+-+.+||+|.||.|++|+.+.+|+.||+|++-.+. .++..-....+|+.+|..++|+|++.+++++.       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            4567888999999999999999999999999998664321 12222233456999999999999999887664       


Q ss_pred             -eCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          116 -DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       116 -~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                       +...+|+||++|+. +|.-++.+. -+++..++..++.+++.||.|+|+..|+|||+|+.|+||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence             34459999999987 999999876 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc--C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--R  270 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~  270 (366)
                      .+...+...      .......+.|.+|++||.+.|.. |+.+.|||..|||+.+|+++.+.+.+.++...+..|..  +
T Consensus       173 ~fs~~~n~~------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  173 AFSTSKNVV------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ceecccccC------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            776554332      22345667899999999987654 99999999999999999999999999888776655532  0


Q ss_pred             -----------------CC---CCCC-------------CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          271 -----------------DI---RFPN-------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       271 -----------------~~---~~~~-------------~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                                       ..   +.|.             .-++++.+|+.++|..||.+|+++     .++++|.||..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a-----d~alnh~~F~k  320 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA-----DQALNHDFFWK  320 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch-----Hhhhchhhhhc
Confidence                             00   1111             125689999999999999999999     78999999963

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-39  Score=293.17  Aligned_cols=240  Identities=20%  Similarity=0.295  Sum_probs=189.5

Q ss_pred             eeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      +.||+|+||.||+|...  .++..+|+|.++....  ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999764  3567899998866432  2223456779999999999999999999999999999999999


Q ss_pred             CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          129 GGELFDQITSKG-----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       129 g~~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +++|.+++....     ..++..+..++.|++.||.|||++|++|+||||+||+++.+++++|+|||.+.........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~--  156 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY--  156 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence            999999987532     3567788899999999999999999999999999999999999999999998754322111  


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCC-------CCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHh-cCCCC-
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIR-  273 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~-~~~~~-  273 (366)
                            .......++..|+|||.+.+.       .++.++|+||+|+++|+|++ |..||......+...... ..... 
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05087         157 ------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL  230 (269)
T ss_pred             ------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence                  011234567889999998642       35789999999999999996 999998766655443322 22222 


Q ss_pred             ----CCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          274 ----FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       274 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                          .....++.+.+++.+|+ .+|++|||++
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~  261 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE  261 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence                22356889999999999 6899999993

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=296.65  Aligned_cols=255  Identities=18%  Similarity=0.209  Sum_probs=191.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhH--------HHHHHHHHHHHhCCCCCcce
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKT--------AYVKLERIVLDQLDHPGVVR  109 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~  109 (366)
                      .+.-++|++.+.||+|+||.||+|.+..+   +..+|+|+............        .....+...+..+.|+++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            34567899999999999999999998877   67788886543211100000        00111223445668999999


Q ss_pred             eEEEEeeCC----eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          110 LFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       110 ~~~~~~~~~----~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                      +++......    ..++++|++.. ++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence            998765433    35788888754 7777777665678999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH----
Q 017775          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----  261 (366)
Q Consensus       186 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----  261 (366)
                      |+|||+|+.+........   ..........||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..    
T Consensus       167 l~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIE---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEcCCceeeccCCcccc---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999987643221110   0111222346999999999999999999999999999999999999999876321    


Q ss_pred             -----HHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          262 -----LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       262 -----~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                           +....+......+ ...++++.+++..|+..+|++||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~  286 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDY  286 (294)
T ss_pred             HHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCH
Confidence                 1223333333333 3468999999999999999999998

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-39  Score=293.19  Aligned_cols=244  Identities=29%  Similarity=0.523  Sum_probs=203.4

Q ss_pred             CeeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecccc-------cchhhHHHHHHHHHHHHh-CCCCCcceeEEEEee
Q 017775           46 DFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFI-------TKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQD  116 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~  116 (366)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+..|+.++.. ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 788999998864321       122223345567777754 799999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          117 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      .+..+++|||++|++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      +.......           ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+....
T Consensus       161 ~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (269)
T cd08528         161 AKQKQPES-----------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV  229 (269)
T ss_pred             eeeccccc-----------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence            87654321           1224467889999999988889999999999999999999999998877776666665543


Q ss_pred             CC-CC-CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          272 IR-FP-NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       272 ~~-~~-~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .. .+ ..+++++.+++.+||+.||++||++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~  260 (269)
T cd08528         230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDI  260 (269)
T ss_pred             CCcCCcccCCHHHHHHHHHHCCCCCccCCCH
Confidence            32 22 2578999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.9e-40  Score=293.84  Aligned_cols=245  Identities=21%  Similarity=0.373  Sum_probs=200.0

Q ss_pred             eeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           47 FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      |.+.+.||+|+||.||+|..+   .++..||+|++..+... ......+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            678899999999999999864   35789999998765332 233455677999999999999999999886432     


Q ss_pred             -eEEEEEeecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          119 -SLYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       119 -~~~iv~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                       ..++++||+.+++|..++...      ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             357889999999998877532      2478899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  270 (366)
                      +..........        ......++..|++||.+.+..++.++||||||+++|+|++ |..||.+.+.......+...
T Consensus       160 ~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05074         160 SKKIYSGDYYR--------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG  231 (273)
T ss_pred             cccccCCccee--------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence            88654322110        1112234567999999988889999999999999999999 99999888776666655543


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       271 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                       ....+...++.+.+++.+||+.+|++|||+
T Consensus       232 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~  262 (273)
T cd05074         232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSF  262 (273)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence             344556788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=326.98  Aligned_cols=249  Identities=24%  Similarity=0.432  Sum_probs=216.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +......+++.||+|.||.||.|.......     .||+|.+.+.  ...+....+.+|..+|+.++||||+++++++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            456678899999999999999998764332     3888877653  456666778889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          117 TFSLYMALESCEGGELFDQITSK-------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      ....+|++|||.||+|..++.+.       ..++......++.+|++|++||++++++||||...|+|++....||++||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999875       24899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHH-H
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR-I  267 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~-i  267 (366)
                      |+|+.+...+++....        .-.-...|||||.+....++.|+||||+||++||+++ |..||.+.+..+++.. .
T Consensus       847 GlArDiy~~~yyr~~~--------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~  918 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHG--------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL  918 (1025)
T ss_pred             chhHhhhhchheeccC--------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence            9999655544432211        1122357999999999999999999999999999999 9999999999888874 4


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          268 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       268 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..+.++.|.+.+..+-+++.+||+.+|++||+.
T Consensus       919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F  951 (1025)
T KOG1095|consen  919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSF  951 (1025)
T ss_pred             hCCccCCCCCCChHHHHHHHHHccCChhhCccH
Confidence            456788899999999999999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1e-40  Score=303.24  Aligned_cols=253  Identities=27%  Similarity=0.471  Sum_probs=213.3

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~  115 (366)
                      +.-.+|.+....|+|-||+|..|.+...|..||||+|....    .-...=..|+++|++|+      .-++++++..|.
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            34568999999999999999999999999999999997642    22223345999999984      457899999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCC
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS  191 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~  191 (366)
                      ..+++|+|+|.+.- +|.+++++.|.   |....++.++.||+.||..|...||+|.||||+|||+++. ..+||||||.
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999999999965 99999988653   8889999999999999999999999999999999999976 5799999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      |.....+..            ..+..+..|+|||++.|.+|+...|+||+||+||||.||+..|.+.+...++.-.....
T Consensus       584 A~~~~enei------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  584 ASFASENEI------------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             ccccccccc------------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            987665432            25667789999999999999999999999999999999999999988877766544322


Q ss_pred             CCCCC-----------------------------------------------------CC-------CHHHHHHHHHhhc
Q 017775          272 IRFPN-----------------------------------------------------YF-------SDAARDLIDRLLD  291 (366)
Q Consensus       272 ~~~~~-----------------------------------------------------~~-------s~~~~~li~~~L~  291 (366)
                      ..+|.                                                     .+       -..+++|+.+||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            22221                                                     01       2458999999999


Q ss_pred             CCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          292 VDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       292 ~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .||++|.|.     .++|.||||+.
T Consensus       732 LdP~KRit~-----nqAL~HpFi~~  751 (752)
T KOG0670|consen  732 LDPEKRITV-----NQALKHPFITE  751 (752)
T ss_pred             cChhhcCCH-----HHHhcCCcccC
Confidence            999999999     88999999974

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.6e-39  Score=288.48  Aligned_cols=239  Identities=17%  Similarity=0.291  Sum_probs=188.0

Q ss_pred             eeeeecCceEEEEEEECCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVGSYSKVVRAKKIDT--GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      +.||+|+||.||++.....  ...+++|.+....  .......+.+|..+++.++||||+++++.+.+....|+||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3689999999999975432  3456677665432  22334567778899999999999999999999999999999999


Q ss_pred             CCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          129 GGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       129 g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      +++|.+++.+.    ...++..++.++.||+.||.|||+.+++||||||+||+++.++.++|+|||++.........   
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence            99999999764    23677788999999999999999999999999999999999999999999987643221100   


Q ss_pred             CCCCCCCccccccCCCCCCceeecC-------CCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-----
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                           .......++..|+|||.+..       ..++.++||||+|+++|+|++ |..||...+..+....+....     
T Consensus       156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  230 (268)
T cd05086         156 -----ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF  230 (268)
T ss_pred             -----hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC
Confidence                 01123457889999998743       235678999999999999996 678998777766666544332     


Q ss_pred             -CCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          272 -IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       272 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                       ...+..+++.+.++++.|| .+|++||++
T Consensus       231 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~  259 (268)
T cd05086         231 KPQLELPYSERWYEVLQFCW-LSPEKRATA  259 (268)
T ss_pred             CCccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence             2234468899999999999 679999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=313.02  Aligned_cols=241  Identities=30%  Similarity=0.507  Sum_probs=196.5

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC------
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF------  118 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------  118 (366)
                      .-|..-+.||+|+||.||+++++.+|+.||||.++......  ..+..-+|++++++++|+|||+++++-++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            55788899999999999999999999999999998764222  2334556999999999999999998876544      


Q ss_pred             eEEEEEeecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--CC--CEEEEecCC
Q 017775          119 SLYMALESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DG--HIKIADFGS  191 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--~~--~vkL~Dfg~  191 (366)
                      .-.+|||||.||+|...+.+.   ..+++.++..++..++.||.|||++||+||||||.||++-.  +|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            468999999999999999763   35999999999999999999999999999999999999853  33  589999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCC----HHHHHHH
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQR  266 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~  266 (366)
                      |+.++.+.           ...+.+||+.|++||++.. ..|+..+|.||+||++|+++||..||....    ..+....
T Consensus       171 Arel~d~s-----------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  171 ARELDDNS-----------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             cccCCCCC-----------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            99876643           4557899999999999985 789999999999999999999999995321    2223333


Q ss_pred             HhcC---------------------CCCCCCCCCHH----HHHHHHHhhcCCCCCCC
Q 017775          267 IIAR---------------------DIRFPNYFSDA----ARDLIDRLLDVDPSGRP  298 (366)
Q Consensus       267 i~~~---------------------~~~~~~~~s~~----~~~li~~~L~~dP~~Rp  298 (366)
                      +..+                     .+++|..+++.    +-..+..+|..+|++|.
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            3221                     23445555554    44567788999999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=309.31  Aligned_cols=253  Identities=30%  Similarity=0.548  Sum_probs=219.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe-----eC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ-----DT  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~  117 (366)
                      -.-|++.+.||.|.+|.||+++++.+|+..|+|+....    .+..+.++.|.++++.. .|||++.+|++|.     .+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            45689999999999999999999999999999998764    33345577788888887 6999999999986     35


Q ss_pred             CeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +.+|+|||||.||+..+++++-  ..+.|+.+..+++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            7899999999999999999864  46899999999999999999999999999999999999999999999999999877


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      +..          ..+..+.+||+.|||||++..     ..|+..+|+||||++..||.-|.+|+...-+...+..|...
T Consensus       174 dsT----------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  174 DST----------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             ecc----------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            654          245567899999999999853     34788899999999999999999999887777666665543


Q ss_pred             C---CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          271 D---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       271 ~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      .   +.-|..++.++.+||..||.+|-.+||+.     .+++.|||++
T Consensus       244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~-----~~ll~hpFi~  286 (953)
T KOG0587|consen  244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPST-----EELLKHPFIT  286 (953)
T ss_pred             CCccccchhhHHHHHHHHHHHHHhhccccCcch-----hhhccCCccc
Confidence            3   22356789999999999999999999999     8899999997

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.2e-39  Score=314.98  Aligned_cols=260  Identities=20%  Similarity=0.282  Sum_probs=183.1

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCC----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE-
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDT----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT-  113 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-  113 (366)
                      ...+..++|++.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....+  .++...+.++..+... 
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence            4456788999999999999999999999988    99999998754211     1111111  1111122222222111 


Q ss_pred             -----EeeCCeEEEEEeecCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcee
Q 017775          114 -----FQDTFSLYMALESCEGGELFDQITSKGH--------------------LSEDEARFYTAEVVDALEYIHSMGLIH  168 (366)
Q Consensus       114 -----~~~~~~~~iv~e~~~g~~L~~~l~~~~~--------------------l~~~~~~~~~~qil~aL~~LH~~~i~H  168 (366)
                           ..+....++|+||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2456679999999999999998875421                    123456789999999999999999999


Q ss_pred             ccCCCCCeEeCC-CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-----------------
Q 017775          169 RDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----------------  230 (366)
Q Consensus       169 ~dlkp~NIli~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------------  230 (366)
                      |||||+|||++. ++.+||+|||+|+.+.....         .......+++.|+|||.+...                 
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp  349 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP  349 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence            999999999986 58999999999986543211         122356789999999965322                 


Q ss_pred             -----CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHh-cCCC---------------------CCCCCCCHHHH
Q 017775          231 -----PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDI---------------------RFPNYFSDAAR  283 (366)
Q Consensus       231 -----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~---------------------~~~~~~s~~~~  283 (366)
                           .++.++||||+||++|+|+++..++..  ....+..++ ....                     ...+..+..+.
T Consensus       350 ~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  427 (566)
T PLN03225        350 VLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW  427 (566)
T ss_pred             hhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence                 233456999999999999987766432  221111111 1110                     01112234566


Q ss_pred             HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       284 ~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      +||.+||++||++|||+     .++++||||++..+..
T Consensus       428 dLi~~mL~~dP~kR~ta-----~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        428 ELLKSMMRFKGRQRISA-----KAALAHPYFDREGLLG  460 (566)
T ss_pred             HHHHHHccCCcccCCCH-----HHHhCCcCcCCCCccc
Confidence            99999999999999999     8999999999877653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=283.48  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=214.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-----
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----  116 (366)
                      -...+|.-++.+|.|.- .|..+.+.-+++.||+|....++.... ......+|..++..++|+||++++.+|.-     
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~-~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQT-HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCc-cchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            34668999999999999 888899999999999999888754433 33445679999999999999999999853     


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 -~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                       -..+|+|||+++. +|...+..  .++.+.+..++.|++.|++|||+.||+||||||+||++..++.+|+.|||+|+.-
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence             3458999999986 99998874  4888999999999999999999999999999999999999999999999999854


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  271 (366)
                      +..           .....++.|..|+|||++.+..+...+||||+||++.||++|...|.|....+.+.++....    
T Consensus       169 ~~~-----------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  169 DTD-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             Ccc-----------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            432           24456789999999999999889999999999999999999999999888777666654310    


Q ss_pred             -----------------------C----CCCC-----------CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          272 -----------------------I----RFPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       272 -----------------------~----~~~~-----------~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                                             .    .+|+           .-+..+++|+.+||..||++|.|+     +++|+|||
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv-----~daL~HPY  312 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV-----DDALRHPY  312 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH-----HHHhcCCe
Confidence                                   0    1111           124568999999999999999999     89999999


Q ss_pred             CC
Q 017775          314 FK  315 (366)
Q Consensus       314 f~  315 (366)
                      ++
T Consensus       313 ~~  314 (369)
T KOG0665|consen  313 IK  314 (369)
T ss_pred             ee
Confidence            98

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=279.89  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=211.4

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ...|+..+.+-++.||.|+||+|++..++.+|+..|||.++....  +.....+..|.. .++.-++||||++|+....+
T Consensus        58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            346778888899999999999999999999999999999987644  223334555665 44556899999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          118 FSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~~LH-~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      +..||.||.|+- +|..+.+     ++..++|+-+-.++.-.+.||.||. ...|+|||+||+|||++..|.|||||||.
T Consensus       136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI  214 (361)
T KOG1006|consen  136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI  214 (361)
T ss_pred             CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence            999999999975 7765543     2356999999999999999999997 56899999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCCCH-HHHHHHHh
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRII  268 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~  268 (366)
                      +-.+...--.           ..-.|-..|||||.+..  ..|+.++|+||||+++||++||..|+.+.+. .+++..+.
T Consensus       215 cGqLv~SiAk-----------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv  283 (361)
T KOG1006|consen  215 CGQLVDSIAK-----------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV  283 (361)
T ss_pred             hHhHHHHHHh-----------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence            8766443211           12247778999999853  3589999999999999999999999987654 34445555


Q ss_pred             cCCCCC---CC---CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          269 ARDIRF---PN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       269 ~~~~~~---~~---~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.++.   +.   .++..+..+|..||.+|-+.||.-     .+++++||+.-.
T Consensus       284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky-----~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKY-----DDLKKFPFYRMY  333 (361)
T ss_pred             cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcch-----hhhhcCchhhhh
Confidence            554432   22   389999999999999999999988     889999999743

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.5e-40  Score=271.15  Aligned_cols=251  Identities=26%  Similarity=0.483  Sum_probs=206.9

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeC--Ce
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT--FS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~  119 (366)
                      ..++|++++.+|+|.|+.|+.|.+..+++.+++|+++      ......+.+|+.+|+.+. ||||++++++..+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4779999999999999999999999999999999884      344556889999999996 99999999998864  45


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~~~~  198 (366)
                      ..+++||++..+...+..   .++.-.++.++.+++.||.|||+.||.|||+||.|++||.. ..++|+|||+|.++...
T Consensus       110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            889999999877665543   48999999999999999999999999999999999999965 57999999999987665


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCC-CCCCHHHHHHHHhc-------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIA-------  269 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~-------  269 (366)
                      ...           .-.+.+..|.-||.+.... |+..-|+|||||++..|+..+.|| .|.+..+++.+|-.       
T Consensus       187 ~eY-----------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  187 KEY-----------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             cee-----------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            422           2446677899999986554 899999999999999999988886 45555444444321       


Q ss_pred             ------CCCCC------------------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          270 ------RDIRF------------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       270 ------~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                            -...+                        ....++++.||+.++|..|-.+|+||     .+.+.||||..+.
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa-----kEam~HpyF~~~~  329 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA-----KEAMAHPYFAPVR  329 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch-----HHHhcCchHHHHH
Confidence                  00000                        01257999999999999999999999     8899999998653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6e-38  Score=276.11  Aligned_cols=240  Identities=43%  Similarity=0.755  Sum_probs=207.7

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCchHHHH
Q 017775           57 SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI  136 (366)
Q Consensus        57 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l  136 (366)
                      +||.||+|.+..+|+.+++|++........  ...+.+|+..++.++|+|++++++.+......++++|++.+++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999999999999999876532221  456778999999999999999999999999999999999999999999


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccc
Q 017775          137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV  216 (366)
Q Consensus       137 ~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~  216 (366)
                      .....++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......           ......
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------~~~~~~  147 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------LLTTFV  147 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------cccccc
Confidence            887669999999999999999999999999999999999999999999999999988765432           122345


Q ss_pred             cCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhcCCCCCCCC---CCHHHHHHHHHhhcC
Q 017775          217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDIRFPNY---FSDAARDLIDRLLDV  292 (366)
Q Consensus       217 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~  292 (366)
                      ++..|+|||...+..++.++|+||+|++++++++|..||.. .........+..........   ++.++.+++.+||..
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVK  227 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccC
Confidence            77889999999888888899999999999999999999987 55555555555554444333   889999999999999


Q ss_pred             CCCCCCCCCCCChHhhhcCCCC
Q 017775          293 DPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       293 dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      +|++||++     .++++||||
T Consensus       228 ~p~~Rp~~-----~~~~~~~~~  244 (244)
T smart00220      228 DPEKRLTA-----EEALQHPFF  244 (244)
T ss_pred             CchhccCH-----HHHhhCCCC
Confidence            99999999     899999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=291.19  Aligned_cols=241  Identities=25%  Similarity=0.373  Sum_probs=192.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-eEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-SLYMA  123 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv  123 (366)
                      ++|.-...||+|+||.||+|.-.. |..||||.+.......   ...+..|+.++.+++|||+++++++|.+.+ ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            467777899999999999998754 4899999776542221   334888999999999999999999999988 59999


Q ss_pred             EeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCeEeCCCCCEEEEecCCccccCC-
Q 017775          124 LESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMG---LIHRDIKPENLLLTADGHIKIADFGSVKPMQD-  197 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~---i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~-  197 (366)
                      +||++.|+|.+.+....  .++.....+|+.+++.||+|||...   |+|||||++|||+|.+.+.||+|||+|+.... 
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999998764  7899999999999999999999854   99999999999999999999999999964432 


Q ss_pred             ccccccCCCCCCCCcccc-ccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC---H---HHH-------
Q 017775          198 SRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---E---WLI-------  263 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~---~~~-------  263 (366)
                      ..           ...+. .||.+|+|||.+.....+.++||||+|+++.|++||+.+.....   .   .+.       
T Consensus       231 ~~-----------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  231 DT-----------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             cc-----------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            11           11111 68999999999988889999999999999999999998876432   1   111       


Q ss_pred             --HHHHhcCCCCCCCCCC--HH---HHHHHHHhhcCCCCCCCCCC
Q 017775          264 --FQRIIARDIRFPNYFS--DA---ARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       264 --~~~i~~~~~~~~~~~s--~~---~~~li~~~L~~dP~~Rps~~  301 (366)
                        ...+++..+.- ..++  ..   +..+..+|++.+|++||++.
T Consensus       300 ~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~  343 (361)
T KOG1187|consen  300 GKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMS  343 (361)
T ss_pred             cchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHH
Confidence              11112222110 2233  22   56778899999999999984

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=298.52  Aligned_cols=248  Identities=23%  Similarity=0.397  Sum_probs=212.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCC--C--cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDT--G--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ..++....++||.|.||.||.|.....  |  -.||||..+.+.  ..+..+.+..|..+++.++||||+++++++.+. 
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            344556678999999999999987543  3  358899877653  334466788899999999999999999999864 


Q ss_pred             eEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      -.|||||.++.|.|..+++.++ .++......++.||+.||.|||+.+++||||...|||+....-|||+|||+++.++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            6899999999999999998874 599999999999999999999999999999999999999999999999999998877


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      ..++...         ...-...|||||.+.-..++.++|||.+||.+||++. |..||.+....++.-.+.++ .++.|
T Consensus       544 ~~yYkaS---------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P  614 (974)
T KOG4257|consen  544 DAYYKAS---------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP  614 (974)
T ss_pred             cchhhcc---------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC
Confidence            6544321         1123457999999999999999999999999999987 99999998887776666655 57789


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      ++.++.+-.|..+||+++|.+||...+
T Consensus       615 ~nCPp~LYslmskcWayeP~kRPrfte  641 (974)
T KOG4257|consen  615 PNCPPALYSLMSKCWAYEPSKRPRFTE  641 (974)
T ss_pred             CCCChHHHHHHHHHhccCcccCCcHHH
Confidence            999999999999999999999999855

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-39  Score=305.13  Aligned_cols=246  Identities=33%  Similarity=0.534  Sum_probs=201.2

Q ss_pred             eeeeeeeeecCce-EEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEE
Q 017775           47 FELGKIYGVGSYS-KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        47 y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      |.-.+++|.|+.| .||+|..  .|+.||||.+-      .+.....++|+.+|+.- +||||+++|+.-.+....||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHh------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            4455788999998 5899987  68899999763      33445677899999887 6999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CC--CEEEEecCCcccc
Q 017775          125 ESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DG--HIKIADFGSVKPM  195 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~----l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~--~vkL~Dfg~a~~~  195 (366)
                      |.|.. +|.++++..+.    ......+.++.|++.||++||+.+|+||||||.||||+.   ++  +++|+|||+++++
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99987 99999988411    122456889999999999999999999999999999986   33  7899999999998


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF  274 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~  274 (366)
                      ...+...       .......||.+|+|||++.....+.++|||||||++|+.++ |.+||...-..  ..+|+.++...
T Consensus       662 ~~~~sS~-------~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L  732 (903)
T KOG1027|consen  662 AGGKSSF-------SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTL  732 (903)
T ss_pred             CCCcchh-------hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccce
Confidence            7764332       23446679999999999999888889999999999999999 59999764433  34566665443


Q ss_pred             C---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          275 P---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       275 ~---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      -   ..-..++.+||.+|++++|..||+|     .++++||+|=
T Consensus       733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa-----~~VL~HPlFW  771 (903)
T KOG1027|consen  733 VHLEPLPDCEAKDLISRMLNPDPQLRPSA-----TDVLNHPLFW  771 (903)
T ss_pred             eeeccCchHHHHHHHHHhcCCCcccCCCH-----HHHhCCCccC
Confidence            2   1122289999999999999999999     8999999993

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.6e-37  Score=292.39  Aligned_cols=263  Identities=22%  Similarity=0.262  Sum_probs=188.7

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEEC----------------CCCcEEEEEEeecccccchh-----------hHHHH
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI----------------DTGTVYALKIMDKKFITKEN-----------KTAYV   92 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~   92 (366)
                      ..+..++|++.++||+|+||+||+|...                ..++.||||.+.........           ..+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            4577899999999999999999999752                34567999998653211100           01122


Q ss_pred             HHHHHHHHhCCCCCc-----ceeEEEEee--------CCeEEEEEeecCCCchHHHHHhCC-------------------
Q 017775           93 KLERIVLDQLDHPGV-----VRLFFTFQD--------TFSLYMALESCEGGELFDQITSKG-------------------  140 (366)
Q Consensus        93 ~~e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~iv~e~~~g~~L~~~l~~~~-------------------  140 (366)
                      ..|..++.+++|.++     +++++++..        ....++||||+.+++|.+++....                   
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            236666677766544     555665542        356899999999999999886421                   


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCcccc
Q 017775          141 -----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  215 (366)
Q Consensus       141 -----~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~  215 (366)
                           .++...++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+.....         ......
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------~~~~~g  370 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---------FNPLYG  370 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---------cCcccc
Confidence                 235567889999999999999999999999999999999999999999999875433210         011122


Q ss_pred             ccCCCCCCceeecCCC--------------------CC--CCCCcccchhhhhhhhcCCC-CCCCCCH-----------H
Q 017775          216 VGTAAYVPPEVLNSSP--------------------AT--FGNDLWALGCTLYQMLSGTS-PFKDTSE-----------W  261 (366)
Q Consensus       216 ~gt~~y~aPE~~~~~~--------------------~~--~~~DiwslG~il~~ll~g~~-pf~~~~~-----------~  261 (366)
                      .+++.|+|||.+....                    ++  .+.|+||+||++|+|++|.. ||.+...           .
T Consensus       371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~  450 (507)
T PLN03224        371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL  450 (507)
T ss_pred             CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH
Confidence            3478999999875322                    11  24699999999999999876 6653211           1


Q ss_pred             HHHHHHhcCCCCC--CCCCCHHHHHHHHHhhcCCC---CCCCCCCCCChHhhhcCCCCCC
Q 017775          262 LIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDP---SGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       262 ~~~~~i~~~~~~~--~~~~s~~~~~li~~~L~~dP---~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ............+  .+..++.+++|+.+||..+|   .+|+|+     +++|.||||.+
T Consensus       451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa-----~eaL~Hp~f~~  505 (507)
T PLN03224        451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV-----GQALSHRFFLP  505 (507)
T ss_pred             HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH-----HHHhCCCCcCC
Confidence            1111222233333  35678999999999999876   689999     89999999964

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=293.95  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=215.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +-.++..+.++||+|+||+|++|.++..+   -.||||+++......  ....+.+|..+|.+++|+|++++|++..+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            44566788999999999999999987543   258999998765443  45568889999999999999999999998 6


Q ss_pred             eEEEEEeecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          119 SLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      .+.+|||.+++|+|.+.+.+  +..|....+..++.||+.|+.||.++++|||||-..|+++-....|||+|||+.+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            78999999999999999987  3568899999999999999999999999999999999999998999999999999887


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      ..+....       ......-...|+|||.+....++.++|+|++||++|||++ |+.||.+....+++++|-.+ .++-
T Consensus       264 ~ned~Yv-------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR  336 (1039)
T KOG0199|consen  264 ENEDMYV-------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR  336 (1039)
T ss_pred             CCCcceE-------ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence            6542221       1112233557999999999999999999999999999998 99999999999999988754 4667


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      |+..++++-+++..||..+|.+||+.
T Consensus       337 Pk~csedIY~imk~cWah~paDRptF  362 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTF  362 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccH
Confidence            88999999999999999999999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=273.27  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=213.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      ..|.+-.+.||.|+||+||.+.+..+|+.||+|++..-+. .-.....+.+|+.+|...+|.|++..++..+-..     
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            4567888999999999999999999999999998865432 2233445667999999999999999887765432     


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+++|.+.. +|..++-....++.+.++-+++||+.||+|||+.||.||||||.|.|++.|..+|++|||+++..+..
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            37889999975 99999888888999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc--------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  269 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------  269 (366)
                      ..         ......+.|-.|+|||++.|.. |+.+.||||+|||+.|++..+..|...++.+.++.|.+        
T Consensus       210 ~~---------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  210 DR---------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             hh---------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            21         1222335678899999998765 99999999999999999999999998888777766543        


Q ss_pred             ---------------CCCCC-----------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          270 ---------------RDIRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       270 ---------------~~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                     .....           +..-..+..+++.++|..||++|.+.     ++.+.|+|.....
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~-----~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV-----EEALQHRYLEEGR  350 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH-----hhhcccccccccc
Confidence                           11111           12345678899999999999999988     8899999987544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=295.38  Aligned_cols=255  Identities=30%  Similarity=0.485  Sum_probs=224.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|+++..+|.|+||.||+++++.+++..|+|+++.+   ...+...+++|+.+++..+||||+.+++.|.....++|.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            67899999999999999999999999999999999875   455566688899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||||.||+|.+...-.++++|.++..+.+..+++|+|||+.|-+|||||-.||++++.|.+||.|||.+..+...     
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-----  165 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-----  165 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-----
Confidence            999999999999888899999999999999999999999999999999999999999999999999998766433     


Q ss_pred             CCCCCCCCccccccCCCCCCceee---cCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-----
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-----  275 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----  275 (366)
                           -.+...+.||+.|||||+.   ....|...+|||++|++..|+.--++|-...-+...+.-+.+..++.|     
T Consensus       166 -----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  166 -----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK  240 (829)
T ss_pred             -----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence                 1234467899999999985   456699999999999999999988888666556555555555555444     


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..+++.+.+|++.+|.++|++||++     +.++.|||...
T Consensus       241 ~kws~~fh~fvK~altknpKkRpta-----eklL~h~fvs~  276 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTA-----EKLLQHPFVSQ  276 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCCh-----hhheeceeecc
Confidence            3579999999999999999999999     67888999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=283.72  Aligned_cols=252  Identities=20%  Similarity=0.282  Sum_probs=212.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +.+.+-.....++++||+|.||.|.+|.-. .+..||+|..+...  .......+..|+.+|.+++||||+.+++++..+
T Consensus       531 al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D  607 (807)
T KOG1094|consen  531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD  607 (807)
T ss_pred             chhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence            334455667889999999999999999763 36899999987653  333456788899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          118 FSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +-+++++||++.|+|.+++.++.  .+.......++.||+.|++||.+.+++||||.+.|+|++.++++|++|||.++.+
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence            99999999999999999998873  3355666779999999999999999999999999999999999999999999976


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc--CCCCCCCCCHHHHHHHHhc----
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSPFKDTSEWLIFQRIIA----  269 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~----  269 (366)
                      -..+++-        .....+-..+|||||.+....++.++|+|++|+++||+++  ...||.....++..++...    
T Consensus       688 ysg~yy~--------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~  759 (807)
T KOG1094|consen  688 YSGDYYR--------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD  759 (807)
T ss_pred             ccCCcee--------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence            5544332        2223455679999999999999999999999999999875  8899998888877666432    


Q ss_pred             ----CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          270 ----RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       270 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                          .-+..|...+..+-+++.+||..+.++||+.
T Consensus       760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF  794 (807)
T KOG1094|consen  760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSF  794 (807)
T ss_pred             CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence                1234567789999999999999999999999

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=273.08  Aligned_cols=134  Identities=28%  Similarity=0.383  Sum_probs=114.9

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--------CCCcceeEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--------HPGVVRLFF  112 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~  112 (366)
                      .|.-.+|-+.++||-|-|++||+|.++.+.+.||+|+.+..    +...+....|+.+|++++        ..+||++++
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            35568999999999999999999999999999999998653    444555667999998872        346999999


Q ss_pred             EEee----CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeC
Q 017775          113 TFQD----TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLT  179 (366)
Q Consensus       113 ~~~~----~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~  179 (366)
                      .|..    ..++++|+|+. |-+|..+|...  +.++...++.|++||+.||.|||+ .||||-||||+|||+.
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9974    56799999999 55899988765  459999999999999999999995 6999999999999983

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=281.29  Aligned_cols=246  Identities=21%  Similarity=0.347  Sum_probs=214.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +...+.....+||-|.||.||.|.++...-.||||.++.+    ....+.+..|..+|+.++|||+|+++++|..+--+|
T Consensus       264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            3445667779999999999999999999999999988654    223455777999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ||+|||..|+|.+++.+..  .++.-.+.+++.||..|++||..+++|||||...|+|+.++..||++|||+++.+....
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999999998753  47777889999999999999999999999999999999999999999999999998776


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ++.-...         .-...|.|||-+....++.++|||++||+|||+.| |-.||.+.+..+++.-+.++ ...-|+.
T Consensus       420 YTAHAGA---------KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeG  490 (1157)
T KOG4278|consen  420 YTAHAGA---------KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEG  490 (1157)
T ss_pred             eecccCc---------cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCC
Confidence            5532211         22457999999998889999999999999999998 99999999888877665544 4567899


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .++.+-+|++.||+.+|.+||+.
T Consensus       491 CPpkVYeLMraCW~WsPsDRPsF  513 (1157)
T KOG4278|consen  491 CPPKVYELMRACWNWSPSDRPSF  513 (1157)
T ss_pred             CCHHHHHHHHHHhcCCcccCccH
Confidence            99999999999999999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=289.74  Aligned_cols=253  Identities=21%  Similarity=0.353  Sum_probs=221.2

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      ...+......+.++||.|.||.|++|+.+..|+   .||||.++.-.  .+.....+..|..+|-+..||||+++.++..
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            445667788999999999999999999887664   69999987653  4445666888999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ...-+.||+|||+.|+|..++.++ +.++..++..+++.|+.|++||-+.|.+||||...|||++.+-.+|++|||+++.
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999999999876 7799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCcccccc--CCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-
Q 017775          195 MQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-  270 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-  270 (366)
                      +++....         ...+..|  ..+|.|||.+....++.++|+||+|++|||.++ |..||...+..++++.|..+ 
T Consensus       781 ledd~~~---------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy  851 (996)
T KOG0196|consen  781 LEDDPEA---------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY  851 (996)
T ss_pred             cccCCCc---------cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc
Confidence            7654311         1111112  357999999999999999999999999999887 99999999999999988765 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      .++.|-+.+..+.+|+..||++|-.+||...|
T Consensus       852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~q  883 (996)
T KOG0196|consen  852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQ  883 (996)
T ss_pred             CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHH
Confidence            56667789999999999999999999999943

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-37  Score=280.97  Aligned_cols=226  Identities=30%  Similarity=0.446  Sum_probs=193.4

Q ss_pred             CCCCCCCcccCccccccCCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhH-----HHHHH
Q 017775           20 SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT-----AYVKL   94 (366)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~   94 (366)
                      +....++......-....+.+.-...+|..++.+|+|+||.|++|.++.+...|++|.+.++.+-.....     ..+-.
T Consensus       536 ~~~ee~~~a~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~  615 (772)
T KOG1152|consen  536 PWFEEPTKAVEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPS  615 (772)
T ss_pred             CCCcCCccccCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccch
Confidence            3444444444444444566777778899999999999999999999999999999999988754333222     23446


Q ss_pred             HHHHHHhCC---CCCcceeEEEEeeCCeEEEEEeec-CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 017775           95 ERIVLDQLD---HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD  170 (366)
Q Consensus        95 e~~~l~~l~---h~~iv~~~~~~~~~~~~~iv~e~~-~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~d  170 (366)
                      |+++|..++   |+||++++++|++++++|++||.- +|.+|++++..++.++|.++..+++|++.|+++||+.||+|||
T Consensus       616 EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrd  695 (772)
T KOG1152|consen  616 EIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRD  695 (772)
T ss_pred             hHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecc
Confidence            999999997   999999999999999999999964 5789999999999999999999999999999999999999999


Q ss_pred             CCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhh
Q 017775          171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQML  249 (366)
Q Consensus       171 lkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll  249 (366)
                      ||-+|+.++.+|-+||+|||.|.......            ...++||..|.|||++.|..| +..-|||+||+++|.+.
T Consensus       696 ikdenvivd~~g~~klidfgsaa~~ksgp------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv  763 (772)
T KOG1152|consen  696 IKDENVIVDSNGFVKLIDFGSAAYTKSGP------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV  763 (772)
T ss_pred             cccccEEEecCCeEEEeeccchhhhcCCC------------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence            99999999999999999999988655443            337799999999999999886 67789999999999999


Q ss_pred             cCCCCCCC
Q 017775          250 SGTSPFKD  257 (366)
Q Consensus       250 ~g~~pf~~  257 (366)
                      ....||.+
T Consensus       764 ykenpyyn  771 (772)
T KOG1152|consen  764 YKENPYYN  771 (772)
T ss_pred             eccCCCcC
Confidence            99999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=311.40  Aligned_cols=235  Identities=20%  Similarity=0.274  Sum_probs=184.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|...+.||+|+||.||+|.+..+|..||+|.+.....       ....|+..+++++||||+++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            45667889999999999999999999999998864321       11235778899999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH---SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH---~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |+++|+|.+++..   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.......     
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999999999853   889999999999999999999   6799999999999999988887765 554432211     


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH-----HHHHHHH---------h
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-----WLIFQRI---------I  268 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i---------~  268 (366)
                               .....+++.|+|||.+.+..++.++||||+||++|||++|+.||.....     .+.....         .
T Consensus       835 ---------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        835 ---------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             ---------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence                     1123578899999999998999999999999999999999999853211     1111110         0


Q ss_pred             cCCC----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          269 ARDI----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       269 ~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ....    ..+.....++.+++.+||+.||++||++     .++++
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~  946 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA-----NDVLK  946 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH-----HHHHH
Confidence            1111    1111122357789999999999999999     56654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.2e-35  Score=264.83  Aligned_cols=265  Identities=28%  Similarity=0.415  Sum_probs=206.9

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  116 (366)
                      +...+.|..+.+||+|+|++||++.+..   .++.||+|.+....     ....+..|+++|..+ .+.||+++.+.+..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            4557789999999999999999999877   78899999886542     234478899999888 59999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~  195 (366)
                      ++.+.+|+||++..+..++...   ++..+++.+++.++.||.++|.+||+||||||.|++.+.. ++-.|+|||+|...
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            9999999999998777777654   7899999999999999999999999999999999999854 78999999999732


Q ss_pred             CCcccc----------ccC------------------------CCCCCCCccccccCCCCCCceeecCCC-CCCCCCccc
Q 017775          196 QDSRIT----------VLP------------------------NAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWA  240 (366)
Q Consensus       196 ~~~~~~----------~~~------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws  240 (366)
                      +.....          ..+                        ............||++|+|||++...+ .+.++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            222100          000                        111122334557999999999987655 788999999


Q ss_pred             chhhhhhhhcCCCCCCCCCH-HHHHHHH--------------hcCC---------------------C------------
Q 017775          241 LGCTLYQMLSGTSPFKDTSE-WLIFQRI--------------IARD---------------------I------------  272 (366)
Q Consensus       241 lG~il~~ll~g~~pf~~~~~-~~~~~~i--------------~~~~---------------------~------------  272 (366)
                      .|+|+..++++.+||..... ...+..|              ..+.                     +            
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            99999999999999853211 0000000              0000                     0            


Q ss_pred             ----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 ----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                          ...+.++..+.+|+.+||+.||.+|.||     +++|+||||...+
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitA-----EeALkHpFF~~~~  388 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITA-----EDALKHPFFDEAD  388 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccH-----HHHhcCcCCcchh
Confidence                0112356689999999999999999999     8999999998654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=239.47  Aligned_cols=214  Identities=25%  Similarity=0.437  Sum_probs=173.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      -++...+..||+|++|.|-+.++..+|...|+|.+...... ... ..+.+|+.+. +...+|++|.+|+.+.+...++|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q-~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQ-KRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHH-HHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            44667789999999999999999999999999999776432 222 2344466654 44579999999999999999999


Q ss_pred             EEeecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          123 ALESCEGGELFDQI----TSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       123 v~e~~~g~~L~~~l----~~~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .||.++. +|..+.    .+.+.++|.-+-+++..++.||.|||++ .++|||+||+||||+.+|+||+||||.+-.+.+
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9999976 776554    3456799999999999999999999965 899999999999999999999999999876644


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeec----CCCCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhcCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~  271 (366)
                      .--..           --.|-..|+|||.+.    ...|+.++||||||+++.||+++++||.. .++.++++++.+..
T Consensus       202 SiAkt-----------~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  202 SIAKT-----------MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             hhHHH-----------HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            31111           123666899999874    34689999999999999999999999964 56677777776653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=275.33  Aligned_cols=249  Identities=25%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEEC---C----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKI---D----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      .++..+.+.||+|.||.|++|.-.   .    ....||||..+.....  .....+..|+.+++.+ +|+||+.+++++.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            334466779999999999999743   1    1457999988765332  4556678899999988 5999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC
Q 017775          116 DTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~  179 (366)
                      ..+.+++|+||+..|+|..++...+                .++......++.||+.|++||++.+++||||-..|||+.
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence            9999999999999999999998765                388999999999999999999999999999999999999


Q ss_pred             CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCC
Q 017775          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (366)
Q Consensus       180 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  258 (366)
                      .+..+|++|||+|+.......+......      .. -...|||||.+....++.++||||+|+++||+++ |..||.+.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~------~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSA------GT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCC------Cc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999965544333211000      00 1235999999999899999999999999999998 99999986


Q ss_pred             C-HHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          259 S-EWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       259 ~-~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      . ..+..+.+..+ ....|...++++-++++.||+.+|++||+..
T Consensus       526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~  570 (609)
T KOG0200|consen  526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS  570 (609)
T ss_pred             CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            5 55666666665 4578888999999999999999999999983

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.5e-32  Score=233.70  Aligned_cols=212  Identities=39%  Similarity=0.664  Sum_probs=185.4

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecCCCch
Q 017775           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (366)
Q Consensus        53 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L  132 (366)
                      ||+|++|.||++....+|+.+++|++.......  ....+.+|+..++.+.|++++++++++......++++|++.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999987653221  345678899999999999999999999999999999999998999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEecCCccccCCccccccCCCCCCC
Q 017775          133 FDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (366)
Q Consensus       133 ~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~  210 (366)
                      .+++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........          
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----------  148 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----------  148 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence            9999876 46899999999999999999999999999999999999999 89999999999886544321          


Q ss_pred             CccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 017775          211 KACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (366)
Q Consensus       211 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  289 (366)
                      ......+...|++||..... .++.++|+|++|++++++                               ..+.+++.+|
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~  197 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKM  197 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHH
Confidence            11234567789999998877 788899999999999999                               5789999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCC
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHP  312 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp  312 (366)
                      ++.||++||++     +++++|+
T Consensus       198 l~~~p~~R~~~-----~~l~~~~  215 (215)
T cd00180         198 LQKDPEKRPSA-----KEILEHL  215 (215)
T ss_pred             hhCCcccCcCH-----HHHhhCC
Confidence            99999999998     7888764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=252.78  Aligned_cols=242  Identities=21%  Similarity=0.326  Sum_probs=191.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC--CCCCcceeEEEEeeCC-
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLFFTFQDTF-  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~-  118 (366)
                      .+....++.++||+|.||.||+|+.  +++.||||++      .....+.+..|..+.+..  +|+||++++.+-+... 
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKif------p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIF------PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhc--cCceeEEEec------CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            3466778899999999999999987  5689999998      445566777888887764  7999999998876544 


Q ss_pred             ---eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCeEeCCCCCEEE
Q 017775          119 ---SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------GLIHRDIKPENLLLTADGHIKI  186 (366)
Q Consensus       119 ---~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~---------~i~H~dlkp~NIli~~~~~vkL  186 (366)
                         .+++|+||.+.|+|.++++.+ .++.....+++..++.||+|||+.         .|+|||||..||||..|++.-|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               799999999999999999986 589999999999999999999963         4999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCC-C-----CCCCcccchhhhhhhhcCCC-------
Q 017775          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-T-----FGNDLWALGCTLYQMLSGTS-------  253 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DiwslG~il~~ll~g~~-------  253 (366)
                      +|||+|.++....        +......-+||.+|||||++.+.-. .     .+.||||+|.|+||+++.-.       
T Consensus       358 aDFGLAl~~~p~~--------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v  429 (534)
T KOG3653|consen  358 ADFGLALRLEPGK--------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV  429 (534)
T ss_pred             eccceeEEecCCC--------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence            9999999886432        1223334689999999999976432 1     35799999999999987422       


Q ss_pred             -----CCC-----CCCHHHHHHHHh--cCCCCCCCC-----CCHHHHHHHHHhhcCCCCCCCCC
Q 017775          254 -----PFK-----DTSEWLIFQRII--ARDIRFPNY-----FSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       254 -----pf~-----~~~~~~~~~~i~--~~~~~~~~~-----~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                           ||.     ..+-+++.....  +.++.+|+.     .-.-+++.+..||+.||+-|.||
T Consensus       430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence                 232     111223333322  234445543     24558999999999999999998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-33  Score=249.20  Aligned_cols=243  Identities=22%  Similarity=0.346  Sum_probs=185.9

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHH--hCCCCCcceeEEEEeeCC--
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD--QLDHPGVVRLFFTFQDTF--  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~--  118 (366)
                      .-++..+.+.||+|.||.||+|.+  -|+.||||++...    +  .....+|.++.+  .++|+||+.+++.-..++  
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr----d--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR----D--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc--cCCceEEEEeccc----c--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            356789999999999999999998  5889999998542    1  233444555555  469999999987755332  


Q ss_pred             --eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEeCCCCCEEEEe
Q 017775          119 --SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIAD  188 (366)
Q Consensus       119 --~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~--------~i~H~dlkp~NIli~~~~~vkL~D  188 (366)
                        ++|+|++|-+.|+|++++.+. .++.+....++..++.||++||..        .|+|||||..||||..+|.+-|+|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence              489999999999999999984 699999999999999999999953        399999999999999999999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCC-----C-CCCCcccchhhhhhhhcC----------C
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-----T-FGNDLWALGCTLYQMLSG----------T  252 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~-~~~DiwslG~il~~ll~g----------~  252 (366)
                      +|+|-.........      .......+||.+|||||++...-.     + ..+||||+|.|+||++..          +
T Consensus       360 LGLAv~h~~~t~~i------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTI------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             ceeeEEecccCCcc------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            99998765543221      223346789999999999865431     1 357999999999999762          5


Q ss_pred             CCCCC-----CCHHHHHHHHh--cCCCCCCCCCC-----HHHHHHHHHhhcCCCCCCCCC
Q 017775          253 SPFKD-----TSEWLIFQRII--ARDIRFPNYFS-----DAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       253 ~pf~~-----~~~~~~~~~i~--~~~~~~~~~~s-----~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +||.+     .+.+++.+-+.  ...+.+|..+.     ..+..+++.||..||.-|.||
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            67753     22233333222  22344444332     236678999999999999998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=265.68  Aligned_cols=245  Identities=19%  Similarity=0.326  Sum_probs=206.7

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+..++||+|+||+||+|.+-..|+    +||+|++....  .......+.+|...|.+++|||++++++++.... +-|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4567899999999999999866555    57888776542  2333455777999999999999999999998765 889


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |++|+++|+|.+++..+ +++-......|..||++|+.|||.++++||||-..|+||..-.++|+.|||+++........
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999999875 56888999999999999999999999999999999999999999999999999877554322


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                      .        ........+.|+|-|.+....|+.++||||+||++||++| |..|+.+..-.++-..+..+ ++..|+..+
T Consensus       855 y--------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCt  926 (1177)
T KOG1025|consen  855 Y--------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICT  926 (1177)
T ss_pred             c--------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCcc
Confidence            2        1112233557899999999999999999999999999999 99999998888776665543 477788999


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      -++-.++.+||-.|+..||++++
T Consensus       927 iDVy~~mvkCwmid~~~rp~fke  949 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKE  949 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHH
Confidence            99999999999999999999843

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-31  Score=233.84  Aligned_cols=214  Identities=40%  Similarity=0.689  Sum_probs=183.1

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |.+.+.||.|++|.||+|....+++.+++|.+......  .....+..|+..++.++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999988999999999765322  2455677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~-l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +++++|.+++..... +++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+.......      
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------  152 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------  152 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence            999999999988766 8999999999999999999999999999999999999999999999999988764432      


Q ss_pred             CCCCCCccccccCCCCCCceee-cCCCCCCCCCcccchhhhhhhhcCCCCCCC-CC-HHHHHHHHhcCC
Q 017775          206 AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKD-TS-EWLIFQRIIARD  271 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~-~~~~~~~i~~~~  271 (366)
                         ........++..|++||.+ ....++.++|+|++|+++++|++|+.||.. .+ ...+.+.+..+.
T Consensus       153 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      153 ---AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ---cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence               0011234577889999998 666678899999999999999999999977 34 445666666554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=229.90  Aligned_cols=236  Identities=24%  Similarity=0.377  Sum_probs=184.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEE-EeeCCeEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT-FQDTFSLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~  121 (366)
                      .+.|.+.+.+|+|.||.+.+|.++.+++.+++|.+..+...    ...+.+|...--.| .|.||+.-|++ |++.+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            46799999999999999999999999999999999876433    33355565543333 68999987765 67778899


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--CCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +++||++.|+|..-+...| +-|..-..++.|++.|+.|+|+++++|||||.+||||-.  ..+|||+|||..+..+..-
T Consensus        99 F~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             EeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999999999998887654 888899999999999999999999999999999999953  3589999999988654431


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCC-----CCCCCCcccchhhhhhhhcCCCCCCCCCH-----HHHHHHHhc
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----ATFGNDLWALGCTLYQMLSGTSPFKDTSE-----WLIFQRIIA  269 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~  269 (366)
                                   .....+..|.+||......     ....+|+|.+|+++|.++||.+||.....     .+..+=...
T Consensus       178 -------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  178 -------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             -------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence                         1122355799999764221     45678999999999999999999963221     222222222


Q ss_pred             CCCCCC---CCCCHHHHHHHHHhhcCCCCCC
Q 017775          270 RDIRFP---NYFSDAARDLIDRLLDVDPSGR  297 (366)
Q Consensus       270 ~~~~~~---~~~s~~~~~li~~~L~~dP~~R  297 (366)
                      .....|   ..+++.+..+.++-|..+|++|
T Consensus       245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             cCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence            333444   3579999999999999999999

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-33  Score=262.07  Aligned_cols=260  Identities=36%  Similarity=0.677  Sum_probs=227.1

Q ss_pred             eeeecCceEEEEEEE---CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEEeec
Q 017775           52 IYGVGSYSKVVRAKK---IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~  127 (366)
                      .+|.|+||.|++++.   ...|..||+|+.++......... ....|..++..++ ||.+++++..++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998753   45688899999887655444433 4556788888886 999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       128 ~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                      .||+|...+.+...+++...+.+...++-|++++|+.+|+|||+|++||+++.+|++++.|||+++..-..+        
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--------  151 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--------  151 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence            999999999888889999999999999999999999999999999999999999999999999998664432        


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID  287 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  287 (366)
                            ..+||..|||||+..  ....++|+||+|+++++|++|..||.+    +....|+...+..|..++..++++++
T Consensus       152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~  219 (612)
T KOG0603|consen  152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFR  219 (612)
T ss_pred             ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHH
Confidence                  127899999999998  667789999999999999999999988    77788999999999999999999999


Q ss_pred             HhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC-CCCCCC
Q 017775          288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKLAS  332 (366)
Q Consensus       288 ~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~-~~~~~~  332 (366)
                      .++..+|.+|.......+.++++|+||+.++|+.+.... +|++++
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp  265 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKP  265 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence            999999999998866677999999999999999776543 344433

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=230.91  Aligned_cols=250  Identities=15%  Similarity=0.267  Sum_probs=208.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe-
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-  115 (366)
                      +...+++....+-+|.||.||.|.+++.+     +.|-+|.++..  ..+-....+..|-.++..+.|||+.++.++.. 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            45668888999999999999999776432     34556655442  13334455666888888889999999988865 


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEE
Q 017775          116 DTFSLYMALESCEGGELFDQITSK--------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~--------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                      +....+.++.+..-|+|..++...        ..++..++..++.|+..|++|||++|++|.||...|.+|++.-+|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence            456678888999889999999732        237888899999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHH
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  266 (366)
                      |=.+++.+-..++........        ....|||||.+.+..|+.++|+||+|+++|||+| |+.|+...++.++..-
T Consensus       439 DsaLSRDLFP~DYhcLGDnEn--------RPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNEN--------RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             cchhccccCcccccccCCCCC--------CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999887776665443221        2457999999999999999999999999999999 9999999999999888


Q ss_pred             HhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          267 IIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       267 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      +.++ ++..|.+.++++-.++.-||..+|++||+..
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~  546 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFS  546 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHH
Confidence            8776 4667889999999999999999999999983

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.8e-32  Score=275.94  Aligned_cols=205  Identities=18%  Similarity=0.196  Sum_probs=147.5

Q ss_pred             CCcceeEEEE-------eeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          105 PGVVRLFFTF-------QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       105 ~~iv~~~~~~-------~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      +||.++++++       .....++.++|++. ++|.+++... ..+++.++..++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4677777766       23346788889885 5999999763 4699999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccc---cccCCC----------------------CCCCCccccccCCCCCCceeecCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRI---TVLPNA----------------------ASDDKACTFVGTAAYVPPEVLNSSP  231 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~----------------------~~~~~~~~~~gt~~y~aPE~~~~~~  231 (366)
                      ||+..|.+|++|||++........   ...+..                      .........+||+.|+|||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            997766666666665543322100   000000                      0000112246899999999999999


Q ss_pred             CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       232 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ++.++||||+||++|||++|.+|+.....  ....+.....+ ....-.+...+++.+||++||.+||++     .++++
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~-----~eil~  264 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSM-----SELLQ  264 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcCh-----HHHhh
Confidence            99999999999999999999988754322  12222111111 111124567899999999999999999     89999


Q ss_pred             CCCCCCC
Q 017775          311 HPFFKGI  317 (366)
Q Consensus       311 hp~f~~~  317 (366)
                      ||||...
T Consensus       265 h~~~~~~  271 (793)
T PLN00181        265 SEFINEP  271 (793)
T ss_pred             chhhhhh
Confidence            9999764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-30  Score=254.43  Aligned_cols=260  Identities=26%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecc---cccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKK---FITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ....++|.|++|.|+.+........++.|.+...   ..........+..|..+-..+.|+|++.....+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            5678899999999998888877777777765522   1111111122555666777889999988777766666666669


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      |||++ +|+.++...+.++..++..++.|++.||+|+|+.||.|||+||+|++++.+|.+|++|||.+..+......   
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~---  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK---  476 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence            99999 99999999888999999999999999999999999999999999999999999999999998766443211   


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCC-CCCCcccchhhhhhhhcCCCCCCCCCHHHHH-HH--------HhcCCCCC
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-QR--------IIARDIRF  274 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~--------i~~~~~~~  274 (366)
                         ........+|+..|+|||.+.+..|+ ...||||.|++++.|.+|+.||......+.. ..        +..+...+
T Consensus       477 ---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  477 ---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             ---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence               11344567899999999999988875 4679999999999999999999765444321 11        11111222


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ...++...+.+|.+||+.||.+|.|+     ++|++.+||+.++-
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti-----~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITI-----EQILNDEWIRSIEC  593 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecH-----HHHhhChHhhhcce
Confidence            34578899999999999999999999     89999999998763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=8.9e-30  Score=214.03  Aligned_cols=158  Identities=25%  Similarity=0.270  Sum_probs=128.9

Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCC
Q 017775          130 GELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (366)
Q Consensus       130 ~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~  208 (366)
                      |+|.+++..+ +.+++.+++.++.|++.||.|||+++      ||+||+++.++.+++  ||++......          
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence            5899999874 46999999999999999999999998      999999999999999  9998765332          


Q ss_pred             CCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCCCC-------CCCCCCH
Q 017775          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIR-------FPNYFSD  280 (366)
Q Consensus       209 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~  280 (366)
                           ...|++.|+|||++.+..++.++||||+||++|+|++|..||...... .....+......       .+..++.
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSA  137 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHh
Confidence                 125789999999999999999999999999999999999999765432 223333222111       1223344


Q ss_pred             --HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          281 --AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       281 --~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                        ++.+++.+||+.||.+||++     .+++.|+|+.
T Consensus       138 ~~~~~~~i~~cl~~~p~~Rp~~-----~~ll~~~~~~  169 (176)
T smart00750      138 ARSFADFMRVCASRLPQRREAA-----NHYLAHCRAL  169 (176)
T ss_pred             hhhHHHHHHHHHhcccccccCH-----HHHHHHHHHH
Confidence              69999999999999999999     8999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-28  Score=200.40  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~  117 (366)
                      .+.+..+.|.+++.||.|+||.+|+|....+|+.||+|+-.....     ...+..|..+.+.+++ ..|..+..+..+.
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            345667899999999999999999999999999999998755422     2235557888888864 6777788888888


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCCcc
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVK  193 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~a~  193 (366)
                      .+-.+|||.. |.+|.+++.-. ..++..++..++-|++.-++|+|.++++||||||+|+|..-+   ..+.|+|||+|+
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence            8899999998 67998887644 469999999999999999999999999999999999999743   479999999999


Q ss_pred             ccCCcccc-ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC---HHHHHHHHhc
Q 017775          194 PMQDSRIT-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIA  269 (366)
Q Consensus       194 ~~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~  269 (366)
                      ++...... ..+    -.......||..|.+--...+...+...|+-|+|.++.++..|..||.+..   ..+-+++|.+
T Consensus       163 ky~d~~t~~HIp----yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E  238 (341)
T KOG1163|consen  163 KYRDIRTRQHIP----YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE  238 (341)
T ss_pred             hhccccccccCc----cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence            87654322 111    123346679999999988888888999999999999999999999998754   3455667777


Q ss_pred             CCCCCC-----CCCCHHHHHHHHHhhcCCCCCCCC
Q 017775          270 RDIRFP-----NYFSDAARDLIDRLLDVDPSGRPG  299 (366)
Q Consensus       270 ~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps  299 (366)
                      .+...|     ..+|.++--.+.-|-..--++-|.
T Consensus       239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence            666544     568888888888887666666664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.6e-27  Score=219.19  Aligned_cols=197  Identities=20%  Similarity=0.210  Sum_probs=143.3

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      .+.+...++|.+.+.||+|+||+||+|.++. +++.+|+|++.....  ........+.+|+.+++.++|+|+++.+.. 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            3455668899999999999999999999876 678889998753311  123345568899999999999999853322 


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCeEeCCCCCEEEEecCCcc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI-KPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dl-kp~NIli~~~~~vkL~Dfg~a~  193 (366)
                        .+..|+||||++|++|.. ...   ..   ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus        90 --~~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             --cCCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence              245899999999999963 211   11   1567899999999999999999999 9999999999999999999999


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCC------CCCCCCcc-cchhhhh
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLW-ALGCTLY  246 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Diw-slG~il~  246 (366)
                      .+........  ...........++..|+|||.+....      .+...|-| .-|=+.+
T Consensus       161 ~~~~~~~~~~--~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~  218 (365)
T PRK09188        161 VFRRRGALYR--IAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVY  218 (365)
T ss_pred             ecccCcchhh--hhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEE
Confidence            7754321100  00011223567888999999985432      23345666 4444444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.95  E-value=7.7e-29  Score=242.87  Aligned_cols=254  Identities=35%  Similarity=0.572  Sum_probs=196.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .-.+|..++.|..|+||.||.++++.+.+.+|+| +++..+       .+++   ++....+|.+|              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn---ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN---ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc---cccccCCccee--------------
Confidence            3568999999999999999999999999999995 333210       0111   33333455444              


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                             |+-...++.-++++.+.        +.|++|||+.||+|||+||+|.+|+.=|++|+.|||+++..-...-..
T Consensus       136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                   46666677767776554        889999999999999999999999999999999999987543221111


Q ss_pred             cC-----CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC-
Q 017775          203 LP-----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-  276 (366)
Q Consensus       203 ~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-  276 (366)
                      .-     ....+......+||+.|.|||++....|+..+|||++|+|+|+.+-|..||.++++++++...+.....+|+ 
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence            10     011122334558999999999999999999999999999999999999999999999999998888777775 


Q ss_pred             --CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc---cCCCCCCCCCCchhh
Q 017775          277 --YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR---GQTPPKLASEPMVNF  338 (366)
Q Consensus       277 --~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~---~~~~~~~~~~~~~~~  338 (366)
                        .++++++++|.++|..+|..|....  +.-++.+|+||+.+||..+.   ....|.+..+....|
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsy  345 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSY  345 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccchhhhhhccccccccccccchh
Confidence              4889999999999999999998764  45889999999999999543   333455544444333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5e-27  Score=216.05  Aligned_cols=249  Identities=22%  Similarity=0.293  Sum_probs=192.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCC----CCCcceeEEEE-eeCCe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLD----HPGVVRLFFTF-QDTFS  119 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~  119 (366)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+..........   .+..|..++..+.    .+++..+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998775 67999987664222211   3556777777775    36889999998 57888


Q ss_pred             EEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-----CCEEEEecCCc
Q 017775          120 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----GHIKIADFGSV  192 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-----~~vkL~Dfg~a  192 (366)
                      -|+||+.+ |.+|.++....  +.++..++..++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 67999988654  479999999999999999999999999999999999999865     36999999999


Q ss_pred             c--ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH---HHHHH
Q 017775          193 K--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL---IFQRI  267 (366)
Q Consensus       193 ~--~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i  267 (366)
                      +  .+.......  ............||..|+++.+..+...+.+.|+||++.++.++..|..||.+.....   .....
T Consensus       175 r~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             ccccccCCCCcc--cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            9  432222111  0011111235669999999999999999999999999999999999999997655322   22222


Q ss_pred             hcCCCC--CCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       268 ~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ......  +....+.++.++...+-..+...+|..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy  287 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDY  287 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCH
Confidence            221111  234456778888888888888999976

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=3.1e-26  Score=209.95  Aligned_cols=258  Identities=38%  Similarity=0.593  Sum_probs=207.7

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC-CcceeEEEEeeCCeEEEEEe
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP-GVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~iv~e  125 (366)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|..+++.+.|+ +++++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999997   78999999876544443566678899999999988 79999999988877899999


Q ss_pred             ecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCcccc
Q 017775          126 SCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ++.++++.+++....   .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+..+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777764   799999999999999999999999999999999999999988 7999999999855433211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecC---CCCCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCC-
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIR-  273 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~-  273 (366)
                      ....    .......|+..|+|||.+.+   ..+....|+||+|++++++++|..||.....    ......+...... 
T Consensus       159 ~~~~----~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         159 SSIP----ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             cccc----ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            1000    12346689999999999987   5788899999999999999999999877663    4444444443332 


Q ss_pred             CCCCC--------CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          274 FPNYF--------SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       274 ~~~~~--------s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .....        ...+.+++.+++..+|..|.+.     .....++|...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~-----~~~~~~~~~~~  280 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS-----SSDLSHDLLAH  280 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCH-----HHHhhchHhhC
Confidence            22111        1579999999999999999988     55555555543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-26  Score=199.85  Aligned_cols=218  Identities=23%  Similarity=0.369  Sum_probs=182.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i  122 (366)
                      --.|+++++||+|+||+++.|.+.-++++||||.-...     .....++.|....+.| ..++|..+|.+..+..+-.+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            34699999999999999999999999999999975443     2234577788888888 57999999988888888899


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-----CEEEEecCCccccC
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----HIKIADFGSVKPMQ  196 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-----~vkL~Dfg~a~~~~  196 (366)
                      |+|.. |.+|.+++.-. ..++...+..++.|++.-++++|++.+|.|||||+|+||...+     .+.++|||+|+.+.
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99998 66888888765 3599999999999999999999999999999999999998543     69999999999886


Q ss_pred             Ccccc-ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC---CCHHHHHHHHhcCC
Q 017775          197 DSRIT-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARD  271 (366)
Q Consensus       197 ~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~~i~~~~  271 (366)
                      ..... ..+    -....+..||.+||+--...+...+.+.|+-|||-++.+++.|..||.+   .+..+.+++|-+.+
T Consensus       181 Dp~TkqHIP----YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  181 DPKTKQHIP----YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             CccccccCc----cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            65422 111    2334467899999999999999999999999999999999999999975   55667777776544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=3.2e-25  Score=187.88  Aligned_cols=143  Identities=20%  Similarity=0.239  Sum_probs=112.7

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhh-----------------------HHHHHHHHHHHHhCCCCC
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-----------------------TAYVKLERIVLDQLDHPG  106 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~~  106 (366)
                      .+.||+|++|.||+|.+. +|+.||+|+++.........                       ......|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999987 89999999997653211110                       122345888999998777


Q ss_pred             cceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeEeCCCCCEE
Q 017775          107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       107 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~L-H~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                      +.....+....  .++||||++|+++.....+.+.+++..+..++.|++.+|.++ |+.||+||||||+||+++ ++.++
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            64433332222  389999999987766555556799999999999999999999 799999999999999998 57999


Q ss_pred             EEecCCccccC
Q 017775          186 IADFGSVKPMQ  196 (366)
Q Consensus       186 L~Dfg~a~~~~  196 (366)
                      |+|||+|....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=3.9e-25  Score=189.70  Aligned_cols=175  Identities=19%  Similarity=0.215  Sum_probs=135.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHH------HHHHHHHHHhCCCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------VKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      +..++|++.+++|.|+||.||++..  ++..+|+|++.......+.....      +++|+..+.++.|++|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            4578999999999999999999655  46789999997665444433333      578888999999999999988866


Q ss_pred             eC--------CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEE
Q 017775          116 DT--------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       116 ~~--------~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                      ..        ...+++|||++|.+|.+..    .+++    ....+++.+|..+|+.|++|||++|+||+++.+| ++|+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence            43        3589999999999998763    2343    2456999999999999999999999999999988 9999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhh
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML  249 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  249 (366)
                      |||...........                      ........++.++|+||||+++..+.
T Consensus       177 Dfg~~~~~~e~~a~----------------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKAK----------------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhhH----------------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99987644221100                      00233444667899999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=6.8e-26  Score=200.05  Aligned_cols=234  Identities=26%  Similarity=0.407  Sum_probs=153.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC----------CCCcceeEEEE-
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD----------HPGVVRLFFTF-  114 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~-  114 (366)
                      .+..++.||.|+++.||.+.+.+||+.+|+|++.............+++|......+.          |-.++-.++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4678899999999999999999999999999988765444445556665654444322          21222222221 


Q ss_pred             --------eeC---C-----eEEEEEeecCCCchHHHHHh---CCCC----CHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 017775          115 --------QDT---F-----SLYMALESCEGGELFDQITS---KGHL----SEDEARFYTAEVVDALEYIHSMGLIHRDI  171 (366)
Q Consensus       115 --------~~~---~-----~~~iv~e~~~g~~L~~~l~~---~~~l----~~~~~~~~~~qil~aL~~LH~~~i~H~dl  171 (366)
                              +..   .     ..+++|+-+.+ +|.+++..   ....    .......+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                    111   1     24678888865 88887642   2111    22233445689999999999999999999


Q ss_pred             CCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC--------CCCCCCCCcccchh
Q 017775          172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--------SPATFGNDLWALGC  243 (366)
Q Consensus       172 kp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~  243 (366)
                      +|+|++++.+|.+.|+||+.....+.....             ...+..|.+||....        ..++.+.|.|+||+
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence            999999999999999999987765543211             234467999997633        24678889999999


Q ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCC
Q 017775          244 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGR  297 (366)
Q Consensus       244 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  297 (366)
                      ++|.|++|..||...........    .+.....+++.+++||+.+|+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999999999986543221110    222223789999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=4.3e-24  Score=181.56  Aligned_cols=144  Identities=21%  Similarity=0.196  Sum_probs=114.4

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHhCCCCC
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------NKTAYVKLERIVLDQLDHPG  106 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~~  106 (366)
                      .+.||+|++|.||+|.+. +|+.||+|+++.......                       ........|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999987 899999999986532110                       01223456888999999998


Q ss_pred             cceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEE
Q 017775          107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       107 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vk  185 (366)
                      +.....+....  .++||||++|+++.........+++.++..++.|++.+|.++|+ .||+||||||+||+++ ++.++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            75544443332  48999999987665443344678899999999999999999999 9999999999999998 89999


Q ss_pred             EEecCCccccCC
Q 017775          186 IADFGSVKPMQD  197 (366)
Q Consensus       186 L~Dfg~a~~~~~  197 (366)
                      |+|||++.....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-24  Score=191.37  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=179.8

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCc-----------------------------------EEEEEEeecccc
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----------------------------------VYALKIMDKKFI   83 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----------------------------------~vavK~~~~~~~   83 (366)
                      .+.|..++|++++.||+|+...||.++-..+|.                                   +.|+|.+-.-..
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            567889999999999999999999987544221                                   234554422111


Q ss_pred             c--chhhHHHHHHHH------HHH--------H--------hCCCCCcceeEEEEe------------------------
Q 017775           84 T--KENKTAYVKLER------IVL--------D--------QLDHPGVVRLFFTFQ------------------------  115 (366)
Q Consensus        84 ~--~~~~~~~~~~e~------~~l--------~--------~l~h~~iv~~~~~~~------------------------  115 (366)
                      .  .......+-+|.      ..+        +        .-+|||||.+...|.                        
T Consensus       231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~  310 (598)
T KOG4158|consen  231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS  310 (598)
T ss_pred             CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence            1  111111111221      000        1        126999999875552                        


Q ss_pred             ---eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC--CCC--CEEEEe
Q 017775          116 ---DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADG--HIKIAD  188 (366)
Q Consensus       116 ---~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~--~~~--~vkL~D  188 (366)
                         +...+|+||..++. +|.+++..+ ..+....+.++.|+++|+.|||++||.|||+|.+|||+.  +|+  .+.++|
T Consensus       311 g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             ccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence               34569999999876 999999775 478888899999999999999999999999999999985  333  689999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC------CCCCCCcccchhhhhhhhcCCCCCCCCCHHH
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL  262 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  262 (366)
                      ||.+-.-+.......-.    ...-...|....||||+....+      .-.++|.|+.|.+.||++....||....+..
T Consensus       389 FGCcLAd~~hGlqlpy~----S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~  464 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYE----SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML  464 (598)
T ss_pred             cceeeeccccccccccc----cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe
Confidence            99876443322221100    1111334677789999975432      1237899999999999999999998744322


Q ss_pred             HH-HHH-hcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          263 IF-QRI-IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       263 ~~-~~i-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      .- ..- ..+-+..|+.+++.+++|+..+|+.||++|+++.-
T Consensus       465 L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  465 LDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             echhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence            11 111 12334567889999999999999999999999853

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=4.8e-25  Score=216.78  Aligned_cols=240  Identities=24%  Similarity=0.370  Sum_probs=181.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +|...+.||++.|=.|.+|++.+ | .|++|++-+..  ..-....+.+. |+. ...+++||.+++.-+-..+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68999999999999999998854 4 49999986643  22222233333 333 6667999999998888888889999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      -+|... +|++.+..++.+..-+.+-++.||+.||..+|..||+|||||.+||||+.=+-+.|+||..-+..-      .
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY------L  172 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY------L  172 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc------C
Confidence            999987 999999999889999999999999999999999999999999999999999999999998654321      1


Q ss_pred             CCCCCCC---CccccccCCCCCCceeecCC----------C-CCCCCCcccchhhhhhhhc-CCCCCCC-----------
Q 017775          204 PNAASDD---KACTFVGTAAYVPPEVLNSS----------P-ATFGNDLWALGCTLYQMLS-GTSPFKD-----------  257 (366)
Q Consensus       204 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~~ll~-g~~pf~~-----------  257 (366)
                      +.+.+.+   -..+...-..|.|||.+...          + .+++=||||+||++.||++ |++||.-           
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~  252 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA  252 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence            1110000   00111223469999987431          1 3456699999999999998 8999852           


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       258 ~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ...+..+++|.          +..+++||..|++.||++|.+|     ++.|+.
T Consensus       253 ~~~e~~Le~Ie----------d~~~Rnlil~Mi~rdPs~RlSA-----edyL~~  291 (1431)
T KOG1240|consen  253 DDPEQLLEKIE----------DVSLRNLILSMIQRDPSKRLSA-----EDYLQK  291 (1431)
T ss_pred             cCHHHHHHhCc----------CccHHHHHHHHHccCchhccCH-----HHHHHh
Confidence            22333333332          3368999999999999999999     666653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.7e-22  Score=169.87  Aligned_cols=200  Identities=14%  Similarity=0.143  Sum_probs=140.8

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..+...|++|+||+|+.+..  .+.+++.+.+...... .......+.+|+.+|+++. |+++.+++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678999999999997765  6788887766543221 1112235788999999995 5889998886    3479999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCeEeCCCCCEEEEecCCccccCCcccc--
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI-KPENLLLTADGHIKIADFGSVKPMQDSRIT--  201 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dl-kp~NIli~~~~~vkL~Dfg~a~~~~~~~~~--  201 (366)
                      ||+.|.+|......      . ...++.|++.+|.++|++||+|||| ||+||+++.+|.++|+|||+|.........  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888654321      1 2357889999999999999999999 799999999999999999999854432100  


Q ss_pred             ccC-CCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCCC
Q 017775          202 VLP-NAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (366)
Q Consensus       202 ~~~-~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~  259 (366)
                      ... .+-..-...-..+++.|++|+...-  ...-...++++.|+-+|.++|+..++.+++
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            000 0000000001125677788875432  222246699999999999999999876554

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=6.7e-22  Score=169.16  Aligned_cols=136  Identities=16%  Similarity=0.173  Sum_probs=108.0

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCcceeEEEEeeCC---e
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPGVVRLFFTFQDTF---S  119 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~  119 (366)
                      .-.+.||+|++|.||.  +..++.. +||++....   ......+.+|+.+++.+     .||||++++++++++.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            4457899999999995  7777666 699886542   22345678899999999     6799999999999874   4


Q ss_pred             EE-EEEee--cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCeEeCCC----CCEEEEecCC
Q 017775          120 LY-MALES--CEGGELFDQITSKGHLSEDEARFYTAEVVDAL-EYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGS  191 (366)
Q Consensus       120 ~~-iv~e~--~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL-~~LH~~~i~H~dlkp~NIli~~~----~~vkL~Dfg~  191 (366)
                      ++ +|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+||+++.+    +.++|+||+-
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            34 78999  5578999999764 46666  35678888887 99999999999999999999743    3899999544


Q ss_pred             c
Q 017775          192 V  192 (366)
Q Consensus       192 a  192 (366)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=5.8e-22  Score=173.58  Aligned_cols=146  Identities=19%  Similarity=0.198  Sum_probs=115.5

Q ss_pred             CeeeeeeeeecCceEEEEEE-ECCCCcEEEEEEeecccccc---------------------hhhHHHHHHHHHHHHhCC
Q 017775           46 DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITK---------------------ENKTAYVKLERIVLDQLD  103 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~  103 (366)
                      .|++.+.||+|++|.||+|. +..+|+.||+|+++......                     ......+..|...++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 67799999999997542110                     001233567999999887


Q ss_pred             CCC--cceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCeEeCC
Q 017775          104 HPG--VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTA  180 (366)
Q Consensus       104 h~~--iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~-i~H~dlkp~NIli~~  180 (366)
                      +.+  +.+++..   . ..++||||++|.+|.........+...++..++.|++.+|.+||++| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3344432   2 35899999999888766545556777778899999999999999999 99999999999998 


Q ss_pred             CCCEEEEecCCccccC
Q 017775          181 DGHIKIADFGSVKPMQ  196 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~  196 (366)
                      ++.++|+|||.+...+
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999987543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.4e-22  Score=202.58  Aligned_cols=229  Identities=26%  Similarity=0.360  Sum_probs=174.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEeeC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDT  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~  117 (366)
                      .+..+.|.+-+.||+|+||.||.|.... |+.||+|+-+......-....      +++.+|+   -+.|..+...+.-.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccC
Confidence            3566789999999999999999999877 999999988765433322222      2333333   35566777777777


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-------CCCEEEEecC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------DGHIKIADFG  190 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-------~~~vkL~Dfg  190 (366)
                      +.-++|+||.+.|+|.+++...+.+++..+..++.|++..|+.||..+||||||||+|+||..       +--++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            888999999999999999998888999999999999999999999999999999999999953       2369999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCC-CCCCHHHHHHHHhc
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIA  269 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~  269 (366)
                      .+..+.--.        +..+.....+|-.+-.+|+..|.++++.+|.|.|+.+++-|+.|++-= .+...+       .
T Consensus       847 ~siDm~lfp--------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~-------~  911 (974)
T KOG1166|consen  847 RSIDMKLFP--------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSW-------M  911 (974)
T ss_pred             cceeeeEcC--------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcce-------e
Confidence            987553211        112444567888999999999999999999999999999999987421 000000       0


Q ss_pred             CCCCCCCCCC-HHHHHHHHHhhc
Q 017775          270 RDIRFPNYFS-DAARDLIDRLLD  291 (366)
Q Consensus       270 ~~~~~~~~~s-~~~~~li~~~L~  291 (366)
                      ....++..+. +-+.+|+..+|+
T Consensus       912 ~~~~~~Ry~~~~~W~~~F~~lLN  934 (974)
T KOG1166|consen  912 VKTNFPRYWKRDMWNKFFDLLLN  934 (974)
T ss_pred             ccccchhhhhHHHHHHHHHHHhC
Confidence            0111333333 335678888888

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=5.5e-22  Score=168.34  Aligned_cols=241  Identities=17%  Similarity=0.271  Sum_probs=190.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+.+.+..+..+|.+...|..|+|++  .|..++.|+++....... ..+.+.+|.-.|+-..||||+.+++.+.....+
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            45667778889999999999999998  455677787765433222 223466788888888999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEE--EecCCccc
Q 017775          121 YMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKI--ADFGSVKP  194 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL--~Dfg~a~~  194 (366)
                      .++..|++.|+|+..+.....  .+..++.+++..++.|++|||+..  |----|....++||++-+.+|  +|--++..
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq  342 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence            999999999999999987643  678899999999999999999886  334457888999998865443  44333221


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCC---CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH--hc
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IA  269 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--~~  269 (366)
                      -                 ......+.|++||.+...+.   -.++|+||+++++|||.|...||...++.+.--+|  ..
T Consensus       343 e-----------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg  405 (448)
T KOG0195|consen  343 E-----------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG  405 (448)
T ss_pred             c-----------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc
Confidence            1                 12245789999999987663   35789999999999999999999988776644333  23


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       270 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      -...+|++++..+..|+.-|++.||.+||..+
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfd  437 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFD  437 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence            35678999999999999999999999999884

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=2e-21  Score=191.31  Aligned_cols=284  Identities=32%  Similarity=0.472  Sum_probs=226.7

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ..+.+++.+.+-+.+|+++.+..+.-..+|..++.|+......-...+.+....+-.++-...+|.++.....+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45678899999999999999999998888888887766543222222233333344444444567777665555566779


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +++++|..+++|...+.+-+..+++-++.++..+++++++||...+.|+|++|.|+++..+|+.++.|||......--..
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999985443322110


Q ss_pred             ccc-------------C-----CC---CCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC
Q 017775          201 TVL-------------P-----NA---ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (366)
Q Consensus       201 ~~~-------------~-----~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  259 (366)
                      ...             .     ..   ..........+|+.|.+||...+...+..+|+|++|+++++.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence            000             0     00   01123445679999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCC---CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC
Q 017775          260 EWLIFQRIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (366)
Q Consensus       260 ~~~~~~~i~~~~~~~~~---~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~  326 (366)
                      +...+++|.......|.   ..+.++++++.+.|..+|.+|..+.  +..++..|+||+.++|+++..+.
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc--cccccccCCccCCCCcccccccc
Confidence            99999999988877664   5799999999999999999999884  22588999999999999987553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=4.6e-22  Score=194.78  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=207.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEEC-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  121 (366)
                      ...|.+.+.||+|+|+.|-.+... .+...+|+|.+.... ........+..|..+-+.+. |.|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            556888888999999999988774 445567777766543 22333344555666666665 999999999999999999


Q ss_pred             EEEeecCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCeEeCCCC-CEEEEecCCccccCC
Q 017775          122 MALESCEGGELFDQI-TSKG-HLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQD  197 (366)
Q Consensus       122 iv~e~~~g~~L~~~l-~~~~-~l~~~~~~~~~~qil~aL~~LH-~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~  197 (366)
                      +.++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999988 5554 6788899999999999999999 99999999999999999999 999999999987755


Q ss_pred             ccccccCCCCCCCCcccccc-CCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH-HHhcC----
Q 017775          198 SRITVLPNAASDDKACTFVG-TAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ-RIIAR----  270 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~----  270 (366)
                      ..       .........+| ++.|.|||...+. ......|+||.|+++..+++|..||.......... .....    
T Consensus       178 ~~-------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (601)
T KOG0590|consen  178 KN-------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF  250 (601)
T ss_pred             cC-------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence            21       11233345567 9999999999884 46778899999999999999999997654433211 11111    


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .......++....+++.+++..+|..|.+.     +++..+||+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~-----~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSI-----EELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhcccc-----ccccccccccc
Confidence            233456789999999999999999999999     78999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=7.5e-20  Score=158.25  Aligned_cols=138  Identities=24%  Similarity=0.299  Sum_probs=114.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++.||+|++|.||+|.+  +|..+++|+.........     .......+|..++..+.|+++.....++.+....+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  678899998654322211     12234667889999999999887777777777889999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.||+++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998876432    7889999999999999999999999999999998 88999999998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.2e-19  Score=155.44  Aligned_cols=141  Identities=23%  Similarity=0.218  Sum_probs=109.4

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-------------------hhHHHHHHHHHHHHhCCCCC-
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-------------------NKTAYVKLERIVLDQLDHPG-  106 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~h~~-  106 (366)
                      |.+.+.||+|+||.||++... +|+.||+|++........                   ........|..++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888899999999999999874 799999999765421000                   01123456788888887764 


Q ss_pred             -cceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          107 -VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       107 -iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                       +...++    ....+++|||++|++|......      .....++.+++.++.++|+.||+||||+|+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2345899999999988764321      45678899999999999999999999999999999999999


Q ss_pred             EEecCCccccCCc
Q 017775          186 IADFGSVKPMQDS  198 (366)
Q Consensus       186 L~Dfg~a~~~~~~  198 (366)
                      |+|||.+......
T Consensus       166 liDfg~~~~~~~~  178 (198)
T cd05144         166 IIDWPQMVSTDHP  178 (198)
T ss_pred             EEECCccccCCCc
Confidence            9999999765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=5.2e-21  Score=176.53  Aligned_cols=181  Identities=29%  Similarity=0.454  Sum_probs=137.1

Q ss_pred             CeEEEEEeecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          118 FSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      .++||.|++|...+|.+++.++.   ..+......++.|+..|++|   +|.+|+|+||.||+...++.+||+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            45899999999999999997553   35677889999999999999   9999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCCCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR  273 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~  273 (366)
                      .....    ............+||..||+||.+.+..|+.++||||||++++|++. -...|..   ...+..+..+.++
T Consensus       406 ~~~~~----~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  406 QDKDE----TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIP  478 (516)
T ss_pred             cccCC----cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCC
Confidence            76544    11111223445689999999999999999999999999999999997 2222211   1122233333332


Q ss_pred             --CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          274 --FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       274 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                        +-..+ ++-..|+.+||...|.+||++     .+.-.|.|.
T Consensus       479 ~~~~~d~-p~e~~ll~~lls~~p~~RP~~-----~~~~~~~~~  515 (516)
T KOG1033|consen  479 PEFLQDY-PEEYTLLQQLLSPSPEERPSA-----IEVALHEFL  515 (516)
T ss_pred             hHHhhcC-cHHHHHHHHhcCCCcccCchH-----HHHhhhhhc
Confidence              11222 334589999999999999976     555555553

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.7e-19  Score=153.31  Aligned_cols=133  Identities=20%  Similarity=0.213  Sum_probs=106.6

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      .||+|++|.||+|..  +|..+++|.........     ......+.+|..+++.+.|+++.....++.+....+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            479999999999985  67889999865432111     11234566799999999888765555555566678999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ++|++|.+.+...+.       .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988765321       8899999999999999999999999999998 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.6e-18  Score=170.16  Aligned_cols=140  Identities=18%  Similarity=0.216  Sum_probs=112.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...|...+.||+|+||.||++....  ..+++|+.......     .......+.+|..+++.++|++++..+.+..+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455778999999999999998744  34454443221111     1122345678999999999999988777777777


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ..++||||++|++|.+++.        ....++.|++.+|.+||+.|++||||||+||++ .++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            7899999999999998875        356789999999999999999999999999999 678999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.79  E-value=9.4e-19  Score=148.44  Aligned_cols=141  Identities=20%  Similarity=0.268  Sum_probs=100.4

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHH---------------------HHHHHHHHHhCCCCC-
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---------------------VKLERIVLDQLDHPG-  106 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~~-  106 (366)
                      +++.||+|+||.||+|.+. +|+.||+|++.............                     ...|...+..+.+.. 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999886 89999999987643221111111                     134555555554332 


Q ss_pred             -cceeEEEEeeCCeEEEEEeecCCCchHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCC
Q 017775          107 -VVRLFFTFQDTFSLYMALESCEGGELFD-QITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       107 -iv~~~~~~~~~~~~~iv~e~~~g~~L~~-~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~  183 (366)
                       +.+.+..    ...++||||++|+.+.. .+... .. ..+++.++.+++.++.++|. .||+|+||||+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             4444443    23589999999854321 11111 01 16788999999999999999 9999999999999999 899


Q ss_pred             EEEEecCCccccCC
Q 017775          184 IKIADFGSVKPMQD  197 (366)
Q Consensus       184 vkL~Dfg~a~~~~~  197 (366)
                      ++|+|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.8e-18  Score=162.52  Aligned_cols=196  Identities=21%  Similarity=0.327  Sum_probs=152.2

Q ss_pred             HHhCCCCCcceeEEEEeeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCCe
Q 017775           99 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGL-IHRDIKPENL  176 (366)
Q Consensus        99 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i-~H~dlkp~NI  176 (366)
                      |+.+.|.|+.++++...+....++|.+||..|+|.+.+... -.++.--...+++.|+.||.|||.-.| .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35678999999999999999999999999999999999884 346777788899999999999998776 9999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC-------CCCCCCcccchhhhhhhh
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-------ATFGNDLWALGCTLYQML  249 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll  249 (366)
                      +++....+||.|||+........        .........-..-|.|||.+.+..       -+.+.|+||+|++++|++
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~--------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETA--------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeeeEEEEechhhhcccccccc--------cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            99999999999999987654310        000111112345699999987642       356789999999999999


Q ss_pred             cCCCCCCCCC----HHHHHHHHhc-CCCC-CCC-----CCCHHHHHHHHHhhcCCCCCCCCCCC
Q 017775          250 SGTSPFKDTS----EWLIFQRIIA-RDIR-FPN-----YFSDAARDLIDRLLDVDPSGRPGAGP  302 (366)
Q Consensus       250 ~g~~pf~~~~----~~~~~~~i~~-~~~~-~~~-----~~s~~~~~li~~~L~~dP~~Rps~~~  302 (366)
                      +...||....    +.+....+.. +... .|.     ...+++..+++.||..+|.+||++.+
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence            9999997522    2334444444 2211 121     34567999999999999999999954

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=2.1e-17  Score=145.06  Aligned_cols=137  Identities=20%  Similarity=0.251  Sum_probs=103.7

Q ss_pred             eeee-ecCceEEEEEEECCCCcEEEEEEeecccc-----c-----chhhHHHHHHHHHHHHhCCCCCc--ceeEEEEeeC
Q 017775           51 KIYG-VGSYSKVVRAKKIDTGTVYALKIMDKKFI-----T-----KENKTAYVKLERIVLDQLDHPGV--VRLFFTFQDT  117 (366)
Q Consensus        51 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~-----~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~  117 (366)
                      ..|| .|+.|+||.+..  .+..+++|.+.....     .     .........+|..++..+.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 788888888866  378899998864321     0     11233456779999999988775  5666654332


Q ss_pred             -Ce---EEEEEeecCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          118 -FS---LYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       118 -~~---~~iv~e~~~g-~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                       ..   .++|||+++| .+|.+++.. +.+++..    +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             22   3599999997 688888765 3566543    578999999999999999999999999999999999999988


Q ss_pred             cc
Q 017775          193 KP  194 (366)
Q Consensus       193 ~~  194 (366)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            64

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2e-18  Score=162.31  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=205.2

Q ss_pred             CCcCCeeeeeeeee--cCceEEEEEEE--CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGV--GSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  116 (366)
                      +..+.+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+............+ +|....+.+ .|++.++.+..+++
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~-~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKL-REFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccccccc-chhhcccccCccccccccCccccc
Confidence            34557788899999  99999999988  88999999998655433222222222 355555555 49999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecC
Q 017775          117 TFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVD----ALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFG  190 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qil~----aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg  190 (366)
                      .+..|+-+|+|. .+|..++..... +++..++..+.+...    ||.++|+.+++|-|+||.||+...+ ...+++|||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999999996 599898887654 899999999999999    9999999999999999999999999 899999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC--CHHHHHHHHh
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--SEWLIFQRII  268 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~  268 (366)
                      +...+....+.....     ......|...|++||...+. ++...|++++|.++.+..+|..++...  +.+.......
T Consensus       269 ~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             eeEEccCCcccccee-----eeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            999887765332211     11222567789999998764 667899999999999999988776554  4444333322


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       269 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                       ...++-...+.++...+..|++.+|..|+++     +.+++|+++..
T Consensus       343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~-----q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA-----QILTALNVIHS  384 (524)
T ss_pred             -CchhhhcCcchhhhhHHHHhcCcchhhhhHH-----HHHhccccccc
Confidence             2334445677888889999999999999999     88999998874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1e-16  Score=130.42  Aligned_cols=132  Identities=23%  Similarity=0.232  Sum_probs=111.1

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEeeCCeEEEEEee
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      +++.||.|.++.||++....  ..+++|.+.....     ...+..|...++.+.+  ..+.+++.+....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999999844  7899998865422     3456778888888876  5888999888888889999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---GLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~---~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      +.|+.+..+       +......++.+++.+|.++|..   +++|+|++|+||++++.+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            998777543       5567778899999999999985   799999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.66  E-value=1.1e-15  Score=145.40  Aligned_cols=237  Identities=17%  Similarity=0.261  Sum_probs=165.6

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEee
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  126 (366)
                      |.+ +...-++.+..-.|..+.++.+|.+.+++...   ........+-+.-++.++||||+++++.++.....|+|+|.
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr   90 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER   90 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence            444 33333333332256777889999999887652   24455677788899999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       127 ~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH-~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      +.  .|..++++.   +...+..-++||+.||.||| +.+++|++|....|+|+..|..||++|.++........     
T Consensus        91 V~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-----  160 (690)
T KOG1243|consen   91 VR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-----  160 (690)
T ss_pred             cc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-----
Confidence            85  677777764   47888889999999999997 67899999999999999999999999998865433211     


Q ss_pred             CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL  285 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  285 (366)
                           ......---.|..|+.+....  -..|.|.||+++++++.|..+  ...           ....+..++.....+
T Consensus       161 -----~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~--~~~-----------~~~~~~~ipk~~~~~  220 (690)
T KOG1243|consen  161 -----PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLL--TKT-----------DLSNTGKIPKALIEL  220 (690)
T ss_pred             -----ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccC--cch-----------hhhccCccchhHHHH
Confidence                 011111222456666654333  346999999999999998332  111           122233445556666


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ..+-+.-.+..||..-.-.....+-|+||++-
T Consensus       221 ~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~  252 (690)
T KOG1243|consen  221 YCKKLGATELKRPNKLRFILECRLLGGFFRND  252 (690)
T ss_pred             HHHHhccccccccchhhHHHHHHhccccccch
Confidence            66666677777776422122333458888753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=1.4e-15  Score=146.52  Aligned_cols=147  Identities=21%  Similarity=0.324  Sum_probs=100.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-------------------------------hhhHHHH
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------------------------------ENKTAYV   92 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~~~~   92 (366)
                      ..+|+. +.||+|++|+||+|+.+.+|+.||||+.+......                               .+....+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            446776 89999999999999998889999999997542100                               0111222


Q ss_pred             HHHHHHH------HhC----CCCCcceeEEEEee-CCeEEEEEeecCCCchHHH--HHhCC----CCCHHHHHHHHHHHH
Q 017775           93 KLERIVL------DQL----DHPGVVRLFFTFQD-TFSLYMALESCEGGELFDQ--ITSKG----HLSEDEARFYTAEVV  155 (366)
Q Consensus        93 ~~e~~~l------~~l----~h~~iv~~~~~~~~-~~~~~iv~e~~~g~~L~~~--l~~~~----~l~~~~~~~~~~qil  155 (366)
                      .+|+.+.      .++    .+...+.+-.++.+ ...-++||||++|+.+.++  +...+    .+.+..+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            3333322      222    23333333333332 4457799999999999764  33333    244555555666654


Q ss_pred             HHHHHHHHCCceeccCCCCCeEeCCCC----CEEEEecCCccccCCc
Q 017775          156 DALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDS  198 (366)
Q Consensus       156 ~aL~~LH~~~i~H~dlkp~NIli~~~~----~vkL~Dfg~a~~~~~~  198 (366)
                             ..|++|+|+||.||+++.+|    +++++|||++..+...
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   59999999999999999888    9999999999877654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.58  E-value=5.8e-14  Score=118.18  Aligned_cols=143  Identities=15%  Similarity=0.178  Sum_probs=103.5

Q ss_pred             eeeeeecCceEEEEEEECC------CCcEEEEEEeeccccc-------------------chhhHHHHH----HHHHHHH
Q 017775           50 GKIYGVGSYSKVVRAKKID------TGTVYALKIMDKKFIT-------------------KENKTAYVK----LERIVLD  100 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~-------------------~~~~~~~~~----~e~~~l~  100 (366)
                      ...||.|.-+.||.|....      .+..+|+|+++.....                   .......+.    .|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998653      3579999998743210                   011122333    7888888


Q ss_pred             hCCC--CCcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeE
Q 017775          101 QLDH--PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLL  177 (366)
Q Consensus       101 ~l~h--~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~L-H~~~i~H~dlkp~NIl  177 (366)
                      ++..  -++..++.+    ..-++||||+.+..+.....+...+++++...+..+++.+|..| |+.|++||||++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8753  445556654    45679999997654432222233466677788899999999999 8999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCC
Q 017775          178 LTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       178 i~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ++ ++.+.|+|||.+-..+.
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            96 57899999998875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.9e-14  Score=137.00  Aligned_cols=144  Identities=21%  Similarity=0.270  Sum_probs=96.3

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh-------------------------------hHH------HH
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-------------------------------KTA------YV   92 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------~~~------~~   92 (366)
                      .+.||.|++|+||+|+.+ +|+.||||+.+......-.                               ...      .+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999874 7999999998643211000                               000      12


Q ss_pred             HHHHHHHHhC----CCCCcceeEEEE-eeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 017775           93 KLERIVLDQL----DHPGVVRLFFTF-QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVD-ALEYIHSMG  165 (366)
Q Consensus        93 ~~e~~~l~~l----~h~~iv~~~~~~-~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~-aL~~LH~~~  165 (366)
                      .+|...+.++    ++.+-+.+-.++ ......++||||++|++|.+..... ...   ....++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            2233333333    222222222222 2234568999999999998876432 112   23445666665 478899999


Q ss_pred             ceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       166 i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ++|+|++|.||+++.+|+++|+|||++..+..
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=2.9e-15  Score=141.18  Aligned_cols=250  Identities=24%  Similarity=0.291  Sum_probs=188.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  119 (366)
                      ....+|..+..||.|.|+.|+.+... .++..|++|...+.......+...+ .|+.+...+ -|.+++.++..|.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccccc
Confidence            34668999999999999999998765 6888999998776544443333333 366665555 58899998888888888


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~~~~  198 (366)
                      .|+-.|||+++++.....-...+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||....+...
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            88999999998887666443458889999999999999999999999999999999999886 78999999998753222


Q ss_pred             cccccCCCCCCCCccccccCCCCC--CceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYV--PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  276 (366)
                      ..             .....-++.  +++......+..+.|++|||..+.+.++|...-.....   ...+..+......
T Consensus       421 ~~-------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~  484 (524)
T KOG0601|consen  421 SG-------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLP  484 (524)
T ss_pred             cc-------------cccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCC
Confidence            11             111222344  45555666788899999999999999998765433322   2234445455445


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      ....++..+.+.++..++..|+++     .++..|.=
T Consensus       485 ~~~~~~q~~~kv~~~~~~~~~~l~-----~~l~~~~~  516 (524)
T KOG0601|consen  485 GLKLQLQVLLKVMINPDRKRRPSA-----VELSLHSE  516 (524)
T ss_pred             chHHhhhhhhhhhcCCccccchhh-----hhhcccch
Confidence            555889999999999999999998     55555543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2.8e-16  Score=137.23  Aligned_cols=247  Identities=19%  Similarity=0.262  Sum_probs=159.9

Q ss_pred             EEEEEEECCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----eEEEEEeecCCCchH
Q 017775           60 KVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SLYMALESCEGGELF  133 (366)
Q Consensus        60 ~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~iv~e~~~g~~L~  133 (366)
                      .||++-++..|.+|+.-.+....... .......+.-..-+-++-|.||++++.+|.+..     ...++.||+..|+|.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            45666666666666544332111111 111111222223344557999999999886543     478899999999999


Q ss_pred             HHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          134 DQITSK----GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       134 ~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                      .++++.    ..+.+...++|+.||+.||.|||+..  |+|+++..+.|++..+|-+|++--.... .... .    ..-
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s-~----~~~  234 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPS-V----NST  234 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc-cchh-h----hhh
Confidence            999764    34888899999999999999999986  9999999999999999988875322111 0000 0    000


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDIRFPNYFSDAARDLI  286 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~s~~~~~li  286 (366)
                      .........+-++|.+||.=.-...+.++|||++|+...+|..+..--.... ..+.-..+...-....+   ..-++++
T Consensus       235 ~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len---~lqr~~i  311 (458)
T KOG1266|consen  235 REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN---GLQRGSI  311 (458)
T ss_pred             hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC---ccccCcC
Confidence            0011112245678999998766667779999999999999988765432221 11111122111111111   1235689


Q ss_pred             HHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      .+||+..|..||++     .+++.||.+-++...
T Consensus       312 ~kcl~~eP~~rp~a-----r~llfHpllfeVhsl  340 (458)
T KOG1266|consen  312 TKCLEGEPNGRPDA-----RLLLFHPLLFEVHSL  340 (458)
T ss_pred             cccccCCCCCCcch-----hhhhcCceeeecchH
Confidence            99999999999999     889999988666543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.52  E-value=7.2e-14  Score=116.36  Aligned_cols=127  Identities=20%  Similarity=0.206  Sum_probs=94.7

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEeeCCeEEEEEeecC
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~iv~e~~~  128 (366)
                      ++.|+.|..+.||++...  |..|++|.......    .......|..+++.+.+.+++ +++....  ...++|||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999874  78899998755421    112345688888887655544 4444433  23579999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL-----IHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       129 g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i-----~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      |.++...        .......+.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887543        11123457899999999999985     9999999999998 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.46  E-value=1.8e-12  Score=105.14  Aligned_cols=144  Identities=20%  Similarity=0.257  Sum_probs=107.7

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEe-----ecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIM-----DKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .+..+-+|+-+.|+.+..  .|+.++||.-     +.+.+...-......+|..++.++.--.|.-..-++.|...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678899999999999977  6788787732     222223333344566788888887655665555566677777899


Q ss_pred             EeecCC-CchHHHHHhC-C-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEEEecCCccc
Q 017775          124 LESCEG-GELFDQITSK-G-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  194 (366)
Q Consensus       124 ~e~~~g-~~L~~~l~~~-~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL~Dfg~a~~  194 (366)
                      |||++| .++.+++... . .........++.+|=+.+.-||.++|+||||..+||++..+|   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 5777777654 2 223333478899999999999999999999999999998765   458999999763

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=1.3e-12  Score=106.35  Aligned_cols=134  Identities=19%  Similarity=0.214  Sum_probs=99.5

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEee-cccc----cchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFI----TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      ..+++|+-+.+|.+..  -|..+++|.=. +...    ...-......+|..++..++--.|...+-+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4578999999999966  34456666332 2222    222223445678888888876666665666677788899999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      |++|..|.+.+...       ...++..+=.-+.-||..||+|+||.++||++... .+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99998888888764       14566666677788999999999999999999655 499999999874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=3.2e-13  Score=129.25  Aligned_cols=181  Identities=22%  Similarity=0.364  Sum_probs=129.6

Q ss_pred             HHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC
Q 017775          152 AEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS  230 (366)
Q Consensus       152 ~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  230 (366)
                      .+.+.|+.|+|+ .+++|++|.|++|.++.+|.+||+.|+++........ ..-..++....-.......|.|||.+.+.
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhccc
Confidence            344599999995 4899999999999999999999999999876655321 11112222333334456789999999998


Q ss_pred             CCCCCCCcccchhhhhhhh-cCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCCh
Q 017775          231 PATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGY  305 (366)
Q Consensus       231 ~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~  305 (366)
                      ..+.++|+||+|+++|.+. .|+..+...+.......-.    .+...+...+++++++=+.++|..++..||++     
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~-----  259 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL-----  259 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch-----
Confidence            8899999999999999999 5666665543322221111    12233457799999999999999999999987     


Q ss_pred             HhhhcCCCCCCCCccccccC-CCCCCCCCCchhh
Q 017775          306 AVLKMHPFFKGIDWKNIRGQ-TPPKLASEPMVNF  338 (366)
Q Consensus       306 ~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~~~~~  338 (366)
                      .+++..|||....-..++.- .-++.-+.....|
T Consensus       260 ~~l~~~~ff~D~~~~aLrfLD~l~~kdn~qKs~F  293 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKALRFLDDLPQKDNSQKSSF  293 (700)
T ss_pred             hhhhcccccCCchhhhhhhcccccccCcHHHHHH
Confidence            78999999998776666532 2233334444444

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=1.5e-11  Score=106.92  Aligned_cols=140  Identities=21%  Similarity=0.233  Sum_probs=105.0

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceeEEEEeeC---CeEEEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP--GVVRLFFTFQDT---FSLYMAL  124 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~iv~  124 (366)
                      .+.|+.|..+.||++...+ |..+++|+.......  .....+..|..+++.+.+.  .+.+++.+....   +..++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            3678999999999998743 689999987654221  1233567789999988653  456677766553   3678999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-----------------------------------------  163 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-----------------------------------------  163 (366)
                      ||++|.++.+.+.. ..+++++...++.+++.+|..||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999888765432 346777777778888888888873                                         


Q ss_pred             ---------------CCceeccCCCCCeEeCC--CCCEEEEecCCcc
Q 017775          164 ---------------MGLIHRDIKPENLLLTA--DGHIKIADFGSVK  193 (366)
Q Consensus       164 ---------------~~i~H~dlkp~NIli~~--~~~vkL~Dfg~a~  193 (366)
                                     ..++|+|++|.||+++.  ++.+.++||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                           23589999999999998  5678999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.27  E-value=6.6e-11  Score=109.98  Aligned_cols=203  Identities=23%  Similarity=0.268  Sum_probs=149.3

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe----eCCeEEEEEeecCC-Cc
Q 017775           57 SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFSLYMALESCEG-GE  131 (366)
Q Consensus        57 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~iv~e~~~g-~~  131 (366)
                      .-.+.|+|....+|..|++|.++-.........   -.-++.++++.|+|+|++.++|.    .+..+++|++|.++ ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~---t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKD---TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccc---hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            345789999999999999999854432222222   22456889999999999998886    34568999999875 67


Q ss_pred             hHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          132 LFDQITS---------------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       132 L~~~l~~---------------~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      |.++.-.               ....+|..+|.++.||..||.++|+.|+..+-|.|.+|+++.+.++++...|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            7776522               2247899999999999999999999999999999999999999899998888765443


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCC-CCCCCHHHH-HHHHhcCCCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLI-FQRIIARDIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~-~~~i~~~~~~~  274 (366)
                      ..+.                        |-+   .-..+-|.=.||.++..|.||..- +........ .+.       +
T Consensus       445 ~d~~------------------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I  490 (655)
T KOG3741|consen  445 EDPT------------------------EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------I  490 (655)
T ss_pred             CCCC------------------------cch---hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------h
Confidence            3210                        001   112356888999999999998543 112222222 122       2


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSG  296 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~  296 (366)
                      -..++.+++++|.-+...++++
T Consensus       491 ~~~yS~D~rn~v~yl~s~~~~~  512 (655)
T KOG3741|consen  491 TTTYSTDLRNVVEYLESLNFRE  512 (655)
T ss_pred             hhhhhHHHHHHHHHHHhcCccc
Confidence            2457899999999999999885

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.20  E-value=6.1e-10  Score=99.01  Aligned_cols=135  Identities=18%  Similarity=0.152  Sum_probs=93.3

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecccccc---h-----hhHHHHHHHHHHHHhCCCCCc--ceeEEEEee-----CCeEE
Q 017775           57 SYSKVVRAKKIDTGTVYALKIMDKKFITK---E-----NKTAYVKLERIVLDQLDHPGV--VRLFFTFQD-----TFSLY  121 (366)
Q Consensus        57 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~  121 (366)
                      ....|+++..  .|+.|.+|.........   .     .......+|...+..+..-+|  ..++.+.+.     ....+
T Consensus        34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            3334555543  56788899764332110   0     011125567777766633332  334444443     23578


Q ss_pred             EEEeecCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-------CCCEEEEecCC
Q 017775          122 MALESCEGG-ELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------DGHIKIADFGS  191 (366)
Q Consensus       122 iv~e~~~g~-~L~~~l~~--~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-------~~~vkL~Dfg~  191 (366)
                      +|||++++. +|.+++..  ....+......++.++...+.-||+.||+|+|+++.|||++.       ++.+.|+||+.
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            999999885 78888764  234667788899999999999999999999999999999975       46899999998


Q ss_pred             cc
Q 017775          192 VK  193 (366)
Q Consensus       192 a~  193 (366)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            75

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.19  E-value=1.9e-10  Score=96.61  Aligned_cols=129  Identities=22%  Similarity=0.247  Sum_probs=83.7

Q ss_pred             EEEEEEECCCCcEEEEEEeeccccc-----------------------chhhHHHHHHHHHHHHhCCCC--CcceeEEEE
Q 017775           60 KVVRAKKIDTGTVYALKIMDKKFIT-----------------------KENKTAYVKLERIVLDQLDHP--GVVRLFFTF  114 (366)
Q Consensus        60 ~V~~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~  114 (366)
                      .||.|.. .+|..+|+|+.+.....                       ........++|...|..+..-  ++.+++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888877 45789999998642110                       111223456799999999765  455666543


Q ss_pred             eeCCeEEEEEeecC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          115 QDTFSLYMALESCE--GGELFDQITSKGHLSEDEARFYTAEVVDALEY-IHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       115 ~~~~~~~iv~e~~~--g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~-LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                        .  -++||||+.  |..+..+....  ++.+....++.+++..+.. +|..||+||||.+.||+++++ .+.++|||.
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             --C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence              2  359999998  65554433322  2355677788888886555 579999999999999999776 999999998


Q ss_pred             ccccC
Q 017775          192 VKPMQ  196 (366)
Q Consensus       192 a~~~~  196 (366)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.12  E-value=6.6e-10  Score=96.13  Aligned_cols=140  Identities=22%  Similarity=0.237  Sum_probs=104.4

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-------------------chhhHHHHHHHHHHHHhCCCC--
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-------------------KENKTAYVKLERIVLDQLDHP--  105 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~h~--  105 (366)
                      +.++..||-|.-|.||.|.+. .|.++|+|.=+.-..+                   ........++|...|..+...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456789999999999999885 6899999954321000                   011223456788899888654  


Q ss_pred             CcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       106 ~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                      .+.+.+++    +.-.+|||+++|-.|...     +++.+.+..++..|++-+.-+-..|++|||+.+-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            66666654    345699999999777543     234666777777777777777799999999999999999999999


Q ss_pred             EEecCCccccC
Q 017775          186 IADFGSVKPMQ  196 (366)
Q Consensus       186 L~Dfg~a~~~~  196 (366)
                      ++||.-+....
T Consensus       243 vIDwPQ~v~~~  253 (304)
T COG0478         243 VIDWPQAVPIS  253 (304)
T ss_pred             EEeCcccccCC
Confidence            99998766443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=4.3e-09  Score=90.47  Aligned_cols=105  Identities=20%  Similarity=0.318  Sum_probs=82.5

Q ss_pred             HHHHHHHHHHHhCCCCC--cceeEEEEeeC----CeEEEEEeecCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 017775           90 AYVKLERIVLDQLDHPG--VVRLFFTFQDT----FSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIH  162 (366)
Q Consensus        90 ~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~iv~e~~~g-~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH  162 (366)
                      ....+|...+..+..-+  +.+.+.+.+..    ...++|+|++++ .+|.+++......+......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34556777666663322  34455555442    246899999987 479999887555778888999999999999999


Q ss_pred             HCCceeccCCCCCeEeCCCC---CEEEEecCCccc
Q 017775          163 SMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  194 (366)
Q Consensus       163 ~~~i~H~dlkp~NIli~~~~---~vkL~Dfg~a~~  194 (366)
                      ++||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.98  E-value=1.5e-08  Score=85.69  Aligned_cols=139  Identities=16%  Similarity=0.195  Sum_probs=100.1

Q ss_pred             eecCceEEEEEEECCCCcEEEEEEeecccc---cchhhHHHHHHHHHHHHhCCCCC--cceeEEEEee----CCeEEEEE
Q 017775           54 GVGSYSKVVRAKKIDTGTVYALKIMDKKFI---TKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQD----TFSLYMAL  124 (366)
Q Consensus        54 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~----~~~~~iv~  124 (366)
                      |+||.+.|+....  .|..|=+|.-.....   ........+.+|...+..+..-+  +.++...-..    ....+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            6789999998765  334677786542111   11335566888998888874322  4444422111    23478999


Q ss_pred             eecCC-CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC--EEEEecCCccc
Q 017775          125 ESCEG-GELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKP  194 (366)
Q Consensus       125 e~~~g-~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~--vkL~Dfg~a~~  194 (366)
                      |-+.| .+|.+++.+.  .+.++.....++.++..++.-||+.|+.|+|+.+.||+++.+|.  +.++||..++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 5888887663  34577888899999999999999999999999999999987777  99999987653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.95  E-value=1.3e-08  Score=92.91  Aligned_cols=232  Identities=16%  Similarity=0.192  Sum_probs=151.3

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceeEEEE------eeCC-e
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVRLFFTF------QDTF-S  119 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~------~~~~-~  119 (366)
                      ..++.||+|+.+.+|..-..  + ..+.|++....-.....      -+..|. .-.||-+-.=+.+-      .+.. .
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aq------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQ------KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh--h-chhheeecCCCchHHHH------HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            34678999999999976432  2 23558887753221111      112222 23566443211111      1222 3


Q ss_pred             EEEEEeecCCCc-hHHHHH---hC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          120 LYMALESCEGGE-LFDQIT---SK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       120 ~~iv~e~~~g~~-L~~~l~---~~---~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      +-++|..++|.. ...++.   ++   ......-+.+.++.|+.|.+.||..|-.-||+.++|+|+++++.|.|+|=..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            778888887742 222221   12   23567788999999999999999999999999999999999999999987643


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcC-CCCCCCCC-------
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSG-TSPFKDTS-------  259 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~-------  259 (366)
                      ..-.+           .......+|...|.+||.-.     +..-+...|.|.||+++++++.| ++||.+..       
T Consensus       165 qi~~n-----------g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~  233 (637)
T COG4248         165 QINAN-----------GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN  233 (637)
T ss_pred             eeccC-----------CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence            32222           22334567899999999743     34456678999999999999985 99997521       


Q ss_pred             HHHHHHHHhcC-----------CCCCC-----CCCCHHHHHHHHHhhcC--CCCCCCCCC
Q 017775          260 EWLIFQRIIAR-----------DIRFP-----NYFSDAARDLIDRLLDV--DPSGRPGAG  301 (366)
Q Consensus       260 ~~~~~~~i~~~-----------~~~~~-----~~~s~~~~~li~~~L~~--dP~~Rps~~  301 (366)
                      +.+  ..|-.+           ..+.|     ..+++++..|..+|+..  ++.-|||++
T Consensus       234 p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         234 PLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             cch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            111  011111           11111     24789999999999975  356899984

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.92  E-value=3.7e-08  Score=83.64  Aligned_cols=141  Identities=21%  Similarity=0.247  Sum_probs=91.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHH------HHHHHHHHHhC---CCCCcceeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------VKLERIVLDQL---DHPGVVRLFF  112 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l---~h~~iv~~~~  112 (366)
                      +..++|...+++-......|.+..-  +|..+++|..+......+.....      ..+++..+..+   .-.....++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            4467888888888877776666644  67899999886543221111111      12233333333   2233333333


Q ss_pred             EEe-----eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEE
Q 017775          113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       113 ~~~-----~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                      +.+     -....+++|||++|..|.+...    +++    .+...+.+++.-+|+.|+.|||.+|.|++++.+ .++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI  176 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII  176 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence            322     2345678999999988866432    333    244667788999999999999999999999755 59999


Q ss_pred             ecCCcc
Q 017775          188 DFGSVK  193 (366)
Q Consensus       188 Dfg~a~  193 (366)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.75  E-value=4.2e-08  Score=94.53  Aligned_cols=144  Identities=22%  Similarity=0.277  Sum_probs=92.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccc-------------------------------hhhHHHHH------
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------------------------------ENKTAYVK------   93 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~~~~~------   93 (366)
                      ..|+.++-|+||.|+.+. |+.||||+.+......                               ++....+.      
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            778899999999998865 9999999986432110                               00011122      


Q ss_pred             HHHHHHHhC-----CCCCcceeEEEEeeCCeEEEEEeecCCCchHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 017775           94 LERIVLDQL-----DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHSMGL  166 (366)
Q Consensus        94 ~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l--~~~~~l~~~~~~~~~~qil~aL~~LH~~~i  166 (366)
                      +|...+.++     +.+++.-..-+++-...-.++|||++|..+.+..  .. ..++...+.....++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            233323222     2344332223334455678999999998887774  33 2345333333222221  233335899


Q ss_pred             eeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       167 ~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      +|+|.+|.||+++.+|++.+.|||....+.+.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            99999999999999999999999998876654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.72  E-value=2e-07  Score=80.06  Aligned_cols=142  Identities=20%  Similarity=0.168  Sum_probs=95.4

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhh---------------------HHHHHHHHHHHHhCC--CC
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK---------------------TAYVKLERIVLDQLD--HP  105 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------------------~~~~~~e~~~l~~l~--h~  105 (366)
                      +...|+.|..+.||+|.. .++..+|+|+++.....-...                     ..-...|..-|+++.  +-
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            344777888889999976 568899999997543221110                     112234666666663  33


Q ss_pred             CcceeEEEEeeCCeEEEEEeecCCCc-hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCC
Q 017775          106 GVVRLFFTFQDTFSLYMALESCEGGE-LFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       106 ~iv~~~~~~~~~~~~~iv~e~~~g~~-L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~  183 (366)
                      .+.+.+.+..    -.+|||++.... -...+.. -.+..+++..+..++++.+.-|-. .+++|+||+.-|||+. +|.
T Consensus       131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             CCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence            4445555443    359999986421 1111111 123444788888899999888866 9999999999999998 889


Q ss_pred             EEEEecCCccccCC
Q 017775          184 IKIADFGSVKPMQD  197 (366)
Q Consensus       184 vkL~Dfg~a~~~~~  197 (366)
                      +.++|||-|....+
T Consensus       205 p~iID~~QaV~~~h  218 (268)
T COG1718         205 PYIIDVSQAVTIDH  218 (268)
T ss_pred             EEEEECccccccCC
Confidence            99999998875543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.68  E-value=4.7e-07  Score=78.86  Aligned_cols=133  Identities=16%  Similarity=0.156  Sum_probs=82.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      ..||.|..+.||+.    .|..+++|......     ....+.+|.++++.+..-+  +.+++.+..+.+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            67899999999984    25578899875432     2233677998888875433  4667777777778899999999


Q ss_pred             CCc-hHHH--------------HHh-------C--CCCCHHH-HHHHHH----------HHHHH-HHHHH----HCCcee
Q 017775          129 GGE-LFDQ--------------ITS-------K--GHLSEDE-ARFYTA----------EVVDA-LEYIH----SMGLIH  168 (366)
Q Consensus       129 g~~-L~~~--------------l~~-------~--~~l~~~~-~~~~~~----------qil~a-L~~LH----~~~i~H  168 (366)
                      |.+ +...              +.+       -  ....... ...+..          .+... ..+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            963 1111              110       0  0011000 001100          01111 11222    124789


Q ss_pred             ccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          169 RDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       169 ~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.64  E-value=2.8e-09  Score=101.74  Aligned_cols=241  Identities=20%  Similarity=0.238  Sum_probs=166.3

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEeeCCeEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv  123 (366)
                      .-|......++|+++.+++.+...+...+ .+.+...        ....-++++|.+++||| .+..++-++.+...+++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            34677788899999999999887665554 6666443        23455888999999999 66667777778889999


Q ss_pred             EeecCCC-chHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          124 LESCEGG-ELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       124 ~e~~~g~-~L~~~l~-~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ++++.++ +-..... ..-.+-+-+.....+.-+.+++++|+..=+|+|    ||+.. ++..++.||+....+....  
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc--
Confidence            9999876 2211111 111234445566677778899999998778888    77664 4789999999887664432  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC-----
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-----  276 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  276 (366)
                               ...+..+++.++|||......+....|.|++|.--.++.-|-+|-...-.  ....+-.+. ..|.     
T Consensus       386 ---------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p-~s~~L~~~~  453 (829)
T KOG0576|consen  386 ---------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGP-NSPMLTDKS  453 (829)
T ss_pred             ---------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCC-Cccccchhh
Confidence                     23466789999999999999999999999999977788877777543110  000000000 0000     


Q ss_pred             CCCHHHH-HHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          277 YFSDAAR-DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       277 ~~s~~~~-~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..++-.. ++...|+..-|..|+..     ..++.|.+|++..
T Consensus       454 aw~~~~~~~~~~~~~~g~P~~pkv~-----mgacfsKvfngCp  491 (829)
T KOG0576|consen  454 AWSPVFHRDFPAPCLNGLPPTPKVH-----MGACFSKVFNGCP  491 (829)
T ss_pred             hcCcccccCCcccccCCCCCCCcch-----hhHHHHHHhccCc
Confidence            0111122 47788999999999988     7788888887654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.60  E-value=4.1e-07  Score=92.64  Aligned_cols=201  Identities=23%  Similarity=0.321  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHhCCCCCcceeEEEEeeCCeE----EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 017775           91 YVKLERIVLDQLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL  166 (366)
Q Consensus        91 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i  166 (366)
                      ....|...+..+.|+|++.++.+-......    .+..++|.+.++...+..-+.++...++.+..++++||.++|+...
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            344566778888999999998887654333    3445799999999999988899999999999999999999999976


Q ss_pred             eeccCCCC---CeEeCCCCCEEEE--ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCC--CCCcc
Q 017775          167 IHRDIKPE---NLLLTADGHIKIA--DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF--GNDLW  239 (366)
Q Consensus       167 ~H~dlkp~---NIli~~~~~vkL~--Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Diw  239 (366)
                      .|.-+..+   +--++..+.+..+  ||+.+..........           ....+..+-++|.........  ..|+|
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-----------~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-----------SDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccch-----------hhcCccccccccccccccchhhhhhHHH
Confidence            66666555   4444555667766  888887665443221           223445677788776665543  47999


Q ss_pred             cchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       240 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++|.....+..|..+-...   .....++      +........+++.+|+..++++|+++     .+++.|+|.+.
T Consensus       377 ~lgll~~~~~~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~-----~~ll~~~f~~~  439 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSA-----LELLTHPFLRF  439 (1351)
T ss_pred             HHHHHHhhhhhcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccch-----hhhhhchhccc
Confidence            9999999999876542211   1111111      11122267889999999999999999     78999999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=4.5e-07  Score=73.83  Aligned_cols=131  Identities=22%  Similarity=0.289  Sum_probs=96.2

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce-eEEEEeeCCeEEEEEe
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR-LFFTFQDTFSLYMALE  125 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~iv~e  125 (366)
                      -++.+.|++|..|.||+|.+  .|..+|+|+-+.+     .....+..|.++|..++-.++.+ +|.+.++    ++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            35668899999999999988  4668999986543     34456778999999988777654 4444333    35599


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCCeEeCCCCCEEEEecCCcccc
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK-PENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlk-p~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      |+.|..|.+.....       -+.-+..++++---|-..||-|+.|. |..+++..++.+.|+||..|+..
T Consensus        93 ~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          93 YIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            99998886654321       13444556666666778899999998 66666667779999999998743

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.47  E-value=6e-06  Score=72.04  Aligned_cols=137  Identities=26%  Similarity=0.295  Sum_probs=80.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceeEEEE---eeCCeEEEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP--GVVRLFFTF---QDTFSLYMAL  124 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~iv~  124 (366)
                      ++.++.|..+.||++....  ..+++|.....     .....+..|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999998855  58999986442     3445566788887777433  245555533   2344579999


Q ss_pred             eecCCCchHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 017775          125 ESCEGGELFD----------------QIT---SK----GHLSEDE------ARFY---------------TAEVVD-ALE  159 (366)
Q Consensus       125 e~~~g~~L~~----------------~l~---~~----~~l~~~~------~~~~---------------~~qil~-aL~  159 (366)
                      ++++|..+..                .+.   +.    ..+....      ....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987776                111   11    0000000      0000               111222 233


Q ss_pred             HHH-------HCCceeccCCCCCeEeC-CCCCEEEEecCCcc
Q 017775          160 YIH-------SMGLIHRDIKPENLLLT-ADGHIKIADFGSVK  193 (366)
Q Consensus       160 ~LH-------~~~i~H~dlkp~NIli~-~~~~vkL~Dfg~a~  193 (366)
                      .++       ...++|+|+.|.||+++ .++.+-++||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            333       24599999999999999 56777899999765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=3e-06  Score=74.86  Aligned_cols=134  Identities=16%  Similarity=0.064  Sum_probs=81.1

Q ss_pred             eeeecCc-eEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEEeecCC
Q 017775           52 IYGVGSY-SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEG  129 (366)
Q Consensus        52 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~g  129 (366)
                      .|..|.. ..||++...  +..+.+|......      ...+..|..+++.+. +--+.+++.+....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            4455555 688998653  4688888765431      223556888877773 34455777777766678999999999


Q ss_pred             CchHHHHH-------------------hCC----CCCH---H---HHHHHHH----------------HHHHHHHHHH--
Q 017775          130 GELFDQIT-------------------SKG----HLSE---D---EARFYTA----------------EVVDALEYIH--  162 (366)
Q Consensus       130 ~~L~~~l~-------------------~~~----~l~~---~---~~~~~~~----------------qil~aL~~LH--  162 (366)
                      .++.....                   .-.    ++..   .   .....+.                .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            77754320                   000    0110   0   0000000                0111122221  


Q ss_pred             -----HCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          163 -----SMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       163 -----~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                           ...++|+|+.|.||++++++.+.|+||+.+.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 2348999999999999988778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.39  E-value=2.1e-05  Score=66.19  Aligned_cols=128  Identities=23%  Similarity=0.316  Sum_probs=88.7

Q ss_pred             CCeeeeeeeeecCc-eEEEEEEECCCCcEEEEEEeeccc----------cc-ch-------hhHHHHHHHHHHHHhC---
Q 017775           45 QDFELGKIYGVGSY-SKVVRAKKIDTGTVYALKIMDKKF----------IT-KE-------NKTAYVKLERIVLDQL---  102 (366)
Q Consensus        45 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~----------~~-~~-------~~~~~~~~e~~~l~~l---  102 (366)
                      .+++.++.||.|+- |.||++.-  +|..||+|++..-.          .. .+       .....+..|.....++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            79999999999999 99999987  67899999943210          00 00       1123455676655444   


Q ss_pred             CCCCc--ceeEEEEeeC------------------CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 017775          103 DHPGV--VRLFFTFQDT------------------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH  162 (366)
Q Consensus       103 ~h~~i--v~~~~~~~~~------------------~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH  162 (366)
                      .+.++  ++++++..=.                  ....||.||.+...         .++...    +.+|+.-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            56677  8888887211                  12467888876533         233333    456667778899


Q ss_pred             HCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          163 SMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       163 ~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      ..||+-+|+++.|..     .=+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999987     2478999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=3e-05  Score=65.76  Aligned_cols=132  Identities=16%  Similarity=0.201  Sum_probs=91.1

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccc-------------cchhhHHHHHHHHHHHHhCC------CCCccee
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-------------TKENKTAYVKLERIVLDQLD------HPGVVRL  110 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~  110 (366)
                      ...||+|+.-.||.-   ..+...+||+......             ..........+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457899999999964   2345678899876540             01112334455655444443      8889999


Q ss_pred             EEEEeeCCeEEEEEeecCC------CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC--
Q 017775          111 FFTFQDTFSLYMALESCEG------GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--  182 (366)
Q Consensus       111 ~~~~~~~~~~~iv~e~~~g------~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~--  182 (366)
                      +++.+++....+|+|.+..      .+|.+++.+. .+++ .+...+   -+-..+|-+++|+.+|++|.||++..++  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999997642      4788888554 4665 444433   4445677899999999999999997542  


Q ss_pred             --CEEEEec
Q 017775          183 --HIKIADF  189 (366)
Q Consensus       183 --~vkL~Df  189 (366)
                        .+.|+|-
T Consensus       158 ~~~lvlIDG  166 (199)
T PF10707_consen  158 EFRLVLIDG  166 (199)
T ss_pred             ceEEEEEeC
Confidence              4677764

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.27  E-value=1.3e-05  Score=83.10  Aligned_cols=81  Identities=20%  Similarity=0.211  Sum_probs=56.7

Q ss_pred             eeeeeeecCceEEEEEEECCCC--cEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCc--ceeEEEEeeC---CeE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV--VRLFFTFQDT---FSL  120 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~  120 (366)
                      -++.++.|.+..+|+......+  ..+++|+......  ......+.+|..+++.+. |.++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            4678899999999998765432  4678887543211  112345778999999885 6665  6777777654   467


Q ss_pred             EEEEeecCCCc
Q 017775          121 YMALESCEGGE  131 (366)
Q Consensus       121 ~iv~e~~~g~~  131 (366)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=1.1e-05  Score=77.85  Aligned_cols=143  Identities=20%  Similarity=0.286  Sum_probs=89.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccc----------------------------hhhHHHHHH------H
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK----------------------------ENKTAYVKL------E   95 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~~~~~~------e   95 (366)
                      -+.||.-+.|+|++|+-+. |+.||||+-+......                            ++....+..      |
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4789999999999998876 9999999876432110                            000011111      2


Q ss_pred             HH----HHHhCCCCC------cceeEEEEeeCCeEEEEEeecCCCchHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 017775           96 RI----VLDQLDHPG------VVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIHS  163 (366)
Q Consensus        96 ~~----~l~~l~h~~------iv~~~~~~~~~~~~~iv~e~~~g~~L~~--~l~~~~~l~~~~~~~~~~qil~aL~~LH~  163 (366)
                      .+    ..+.+.|-+      |.++|..+  ...-.++|||++|..+.+  .+.+.+ ++...+...+.+...  .-+=.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHh
Confidence            21    222334444      33443333  334679999999976654  444443 565544443333322  22235


Q ss_pred             CCceeccCCCCCeEeCC----CCCEEEEecCCccccCCc
Q 017775          164 MGLIHRDIKPENLLLTA----DGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~----~~~vkL~Dfg~a~~~~~~  198 (366)
                      .|++|+|=+|.||++..    ++.+.+.|||+...+...
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            68999999999999994    568999999998766544

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.21  E-value=1.8e-05  Score=66.68  Aligned_cols=100  Identities=17%  Similarity=0.245  Sum_probs=78.8

Q ss_pred             HHHHHHHHhCCC-CCcceeEEEEeeCCeEEEEEeecCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 017775           93 KLERIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQ---ITSKGHLSEDEARFYTAEVVDALEYIHS---MG  165 (366)
Q Consensus        93 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~---l~~~~~l~~~~~~~~~~qil~aL~~LH~---~~  165 (366)
                      ..|..+++.+.+ +++.++++++.+    ++++||...+++...   +.+.-..+......++.++++.+.+++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            347778888865 689999998854    578899986655421   1111235788899999999999999997   45


Q ss_pred             ceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       166 i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      +.-.|++|+|+-++++|++|++|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.18  E-value=3.2e-05  Score=67.77  Aligned_cols=75  Identities=20%  Similarity=0.194  Sum_probs=47.5

Q ss_pred             eeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEeeCCeEEEEEeec
Q 017775           50 GKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~  127 (366)
                      ++.|..|-...+|++.... .+..|++|+.......    .....+|..+++.+...++ .+++....  +  .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4677888888999997543 3578999977543111    1123457778887754344 34444332  2  3799999


Q ss_pred             CCCch
Q 017775          128 EGGEL  132 (366)
Q Consensus       128 ~g~~L  132 (366)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            99765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=2.2e-05  Score=68.89  Aligned_cols=74  Identities=14%  Similarity=0.015  Sum_probs=44.6

Q ss_pred             eeeeeecCce-EEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC---CcceeEEEEeeC---CeEEE
Q 017775           50 GKIYGVGSYS-KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP---GVVRLFFTFQDT---FSLYM  122 (366)
Q Consensus        50 ~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~i  122 (366)
                      ++.|+.|+.. .||++     +..+++|.....     .....+..|..+++.+...   -+.+++......   ...++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            3567766666 58976     235788875432     1233577788888777531   233444433322   23588


Q ss_pred             EEeecCCCchH
Q 017775          123 ALESCEGGELF  133 (366)
Q Consensus       123 v~e~~~g~~L~  133 (366)
                      +|++++|.++.
T Consensus        72 l~~~i~G~~l~   82 (235)
T cd05155          72 VYRWLEGETAT   82 (235)
T ss_pred             EEEeecCCCCC
Confidence            99999997663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.97  E-value=4.4e-05  Score=67.95  Aligned_cols=132  Identities=17%  Similarity=0.235  Sum_probs=75.3

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEeeCCeEEEEEeecCCC
Q 017775           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~iv~e~~~g~  130 (366)
                      .+..|-.+.+|++.  .+|..+++|........-.   .....|..+++.+...++. +++...  .  -++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG---VDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc---CcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            34567778899886  3567899997644211100   1235688888887544343 334332  2  36899999986


Q ss_pred             chHHH-------H-------H---hC----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeccC
Q 017775          131 ELFDQ-------I-------T---SK----GHLSE-DEARFYTAEV---------VDALEYIHS--------MGLIHRDI  171 (366)
Q Consensus       131 ~L~~~-------l-------~---~~----~~l~~-~~~~~~~~qi---------l~aL~~LH~--------~~i~H~dl  171 (366)
                      .+...       .       .   +.    .+++. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            65321       1       1   11    01111 1222222121         111222222        24899999


Q ss_pred             CCCCeEeCCCCCEEEEecCCcc
Q 017775          172 KPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       172 kp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .|.||++++++ +.++||+.+.
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccC
Confidence            99999999877 7899999876

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.90  E-value=0.00027  Score=64.29  Aligned_cols=79  Identities=9%  Similarity=-0.025  Sum_probs=55.0

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC---CCcceeEEEEee---CCeE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH---PGVVRLFFTFQD---TFSL  120 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~  120 (366)
                      -.-.+.||.|..+.||.....  +..+.+|..+.     ......+..|...++.+.-   -.+.++++++.+   .+..
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--QGNPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--CCCEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            345678999999999998542  23577787432     1122457778888888742   357778877654   3668


Q ss_pred             EEEEeecCCCch
Q 017775          121 YMALESCEGGEL  132 (366)
Q Consensus       121 ~iv~e~~~g~~L  132 (366)
                      ++|||+++|.++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.87  E-value=0.00017  Score=65.61  Aligned_cols=138  Identities=19%  Similarity=0.109  Sum_probs=81.4

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceeEE------EEeeCCe
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFF------TFQDTFS  119 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~~~~~  119 (366)
                      .-.+.+..|....+|++..  ++..+++|+...      .....+..|..++..+.+.+  +.+++.      +....+.
T Consensus        17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             hheecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            3466777888889999865  345789998753      11233555777776664322  344432      2233456


Q ss_pred             EEEEEeecCCCchHH----HHH----------h--CC---C----CCHHHHH------------HHHHHHHHHHHHHHH-
Q 017775          120 LYMALESCEGGELFD----QIT----------S--KG---H----LSEDEAR------------FYTAEVVDALEYIHS-  163 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~----~l~----------~--~~---~----l~~~~~~------------~~~~qil~aL~~LH~-  163 (366)
                      .++++++++|..+..    ...          .  .+   .    .......            .....+..++.++.+ 
T Consensus        89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  168 (296)
T cd05153          89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF  168 (296)
T ss_pred             eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence            789999999866421    110          0  00   0    0000000            011112334444443 


Q ss_pred             ------CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 ------MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ------~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                            .+++|+|+.|.||+++.++.+.++||+.+.
T Consensus       169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                  469999999999999987777899999765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.84  E-value=0.00026  Score=64.57  Aligned_cols=145  Identities=19%  Similarity=0.241  Sum_probs=96.1

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-----------------------hhhHHHHHHHHHHHHhCCC
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----------------------ENKTAYVKLERIVLDQLDH  104 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~h  104 (366)
                      .+-..|..|.-+.||.|.. .+|..+|||+++.+.+.-                       .-.......|..-|++++.
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            4456778889999999866 568889999987542210                       0111123346666777765


Q ss_pred             CCcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeEeCCCCC
Q 017775          105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       105 ~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~L-H~~~i~H~dlkp~NIli~~~~~  183 (366)
                      ..|.-.--...  ..-.+||+++.+-....-..+.-.++...+..+-.|++.-+.-| |..+++|.||.--|+|+ .+|.
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            55432111111  12468999985422211112234588888999888888888777 67899999999999999 6789


Q ss_pred             EEEEecCCccccC
Q 017775          184 IKIADFGSVKPMQ  196 (366)
Q Consensus       184 vkL~Dfg~a~~~~  196 (366)
                      +.++|.+-+-..+
T Consensus       303 lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  303 LYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEccccccCC
Confidence            9999998776443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.83  E-value=0.00018  Score=65.67  Aligned_cols=76  Identities=14%  Similarity=0.062  Sum_probs=47.4

Q ss_pred             eeeeeecCceEEEEEEECC------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEeeCCeEEE
Q 017775           50 GKIYGVGSYSKVVRAKKID------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYM  122 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~i  122 (366)
                      ++.+..|-...+|++....      +++.|++|+......    ......+|..+++.+...++ .+++..+..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            4556677777899887543      367899999765321    11234567777777753333 345555432    35


Q ss_pred             EEeecCCCchH
Q 017775          123 ALESCEGGELF  133 (366)
Q Consensus       123 v~e~~~g~~L~  133 (366)
                      |+||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.76  E-value=0.00095  Score=62.80  Aligned_cols=80  Identities=14%  Similarity=0.091  Sum_probs=52.0

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cc--hhhHHHHHHHHHHHHhCC---CCCcceeEEEEeeCCeEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TK--ENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+.||.|.+..||++.....++.++||.-.....  ..  .........|...|+.+.   ...+.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4688999999999999864446899997532110  01  122334555777777652   2456666666  4455789


Q ss_pred             EEeecCCCc
Q 017775          123 ALESCEGGE  131 (366)
Q Consensus       123 v~e~~~g~~  131 (366)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.71  E-value=0.00092  Score=61.15  Aligned_cols=144  Identities=19%  Similarity=0.182  Sum_probs=82.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceeEEE------E
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFT------F  114 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~  114 (366)
                      ..+.....+.++.|....+|++.. . +..+++|+.....  .   ...+..|..++..+...+  +.+++..      .
T Consensus        20 ~~~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~   92 (307)
T TIGR00938        20 DLGELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS   92 (307)
T ss_pred             CCCCceeccccCCccccceEEEEe-C-CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence            344455567788888889998864 3 3468889875421  1   122344566665553222  3333321      1


Q ss_pred             eeCCeEEEEEeecCCCchH----HH-------H---Hh--CC---C----CCHHH-----HH----------HHHHHHHH
Q 017775          115 QDTFSLYMALESCEGGELF----DQ-------I---TS--KG---H----LSEDE-----AR----------FYTAEVVD  156 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~----~~-------l---~~--~~---~----l~~~~-----~~----------~~~~qil~  156 (366)
                      ...+..++++||++|.++.    ..       +   +.  .+   .    .....     ..          .....+..
T Consensus        93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~  172 (307)
T TIGR00938        93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK  172 (307)
T ss_pred             hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence            2345678999999985431    11       1   10  00   0    00000     00          00112233


Q ss_pred             HHHHHH-------HCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          157 ALEYIH-------SMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       157 aL~~LH-------~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .++++.       ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus       173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            455553       2689999999999999988877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.0018  Score=59.56  Aligned_cols=30  Identities=30%  Similarity=0.395  Sum_probs=25.7

Q ss_pred             CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .++||+|++|.||+++.+...-++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999866556899999875

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.66  E-value=5.7e-05  Score=67.62  Aligned_cols=138  Identities=18%  Similarity=0.210  Sum_probs=93.4

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-------c------------hhhHHHHHHHHHHHHhCC-CCC
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-------K------------ENKTAYVKLERIVLDQLD-HPG  106 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~------------~~~~~~~~~e~~~l~~l~-h~~  106 (366)
                      +.++..||-|.-+.||.+-+ ..|+++++|.=+.-..+       .            .-..-....|...|+.+. |-.
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56789999999999999977 45888999854321100       0            001112335777777774 322


Q ss_pred             -cceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          107 -VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       107 -iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                       +.+.+    +.+.-++|||.+.|..|...-.      ...+..+...++.-+.-|..+|+||||+.-=||++.+++.++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence             23333    3455679999999988765432      122334445555566678899999999999999999999999


Q ss_pred             EEecCCcccc
Q 017775          186 IADFGSVKPM  195 (366)
Q Consensus       186 L~Dfg~a~~~  195 (366)
                      ++||.-....
T Consensus       243 vIDFPQmvS~  252 (465)
T KOG2268|consen  243 VIDFPQMVST  252 (465)
T ss_pred             EeechHhhcc
Confidence            9999865443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.56  E-value=1.8e-06  Score=90.12  Aligned_cols=254  Identities=14%  Similarity=0.012  Sum_probs=155.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cchhhHHHHHHHHHHHHhCCCCCcceeEEEEe--eCC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI---TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~  118 (366)
                      ++.|++.--+|-|.++.--.-+.+..  -+.+|+.+.-..   ... ..++...|...++...|+++.....-..  +..
T Consensus      1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LseP-lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEP-LKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred             hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhH-HHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence            45666666666666553222222222  245555433211   111 1222333555556678888876655443  244


Q ss_pred             eEEEEEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCeEeCCCCCEEEEec
Q 017775          119 SLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~-----i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      .-|+.++|+.+|.+...+.+.    ..+.+.-+.....+.+.+..-+|+..     .+|+++|+-|.+|..+-+++++++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            578999999999999998764    22333333333334377777777542     689999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      |+.+...+.          ....+..++++.|++|++...-.++.++|+|..|+-+|....|..+|...........+.+
T Consensus      1385 gLdKIknp~----------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn 1454 (2724)
T KOG1826|consen 1385 GLDKIKNPV----------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDN 1454 (2724)
T ss_pred             ccccccCch----------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccc
Confidence            998833222          1223355778888999998888888889999999999999988877643222221111111


Q ss_pred             C-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          270 R-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       270 ~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      . ..+.+...|.++......+|-..-..||+-     ...+..+.|.
T Consensus      1455 ~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q-----~isls~d~~a 1496 (2724)
T KOG1826|consen 1455 HTFFSIEKLKPGDANVEALHRLLWKYMERPGQ-----YISLSRDHFA 1496 (2724)
T ss_pred             cccccccccCCCcccHHHHHHHHHHhhhcchh-----hhhccccccc
Confidence            1 122333344555555555555566677765     4555555553

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.36  E-value=0.002  Score=59.59  Aligned_cols=139  Identities=14%  Similarity=0.159  Sum_probs=77.3

Q ss_pred             CeeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEeeCCeEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLY  121 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~  121 (366)
                      +.. ++.|..|-...+|++.....   +..|++|+.....   +. .-...+|..+++.+..-++- +++.++. .+   
T Consensus        16 ~i~-i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---   86 (330)
T PLN02421         16 DFS-VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---   86 (330)
T ss_pred             ceE-EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---Ce-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence            344 34444477778998865432   3489999876531   11 11134577788877655553 4555553 22   


Q ss_pred             EEEeecCCCchHH-------HH----------HhCC-C----CC-HHHHHHHHHHH----------------------HH
Q 017775          122 MALESCEGGELFD-------QI----------TSKG-H----LS-EDEARFYTAEV----------------------VD  156 (366)
Q Consensus       122 iv~e~~~g~~L~~-------~l----------~~~~-~----l~-~~~~~~~~~qi----------------------l~  156 (366)
                      +|.+|++|.+|..       .+          +... +    .+ -..+..+..++                      ..
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            5889988866521       11          0100 0    11 12222222221                      11


Q ss_pred             HHHHHH----HCC----ceeccCCCCCeEeCC-CCCEEEEecCCcc
Q 017775          157 ALEYIH----SMG----LIHRDIKPENLLLTA-DGHIKIADFGSVK  193 (366)
Q Consensus       157 aL~~LH----~~~----i~H~dlkp~NIli~~-~~~vkL~Dfg~a~  193 (366)
                      .+..+.    ..+    ++|+|+.+.||++++ ++.++++||..|.
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            222222    112    799999999999975 4789999999875

>PLN02236 choline kinase

Probab=97.33  E-value=0.003  Score=58.68  Aligned_cols=137  Identities=18%  Similarity=0.166  Sum_probs=79.1

Q ss_pred             eeeeeeecCceEEEEEEECC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEeeCCeEEEE
Q 017775           49 LGKIYGVGSYSKVVRAKKID----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMA  123 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~iv  123 (366)
                      -++.+..|-.-.+|++....    ++..|++|+.....   ..... ...|..+++.+..-++. ++++.+...    .|
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence            34455557788999986432    34789999886532   11111 24577888877544443 455555332    57


Q ss_pred             EeecCCCchHHH----------H-------HhCC----C-C-CHHHHHHHHHHH-----------------HHHHHHH--
Q 017775          124 LESCEGGELFDQ----------I-------TSKG----H-L-SEDEARFYTAEV-----------------VDALEYI--  161 (366)
Q Consensus       124 ~e~~~g~~L~~~----------l-------~~~~----~-l-~~~~~~~~~~qi-----------------l~aL~~L--  161 (366)
                      .+|++|.+|...          +       ++..    . . ..+.+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            899988766321          1       0100    0 1 112233332221                 1111112  


Q ss_pred             --H----HCCceeccCCCCCeEeCC-CCCEEEEecCCcc
Q 017775          162 --H----SMGLIHRDIKPENLLLTA-DGHIKIADFGSVK  193 (366)
Q Consensus       162 --H----~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a~  193 (366)
                        .    ...++|+|+++.||++++ ++.+.++||..+.
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence              1    235899999999999986 4789999999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.33  E-value=0.0026  Score=58.77  Aligned_cols=76  Identities=17%  Similarity=0.085  Sum_probs=45.8

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccc----cchhhHHHHHHHHHHHHhCC--CCC-cceeEEEEeeCCeEEEEE
Q 017775           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI----TKENKTAYVKLERIVLDQLD--HPG-VVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~iv~  124 (366)
                      .||-|....||++.+...+..++||.-..-..    .-.........|...|+...  .|. +.++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999854446899995432111    11222333445666666553  343 4444443  445567999


Q ss_pred             eecCC
Q 017775          125 ESCEG  129 (366)
Q Consensus       125 e~~~g  129 (366)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.20  E-value=0.0006  Score=64.74  Aligned_cols=159  Identities=18%  Similarity=0.213  Sum_probs=102.0

Q ss_pred             HHHHHHHHHhCCCCCcceeEEEEee-CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 017775           92 VKLERIVLDQLDHPGVVRLFFTFQD-TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD  170 (366)
Q Consensus        92 ~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~d  170 (366)
                      +.-...+++.+.|++...++++.+. .....+|||++.- +|.+....+. +-.....                  +||=
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~------------------~~~~   88 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL------------------AHGV   88 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhhc------------------cccc
Confidence            4446678899999999999988765 3448899999964 9998887653 2221111                  2221


Q ss_pred             CCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc
Q 017775          171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS  250 (366)
Q Consensus       171 lkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  250 (366)
                      + +.||       ++.+| .++..                          |       ..+.++|+||||+|.++.++..
T Consensus        89 ~-~~~~-------~~~td-~~~t~--------------------------~-------~~~~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   89 L-HLNI-------IYITD-HFLTK--------------------------Y-------PSPIGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             c-eehh-------hhccc-ccccc--------------------------C-------CCCCCcchhhhhHHHHHHHHHH
Confidence            1 1122       22222 11110                          0       0111249999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCC------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          251 GTSPFKDTSEWLIFQRIIARDIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       251 g~~pf~~~~~~~~~~~i~~~~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      |...+......+..+.+..-...            +--..+..+.++..+|+-..|..||..     .++..++-|..+
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~-----~~~~k~~i~~ev  200 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP-----MELSKRCSFTEV  200 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch-----hHHhcCccHHHH
Confidence            98887766665555544432111            011246668889999999999999966     778888888654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.18  E-value=0.0037  Score=56.17  Aligned_cols=29  Identities=28%  Similarity=0.590  Sum_probs=24.8

Q ss_pred             CceeccCCCCCeEeCCCCC-EEEEecCCcc
Q 017775          165 GLIHRDIKPENLLLTADGH-IKIADFGSVK  193 (366)
Q Consensus       165 ~i~H~dlkp~NIli~~~~~-vkL~Dfg~a~  193 (366)
                      .++|+|++|.||++++++. .-++||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            3899999999999987565 4699999876

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.02  E-value=0.034  Score=50.80  Aligned_cols=29  Identities=28%  Similarity=0.492  Sum_probs=25.5

Q ss_pred             CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+++|||+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.97  E-value=0.002  Score=55.45  Aligned_cols=29  Identities=34%  Similarity=0.696  Sum_probs=21.1

Q ss_pred             CceeccCCCCCeEe-CCCCCEEEEecCCcc
Q 017775          165 GLIHRDIKPENLLL-TADGHIKIADFGSVK  193 (366)
Q Consensus       165 ~i~H~dlkp~NIli-~~~~~vkL~Dfg~a~  193 (366)
                      -++|+|+.|.||++ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999999876

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.96  E-value=0.0092  Score=54.32  Aligned_cols=144  Identities=16%  Similarity=0.177  Sum_probs=81.2

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEeeCC--eEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTF--SLYM  122 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~i  122 (366)
                      ..+++.+..|..-.+|...++  ++.++++ ... ............+|..+++.+.-  --+...+..+.++.  ..|.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            344555544444456666553  7888988 221 12223334456667877777643  22333455555554  6799


Q ss_pred             EEeecCCCchH----------HHHH--------h--------------CCCCCHHHHHHHHHHH--------------HH
Q 017775          123 ALESCEGGELF----------DQIT--------S--------------KGHLSEDEARFYTAEV--------------VD  156 (366)
Q Consensus       123 v~e~~~g~~L~----------~~l~--------~--------------~~~l~~~~~~~~~~qi--------------l~  156 (366)
                      ||++++|..+.          .+..        .              .+.....++..+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            99999984221          1111        0              0000111222222221              22


Q ss_pred             HHHHHHHC--------CceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          157 ALEYIHSM--------GLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       157 aL~~LH~~--------~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      -..+++.+        .++|||+++.|+++++++-+=++||+.+..
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            23444433        379999999999999998899999999864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.93  E-value=0.03  Score=51.29  Aligned_cols=29  Identities=14%  Similarity=0.200  Sum_probs=27.2

Q ss_pred             CceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          165 GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       165 ~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ++||+|+.++|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            69999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.80  E-value=0.013  Score=54.82  Aligned_cols=78  Identities=19%  Similarity=0.205  Sum_probs=49.1

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cchhhHHHHHHHHHHHHhCC--CCC-cceeEEEEeeCCeEEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI---TKENKTAYVKLERIVLDQLD--HPG-VVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~iv  123 (366)
                      .+.||-|.-..||++.+...+..|+||.-..-..   .-.-.......|...|+...  .|. +.++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            7788999999999999854456799995432111   11223344555777777653  454 4445443  45567789


Q ss_pred             EeecCC
Q 017775          124 LESCEG  129 (366)
Q Consensus       124 ~e~~~g  129 (366)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.80  E-value=0.024  Score=53.36  Aligned_cols=77  Identities=13%  Similarity=0.033  Sum_probs=49.0

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCC---CCCcceeEEEEeeCCeEE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKE---NKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~  121 (366)
                      ..+.||.|....||++.+  .+..++||.-..... ...   ........|...|+.+.   ...+.+++.+..+  ..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            477889999999999987  345689996542111 111   12223333566665553   2467777777664  467


Q ss_pred             EEEeecCC
Q 017775          122 MALESCEG  129 (366)
Q Consensus       122 iv~e~~~g  129 (366)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PTZ00384 choline kinase; Provisional

Probab=96.72  E-value=0.018  Score=54.28  Aligned_cols=77  Identities=17%  Similarity=0.094  Sum_probs=44.6

Q ss_pred             eeeeeeecCceEEEEEEECCC-CcE-----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEeeCCeEE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDT-GTV-----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLY  121 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~  121 (366)
                      .++.|..|-...+|++..... +..     |.++.....   .... -.-.+|..+++.+...++- ++++.+..    +
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            344565688889999975432 222     444433211   1111 1134578888888655554 55565543    5


Q ss_pred             EEEeecCCCchH
Q 017775          122 MALESCEGGELF  133 (366)
Q Consensus       122 iv~e~~~g~~L~  133 (366)
                      ++.||++|.+|.
T Consensus       126 ~l~efIeGr~l~  137 (383)
T PTZ00384        126 TIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEeccccCC
Confidence            999999987663

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.45  E-value=0.0098  Score=54.50  Aligned_cols=85  Identities=18%  Similarity=0.306  Sum_probs=59.9

Q ss_pred             CCCcceeEEEE-eeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCC
Q 017775          104 HPGVVRLFFTF-QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTAD  181 (366)
Q Consensus       104 h~~iv~~~~~~-~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~  181 (366)
                      -++..+.+-+- .+..+.|++|++- |+.+. .+.   ...-+++..++++.+..+.-+..+ .+-|||+...||+|+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            34444433333 3445678888875 33442 222   245678888888888877777644 589999999999998 9


Q ss_pred             CCEEEEecCCccc
Q 017775          182 GHIKIADFGSVKP  194 (366)
Q Consensus       182 ~~vkL~Dfg~a~~  194 (366)
                      |+|.|+||-+++.
T Consensus       358 GnvtLIDfklsRl  370 (488)
T COG5072         358 GNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEeeeeec
Confidence            9999999999883

>PTZ00296 choline kinase; Provisional

Probab=96.18  E-value=0.074  Score=51.09  Aligned_cols=76  Identities=14%  Similarity=0.016  Sum_probs=45.3

Q ss_pred             eeeeeeecCceEEEEEEECC--------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eeEEEEeeCCe
Q 017775           49 LGKIYGVGSYSKVVRAKKID--------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFS  119 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~  119 (366)
                      -++.|..|-.-.+|++....        .++.|.+++.....   +... ....|..+++.+...+|- ++++.+.    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS----  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence            56667777777888887542        25689999875531   1111 123466666666544443 4555443    


Q ss_pred             EEEEEeecCCCch
Q 017775          120 LYMALESCEGGEL  132 (366)
Q Consensus       120 ~~iv~e~~~g~~L  132 (366)
                      -+.+.||++|.+|
T Consensus       181 gg~I~efi~g~~l  193 (442)
T PTZ00296        181 GGRIEEWLYGDPL  193 (442)
T ss_pred             CCEEEEeeCCccC
Confidence            2457889887644

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.18  E-value=0.2  Score=46.27  Aligned_cols=28  Identities=25%  Similarity=0.444  Sum_probs=23.8

Q ss_pred             CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+++|+|+.+.||+++ + .+.++||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 57899999765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.15  E-value=0.14  Score=46.28  Aligned_cols=75  Identities=17%  Similarity=0.101  Sum_probs=46.8

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEeeCCeEEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +-.+.++.|....+|+..  .+++.+.+|+-..      .....+..|..-|+.|   ..-.+.+++.+....+..+++|
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            456788889999999987  5788899997642      2233466677777766   3455778888888777789999


Q ss_pred             eecCCC
Q 017775          125 ESCEGG  130 (366)
Q Consensus       125 e~~~g~  130 (366)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998865

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.75  E-value=0.29  Score=52.27  Aligned_cols=30  Identities=37%  Similarity=0.614  Sum_probs=26.1

Q ss_pred             CCceeccCCCCCeEeCCCC--CEE-EEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADG--HIK-IADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~--~vk-L~Dfg~a~  193 (366)
                      .++||+|+.+.||+++.++  ++. |+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            5799999999999999875  666 99999875

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.40  E-value=0.072  Score=49.76  Aligned_cols=61  Identities=20%  Similarity=0.208  Sum_probs=45.2

Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCeEeCCC
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTAD  181 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~L-H~~~i~H~dlkp~NIli~~~  181 (366)
                      ..++=+|..|.++..+++.. ..++.-.+.++.-.++|+-.+ --.+++|.|++|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            45666788898888888654 356666677777777776554 45689999999999999643

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.37  E-value=0.15  Score=43.99  Aligned_cols=78  Identities=15%  Similarity=0.100  Sum_probs=51.3

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEeeCCeEEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +..+.+.-|.--..|.+.+  ...+|-+|+-      .......+..|..-|+.+   +.-.+.+++.+..+..+.|+||
T Consensus        19 ~er~~v~gG~inea~~v~d--g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD--GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             hcccccCCccccceeEeec--CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            3344455555555665554  3456888863      333345566666655555   4567888899999999999999


Q ss_pred             eecCCCchH
Q 017775          125 ESCEGGELF  133 (366)
Q Consensus       125 e~~~g~~L~  133 (366)
                      ||.+-+.+.
T Consensus        91 e~L~~~~~d   99 (286)
T COG3001          91 EYLPTGPLD   99 (286)
T ss_pred             eeccCCCCC
Confidence            999875553

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.15  E-value=0.016  Score=48.45  Aligned_cols=27  Identities=26%  Similarity=0.538  Sum_probs=24.5

Q ss_pred             ceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          166 LIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       166 i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+|+|+.|.||+++++| ++|+||+.+.
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCccc
Confidence            69999999999998777 9999999876

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	366
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-70
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-69
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-69
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-69
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-69
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-69
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-69
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-69
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-69
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-69
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-69
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-69
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-69
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-69
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-69
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-69
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-69
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-69
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-68
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-68
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-68
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-49
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-49
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-49
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-49
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-49
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-47
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-47
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-46
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-46
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-46
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-46
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-46
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-46
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-45
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-45
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-45
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-45
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-45
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-45
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-45
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-45
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-45
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-45
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-45
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-45
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-45
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-45
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-45
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-45
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-45
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-45
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-45
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-45
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-44
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-44
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-44
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-44
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-44
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-44
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-44
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-44
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-44
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-44
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-44
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-44
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-44
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-44
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-44
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-44
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-44
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-44
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-44
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-44
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-44
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-44
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-44
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-44
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-44
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-44
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-43
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-43
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-43
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-43
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-43
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-43
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-43
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-43
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-43
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-43
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-43
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-43
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-43
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-43
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-43
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-43
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-43
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-42
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-42
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-42
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-42
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-42
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-41
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-40
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-40
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-39
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-39
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-38
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-38
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-38
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-38
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-38
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-38
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-35
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-35
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-35
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-35
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-35
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-35
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-35
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-34
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-34
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-34
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-34
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-34
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-34
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-34
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-34
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-34
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-34
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-33
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-33
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-33
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-33
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-33
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-33
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-33
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-33
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-33
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-33
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-33
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-33
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-33
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-33
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-33
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-33
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-33
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-33
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-33
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-33
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-32
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-32
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-32
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-32
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-32
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-32
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-32
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-32
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-32
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-31
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-30
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-30
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-30
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-30
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-30
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-30
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-30
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-30
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-30
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-30
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-30
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-30
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-29
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-29
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-29
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-29
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-29
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-29
3soa_A	444	Full-Length Human Camkii Length = 444		6e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-29
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-28
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-28
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-28
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-28
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-28
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-28
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-28
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-28
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-28
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-28
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-27
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-27
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-27
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-27
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-27
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-26
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-26
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-26
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-26
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-26
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-26
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-26
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-25
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-25
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-25
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-25
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-25
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-25
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-25
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-25
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-25
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-25
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-25
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-25
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-25
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-25
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-25
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-25
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-25
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-25
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-24
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-24
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-24
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-24
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-24
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-24
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-24
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-23
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-23
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-23
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-23
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-23
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-23
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-23
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-23
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-23
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-22
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-22
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-22
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-22
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-22
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-21
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-21
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-20
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-20
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-20
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-19
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-17
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-17
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-17
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-17
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-16
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-15
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-14
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		6e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		9e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		9e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		9e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-08
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-07
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-07

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  261 bits (666), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 175/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 200
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 309

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 200
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 309

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  259 bits (663), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANAFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  259 bits (663), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 174/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 311

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 173/288 (60%), Gaps = 9/288 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 178
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 238
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA 331
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL 
Sbjct: 239 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 286

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 185
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 245
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 246 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 292

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 179
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 286

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 173/288 (60%), Gaps = 9/288 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 181
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 241
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA 331
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL 
Sbjct: 242 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 289

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 311

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  258 bits (658), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARD 266
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 267 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 313

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  257 bits (657), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 132/286 (46%), Positives = 172/286 (60%), Gaps = 9/286 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 180
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 240
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPK 329
                     + R G     GY  LK HPFF+ + W+N+  QTPPK
Sbjct: 241 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 286

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  257 bits (656), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 174/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + G L   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A+  +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  257 bits (656), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 172/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S  V A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  256 bits (655), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 172/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+F FQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 208
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 268
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 269 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 315

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  254 bits (649), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 171/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E LIF +II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  254 bits (648), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 171/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E LIF +II  +  FP  F      
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/306 (35%), Positives = 162/306 (52%), Gaps = 19/306 (6%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKE 86
           S++   R P E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I + 
Sbjct: 3   SETSVNRGP-EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 87  NK-TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSED 145
            K TA+ K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK-PMQDSRITVLP 204
            A FY AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K  + D  +T   
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--- 178
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
                    TF GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +     
Sbjct: 179 --------HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
Query: 265 QRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-- 322
            +I+   +  P Y +               + R GAGPG    ++ HPFF+ I+W+ +  
Sbjct: 231 DKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA 290
Query: 323 RGQTPP 328
           R   PP
Sbjct: 291 RKVEPP 296

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  191 bits (486), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 107/306 (34%), Positives = 161/306 (52%), Gaps = 19/306 (6%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKE 86
           S++   R P E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I + 
Sbjct: 3   SETSVNRGP-EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 87  NK-TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSED 145
            K TA+ K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK-PMQDSRITVLP 204
            A FY AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K  + D  +T   
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--- 178
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
                     F GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +     
Sbjct: 179 --------HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
Query: 265 QRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-- 322
            +I+   +  P Y +               + R GAGPG    ++ HPFF+ I+W+ +  
Sbjct: 231 DKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA 290
Query: 323 RGQTPP 328
           R   PP
Sbjct: 291 RKVEPP 296

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  191 bits (485), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 84
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 194
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 85
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 195
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 255
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 256 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 302

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 84
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 194
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 99/287 (34%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   +K+   D+G +YA+K++ KK   K       K+ER +L  ++
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL-KKATLKVRDRVRTKMERDILADVN 88
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP VV+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+   L+++HS
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID----------HEKKAYSFCGTVEYMA 198
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    +   D W+ G  +++ML+G+ PF+          I+   +  P + S    
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQ 258
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R G+GP G   +K H F+  IDW  +  R   PP
Sbjct: 259 SLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPP 305

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 153/281 (54%), Gaps = 13/281 (4%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K + D                   GT  Y
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------------TYXLCGTPDY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F+  
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                        S R G    G   +K HP+FK + W+ +
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 174
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 234
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 235 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 275

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 176
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 236
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 237 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 277

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 154/290 (53%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA++++ K+ +  +    +V+ E+ V +Q
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF GT  
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCGTPN 218
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 277
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPG-GYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +  T  GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWTLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +  T  GT  Y+ 
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWTLCGTPEYLA 192
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 252
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 253 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 288

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/294 (34%), Positives = 150/294 (51%), Gaps = 13/294 (4%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL    HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 158 LEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K       T+           TF 
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFC 310
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP 
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
Query: 277 YFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                            P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 102/294 (34%), Positives = 150/294 (51%), Gaps = 13/294 (4%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  
Sbjct: 144 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 203
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL    HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V A
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 263
Query: 158 LEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K       T+           TF 
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM----------KTFC 313
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP 
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 373
Query: 277 YFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                            P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 374 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 427

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GG++F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GG++F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 230
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPG-GYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 231 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 186
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 245
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPG-GYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 246 QIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDW 295

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 175
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 234
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPG-GYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 148/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G  P G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDW 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P + +L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P + +L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  +  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +   ++
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM LE   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 199
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 295

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 227
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 288 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 148/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++ +               T  GT
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-------------TWTLCGT 222
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 282
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 283 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +YQM +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P + +L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 147/289 (50%), Gaps = 13/289 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           S   +++RD+K ENL+L  DGHIKI DFG  K       T+            F GT  Y
Sbjct: 126 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------XFCGTPEY 175
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 235
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 236 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 284

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 147/289 (50%), Gaps = 13/289 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           S   +++RD+K ENL+L  DGHIKI DFG  K       T+            F GT  Y
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------XFCGTPEY 176
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 236
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 237 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 285

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 147/289 (50%), Gaps = 13/289 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           S   +++RD+K ENL+L  DGHIKI DFG  K       T+            F GT  Y
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------XFCGTPEY 177
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 237
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 238 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 286

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 199
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 295

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +  H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDW 303

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLAGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  174 bits (440), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 202
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 262
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 263 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLXGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 26  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 85
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 192
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 252
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 253 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 289

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 159/300 (53%), Gaps = 20/300 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLE 95
           E   I++FEL K+ G G+Y KV   +KI   DTG +YA+K++ K  I ++ KT  + + E
Sbjct: 49  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 96  RIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           R VL+ +   P +V L + FQ    L++ L+   GGELF  ++ +   +E E + Y  E+
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V ALE++H +G+I+RDIK EN+LL ++GH+ + DFG  K            A   ++A  
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV---------ADETERAYD 219
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRII 268
           F GT  Y+ P+++    +      D W+LG  +Y++L+G SPF    +  S+  I +RI+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 269 ARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
             +  +P   S              P  R G GP     +K H FF+ I+W ++  +  P
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENL++   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 147/281 (52%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  +E  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 34  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 93
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 200
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 260
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 261 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 222
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 282
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 283 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ P ++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               +   G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 146/281 (51%), Gaps = 13/281 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGT 201
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
              + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++F
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           S               + R G    G   +K H +F   DW
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 149/291 (51%), Gaps = 14/291 (4%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD- 100
             I +FE  ++ G GS+ KV+ A+  +TG +YA+K++ K  I +++       E+ +L  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP + +LF  FQ    L+  +E   GG+L   I       E  ARFY AE++ AL +
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL  +GH K+ADFG  K    + +T            TF GT  
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----------TATFCGTPD 189
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+ PE+L         D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P +   
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249
Query: 281 XXXXXXXXXXXXXPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPP 328
                        P+ R G+   GG   +  HPFFK IDW   N R   PP
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 159/311 (51%), Gaps = 19/311 (6%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F  +  Q     +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K 
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 145
            +TA  + ER VL   D   +  L + FQD  +LY+ ++   GG+L   ++  +  L E+
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLP 204
            ARFY AE+V A++ +H +  +HRDIKP+N+L+  +GHI++ADFGS +K M+D  +    
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV---- 231
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTS 259
                 ++   VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S
Sbjct: 232 ------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 260 EWLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
               + +I+    R  FP   +               S     G  G    K HPFF GI
Sbjct: 286 LVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345
Query: 318 DWKNIRGQTPP 328
           DW NIR    P
Sbjct: 346 DWDNIRNCEAP 356

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 159/310 (51%), Gaps = 17/310 (5%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F     +     +DFE+ K+ G G++ +V   K  +T  +YA+KI++K  + K 
Sbjct: 56  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 145
            +TA  + ER VL   D   +  L + FQD   LY+ ++   GG+L   ++  +  L ED
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 175
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY  E+V A++ IH +  +HRDIKP+N+LL  +GHI++ADFGS   M D   TV  +
Sbjct: 176 MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSS 234
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
            A        VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 235 VA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 286
Query: 261 WLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID 318
              + +I+  + R  FP++ +               S     G  G    K H FF+G++
Sbjct: 287 VETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 346
Query: 319 WKNIRGQTPP 328
           W+NIR    P
Sbjct: 347 WENIRNLEAP 356

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 159/310 (51%), Gaps = 17/310 (5%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F     +     +DFE+ K+ G G++ +V   K  +T  +YA+KI++K  + K 
Sbjct: 72  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 145
            +TA  + ER VL   D   +  L + FQD   LY+ ++   GG+L   ++  +  L ED
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 191
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY  E+V A++ IH +  +HRDIKP+N+LL  +GHI++ADFGS   M D   TV  +
Sbjct: 192 MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSS 250
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
            A        VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 251 VA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 302
Query: 261 WLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID 318
              + +I+  + R  FP++ +               S     G  G    K H FF+G++
Sbjct: 303 VETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 362
Query: 319 WKNIRGQTPP 328
           W+NIR    P
Sbjct: 363 WENIRNLEAP 372

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/305 (32%), Positives = 149/305 (48%), Gaps = 16/305 (5%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           +   + DF    + G GS+ KV+ A +  T  +YA+KI+ K  + +++      +E+ VL
Sbjct: 14  DRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVL 73
Query: 100 DQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
             LD P  + +L   FQ    LY  +E   GG+L   I   G   E +A FY AE+   L
Sbjct: 74  ALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGL 133
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            ++H  G+I+RD+K +N++L ++GHIKIADFG  K      +T             F GT
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTR----------EFCGT 183
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 243
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG---QTP--PKLASE 333
           S              P+ R G GP G   ++ H FF+ IDW+ +     Q P  PK+  +
Sbjct: 244 SKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGK 303
Query: 334 PMVNF 338
              NF
Sbjct: 304 GAENF 308

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 145/291 (49%), Gaps = 14/291 (4%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVL 99
           H    DF   K+ G GS+ KV+ A+       YA+K++ KK I K+ +  ++  ER ++L
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
             + HP +V L F+FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS+ +++RD+KPEN+LL + GHI + DFG  K           N   +    TF GT 
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK----------ENIEHNSTTSTFCGTP 203
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            Y+ PEVL+  P     D W LG  LY+ML G  PF   +   ++  I+ + ++     +
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 280 XXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                          + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPP 313

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 147/306 (48%), Gaps = 16/306 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +++      +E+ V
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 99  LDQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L     P  + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L ++ S G+I+RD+K +N++L ++GHIKIADFG  K      +T             F G
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK----------XFCG 504
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P  
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 564
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW-----KNIRGQTPPKLAS 332
            S              P  R G GP G   +K H FF+ IDW     K I+    PK + 
Sbjct: 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624
Query: 333 EPMVNF 338
               NF
Sbjct: 625 RNAENF 630

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 99/319 (31%), Positives = 147/319 (46%), Gaps = 16/319 (5%)
Query: 26  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 85
           T      F     ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 86  ENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 144
           ++      +E+ VL     P  + +L   FQ    LY  +E   GG+L   I   G   E
Sbjct: 61  DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
             A FY AE+   L ++ S G+I+RD+K +N++L ++GHIKIADFG  K           
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------E 170
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           N         F GT  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +F
Sbjct: 171 NIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
Query: 265 QRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW----- 319
           Q I+  ++ +P   S              P  R G GP G   +K H FF+ IDW     
Sbjct: 231 QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 290
Query: 320 KNIRGQTPPKLASEPMVNF 338
           K I+    PK       NF
Sbjct: 291 KEIQPPYKPKACGRNAENF 309

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 139/293 (47%), Gaps = 17/293 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    I+DFEL K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ V
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 99  LD-QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K   F G
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNEFCG 181
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 241
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
                           P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 242 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPP 290

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 150/312 (48%), Gaps = 19/312 (6%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           +Q ++    R  +      DFE+ K+ G G++S+V   K   TG VYA+KIM+K  + K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSED 145
            + +  + ER VL   D   + +L F FQD   LY+ +E   GG+L   ++  G  +  +
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY AE+V A++ +H +G +HRDIKP+N+LL   GHI++ADFGS   ++         
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR--------- 213
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLSGTSPFKDT 258
           A    ++   VGT  Y+ PE+L +     G        D WALG   Y+M  G +PF   
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273
Query: 259 SEWLIFQRII--ARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKG 316
           S    + +I+     +  P                         G GG    + HPFF G
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
Query: 317 IDWKNIRGQTPP 328
           +DW  +R   PP
Sbjct: 334 LDWDGLRDSVPP 345

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 138/293 (47%), Gaps = 17/293 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ V
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 99  LD-QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K   F G
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNXFCG 180
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
                           P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPP 289

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 243
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 302
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 303 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 354

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 238
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 297
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 349

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 243
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 302
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 303 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 354

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 152/292 (52%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF  FQD   LYM +E   GG+L + + S   + E  A+FYTAEVV AL+ IHSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           GLIHRD+KP+N+LL   GH+K+ADFG+   M ++ +             T VGT  Y+ P
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV---------HCDTAVGTPDYISP 244
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  L++ML G +PF   S    + +I+     + FP   
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED- 303
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKG--IDWKNIRGQTPP 328
           +                     G  G   +K HPFFK    +W NIR    P
Sbjct: 304 AEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAP 355

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 133/237 (56%), Gaps = 11/237 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I+DF++G + G GS++ V RA+ I TG   A+K++DKK + K      V+ E  +  QL 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP ++ L+  F+D+  +Y+ LE C  GE+   + ++    SE+EAR +  +++  + Y+H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S G++HRD+   NLLLT + +IKIADFG    ++      +P+    +K  T  GT  Y+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK------MPH----EKHYTLCGTPNYI 179
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            PE+   S     +D+W+LGC  Y +L G  PF   +      +++  D   P++ S
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 120/242 (49%), Gaps = 12/242 (4%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+  F+I DF++G+  G G +  V  A++     + ALK++ K  + KE     ++ E  
Sbjct: 8   PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 67
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E+ DA
Sbjct: 68  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L Y H   +IHRDIKPENLL+   G +KIADFG          +V   +      C   G
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG---------WSVHAPSLRRRXMC---G 175
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D++FP +
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 235
Query: 278 FS 279
            S
Sbjct: 236 LS 237

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++RL+  F D   +Y+ LE    GE++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------ 169
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGRP 298
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 146/300 (48%), Gaps = 24/300 (8%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 218 TAAYVPPEVLNSSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   +  W +LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 330
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q  PP L
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 146/300 (48%), Gaps = 24/300 (8%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 218 TAAYVPPEVLNSSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   +  W +LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 330
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q  PP L
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 146/300 (48%), Gaps = 24/300 (8%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 218 TAAYVPPEVLNSSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   +  W +LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 330
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q  PP L
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 146/300 (48%), Gaps = 24/300 (8%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 184 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 351
Query: 218 TAAYVPPEVLNSSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   +  W +LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 409
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 330
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q  PP L
Sbjct: 410 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 469

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 127/265 (47%), Gaps = 12/265 (4%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++RL+  F D   +Y+ LE    GE++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L          
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---------- 171
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 172 --XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGRP 298
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 119/242 (49%), Gaps = 12/242 (4%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+  F+I DF++ +  G G +  V  A++     + ALK++ K  + KE     ++ E  
Sbjct: 7   PKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E+ DA
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L Y H   +IHRDIKPENLL+   G +KIADFG          +V   +      C   G
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG---------WSVHAPSLRRRXMC---G 174
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D++FP +
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 234
Query: 278 FS 279
            S
Sbjct: 235 LS 236

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 127/265 (47%), Gaps = 12/265 (4%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------ 169
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGRP 298
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 133/281 (47%), Gaps = 16/281 (5%)
Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
           NN      + Q+++     + +  ++++DFE+G+  G G +  V  A++  +  + ALK+
Sbjct: 11  NNPEEELASKQKNEE----SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV 66
Query: 78  MDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           + K  + K      ++ E  +   L HP ++RL+  F D   +Y+ LE    G ++ ++ 
Sbjct: 67  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
                 E     Y  E+ +AL Y HS  +IHRDIKPENLLL + G +KIADFG       
Sbjct: 127 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 186
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           SR T            T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+ 
Sbjct: 187 SRRT------------TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234
Query: 258 TSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRP 298
            +    ++RI   +  FP++ +              PS RP
Sbjct: 235 NTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 133/281 (47%), Gaps = 16/281 (5%)
Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
           NN      + Q+++     + +  ++++DFE+G+  G G +  V  A++  +  + ALK+
Sbjct: 2   NNPEEELASKQKNEE----SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV 57
Query: 78  MDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           + K  + K      ++ E  +   L HP ++RL+  F D   +Y+ LE    G ++ ++ 
Sbjct: 58  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 117
Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
                 E     Y  E+ +AL Y HS  +IHRDIKPENLLL + G +KIADFG       
Sbjct: 118 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 177
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           SR T            T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+ 
Sbjct: 178 SRRT------------TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225
Query: 258 TSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRP 298
            +    ++RI   +  FP++ +              PS RP
Sbjct: 226 NTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 266

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLC 170
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 231 FVTEGARDLISRLLKHNPSQRP 252

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 12/258 (4%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT  
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGTLD 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 XXXXXXXXXXXXXPSGRP 298
                        PS RP
Sbjct: 232 GARDLISRLLKHNPSQRP 249

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 88/246 (35%), Positives = 133/246 (54%), Gaps = 17/246 (6%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           A  E   I ++ L K  G G+++KV  A+ + TG   A+KI+DK   T+ N T+  KL R
Sbjct: 7   ATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDK---TQLNPTSLQKLFR 63
Query: 97  IV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
            V  +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V A++Y H   ++HRD+K ENLLL  D +IKIADFG       +  TV       +K  T
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGF-----SNEFTV------GNKLDT 172
Query: 215 FVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           F G+  Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 274 FPNYFS 279
            P Y S
Sbjct: 233 IPFYMS 238

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 173
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 233
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 234 TEGARDLISRLLKHNPSQRP 253

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLC 172
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE +         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 233 FVTEGARDLISRLLKHNPSQRP 254

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 136/282 (48%), Gaps = 18/282 (6%)
Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
           NN      + Q+++     + +  ++++DFE+G+  G G +  V  A++  +  + ALK+
Sbjct: 11  NNPEEELASKQKNEE----SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV 66
Query: 78  MDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           + K  + K      ++ E  +   L HP ++RL+  F D   +Y+ LE    G ++ ++ 
Sbjct: 67  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQ 196
                 E     Y  E+ +AL Y HS  +IHRDIKPENLLL + G +KIADFG SV    
Sbjct: 127 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--- 183
Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                  P++  DD      GT  Y+PPE++         DLW+LG   Y+ L G  PF+
Sbjct: 184 ------APSSRRDD----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
Query: 257 DTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRP 298
             +    ++RI   +  FP++ +              PS RP
Sbjct: 234 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 275

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/243 (36%), Positives = 132/243 (54%), Gaps = 17/243 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R V 
Sbjct: 7   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFREVR 63
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 123
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG       +  TV        K  TF G
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTV------GGKLDTFCG 172
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           +  Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 232
Query: 277 YFS 279
           Y S
Sbjct: 233 YMS 235

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLC 170
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 231 FVTEGARDLISRLLKHNPSQRP 252

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 168
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 228
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 229 TEGARDLISRLLKHNPSQRP 248

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT------------TLSGT 170
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 231 TEGARDLISRLLKHNPSQRP 250

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 133/261 (50%), Gaps = 17/261 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           +  Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 234
Query: 277 YFSXXXXXXXXXXXXXXPSGR 297
           Y S              PS R
Sbjct: 235 YMSTDCENLLKKFLILNPSKR 255

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 133/261 (50%), Gaps = 17/261 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           +  Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 234
Query: 277 YFSXXXXXXXXXXXXXXPSGR 297
           Y S              PS R
Sbjct: 235 YMSTDCENLLKKFLILNPSKR 255

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 12/258 (4%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT  
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL------------CGTLD 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 XXXXXXXXXXXXXPSGRP 298
                        PS RP
Sbjct: 232 GARDLISRLLKHNPSQRP 249

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 14/263 (5%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTF 215
           AL Y HS  +IHRDIKPENLLL + G +KIADFG SV           P++  D    T 
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRD----TL 167
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227
Query: 276 NYFSXXXXXXXXXXXXXXPSGRP 298
           ++ +              PS RP
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRP 250

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 127/259 (49%), Gaps = 14/259 (5%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTA 219
            HS  +IHRDIKPENLLL + G +KIADFG SV           P++  DD      GT 
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRDD----LCGTL 173
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 280 XXXXXXXXXXXXXXPSGRP 298
                         PS RP
Sbjct: 234 EGARDLISRLLKHNPSQRP 252

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 126/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++ ++  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D+  +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L             GT
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIA+FG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------------TLCGT 172
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------C 172
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 233 FVTEGARDLISRLLKHNPSQRP 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 126/262 (48%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIA+FG       SR T            T  
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------------TLC 169
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 229
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 230 FVTEGARDLISRLLKHNPSQRP 251

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------C 168
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 229 FVTEGARDLISRLLKHNPSQRP 250

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 123/257 (47%), Gaps = 12/257 (4%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           ++++DFE+G+  G G +  V  A++     + ALK++ K  + K      ++ E  +   
Sbjct: 2   WALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT  Y
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGTLDY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 229
Query: 282 XXXXXXXXXXXXPSGRP 298
                       PS RP
Sbjct: 230 ARDLISRLLKHNPSQRP 246

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 133/261 (50%), Gaps = 17/261 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A++I+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           +  Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 234
Query: 277 YFSXXXXXXXXXXXXXXPSGR 297
           Y S              PS R
Sbjct: 235 YMSTDCENLLKKFLILNPSKR 255

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 123/258 (47%), Gaps = 12/258 (4%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            HS  +IHRDIKPENLLL + G +KIADFG       SR   L             GT  
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL------------CGTLD 174
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 XXXXXXXXXXXXXPSGRP 298
                        PS RP
Sbjct: 235 GARDLISRLLKHNPSQRP 252

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 132/259 (50%), Gaps = 17/259 (6%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--L 99
             I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V  +
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVRIM 60
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
             L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A++
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G+ 
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCGSP 169
Query: 220 AYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
            Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P Y 
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 229
Query: 279 SXXXXXXXXXXXXXXPSGR 297
           S              PS R
Sbjct: 230 STDCENLLKKFLILNPSKR 248

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCG 168
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 125/262 (47%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L             
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL------------C 169
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 229
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 230 FVTEGARDLISRLLKHNPSQRP 251

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 88/243 (36%), Positives = 130/243 (53%), Gaps = 17/243 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R V 
Sbjct: 10  EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFREVR 66
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG       +  TV        K   F G
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTV------GGKLDAFCG 175
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
              Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 235
Query: 277 YFS 279
           Y S
Sbjct: 236 YMS 238

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 125/262 (47%), Gaps = 12/262 (4%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 122
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L             
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL------------C 170
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 277 YFSXXXXXXXXXXXXXXPSGRP 298
           + +              PS RP
Sbjct: 231 FVTEGARDLISRLLKHNPSQRP 252

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 131/261 (50%), Gaps = 17/261 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDAFCG 174
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
              Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 234
Query: 277 YFSXXXXXXXXXXXXXXPSGR 297
           Y S              PS R
Sbjct: 235 YMSTDCENLLKKFLILNPSKR 255

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FE  +  G G++S+VV A++  TG ++A+K + KK +  + K + ++ E  VL ++ H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIAVLRKIKHEN 81
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA+ Y+H MG+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 167 IHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL  +   +  I I+DFG  K M+             D   T  GT  YV 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSK-ME----------GKGDVMSTACGTPGYVA 190
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEF 241

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 132/261 (50%), Gaps = 17/261 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A++I+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDEFCG 174
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           +  Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 234
Query: 277 YFSXXXXXXXXXXXXXXPSGR 297
           Y S              PS R
Sbjct: 235 YMSTDCENLLKKFLILNPSKR 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 122/241 (50%), Gaps = 12/241 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DF++G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL ++G +KIADFG       SR T            T  GT
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT------------TLCGT 173
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFV 233
Query: 279 S 279
           +
Sbjct: 234 T 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/236 (35%), Positives = 120/236 (50%), Gaps = 14/236 (5%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           HF+I DFE+G+  G G +  V  A++  +  + ALK++ K  I KE     ++ E  +  
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    GEL+ ++       E        E+ DAL Y
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H   +IHRDIKPENLLL   G +KIADFG SV              A   +  T  GT 
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVH-------------APSLRRKTMCGTL 185
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            Y+PPE++         DLW +G   Y++L G  PF+  S    ++RI+  D++FP
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP 241

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + KK +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 125/242 (51%), Gaps = 14/242 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DF++G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL ++G +KIADFG SV           P++  D    T  G
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHA---------PSSRRD----TLCG 172
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF 232
Query: 278 FS 279
            +
Sbjct: 233 VT 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 117/219 (53%), Gaps = 14/219 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           E  +   FE+ +  G GS+ KV   +K DT  +YA+K M+K+   + N+   V  E  ++
Sbjct: 10  EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
             L+HP +V L+++FQD   ++M ++   GG+L   +    H  E+  + +  E+V AL+
Sbjct: 70  QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ +  +IHRD+KP+N+LL   GH+ I DF            +LP      +  T  GT 
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--------AMLPRET---QITTMAGTK 178
Query: 220 AYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPF 255
            Y+ PE+ +S      +F  D W+LG T Y++L G  P+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 128/261 (49%), Gaps = 17/261 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
               L+HP +V+LF   +   +LY+  E   GGE+FD + + G   E EAR    ++V A
Sbjct: 66  IXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF-----------TFGNKLDAFCG 174
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
              Y  PE+           D+W+LG  LY ++SG+ PF   +   + +R++    R P 
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 234
Query: 277 YFSXXXXXXXXXXXXXXPSGR 297
           Y S              PS R
Sbjct: 235 YXSTDCENLLKKFLILNPSKR 255

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/221 (35%), Positives = 120/221 (54%), Gaps = 20/221 (9%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
              +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 172 KPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           KPEN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL 
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-------QNTKMKDR----IGTAYYIAPEVLR 196
Query: 229 SSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
               T+    D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 197 ---GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 191 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 236

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 192 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 237

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/222 (33%), Positives = 122/222 (54%), Gaps = 19/222 (8%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 224
Query: 228 NSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +    T+    D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 225 H---GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 263

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 118/217 (54%), Gaps = 16/217 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF  
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 174 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           EN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL  +
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQ-------NTKMKDR----IGTAYYIAPEVLRGT 198
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                 D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 199 YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 182 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 227

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 118/217 (54%), Gaps = 16/217 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF  
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 174 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           EN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL  +
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQ-------NTKMKDR----IGTAYYIAPEVLRGT 198
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                 D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 199 YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/222 (33%), Positives = 122/222 (54%), Gaps = 19/222 (8%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 223
Query: 228 NSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +    T+    D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 224 H---GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 206
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 207 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 245

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 186 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 231

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 75/222 (33%), Positives = 122/222 (54%), Gaps = 19/222 (8%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 200
Query: 228 NSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +    T+    D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 201 H---GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           +++L +  G G++S V R  KI TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 219
            G++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           +++L +  G G++S V R  KI TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 219
            G++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 227

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 92/289 (31%), Positives = 136/289 (47%), Gaps = 56/289 (19%)
Query: 16  GNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYAL 75
           G++ SS +C  + +            ++++D E+GK    GSY  V  A   +  T YA+
Sbjct: 1   GSSGSSGDCVQLNQ------------YTLKD-EIGK----GSYGVVKLAYNENDNTYYAM 43
Query: 76  KIMDKKFITKE-----------------------NKTAYVKLERIVLDQLDHPGVVRLFF 112
           K++ KK + ++                            V  E  +L +LDHP VV+L  
Sbjct: 44  KVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVE 103
Query: 113 TFQDTFS--LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
              D     LYM  E    G + +  T K  LSED+ARFY  +++  +EY+H   +IHRD
Sbjct: 104 VLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRD 162
Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           IKP NLL+  DGHIKIADFG     +           SD      VGT A++ PE L+ +
Sbjct: 163 IKPSNLLVGEDGHIKIADFGVSNEFK----------GSDALLSNTVGTPAFMAPESLSET 212
Query: 231 PATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
              F     D+WA+G TLY  + G  PF D     +  +I ++ + FP+
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 75/222 (33%), Positives = 120/222 (54%), Gaps = 19/222 (8%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP + +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y H   ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KXKDKIGTAYYIAPEVL 200
Query: 228 NSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +    T+    D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 201 H---GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 123/235 (52%), Gaps = 18/235 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLDH 104
           ++L +  G G++S V R  K+  G  YA KI++ K ++  +   + KLER   +   L H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD---HQKLEREARICRLLKH 80
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H M
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 165 GLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLLL +      +K+ADFG    ++  +               F GT  Y
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----------GFAGTPGY 190
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           + PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 190 PEV----------DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 86
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 195
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 172
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 172
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 190 PEV----------DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 227

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G G+Y +V+  K   TG   A+KI+ K  +T  + +  +  E  VL QLDHP +++L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D  + Y+ +E   GGELFD+I  +   SE +A     +V+    Y+H   ++HRD
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 171 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL +   D  IKI DFG           +  +     K    +GTA Y+ PEVL
Sbjct: 147 LKPENLLLESKSRDALIKIVDFG-----------LSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                    D+W+ G  LY +L G  PF   ++  I +R+
Sbjct: 196 RKKYDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 124/237 (52%), Gaps = 18/237 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQL 102
           ++++L +  G G++S V R  K+  G  YA  I++ K ++  +   + KLER   +   L
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD---HQKLEREARICRLL 67
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 163 SMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            MG++HR++KPENLLL +      +K+ADFG    ++  +               F GT 
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----------GFAGTP 177
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++  T  GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKTLCGTPNYI 209
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 283 XXXXXXXXXXXPSGRPGAGP--------GGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   K   TG   A+KI++++ I   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+        ++M +E   GGELFD I   G L E E+R    +++  ++Y H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 195 PEV----------DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G G+Y +V+  K   TG   A+KI+ K  +T  + +  +  E  VL QLDHP +++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D  + Y+ +E   GGELFD+I  +   SE +A     +V+    Y+H   ++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 171 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL +   D  IKI DFG           +  +     K    +GTA Y+ PEVL
Sbjct: 130 LKPENLLLESKSRDALIKIVDFG-----------LSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                    D+W+ G  LY +L G  PF   ++  I +R+
Sbjct: 179 RKKYDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 134/243 (55%), Gaps = 21/243 (8%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKENK 88
           +++  F++ +++  +Q        G GS+ K +  K  + G  Y +K ++  +  +KE +
Sbjct: 15  TENLYFQSMEKYVRLQKI------GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 89  TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHL-SEDE 146
            +  + E  VL  + HP +V+   +F++  SLY+ ++ CEGG+LF +I + KG L  ED+
Sbjct: 69  ES--RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
              +  ++  AL+++H   ++HRDIK +N+ LT DG +++ DFG  +        VL + 
Sbjct: 127 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR--------VLNST 178
Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
               +AC  +GT  Y+ PE+  + P    +D+WALGC LY++ +    F+  S   +  +
Sbjct: 179 VELARAC--IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236
Query: 267 IIA 269
           II+
Sbjct: 237 IIS 239

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/226 (34%), Positives = 119/226 (52%), Gaps = 20/226 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FE+    G G+ S V R K+  T   YALK++ KK + K+     V+ E  VL +L HP 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKK----IVRTEIGVLLRLSHPN 109
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +++L   F+    + + LE   GGELFD+I  KG+ SE +A     ++++A+ Y+H  G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 167 IHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL      D  +KIADFG  K ++   +             T  GT  Y  
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-----------TVCGTPGYCA 218
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRII 268
           PE+L         D+W++G   Y +L G  PF D   +  +F+RI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 143/299 (47%), Gaps = 18/299 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I   G     EAR  FY AE+   LE +H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPEN+LL   GHI+I+D G    + + +                VGT  Y+ P
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----------GRVGTVGYMAP 354
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI--RFPNYFSX 280
           EV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + +++   +   FS 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 281 XXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVNF 338
                        P+ R G   G    +K HP FK +++K +  G   P    +P   +
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY 473

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 125/237 (52%), Gaps = 20/237 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           +++L +  G G++S V R  K+ TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H 
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 164 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 219
           MG++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL         D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 227

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 143/299 (47%), Gaps = 18/299 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I   G     EAR  FY AE+   LE +H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPEN+LL   GHI+I+D G    + + +                VGT  Y+ P
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----------GRVGTVGYMAP 354
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI--RFPNYFSX 280
           EV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + +++   +   FS 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 281 XXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVNF 338
                        P+ R G   G    +K HP FK +++K +  G   P    +P   +
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY 473

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 121/226 (53%), Gaps = 18/226 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F   ++ G G++S+V   K+  TG ++ALK + K   +   + + ++ E  VL ++ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKH 65
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             +V L   ++ T   Y+ ++   GGELFD+I  +G  +E +A     +V+ A++Y+H  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLL      +  I I DFG  K  Q+  ++          AC   GT  Y
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---------AC---GTPGY 173
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           V PEVL   P +   D W++G   Y +L G  PF + +E  +F++I
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKXLCGTPNYI 209
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 283 XXXXXXXXXXXPSGRPGAGP--------GGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 24  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 83
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 143
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKDLCGTPNYI 193
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 253
Query: 283 XXXXXXXXXXXPSGRPGAGP--------GGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 254 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 289

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKDLCGTPNYI 209
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 283 XXXXXXXXXXXPSGRPGAGP--------GGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ KV  A    T    ALK + ++ + K +    V+ E   L  L HP +++L+  
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
                 + M +E   GGELFD I  K  ++EDE R +  +++ A+EY H   ++HRD+KP
Sbjct: 78  ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN----S 229
           ENLLL  + ++KIADFG    M D                T  G+  Y  PEV+N    +
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLK-----------TSCGSPNYAAPEVINGKLYA 185
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            P     D+W+ G  LY ML G  PF D     +F+++ +     P++ S
Sbjct: 186 GPEV---DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 121/236 (51%), Gaps = 18/236 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           D++L +  G G++S V R  K      YA KI++ K ++  +   + KLER   +   L 
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARD---HQKLEREARICRLLK 88
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ +IH 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 164 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
             ++HRD+KPENLLL +      +K+ADFG    +Q  +               F GT  
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF----------GFAGTPG 198
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 254

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 146 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 255
Query: 294 PSGRP 298
           P+ RP
Sbjct: 256 PTARP 260

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 146 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 255
Query: 294 PSGRP 298
           P+ RP
Sbjct: 256 PTARP 260

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 30  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 90  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 149
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 150 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 259
Query: 294 PSGRP 298
           P+ RP
Sbjct: 260 PTARP 264

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 103
           +E+G+  G G ++ V + ++  TG  YA K + K+ ++   +  +  ++ER V  L ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 164 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 175
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 278
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235
Query: 279 S 279
           S
Sbjct: 236 S 236

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 103
           +E+G+  G G ++ V + ++  TG  YA K + K+ ++   +  +  ++ER V  L ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 164 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 182
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 278
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 242
Query: 279 S 279
           S
Sbjct: 243 S 243

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 124/241 (51%), Gaps = 19/241 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 103
           +E+G+  G G ++ V + ++  TG  YA K + K+ +    +  +  ++ER V  L ++ 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 164 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 196
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 278
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 256
Query: 279 S 279
           S
Sbjct: 257 S 257

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279
Query: 294 PSGRP 298
           P+ RP
Sbjct: 280 PTARP 284

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 48  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 107
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 108 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 167
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 168 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 277
Query: 294 PSGRP 298
           P+ RP
Sbjct: 278 PTARP 282

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 84  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253
Query: 294 PSGRP 298
           P+ RP
Sbjct: 254 PTARP 258

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 116/238 (48%), Gaps = 33/238 (13%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVV 108
           K  G GS+S   +     +   +A+KI+ K+    T++  TA    E        HP +V
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-------GHPNIV 69
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
           +L   F D    ++ +E   GGELF++I  K H SE EA +   ++V A+ ++H +G++H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 169 RDIKPENLLLTADG---HIKIADFG--SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           RD+KPENLL T +     IKI DFG   +KP         P+       C    T  Y  
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP---------PDNQPLKTPCF---TLHYAA 177
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-------TSEWLIFQRIIARDIRF 274
           PE+LN +      DLW+LG  LY MLSG  PF+        TS   I ++I   D  F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 44  IQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK---TAYVKLERIVL 99
           ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            Q+ HP ++ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + 
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 160 YIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           Y+H+  + H D+KPEN++L        HIK+ DFG    ++D             +    
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----------EFKNI 178
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 120/231 (51%), Gaps = 24/231 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++  V   ++  +G    +K ++K     +     ++ E  VL  LDHP ++++F  
Sbjct: 31  GSGAFGDVHLVEERSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV----VDALEYIHSMGLIHR 169
           F+D  ++Y+ +E+CEGGEL ++I S     +  +  Y AE+    ++AL Y HS  ++H+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 170 DIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           D+KPEN+L    +    IKI DFG  +  +           SD+ +    GTA Y+ PEV
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFK-----------SDEHSTNAAGTALYMAPEV 197
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
                 TF  D+W+ G  +Y +L+G  PF  TS   + Q+   ++   PNY
Sbjct: 198 FKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---PNY 244

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 118/220 (53%), Gaps = 16/220 (7%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G G+Y +V+  +   T    A+KI+ K  ++  + +  ++ E  VL  LDHP +++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKL 101
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D  + Y+ +E  +GGELFD+I  +   +E +A     +V+  + Y+H   ++HRD
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 171 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL +   D  IKI DFG     ++ +           K    +GTA Y+ PEVL
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQK-----------KMKERLGTAYYIAPEVL 210
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                    D+W++G  L+ +L+G  PF   ++  I +++
Sbjct: 211 RKKYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/229 (35%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +      + A+K +++     EN    VK E I    L HP 
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 76
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KIADFG  K    S +   P +A        VGT AY+
Sbjct: 137 AHRDLKLENTLL--DGSPAPRLKIADFGYSKA---SVLHSQPKSA--------VGTPAYI 183
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           GVGSYS+  R     T   YA+K++DK   +K + +  ++   I+L    HP ++ L   
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDK---SKRDPSEEIE---ILLRYGQHPNIITLKDV 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           + D   +Y+  E   GGEL D+I  +   SE EA F    +   +EY+HS G++HRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 174 ENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
            N+L   +      ++I DFG  K ++          A +    T   TA +V PEVL  
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFVAPEVLKR 199
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKD 257
                G D+W+LG  LY ML+G +PF +
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           GVGSYS+  R     T   YA+K++DK   +K + +  ++   I+L    HP ++ L   
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDK---SKRDPSEEIE---ILLRYGQHPNIITLKDV 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           + D   +Y+  E   GGEL D+I  +   SE EA F    +   +EY+HS G++HRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 174 ENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
            N+L   +      ++I DFG  K ++          A +    T   TA +V PEVL  
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFVAPEVLKR 199
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKD 257
                G D+W+LG  LY ML+G +PF +
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 123/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
            A+V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     E   A VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIAANVKREIINHRSLRHPN 76
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 183
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 75
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 136 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 182
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 231

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 131/260 (50%), Gaps = 34/260 (13%)
Query: 18  NNSSTNCPTVQRSKSFAF-------RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG 70
           NN+S    ++ R+K F F       ++        ++ + K  G G+  +V  A +  T 
Sbjct: 115 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 174
Query: 71  TVYALKIMDK-KFITKENKTA----YVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMA 123
              A++I+ K KF     + A     V+ E  +L +L+HP ++++  FF  +D    Y+ 
Sbjct: 175 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---YYIV 231
Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--- 180
           LE  EGGELFD++     L E   + Y  +++ A++Y+H  G+IHRD+KPEN+LL++   
Sbjct: 232 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 291
Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---D 237
           D  IKI DFG  K + ++ +             T  GT  Y+ PEVL S      N   D
Sbjct: 292 DCLIKITDFGHSKILGETSLMR-----------TLCGTPTYLAPEVLVSVGTAGYNRAVD 340
Query: 238 LWALGCTLYQMLSGTSPFKD 257
            W+LG  L+  LSG  PF +
Sbjct: 341 CWSLGVILFICLSGYPPFSE 360

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 129/258 (50%), Gaps = 30/258 (11%)
Query: 18  NNSSTNCPTVQRSKSFAF-------RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG 70
           NN+S    ++ R+K F F       ++        ++ + K  G G+  +V  A +  T 
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 71  TVYALKIMDK-KFITKENKTA----YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE 125
              A++I+ K KF     + A     V+ E  +L +L+HP ++++   F D    Y+ LE
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK-NFFDAEDYYIVLE 219
Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DG 182
             EGGELFD++     L E   + Y  +++ A++Y+H  G+IHRD+KPEN+LL++   D 
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 279
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---DLW 239
            IKI DFG  K + ++ +             T  GT  Y+ PEVL S      N   D W
Sbjct: 280 LIKITDFGHSKILGETSLMR-----------TLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 240 ALGCTLYQMLSGTSPFKD 257
           +LG  L+  LSG  PF +
Sbjct: 329 SLGVILFICLSGYPPFSE 346

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 104
           +EL ++ G G++S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 160
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 161 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            H   +IHRD+KPEN+LL +  +   +K+ DFG    + +S +           A   VG
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV----------AGGRVG 195
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 245

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 76
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI  FG       S+ +VL +   D      VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICAFGY------SKSSVLHSQPKDT-----VGTPAYI 183
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 77  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 133
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 182
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 70  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 126
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 175
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 179
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 278 FS 279
           FS
Sbjct: 240 FS 241

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++  V R  +  TG V+  K ++  +   +     VK E  +++QL HP ++ L   
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLHDA 116
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H   ++H DIK
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176
Query: 173 PENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           PEN++        +KI DFG    +    I  +  A           TA +  PE+++  
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-----------TAEFAAPEIVDRE 225
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 179
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 278 FS 279
           FS
Sbjct: 240 FS 241

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  GVGSYS   R     T   +A+KI+DK   +K + T  ++   I+L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIE---ILLRYGQHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+ G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTANFV 187
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            PEVL         D+W+LG  LY ML+G +PF +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 22/237 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 82
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 83  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 165 GLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            + HRD+KPEN L    + D  +K+ DFG     +  ++             T VGT  Y
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-----------TKVGTPYY 191
Query: 222 VPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP 
Sbjct: 192 VSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 245

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 22/237 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 65
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 165 GLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            + HRD+KPEN L    + D  +K+ DFG     +  ++             T VGT  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-----------TKVGTPYY 174
Query: 222 VPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP 
Sbjct: 175 VSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 76
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI  FG       S+ +VL +        + VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICAFGY------SKSSVLHSQPK-----STVGTPAYI 183
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 14/235 (5%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           P  Q     A R    + ++ +F + K  G G +S+V RA  +  G   ALK +    + 
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 85  KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKG 140
                A    E  +L QL+HP V++ + +F +   L + LE  + G+L   I      K 
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            + E     Y  ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKT 190
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T          A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF
Sbjct: 191 TA---------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 122/231 (52%), Gaps = 16/231 (6%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQL 102
           I  + +G + G GSY KV      +T    A+KI+ KK + +  N  A VK E  +L +L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 103 DHPGVVRLFFTF--QDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDAL 158
            H  V++L      ++   +YM +E C  G  E+ D +  K      +A  Y  +++D L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGL 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS G++H+DIKP NLLLT  G +KI+  G  + +           A+DD   T  G+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP--------FAADDTCRTSQGS 174
Query: 219 AAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
            A+ PPE+ N   + + F  D+W+ G TLY + +G  PF+  + + +F+ I
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 118/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+ + + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV 232

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + +  E   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  GVGSYS   R     T   +A+KI+DK   +K + T  ++   I+L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK---SKRDPTEEIE---ILLRYGQHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+ G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLXTPCYTANFV 187
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            PEVL         D+W+LG  LY  L+G +PF +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFAN 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIM-----DKKFITKENKTAYVKLERI-----VLDQLD 103
           G G+Y +V+  K+ +  +  A+K++     DK   + +NK      E I     +L  LD
Sbjct: 45  GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++LF  F+D    Y+  E  EGGELF+QI ++    E +A     +++  + Y+H 
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK 164
Query: 164 MGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
             ++HRDIKPEN+LL       +IKI DFG           +    + D K    +GTA 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFG-----------LSSFFSKDYKLRDRLGTAY 213
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           Y+ PEVL         D+W+ G  +Y +L G  PF   ++  I +++
Sbjct: 214 YIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 119/225 (52%), Gaps = 23/225 (10%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           +I G G + +V + ++  TG   A KI+  + +  + +   VK E  V++QLDH  +++L
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE---VKNEISVMNQLDHANLIQL 151
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHR 169
           +  F+    + + +E  +GGELFD+I  + + L+E +   +  ++ + + ++H M ++H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 170 DIKPENLL-LTADG-HIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           D+KPEN+L +  D   IKI DFG     KP +  ++                GT  ++ P
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--------------GTPEFLAP 257
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
           EV+N    +F  D+W++G   Y +LSG SPF   ++      I+A
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 33/276 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 28  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPYIVKLLGA 84
Query: 114 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +     L++ +E C GG + D I     +G L+E + +    ++++AL ++HS  +IHRD
Sbjct: 85  YYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 171 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 226
           +K  N+L+T +G I++ADFG S K           N  +  K  +F+GT  ++ PEV   
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAK-----------NLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 227 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSXX 281
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   D   +  P+ +S  
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
                       P  RP A     A L  HPF   I
Sbjct: 252 FRDFLKIALDKNPETRPSA-----AQLLEHPFVSSI 282

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 139/283 (49%), Gaps = 33/283 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+    G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   DHP 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPY 69
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHS 163
           +V+L   +     L++ +E C GG + D I     +G L+E + +    ++++AL ++HS
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS 127
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             +IHRD+K  N+L+T +G I++ADFG S K           N  +  K  +F+GT  ++
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAK-----------NLKTLQKRDSFIGTPYWM 176
Query: 223 PPEV-----LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 274
            PEV     +  +P  +  D+W+LG TL +M     P  + +   +  +I   D   +  
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 236
Query: 275 PNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
           P+ +S              P  RP A     A L  HPF   I
Sbjct: 237 PSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVSSI 274

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N+L++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++  K  G G++      +   T  + A+K +++     EN    V+ E I    L HP 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGEL+++I + G  SEDEARF+  +++  + Y HSM +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 138 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 184
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   +++ I R
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 173
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 59
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 171
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 172 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 173
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 173
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 88
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 201
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 249

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 36/267 (13%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI---TKENKTAYVKLERIVLDQL 102
           ++ LG + G G +  V    ++      A+K++ +  +   +  + +    LE  +L ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 103 D----HPGVVRLFFTFQDTFSLYMALES-CEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
                HPGV+RL   F+      + LE      +LFD IT KG L E  +R +  +VV A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 158 LEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           +++ HS G++HRDIK EN+L+    G  K+ DFGS   + D   T             F 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT------------DFD 199
Query: 217 GTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           GT  Y PPE +     ++ PAT    +W+LG  LY M+ G  PF+        Q I+  +
Sbjct: 200 GTRVYSPPEWISRHQYHALPAT----VWSLGILLYDMVCGDIPFERD------QEILEAE 249
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRP 298
           + FP + S              PS RP
Sbjct: 250 LHFPAHVSPDCCALIRRCLAPKPSSRP 276

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINAM 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 173
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  Y
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPY 173
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N           GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--------KMXGTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+Y +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 17  PEELFT----KLDRI-GKGSFGEVYKGIDNHTKEVVAIKIID--LEEAEDEIEDIQQEIT 69
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P + R F ++  +  L++ +E   GG   D +   G L E        E++  
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKG 128
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 129 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNXFVG 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S   F  D+W+LG T  ++  G  P  D
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 122/247 (49%), Gaps = 24/247 (9%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H   +++E  +I G G  S V R     T   YA+KI+D       +     +L    L 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 101 QLD-------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           ++D       HP +++L  T++     ++  +  + GELFD +T K  LSE E R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +++ +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K  
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-----------EKLR 181
Query: 214 TFVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +  GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ + I
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
Query: 268 IARDIRF 274
           ++ + +F
Sbjct: 242 MSGNYQF 248

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 106
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP +V L   F+D   + M  E   GGELF+++  + + +SEDEA  Y  +V   L ++H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 163 SMGLIHRDIKPENLLLTA--DGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVG 217
               +H D+KPEN++ T      +K+ DFG    + P Q  ++T               G
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--------------G 212
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           TA +  PEV    P  +  D+W++G   Y +LSG SPF
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 119/245 (48%), Gaps = 29/245 (11%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---------KTAYVKLE 95
           Q ++   + G G  S V R     TG  +A+KIM+   +T E          + A  +  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME---VTAERLSPEQLEEVREATRRET 150
Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            I+     HP ++ L  +++ +  +++  +    GELFD +T K  LSE E R     ++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +A+ ++H+  ++HRD+KPEN+LL  +  I+++DFG    ++             +K    
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-----------EKLREL 259
Query: 216 VGTAAYVPPEVLNSS----PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
            GT  Y+ PE+L  S       +G   DLWA G  L+ +L+G+ PF    + L+ + I+ 
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 270 RDIRF 274
              +F
Sbjct: 320 GQYQF 324

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 104
           +EL ++ G G +S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 160
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 161 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            H   +IHRD+KP  +LL +  +   +K+  FG    + +S +           A   VG
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV----------AGGRVG 197
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 247

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 212
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP +V L   F+D   + M  E   GGELF+++  + + +SEDEA  Y  +V   L ++H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 163 SMGLIHRDIKPENLLLTA--DGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVG 217
               +H D+KPEN++ T      +K+ DFG    + P Q  ++T               G
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--------------G 318
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           TA +  PEV    P  +  D+W++G   Y +LSG SPF
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 30/250 (12%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H   +++E  +I G G  S V R     T   YA+KI+D       +     +L    L 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 101 QLD-------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           ++D       HP +++L  T++     ++  +  + GELFD +T K  LSE E R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDD 210
           +++ +  +H + ++HRD+KPEN+LL  D +IK+ DFG    + P +  R           
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----------- 181
Query: 211 KACTFVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           + C   GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ 
Sbjct: 182 EVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 265 QRIIARDIRF 274
           + I++ + +F
Sbjct: 239 RMIMSGNYQF 248

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 131/283 (46%), Gaps = 27/283 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E ++L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 106 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 151
            VVR +  +             +   +L++ +E CE G L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA----A 207
            ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S   +  ++     
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-IFQ 265
           S D   + +GTA YV  EVL+ +       D+++LG   ++M+    PF    E + I +
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 266 RIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 308
           ++ +  I FP  F                   P   PG   +L
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 124/246 (50%), Gaps = 30/246 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-------KKFITKENKTAYVKLERI 97
           +++E  +I G G  S V R     T   YA+KI+D            +E + A +K   I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +     HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACT 214
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    + P +  R           + C 
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-----------EVC- 171
Query: 215 FVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
             GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ + I+
Sbjct: 172 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 229
Query: 269 ARDIRF 274
           + + +F
Sbjct: 230 SGNYQF 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 104
           +EL ++ G G +S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 160
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 161 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            H   +IHRD+KP  +LL +  +   +K+  FG    + +S +           A   VG
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV----------AGGRVG 195
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 245

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           + P+E F +    L K+ G GSY  V +A   +TG + A+K      +  E+    +  E
Sbjct: 25  KQPEEVFDV----LEKL-GEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKE 74
Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEV 154
             ++ Q D P VV+ + ++     L++ +E C  G + D I  +   L+EDE        
Sbjct: 75  ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQST 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  LEY+H M  IHRDIK  N+LL  +GH K+ADFG    + D             K   
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA----------KRNX 184
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            +GT  ++ PEV+         D+W+LG T  +M  G  P+ D
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 115/224 (51%), Gaps = 23/224 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQ 101
           ++D++L +  G G+  +V  A    T    A+KI+D K      EN    +K E  +   
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L+H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  Y
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPY 172
Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           V PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 173 VAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 114/215 (53%), Gaps = 17/215 (7%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G+Y+KV  A  +  G  YA+KI++K+     ++  + ++E +   Q  +  ++ L
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV-FREVETLYQCQ-GNKNILEL 76
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
              F+D    Y+  E  +GG +   I  + H +E EA     +V  AL+++H+ G+ HRD
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRD 136
Query: 171 IKPENLLLTADGH---IKIADF--GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +KPEN+L  +      +KI DF  GS   + +S   +     +  +  T  G+A Y+ PE
Sbjct: 137 LKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI-----TTPELTTPCGSAEYMAPE 191
Query: 226 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 255
           V+   +  ATF +   DLW+LG  LY MLSG  PF
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 158
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 159 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  H        ++HRD+KP N+ L    ++K+ DFG  + +             +D A 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------HDEDFAK 174
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 5   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 57
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 116
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNTFVG 166
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 22/222 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 158
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 159 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  H        ++HRD+KP N+ L    ++K+ DFG  +        +L +  S  K  
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--------ILNHDTSFAK-- 174
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           TFVGT  Y+ PE +N       +D+W+LGC LY++ +   PF
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 112/225 (49%), Gaps = 18/225 (8%)
Query: 33  FAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
           F    P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   +
Sbjct: 20  FQSMDPEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDI 72
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
           + E  VL Q D P V + + ++     L++ +E   GG   D +   G L E +      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILR 131
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           E++  L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K 
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KR 181
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            TFVGT  ++ PEV+  S      D+W+LG T  ++  G  P  +
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 226

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 21/221 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---- 227
           K  N+L T DG IK+ADFG              N  +  +  +F+GT  ++ PEV+    
Sbjct: 162 KAGNILFTLDGDIKLADFG----------VSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 228 -NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
               P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 22/222 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 158
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 159 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  H        ++HRD+KP N+ L    ++K+ DFG  +        +L +  S  KA 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--------ILNHDTSFAKA- 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 21/221 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---- 227
           K  N+L T DG IK+ADFG              N     +  +F+GT  ++ PEV+    
Sbjct: 162 KAGNILFTLDGDIKLADFG----------VSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 228 -NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
               P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A +  TG   A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 54  GEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 111 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT+DG IK++DFG    +          +    K    VGT  ++ PEV++  P  
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQV----------SKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
              D+W+LG  + +M+ G  P+ +       +RI
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E ++L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 106 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 151
            VVR +  +             +   +L++ +E CE   L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA----A 207
            ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S   +  ++     
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-IFQ 265
           S D   + +GTA YV  EVL+ +       D+++LG   ++M+    PF    E + I +
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 266 RIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 308
           ++ +  I FP  F                   P   PG   +L
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---- 227
           K  N+L T DG IK+ADFG              N     +   F+GT  ++ PEV+    
Sbjct: 162 KAGNILFTLDGDIKLADFG----------VSAKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 228 -NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
               P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 20  PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 72
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 131
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNXFVG 181
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A++  +G   A+K+MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  +GG L D I S+  L+E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P      K    VGT  ++ PEV++ S   
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKD----VP------KRKXLVGTPYWMAPEVISRSLYA 219
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPY 241

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 5   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 57
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 116
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNXFVG 166
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 206

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 21/216 (9%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRL 110
           + G G+Y  V   + +       ++I  K+   ++++ +    E I L + L H  +V+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSN----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEAR--FYTAEVVDALEYIHSMGLI 167
             +F +   + + +E   GG L   + SK G L ++E    FYT ++++ L+Y+H   ++
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 168 HRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ PE+
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRL----------AGINPCTETFTGTLQYMAPEI 180
Query: 227 LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
           ++  P  +G   D+W+LGCT+ +M +G  PF +  E
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 54/281 (19%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--KTAYVKLERIVLDQL 102
           + + L    G GSY  V  A +  T  + A+KIM+K  I + N      +K E  ++ +L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTA----- 152
            HP + RL+  ++D   + + +E C GG L D++      S G  + D  +         
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 153 ------------------------------EVVDALEYIHSMGLIHRDIKPENLLLTADG 182
                                         ++  AL Y+H+ G+ HRDIKPEN L + + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 183 --HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDL 238
              IK+ DFG  K           N        T  GT  +V PEVLN++  ++G   D 
Sbjct: 206 SFEIKLVDFGLSKEFYKL------NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNY 277
           W+ G  L+ +L G  PF   ++     +++ + + F  PNY
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 21/216 (9%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRL 110
           + G G+Y  V   + +       ++I  K+   ++++ +    E I L + L H  +V+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSN----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEAR--FYTAEVVDALEYIHSMGLI 167
             +F +   + + +E   GG L   + SK G L ++E    FYT ++++ L+Y+H   ++
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 168 HRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ PE+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL----------AGINPCTETFTGTLQYMAPEI 194
Query: 227 LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
           ++  P  +G   D+W+LGCT+ +M +G  PF +  E
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 104
           ++GKI G GSY  V + +  DTG + A+K    KF+  E+     K+   E  +L QL H
Sbjct: 7   KIGKI-GEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V L   F+    L++  E C+   L +    +  + E   +  T + + A+ + H  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             IHRD+KPEN+L+T    IK+ DFG       +R+   P+   DD+    V T  Y  P
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF------ARLLTGPSDYYDDE----VATRWYRSP 171
Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGT 252
           E+L      +G   D+WA+GC   ++LSG 
Sbjct: 172 ELLVGD-TQYGPPVDVWAIGCVFAELLSGV 200

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 177
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 178 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 230
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 231 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 265

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 226
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 247 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 281

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 192
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 193 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 245
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 246 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 220
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 221 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 273
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 274 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 21  PEELFT----KLERI-GKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIT 73
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D   V + + ++     L++ +E   GG   D + + G   E +      E++  
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKG 132
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 133 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S      D+W+LG T  ++  G  P  D
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 222

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 177
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 178 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 230
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 231 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 220
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 221 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 273
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 274 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 212
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 213 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 265
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 266 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 300

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 247 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 281

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 192
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 193 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 245
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 246 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 280

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 176
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 177 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 229
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 230 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 225
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 226 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 278
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 279 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 313

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 200
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 201 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 253
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 254 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 288

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 85  KENKTAYVKLERIVLD--QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
           +E +    + ER V +  QL H  +V +    ++    Y+ +E  EG  L + I S G L
Sbjct: 49  REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           S D A  +T +++D +++ H M ++HRDIKP+N+L+ ++  +KI DFG  K + ++ +T 
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT- 167
Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                   +    +GT  Y  PE           D++++G  LY+ML G  PF
Sbjct: 168 --------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 34/228 (14%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G+Y +V + + + TG + A+K+MD       ++   +K E  +L +  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHH- 80
Query: 107 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 154
             R   T+   F           L++ +E C  G + D I  +KG+ L E+   +   E+
Sbjct: 81  --RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L ++H   +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTVG---------RRNT 188
Query: 215 FVGTAAYVPPEVL--NSSPAT---FGNDLWALGCTLYQMLSGTSPFKD 257
           F+GT  ++ PEV+  + +P     F +DLW+LG T  +M  G  P  D
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 104 H--PGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              P  RP      +  ++ HP+ + +
Sbjct: 247 VSXECQHLIRWCLALRPXDRP-----TFEEIQNHPWMQDV 281

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 27/255 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DFE  +  G G +  V  AK       YA+K +  +   +E     V  E   L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLE 61
Query: 104 HPGVVRLFFTFQDTFS------------LYMALESCEGGELFDQITSKGHLSEDEARFYT 151
           HPG+VR F  + +  +            LY+ ++ C    L D +  +  + E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 152 ---AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--QDSRITVLPNA 206
               ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DFG V  M   +   TVL   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +  +    VGT  Y+ PE ++ +  +   D+++LG  L+++L    PF    E +   R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERV---R 235
Query: 267 II--ARDIRFPNYFS 279
            +   R+++FP  F+
Sbjct: 236 TLTDVRNLKFPPLFT 250

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 217 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPY 347

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 83  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 140 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 198
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPPY 270

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 38  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 95  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 153
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPPY 225

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 40  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 97  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 155
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPPY 227

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 27/283 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E  +L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVXLLASLNHQ 62
Query: 106 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 151
            VVR +  +             +   +L++  E CE   L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA----A 207
            ++++AL YIHS G+IHR++KP N+ +    ++KI DFG  K +  S   +  ++     
Sbjct: 123 RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-IFQ 265
           S D   + +GTA YV  EVL+ +       D ++LG   ++ +    PF    E + I +
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILK 239
Query: 266 RIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 308
           ++ +  I FP  F                   P   PG   +L
Sbjct: 240 KLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 33  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 90  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 148
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P      +    VGT  ++ PE+++  P  
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQVSKE----VP------RRKXLVGTPYWMAPELISRLPYG 198
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPY 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 29  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P      +    VGT  ++ PE+++  P  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKE----VP------RRKXLVGTPYWMAPELISRLPYG 194
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 23/249 (9%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQ 101
           ++ +EL K  G G+Y  V ++    TG V A+K   K F   +N T   +   E ++L +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 102 LD-HPGVVRLFFTFQ--DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  H  +V L    +  +   +Y+  +  E       +     L     ++   +++  +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR-------ITVLPNAAS--D 209
           +Y+HS GL+HRD+KP N+LL A+ H+K+ADFG  +   + R       +++  N  +  D
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 210 DK--ACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
           D+     +V T  Y  PE+ L S+  T G D+W+LGC L ++L G   F  +S     +R
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 267 IIARDIRFP 275
           II   I FP
Sbjct: 243 IIGV-IDFP 250

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 191
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVL 99
           S++ +E   + G GSY  V++ +  DTG + A+K    KF+  ++     K+   E  +L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLL 78
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            QL H  +V L    +     Y+  E  +   L D       L     + Y  ++++ + 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           + HS  +IHRDIKPEN+L++  G +K+ DFG       +R    P    DD+    V T 
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGF------ARTLAAPGEVYDDE----VATR 188
Query: 220 AYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            Y  PE+L      +G   D+WA+GC + +M  G   F   S+
Sbjct: 189 WYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 76
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 77  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 183
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 184 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 75
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 76  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 182
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 183 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 74
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 75  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 182 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  G G +  V+R    DTG   A+K   ++ ++ +N+  +  LE  ++ +L+HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWC-LEIQIMKKLNHPN 74
Query: 107 VVRLFFTFQDTFSL------YMALESCEGGEL---FDQITSKGHLSEDEARFYTAEVVDA 157
           VV           L       +A+E CEGG+L    +Q  +   L E   R   +++  A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI---KIADFGSVKPMQDSRITVLPNAASDDKACT 214
           L Y+H   +IHRD+KPEN++L         KI D G  K +    +            CT
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------------CT 182
Query: 215 -FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  G G +  V+R    DTG   A+K   ++ ++ +N+  +  LE  ++ +L+HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWC-LEIQIMKKLNHPN 73
Query: 107 VVRLFFTFQDTFSL------YMALESCEGGEL---FDQITSKGHLSEDEARFYTAEVVDA 157
           VV           L       +A+E CEGG+L    +Q  +   L E   R   +++  A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI---KIADFGSVKPMQDSRITVLPNAASDDKACT 214
           L Y+H   +IHRD+KPEN++L         KI D G  K +    +            CT
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------------CT 181
Query: 215 -FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 69
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 70  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 176
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 177 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 176 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 84
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 85  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 191
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 192 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVV 108
            K  G G ++ V +     TG  YA K + K+   ++ + A +  E  VL+     P V+
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVI 92
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGL 166
            L   +++T  + + LE   GGE+F     +    +SE++      ++++ + Y+H   +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 167 IHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF---VGTAA 220
           +H D+KP+N+LL++    G IKI DFG  + +                AC     +GT  
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--------------GHACELREIMGTPE 198
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           Y+ PE+LN  P T   D+W +G   Y +L+ TSPF
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 120
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 121 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 227
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 177
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 114
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 221
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 177
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H++     LG+    GS+ +V R +   TG   A+K +  +    E        E +   
Sbjct: 74  HWATHQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACA 121
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L  P +V L+   ++   + + +E  EGG L   +  +G L ED A +Y  + ++ LEY
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 181
Query: 161 IHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDD--KACTFVG 217
           +HS  ++H D+K +N+LL++DG H  + DFG         + + P+    D        G
Sbjct: 182 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHA-------VCLQPDGLGKDLLTGDYIPG 234
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T  ++ PEV+         D+W+  C +  ML+G  P+
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           D+EL ++ G G+ + VV+A           K+  K+   ++ +T+  +L  E   + Q  
Sbjct: 11  DYELQEVIGSGA-TAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFD---QITSKGH-----LSEDEARFYTAEVV 155
           HP +V  + +F     L++ ++   GG + D    I +KG      L E        EV+
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + LEY+H  G IHRD+K  N+LL  DG ++IADFG       + +    +   +    TF
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-----SAFLATGGDITRNKVRKTF 181
Query: 216 VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPF 255
           VGT  ++ PEV+       F  D+W+ G T  ++ +G +P+
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           D+EL ++ G G+ + VV+A           K+  K+   ++ +T+  +L  E   + Q  
Sbjct: 16  DYELQEVIGSGA-TAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFD---QITSKGH-----LSEDEARFYTAEVV 155
           HP +V  + +F     L++ ++   GG + D    I +KG      L E        EV+
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + LEY+H  G IHRD+K  N+LL  DG ++IADFG       + +    +   +    TF
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-----SAFLATGGDITRNKVRKTF 186
Query: 216 VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPF 255
           VGT  ++ PEV+       F  D+W+ G T  ++ +G +P+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 106 GVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 165 GLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT  Y P
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTRVYSP 224
Query: 224 PEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           PE +       G    +W+LG  LY M+ G  PF+   E      II   + F    S  
Sbjct: 225 PEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSE 277
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
                       PS RP      +  ++ HP+ + +
Sbjct: 278 CQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHR+IK 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRNIKS 145
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 192
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SXMVGTPYWMAPEVVTRK 191
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 145
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SXMVGTPYWMAPEVVTRK 192
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SEMVGTPYWMAPEVVTRK 191
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  +  + +G   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 60  GSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 117
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 177
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 178 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 224
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           N        D+W++GC + ++L+G + F  T      Q+I+
Sbjct: 225 NWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIM 265

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H++     LG+    GS+ +V R +   TG   A+K +  +    E        E +   
Sbjct: 93  HWATHQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACA 140
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L  P +V L+   ++   + + +E  EGG L   +  +G L ED A +Y  + ++ LEY
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 200
Query: 161 IHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +HS  ++H D+K +N+LL++DG H  + DFG    +Q   +       S        GT 
Sbjct: 201 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL-----GKSLLTGDYIPGTE 255
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            ++ PEV+         D+W+  C +  ML+G  P+
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
               T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 24/223 (10%)
Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D E LG++ G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL   
Sbjct: 24  INDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-VVLKSH 81
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEY 160
           D P +V+ F TF     +++A+E    G   +++  +  G + E      T  +V AL Y
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 161 I-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +    G+IHRD+KP N+LL   G IK+ DFG    + D +       A D  A    G A
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-------AKDRSA----GCA 188
Query: 220 AYVPPEVLNSSPAT-----FGNDLWALGCTLYQMLSGTSPFKD 257
           AY+ PE ++    T        D+W+LG +L ++ +G  P+K+
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDSELKILDFGLCR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 81  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 132
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 174 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
           +N+LL++DG    + DFG    +Q   +       S        GT  ++ PEV+   P 
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGL-----GKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 233 TFGNDLWALGCTLYQMLSGTSPF 255
               D+W+  C +  ML+G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N+       D+W++GC + ++L+G + F  T
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 83  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 134
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 174 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
           +N+LL++DG    + DFG    +Q   +       S        GT  ++ PEV+   P 
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGL-----GKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 233 TFGNDLWALGCTLYQMLSGTSPF 255
               D+W+  C +  ML+G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + K F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 118
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 174 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 233
Query: 233 TFGNDLWALGCTLYQMLSGTSPF 255
               D+W+  C +  ML+G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G G++++V     + T   YA+KI++K+     ++  + ++E +   Q  H  V+ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQ-GHRNVLELI 77
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
             F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H+ G+ HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 172 KPENLLLTADGH---IKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           KPEN+L         +KI DFG    +K   D      P         T  G+A Y+ PE
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL------TPCGSAEYMAPE 191
Query: 226 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 255
           V+   S  A+  +   DLW+LG  LY +LSG  PF
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 65
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 66  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 124 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 174
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 84
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 85  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 193
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 221
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDSELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDSELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 11  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 68
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 69  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 127 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 177
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 7   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 64
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 65  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 122
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 123 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 173
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 221
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 42  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 99
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 160 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 206
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 29  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 86
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 146
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 147 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 193
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 224

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 215
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 54  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 111
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 218
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 50  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 107
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 214
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 215
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 42  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 99
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 160 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 206
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 28  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 85
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 192
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 84
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 85  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ     V+ ++         VGT  
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ--------VGTVN 193
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 30  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 87
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 147
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 148 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 194
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 28  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 85
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 192
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 50  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 107
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 214
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 41  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 98
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 158
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 159 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 205
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 236

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 43/235 (18%)
Query: 38  PQEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           P+++    D++L K + G+G   KV+      TG   ALK++      ++          
Sbjct: 2   PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------- 51
Query: 97  IVLDQLDH-------PGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LS 143
               ++DH       P +V +   +++       L + +E  EGGELF +I  +G    +
Sbjct: 52  ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 107
Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRI 200
           E EA     ++  A++++HS  + HRD+KPENLL T+   D  +K+ DFG  K    + +
Sbjct: 108 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 167
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                        T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 168 Q------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 47/260 (18%)
Query: 38  PQEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           P+++    D++L K + G+G   KV+      TG   ALK++      ++          
Sbjct: 21  PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------- 70
Query: 97  IVLDQLDH-------PGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LS 143
               ++DH       P +V +   +++       L + +E  EGGELF +I  +G    +
Sbjct: 71  ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 126
Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRI 200
           E EA     ++  A++++HS  + HRD+KPENLL T+   D  +K+ DFG  K    + +
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
                        T   T  YV PEVL         D+W+LG  +Y +L G  PF   + 
Sbjct: 187 Q------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234
Query: 261 WLIF----QRIIARDIRFPN 276
             I     +RI      FPN
Sbjct: 235 QAISPGMKRRIRLGQYGFPN 254

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 54  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 111
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMXGYVATRWYRAPEIML 218
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 105 PGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDAL 158
           P +VR+   +++ ++    L +  E  +GGELF +I  +G    +E EA      + +A+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   T 
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLTTP 223
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
             T  YV PEVL         D W+LG   Y +L G  PF
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 110
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 217
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 114
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 221
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 112
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 219
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 104
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 211
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 89
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 196
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 197 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D+G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDYGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 155
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 262
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 263 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 81
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 188
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VG   
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGAVN 221
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G G++++V     + T   YA+KI++K+     ++  + ++E +   Q  H  V+ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQ-GHRNVLELI 77
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
             F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H+ G+ HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 172 KPENLLLTADGH---IKIADF---GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           KPEN+L         +KI DF     +K   D      P         T  G+A Y+ PE
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL------TPCGSAEYMAPE 191
Query: 226 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 255
           V+   S  A+  +   DLW+LG  LY +LSG  PF
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 34  GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR--LLKHMRHENVIGLLD 91
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      D F+ +  +    G +L  ++     L ED  +F   +++  L YIH+ G+I
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP NL +  D  +KI DFG  +              +D +    V T  Y  PEV 
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR-------------QADSEMXGXVVTRWYRAPEVI 197
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           LN    T   D+W++GC + +M++G + FK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+    V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGXVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+    V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMXGXVATRWYRAPEIML 215
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 37/224 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 80
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 187
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F   S
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 77
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 184
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 88
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 195
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 84
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 191
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 192 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 26/240 (10%)
Query: 28  QRSKSFAFRAPQE---HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           QR +  AF   ++        DFE     G G+   V +     +G V     M +K I 
Sbjct: 5   QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIH 59
Query: 85  KENKTAY---VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-G 140
            E K A    +  E  VL + + P +V  +  F     + + +E  +GG L DQ+  K G
Sbjct: 60  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAG 118
Query: 141 HLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            + E      +  V+  L Y+     ++HRD+KP N+L+ + G IK+ DFG    + DS 
Sbjct: 119 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 178
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                       A +FVGT +Y+ PE L  +  +  +D+W++G +L +M  G  P    S
Sbjct: 179 ------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 95
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 202
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 203 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 110
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN +        +
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVSX-------I 217
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 88
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN +        +
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVSX-------I 195
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 28  QRSKSFAFRAPQE---HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           QR +  AF   ++        DFE     G G+   V +     +G V A     +K I 
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-----RKLIH 67
Query: 85  KENKTAY---VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH 141
            E K A    +  E  VL + + P +V  +  F     + + +E  +GG L   +   G 
Sbjct: 68  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127
Query: 142 LSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           + E      +  V+  L Y+     ++HRD+KP N+L+ + G IK+ DFG    + DS  
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 186
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                      A +FVGT +Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 187 -----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 28  QRSKSFAFRAPQE---HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           QR +  AF   ++        DFE     G G+   V +     +G V     M +K I 
Sbjct: 48  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIH 102
Query: 85  KENKTAY---VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH 141
            E K A    +  E  VL + + P +V  +  F     + + +E  +GG L   +   G 
Sbjct: 103 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 162
Query: 142 LSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           + E      +  V+  L Y+     ++HRD+KP N+L+ + G IK+ DFG    + DS  
Sbjct: 163 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 221
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                      A +FVGT +Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 222 -----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 121
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 122 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 119
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI  FG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILGFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 101
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 102 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                FV
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDAGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDRGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           L  I G G+ + V R +   TG ++A+K+ +     +       + E  VL +L+H  +V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE--VLKKLNHKNIV 70
Query: 109 RLFFTFQDTFSLY--MALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHS 163
           +LF   ++T + +  + +E C  G L+  +    +   L E E      +VV  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 164 MGLIHRDIKPENLL--LTADGH--IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            G++HR+IKP N++  +  DG    K+ DFG+ + ++D           D++  +  GT 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------DEQFVSLYGTE 179
Query: 220 AYVPPEVLNSS------PATFGN--DLWALGCTLYQMLSGTSPFK 256
            Y+ P++   +         +G   DLW++G T Y   +G+ PF+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 81  KFITKEN----------KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 130
           KFI KE           K   V LE  +L +++H  ++++   F++     + +E    G
Sbjct: 55  KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG 114
Query: 131 -ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
            +LF  I     L E  A +   ++V A+ Y+    +IHRDIK EN+++  D  IK+ DF
Sbjct: 115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQM 248
           GS   ++  ++             TF GT  Y  PEVL  +P      ++W+LG TLY +
Sbjct: 175 GSAAYLERGKLFY-----------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 249 LSGTSPFKDTSE 260
           +   +PF +  E
Sbjct: 224 VFEENPFCELEE 235

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 16  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 71
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 176
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 94
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + FS    + +  G +L + + S+  LS++  +F   +++  L+YIHS G+I
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 200
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDGGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DF   +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFYLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG            +     D+ A  FVGT +Y
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQLIDEMANEFVGTRSY 172
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           + PE L  +  +  +D+W++G +L +M  G  P
Sbjct: 173 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 121
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G +  V R  +  +   Y  K +      K      VK E  +L+   H  ++ L  +
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 114 FQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           F+    L M  E   G ++F++I TS   L+E E   Y  +V +AL+++HS  + H DI+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 173 PENLLLTA--DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           PEN++        IKI +FG  + ++            D+    F     Y  PEV    
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLK----------PGDNFRLLFTA-PEYYAPEVHQHD 178
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
             +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E  +   + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 120
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           L  I G G+ + V R +   TG ++A+K+ +     +       + E  VL +L+H  +V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE--VLKKLNHKNIV 70
Query: 109 RLFFTFQDTFSLY--MALESCEGGELF---DQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           +LF   ++T + +  + +E C  G L+   ++ ++   L E E      +VV  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 164 MGLIHRDIKPENLL--LTADGH--IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            G++HR+IKP N++  +  DG    K+ DFG+ + ++D           D++     GT 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------DEQFVXLYGTE 179
Query: 220 AYVPPEVLNSS------PATFGN--DLWALGCTLYQMLSGTSPFK 256
            Y+ P++   +         +G   DLW++G T Y   +G+ PF+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 101
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 102 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                +V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ E+ ++ G G++  V +AK       +  K +  K I  E++     +E   L +++H
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSRVNH 61
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYI 161
           P +V+L+    +   L M  E  EGG L++ +     L   +   A  +  +    + Y+
Sbjct: 62  PNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 162 HSM---GLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           HSM    LIHRD+KP NLLL A G + KI DFG+   +Q           +++K     G
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNK-----G 166
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           +AA++ PEV   S  +   D+++ G  L+++++   PF +
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ E+ ++ G G++  V +AK       +  K +  K I  E++     +E   L +++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYI 161
           P +V+L+    +   L M  E  EGG L++ +     L   +   A  +  +    + Y+
Sbjct: 61  PNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 162 HSM---GLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           HSM    LIHRD+KP NLLL A G + KI DFG+   +Q           +++K     G
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNK-----G 165
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           +AA++ PEV   S  +   D+++ G  L+++++   PF +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F   S
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F   S
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++E+ +  G G+Y  V  A++  TG   A+K +   F    N    ++ E  +L    H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHD 114
Query: 106 GVVRLFFTFQDTF------SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            ++ +    + T       S+Y+ L+  E  +L   I S   L+ +  R++  +++  L+
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  +IHRD+KP NLL+  +  +KI DFG  + +  S       A        +V T 
Sbjct: 174 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS------PAEHQYFMTEYVATR 227
Query: 220 AYVPPEVLNS-SPATFGNDLWALGCTLYQMLS 250
            Y  PE++ S    T   DLW++GC   +ML+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++E+ +  G G+Y  V  A++  TG   A+K +   F    N    ++ E  +L    H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHD 113
Query: 106 GVVRLFFTFQDTF------SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            ++ +    + T       S+Y+ L+  E  +L   I S   L+ +  R++  +++  L+
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  +IHRD+KP NLL+  +  +KI DFG  + +  S       A        +V T 
Sbjct: 173 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS------PAEHQYFMTEYVATR 226
Query: 220 AYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF 255
            Y  PE++ S    T   DLW++GC   +ML+    F
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 94
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + FS    + +  G +L + +  +  LS++  +F   +++  L+YIHS G+I
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 200
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 74
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 75  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 126
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 179
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            TV    +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 180 -TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238
Query: 257 DTS 259
           + +
Sbjct: 239 NIN 241

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 17  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 73
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 74  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 125
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 126 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 178
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            TV    +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 179 -TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 237
Query: 257 DTS 259
           + +
Sbjct: 238 NIN 240

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 63
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 184 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 213

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V + +   +G      IM +K I  E K A    +  E  VL + 
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +     + E+     +  V+  L Y+ 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRSY 179
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L ++  G  P 
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 28  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 83
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 84  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          T     +   +     G+  +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TEKSRWSGSHQFEQLSGSILW 188
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 29  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 86
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + FS    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADL-NNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 146 HRDLKPSNVAVNEDCELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 192
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 28  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 83
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 84  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          T     +   +     G+  +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TEKSRWSGSHQFEQLSGSILW 188
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 101
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 102 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                 V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 114/253 (45%), Gaps = 34/253 (13%)
Query: 39  QEHFSIQDFELG-------KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY 91
           Q  F  Q  ELG       ++   G ++ V  A+ + +G  YALK   +    +E K   
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK---RLLSNEEEKNRA 71
Query: 92  VKLERIVLDQLD-HPGVVRLFF----------TFQDTFSLYMALESCEGG--ELFDQITS 138
           +  E   + +L  HP +V+             T Q  F L   L  C+G   E   ++ S
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL--CKGQLVEFLKKMES 129
Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
           +G LS D       +   A++++H     +IHRD+K ENLLL+  G IK+ DFGS   + 
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189
Query: 197 ---DSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLS 250
              D   +    A  +++  T   T  Y  PE+++   + P     D+WALGC LY +  
Sbjct: 190 HYPDYSWSAQRRALVEEEI-TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
Query: 251 GTSPFKDTSEWLI 263
              PF+D ++  I
Sbjct: 249 RQHPFEDGAKLRI 261

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +Q +E  +  G G+Y  V +AK  +T  + ALK + +     E   +    E  +L +L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           H  +VRL         L +  E C+    + FD  +  G L  +  + +  +++  L + 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  ++HRD+KP+NLL+  +G +K+ADFG  +      I V   +A        V T  Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFG---IPVRCYSAE-------VVTLWY 167
Query: 222 VPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
            PP+VL  +   +   D+W+ GC   ++ +   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEG-----GELFDQITSKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+            + +  +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSR--AKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F   S
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVL 99
           +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY +L  ++L
Sbjct: 38  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL--LLL 95
Query: 100 DQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
             + H  V+ L   F      ++ +  Y+ +   +      Q       SE++ ++   +
Sbjct: 96  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGMEFSEEKIQYLVYQ 152
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +              +D +  
Sbjct: 153 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMT 199
Query: 214 TFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFK 256
            +V T  Y  PEV+ S        D+W++GC + +ML+G + FK
Sbjct: 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 188 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 34/249 (13%)
Query: 42  FSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
            +I  F+LG  Y      G G    V  A   D     A+K   K  +T      +   E
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALRE 58
Query: 96  RIVLDQLDHPGVVRLFF--------------TFQDTFSLYMALESCEGGELFDQITSKGH 141
             ++ +LDH  +V++F               +  +  S+Y+  E  E       +  +G 
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP 116
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRI 200
           L E+ AR +  +++  L+YIHS  ++HRD+KP NL + T D  +KI DFG  + M     
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
              P+ +        + T  Y  P +L S +  T   D+WA GC   +ML+G + F    
Sbjct: 173 ---PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 260 EWLIFQRII 268
           E    Q I+
Sbjct: 230 ELEQMQLIL 238

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 184
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 185 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G IK+ADFG       +R   +P      +  T      Y 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGL------ARAFGVPVRTYTHEVVTL----WYR 177
Query: 223 PPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PE+ L     +   D+W+LGC   +M++  + F   SE
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 25/269 (9%)
Query: 6   KDFDSKLRIEG----------NNNSSTNCPTVQRSKSFAFRA-PQEHFSI--QDFELGKI 52
           +  D+  R+EG          ++  ST  P  ++S     RA P++ + +  +D  LG+ 
Sbjct: 62  QSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQ 121
Query: 53  YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 112
            G G++ +V   +     T+ A+K   ++ +  + K  +++  RI L Q  HP +VRL  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIG 179
Query: 113 TFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                  +Y+ +E  +GG+    + ++G  L          +    +EY+ S   IHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
              N L+T    +KI+DFG  +   D     +  A+   +      TA    PE LN   
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG----VXAASGGLRQVPVKWTA----PEALNYGR 291
Query: 232 ATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +  +D+W+ G  L++  S G SP+ + S
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G IK+ADFG       +R   +P      +  T      Y 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGL------ARAFGVPVRTYTHEVVTL----WYR 170
Query: 223 PPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PE+ L     +   D+W+LGC   +M++  + F   SE
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVL 99
           +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY +L  ++L
Sbjct: 20  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL--LLL 77
Query: 100 DQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
             + H  V+ L   F      ++ +  Y+ +   +      Q       SE++ ++   +
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQ 134
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +              +D +  
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMT 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFK 256
            +V T  Y  PEV+ S        D+W++GC + +ML+G + FK
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 105 PGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           P +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTFV 216
             ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 STAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
           G +L+  + ++ HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI D
Sbjct: 129 GADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 187
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQ 247
           FG  +          P+         +V T  Y  PE+ LNS   T   D+W++GC L +
Sbjct: 188 FGLAR-------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 240
Query: 248 MLSGTSPF 255
           MLS    F
Sbjct: 241 MLSNRPIF 248

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 74
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 75  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 126
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 179
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            T     +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 180 -TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238
Query: 257 DTS 259
           + +
Sbjct: 239 NIN 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 6   KDFDSKLRIEG----------NNNSSTNCPTVQRSKSFAFRA-PQEHFSI--QDFELGKI 52
           +  D+  R+EG          ++  ST  P  ++S     RA P++ + +  +D  LG+ 
Sbjct: 62  QSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQ 121
Query: 53  YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 112
            G G++ +V   +     T+ A+K   ++ +  + K  +++  RI L Q  HP +VRL  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIG 179
Query: 113 TFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                  +Y+ +E  +GG+    + ++G  L          +    +EY+ S   IHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
              N L+T    +KI+DFG  +   D        AAS       V    +  PE LN   
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGVY-----AASGGLRQVPV---KWTAPEALNYGR 291
Query: 232 ATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +  +D+W+ G  L++  S G SP+ + S
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 10  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 66
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 67  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 118
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 119 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 171
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            T     +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 172 -TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 230
Query: 257 DTS 259
           + +
Sbjct: 231 NIN 233

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 40  EHFSIQDFELGKIY--GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           ++F ++  +L  I   G G+Y  V + + + +G + A+K +     ++E K   + L+ I
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-I 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGH-LSEDEARFYTAEV 154
            +  +D P  V  +        +++ +E  +    + + Q+  KG  + ED        +
Sbjct: 103 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 155 VDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V ALE++HS + +IHRD+KP N+L+ A G +K+ DFG    + DS       A + D  C
Sbjct: 163 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV------AKTIDAGC 216
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
                   + PE LN    +  +D+W+LG T+ ++
Sbjct: 217 KPYMAPERINPE-LNQKGYSVKSDIWSLGITMIEL 250

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 111
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP+NLL+  +G +KIADFG  +                 K    V T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           S   +   D+W++GC   +M++GT  F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 172
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 14  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 69
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 70  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 174
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 175 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 111
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP+NLL+  +G +KIADFG  +                 K    + T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           S   +   D+W++GC   +M++GT  F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 17  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 72
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 177
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 172
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 37  APQEH--FSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           +P++H  F+ +D  +LG+I G G+Y  V +     +G + A+K +      KE K   + 
Sbjct: 12  SPEQHWDFTAEDLKDLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 94  LERIVLDQLDHPGVVRLF---FTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEAR 148
           L+ +V+   D P +V+ +   F   D + + M L S    + +  + S     + E+   
Sbjct: 71  LD-VVMRSSDCPYIVQFYGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 149 FYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
             T   V AL ++  ++ +IHRDIKP N+LL   G+IK+ DFG    + DS       A 
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS------IAK 182
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPF 255
           + D  C       Y+ PE ++ S +  G    +D+W+LG TLY++ +G  P+
Sbjct: 183 TRDAGCR-----PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V + K      V  LK++D    T E   A+ + E  VL +  H  ++ LF  
Sbjct: 45  GSGSFGTVYKGKWHGDVAVKILKVVDP---TPEQFQAF-RNEVAVLRKTRHVNIL-LFMG 99
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYIHSMGL 166
           +    +L +  + CEG  L+       HL   E +F   +++D        ++Y+H+  +
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYK------HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+K  N+ L     +KI DFG          TV    +   +     G+  ++ PEV
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLA--------TVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 227 L---NSSPATFGNDLWALGCTLYQMLSGTSPF 255
           +   +++P +F +D+++ G  LY++++G  P+
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 17  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 72
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 177
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +Q +E  +  G G+Y  V +AK  +T  + ALK + +     E   +    E  +L +L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           H  +VRL         L +  E C+    + FD  +  G L  +  + +  +++  L + 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  ++HRD+KP+NLL+  +G +K+A+FG  +      I V   +A        V T  Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAE-------VVTLWY 167
Query: 222 VPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
            PP+VL  +   +   D+W+ GC   ++ +   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 116 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLAR- 174
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 175 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 254 PF 255
            F
Sbjct: 229 IF 230

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V AL  +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V AL  +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE----NKTAYVKLERIVLDQLDHPGVVR 109
           G G ++ V +A+  +T  + A+K +     ++     N+TA  +++  +L +L HP ++ 
Sbjct: 19  GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK--LLQELSHPNIIG 76
Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   F    ++ +  +  E         +   L+    + Y    +  LEY+H   ++HR
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP NLLL  +G +K+ADFG  K          PN A   +    V T  Y  PE+L  
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGS------PNRAYXHQ----VVTRWYRAPELLFG 186
Query: 229 SSPATFGNDLWALGCTLYQML 249
           +     G D+WA+GC L ++L
Sbjct: 187 ARMYGVGVDMWAVGCILAELL 207

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 114 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR- 172
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 173 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 254 PF 255
            F
Sbjct: 227 IF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR- 176
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 177 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 254 PF 255
            F
Sbjct: 231 IF 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR- 176
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 177 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 254 PF 255
            F
Sbjct: 231 IF 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 114 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR- 172
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 173 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 254 PF 255
            F
Sbjct: 227 IF 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 176
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 177 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 254 PF 255
            F
Sbjct: 231 IF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 114 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 172
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 173 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 254 PF 255
            F
Sbjct: 227 IF 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 119 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 177
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 178 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
Query: 254 PF 255
            F
Sbjct: 232 IF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 120 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 178
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 179 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 232
Query: 254 PF 255
            F
Sbjct: 233 IF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 111 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 169
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 170 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 223
Query: 254 PF 255
            F
Sbjct: 224 IF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 176
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 177 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 254 PF 255
            F
Sbjct: 231 IF 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 112 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 170
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 171 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
Query: 254 PF 255
            F
Sbjct: 225 IF 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 112 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 170
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 171 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
Query: 254 PF 255
            F
Sbjct: 225 IF 226

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 116 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 174
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 175 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 254 PF 255
            F
Sbjct: 229 IF 230

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 116 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 174
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 175 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 254 PF 255
            F
Sbjct: 229 IF 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 114 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLAR- 172
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 173 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 254 PF 255
            F
Sbjct: 227 IF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 122 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 180
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 181 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 234
Query: 254 PF 255
            F
Sbjct: 235 IF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 114 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 172
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 173 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 254 PF 255
            F
Sbjct: 227 IF 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 134 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 192
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 193 ------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 254 PF 255
            F
Sbjct: 247 IF 248

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V + K   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                SL +  E  +  +L   +   G++ +    + +  +++  L Y H   ++HRD+K
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 231
           P+NLL+   G +K+ADFG       +R   +P    D++  T      Y PP++ L S+ 
Sbjct: 128 PQNLLINERGELKLADFGL------ARAKSIPTKTYDNEVVTL----WYRPPDILLGSTD 177
Query: 232 ATFGNDLWALGCTLYQMLSGTSPF 255
            +   D+W +GC  Y+M +G   F
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 49/222 (22%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K     +          DK+C
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY---------DKSC 179
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                                  D+W+LG  +Y +L G  PF
Sbjct: 180 -----------------------DMWSLGVIMYILLCGYPPF 198

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 228
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG T  ++     P 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS         +  KA        +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---------TXXKASKGKLPIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 111
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP+NLL+  +G +KIADFG  +                 K    V T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           S   +   D+W++GC   +M++G   F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 189
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG T  ++     P 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y  V + + + +G + A+K +     ++E K   + L+ I +  +D P  V  +  
Sbjct: 16  GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISMRTVDCPFTVTFYGA 74
Query: 114 FQDTFSLYMALESCEGG--ELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS-MGLIHR 169
                 +++ +E  +    + + Q+  KG  + ED        +V ALE++HS + +IHR
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD-DKACTFVGTAAYVPPEVLN 228
           D+KP N+L+ A G +K+ DFG    + D       + A D D  C        + PE LN
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVD-------DVAKDIDAGCKPYMAPERINPE-LN 186
Query: 229 SSPATFGNDLWALGCTLYQM 248
               +  +D+W+LG T+ ++
Sbjct: 187 QKGYSVKSDIWSLGITMIEL 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 87/170 (51%), Gaps = 19/170 (11%)
Query: 120 LYMALESCEGGELFDQITSKGHLSEDE---ARFYTAEVVDALEYIHSMGLIHRDIKPENL 176
           LY+ ++ C    L D +  +  L + E         ++ +A+E++HS GL+HRD+KP N+
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 177 LLTADGHIKIADFGSVKPM-QDSR----ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
             T D  +K+ DFG V  M QD      +T +P  A+       VGT  Y+ PE ++ + 
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQ---VGTKLYMSPEQIHGNN 252
Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYFS 279
            +   D+++LG  L+++L   S   +        RII   R+++FP  F+
Sbjct: 253 YSHKVDIFSLGLILFELLYSFSTQMERV------RIITDVRNLKFPLLFT 296

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y  V +AK    G + ALK +  +   ++       +  I +L +L HP +V L  
Sbjct: 30  GEGTYGVVYKAKD-SQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 113 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
                  L +  E  E    ++ D+  +K  L + + + Y  +++  + + H   ++HRD
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NS 229
           +KP+NLL+ +DG +K+ADFG       +R   +P  +   +  T      Y  P+VL  S
Sbjct: 145 LKPQNLLINSDGALKLADFGL------ARAFGIPVRSYTHEVVTL----WYRAPDVLMGS 194
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF 255
              +   D+W++GC   +M++G   F
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 36/223 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIM-DKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           K+ G GS+  V +AK +++  V   K++ DK+F  +E     +++ RIV     HP VV 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE-----LQIMRIV----KHPNVVD 96
Query: 110 LFFTF------QDTFSLYMALESC-----EGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L   F      +D   L + LE            + ++  K  +     + Y  +++ +L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSL 154
Query: 159 EYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            YIHS+G+ HRDIKP+NLLL    G +K+ DFGS K +    I   PN +        + 
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL----IAGEPNVSX-------IC 203
Query: 218 TAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           +  Y  PE +  ++  T   D+W+ GC + +++ G   F   S
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y  V +AK    G + ALK +  +   ++       +  I +L +L HP +V L  
Sbjct: 30  GEGTYGVVYKAKD-SQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 113 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
                  L +  E  E    ++ D+  +K  L + + + Y  +++  + + H   ++HRD
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NS 229
           +KP+NLL+ +DG +K+ADFG       +R   +P  +   +  T      Y  P+VL  S
Sbjct: 145 LKPQNLLINSDGALKLADFGL------ARAFGIPVRSYTHEVVTL----WYRAPDVLMGS 194
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF 255
              +   D+W++GC   +M++G   F
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 98  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 155
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 206
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG     + SR       +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSR------WSGSHQFEQLSGSILW 172
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 8/217 (3%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P   F   D   G++ G G + + ++    +TG V  +K + +    +E +  ++K E  
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLK-EVK 59
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVD 156
           V+  L+HP V++          L    E  +GG L   I S         R  +  ++  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--LPNAASDD--KA 212
            + Y+HSM +IHRD+   N L+  + ++ +ADFG  + M D +     L +    D  K 
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
            T VG   ++ PE++N        D+++ G  L +++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 75  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 132
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 183
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++A   +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 73  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 130
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 181
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 67  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 124
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 175
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 72  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 129
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 180
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 61/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 176
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+          V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 177 ------VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 254 PF 255
            F
Sbjct: 231 IF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 61/122 (50%), Gaps = 8/122 (6%)
Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
           ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  + 
Sbjct: 119 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR- 177
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTS 253
                    P+          V T  Y  PE+ LNS   T   D+W++GC L +MLS   
Sbjct: 178 ------VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
Query: 254 PF 255
            F
Sbjct: 232 IF 233

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH- 104
           D++L +  G G YS+V  A  I       +KI+      K+NK   +K E  +L+ L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKNK---IKREIKILENLRGG 91
Query: 105 PGVVRLFFTFQDTFSLYMAL--ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           P ++ L    +D  S   AL  E     + F Q+     L++ + RFY  E++ AL+Y H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 163 SMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQDSRITVLPNAASDDKACTFVGT 218
           SMG++HRD+KP N+++  +   +++ D+G  +   P Q+  +               V +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--------------VAS 194
Query: 219 AAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 16/226 (7%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKI--YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 87
           +++  F+   E+F ++  +L  I   G G+Y  V + + + +G + A+K +     ++E 
Sbjct: 17  TENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQ 76
Query: 88  KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGH-LSE 144
           K     L+ I    +D P  V  +        +++  E  +    + + Q+  KG  + E
Sbjct: 77  KRLLXDLD-ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPE 135
Query: 145 DEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
           D        +V ALE++HS + +IHRD+KP N+L+ A G +K  DFG    + D      
Sbjct: 136 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD------ 189
Query: 204 PNAASD-DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
            + A D D  C        + PE LN    +  +D+W+LG T  ++
Sbjct: 190 -DVAKDIDAGCKPYXAPERINPE-LNQKGYSVKSDIWSLGITXIEL 233

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 93
           + P +H + + +E+ K+ G GS+ +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 94  LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 209
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
            +  T + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           E F  Q F+     G GSY +V + +  + G +YA+K     F   +++    KL  +  
Sbjct: 52  ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR--KLAEVGS 109
Query: 100 DQL--DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVD 156
            +    HP  VRL   +++   LY+  E C G  L     + G  L E +   Y  + + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL ++HS GL+H D+KP N+ L   G  K+ DFG           +L    +        
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG-----------LLVELGTAGAGEVQE 217
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           G   Y+ PE+L  S  T   D+++LG T+ ++
Sbjct: 218 GDPRYMAPELLQGSYGT-AADVFSLGLTILEV 248

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 93
           + P +H + + +E+ K+ G GS+ +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 94  LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 209
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
            +  T + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 507
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++A   +K+ DFG  + M+DS            KA        +
Sbjct: 508 ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKW 558
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 507
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS            KA        +
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKW 558
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 9/185 (4%)
Query: 72  VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGE 131
           + ALK+  +   +        + E     +L  P VV +    +    LY+      G +
Sbjct: 61  IVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVD 120
Query: 132 LFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
           L   +  +G L+   A     ++  AL+  H+ G  HRD+KPEN+L++AD    + DFG 
Sbjct: 121 LAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180
Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
                D ++T L N          VGT  Y  PE  + S AT+  D++AL C LY+ L+G
Sbjct: 181 ASATTDEKLTQLGNT---------VGTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231
Query: 252 TSPFK 256
           + P++
Sbjct: 232 SPPYQ 236

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF- 111
           G G +S V   + +  G  YALK I+  +   +E       + R+     +HP ++RL  
Sbjct: 38  GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL----FNHPNILRLVA 93
Query: 112 FTFQD---TFSLYMALESCEGGELFDQIT---SKGH-LSEDEARFYTAEVVDALEYIHSM 164
           +  ++       ++ L   + G L+++I     KG+ L+ED+  +    +   LE IH+ 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKP----MQDSR--ITVLPNAASDDKACTFVGT 218
           G  HRD+KP N+LL  +G   + D GS+      ++ SR  +T+   AA   + CT    
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA---QRCTI--- 207
Query: 219 AAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +Y  PE+ +           D+W+LGC LY M+ G  P+      ++FQ+
Sbjct: 208 -SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQK 252

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKT 89
           +PQ   + +D  L +I G G + +V        + +KI+           KK  T +NK 
Sbjct: 16  SPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKE 70
Query: 90  AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEAR 148
            ++  E +++  LDHP +V+L    ++  + ++ +E    GEL   +  +K  L      
Sbjct: 71  KFMS-EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLV 128
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVL 203
            Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T L
Sbjct: 129 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 189 P--------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 8   FDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRA--- 64
           ++S+L++     SS N       + + +    E F  ++ E GK+ G G++ KV+ A   
Sbjct: 9   YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWE-FPRENLEFGKVLGSGAFGKVMNATAY 67
Query: 65  --KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY 121
              K       A+K++ +K  + E +    +L+  ++ QL  H  +V L      +  +Y
Sbjct: 68  GISKTGVSIQVAVKMLKEKADSSEREALMSELK--MMTQLGSHENIVNLLGACTLSGPIY 125
Query: 122 MALESCEGGELFDQITSKGH-LSEDEARF----------------------YTAEVVDAL 158
           +  E C  G+L + + SK    SEDE  +                      +  +V   +
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVG 217
           E++     +HRD+   N+L+T    +KI DFG  +  M DS   V  NA    K      
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK------ 239
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              ++ PE L     T  +D+W+ G  L+++ S G +P+
Sbjct: 240 ---WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  L +I G+G + KV RA  I D   V A +    + I++  +   V+ E  +   L H
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIEN--VRQEAKLFAMLKH 65
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS- 163
           P ++ L        +L + +E   GG L +++ S   +  D    +  ++   + Y+H  
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 164 --MGLIHRDIKPENLLLT--------ADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
             + +IHRD+K  N+L+         ++  +KI DFG  +     R T +  A       
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA------- 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
              G  A++ PEV+ +S  + G+D+W+ G  L+++L+G  PF+
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V +     TG   ALK  + K  ++E   +    E  ++ +L H  +VRL+  
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALK--EVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 114 FQDTFSLYMALESCEGG--ELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
                 L +  E  +    +  D  T   +   L  +  +++  +++  L + H   ++H
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL- 227
           RD+KP+NLL+   G +K+ DFG  +        +  N  S +     V T  Y  P+VL 
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARA-----FGIPVNTFSSE-----VVTLWYRAPDVLM 181
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            S   +   D+W+ GC L +M++G   F  T++
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 30  SKSFAFRAPQEHFSI-QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN- 87
           S+ ++ +     F++ + ++  K  G G+   V  A     G   A+K + + F  + + 
Sbjct: 6   SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 65
Query: 88  KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALESCEGGELFDQITSKGH 141
           K AY +L  ++L  ++H  ++ L   FT Q T      +Y+ +E  +       +    H
Sbjct: 66  KRAYREL--VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIH 118
Query: 142 LSEDEAR--FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
           +  D  R  +   +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG  +      
Sbjct: 119 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------ 172
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                 A+++     +V T  Y  PEV+         D+W++GC + +++ G+  F+ T 
Sbjct: 173 -----TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 227
Query: 260 EWLIFQRIIAR 270
               + ++I +
Sbjct: 228 HIDQWNKVIEQ 238

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKT 89
            PQ   + +D  L +I G G + +V        + +KI+           KK  T +NK 
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKE 58
Query: 90  AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEAR 148
            ++  E +++  LDHP +V+L    ++  + ++ +E    GEL   +  +K  L      
Sbjct: 59  KFMS-EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVL 203
            Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T L
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 177 P--------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 21  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 75
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 133
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 187
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 188 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKTA 90
           PQ   + +D  L +I G G + +V        + +KI+           KK  T +NK  
Sbjct: 1   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKEK 55
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARF 149
           ++  E +++  LDHP +V+L    ++  + ++ +E    GEL   +  +K  L       
Sbjct: 56  FMS-EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVL 113
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVLP 204
           Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T LP
Sbjct: 114 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 173
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 174 --------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 111/236 (47%), Gaps = 27/236 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQL 102
           ++ ++  K  G G+   V  A     G   A+K + + F  + + K AY +L  ++L  +
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCV 80
Query: 103 DHPGVVRLF--FTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEV 154
           +H  ++ L   FT Q T      +Y+ +E  +       +    H+  D  R  +   ++
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQM 135
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  ++++HS G+IHRD+KP N+++ +D  +KI DFG  +            A ++     
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMTP 184
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
           +V T  Y  PEV+         D+W++GC + +++ G   F+ T     + ++I +
Sbjct: 185 YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQ 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 113/263 (42%), Gaps = 50/263 (19%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL- 102
           I D+ + +    G ++K++  +K      YALK  +K  + K+        ++I +    
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 103 -DHPGVVRLFFTFQDTFSLYMALESCEG--------GELFDQITSKGHLSEDEARF---- 149
            D    +++    ++ + L     +CEG          +++ + +   L  DE  F    
Sbjct: 88  DDFKNELQIITDIKNEYCL-----TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 150 -YTA------------EVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
            YT              V+++  YIH+   + HRD+KP N+L+  +G +K++DFG  + M
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTS 253
            D +I                GT  ++PPE  ++  +  G   D+W+LG  LY M     
Sbjct: 203 VDKKIK------------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 254 PFK-DTSEWLIFQRIIARDIRFP 275
           PF    S   +F  I  ++I +P
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYP 273

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G G+   +V     D   V   +I+ + F   + +   ++      +  +HP V+R F
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLR------ESDEHPNVIRYF 84
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
            T +D    Y+A+E C    L + +  K   HL  +       +    L ++HS+ ++HR
Sbjct: 85  CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQ-QTTSGLAHLHSLNIVHR 142
Query: 170 DIKPENLLLT---ADGHIK--IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           D+KP N+L++   A G IK  I+DFG  K +   R        S  +     GT  ++ P
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-------HSFSRRSGVPGTEGWIAP 195
Query: 225 EVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPF 255
           E+L+       T+  D+++ GC  Y ++S G+ PF
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 93
           + P +H + + +E+ K+ G G + +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 94  LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 209
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
            +    + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 9/126 (7%)
Query: 131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           +L+  + S+  LS D   ++  +++  L+YIHS  ++HRD+KP NLL+     +KI DFG
Sbjct: 131 DLYKLLKSQ-QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFG 189
Query: 191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
             +          P           V T  Y  PE+ LNS   T   D+W++GC L +ML
Sbjct: 190 LAR-------IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242
Query: 250 SGTSPF 255
           S    F
Sbjct: 243 SNRPIF 248

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-----LDQLDHPGVV 108
           GVG+Y  V +A+   +G   ALK +             +   R V     L+  +HP VV
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 109 RLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           RL      +       + +  E  +       D+    G L  +  +    + +  L+++
Sbjct: 78  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP----------VVVTLWY 185
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             PEVL  S      D+W++GC   +M      F   SE
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV----LDQLDHPGVVR 109
           GVG+Y  V +A+   +G   ALK +  +    E       +  +     L+  +HP VVR
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSV--RVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 110 LFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           L      +       + +  E  +       D+    G L  +  +    + +  L+++H
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y 
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALFP----------VVVTLWYR 178
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PEVL  S      D+W++GC   +M      F   SE
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 17  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 121
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 176
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 177 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 18  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 77  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM-----QEHRKVPF-- 188
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 189 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 39  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 92
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------EVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 93  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 209
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 210 DKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPFKD 257
                  GT+ +  PE+L  S     T   D++++GC  Y +LS G  PF D
Sbjct: 211 S------GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 34  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 85  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 138
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 139 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 193
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 194 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 243

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 18  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 77  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 188
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 189 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV----LDQLDHPGVVR 109
           GVG+Y  V +A+   +G   ALK +  +    E       +  +     L+  +HP VVR
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSV--RVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 110 LFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           L      +       + +  E  +       D+    G L  +  +    + +  L+++H
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y 
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALAP----------VVVTLWYR 178
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PEVL  S      D+W++GC   +M      F   SE
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 39  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 92
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------EVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 93  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 209
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 210 DKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPFKD 257
                  GT+ +  PE+L  S     T   D++++GC  Y +LS G  PF D
Sbjct: 211 S------GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           F++ ++ G G++  V   K+  TG   A+K  I D +F  +E +          L  L H
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD------LAVLHH 78
Query: 105 PGVVRL---FFTF--QDTFSLYM---------ALESCEGGELFDQITSKGHLSEDEARFY 150
           P +V+L   F+T   +D   +Y+          L  C       Q+     L     + +
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL----IKVF 134
Query: 151 TAEVVDALEYIH--SMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAA 207
             +++ ++  +H  S+ + HRDIKP N+L+  ADG +K+ DFGS K +  S     PN A
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNVA 190
Query: 208 SDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                  ++ +  Y  PE +  +   T   D+W++GC   +M+ G   F+
Sbjct: 191 -------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  + +  G GS+  V RA+    G+  A+KI+ ++    E    +++ E  ++ +L HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE-DEARFYTA--EVVDALEYIH 162
            +V          +L +  E    G L+  +   G   + DE R  +   +V   + Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 163 SMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV---- 216
           +    ++HR++K  NLL+     +K+ DFG       SR+          KA TF+    
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL------SRL----------KASTFLSSKS 198
Query: 217 --GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
             GT  ++ PEVL   P+   +D+++ G  L+++ +   P+
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  + +  G GS+  V RA+    G+  A+KI+ ++    E    +++ E  ++ +L HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE-DEARFYTA--EVVDALEYIH 162
            +V          +L +  E    G L+  +   G   + DE R  +   +V   + Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 163 SMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +    ++HRD+K  NLL+     +K+ DFG       SR+       S   A    GT  
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL------SRLKASXFLXSKXAA----GTPE 204
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           ++ PEVL   P+   +D+++ G  L+++ +   P+
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 103
           DF+  ++ G G + +V +AK          +I  K ++ K  K    K ER V  L +LD
Sbjct: 12  DFKEIELIGSGGFGQVFKAKH---------RIDGKTYVIKRVKYNNEKAEREVKALAKLD 62
Query: 104 HPGVVRLFFTFQ----------------DTFSLYMALESCEGGELFDQITSKGHLSEDE- 146
           H  +V     +                  T  L++ +E C+ G L   I  +     D+ 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 147 -ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            A     ++   ++YIHS  LI+RD+KP N+ L     +KI DFG V  +++        
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-------- 174
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
              D K     GT  Y+ PE ++S       DL+ALG  L ++L
Sbjct: 175 ---DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM-----QEHRKVPF-- 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 17  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 121
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 176
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 177 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 12  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 71  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 183 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 12  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 71  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 183 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 44  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 95  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 148
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 149 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 203
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 204 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 253

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 -------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
                    ++Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV----LDQLDHPGVVR 109
           GVG+Y  V +A+   +G   ALK +  +    E       +  +     L+  +HP VVR
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSV--RVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 110 LFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           L      +       + +  E  +       D+    G L  +  +    + +  L+++H
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y 
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALDP----------VVVTLWYR 178
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PEVL  S      D+W++GC   +M      F   SE
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 49/239 (20%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 21  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 74
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------EVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 75  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPM---QDSRITVLPNA 206
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   Q S  T L N 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 207 ASDDKACTFVGTAAYVPPEVLNSSP-------ATFGNDLWALGCTLYQMLS-GTSPFKD 257
           +         GT+ +  PE+L  S         T   D++++GC  Y +LS G  PF D
Sbjct: 193 S---------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 149
           +     H  +V L         + +  E C  G+L + +  K  + E +  F        
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 150 ------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 201
                 ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 149
           +     H  +V L         + +  E C  G+L + +  K  + E +  F        
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 150 ------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 201
                 ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEAR------- 148
           +     H  +V L         + +  E C  G+L + +  K    L +++ R       
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 149 -FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPN 205
             ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   V  N
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           A    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 214 ARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEAR------- 148
           +     H  +V L         + +  E C  G+L + +  K    L +++ R       
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 149 -FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPN 205
             ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   V  N
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           A    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 ARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 55  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 112
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 113 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 169
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +    S + V            FV T  Y  PEV+         D+W++GC + 
Sbjct: 170 LDFGLARTAGTSFMMV-----------PFVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 218
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 219 EMIKGGVLFPGTDHIDQWNKVIEQ 242

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 38  PQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           P   + I D +E+  + G GSY  V  A       V A+K + + F    +    ++ E 
Sbjct: 45  PHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EI 103
Query: 97  IVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARF 149
            +L++L+H  VV++         +    LY+ LE  +    +LF    +  +L+E   + 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF---RTPVYLTELHIKT 160
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---------------SVKP 194
               ++  ++Y+HS G++HRD+KP N L+  D  +K+ DFG                + P
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 195 MQDS-RITVLPNAASDDKACT-FVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 250
            +D   +   P+  +  +  T  V T  Y  PE +L     T   D+W++GC   ++L+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 21  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 74
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------EVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 75  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 209
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 210 DKACTFVGTAAYVPPEVLNSSP-------ATFGNDLWALGCTLYQMLS-GTSPFKD 257
                  GT+ +  PE+L  S         T   D++++GC  Y +LS G  PF D
Sbjct: 193 S------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 117 TFSLYMALESCEGGELFDQITSKGHLSEDE--ARFYTAEVVDALEYIHSMGLIHRDIKPE 174
           T  L++ +E C+ G L   I  +     D+  A     ++   ++YIHS  LIHRD+KP 
Sbjct: 106 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPS 165
Query: 175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF 234
           N+ L     +KI DFG V  ++           +D K     GT  Y+ PE ++S     
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLK-----------NDGKRTRSKGTLRYMSPEQISSQDYGK 214
Query: 235 GNDLWALGCTLYQML 249
             DL+ALG  L ++L
Sbjct: 215 EVDLYALGLILAELL 229

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++++ +L +  G G +  V+       G   A+K +      K + TA   L E  V+ 
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMT 60
Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDA 157
           QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDDKACTFV 216
           +EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP            
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------------ 168
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               +  PE L  +  +  +D+W+ G  L+++ S G  P+
Sbjct: 169 --VKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 103/245 (42%), Gaps = 26/245 (10%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 90
           A R   +       ++ K+ GVG + +V   +    G      A+K +   +  K+ +  
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
               E  ++ Q DHP ++ L         + +  E  E G L         L +++ RF 
Sbjct: 63  LS--EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFT 114
Query: 151 TAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
             ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----- 169
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL 262
           P AA   +         +  PE +     T  +D+W+ G  +++++S G  P+ D S   
Sbjct: 170 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 227
Query: 263 IFQRI 267
           + + I
Sbjct: 228 VIKAI 232

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            ++ K+ GVG + +V   +    G      A+K +   +  K+ +      E  ++ Q D
Sbjct: 31  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS--EASIMGQFD 88
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV-------D 156
           HP ++ L         + +  E  E G L         L +++ RF   ++V        
Sbjct: 89  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            ++Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      P AA   +     
Sbjct: 143 GMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKI- 196
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
               +  PE +     T  +D+W+ G  +++++S G  P+ D S   + + I
Sbjct: 197 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            ++ K+ GVG + +V   +    G      A+K +   +  K+ +      E  ++ Q D
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS--EASIMGQFD 67
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV-------D 156
           HP ++ L         + +  E  E G L         L +++ RF   ++V        
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            ++Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      P AA   +     
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKI- 175
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
               +  PE +     T  +D+W+ G  +++++S G  P+ D S   + + I
Sbjct: 176 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 176
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE +N    T  +D+W+ G  LY++++ G  P+
Sbjct: 177 --------WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 85  KENKTAYVKL-ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH- 141
           K + TA   L E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G  
Sbjct: 53  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 142 -LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            L  D    ++ +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ 
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 201 T-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           T  LP                +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 173 TGKLP--------------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++++ +L +  G G +  V+       G   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMT 54
Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDA 157
           QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDDKACTFV 216
           +EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP            
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------------ 162
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 163 --VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 95  ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYT 151
           E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDD 210
            +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP      
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------ 349
Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 350 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            V+ + + F+    + +A+   E     D + S   LS  E R Y   +  AL+ IH  G
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS---LSFQEVREYMLNLFKALKRIHQFG 137
Query: 166 LIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKA-------CTFV- 216
           ++HRD+KP N L         + DFG  +   D++I +L    S+ +        C+   
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 217 ----------GTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 262
                     GT  +  PEVL   P  T   D+W+ G     +LSG  PF   S+ L
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKV------VRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
           +++  I D ELG     G++  V      +R K+ID     A+K++ +   T++  T  +
Sbjct: 8   RDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDV----AIKVLKQG--TEKADTEEM 57
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
             E  ++ QLD+P +VRL    Q   +L + +E   GG L   +  K    E+      A
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVA 113
Query: 153 EVVD----ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           E++      ++Y+     +HRD+   N+LL    + KI+DFG  K +            +
Sbjct: 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL-----------GA 162
Query: 209 DDKACTFVGTA----AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           DD   T          +  PE +N    +  +D+W+ G T+++ LS G  P+K
Sbjct: 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 32/235 (13%)
Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            ++ ++ G G + +V   + K+      A+ I   K    E +      E  ++ Q DHP
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE------ 159
            VV L         + + +E  E G L         L + + +F   ++V  L       
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGAL------DAFLRKHDGQFTVIQLVGMLRGIAAGM 158
Query: 160 -YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+  MG +HRD+   N+L+ ++   K++DFG            L     DD    +  T
Sbjct: 159 RYLADMGYVHRDLAARNILVNSNLVCKVSDFG------------LSRVIEDDPEAVYTTT 206
Query: 219 AAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
              +P     PE +     T  +D+W+ G  +++++S G  P+ D S   + + I
Sbjct: 207 GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 119/256 (46%), Gaps = 32/256 (12%)
Query: 30  SKSFAFRAPQEHFSIQDF-------ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF 82
           ++SF  +A Q    +Q++       E+G++ G G + +V   +    G V A++++D   
Sbjct: 11  ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEV-AIRLID--- 64
Query: 83  ITKENKTAYVKLERIVL--DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SK 139
           I ++N+      +R V+   Q  H  VV           L +    C+G  L+  +  +K
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
             L  ++ R    E+V  + Y+H+ G++H+D+K +N+    +G + I DFG       S 
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF-----SI 178
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---------NSSPATFGNDLWALGCTLYQMLS 250
             VL     +DK     G   ++ PE++         +  P +  +D++ALG   Y++ +
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 251 GTSPFKDT-SEWLIFQ 265
              PFK   +E +I+Q
Sbjct: 239 REWPFKTQPAEAIIWQ 254

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 218 EMIKGGVLFPGTDHIDQWNKVIEQ 241

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 122
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 170
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 171 LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 160
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 247 QML 249
           +M+
Sbjct: 210 EMV 212

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 33/237 (13%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GH 141
           +     H  +V L         + +  E C  G+L + +  K                  
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSR 199
           LS  +   ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS 
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 221
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 YIVKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 106
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 154
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 155 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 107
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 155
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 156 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 122
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 170
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 49  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 102
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 103 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 150
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 113
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 161
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 162 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/256 (20%), Positives = 113/256 (44%), Gaps = 31/256 (12%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 90
           A R   +   +   ++ ++ G G + +V R +    G   +  A+K +   + T+  +  
Sbjct: 5   AVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRRE 63
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
           ++  E  ++ Q +HP ++RL     ++  + +  E  E G L         L  ++ +F 
Sbjct: 64  FLS-EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFT 116
Query: 151 TAEVV-------DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
             ++V         + Y+  M  +HRD+   N+L+ ++   K++DFG  + ++++     
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN----- 171
Query: 204 PNAASDDKACTFVGTA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
              +SD    + +G      +  PE +     T  +D W+ G  +++++S G  P+ D S
Sbjct: 172 ---SSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 228
Query: 260 EWLIFQRIIARDIRFP 275
              +    I +D R P
Sbjct: 229 NQDVIN-AIEQDYRLP 243

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+   VV A         A+K + + F  + + K AY +L  +++  ++H  ++ L  
Sbjct: 33  GSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLN 90
Query: 113 TFQDTFSL------YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
            F    SL      Y+ +E  +      Q+  +  L  +   +   +++  ++++HS G+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGI 147
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+KP N+++ +D  +KI DFG  +            A +      +V T  Y  PEV
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEV 196
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
           +         D+W++G  + +M+ G   F  T     + ++I +
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+L+  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 63/121 (52%), Gaps = 11/121 (9%)
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAA 207
            Y  ++  A+ +IHS+G+ HRDIKP+NLL+ + D  +K+ DFGS K        ++P+  
Sbjct: 145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK-------KLIPSEP 197
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           S    C+    A   P  +L ++  T   DLW++GC   +++ G   F   +      RI
Sbjct: 198 SVAXICSRFYRA---PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRI 254
Query: 268 I 268
           I
Sbjct: 255 I 255

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 104 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 167
Query: 156 DALEYIHS--MGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS-------------SCQLGQR 214
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 215 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQLDHPGVVRL 110
           G G++ +V+  + ID    YA+K++  + I K  ++A ++   L++I  D +++  +V+ 
Sbjct: 44  GDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIH 168
              F     + +  E   G  L++ IT   +     ++ + Y  E++ AL Y+  M L H
Sbjct: 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160
Query: 169 RDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF--------V 216
            D+KPEN+LL         I +      K +Q  R         D    TF        +
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSII 220
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            T  Y  PEV+ +      +D+W+ GC L ++ +G+  F+
Sbjct: 221 NTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 175
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE +N    T  +++W+ G  LY++++ G  P+
Sbjct: 176 --------WTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 89
Query: 104 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 148
Query: 156 DALEYIHS--MGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS-------------SCQLGQR 195
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 196 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 104 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 167
Query: 156 DALEYIHS--MGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASDDK 211
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGS-------------SCQLGQR 214
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 215 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 25/159 (15%)
Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSL-----YMALESCEGGELFDQITSKGH-LSEDEARF 149
           R  L ++ HP +V++F   + T        Y+ +E   G  L     SKG  L   EA  
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIA 186
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           Y  E++ AL Y+HS+GL++ D+KPEN++LT +  +K+ D G+V     SRI         
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV-----SRI--------- 231
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           +      GT  +  PE++ + P T   D++ +G TL  +
Sbjct: 232 NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++ +  + G GSY  V  A   +T    A+K +++ F    +    ++ E  +L++L   
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSD 85
Query: 106 GVVRLF-FTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            ++RL+     D       LY+ LE  +  +L     +   L+E+  +     ++    +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA-------- 212
           IH  G+IHRD+KP N LL  D  +K+ DFG  + +   + T + N   +++         
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 213 ----CTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 250
                + V T  Y  PE +L     T   D+W+ GC   ++L+
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++G  + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 186 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 187 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 187 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 133 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 192
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 193 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKV------VRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
           +++  I D ELG     G++  V      +R K+ID     A+K++ +   T++  T  +
Sbjct: 334 RDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDV----AIKVLKQG--TEKADTEEM 383
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
             E  ++ QLD+P +VRL    Q   +L + +E   GG L   +  K    E+      A
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVA 439
Query: 153 EVVD----ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           E++      ++Y+     +HR++   N+LL    + KI+DFG  K +            +
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-----------GA 488
Query: 209 DDKACTFVGTA----AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           DD   T          +  PE +N    +  +D+W+ G T+++ LS G  P+K
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 52  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 110 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 166
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 167 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 215
Query: 247 QML 249
           +M+
Sbjct: 216 EMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 247 QML 249
           +M+
Sbjct: 218 EMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 247 QML 249
           +M+
Sbjct: 218 EMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 247 QML 249
           +M+
Sbjct: 210 EMV 212

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +       V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDTSEWLIFQRIIAR 270
           +M+ G   F  T     + ++I +
Sbjct: 217 EMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 19/234 (8%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 69
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 70  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 179
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFP 275
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMP 232

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 247 QML 249
           +M+
Sbjct: 211 EMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 149 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 206 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 247 QML 249
           +M+
Sbjct: 255 EMV 257

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 247 QML 249
           +M+
Sbjct: 211 EMV 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ ++ G G + +V R +    G   +  A+K +   + T+  +  ++  E  ++ Q +H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRREFLS-EASIMGQFEH 74
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE----- 159
           P ++RL     ++  + +  E  E G L         L  ++ +F   ++V  L      
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 160 --YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
             Y+  M  +HRD+   N+L+ ++   K++DFG  + ++++        +SD    + +G
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN--------SSDPTYTSSLG 180
Query: 218 TA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR 273
                 +  PE +     T  +D W+ G  +++++S G  P+ D S   +    I +D R
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN-AIEQDYR 239
Query: 274 FP 275
            P
Sbjct: 240 LP 241

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 149 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 206 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 247 QML 249
           +M+
Sbjct: 255 EMV 257

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A+  P+E   ++     K  G G + +V  A   +  T  A+K M    ++ E   A   
Sbjct: 182 AWEIPRESLKLE-----KKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA--- 232
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YT 151
            E  V+  L H  +V+L         +Y+  E    G L D + S     +   +   ++
Sbjct: 233 -EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           A++ + + +I     IHRD++  N+L++A    KIADFG  + ++D+  T    A    K
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
                    +  PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R
Sbjct: 351 ---------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALER 400
Query: 271 DIRFP 275
             R P
Sbjct: 401 GYRMP 405

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 40/244 (16%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH---------------L 142
           +     H  +V L         + +  E C  G+L + +  K                 L
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 143 SEDEAR--------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVK 193
            +++ R         ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLAR 206
Query: 194 P-MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
             M DS   V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G
Sbjct: 207 DIMNDSNYIVKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 257
Query: 252 TSPF 255
            +P+
Sbjct: 258 LNPY 261

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 32/297 (10%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 9   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 68
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 69  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 139 KGH--------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
           K +              L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +
Sbjct: 128 KRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVV 187
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 244
           KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G  
Sbjct: 188 KICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 245 LYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 30/295 (10%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
           K +            L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKI 185
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L+
Sbjct: 186 XDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 247 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           ++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 EIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 107
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG  +        VL +  
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-------YVLDDEY 160
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           +  +   F     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 161 TSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 88/183 (48%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 58  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 115
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 116 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 172
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         DLW++GC + 
Sbjct: 173 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 221
Query: 247 QML 249
           +M+
Sbjct: 222 EMV 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 108/264 (40%), Gaps = 38/264 (14%)
Query: 33  FAFRAPQE-------HFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKF 82
           F F  P E          I   ++ ++ G G + +V        G      A+K +   +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
             K+ +      E  ++ Q DHP V+ L      +  + +  E  E G L         L
Sbjct: 74  TEKQRRDFLS--EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFL 125
Query: 143 SEDEARFYTAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
            +++ +F   ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + +
Sbjct: 126 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 196 QDSRITVLPNAASDDKACTFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
           +D          SD    + +G      +  PE +     T  +D+W+ G  +++++S G
Sbjct: 186 EDD--------TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 252 TSPFKDTSEWLIFQRIIARDIRFP 275
             P+ D +   +    I +D R P
Sbjct: 238 ERPYWDMTNQDVIN-AIEQDYRLP 260

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +      V    A             ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDAR--------LPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 30/295 (10%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
           K +            L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKI 185
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L+
Sbjct: 186 CDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 247 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           ++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 33/298 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 8   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 67
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 68  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 126
Query: 139 KGH---------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
           K +               L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    
Sbjct: 127 KRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 243
           +KI DFG  + +      V    A             ++ PE +     T  +D+W+ G 
Sbjct: 187 VKICDFGLARDIXKDPDXVRKGDAR--------LPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 244 TLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
            L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +      V    A             ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIYKDPDXVRKGDAR--------LPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 88/183 (48%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 104
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         DLW++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 210
Query: 247 QML 249
           +M+
Sbjct: 211 EMV 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVK 93
           A +  ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V 
Sbjct: 2   AMKSRYTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV- 59
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARF 149
               VL Q  H  VVR F  + +   + +  E C GG L D I+       +  E E + 
Sbjct: 60  YAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +V   L YIHSM L+H DIKP N+ ++                     T +PNAAS+
Sbjct: 118 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASE 157
Query: 210 D 210
           +
Sbjct: 158 E 158

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 56  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 115 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 170
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 171 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 14/215 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-VKLERIVLDQLDHP 105
           F LG+  G GS+ ++     I T    A+K+ + K  TK  +  Y  K+ RI+      P
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIP 66
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            V R F    D   L M L      +LF+  + K  LS         ++++ +E++HS  
Sbjct: 67  NV-RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 123
Query: 166 LIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI-TVLPNAASDDKACTFVGTAAY 221
            +HRDIKP+N L+        + I DFG  K  +D+     +P   + +      GTA Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN----LTGTARY 179
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                      +  +DL +LG  L   L G+ P++
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 62  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 121 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 176
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 177 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 67  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 181
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 182 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 67
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+ +E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK---------WTA 178
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++E+  + G GSY  V  A   +     A+K +++ F    +    ++ E  +L++L   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSD 87
Query: 106 GVVRL--FFTFQDTF---SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            ++RL      +D      LY+ LE  +  +L     +   L+E   +     ++   ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ-DSRITVL-------------PNA 206
           IH  G+IHRD+KP N LL  D  +KI DFG  + +  D  I ++             P+ 
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 207 ASDDKACT-FVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 250
            +  K  T  V T  Y  PE +L     T   D+W+ GC   ++L+
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 63  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 122 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 177
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 178 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 69
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+ +E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 180
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 66  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 125 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 181 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 67  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 181
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 182 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 69  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 128 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 183
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 184 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 69
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+ +E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 180
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y +V +A  IDT T   + I   +   +E       +  + +L +L H  ++ L  
Sbjct: 43  GEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                  L++  E  E  +L   +     +S    + +  ++++ + + HS   +HRD+K
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 173 PENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           P+NLLL+         +KI DFG       +R   +P      +  T      Y PPE+ 
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGL------ARAFGIPIRQFTHEIITL----WYRPPEIL 209
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           L S   +   D+W++ C   +ML  T  F   SE
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 70  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 129 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 184
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 185 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 71  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 130 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 185
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 186 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 221

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +      V    A             ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDAR--------LPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L     +    L + +E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL 102
            D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++    
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 83
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDE 146
            HP ++ L    +    LY+A+E    G L D +                ++   LS  +
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVL 203
              + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  L
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 204 P--------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 44  PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 103
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 104 EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 162
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 163 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 223 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 274
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 333

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 9   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 68
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 69  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 128 KRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 187
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +      V    A             ++ PE +     T  +D+W+ G
Sbjct: 188 VVKICDFGLARDIYKDPDYVRKGDAR--------LPLKWMAPETIFDRVYTIQSDVWSFG 239
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 240 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 298

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 98
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 7   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 154
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 65  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 158

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 98
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 9   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 66
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 154
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 67  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 160

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 111/293 (37%), Gaps = 61/293 (20%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 98
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 5   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 62
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 154
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 63  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS-----D 209
              L YIHSM L+H DIKP N+ ++                     T +PNAAS     D
Sbjct: 121 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEEGDED 160
Query: 210 DKACTFV--------------------GTAAYVPPEVLNSSPATFGN-DLWALGCTLYQM 248
           D A   V                    G + ++  EVL  +       D++AL  T+   
Sbjct: 161 DWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXA 220
Query: 249 LSGTSPF-KDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 300
            +G  P  ++  +W   ++   R  R P   S              P  RP A
Sbjct: 221 -AGAEPLPRNGDQWHEIRQ--GRLPRIPQVLSQEFTELLKVMIHPDPERRPSA 270

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V + + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYT 159
Query: 214 TFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +  GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 160 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL 102
            D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++    
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 73
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDE 146
            HP ++ L    +    LY+A+E    G L D +                ++   LS  +
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVL 203
              + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  L
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 194 P--------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 67
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK---------WTA 178
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +
Sbjct: 55  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V + + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYT 162
Query: 214 TFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +  GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 162
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALE 159
           +L HP +V+ +      + +Y+  E    G L + + S G  L   +      +V + + 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT- 218
           ++ S   IHRD+   N L+  D  +K++DFG            +     DD+  + VGT 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFG------------MTRYVLDDQYVSSVGTK 166
Query: 219 --AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               +  PEV +    +  +D+WA G  ++++ S G  P+
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 74
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+ +E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V + + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYT 179
Query: 214 TFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +  GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 180 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 229

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 160
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 69
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 180
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 69
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 180
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 70
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+ +E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK---------WTA 181
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 74
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 57  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHR+++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 116 EGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 171
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 172 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 175
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 176 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 163
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HS G++HRD+KP N+++      +++ D+G  +   P Q+
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 193
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 194 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 73
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 184
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/233 (21%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL 102
            D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++    
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 80
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDE 146
            HP ++ L    +    LY+A+E    G L D +                ++   LS  +
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVL 203
              + A+V   ++Y+     IHR++   N+L+  +   KIADFG  +  +      +  L
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 201 P--------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 74
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK---------WTA 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HS G++HRD+KP N+++      +++ D+G  +   P Q+
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 188
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 189 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 69
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 180
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 69
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 180
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 74
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 79/173 (45%), Gaps = 21/173 (12%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  ++ Q DHP ++ L      +  + +  E  E G L         L +++ +F   ++
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKNDGQFTVIQL 126
Query: 155 VDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
           V  L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA
Sbjct: 127 VGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAA 181
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
              +         +  PE +     T  +D+W+ G  +++++S G  P+ + +
Sbjct: 182 YTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMT 232

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 71
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 182
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 82
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 193
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 194 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 74
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 71
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 182
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 70
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK---------WTA 181
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 71
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHRD+   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK---------WTA 182
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMALES 126
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 59  TGEMVAVKAL-KADAGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
              G L D +  +  +   +   +  ++ + + Y+H+   IHRD+   N+LL  D  +KI
Sbjct: 117 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI 175
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 176 GDFGLAKAVPEGHEXY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 247 QMLS 250
           ++L+
Sbjct: 229 ELLT 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +       V T  Y  PEV+         DLW++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 276
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHR++   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 387
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK- 196
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 197 --------WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/269 (20%), Positives = 108/269 (40%), Gaps = 34/269 (12%)
Query: 12  LRIEGNNNSSTNCPTVQRSKSFAF-RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI--- 67
           +RI    +S+ + P +     +     P+  F      LGK  G G + +VV A+ +   
Sbjct: 47  VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106
Query: 68  ----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
                     A+K++      K+      ++E + +    H  ++ L         LY+ 
Sbjct: 107 KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVI 165
Query: 124 LESCEGGELFDQITSK-----------GHLSEDEARFY-----TAEVVDALEYIHSMGLI 167
           +E    G L + + ++             + E++  F      T ++   +EY+ S   I
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HRD+   N+L+T +  +KIADFG  + +         N     K         ++ PE L
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDIN--------NIDYYKKTTNGRLPVKWMAPEAL 277
Query: 228 NSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                T  +D+W+ G  ++++ + G SP+
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITK 85
           S +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +  +  T+
Sbjct: 1   SGAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTE 57
Query: 86  ENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHL 142
           E+   + + E  +L  L H  +V+           +L + +E    G L D +   K  +
Sbjct: 58  EHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
              +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        V
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------V 168
Query: 203 LPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           LP     DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K 
Sbjct: 169 LPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KS 222
Query: 258 TSEWLIFQRIIARD 271
            S    F R+I  D
Sbjct: 223 KSPPAEFMRMIGND 236

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERIVLDQLDHPGVV 108
           K+ G G +  V +   I  G    + +  K    K  + ++  V    + +  LDH  +V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           RL      + SL +  +    G L D +   +G L       +  ++   + Y+   G++
Sbjct: 97  RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 155
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HR++   N+LL +   +++ADFG           +LP    DDK   +  + A  P + +
Sbjct: 156 HRNLAARNVLLKSPSQVQVADFGVAD--------LLP---PDDKQLLY--SEAKTPIKWM 202
Query: 228 NSSPATFG-----NDLWALGCTLYQMLS-GTSPF 255
                 FG     +D+W+ G T++++++ G  P+
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERIVLDQLDHPGVV 108
           K+ G G +  V +   I  G    + +  K    K  + ++  V    + +  LDH  +V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           RL      + SL +  +    G L D +   +G L       +  ++   + Y+   G++
Sbjct: 79  RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HR++   N+LL +   +++ADFG           +LP    DDK   +  + A  P + +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVAD--------LLP---PDDKQLLY--SEAKTPIKWM 184
Query: 228 NSSPATFG-----NDLWALGCTLYQMLS-GTSPF 255
                 FG     +D+W+ G T++++++ G  P+
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++ K   T+E+ + 
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSD 86
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
            V    ++     H  ++ L         LY+ +E    G L + + ++           
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITK 85
           S +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +  +  T+
Sbjct: 3   SGAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTE 59
Query: 86  ENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHL 142
           E+   + + E  +L  L H  +V+           +L + +E    G L D +   K  +
Sbjct: 60  EHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
              +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        V
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------V 170
Query: 203 LPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           LP     DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K 
Sbjct: 171 LPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KS 224
Query: 258 TSEWLIFQRIIARD 271
            S    F R+I  D
Sbjct: 225 KSPPAEFMRMIGND 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           HF  +  +  +  G G + KV   +      +TG   A+K +  +  +  N  A +K E 
Sbjct: 5   HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEI 62
Query: 97  IVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 63  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG  K ++  +         DD+  
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX---TVKDDRD- 178
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
                  +  PE L  S     +D+W+ G TL+++L+      D+S   +F ++I 
Sbjct: 179 ---SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD--SDSSPMALFLKMIG 229

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           HF  +  +  +  G G + KV   +      +TG   A+K +  +  +  N  A +K E 
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEI 74
Query: 97  IVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG  K ++  +         DD+  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX---TVKDDRD- 190
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
                  +  PE L  S     +D+W+ G TL+++L+      D+S   +F ++I 
Sbjct: 191 ---SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD--SDSSPMALFLKMIG 241

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 2   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 58
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 144
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 59  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 117
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 118 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 169
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 170 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 223
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 224 PPAEFMRMIGND 235

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 4   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 60
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 144
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 61  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 119
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 120 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 171
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 172 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 225
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 226 PPAEFMRMIGND 237

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 62  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++           +  KA T
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------NXYKAQT 172
Query: 215 F-VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                  +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 29  AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 85
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 144
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 86  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 144
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 196
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 197 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 250
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 251 PPAEFMRMIGND 262

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +       V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 315
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHR++   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 426
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF 274
           PE L  +  +  +D+WA G  L+++ + G SP+       +++ ++ +D R 
Sbjct: 427 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM 477

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 55  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 172 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 219
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 220 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 249

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 55  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 172 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 219
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 220 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 249

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/250 (20%), Positives = 104/250 (41%), Gaps = 31/250 (12%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLER 96
           +   I   ++ ++ G G + +V        G      A+K +   +  K+ +      E 
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS--EA 59
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            ++ Q DHP V+ L      +  + +  E  E G L         L +++ +F   ++V 
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVG 113
Query: 157 AL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
            L       +Y+  M  +HR +   N+L+ ++   K++DFG  + ++D          SD
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDD--------TSD 165
Query: 210 DKACTFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ 265
               + +G      +  PE +     T  +D+W+ G  +++++S G  P+ D +   +  
Sbjct: 166 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 225
Query: 266 RIIARDIRFP 275
             I +D R P
Sbjct: 226 -AIEQDYRLP 234

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 35  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 91
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 92  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 151
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 152 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 199
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 200 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +  +  T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 40  NTGEVVAVKKL--QHSTEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 97  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 156
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 157 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 204
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 205 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 234

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 36  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 92
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 93  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 152
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 153 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 200
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 201 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 230

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 62  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 175
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMALES 126
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
              G L D +  +  +   +   +  ++ + + Y+HS   IHR++   N+LL  D  +KI
Sbjct: 100 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKI 158
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 159 GDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 247 QMLS 250
           ++L+
Sbjct: 212 ELLT 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 13  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 72
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 73  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 191 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 242 SLGSSPY 248

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +  +  T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKL--QHSTEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 68  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 182 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           + +  I    N  +      ++       PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 INN--IDYYKNTTNGRLPVKWMA------PEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 58  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 171
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 172 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 56  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 114
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 115 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 169
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 170 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 210

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 76  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 135 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 189
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 190 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 230

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 29  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 88
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 89  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 146
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 147 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 206
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 207 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 258 SLGSSPY 264

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 17  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 76
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 77  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 135
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 136 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 196 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 247
Query: 254 PF 255
           P+
Sbjct: 248 PY 249

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 177
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 87  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 146
Query: 178 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 197
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 78  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 191
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 192 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 78  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 136
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 137 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 191
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 192 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 15  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 74
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 75  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 133
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 134 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 194 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 245
Query: 254 PF 255
           P+
Sbjct: 246 PY 247

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 177
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 88  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 147
Query: 178 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 198
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 199 SDVWSFGVVLYELFT 213

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 31  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 90
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 91  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 148
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 149 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 208
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 209 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 260 SLGSSPY 266

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 96  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 153
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 154 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 214 LARHIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 265 SLGSSPY 271

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 20  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 79
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 80  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 138
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 139 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 199 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 250
Query: 254 PF 255
           P+
Sbjct: 251 PY 252

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 177
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 178 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 210
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 211 SDVWSFGVVLYELFT 225

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 96  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 153
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 154 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 214 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 265 SLGSSPY 271

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 19/127 (14%)
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP     
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLPQ---- 169
Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S    F
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEF 227
Query: 265 QRIIARD 271
            R+I  D
Sbjct: 228 MRMIGND 234

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 1   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 57
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGH-LSE 144
              + + E  +L  L H  +V+           +L + +E    G L D + +    +  
Sbjct: 58  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDH 116
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 117 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 168
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 169 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 222
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 223 PPAEFMRMIGND 234

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  ++IADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 108
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 109 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           RL       T  L   L     G L + +   K ++       +  ++   + Y+    L
Sbjct: 104 RLLGVCLSPTIQLVTQL--MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG---TAAYVP 223
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 210
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 84/203 (41%), Gaps = 38/203 (18%)
Query: 85  KENKTAYVKLERI-------VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           K  K  Y + +R+       ++ Q  H  ++RL         + +  E  E G L     
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL----- 133
Query: 138 SKGHLSEDEARFYTAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
               L E +  F   ++V  L       +Y+ +M  +HRD+   N+L+ ++   K++DFG
Sbjct: 134 -DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTL 245
                       L     DD   T+  +   +P     PE ++    T  +D+W+ G  +
Sbjct: 193 ------------LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
Query: 246 YQMLS-GTSPFKDTSEWLIFQRI 267
           +++++ G  P+ + S   + + I
Sbjct: 241 WEVMTYGERPYWELSNHEVMKAI 263

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 420 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 478
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 479 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKW-- 534
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 535 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 421 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 479
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 480 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKW-- 535
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 536 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 575

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 108
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 109 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           RL       T  L   L     G L + +   K ++       +  ++   + Y+    L
Sbjct: 81  RLLGVCLSPTIQLVTQL--MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA---AYVP 223
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 187
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 120 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL 178
           L + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L+
Sbjct: 85  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 144
Query: 179 TADGHIKIADFGSVKPM---QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
            ++ H+KIADFG  K +   +D  +   P  +             +  PE L+ +  +  
Sbjct: 145 ESEAHVKIADFGLAKLLPLDKDXXVVREPGQS----------PIFWYAPESLSDNIFSRQ 194
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 195 SDVWSFGVVLYELFT 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMALES 126
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
              G L D +  +  +   +   +  ++ + + Y+H+   IHR++   N+LL  D  +KI
Sbjct: 100 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKI 158
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 159 GDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 247 QMLS 250
           ++L+
Sbjct: 212 ELLT 215

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 47  FELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +EL  + G G      V  A+   TG    ++ ++ +  + E  T +++ E  V    +H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 85
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH 162
           P +V    TF     L++       G   D I +     ++E    +    V+ AL+YIH
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----QDSRITVLPNAASDDKACTFVGT 218
            MG +HR +K  ++L++ DG + ++   S   M    Q  R+         D     V  
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-------HDFPKYSVKV 198
Query: 219 AAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 257
             ++ PEVL  +   +   +D++++G T  ++ +G  PFKD
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 47  FELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +EL  + G G      V  A+   TG    ++ ++ +  + E  T +++ E  V    +H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 69
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH 162
           P +V    TF     L++       G   D I +     ++E    +    V+ AL+YIH
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----QDSRITVLPNAASDDKACTFVGT 218
            MG +HR +K  ++L++ DG + ++   S   M    Q  R+         D     V  
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-------HDFPKYSVKV 182
Query: 219 AAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 257
             ++ PEVL  +   +   +D++++G T  ++ +G  PFKD
Sbjct: 183 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLER--IVLDQ 101
           + E  K  G G +  V + + +   +V A+K  I+       E    + + +R   ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVDALEY 160
           L+HP +V+L+    +   + M    C  G+L+ ++  K H  +   +     ++   +EY
Sbjct: 80  LNHPNIVKLYGLMHNPPRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 161 IHSMG--LIHRDIKPENLLL-----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +    ++HRD++  N+ L      A    K+ADFG+             +  S     
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT-------------SQQSVHSVS 184
Query: 214 TFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTS 259
             +G   ++ PE + +   ++    D ++    LY +L+G  PF + S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD----QLDHPG--- 106
           G G +S V  AK +   T  A+KI+    +  E     +KL + V D    + D  G   
Sbjct: 28  GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87
Query: 107 VVRLFFTFQ----DTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEY 160
           +++L   F     +   + M  E   G  L   I    H  +     +  + +++  L+Y
Sbjct: 88  ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 146
Query: 161 IHSM-GLIHRDIKPENLLL-TADG-----HIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +H   G+IH DIKPEN+L+   D       IKIAD G+                 D+   
Sbjct: 147 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------------CWYDEHYT 193
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
             + T  Y  PEVL  +P   G D+W+  C ++++++G   F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPF--GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 183
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD----QLDHPG--- 106
           G G +S V  AK +   T  A+KI+    +  E     +KL + V D    + D  G   
Sbjct: 28  GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87
Query: 107 VVRLFFTFQ----DTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEY 160
           +++L   F     +   + M  E   G  L   I    H  +     +  + +++  L+Y
Sbjct: 88  ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 146
Query: 161 IHSM-GLIHRDIKPENLLL-TADG-----HIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +H   G+IH DIKPEN+L+   D       IKIAD G+                 D+   
Sbjct: 147 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------------CWYDEHYT 193
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
             + T  Y  PEVL  +P   G D+W+  C ++++++G   F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 186
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 144
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 145 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSXV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 249 LS-GTSPF 255
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/247 (21%), Positives = 99/247 (40%), Gaps = 37/247 (14%)
Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           Q F LG++ G G +  V  A+ K + G+    A+K++    I   +   +++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 102 LDHPGVVRL------------------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
            DHP V +L                     F     L+  L +   GE      +  +L 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE------NPFNLP 135
Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
                 +  ++   +EY+ S   IHRD+   N +L  D  + +ADFG  + +        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL 262
                  + C       ++  E L  +  T  +D+WA G T++++++ G +P+       
Sbjct: 194 ------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 263 IFQRIIA 269
           I+  +I 
Sbjct: 248 IYNYLIG 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 77  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 187
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 38  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 94
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHR++   N+L+  +  +
Sbjct: 95  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRV 154
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 155 KIGDFGLTK--------VLPQ----DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 202
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 203 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 232

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +     G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 84  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 194
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 85  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 195
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 181
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 182 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 181
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 182 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 124 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 182
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 183 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 81  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 191
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------------GHLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 133 -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 243
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL------ 205
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 260

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 35/247 (14%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +E+    G G++ KVV       G  + A+KI+       +N   Y +  R  +  L+H 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 106 G---------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL--SEDEARFYTAEV 154
                      V++   F+    + +  E   G   +D I   G L    D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN--------- 205
             ++ ++HS  L H D+KPEN+L     + +  +    K  +D R  + P+         
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSA 184
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS--PFKDTSEWL- 262
              D+   T V T  Y  PEV+ +   +   D+W++GC L +   G +  P  D+ E L 
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 263 IFQRIIA 269
           + +RI+ 
Sbjct: 245 MMERILG 251

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 186
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 143 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 201
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 202 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 144
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 145 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSXV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 249 LS-GTSPF 255
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 79  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 185
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 144
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 198
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 253

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 171
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 225
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 280

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 183
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 150
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 259

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 170
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 224
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 279

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +     G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 205
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 260

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 144
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 145 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 249 LS-GTSPF 255
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLER--IVLDQ 101
           + E  K  G G +  V + + +   +V A+K  I+       E    + + +R   ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVDALEY 160
           L+HP +V+L+    +   + M    C  G+L+ ++  K H  +   +     ++   +EY
Sbjct: 80  LNHPNIVKLYGLMHNPPRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 161 IHSMG--LIHRDIKPENLLL-----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +    ++HRD++  N+ L      A    K+ADFG              +  S     
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-------------SQQSVHSVS 184
Query: 214 TFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTS 259
             +G   ++ PE + +   ++    D ++    LY +L+G  PF + S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAAS 208
           +++D + Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADL 192
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           D    TF   A   P  +L +   T   D+WA+GC   ++L+    F    E
Sbjct: 193 DPVVVTFWYRA---PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 26/190 (13%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY---- 150
           E  ++ +L H  +V+L+    +   +Y+  E    G L D       L + E R      
Sbjct: 54  EAQIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLD------FLKDGEGRALKLPN 106
Query: 151 ----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
                A+V   + YI  M  IHRD++  N+L+      KIADFG  + ++D+  T    A
Sbjct: 107 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGA 166
Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ 265
               K         +  PE       T  +D+W+ G  L ++++ G  P+   +   + +
Sbjct: 167 KFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE 217
Query: 266 RIIARDIRFP 275
           + + R  R P
Sbjct: 218 Q-VERGYRMP 226

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 254 PF 255
           P+
Sbjct: 381 PY 382

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 254 PF 255
           P+
Sbjct: 381 PY 382

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 265
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  ++ Q DHP ++RL           +  E  E G L   + T  G  +  +       
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V   + Y+  +G +HRD+   N+L+ ++   K++DFG  + ++D      P+AA      
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAA------ 208
Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            +  T   +P     PE +     +  +D+W+ G  ++++L+ G  P+
Sbjct: 209 -YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 157
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 211
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 266

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 113/262 (43%), Gaps = 28/262 (10%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 297
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 298 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 352
Query: 137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 413 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 254 PFKDTSEWLIFQRIIARDIRFP 275
           P+       +  + + R  R P
Sbjct: 464 PYPGMVNREVLDQ-VERGYRMP 484

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 29/246 (11%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           + +E+    G G++ +VV+   +D    G   ALKI+  K + K  + A  +LE  VL++
Sbjct: 33  ERYEIVSTLGEGTFGRVVQC--VDHRRGGARVALKII--KNVEKYKEAA--RLEINVLEK 86
Query: 102 LDHPG------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE--DEARFYTAE 153
           ++          V++F  F     + ++ E   G   FD +    +L     + R    +
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 154 VVDALEYIHSMGLIHRDIKPENLL-LTADGHI-----KIADFGSVKPMQDSRITVLPNAA 207
           +  A++++H   L H D+KPEN+L + +D  +     K  D  SVK     R+    +A 
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTA-VRVVDFGSAT 204
Query: 208 SD-DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWL-I 263
            D +   T V T  Y  PEV+     +   D+W++GC +++   G + F+  D  E L +
Sbjct: 205 FDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 264 FQRIIA 269
            +RI+ 
Sbjct: 265 MERILG 270

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 150
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 259

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 207
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 262

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +    +A
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 178 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL------ 207
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 262

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +    +A
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 178 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYAL--KIMDKKFITKENKTAYVKLERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    +   IM+ +  T       +  E  V+  +D
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 168 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 216
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  ++ Q DHP ++RL           +  E  E G L   + T  G  +  +       
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V   + Y+  +G +HRD+   N+L+ ++   K++DFG  + ++D      P+AA      
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAXTTTGG 214
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                  +  PE +     +  +D+W+ G  ++++L+ G  P+
Sbjct: 215 KI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFL 269
Query: 137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 254 PF 255
           P+
Sbjct: 381 PY 382

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 11/116 (9%)
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
            +  ++ + + Y+H+   IHR +   N+LL  D  +KI DFG  K + +           
Sbjct: 115 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML----SGTSPFKDTSE 260
           D           +  PE L      + +D+W+ G TLY++L    S  SP    +E
Sbjct: 175 D-------SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE 223

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 11/116 (9%)
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
            +  ++ + + Y+H+   IHR +   N+LL  D  +KI DFG  K + +           
Sbjct: 116 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML----SGTSPFKDTSE 260
           D           +  PE L      + +D+W+ G TLY++L    S  SP    +E
Sbjct: 176 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE 224

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 189
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 54  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 171
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 172 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 106/242 (43%), Gaps = 23/242 (9%)
Query: 17  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
            N   T+ P  Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 162 TNVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 215
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 216 TLKPGNMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 270
Query: 137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 271 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRL 330
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 331 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381
Query: 254 PF 255
           P+
Sbjct: 382 PY 383

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 40/249 (16%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A+  P+E   ++     K  G G + +V  A   +  T  A+K M    ++ E   A   
Sbjct: 176 AWEIPRESLKLE-----KKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA--- 226
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YT 151
            E  V+  L H  +V+L         +Y+  E    G L D + S     +   +   ++
Sbjct: 227 -EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           A++ + + +I     IHRD++  N+L++A    KIADFG  +                  
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR------------------ 326
Query: 212 ACTFVGTA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
               VG      +  PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R 
Sbjct: 327 ----VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RA 381
Query: 268 IARDIRFPN 276
           + R  R P 
Sbjct: 382 LERGYRMPR 390

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 56  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 173
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 174 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++ + + Y+
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 131 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 179
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 52  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 169
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 170 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 187
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 134 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 194 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 240
Query: 248 MLSGTSPFK 256
              G + F+
Sbjct: 241 YYRGFTLFQ 249

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 102/247 (41%), Gaps = 35/247 (14%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +E+    G G++ KVV       G  + A+KI+       +N   Y +  R  +  L+H 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 106 G---------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL--SEDEARFYTAEV 154
                      V++   F+    + +  E   G   +D I   G L    D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN--------- 205
             ++ ++HS  L H D+KPEN+L     + +  +    K  +D R  + P+         
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSA 184
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS--PFKDTSEWL- 262
              D+   T V    Y  PEV+ +   +   D+W++GC L +   G +  P  D+ E L 
Sbjct: 185 TYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 263 IFQRIIA 269
           + +RI+ 
Sbjct: 245 MMERILG 251

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 187
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 185 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 248 MLSGTSPFK 256
              G + F+
Sbjct: 232 YYRGFTLFQ 240

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 187
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 157 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 217 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 263
Query: 248 MLSGTSPFK 256
              G + F+
Sbjct: 264 YYRGFTLFQ 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+   G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 83  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 189
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 185
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 185
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL---FFTFQD--TFSLYMALESCE- 128
           + I+   F+ K      V  E  +L+   HP ++ L   F  F++     LY+  E    
Sbjct: 64  VNILSDSFLCKR-----VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 129 --GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
                + DQ   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I
Sbjct: 119 DLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTL 245
            DF   +  +D+         +D     +V    Y  PE V+     T   D+W+ GC +
Sbjct: 176 CDFNLAR--EDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 246 YQMLSGTSPFKDTSEWLIFQRII 268
            +M +  + F+ ++ +    +I+
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIV 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 51  KIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           K+ G G++  V +   I  G       A+K++ +    K NK   +  E  V+  +  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 80
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
           V RL       T  L   L     G L D +  ++G L   +   +  ++   + Y+  +
Sbjct: 81  VSRLLGICLTSTVQLVTQLMPY--GCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            L+HRD+   N+L+ +  H+KI DFG  + +             D     +      VP 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------------DIDETEYHADGGKVPI 185
Query: 225 -----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                E +     T  +D+W+ G T++++++ G  P+
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           G   G G +  VV    ++  TV   K+     IT E        E  V+ +  H  +V 
Sbjct: 36  GNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITS-------KGHLSEDEARFYTAE-VVDALEYI 161
           L     D   L +       G L D+++          H+     R   A+   + + ++
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM-----RCKIAQGAANGINFL 149
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H    IHRDIK  N+LL      KI+DFG  +  +    TV+ +          VGT AY
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS--------RIVGTTAY 201
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
           + PE L     T  +D+++ G  L ++++G
Sbjct: 202 MAPEALRGE-ITPKSDIYSFGVVLLEIITG 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 82  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 140 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 188
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 185
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 189
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL---FFTFQD--TFSLYMALESCE- 128
           + I+   F+ K      V  E  +L+   HP ++ L   F  F++     LY+  E    
Sbjct: 64  VNILSDSFLCKR-----VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 129 --GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
                + DQ   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I
Sbjct: 119 DLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTL 245
            DF   +  +D+         +D     +V    Y  PE V+     T   D+W+ GC +
Sbjct: 176 CDFNLAR--EDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 246 YQMLSGTSPFKDTSEWLIFQRII 268
            +M +  + F+ ++ +    +I+
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIV 247

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 86  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 144 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 192
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 39/241 (16%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-- 97
           +H   +D  L +  G G++ KV  A+  +        ++  K +      A    +R   
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGH 141
           +L  L H  +V+ +    D   L M  E  + G+L   +                 +KG 
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--- 198
           L   +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  +   
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 199 RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 254
           R+   T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P
Sbjct: 190 RVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 255 F 255
           +
Sbjct: 236 W 236

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	366
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-142
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-109
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-109
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-105
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-104
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-104
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-103
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-103
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-102
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-102
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-102
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-102
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-101
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-101
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-101
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-101
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-100
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-100
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-99
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-99
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-98
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-90
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-86
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-86
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-86
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-83
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-82
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-82
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-82
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-80
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-80
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-80
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-80
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-80
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-80
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-80
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-80
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-79
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-79
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-78
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-78
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-78
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-78
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-78
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-78
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-78
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-77
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-77
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-77
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-77
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-77
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-77
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-76
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-76
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-76
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-76
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-76
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-75
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-74
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-74
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-74
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-74
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-74
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-73
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-73
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-73
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-73
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-73
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-73
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-72
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-72
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-72
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-72
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-70
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-70
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-70
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-68
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-68
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-68
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-68
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-66
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-66
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-66
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-66
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-64
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-61
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-58
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-58
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-57
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-52
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-51
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-48
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-48
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-47
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-47
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-47
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-46
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-46
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-45
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-45
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-45
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-45
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-44
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-42
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-35
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-34
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-34
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-33
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-33
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-32
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-32
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-31
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-31
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-30
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-30
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-29
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-28
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-28
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-28
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-27
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-23
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-19
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-14
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-14
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-11
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-10
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-10
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  403 bits (1039), Expect = e-142
 Identities = 144/317 (45%), Positives = 193/317 (60%), Gaps = 10/317 (3%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQ-EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           + ++        S   A   PQ      +DF+ GKI G GS+S VV A+++ T   YA+K
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
           I++K+ I KENK  YV  ER V+ +LDHP  V+L+FTFQD   LY  L   + GEL   I
Sbjct: 62  ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
              G   E   RFYTAE+V ALEY+H  G+IHRD+KPEN+LL  D HI+I DFG+ K   
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--- 178

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                VL   +   +A +FVGTA YV PE+L    A   +DLWALGC +YQ+++G  PF+
Sbjct: 179 -----VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 257 DTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFK 315
             +E+LIFQ+II  +  FP  F   ARDL+++LL +D + R G     GY  LK HPFF+
Sbjct: 234 AGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

Query: 316 GIDWKNIRGQTPPKLAS 332
            + W+N+  QTPPKL +
Sbjct: 294 SVTWENLHQQTPPKLTA 310

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  321 bits (824), Expect = e-109
 Identities = 101/289 (34%), Positives = 164/289 (56%), Gaps = 15/289 (5%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K                D   T  GT  Y
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAK-------------YVPDVTYTLCGTPDY 169

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F++ 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +DL+ RL+  D S R G    G   +K HP+FK + W+ +  R    P
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  321 bits (826), Expect = e-109
 Identities = 101/295 (34%), Positives = 156/295 (52%), Gaps = 15/295 (5%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
              Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           + +L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
              EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K                 +  T 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------------RVKGRTWTL 198

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            GT   + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           ++FS   +DL+  LL VD + R G    G   +K H +F   DW  I  R    P
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  311 bits (798), Expect = e-105
 Identities = 109/305 (35%), Positives = 163/305 (53%), Gaps = 16/305 (5%)

Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFI-TK 85
           S   +     E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I   
Sbjct: 2   SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61

Query: 86  ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSED 145
              TA+ K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            A FY AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K           +
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK----------ES 171

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ 265
                   TF GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      
Sbjct: 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

Query: 266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--R 323
           +I+   +  P Y +  ARDL+ +LL  + + R GAGPG    ++ HPFF+ I+W+ +  R
Sbjct: 232 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291

Query: 324 GQTPP 328
              PP
Sbjct: 292 KVEPP 296

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  309 bits (794), Expect = e-104
 Identities = 106/302 (35%), Positives = 165/302 (54%), Gaps = 16/302 (5%)

Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK 88
           +   +   E      FEL K+ G GS+ KV   KKI   D   +YA+K++ K  + K   
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRD 69

Query: 89  TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR 148
               K+ER +L +++HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +
Sbjct: 70  RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           FY AE+  AL+++HS+G+I+RD+KPEN+LL  +GHIK+ DFG  K           +   
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK----------ESIDH 179

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           + KA +F GT  Y+ PEV+N    T   D W+ G  +++ML+GT PF+          I+
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQT 326
              +  P + S  A+ L+  L   +P+ R GAGP G   +K H FF  IDW  +  R   
Sbjct: 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299

Query: 327 PP 328
           PP
Sbjct: 300 PP 301

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  310 bits (797), Expect = e-104
 Identities = 108/315 (34%), Positives = 157/315 (49%), Gaps = 25/315 (7%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           +Q ++    R  +      DFE+ K+ G G++S+V   K   TG VYA+KIM+K  + K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102

Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSED 145
            + +  + ER VL   D   + +L F FQD   LY+ +E   GG+L   ++  G  +  +
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY AE+V A++ +H +G +HRDIKP+N+LL   GHI++ADFGS   +          
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL---------R 213

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLSGTSPFKDT 258
           A    ++   VGT  Y+ PE+L +     G        D WALG   Y+M  G +PF   
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273

Query: 259 SEWLIFQRIIARDIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           S    + +I+                + ARD I RLL   P  R G   GG    + HPF
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR--GGAGDFRTHPF 330

Query: 314 FKGIDWKNIRGQTPP 328
           F G+DW  +R   PP
Sbjct: 331 FFGLDWDGLRDSVPP 345

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  311 bits (798), Expect = e-103
 Identities = 105/313 (33%), Positives = 162/313 (51%), Gaps = 23/313 (7%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F  +  Q     +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K 
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSED 145
            +TA  + ER VL   D   +  L + FQD  +LY+ ++   GG+L   ++  +  L E+
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY AE+V A++ +H +  +HRDIKP+N+L+  +GHI++ADFGS   +          
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---------M 226

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
                ++   VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286

Query: 261 WLIFQRIIARDIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              + +I+    RF         S+ A+DLI RL+      R   G  G    K HPFF 
Sbjct: 287 VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHR--LGQNGIEDFKKHPFFS 343

Query: 316 GIDWKNIRGQTPP 328
           GIDW NIR    P
Sbjct: 344 GIDWDNIRNCEAP 356

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  309 bits (793), Expect = e-103
 Identities = 110/312 (35%), Positives = 158/312 (50%), Gaps = 23/312 (7%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           + R K    +        +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K 
Sbjct: 51  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110

Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
           + +A+   ER ++   + P VV+LF+ FQD   LYM +E   GG+L   + S   + E  
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKW 169

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
           ARFYTAEVV AL+ IHSMG IHRD+KP+N+LL   GH+K+ADFG+   M         N 
Sbjct: 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---------NK 220

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGN----DLWALGCTLYQMLSGTSPFKDTSEWL 262
               +  T VGT  Y+ PEVL S           D W++G  LY+ML G +PF   S   
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

Query: 263 IFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
            + +I+     + FP+    S  A++LI   L  D   R   G  G   +K H FFK   
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVR--LGRNGVEEIKRHLFFKNDQ 337

Query: 319 WK--NIRGQTPP 328
           W    +R    P
Sbjct: 338 WAWETLRDTVAP 349

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  302 bits (776), Expect = e-102
 Identities = 97/296 (32%), Positives = 141/296 (47%), Gaps = 23/296 (7%)

Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
               P+  F+I DF++G+  G G +  V  A++     + ALK++ K  + KE     ++
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKA 212
           + DAL Y H   +IHRDIKPENLL+   G +KIADFG SV      R T           
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----------M 172

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           C   GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D+
Sbjct: 173 C---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           +FP + SD ++DLI +LL   P  R          +  HP+ K     N R   PP
Sbjct: 230 KFPPFLSDGSKDLISKLLRYHPPQRLPL-----KGVMEHPWVK----ANSRRVLPP 276

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  302 bits (775), Expect = e-102
 Identities = 91/290 (31%), Positives = 141/290 (48%), Gaps = 17/290 (5%)

Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T               
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------DLC 168

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT 326
           + ++ ARDLI RLL  +PS RP         +  HP+      K    Q 
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPML-----REVLEHPWITANSSKPSNCQN 273

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  304 bits (780), Expect = e-102
 Identities = 108/338 (31%), Positives = 173/338 (51%), Gaps = 24/338 (7%)

Query: 5   EKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRA 64
                +    +G +            ++       E   I++FEL K+ G G+Y KV   
Sbjct: 14  SSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLV 73

Query: 65  KKI---DTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFS 119
           +KI   DTG +YA+K++ K  I  K   T + + ER VL+ +   P +V L + FQ    
Sbjct: 74  RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133

Query: 120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT 179
           L++ L+   GGELF  ++ +   +E E + Y  E+V ALE++H +G+I+RDIK EN+LL 
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193

Query: 180 ADGHIKIADFGSVK-PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-- 236
           ++GH+ + DFG  K  + D            ++A  F GT  Y+ P+++    +      
Sbjct: 194 SNGHVVLTDFGLSKEFVAD----------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243

Query: 237 DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 292
           D W+LG  +Y++L+G SPF    +  S+  I +RI+  +  +P   S  A+DLI RLL  
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 303

Query: 293 DPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           DP  R G GP     +K H FF+ I+W ++  +    P
Sbjct: 304 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  302 bits (777), Expect = e-102
 Identities = 105/289 (36%), Positives = 154/289 (53%), Gaps = 12/289 (4%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
            ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
             HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +++RDIK ENL+L  DGHIKI DFG  K             +      TF GT  Y
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----------EGISDGATMKTFCGTPEY 171

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           A+ L+  LL  DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  303 bits (778), Expect = e-101
 Identities = 101/319 (31%), Positives = 153/319 (47%), Gaps = 16/319 (5%)

Query: 26  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 85
           T      F     ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60

Query: 86  ENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 144
           ++      +E+ VL      P + +L   FQ    LY  +E   GG+L   I   G   E
Sbjct: 61  DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120

Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
             A FY AE+   L ++ S G+I+RD+K +N++L ++GHIKIADFG  K           
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------E 170

Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           N        TF GT  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +F
Sbjct: 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

Query: 265 QRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-- 322
           Q I+  ++ +P   S  A  +   L+   P  R G GP G   +K H FF+ IDW+ +  
Sbjct: 231 QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 290

Query: 323 RGQTP---PKLASEPMVNF 338
           +   P   PK       NF
Sbjct: 291 KEIQPPYKPKACGRNAENF 309

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  303 bits (779), Expect = e-101
 Identities = 106/313 (33%), Positives = 161/313 (51%), Gaps = 14/313 (4%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
           N++   P     +     +   H    DF   K+ G GS+ KV+ A+       YA+K++
Sbjct: 12  NANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL 71

Query: 79  DKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
            KK I K+ +  ++  ER VL + + HP +V L F+FQ    LY  L+   GGELF  + 
Sbjct: 72  QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ 131

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
            +    E  ARFY AE+  AL Y+HS+ +++RD+KPEN+LL + GHI + DFG  K    
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---- 187

Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
                  N   +    TF GT  Y+ PEVL+  P     D W LG  LY+ML G  PF  
Sbjct: 188 ------ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

Query: 258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
            +   ++  I+ + ++     +++AR L++ LL  D + R GA    +  +K H FF  I
Sbjct: 242 RNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA-KDDFMEIKSHVFFSLI 300

Query: 318 DWKNI--RGQTPP 328
           +W ++  +  TPP
Sbjct: 301 NWDDLINKKITPP 313

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  307 bits (789), Expect = e-101
 Identities = 86/299 (28%), Positives = 145/299 (48%), Gaps = 19/299 (6%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +      F   ++ G G + +V   +   TG +YA K ++KK + K        +E+ +
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEV 154
           L ++    +V L + F+    L + +    GG++   I +         E  A FYTA++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V  LE++H   +I+RD+KPEN+LL  DG+++I+D G                A   K   
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV----------ELKAGQTKTKG 348

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIAR 270
           + GT  ++ PE+L      F  D +ALG TLY+M++   PF+   E +    + QR++ +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408

Query: 271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
            + +P+ FS A++D  + LL  DP  R G   G    L+ HP F+ I W+ +  G   P
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTP 467

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  304 bits (780), Expect = e-101
 Identities = 107/313 (34%), Positives = 160/313 (51%), Gaps = 13/313 (4%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
           + S +  +       +   P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 181

Query: 79  DKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS 138
            K+ I  +++ A+   E  VL    HP +  L ++FQ    L   +E   GGELF  ++ 
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 139 KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
           +   SED ARFY AE+V AL+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K    
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---- 297

Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
                           TF GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +
Sbjct: 298 ------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

Query: 258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
                +F+ I+  +IRFP      A+ L+  LL  DP  R G G      +  H FF GI
Sbjct: 352 QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

Query: 318 DWKNI--RGQTPP 328
            W+++  +  +PP
Sbjct: 412 VWQHVYEKKLSPP 424

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  301 bits (774), Expect = e-100
 Identities = 83/298 (27%), Positives = 145/298 (48%), Gaps = 23/298 (7%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            E  +   FE+ +  G GS+ KV   +K DT  +YA+K M+K+   + N+   V  E  +
Sbjct: 9   NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +  L+HP +V L+++FQD   ++M ++   GG+L   +    H  E+  + +  E+V AL
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           +Y+ +  +IHRD+KP+N+LL   GH+ I DF     +             + +  T  GT
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-----------ETQITTMAGT 177

Query: 219 AAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDI 272
             Y+ PE+ +S      +F  D W+LG T Y++L G  P+     TS   I        +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +P+ +S     L+ +LL+ +P  R        + ++  P+   I+W  +  +   P 
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR----FSQLSDVQNFPYMNDINWDAVFQKRLIPG 291

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  298 bits (766), Expect = e-100
 Identities = 96/295 (32%), Positives = 153/295 (51%), Gaps = 14/295 (4%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
                 I +FE  ++ G GS+ KV+ A+  +TG +YA+K++ K  I +++       E+ 
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75

Query: 98  VLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
           +L    +HP + +LF  FQ    L+  +E   GG+L   I       E  ARFY AE++ 
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL ++H  G+I+RD+K +N+LL  +GH K+ADFG  K              +     TF 
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----------EGICNGVTTATFC 185

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+ PE+L         D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P 
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           +  + A  ++   +  +P+ R G+   GG   +  HPFFK IDW  +  R   PP
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  304 bits (781), Expect = 2e-99
 Identities = 91/296 (30%), Positives = 144/296 (48%), Gaps = 18/296 (6%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           +  +   F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDA 157
           ++++   VV L + ++   +L + L    GG+L   I   G     E  A FY AE+   
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE +H   +++RD+KPEN+LL   GHI+I+D G    + +                  VG
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-----------GQTIKGRVG 347

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIR 273
           T  Y+ PEV+ +   TF  D WALGC LY+M++G SPF+   + +    + + +      
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
           +   FS  AR L  +LL  DP+ R G   G    +K HP FK +++K +  G   P
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEP 463

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  307 bits (788), Expect = 4e-99
 Identities = 98/300 (32%), Positives = 151/300 (50%), Gaps = 24/300 (8%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
             H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 99  LDQL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           L  +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHAS 350

Query: 216 VGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIA 269
           VGT  Y+ PEVL          D ++LGC L+++L G SPF     KD  E  I +  + 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLT 408

Query: 270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
             +  P+ FS   R L++ LL  D + R G    G   +K  PFF+ +DW+ +   + PP
Sbjct: 409 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  293 bits (753), Expect = 5e-98
 Identities = 98/295 (33%), Positives = 148/295 (50%), Gaps = 17/295 (5%)

Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + Q    I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 97  IVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            VL    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K  TF
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNTF 178

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            GT  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +    A+DL+ +L   +P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPP 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  292 bits (751), Expect = 1e-97
 Identities = 102/303 (33%), Positives = 162/303 (53%), Gaps = 23/303 (7%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +   +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 99  LDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +Q  +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  A
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L Y+H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF G
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCG 172

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---------KDTSEWLIFQRII 268
           T  Y+ PE+L      F  D WALG  +++M++G SPF            +E  +FQ I+
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQ 325
            + IR P   S  A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  +  
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 292

Query: 326 TPP 328
            PP
Sbjct: 293 VPP 295

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  302 bits (774), Expect = 3e-97
 Identities = 99/316 (31%), Positives = 152/316 (48%), Gaps = 13/316 (4%)

Query: 16  GNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYAL 75
           G    +    T      F     ++   + DF    + G GS+ KV+ +++  T  +YA+
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAV 371

Query: 76  KIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFD 134
           KI+ K  + +++      +E+ VL      P + +L   FQ    LY  +E   GG+L  
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 431

Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
            I   G   E  A FY AE+   L ++ S G+I+RD+K +N++L ++GHIKIADFG  K 
Sbjct: 432 HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK- 490

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
                     N        TF GT  Y+ PE++   P     D WA G  LY+ML+G +P
Sbjct: 491 ---------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

Query: 255 FKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           F+   E  +FQ I+  ++ +P   S  A  +   L+   P  R G GP G   +K H FF
Sbjct: 542 FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

Query: 315 KGIDWKNI--RGQTPP 328
           + IDW+ +  +   PP
Sbjct: 602 RYIDWEKLERKEIQPP 617

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  292 bits (750), Expect = 7e-97
 Identities = 101/304 (33%), Positives = 161/304 (52%), Gaps = 23/304 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
                 +QDF+L ++ G GSY+KV+  +   T  +YA++++ K+ +  +    +V+ E+ 
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104

Query: 98  VLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
           V +Q  +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y+H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF 
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFC 214

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---------KDTSEWLIFQRI 267
           GT  Y+ PE+L      F  D WALG  +++M++G SPF            +E  +FQ I
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

Query: 268 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RG 324
           + + IR P   S  A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  + 
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ 334

Query: 325 QTPP 328
             PP
Sbjct: 335 VVPP 338

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  274 bits (703), Expect = 2e-91
 Identities = 90/275 (32%), Positives = 147/275 (53%), Gaps = 18/275 (6%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            I+DF++G + G GS++ V RA+ I TG   A+K++DKK + K      V+ E  +  QL
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
            HP ++ L+  F+D+  +Y+ LE C  GE+   + ++    SE+EAR +  +++  + Y+
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           HS G++HRD+   NLLLT + +IKIADFG + +                +K  T  GT  
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-----------HEKHYTLCGTPN 177

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD 280
           Y+ PE+   S     +D+W+LGC  Y +L G  PF   +      +++  D   P++ S 
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            A+DLI +LL  +P+ R        + +  HPF  
Sbjct: 238 EAKDLIHQLLRRNPADRLSL-----SSVLDHPFMS 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  272 bits (698), Expect = 2e-90
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 24/289 (8%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S + +  G+  G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L
Sbjct: 13  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            H  VV     F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
              +IHRD+K  NL L  D  +KI DFG + K   D            ++     GT  Y
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----------GERKKVLCGTPNY 181

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEVL+    +F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +  
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
           A  LI ++L  DP+ RP         L    FF         G  P +L
Sbjct: 242 AASLIQKMLQTDPTARPTI-----NELLNDEFFT-------SGYIPARL 278

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  272 bits (698), Expect = 6e-90
 Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 24/296 (8%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
               +  S + +  G+  G G ++K       DT  V+A KI+ K  + K ++   + +E
Sbjct: 32  EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             +   L H  VV     F+D   +++ LE C    L +    +  L+E EAR+Y  ++V
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACT 214
              +Y+H   +IHRD+K  NL L  D  +KI DFG + K   D            ++   
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----------GERKKV 200

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
             GT  Y+ PEVL+    +F  D+W++GC +Y +L G  PF+ +     + RI   +   
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
           P + +  A  LI ++L  DP+ RP         L    FF         G  P +L
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTI-----NELLNDEFFT-------SGYIPARL 304

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  262 bits (672), Expect = 2e-86
 Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 36/295 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE   + G G++ +VV+A+       YA+K +       E K + +  E ++L  L+H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNH 61

Query: 105 PGVVRLFFTFQDTFS-------------LYMALESCEGGELFDQITSKG-HLSEDEARFY 150
             VVR +  + +  +             L++ +E CE G L+D I S+  +   DE    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS----RITVLPNA 206
             ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S    ++      
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIF 264
            S D   + +GTA YV  EVL+ +   +    D+++LG   ++M+             I 
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238

Query: 265 QRIIARDIRFPNYF----SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +++ +  I FP  F        + +I  L+D DP+ RPGA       L    +  
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLP 288

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  262 bits (672), Expect = 3e-86
 Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 24/311 (7%)

Query: 8   FDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI 67
           F S  +++    S     +          +  E F  Q F+     G GSY +V + +  
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC 127
           + G +YA+K     F   +++   +           HP  VRL   +++   LY+  E C
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 128 EGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            G  L     + G  L E +   Y  + + AL ++HS GL+H D+KP N+ L   G  K+
Sbjct: 140 -GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198

Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG +  +            +        G   Y+ PE+L         D+++LG T+ 
Sbjct: 199 GDFGLLVEL-----------GTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTIL 246

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGG 304
           ++            W   Q++    +   F    S   R ++  +L+ DP  R  A    
Sbjct: 247 EVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATA---- 299

Query: 305 YAVLKMHPFFK 315
              L   P  +
Sbjct: 300 -EALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  263 bits (673), Expect = 5e-86
 Identities = 64/350 (18%), Positives = 126/350 (36%), Gaps = 70/350 (20%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
           ++ +N   + +         ++   I D+ + +    G ++K++  +K      YALK  
Sbjct: 11  SNYSNLIYLNKYVK------EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKY 62

Query: 79  DKKFITKENKTAY--------------VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL 124
           +K  + K+                    K E  ++  + +   +       +   +Y+  
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122

Query: 125 ESCEGGELFDQITSKGHL--------SEDEARFYTAEVVDALEYIHS-MGLIHRDIKPEN 175
           E  E   +         L             +     V+++  YIH+   + HRD+KP N
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182

Query: 176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           +L+  +G +K++DFG                  D K     GT  ++PPE  ++  +  G
Sbjct: 183 ILMDKNGRVKLSDFG------------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230

Query: 236 N--DLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFP----------------- 275
              D+W+LG  LY M     PF    S   +F  I  ++I +P                 
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290

Query: 276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
             N+ S+   D +   L  +P+ R  +          H +    + +++R
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHEWLADTNIEDLR 335

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  253 bits (649), Expect = 4e-83
 Identities = 83/279 (29%), Positives = 139/279 (49%), Gaps = 24/279 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            ++++ +  G G++S V R     TG  +A KI++ K ++  +    ++ E  +  +L H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQH 64

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HR++KPENLLL +      +K+ADFG    + D            +    F GT  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-----------SEAWHGFAGTPGY 173

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 278
           + PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P   +  
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233

Query: 279 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            +  A+ LID +L V+P  R  A       LK  P+   
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITA----DQALK-VPWICN 267

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  252 bits (645), Expect = 1e-82
 Identities = 88/295 (29%), Positives = 145/295 (49%), Gaps = 30/295 (10%)

Query: 43  SIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIV 98
            ++D  E+G+  G G ++ V + ++  TG  YA K + K+ ++   +      ++ E  +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L ++ HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D +
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 159 EYIHSMGLIHRDIKPENLLLT----ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKAC 213
            Y+HS  + H D+KPEN++L      +  IK+ DFG + K    +               
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK------------ 169

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229

Query: 274 FP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 324
           F   YF   S+ A+D I RLL  DP  R          L+ H + K I  +N+RG
Sbjct: 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNVRG 279

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  251 bits (644), Expect = 3e-82
 Identities = 86/279 (30%), Positives = 142/279 (50%), Gaps = 27/279 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F   ++ G G++S+V   K+  TG ++ALK + K    +++    ++ E  VL ++ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKH 65

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             +V L   ++ T   Y+ ++   GGELFD+I  +G  +E +A     +V+ A++Y+H  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLL      +  I I DFG  K  Q+  ++            T  GT  Y
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS------------TACGTPGY 173

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 278
           V PEVL   P +   D W++G   Y +L G  PF + +E  +F++I      F   ++  
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233

Query: 279 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            S++A+D I  LL+ DP+ R          L  HP+  G
Sbjct: 234 ISESAKDFICHLLEKDPNERYTC----EKALS-HPWIDG 267

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  251 bits (643), Expect = 4e-82
 Identities = 81/296 (27%), Positives = 140/296 (47%), Gaps = 33/296 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI------V 98
           +++E  +I G G  S V R     T   YA+KI+D       +     +L         +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 99  LDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L ++  HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K     G
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------GEKLREVCG 185

Query: 218 TAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           T +Y+ PE++  S            D+W+ G  +Y +L+G+ PF    + L+ + I++ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
            +F     + +SD  +DL+ R L V P  R  A       L  HPFF+    + +R
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA----EEALA-HPFFQQYVVEEVR 296

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  249 bits (639), Expect = 1e-80
 Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 26/304 (8%)

Query: 20  SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD 79
           S T    + R   F        FS  ++++ +  G G++S V R     TG  +A KI++
Sbjct: 6   SMTGGQQMGRGSEFMMN-ASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK 139
            K ++  +    ++ E  +  +L HP +VRL  + Q+    Y+  +   GGELF+ I ++
Sbjct: 64  TKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQ 196
              SE +A     ++++++ Y HS G++HR++KPENLLL +      +K+ADFG    + 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           D            +    F GT  Y+ PEVL   P +   D+WA G  LY +L G  PF 
Sbjct: 183 D-----------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231

Query: 257 DTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
           D  +  ++ +I A    +P   +   +  A+ LID +L V+P  R  A       LK  P
Sbjct: 232 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA----DQALK-VP 286

Query: 313 FFKG 316
           +   
Sbjct: 287 WICN 290

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  248 bits (635), Expect = 1e-80
 Identities = 86/315 (27%), Positives = 144/315 (45%), Gaps = 30/315 (9%)

Query: 43  SIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIV 98
           ++ D+ + G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L ++ HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 159 EYIHSMGLIHRDIKPENLLLT----ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKAC 213
            Y+HS+ + H D+KPEN++L         IKI DFG + K    +               
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK------------ 175

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235

Query: 274 FP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK 329
           F   YF   S  A+D I RLL  DP  R          L+ HP+ K  D +    +    
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTI----QDSLQ-HPWIKPKDTQQALSRKASA 290

Query: 330 LASEPMVNFLLLIKL 344
           +  E    F    K 
Sbjct: 291 VNMEKFKKFAARKKS 305

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  247 bits (634), Expect = 2e-80
 Identities = 78/312 (25%), Positives = 139/312 (44%), Gaps = 29/312 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIVLDQ 101
             +++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + Y+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 162 HSMGLIHRDIKPENLLLTA----DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 216
           H+  + H D+KPEN++L        HIK+ DFG + +                       
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK------------NIF 179

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP- 275
           GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I +    F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239

Query: 276 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
            +F   S+ A+D I +LL  +   R          L+ HP+   +D +    +    +  
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITPVDNQQAMVRRESVVNL 294

Query: 333 EPMVNFLLLIKL 344
           E      +  + 
Sbjct: 295 ENFRKQYVRRRW 306

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  246 bits (631), Expect = 2e-80
 Identities = 90/282 (31%), Positives = 146/282 (51%), Gaps = 31/282 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + +  + G GS+ +V++ K   T   YA+K+++K     ++ +  +  E  +L +LDH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +++LF   +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            ++HRD+KPEN+LL +   D  IKI DFG S    Q++++               +GTA 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK------------DRIGTAY 188

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--- 275
           Y+ PEVL  +   +    D+W+ G  LY +LSGT PF   +E+ I +R+      F    
Sbjct: 189 YIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
               SD A+DLI ++L   PS R  A       L+ HP+ + 
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQK 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  247 bits (633), Expect = 3e-80
 Identities = 94/326 (28%), Positives = 146/326 (44%), Gaps = 37/326 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 99
            ++ + K  G G+  +V  A +  T    A+KI+ K+     +         +     +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            +L+HP ++++   F      Y+ LE  EGGELFD++     L E   + Y  +++ A++
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 160 YIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + +                T  
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----------TSLMRTLC 177

Query: 217 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 272
           GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +  ++  +  +I +   
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237

Query: 273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
            F        S+ A DL+ +LL VDP  R          L+ HP+ +  D K    +   
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTT----EEALR-HPWLQDEDMK----RKFQ 288

Query: 329 KLASEPMVNFLLLIKLLSVVKSNLLP 354
            L SE   +  L   L     S   P
Sbjct: 289 DLLSEENESTALPQVLAQPSTSRKRP 314

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  248 bits (635), Expect = 4e-80
 Identities = 83/287 (28%), Positives = 136/287 (47%), Gaps = 32/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 99
           Q ++   + G G  S V R     TG  +A+KIM+        +      E       +L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 100 DQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
            Q+  HP ++ L  +++ +  +++  +    GELFD +T K  LSE E R     +++A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            ++H+  ++HRD+KPEN+LL  +  I+++DFG    ++             +K     GT
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-----------GEKLRELCGT 262

Query: 219 AAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
             Y+ PE+L  S            DLWA G  L+ +L+G+ PF    + L+ + I+    
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322

Query: 273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +F     +  S   +DLI RLL VDP  R  A       L+ HPFF+
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA----EQALQ-HPFFE 364

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  248 bits (634), Expect = 5e-80
 Identities = 79/312 (25%), Positives = 140/312 (44%), Gaps = 29/312 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQ 101
             +++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + Y+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 162 HSMGLIHRDIKPENLLLTA----DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 216
           H+  + H D+KPEN++L        HIK+ DFG + +                       
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK------------NIF 179

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP- 275
           GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A    F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239

Query: 276 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
            +F   S+ A+D I +LL  +   R          L+ HP+   +D +    +    +  
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITPVDTQQAMVRRESVVNL 294

Query: 333 EPMVNFLLLIKL 344
           E      +  + 
Sbjct: 295 ENFKKQYVRRRW 306

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  244 bits (626), Expect = 8e-80
 Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 31/281 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 65

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            + HRD+KPEN L      D  +K+ DFG     +                 T VGT  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-----------GKMMRTKVGTPYY 174

Query: 222 VPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 275
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP    
Sbjct: 175 VSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              S  A  LI RLL   P  R  +       L+ H +F+ 
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWFEK 267

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  245 bits (628), Expect = 1e-79
 Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 33/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L  
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 85

Query: 105 P--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
               ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  IH
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VGT  Y+
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGTVNYM 195

Query: 223 PPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR 270
           PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II  
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255

Query: 271 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 297

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  248 bits (635), Expect = 2e-79
 Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 33/293 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 99
            ++ + K  G G+  +V  A +  T    A++I+ K+     +         +     +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            +L+HP ++++   F      Y+ LE  EGGELFD++     L E   + Y  +++ A++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 160 YIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T  
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TLC 302

Query: 217 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 272
           GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +  ++  +  +I +   
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362

Query: 273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 321
            F        S+ A DL+ +LL VDP  R          L+ HP+ +  D K 
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTT----EEALR-HPWLQDEDMKR 410

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  243 bits (623), Expect = 2e-78
 Identities = 77/295 (26%), Positives = 146/295 (49%), Gaps = 23/295 (7%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S++ +   +  G GS+ K +  K  + G  Y +K ++   ++ + +    + E  VL  +
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR-EVAVLANM 80

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEY 160
            HP +V+   +F++  SLY+ ++ CEGG+LF +I +       ED+   +  ++  AL++
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H   ++HRDIK +N+ LT DG +++ DFG  + +           ++ + A   +GT  
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN----------STVELARACIGTPY 190

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFS 279
           Y+ PE+  + P    +D+WALGC LY++ +    F+  S   +  +II+        ++S
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
              R L+ +L   +P  RP       ++L+   F      K I     P+L +E 
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVN----SILE-KGFIA----KRIEKFLSPQLIAEE 296

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  243 bits (621), Expect = 2e-78
 Identities = 82/337 (24%), Positives = 134/337 (39%), Gaps = 62/337 (18%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 88
           R   +           + + L    G GSY  V  A +  T  + A+KIM+K  I + N 
Sbjct: 11  RENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69

Query: 89  TAYVKLER--IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----- 141
               +++    ++ +L HP + RL+  ++D   + + +E C GG L D++          
Sbjct: 70  KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 142 -----------------------------------LSEDEARFYTAEVVDALEYIHSMGL 166
                                                E        ++  AL Y+H+ G+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189

Query: 167 IHRDIKPENLLLTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            HRDIKPEN L + +    IK+ DFG       S+     N        T  GT  +V P
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGL------SKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 278
           EVLN++  ++G   D W+ G  L+ +L G  PF   ++     +++ + + F     N  
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           S  ARDL+  LL+ +   R  A       L+ HP+  
Sbjct: 304 SPLARDLLSNLLNRNVDERFDA----MRALQ-HPWIS 335

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  243 bits (621), Expect = 3e-78
 Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 33/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 66

Query: 105 P--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
               ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  IH
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VGT  Y+
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGTVNYM 176

Query: 223 PPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR 270
           PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 271 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 278

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  242 bits (619), Expect = 5e-78
 Identities = 79/306 (25%), Positives = 134/306 (43%), Gaps = 33/306 (10%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
              + +   ELG+    G ++ V +     TG  YA K + K+   ++ +   +  E  V
Sbjct: 27  NNFYILTSKELGR----GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAV 81

Query: 99  LDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 155
           L+     P V+ L   +++T  + + LE   GGE+F     +    +SE++      +++
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 156 DALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFG-SVKPMQDSRITVLPNAASDDK 211
           + + Y+H   ++H D+KP+N+LL      G IKI DFG S K      +           
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---------- 191

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
               +GT  Y+ PE+LN  P T   D+W +G   Y +L+ TSPF        +  I   +
Sbjct: 192 --EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249

Query: 272 IRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP 327
           + +    F   S  A D I  LL  +P  RP A       L  H + +  D++N+     
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA----EICLS-HSWLQQWDFENLFHPEE 304

Query: 328 PKLASE 333
              +S+
Sbjct: 305 TSSSSQ 310

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  246 bits (630), Expect = 6e-78
 Identities = 99/325 (30%), Positives = 154/325 (47%), Gaps = 35/325 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + +  + G GS+ +V++ K   T   YA+K+++K     ++ +  +  E  +L +LDH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +++LF   +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++HRD+KPEN+LL     D  IKI DFG     Q            + K    +GTA Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-----------NTKMKDRIGTAYY 189

Query: 222 VPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 275
           + PEVL  +   +    D+W+ G  LY +LSGT PF   +E+ I +R+      F     
Sbjct: 190 IAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS--E 333
              SD A+DLI ++L   PS R  A       L+ HP+ +    +       P L S   
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQKYSSETPTISDLPSLESAMT 301

Query: 334 PMVNFLLLIKL----LSVVKSNLLP 354
            +  F    KL    L  + S L  
Sbjct: 302 NIRQFQAEKKLAQAALLYMASKLTT 326

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  245 bits (627), Expect = 7e-78
 Identities = 86/279 (30%), Positives = 141/279 (50%), Gaps = 23/279 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++++L +  G G++S V R  K+  G  YA  I++ K ++  +    ++ E  +   L H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKH 69

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HR++KPENLLL        +K+ADFG    ++                  F GT  Y
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFGFAGTPGY 179

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 277
           + PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP    + 
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            +  A+DLI+++L ++PS R  A       LK HP+   
Sbjct: 240 VTPEAKDLINKMLTINPSKRITA----AEALK-HPWISH 273

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  241 bits (617), Expect = 8e-78
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 30/287 (10%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           +    + + + +  G G +  V R  +  +   Y  K +  K   +      VK E  +L
Sbjct: 1   KELY-EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISIL 55

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDAL 158
           +   H  ++ L  +F+    L M  E   G ++F++I +    L+E E   Y  +V +AL
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 159 EYIHSMGLIHRDIKPENLLLTA--DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTF 215
           +++HS  + H DI+PEN++        IKI +FG + +        +L            
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL------------ 163

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
                Y  PEV      +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F 
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223

Query: 276 -NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
              F   S  A D +DRLL  +   R  A       L+ HP+ K   
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTA----SEALQ-HPWLKQKI 265

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  246 bits (629), Expect = 1e-77
 Identities = 99/353 (28%), Positives = 163/353 (46%), Gaps = 36/353 (10%)

Query: 17  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
              +      +Q +      + + H S + ++  K  G G+Y +V+  +   T    A+K
Sbjct: 10  GRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68

Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
           I+ K  ++  + +  +  E  VL  LDHP +++L+  F+D  + Y+ +E  +GGELFD+I
Sbjct: 69  IIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVK 193
             +   +E +A     +V+  + Y+H   ++HRD+KPENLLL     D  IKI DFG   
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSG 251
             ++             K    +GTA Y+ PEVL      +    D+W++G  L+ +L+G
Sbjct: 188 VFEN-----------QKKMKERLGTAYYIAPEVLRKK---YDEKCDVWSIGVILFILLAG 233

Query: 252 TSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
             PF   ++  I +++      F        S+ A+DLI ++L  D   R  A       
Sbjct: 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA----QQA 289

Query: 308 LKMHPFFKGIDWKNIRGQTPPKLAS--EPMVNFLLLIKL----LSVVKSNLLP 354
           L+ HP+ K +  K   G   P LA+  E M  F    KL    L  + S L  
Sbjct: 290 LE-HPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTS 341

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  241 bits (617), Expect = 1e-77
 Identities = 92/310 (29%), Positives = 147/310 (47%), Gaps = 32/310 (10%)

Query: 17  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYAL 75
           ++ +++  P         +       ++ DF E+    G G+ S V R K+  T   YAL
Sbjct: 24  SSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYAL 83

Query: 76  KIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ 135
           K++ K           V+ E  VL +L HP +++L   F+    + + LE   GGELFD+
Sbjct: 84  KVLKKT-----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138

Query: 136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFG-S 191
           I  KG+ SE +A     ++++A+ Y+H  G++HRD+KPENLL      D  +KIADFG S
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
                   +             T  GT  Y  PE+L         D+W++G   Y +L G
Sbjct: 199 KIVEHQVLMK------------TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

Query: 252 TSPFKD-TSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYA 306
             PF D   +  +F+RI+  +  F   ++   S  A+DL+ +L+ +DP  R       + 
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT----FQ 302

Query: 307 VLKMHPFFKG 316
            L+ HP+  G
Sbjct: 303 ALQ-HPWVTG 311

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  245 bits (627), Expect = 2e-77
 Identities = 92/321 (28%), Positives = 154/321 (47%), Gaps = 32/321 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             ++  ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +++L+  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++HRD+KPENLLL +   D +I+I DFG     +              K    +GTA Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-----------SKKMKDKIGTAYY 194

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 277
           + PEVL+ +      D+W+ G  LY +LSG  PF   +E+ I +++      F       
Sbjct: 195 IAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVN 337
            S++A+DLI ++L   PS R  A       L  H       W  I+  T  +++ +    
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISA----RDALD-HE------W--IQTYTKEQISVDVPSL 300

Query: 338 FLLLIKLLSVVKSNLLPCLAL 358
              ++ +     +  L   AL
Sbjct: 301 DNAILNIRQFQGTQKLAQAAL 321

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  241 bits (616), Expect = 2e-77
 Identities = 88/308 (28%), Positives = 138/308 (44%), Gaps = 30/308 (9%)

Query: 25  PTVQRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI 83
           P +            +    +D +EL ++ G G +S V R    +TG  +A+KI+D    
Sbjct: 3   PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKF 62

Query: 84  TKENKTAYVKLER--IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH 141
           T     +   L+R   +   L HP +V L  T+     LYM  E  +G +L  +I  +  
Sbjct: 63  TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 142 ----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKP 194
                SE  A  Y  ++++AL Y H   +IHRD+KP  +LL +      +K+  FG    
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           + +          S   A   VGT  ++ PEV+   P     D+W  G  L+ +LSG  P
Sbjct: 183 LGE----------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

Query: 255 FKDTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
           F  T E  +F+ II    +     +   S++A+DL+ R+L +DP+ R       Y  L  
Sbjct: 233 FYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITV----YEALN- 286

Query: 311 HPFFKGID 318
           HP+ K  D
Sbjct: 287 HPWLKERD 294

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  242 bits (619), Expect = 2e-77
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 33/288 (11%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112

Query: 104 HP--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
                ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  I
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VG   Y
Sbjct: 172 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGAVNY 222

Query: 222 VPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA 269
           +PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II 
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282

Query: 270 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 325

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  238 bits (610), Expect = 2e-77
 Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 33/283 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             F   +  G G++  V   ++  +G    +K ++K       +   ++ E  VL  LDH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ--IEAEIEVLKSLDH 79

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEY 160
           P ++++F  F+D  ++Y+ +E+CEGGEL ++I S       LSE        ++++AL Y
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 161 IHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            HS  ++H+D+KPEN+L         IKI DFG  +  +            D+ +    G
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-----------DEHSTNAAG 188

Query: 218 TAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
           TA Y+ PEV     +      D+W+ G  +Y +L+G  PF  TS   + Q+   ++  + 
Sbjct: 189 TALYMAPEVFKRDVTFKC---DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245

Query: 276 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 +  A DL+ ++L  DP  RP A      VL  H +FK
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSA----AQVLH-HEWFK 283

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  238 bits (610), Expect = 2e-76
 Identities = 92/286 (32%), Positives = 134/286 (46%), Gaps = 34/286 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLD 103
             +E+ +  GVGSYS   R     T   +A+KI+DK    K +       E  I+L    
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRD----PTEEIEILLRYGQ 74

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 164 MGLIHRDIKPENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            G++HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTA 184

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFP- 275
            +V PEVL         D+W+LG  LY ML+G +PF    D +   I  RI +       
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
              N  SD A+DL+ ++L VDP  R  A      VL+ HP+    D
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTA----ALVLR-HPWIVHWD 285

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  239 bits (612), Expect = 2e-76
 Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 28/280 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +++ +  G G++  V R  +  TG V+  K ++       +K   VK E  +++QL H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYT-VKNEISIMNQLHH 107

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS 163
           P ++ L   F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 164 MGLIHRDIKPENLLLTA--DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
             ++H DIKPEN++        +KI DFG + K   D  + V               TA 
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT------------TATAE 215

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF- 278
           +  PE+++  P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F  + F 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275

Query: 279 --SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
             S  A+D I  LL  +P  R       +  L+ HP+ KG
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTV----HDALE-HPWLKG 310

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  235 bits (602), Expect = 3e-76
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 45/289 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DF+  ++ G G + +V +AK    G  Y +K +       E      + E   L +LDH
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEK----AEREVKALAKLDH 63

Query: 105 PGVVRLFFTFQDTFS----------------LYMALESCEGGELFDQI--TSKGHLSEDE 146
             +V     +                     L++ +E C+ G L   I       L +  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
           A     ++   ++YIHS  LI+RD+KP N+ L     +KI DFG V  ++          
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---------- 173

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +D K     GT  Y+ PE ++S       DL+ALG  L ++L       +TS+   F  
Sbjct: 174 -NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230

Query: 267 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +  RD    + F    + L+ +LL   P  RP        +L+      
Sbjct: 231 L--RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT----SEILR-TLTVW 272

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  235 bits (602), Expect = 7e-76
 Identities = 95/305 (31%), Positives = 142/305 (46%), Gaps = 52/305 (17%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------------ 91
           +  + L    G GSY  V  A   +  T YA+K++ KK + ++                 
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 92  -----------VKLERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITS 138
                      V  E  +L +LDHP VV+L       +   LYM  E    G + + + +
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 198
              LSED+ARFY  +++  +EY+H   +IHRDIKP NLL+  DGHIKIADFG     +  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189

Query: 199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPF 255
                    SD      VGT A++ PE L+ +   F     D+WA+G TLY  + G  PF
Sbjct: 190 ---------SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 256 KDTSEWLIFQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGR---PGAGPGGYAVLKM 310
            D     +  +I ++ + FP+    ++  +DLI R+LD +P  R   P         +K+
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE--------IKL 292

Query: 311 HPFFK 315
           HP+  
Sbjct: 293 HPWVT 297

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  236 bits (604), Expect = 8e-76
 Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 35/297 (11%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 88
           ++      A  E    Q +      G G++  V  A   +      +K + K+ + ++  
Sbjct: 8   KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67

Query: 89  TAYVKLERI-----VLDQLDHPGVVRLFFTFQDTFSLYMALES-CEGGELFDQITSKGHL 142
               KL ++     +L +++H  ++++   F++     + +E    G +LF  I     L
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
            E  A +   ++V A+ Y+    +IHRDIK EN+++  D  IK+ DFGS   ++      
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER----- 182

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
                      TF GT  Y  PEVL       P     ++W+LG TLY ++   +PF + 
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL---EMWSLGVTLYTLVFEENPFCE- 232

Query: 259 SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 +  +   I  P   S     L+  LL   P  R          L   P+  
Sbjct: 233 -----LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRT-----TLEKLVTDPWVT 279

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  241 bits (617), Expect = 1e-75
 Identities = 88/358 (24%), Positives = 145/358 (40%), Gaps = 40/358 (11%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
              +     +  +     R  +     + +   +  G G+Y +V+  K+ +  +  A+K+
Sbjct: 10  GRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 78  MDKKFITKENKTAY----------VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC 127
           + K    K   +            +  E  +L  LDHP +++LF  F+D    Y+  E  
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128

Query: 128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHI 184
           EGGELF+QI ++    E +A     +++  + Y+H   ++HRDIKPEN+LL    +  +I
Sbjct: 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188

Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 244
           KI DFG                  D K    +GTA Y+ PEVL         D+W+ G  
Sbjct: 189 KIVDFGLSSFFSK-----------DYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVI 236

Query: 245 LYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGA 300
           +Y +L G  PF   ++  I +++      F        SD A++LI  +L  D + R  A
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTP-PKLASEPMVNFLLLIKL----LSVVKSNLL 353
                  L    + K       +        A   M  F    KL    +  + S L 
Sbjct: 297 ----EEALN-SRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLT 349

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  234 bits (600), Expect = 1e-74
 Identities = 80/302 (26%), Positives = 141/302 (46%), Gaps = 28/302 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
                +I G G + +V + ++  TG   A KI+  +    ++K   VK E  V++QLDH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEE-VKNEISVMNQLDHA 146

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            +++L+  F+    + + +E  +GGELFD+I  + + L+E +   +  ++ + + ++H M
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 165 GLIHRDIKPENLLLT--ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++H D+KPEN+L        IKI DFG + +     ++ V              GT  +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN------------FGTPEF 254

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 278
           + PEV+N    +F  D+W++G   Y +LSG SPF   ++      I+A         F  
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314

Query: 279 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVN 337
            S+ A++ I +LL  + S R  A       LK HP+       +       K       +
Sbjct: 315 ISEEAKEFISKLLIKEKSWRISA----SEALK-HPWLSDHKLHSRLSAQKKKNRGSDAQD 369

Query: 338 FL 339
           F+
Sbjct: 370 FV 371

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  231 bits (591), Expect = 4e-74
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 21/279 (7%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQL 102
           I  + +G + G GSY KV      +T    A+KI+ KK + +  N  A VK E  +L +L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 103 DHPGVVRLF--FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDAL 158
            H  V++L      ++   +YM +E C  G  E+ D +  +      +A  Y  +++D L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGL 122

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS G++H+DIKP NLLLT  G +KI+  G  + +            +DD   T  G+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA--------ADDTCRTSQGS 174

Query: 219 AAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            A+ PPE+ N      G   D+W+ G TLY + +G  PF+  + + +F+ I       P 
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                  DL+  +L+ +P+ R          ++ H +F+
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKR-----FSIRQIRQHSWFR 268

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  233 bits (596), Expect = 4e-74
 Identities = 51/329 (15%), Positives = 95/329 (28%), Gaps = 72/329 (21%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--- 102
               G + G       + A   +TG  + + +         N    +K E + L  L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 103 ----------------------DHPGVVRLFFTFQDT-----FSLYMALESC---EGGEL 132
                                     ++R+    +D      F LY  ++S     G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
               ++   L        T +V+  L  +H  GL+H  ++P +++L   G + +  F  +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWAL 241
                                    +  + PPE+              +  TF  D WAL
Sbjct: 254 VRDGARV--------------VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299

Query: 242 GCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
           G  +Y +     P    +     + I     R         R L++  L      R    
Sbjct: 300 GLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 302 PGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                 ++  P +     + +R +    L
Sbjct: 356 ----QAME-TPEY-----EQLRTELSAAL 374

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  229 bits (587), Expect = 6e-74
 Identities = 88/277 (31%), Positives = 134/277 (48%), Gaps = 25/277 (9%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAYV 222
             ++HRD+KPEN+LL A  + KIADFG            L N  SD +   T  G+  Y 
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFG------------LSNMMSDGEFLRTSCGSPNYA 177

Query: 223 PPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
            PEV++    + P     D+W+ G  LY +L GT PF D     +F++I       P Y 
Sbjct: 178 APEVISGRLYAGPEV---DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           + +   L+  +L VDP  R          ++ H +FK
Sbjct: 235 NRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  229 bits (586), Expect = 7e-74
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 28/284 (9%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK 63

Query: 104 HPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDA 157
           HP +VR +    D  +  LY+ +E CEGG+L   IT     + +L E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 158 LEYIHSMGL-----IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           L+  H         +HRD+KP N+ L    ++K+ DFG  + +                A
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------HDTSFA 173

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
            TFVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+  +  +I     
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233

Query: 273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            R P  +SD   ++I R+L++    RP        +L+ +P   
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSV----EEILE-NPLIL 272

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  229 bits (587), Expect = 2e-73
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 34/292 (11%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
             S   P      +      ++      +++G + G G +  V    ++      A+K +
Sbjct: 17  RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76

Query: 79  DKKFITKENKTAY---VKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALESCEG-GEL 132
           +K  I+   +      V +E ++L ++     GV+RL   F+   S  + LE  E   +L
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS 191
           FD IT +G L E+ AR +  +V++A+ + H+ G++HRDIK EN+L+  + G +K+ DFGS
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLY 246
              ++D+  T             F GT  Y PPE +         A     +W+LG  LY
Sbjct: 197 GALLKDTVYT------------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLY 240

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            M+ G  PF+        + II   + F    S   + LI   L + PS RP
Sbjct: 241 DMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  229 bits (586), Expect = 3e-73
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 40/301 (13%)

Query: 45  QDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL- 102
             ++L + + G G++++V     + T   YA+KI++K+     ++   V  E  +L Q  
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR---VFREVEMLYQCQ 68

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            H  V+ L   F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 163 SMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           + G+ HRD+KPEN+L         +KI DF     ++ +      +  S  +  T  G+A
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC---SPISTPELLTPCGSA 185

Query: 220 AYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPF---------------KDTS 259
            Y+ PEV+ +            DLW+LG  LY +LSG  PF                   
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 260 EWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           + ++F+ I      FP     + S AA+DLI +LL  D   R  A      VL+ HP+ +
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA----AQVLQ-HPWVQ 300

Query: 316 G 316
           G
Sbjct: 301 G 301

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  229 bits (586), Expect = 3e-73
 Identities = 91/318 (28%), Positives = 136/318 (42%), Gaps = 42/318 (13%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV 107
             K  G GS+S   +     +   +A+KI+ K+        A  + E   L   + HP +
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNI 68

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V+L   F D    ++ +E   GGELF++I  K H SE EA +   ++V A+ ++H +G++
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128

Query: 168 HRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           HRD+KPENLL T    +  IKI DFG  +               +    T   T  Y  P
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLHYAAP 178

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-------IFQRIIARDIRFP-- 275
           E+LN +      DLW+LG  LY MLSG  PF+     L       I ++I   D  F   
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASE 333
                S  A+DLI  LL VDP+ R         +   + + +         Q        
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKM----SGLRY-NEWLQD------GSQLSSNPLMT 287

Query: 334 PMVNFLLLIKLLSVVKSN 351
           P +       + + VK+ 
Sbjct: 288 PDILGSSGAAVHTCVKAT 305

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  228 bits (584), Expect = 5e-73
 Identities = 83/292 (28%), Positives = 124/292 (42%), Gaps = 36/292 (12%)

Query: 21  STNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK 80
               P    + +             ++ LG + G G +  V    ++      A+K++ +
Sbjct: 7   LQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR 66

Query: 81  KFITKENKTAY---VKLE----RIVLDQLDHPGVVRLFFTFQDTFSLYMALE-SCEGGEL 132
             +   +  +      LE      V     HPGV+RL   F+      + LE      +L
Sbjct: 67  NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS 191
           FD IT KG L E  +R +  +VV A+++ HS G++HRDIK EN+L+    G  K+ DFGS
Sbjct: 127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLY 246
              + D   T             F GT  Y PPE ++       PA     +W+LG  LY
Sbjct: 187 GALLHDEPYT------------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLY 230

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            M+ G  PF+        Q I+  ++ FP + S     LI R L   PS RP
Sbjct: 231 DMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP 276

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  236 bits (603), Expect = 5e-73
 Identities = 86/353 (24%), Positives = 144/353 (40%), Gaps = 37/353 (10%)

Query: 5   EKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQD-----FELGKIYGVGSYS 59
             D D + +I     + ++         +    PQ      D     +++ +  G G++ 
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171

Query: 60  KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS 119
            V R  +  TG  +A K +       E+    V+ E   +  L HP +V L   F+D   
Sbjct: 172 VVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL 178
           + M  E   GGELF+++  +   +SEDEA  Y  +V   L ++H    +H D+KPEN++ 
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288

Query: 179 T--ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           T      +K+ DFG +        + V              GTA +  PEV    P  + 
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVT------------TGTAEFAAPEVAEGKPVGYY 336

Query: 236 NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLD 291
            D+W++G   Y +LSG SPF   ++    + + + D     + F   S+  +D I +LL 
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

Query: 292 VDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIKL 344
            DP+ R       +  L+ HP+    +      Q    + S         IK 
Sbjct: 397 ADPNTRMTI----HQALE-HPWLTPGNAPGRDSQ----IPSSRYTKIRDSIKT 440

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  228 bits (584), Expect = 7e-73
 Identities = 86/283 (30%), Positives = 135/283 (47%), Gaps = 24/283 (8%)

Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
              E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK  +   +    +  E 
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREV 65

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            ++  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V 
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++Y H   ++HRD+K ENLLL AD +IKIADFG                    K   F 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-----------GGKLDAFC 174

Query: 217 GTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           G   Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    
Sbjct: 175 GAPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R P Y S    +L+ R L ++P  R          +    +  
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRGTL-----EQIMKDRWIN 269

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  228 bits (583), Expect = 7e-73
 Identities = 79/294 (26%), Positives = 138/294 (46%), Gaps = 19/294 (6%)

Query: 16  GNNNSSTNCPTVQRSKSFAFRAPQEHFS-IQDFELGKIYGVGSYSKVVRAKKIDTGTVYA 74
              +     P V + +      P   ++ + +F + K  G G +S+V RA  +  G   A
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD 134
           LK +    +      A    E  +L QL+HP V++ + +F +   L + LE  + G+L  
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121

Query: 135 QI----TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
            I      K  + E     Y  ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181

Query: 191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
             +             +    A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +
Sbjct: 182 LGRFFS----------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

Query: 251 GTSPF--KDTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 300
             SPF     + + + ++I   D      +++S+  R L++  ++ DP  RP  
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  226 bits (578), Expect = 1e-72
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 63

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +G+ HRDIKPENLLL    ++KI+DFG +     ++R  +L             GT  YV
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---------KMCGTLPYV 174

Query: 223 PPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRFP- 275
            PE+L        P     D+W+ G  L  ML+G  P+   S+    +     +      
Sbjct: 175 APELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV--LKMHPFFK 315
                 A   L+ ++L  +PS R         +  +K   ++ 
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR-------ITIPDIKKDRWYN 266

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  227 bits (581), Expect = 2e-72
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 18/268 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + +   +  G G +S V   + +  G  YALK +      ++      + E  +    +H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNH 85

Query: 105 PGVVRLFFTFQD----TFSLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAEVVD 156
           P ++RL              ++ L   + G L+++I         L+ED+  +    +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            LE IH+ G  HRD+KP N+LL  +G   + D GS+       +     A +        
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQR 204

Query: 217 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDI 272
            T +Y  PE+ +       +   D+W+LGC LY M+ G  P+    +        +   +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 273 RFPNY--FSDAARDLIDRLLDVDPSGRP 298
             P     S A   L++ ++ VDP  RP
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRP 292

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  226 bits (578), Expect = 6e-72
 Identities = 81/306 (26%), Positives = 139/306 (45%), Gaps = 38/306 (12%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 63

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +G+ HRDIKPENLLL    ++KI+DFG +     ++R  +L             GT  YV
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---------KMCGTLPYV 174

Query: 223 PPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRFP- 275
            PE+L        P     D+W+ G  L  ML+G  P+   S+    +     +      
Sbjct: 175 APELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV--LKMHPFFKGIDWKNI-RGQTPPKLA 331
                 A   L+ ++L  +PS R         +  +K   ++     K + +G   P++ 
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR-------ITIPDIKKDRWYN----KPLKKGAKRPRVT 279

Query: 332 SEPMVN 337
           S  +  
Sbjct: 280 SGGVSE 285

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  226 bits (579), Expect = 2e-70
 Identities = 87/277 (31%), Positives = 134/277 (48%), Gaps = 25/277 (9%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   K   TG   A+KI++++ I   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+        ++M +E   GGELFD I   G L E E+R    +++  ++Y H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAYV 222
             ++HRD+KPEN+LL A  + KIADFG            L N  SD +   T  G+  Y 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFG------------LSNMMSDGEFLRTSCGSPNYA 182

Query: 223 PPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
            PEV++    + P     D+W+ G  LY +L GT PF D     +F++I       P Y 
Sbjct: 183 APEVISGRLYAGPEV---DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           + +   L+  +L VDP  R          ++ H +FK
Sbjct: 240 NPSVISLLKHMLQVDPMKR-----ATIKDIREHEWFK 271

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  221 bits (566), Expect = 4e-70
 Identities = 86/282 (30%), Positives = 134/282 (47%), Gaps = 24/282 (8%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
                 I  + + +  G GS+ KV  A    T    ALK + ++ + K +    V+ E  
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            L  L HP +++L+        + M +E   GGELFD I  K  ++EDE R +  +++ A
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +EY H   ++HRD+KPENLLL  + ++KIADFG    M D            +   T  G
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-----------GNFLKTSCG 169

Query: 218 TAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +  Y  PEV+N    + P     D+W+ G  LY ML G  PF D     +F+++ +    
Sbjct: 170 SPNYAAPEVINGKLYAGPEV---DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV 226

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            P++ S  A+ LI R++  DP  R          ++  P+F 
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQR-----ITIQEIRRDPWFN 263

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  222 bits (567), Expect = 7e-70
 Identities = 90/326 (27%), Positives = 138/326 (42%), Gaps = 36/326 (11%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
              ++  K  G G++      +   T  + A+K +++     EN    V+ E I    L 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLR 74

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VR          L + +E   GGEL+++I + G  SEDEARF+  +++  + Y HS
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 164 MGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           M + HRD+K EN LL       +KI DFG  K                 +  + VGT AY
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------HSQPKSTVGTPAY 183

Query: 222 VPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRIIARDIR 273
           + PEVL             D+W+ G TLY ML G  PF+D  E   +    QRI++    
Sbjct: 184 IAPEVLLRQEYDGKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240

Query: 274 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF-KGIDWKNIRGQTPPKL 330
            P+    S     LI R+   DP+ R          +K H +F K +    +        
Sbjct: 241 IPDDIRISPECCHLISRIFVADPATR-----ISIPEIKTHSWFLKNLPADLMNESNTGSQ 295

Query: 331 ASEPMVNFLLLIKLLSVVKSNLLPCL 356
             EP      L  ++ ++    +P +
Sbjct: 296 FQEPEQPMQSLDTIMQIISEATIPAV 321

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  216 bits (552), Expect = 3e-68
 Identities = 58/308 (18%), Positives = 116/308 (37%), Gaps = 59/308 (19%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +  S   + L  I G G+ + V R +   TG ++A+K+ +     +         E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEV 60

Query: 99  LDQLDHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSKGH---LSEDEARFYTAE 153
           L +L+H  +V+LF   ++T +    + +E C  G L+  +    +   L E E      +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           VV  + ++   G++HR+IKP N++           K+ DFG+ + ++D           D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------D 169

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN--------DLWALGCTLYQMLSGTSPFKDT--- 258
           ++  +  GT  Y+ P++   +     +        DLW++G T Y   +G+ PF+     
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 259 --------------------------SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 292
                                     +  + +   +                ++  +L+ 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 293 DPSGRPGA 300
           D     G 
Sbjct: 290 DQEKCWGF 297

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  215 bits (549), Expect = 5e-68
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 31/295 (10%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DFE  +  G G +  V  AK       YA+K +         +      E   L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV--MREVKALAKLE 61

Query: 104 HPGVVRLFFTFQD------------TFSLYMALESCEGGELFDQITSKGHLSEDEARF-- 149
           HPG+VR F  + +               LY+ ++ C    L D +  +  + E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 150 -YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ--DSRITVLPNA 206
               ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DFG V  M   +   TVL   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +  +    VGT  Y+ PE ++ +  +   D+++LG  L+++L    PF    E +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLT 238

Query: 267 IIARDIRFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
            + R+++FP            ++  +L   P  RP A       +  +  F+ +D
Sbjct: 239 DV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLD 287

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  216 bits (552), Expect = 5e-68
 Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 44/291 (15%)

Query: 45  QDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTAYVKLERIVLDQL 102
            D++L K + G+G   KV+      TG   ALK++       +E                
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE--------VDHHWQAS 79

Query: 103 DHPGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +V +   +++       L + +E  EGGELF +I  +G    +E EA     ++  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 157 ALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++++HS  + HRD+KPENLL T    D  +K+ DFG  K    + +             
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ------------ 187

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRIIA 269
           T   T  YV PEVL         D+W+LG  +Y +L G  PF   +       + +RI  
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247

Query: 270 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
               FPN      S+ A+ LI  LL  DP+ R          +  HP+   
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI----TQFMN-HPWINQ 293

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  218 bits (556), Expect = 9e-68
 Identities = 43/310 (13%), Positives = 82/310 (26%), Gaps = 56/310 (18%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---- 102
              G + G       + A   +TG  + + +         N    +K E + L  L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 103 ---------------------DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQIT 137
                                    ++R+    +D +                   + + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 138 SK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 193
           S       L        T +V+  L  +H  GL+H  ++P +++L   G + +  F  + 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-----TFGNDLWALGCTLYQM 248
               S ++                        +L          TF  D W LG  +Y +
Sbjct: 260 RDGASAVS---------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 249 LSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 308
                P  D +     + I       P       R L++  L      R           
Sbjct: 311 WCADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLP-----LQA 361

Query: 309 KMHPFFKGID 318
              P ++ + 
Sbjct: 362 METPEYEQLR 371

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  215 bits (548), Expect = 1e-66
 Identities = 58/308 (18%), Positives = 115/308 (37%), Gaps = 59/308 (19%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +  S   + L  I G G+ + V R +   TG ++A+K+ +     +         E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD--VQMREFEV 60

Query: 99  LDQLDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAE 153
           L +L+H  +V+LF   ++  T    + +E C  G L+  +    +   L E E      +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           VV  + ++   G++HR+IKP N++           K+ DFG+ + ++D           D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------D 169

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN--------DLWALGCTLYQMLSGTSPFKDT--- 258
           ++  +  GT  Y+ P++   +     +        DLW++G T Y   +G+ PF+     
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 259 --------------------------SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 292
                                     +  + +   +                ++  +L+ 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 293 DPSGRPGA 300
           D     G 
Sbjct: 290 DQEKCWGF 297

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  211 bits (539), Expect = 1e-66
 Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 19/287 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            +F   +  G G +  V +  K   G +YA+K   K      ++   ++          H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEY 160
             VVR F  + +   + +  E C GG L D I+       +  E E +    +V   L Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-----LPNAASDDKACTF 215
           IHSM L+H DIKP N+ ++       A     +    S   +     L +          
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 216 VGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R 273
            G + ++  EVL  +       D++AL  T+          ++  +W     I    + R
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQGRLPR 247

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK 320
            P   S    +L+  ++  DP  RP A     A++K H        K
Sbjct: 248 IPQVLSQEFTELLKVMIHPDPERRPSA----MALVK-HSVLLSASRK 289

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  214 bits (547), Expect = 3e-66
 Identities = 75/309 (24%), Positives = 129/309 (41%), Gaps = 39/309 (12%)

Query: 27  VQRSKSFAFRAPQEHFSI-----QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKK 81
           +  S S       E  S+       F    + G G+   +V           A+K +  +
Sbjct: 1   MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPE 59

Query: 82  FITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG 140
             +  ++      E  +L + D HP V+R F T +D    Y+A+E C    L + +  K 
Sbjct: 60  CFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 141 H-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKP 194
                 E      +    L ++HS+ ++HRD+KP N+L++           I+DFG  K 
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLS- 250
           +   R        S  +     GT  ++ PE+L+       T+  D+++ GC  Y ++S 
Sbjct: 173 LAVGR-------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

Query: 251 GTSPFKDTSEWLIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
           G+ PF  + +      + A  +   +        AR+LI++++ +DP  RP A      V
Sbjct: 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAK----HV 281

Query: 308 LKMHPFFKG 316
           LK HPFF  
Sbjct: 282 LK-HPFFWS 289

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  212 bits (541), Expect = 5e-66
 Identities = 49/344 (14%), Positives = 98/344 (28%), Gaps = 66/344 (19%)

Query: 20  SSTNCPTVQRSKSFAFRAPQEHFSI-----QDFELGKIYGVGSYSKVVRAKKIDTGTVYA 74
                     +  +   A     S+     +  +L +   VG  S V   + ++    +A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ------------------- 115
           LK+         ++   +        +L            +                   
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 116 -------DTFSLYMALESCEG------GELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
                     +  + + +           L      +G          TA+++     + 
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S GL+H    P+NL +  DG + + D  ++  +               +         Y 
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV-------------GTRGPASSVPVTYA 258

Query: 223 PPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQRIIARDIRFPNY- 277
           P E LN+S    T   + W LG ++Y++     PF   +  +   ++R   R     +  
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318

Query: 278 ------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                   D  + LI R L+ D   R          ++  P F 
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPL----EAME-TPEFL 357

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  212 bits (542), Expect = 9e-66
 Identities = 79/323 (24%), Positives = 139/323 (43%), Gaps = 48/323 (14%)

Query: 17  NNNSSTNCPTVQRSKSFAFRA---PQEHFSIQDFEL-GKIYGVGSYSKVVRAKKIDTGTV 72
           +  +    P  Q+   F  ++    +++  I D+++  ++ G+G   KV++     T   
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 73  YALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVRLFFTFQDTFS----LYMALESC 127
           +ALK++      +         E  +       P +VR+   +++ ++    L + +E  
Sbjct: 90  FALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141

Query: 128 EGGELFDQITSKGHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADG 182
           +GGELF +I  +G    +E EA      + +A++Y+HS+ + HRD+KPENLL T    + 
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201

Query: 183 HIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWAL 241
            +K+ DFG + +    + +T            T   T  YV PEVL         D+W+L
Sbjct: 202 ILKLTDFGFAKETTSHNSLT------------TPCYTPYYVAPEVLGPEKYDKSCDMWSL 249

Query: 242 GCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYF----SDAARDLIDRLLDVD 293
           G  +Y +L G  PF           +  RI      FPN      S+  + LI  LL  +
Sbjct: 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309

Query: 294 PSGRPGAGPGGYAVLKMHPFFKG 316
           P+ R          +  HP+   
Sbjct: 310 PTQRMTI----TEFMN-HPWIMQ 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  208 bits (532), Expect = 6e-64
 Identities = 80/308 (25%), Positives = 118/308 (38%), Gaps = 57/308 (18%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 103
                 KI G GS   VV       G   A+K M   F           +E  +L + D 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDI------ALMEIKLLTESDD 67

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE-------VVD 156
           HP V+R + +      LY+ALE C    L D + SK    E+               +  
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 157 ALEYIHSMGLIHRDIKPENLLLT-------------ADGHIKIADFGSVKPMQDSRITVL 203
            + ++HS+ +IHRD+KP+N+L++              +  I I+DFG  K +   + +  
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLS-GTSPF 255
            N           GT+ +  PE+L  S             D++++GC  Y +LS G  PF
Sbjct: 187 TNLN------NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 256 KDTSEWLIFQRIIARDIRFPNY-------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 308
            D         II                    A DLI +++D DP  RP A      VL
Sbjct: 241 GDKYS--RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM----KVL 294

Query: 309 KMHPFFKG 316
           + HP F  
Sbjct: 295 R-HPLFWP 301

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  198 bits (505), Expect = 5e-61
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 29/273 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
             + ++   G ++ V  A+ + +G  YALK +      +E K   +  E   + +L  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHP 86

Query: 106 GVVRLFFTFQDTFS-------LYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVV 155
            +V+                  ++ L     G+L + +    S+G LS D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 156 DALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLPNAASDD 210
            A++++H     +IHRD+K ENLLL+  G IK+ DFGS   +    D   +    A  ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 211 KACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +  T   T  Y  PE+++     P     D+WALGC LY +     PF+D +      RI
Sbjct: 207 EI-TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261

Query: 268 IARDIRFPNY--FSDAARDLIDRLLDVDPSGRP 298
           +      P +         LI  +L V+P  R 
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  204 bits (521), Expect = 2e-60
 Identities = 71/312 (22%), Positives = 116/312 (37%), Gaps = 54/312 (17%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +   +E+ +  G G +  V+R    DTG   A+K   ++   K  +     LE  ++ +L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER--WCLEIQIMKKL 69

Query: 103 DHPGVVRLFFTFQDTFSL------YMALESCEGGELFDQITSKGH---LSEDEARFYTAE 153
           +HP VV           L       +A+E CEGG+L   +    +   L E   R   ++
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDD 210
           +  AL Y+H   +IHRD+KPEN++L         KI D G  K +              +
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-----------GE 178

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
               FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF    + + +   +  
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 271 DIRF--------------------PNYFSDAARDLIDRL----LDVDPSGRPGAGPGGYA 306
                                   PN+ S      ++R     L      R     G   
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDP 293

Query: 307 VLKMHPFFKGID 318
                  F+ +D
Sbjct: 294 QNPNVGCFQALD 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  192 bits (490), Expect = 1e-58
 Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 31/312 (9%)

Query: 10  SKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDT 69
            +L  E  +N         +   + +R      + Q   +G+    GS+ +V R K   T
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR-VGR----GSFGEVHRMKDKQT 82

Query: 70  GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 129
           G   A+K +  +    E        E +    L  P +V L+   ++   + + +E  EG
Sbjct: 83  GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134

Query: 130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIAD 188
           G L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K +N+LL++DG    + D
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCD 194

Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG         +       S        GT  ++ PEV+   P     D+W+  C +  M
Sbjct: 195 FGHAL-----CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 249 LSGTSPFKDTSEW-LIFQRIIARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
           L+G  P+       L  +  IA +       P   +      I   L  +P  R  A   
Sbjct: 250 LNGCHPWTQYFRGPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA--- 304

Query: 304 GYAVLKMHPFFK 315
               L+      
Sbjct: 305 --MELRRKVGKA 314

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  190 bits (486), Expect = 1e-58
 Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 68/294 (23%)

Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQ 101
           I D+++  ++ G+G   KV++     T   +ALK++      +         E  +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 67

Query: 102 LDHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHL--SEDEARFYTAEVV 155
              P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 156 DALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +A++Y+HS+ + HRD+KPENLL T    +  +K+ DFG                      
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165

Query: 213 CTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWL----IFQR 266
                       E        +    D+W+LG  +Y +L G  PF           +  R
Sbjct: 166 ---------FAKETTGEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 267 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
           I      FP    +  S+  + LI  LL  +P+ R          +  HP+   
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI----TEFMN-HPWIMQ 262

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  189 bits (481), Expect = 4e-57
 Identities = 41/284 (14%), Positives = 86/284 (30%), Gaps = 42/284 (14%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLE 95
               +   +  + G G++++V  A + D         + LK+       +          
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQL 117

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-----TSKGHLSEDEARFY 150
              L        ++ +          +  E    G L + I     T +  + +     +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLT-----------ADGHIKIADFGSVKPMQDSR 199
              ++  +E +H   +IH DIKP+N +L                + + D G    M+   
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KD 257
                             T+ +   E+L++ P  +  D + +  T+Y ML GT      +
Sbjct: 238 --------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

Query: 258 TSEWLIFQRIIARDIRFPNYF-SDAARDLIDRLLDVDPSGRPGA 300
             E             F      D   +    +L++       +
Sbjct: 290 GGECKPEG-------LFRRLPHLDMWNEFFHVMLNIPDCHHLPS 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  178 bits (453), Expect = 2e-53
 Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 19/254 (7%)

Query: 73  YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL 132
           +         ++  +      ++   +D       V           LY+ ++ C    L
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148

Query: 133 FDQITSKGHLSEDE---ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
            D +  +  L + E         ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DF
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208

Query: 190 GSVKPMQDS--RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           G V  M       TVL    +       VGT  Y+ PE ++ +  +   D+++LG  L++
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

Query: 248 MLSGTSPFKDTSE-WLIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGRPGAGPG 303
           +L     F    E   I   +  R+++FP  F         ++  +L   P+ RP A   
Sbjct: 269 LL---YSFSTQMERVRIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA--- 320

Query: 304 GYAVLKMHPFFKGI 317
              +++ +  F+ +
Sbjct: 321 -TDIIE-NAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE  +  G G +  V  AK       YA+K +         +   V  E   L +L+H
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--VMREVKALAKLEH 63

Query: 105 PGVVRLFFTFQDTFSLYMALESC 127
           PG+VR F  + +T       E  
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMD 86

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  173 bits (441), Expect = 6e-52
 Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 33/291 (11%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-- 96
           +  +   +     + G G+Y  V   + +      A+K      I + +      L    
Sbjct: 16  EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE-----IPERDSRYSQPLHEEI 70

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEA--RFYTAE 153
            +   L H  +V+   +F +   + + +E   GG L   + SK G L ++E    FYT +
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 154 VVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++ L+Y+H   ++HRDIK +N+L+ T  G +KI+DFG+ K +                 
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----------PCT 180

Query: 213 CTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWL--IFQRII 268
            TF GT  Y+ PE+++  P  +G   D+W+LGCT+ +M +G  PF +  E    +F ++ 
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVG 239

Query: 269 ARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
              +    P   S  A+  I +  + DP  R  A       L +  F K  
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACA-----NDLLVDEFLKVS 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  171 bits (436), Expect = 4e-51
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 28/281 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+  + ++GK    GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 20  PEELFTKLE-KIGK----GSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEIT 72

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +     L E +      E++  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 131

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++           K  TFVG
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----------IKRNTFVG 181

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARDI--RF 274
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +     ++F  +I ++     
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTL 239

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              +S   ++ ++  L+ +PS RP A       L  H F  
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTA-----KELLKHKFIL 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  165 bits (419), Expect = 1e-48
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 32/287 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P E + I   ELG     G++ KV +AK  +TG + A K+++      E +     +E  
Sbjct: 17  PNEVWEIVG-ELGD----GAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIE 68

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVD 156
           +L   DHP +V+L   +     L++ +E C GG +   +      L+E + +    ++++
Sbjct: 69  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL ++HS  +IHRD+K  N+L+T +G I++ADFG       +            K  +F+
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----------QKRDSFI 178

Query: 217 GTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           GT  ++ PEV+              D+W+LG TL +M     P  + +   +  +I   D
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238

Query: 272 ---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              +  P+ +S   RD +   LD +P  RP A     A L  HPF  
Sbjct: 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVS 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  162 bits (413), Expect = 9e-48
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 38/308 (12%)

Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 87
           + S +  +   ++ + +Q+     I G G+ + V  A         A+K ++      + 
Sbjct: 3   EDSSALPWSINRDDYELQE----VI-GSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQT 55

Query: 88  KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-------- 139
               +  E   + Q  HP +V  + +F     L++ ++   GG + D I           
Sbjct: 56  SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDS 198
           G L E        EV++ LEY+H  G IHRD+K  N+LL  DG ++IADFG S      +
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS------A 169

Query: 199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKD 257
            +    +   +    TFVGT  ++ PEV+       F  D+W+ G T  ++ +G +P+  
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

Query: 258 TSE----WLIFQ------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
                   L  Q          +D      +  + R +I   L  DP  RP A      +
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA----EL 285

Query: 308 LKMHPFFK 315
           L+ H FF+
Sbjct: 286 LR-HKFFQ 292

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  163 bits (414), Expect = 1e-47
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 27/281 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+           KI G GS   V  A++  +G   A+K+MD   + K+ +   +  E +
Sbjct: 43  PRLLLDS----YVKI-GEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVV 94

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           ++    H  VV ++ ++     L++ +E  +GG L D I S+  L+E++       V+ A
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQA 153

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L Y+H+ G+IHRDIK +++LLT DG +K++DFG    +               K  + VG
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----------PKRKSLVG 203

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 274
           T  ++ PEV++ S      D+W+LG  + +M+ G  P+   S     +R+       ++ 
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 263

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +  S   RD ++R+L  DP  R  A       L  HPF  
Sbjct: 264 SHKVSPVLRDFLERMLVRDPQERATA-----QELLDHPFLL 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  162 bits (411), Expect = 3e-47
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 27/291 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             I D E     G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL  
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-VVLKS 80

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            D P +V+ F TF     +++A+E         +   +G + E      T  +V AL Y+
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
               G+IHRD+KP N+LL   G IK+ DFG    + D +                 G AA
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-----------AKDRSAGCAA 189

Query: 221 YVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI-R 273
           Y+ PE ++    T  +     D+W+LG +L ++ +G  P+K+  +++ +  +++  +   
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249

Query: 274 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            P    FS   +  +   L  D   RP      Y  L  H F K  +   +
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKRYETLEV 295

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  160 bits (408), Expect = 4e-47
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 27/281 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P++ ++       KI G G+   V  A  + TG   A++ M+   + ++ K   +  E +
Sbjct: 18  PKKKYTR----FEKI-GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEIL 69

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           V+ +  +P +V    ++     L++ +E   GG L D + ++  + E +      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++HS  +IHRDIK +N+LL  DG +K+ DFG    +   +           K  T VG
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----------SKRSTMVG 178

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 274
           T  ++ PEV+         D+W+LG    +M+ G  P+ + +       I       ++ 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           P   S   RD ++R L++D   R  A       L  H F K
Sbjct: 239 PEKLSAIFRDFLNRCLEMDVEKRGSA-----KELLQHQFLK 274

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  160 bits (407), Expect = 2e-46
 Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 30/301 (9%)

Query: 25  PTVQRSKSFAFRAPQEHFSIQD----FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK 80
           P   R+ S       E F   D    F   +  G GS+  V  A+ +    V A+K M  
Sbjct: 30  PAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY 89

Query: 81  KFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG 140
                  K   +  E   L +L HP  ++    +    + ++ +E C G         K 
Sbjct: 90  SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 149

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            L E E    T   +  L Y+HS  +IHRD+K  N+LL+  G +K+ DFGS         
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--------- 200

Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
                A+    A +FVGT  ++ PEV+ +      +   D+W+LG T  ++     P  +
Sbjct: 201 -----ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255

Query: 258 TSEWLIFQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
            +       I   +   ++  + +S+  R+ +D  L   P  RP +      VL  H F 
Sbjct: 256 MNAMSALYHIAQNESPALQSGH-WSEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFV 309

Query: 315 K 315
            
Sbjct: 310 L 310

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  159 bits (403), Expect = 4e-46
 Identities = 84/284 (29%), Positives = 129/284 (45%), Gaps = 33/284 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F + +    K+ G GSY  V +A   +TG + A+K +    +  + +   +  E  
Sbjct: 27  PEEVFDVLE----KL-GEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE--IIKEIS 76

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           ++ Q D P VV+ + ++     L++ +E C  G + D I      L+EDE        + 
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            LEY+H M  IHRDIK  N+LL  +GH K+ADFG    + D+            K  T +
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM----------AKRNTVI 186

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD---- 271
           GT  ++ PEV+         D+W+LG T  +M  G  P+ D      IF  +I  +    
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPTNPPPT 244

Query: 272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            R P  +SD   D + + L   P  R  A       L  HPF +
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATA-----TQLLQHPFVR 283

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  160 bits (406), Expect = 7e-46
 Identities = 66/334 (19%), Positives = 115/334 (34%), Gaps = 62/334 (18%)

Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           +F      + +    +GK  G      V  A+   TG    ++ ++ +  + E  T    
Sbjct: 19  SFLPEGGCYELLT-VIGK--GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYT 151
            E  V    +HP +V    TF     L++       G   D I +     ++E    +  
Sbjct: 76  -ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
             V+ AL+YIH MG +HR +K  ++L++ DG + ++   S   M              D 
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS---HGQRQRVVHDF 191

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKD------------ 257
               V    ++ PEVL  +   +    D++++G T  ++ +G  PFKD            
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 258 ----------------------------------TSEWLIFQRIIARDIRFPNYFSDAAR 283
                                             T+         +    +   FS    
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
             +++ L  +P  RP A     + L  H FFK I
Sbjct: 312 HFVEQCLQRNPDARPSA-----STLLNHSFFKQI 340

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  156 bits (397), Expect = 2e-45
 Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 29/277 (10%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
                G GS+  V +    +T    A   +  + +TK  +    K E  +L  L HP +V
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIV 88

Query: 109 RLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           R + +++ T      + +  E    G L   +     +     R +  +++  L+++H+ 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 165 G--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
              +IHRD+K +N+ +T   G +KI D G     + S             A   +GT  +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------FAKAVIGTPEF 196

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPNYF 278
           + PE+          D++A G  + +M +   P+ +        R +   ++   F    
Sbjct: 197 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
               +++I+  +  +   R          L  H FF+
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ 287

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  156 bits (397), Expect = 2e-45
 Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 28/292 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
               D E     G G+Y  V + + + +G + A+K +     ++E K   + L+ I +  
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISMRT 62

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSK-GHLSEDEARFYTAEVVDAL 158
           +D P  V  +        +++ +E  +    + + Q+  K   + ED        +V AL
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 159 EYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           E++HS + +IHRD+KP N+L+ A G +K+ DFG    + D                   G
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----------AKDIDAG 171

Query: 218 TAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 272
              Y+ PE +N      G    +D+W+LG T+ ++     P+    + +   ++++    
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231

Query: 273 -RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            + P + FS    D   + L  +   RP      Y  L  HPFF   + K  
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERP-----TYPELMQHPFFTLHESKGT 278

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  154 bits (392), Expect = 9e-45
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 32/266 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 97
           +++    G G  S V  A+        A+K +       ++ + +   E   +       
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS------- 65

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
              QL H  +V +    ++    Y+ +E  EG  L + I S G LS D A  +T +++D 
Sbjct: 66  --SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +++ H M ++HRDIKP+N+L+ ++  +KI DFG  K + ++ +T         +    +G
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT---------QTNHVLG 174

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIRFPN 276
           T  Y  PE           D++++G  LY+ML G  PF  +T+  +  + I         
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234

Query: 277 YF----SDAARDLIDRLLDVDPSGRP 298
                   +  ++I R  + D + R 
Sbjct: 235 DVRKDIPQSLSNVILRATEKDKANRY 260

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  156 bits (396), Expect = 9e-45
 Identities = 72/343 (20%), Positives = 125/343 (36%), Gaps = 67/343 (19%)

Query: 28  QRSKSFAFRAPQEH---FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           QR +  AF   ++        DFE     G G+   V +     +G V A K++  +   
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--I 70

Query: 85  KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 144
           K      +  E  VL + + P +V  +  F     + + +E  +GG L   +   G + E
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130

Query: 145 DEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
                 +  V+  L Y+     ++HRD+KP N+L+ + G IK+ DFG    + DS     
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 185

Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
                   A +FVGT +Y+ PE L  +  +  +D+W++G +L +M  G  P        +
Sbjct: 186 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

Query: 264 FQRIIARDIRF--------------------------------------------PNYFS 279
                 +                                                   FS
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
              +D +++ L  +P+ R          L +H F K  D + +
Sbjct: 299 LEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV 336

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  154 bits (392), Expect = 1e-44
 Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 30/264 (11%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 97
           + L ++ G G    V  A+      + ALK+M      D  F T+   E +TA       
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA------- 88

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
              +L  P VV +    +    LY+ +    G +L   +  +G L+   A     ++  A
Sbjct: 89  --GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+  H+ G  HRD+KPEN+L++AD    + DFG      D ++T         +    VG
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT---------QLGNTVG 197

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IARDIRF 274
           T  Y+ PE  + S AT+  D++AL C LY+ L+G+ P++     ++   I   I R    
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTV 257

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
                 A   +I R +  +P  R 
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDRY 281

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  154 bits (391), Expect = 3e-44
 Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 36/304 (11%)

Query: 38  PQEHFSIQ--DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           P++H+     D +     G G+Y  V +     +G + A+K +      KE K   + L+
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSK--GHLSEDEARFYT 151
            +V+   D P +V+ +         ++ +E       + +  + S     + E+     T
Sbjct: 73  -VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 152 AEVVDALEYIHSMG-LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              V AL ++     +IHRDIKP N+LL   G+IK+ DFG    + DS            
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----------- 180

Query: 211 KACTFVGTAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPFKD--TSEWLIF 264
                 G   Y+ PE ++ S +  G    +D+W+LG TLY++ +G  P+    +    + 
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 265 QRIIARDI-RFPNY----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           Q ++  D  +  N     FS +  + ++  L  D S RP      Y  L  HPF    + 
Sbjct: 241 Q-VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEE 294

Query: 320 KNIR 323
           + + 
Sbjct: 295 RAVE 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  152 bits (385), Expect = 2e-43
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 42/295 (14%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P   F + +  +G     G+Y +V + + + TG + A+K+MD   +T + +    +   +
Sbjct: 22  PAGIFELVE-LVGN----GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINM 73

Query: 98  VLDQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFD--QITSKGHLSEDEARF 149
           +     H  +   +  F           L++ +E C  G + D  + T    L E+   +
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              E++  L ++H   +IHRDIK +N+LLT +  +K+ DFG    +  +           
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---------- 183

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTS-EWLI 263
            +  TF+GT  ++ PEV+              DLW+LG T  +M  G  P  D      +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

Query: 264 FQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           F   I R+         +S   +  I+  L  + S RP         L  HPF +
Sbjct: 244 FL--IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIR 291

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  149 bits (378), Expect = 2e-42
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 35/270 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 97
           +ELG+I G G  S+V  A+ +      A+K++      D  F  +   E + A       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA------- 66

Query: 98  VLDQLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
               L+HP +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+
Sbjct: 67  --AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
              AL + H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   A       
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA------- 177

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDI 272
             +GTA Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q  +  D 
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDP 236

Query: 273 RFPNYF----SDAARDLIDRLLDVDPSGRP 298
             P+      S     ++ + L  +P  R 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRY 266

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  146 bits (370), Expect = 4e-39
 Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 44/264 (16%)

Query: 47  FELGKIYGVGSYSKVVRAK--KIDTGTVYALKIM----DKKFITKENKTAYVKLERIVLD 100
           +E+      G    +  A    ++   V  LK +    D +             ER  L 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAM------AMAERQFLA 134

Query: 101 QLDHPGVVRLFFTFQDT-----FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           ++ HP +V++F   + T        Y+ +E   G  L         L   EA  Y  E++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEIL 192

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAASDDKACT 214
            AL Y+HS+GL++ D+KPEN++LT +  +K+ D G+V  +     +              
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL-------------- 237

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
             GT  +  PE++ + P T   D++ +G TL  +                  +   D   
Sbjct: 238 -YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----DGLPEDDPVL 291

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
             Y  D+   L+ R +D DP  R 
Sbjct: 292 KTY--DSYGRLLRRAIDPDPRQRF 313

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  136 bits (345), Expect = 1e-37
 Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 59/318 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAY--VKLERIVLDQLDHP 105
           +GKI G GSY  V + +  DTG + A+K  ++ +      K A   +++    L QL HP
Sbjct: 8   IGKI-GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRM----LKQLKHP 62

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
            +V L   F+    L++  E C+   +  ++   +  + E   +  T + + A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVP 223
             IHRD+KPEN+L+T    IK+ DFG       +R+   P+           V T  Y  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF------ARLLTGPS-----DYYDDEVATRWYRS 170

Query: 224 PEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI----------- 267
           PE+L          D+WA+GC   ++LSG   +   S+    +LI + +           
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230

Query: 268 ----IARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
                   ++ P+              S  A  L+   L +DP+ R         +L  H
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC----EQLLH-H 285

Query: 312 PFFKGIDWKNIRGQTPPK 329
           P+F+ I       +   K
Sbjct: 286 PYFENIREIEDLAKEHDK 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  135 bits (343), Expect = 3e-37
 Identities = 81/335 (24%), Positives = 130/335 (38%), Gaps = 71/335 (21%)

Query: 25  PTVQRSKSFAFRAPQEHF-SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF 82
                S          +F S++ +E LG + G GSY  V++ +  DTG + A+K    KF
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMEKYENLGLV-GEGSYGMVMKCRNKDTGRIVAIK----KF 58

Query: 83  ITKE-----NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELF 133
           +  +      K A   +KL    L QL H  +V L    +     Y+  E  +    +  
Sbjct: 59  LESDDDKMVKKIAMREIKL----LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114

Query: 134 DQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 193
           +       L     + Y  ++++ + + HS  +IHRDIKPEN+L++  G +K+ DFG   
Sbjct: 115 E--LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-- 170

Query: 194 PMQDSRITVLPNAASDDKACT-FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSG 251
               +R    P      +     V T  Y  PE+L          D+WA+GC + +M  G
Sbjct: 171 ----ARTLAAPG-----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

Query: 252 TSPFKDTSE----WLIFQRI---------------IARDIRFPNY------------FSD 280
              F   S+    + I   +               +   +R P               S+
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE 281

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              DL  + L +DP  RP        +L  H FF+
Sbjct: 282 VVIDLAKKCLHIDPDKRPFC----AELLH-HDFFQ 311

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  131 bits (332), Expect = 7e-36
 Identities = 64/265 (24%), Positives = 113/265 (42%), Gaps = 34/265 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ E+ ++ G G++  V +AK        A+K ++ +   K         E   L +++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIV-----ELRQLSRVNH 60

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEY 160
           P +V+L+         + + +E  EGG L++ +       + +   A  +  +    + Y
Sbjct: 61  PNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 161 IHSM---GLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           +HSM    LIHRD+KP NLLL A G  +KI DFG+   +Q                    
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------------K 164

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI-FQRIIARDIR-- 273
           G+AA++ PEV   S  +   D+++ G  L+++++   PF +           +    R  
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRP 298
                      L+ R    DPS RP
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRP 249

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (325), Expect = 9e-35
 Identities = 53/261 (20%), Positives = 112/261 (42%), Gaps = 22/261 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           D  + +  G GS+  V RA+     G+  A+KI+ ++    E    +++ E  ++ +L H
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRH 93

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI---TSKGHLSEDEARFYTAEVVDALEYI 161
           P +V          +L +  E    G L+  +    ++  L E        +V   + Y+
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 162 HSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           H+    ++HR++K  NLL+     +K+ DFG  +    + ++            +  GT 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK----------SAAGTP 203

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 277
            ++ PEVL   P+   +D+++ G  L+++ +   P+ + +   +   +  +  R   P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263

Query: 278 FSDAARDLIDRLLDVDPSGRP 298
            +     +I+     +P  RP
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRP 284

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  129 bits (326), Expect = 1e-34
 Identities = 84/326 (25%), Positives = 131/326 (40%), Gaps = 77/326 (23%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLE 95
            +  +E L KI G G++ +V +A+   TG   ALK  +M+ +   KE    TA   +K+ 
Sbjct: 15  EVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKI- 69

Query: 96  RIVLDQLDHPGVVRLF--------FTFQDTFSLYMALESCEG--GELFDQITSKGHLSED 145
              L  L H  VV L            +   S+Y+  + CE     L          +  
Sbjct: 70  ---LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLS 124

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           E +     +++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L  
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAK 178

Query: 206 AASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 260
            +  ++    V T  Y PPE+L    +  P     DLW  GC + +M + +   +  +E 
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPI---DLWGAGCIMAEMWTRSPIMQGNTEQ 235

Query: 261 -----------------W-----------LIFQRIIARDIR--FPNYF-SDAARDLIDRL 289
                            W           L   +   R ++     Y     A DLID+L
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFK 315
           L +DP+ R  +       L  H FF 
Sbjct: 296 LVLDPAQRIDSD----DALN-HDFFW 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  128 bits (323), Expect = 2e-34
 Identities = 79/347 (22%), Positives = 135/347 (38%), Gaps = 69/347 (19%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           ++  T     Q   S +  A     SI  +  + K+ G G+Y +V +A    T    A+K
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIK 65

Query: 77  --IMDKKFITKE--NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 130
              ++ +   +E    TA   V L    L +L H  ++ L         L++  E  E  
Sbjct: 66  RIRLEHE---EEGVPGTAIREVSL----LKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117

Query: 131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----DGHIK 185
           +L   +     +S    + +  ++++ + + HS   +HRD+KP+NLLL+         +K
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177

Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGC 243
           I DFG       +R   +P      +  T  + T  Y PPE+L  S   +   D+W++ C
Sbjct: 178 IGDFGL------ARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226

Query: 244 TLYQMLSGTSPFKDTSE------------------W----------LIFQRIIARDIR-- 273
              +ML  T  F   SE                  W            F +   + ++  
Sbjct: 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK 320
                 D   DL+  +L++DP  R  A       L+ HP+F   D+ 
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISA----KNALE-HPYFSHNDFD 328

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  129 bits (326), Expect = 4e-34
 Identities = 81/334 (24%), Positives = 133/334 (39%), Gaps = 69/334 (20%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           +   K+ G GS+  V +AK  D+G + A+K  + DK+F  +E     +++    + +LDH
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQI----MRKLDH 106

Query: 105 PGVVRL---FFTFQDTFS---LYMALESCEG---GELFDQITSKGHLSEDEARFYTAEVV 155
             +VRL   F++  +      L + L+               +K  L     + Y  ++ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 156 DALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
            +L YIHS G+ HRDIKP+NLLL  D   +K+ DFGS K +      V           +
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-----------S 215

Query: 215 FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII----- 268
           ++ +  Y  PE+   ++  T   D+W+ GC L ++L G   F   S       II     
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275

Query: 269 ------------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGG 304
                         + +FP                  A  L  RLL+  P+ R       
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP---- 331

Query: 305 YAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNF 338
                 H FF   + ++   + P    +  + NF
Sbjct: 332 LEACA-HSFFD--ELRDPNVKLPNGRDTPALFNF 362

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  125 bits (317), Expect = 1e-33
 Identities = 74/316 (23%), Positives = 119/316 (37%), Gaps = 64/316 (20%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK----IMDKKFITKENKTAY--VKLE 95
           +   +E + +I GVG+Y  V +A+   +G   ALK                +    V L 
Sbjct: 7   ATSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 96  RIVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEAR 148
           R  L+  +HP VVRL              + +  E  +       D+    G L  +  +
Sbjct: 66  R-RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIK 123

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
               + +  L+++H+  ++HRD+KPEN+L+T+ G +K+ADFG            L    S
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG------------LARIYS 171

Query: 209 DDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLI 263
              A T  V T  Y  PEVL  S      D+W++GC   +M      F   SE      I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 264 FQ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPG 299
           F                           R ++   P    ++   L+  +L  +P  R  
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRIS 290

Query: 300 AGPGGYAVLKMHPFFK 315
           A    +  L+ H +  
Sbjct: 291 A----FRALQ-HSYLH 301

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  126 bits (318), Expect = 2e-33
 Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 64/313 (20%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLE 95
             + +E L  + G G ++ V +A+  +T  + A+K   +  +   K+  N+TA   +KL 
Sbjct: 8   RAKRYEKLDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL- 65

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAE 153
              L +L HP ++ L   F    ++ +  +  E     +     +   L+    + Y   
Sbjct: 66  ---LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLM 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
            +  LEY+H   ++HRD+KP NLLL  +G +K+ADFG  K          PN     +A 
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PN-----RAY 169

Query: 214 T-FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----------- 260
           T  V T  Y  PE+L  +     G D+WA+GC L ++L         S+           
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229

Query: 261 ----------------WLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGP 302
                           ++ F+      +   F     D   DLI  L   +P  R  A  
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA-AGDDLLDLIQGLFLFNPCARITA-- 286

Query: 303 GGYAVLKMHPFFK 315
                LK   +F 
Sbjct: 287 --TQALK-MKYFS 296

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  122 bits (309), Expect = 8e-33
 Identities = 40/261 (15%), Positives = 74/261 (28%), Gaps = 46/261 (17%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           + L   +G     +  +A         AL  +D + +  ++         + L ++D PG
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           V R+           +  E   GG L +        S   A      +  A +  H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
                 P  + ++ DG + +A                                  +P   
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------TMPDA- 179

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD-- 284
              +P     D+  +G +LY +L    P  +                 P   +D  RD  
Sbjct: 180 ---NPQD---DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233

Query: 285 -----LIDRLLDVDPSGRPGA 300
                +  R +  D   R  +
Sbjct: 234 FQISAVAARSVQGDGGIRSAS 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  123 bits (311), Expect = 1e-32
 Identities = 75/316 (23%), Positives = 123/316 (38%), Gaps = 68/316 (21%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAY--VKLERIVL 99
           ++ +      G G+Y+ V + K   T  + ALK +  +   +E    TA   V L    L
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSL----L 54

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVVDA 157
             L H  +V L        SL +  E  +    +  D       ++    + +  +++  
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLLRG 112

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF-- 215
           L Y H   ++HRD+KP+NLL+   G +K+ADFG       +R   +P         T+  
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGL------ARAKSIPTK-------TYDN 159

Query: 216 -VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRII- 268
            V T  Y PP++L  S   +   D+W +GC  Y+M +G   F  ++       IF RI+ 
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF-RILG 218

Query: 269 ---------------ARDIRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGP 302
                           +   +P Y                 DL+ +LL  +   R  A  
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-- 276

Query: 303 GGYAVLKMHPFFKGID 318
                +K HPFF  + 
Sbjct: 277 --EDAMK-HPFFLSLG 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  122 bits (309), Expect = 1e-32
 Identities = 56/273 (20%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL----ERIVLD 100
            + E  K  G G +  V + + +   +V A+K +       E +          E  ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDAL 158
            L+HP +V+L+           M +E    G+L+ ++  K H +          ++   +
Sbjct: 79  NLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 159 EYIHSMG--LIHRDIKPENLLLTADG-----HIKIADFGSVKPMQDSRITVLPNAASDDK 211
           EY+ +    ++HRD++  N+ L +         K+ADFG       S+        S   
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQ-------SVHS 182

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLI--FQRI 267
               +G   ++ PE + +   ++    D ++    LY +L+G  PF + S   I     I
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
               +R   P       R++I+     DP  RP
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  123 bits (310), Expect = 2e-32
 Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 68/320 (21%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKI-DTGTVYALK--IMDKKFITKE--NKTAY--VKL 94
           + Q +E + +I G G+Y KV +A+ + + G   ALK   +      +E    +    V +
Sbjct: 9   ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAV 64

Query: 95  ERIVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEA 147
            R  L+  +HP VVRLF             L +  E  +       D++   G +  +  
Sbjct: 65  LR-HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETI 122

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
           +    +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG            L    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG------------LARIY 170

Query: 208 SDDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WL 262
           S   A T  V T  Y  PEVL  S      DLW++GC   +M      F+ +S+      
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

Query: 263 IFQ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
           I                           A+ I     +   +  +DL+ + L  +P+ R 
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRI 289

Query: 299 GAGPGGYAVLKMHPFFKGID 318
            A    Y+ L  HP+F+ ++
Sbjct: 290 SA----YSALS-HPYFQDLE 304

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  122 bits (308), Expect = 3e-32
 Identities = 81/334 (24%), Positives = 138/334 (41%), Gaps = 71/334 (21%)

Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKF 82
                 ++  F+   E +      L K+ G G+Y  V +AK    G + ALK   +D + 
Sbjct: 6   HHSSGRENLYFQGLMEKYQK----LEKV-GEGTYGVVYKAKDS-QGRIVALKRIRLDAE- 58

Query: 83  ITKE--NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQI 136
              E    TA   + L    L +L HP +V L         L +  E  E    ++ D  
Sbjct: 59  --DEGIPSTAIREISL----LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD-- 110

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
            +K  L + + + Y  +++  + + H   ++HRD+KP+NLL+ +DG +K+ADFG      
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL----- 165

Query: 197 DSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSP 254
            +R   +P      ++ T  V T  Y  P+VL  S   +   D+W++GC   +M++G   
Sbjct: 166 -ARAFGIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219

Query: 255 FKDTSE----WLIFQRI---------------IARDIRFPNY-----------FSDAARD 284
           F   ++      IF  +               + +   F  +           F     D
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
           L+  +L  DP+ R  A       +  HP+FK +D
Sbjct: 280 LLSNMLCFDPNKRISA----RDAMN-HPYFKDLD 308

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  121 bits (305), Expect = 5e-32
 Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 69/316 (21%)

Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLER 96
           ++ +  L KI G G+Y  V +A+  + G  +ALK   ++K+    E    T    + +  
Sbjct: 1   MEKYHGLEKI-GEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISI-- 53

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             L +L H  +V+L+        L +  E  +    +L D    +G L    A+ +  ++
Sbjct: 54  --LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQL 109

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ + Y H   ++HRD+KP+NLL+  +G +KIADFG       +R   +P      +  T
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL------ARAFGIPV-----RKYT 158

Query: 215 F-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE------------ 260
             + T  Y  P+VL  S   +   D+W++GC   +M++GT  F   SE            
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

Query: 261 ------W----------LIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGP 302
                 W            F                 ++  DL+ ++L +DP+ R  A  
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITA-- 275

Query: 303 GGYAVLKMHPFFKGID 318
                L+ H +FK  +
Sbjct: 276 --KQALE-HAYFKENN 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  120 bits (304), Expect = 6e-32
 Identities = 78/314 (24%), Positives = 127/314 (40%), Gaps = 69/314 (21%)

Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLER 96
           +Q +E L KI G G+Y  V +AK  +T  + ALK   +D      E    +A   + L  
Sbjct: 1   MQKYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICL-- 54

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             L +L H  +VRL         L +  E C+    + FD     G L  +  + +  ++
Sbjct: 55  --LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L + HS  ++HRD+KP+NLL+  +G +K+A+FG       +R   +P      +  +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL------ARAFGIPV-----RCYS 159

Query: 215 F-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSP-FKDTSE----WLIFQ-- 265
             V T  Y PP+VL  +   +   D+W+ GC   ++ +   P F           IF+  
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 266 ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAG 301
                                       +    P   +   RDL+  LL  +P  R  A 
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISA- 277

Query: 302 PGGYAVLKMHPFFK 315
                 L+ HP+F 
Sbjct: 278 ---EEALQ-HPYFS 287

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  122 bits (308), Expect = 8e-32
 Identities = 84/335 (25%), Positives = 135/335 (40%), Gaps = 83/335 (24%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           +   K+ G GS+  V +AK +++  V A+K  + DK+F  +E     +++    +  + H
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNRE-----LQI----MRIVKH 91

Query: 105 PGVVRLFFTF------QDTFSLYMALESCEGGELFDQ---------ITSKGHLSEDEARF 149
           P VV L   F      +D   L + LE         +            K  +     + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLE------YVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAAS 208
           Y  +++ +L YIHS+G+ HRDIKP+NLLL    G +K+ DFGS K +      V      
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV------ 199

Query: 209 DDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                +++ +  Y  PE+   ++  T   D+W+ GC + +++ G   F   S       I
Sbjct: 200 -----SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254

Query: 268 I-----------------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRP 298
           I                   + +FP                  A DLI RLL+  PS R 
Sbjct: 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314

Query: 299 GAGPGGYAVLKMHPFFKGI---DWKNIRGQTPPKL 330
            A       L  HPFF  +   + +   G+  P L
Sbjct: 315 TA----IEALC-HPFFDELRTGEARMPNGRELPPL 344

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  120 bits (304), Expect = 1e-31
 Identities = 60/296 (20%), Positives = 123/296 (41%), Gaps = 37/296 (12%)

Query: 26  TVQRSKSFAFRAPQEHFSIQDFE-------LGKIYGVGSYSKVVRAK-KIDTGTVYALKI 77
           ++  ++SF  +A Q    +Q+++       +G++ G G + +V   +     G V A+++
Sbjct: 7   SLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH---GEV-AIRL 62

Query: 78  MDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           +D +   ++   A+ K E +   Q  H  VV           L +    C+G  L+  + 
Sbjct: 63  IDIERDNEDQLKAF-KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121

Query: 138 S-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
             K  L  ++ R    E+V  + Y+H+ G++H+D+K +N+    +G + I DFG      
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL----- 175

Query: 197 DSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGN---------DLWALGCTLY 246
              I+ +  A   +       G   ++ PE++                  D++ALG   Y
Sbjct: 176 -FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 247 QMLSGTSPFKD-TSEWLIFQRIIARDIRF---PNYFSDAARDLIDRLLDVDPSGRP 298
           ++ +   PFK   +E +I+Q  +   ++             D++      +   RP
Sbjct: 235 ELHAREWPFKTQPAEAIIWQ--MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  119 bits (301), Expect = 3e-31
 Identities = 74/319 (23%), Positives = 124/319 (38%), Gaps = 69/319 (21%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAY--VKLERI 97
           S   F+ L K+ G G+Y+ V +     TG   ALK +  K  ++E    TA   + L   
Sbjct: 3   SSSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISL--- 56

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG-----ELFDQITSKGHLSEDEARFYTA 152
            + +L H  +VRL+        L +  E  +       +      +   L  +  +++  
Sbjct: 57  -MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++  L + H   ++HRD+KP+NLL+   G +K+ DFG       +R   +P        
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL------ARAFGIPV-----NT 164

Query: 213 CTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE---------- 260
            +  V T  Y  P+VL  S   +   D+W+ GC L +M++G   F  T++          
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

Query: 261 --------W----------LIFQRIIARDIR------FPNYFSDAARDLIDRLLDVDPSG 296
                   W             Q+   RD+R                D +  LL ++P  
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284

Query: 297 RPGAGPGGYAVLKMHPFFK 315
           R  A       L  HP+F 
Sbjct: 285 RLSA----KQALH-HPWFA 298

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (297), Expect = 4e-31
 Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 31/269 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDK-KFITKENKTAYVKLERIVLDQL 102
            +  L +I G+G + KV RA      G   A+K                V+ E  +   L
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP ++ L        +L + +E   GG L   ++ K  +  D    +  ++   + Y+H
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLH 122

Query: 163 SMG---LIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAASDDK 211
                 +IHRD+K  N+L+             +KI DFG  +    +             
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM---------- 172

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
             +  G  A++ PEV+ +S  + G+D+W+ G  L+++L+G  PF+      +   +    
Sbjct: 173 --SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230

Query: 272 IR--FPNYFSDAARDLIDRLLDVDPSGRP 298
           +    P+   +    L++   + DP  RP
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRP 259

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  119 bits (301), Expect = 5e-31
 Identities = 73/324 (22%), Positives = 122/324 (37%), Gaps = 75/324 (23%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK-------IMDKKFITKENKTAYVKLERI 97
            DF+L  + G G+Y  V  A    TG + A+K        +      +E     +K+   
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-----IKI--- 62

Query: 98  VLDQLDHPGVVRL--------FFTFQDTFSLYMALESCEGGELFD----QITSKGHLSED 145
            L    H  ++ +        F  F +   +Y+  E      L      ++ S   LS+D
Sbjct: 63  -LKHFKHENIITIFNIQRPDSFENFNE---VYIIQE------LMQTDLHRVISTQMLSDD 112

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
             +++  + + A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S       
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 206 AASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---- 260
                    FV T  Y  PEV L S+  +   D+W+ GC L ++      F         
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232

Query: 261 WLIFQ------------RIIARDIR-------------FPNYFSDA---ARDLIDRLLDV 292
            LIF              I +   R                 F        DL+ R+L  
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292

Query: 293 DPSGRPGAGPGGYAVLKMHPFFKG 316
           DP+ R  A       L+ HP+ + 
Sbjct: 293 DPAKRITAK----EALE-HPYLQT 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  118 bits (298), Expect = 1e-30
 Identities = 76/356 (21%), Positives = 139/356 (39%), Gaps = 89/356 (25%)

Query: 23  NCPTVQRSKSFA---FRAPQEH---------FSIQD-FELGKIYGVGSYSKVVRAKKIDT 69
           + P   R++ +       P+E+         +  QD ++L +  G G YS+V  A  I  
Sbjct: 1   SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 60

Query: 70  GTVYALKIM---DKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD--TFSLYMA 123
                +KI+    KK I +E     +K+    L+ L   P ++ L    +D  + +  + 
Sbjct: 61  NEKVVVKILKPVKKKKIKRE-----IKI----LENLRGGPNIITLADIVKDPVSRTPALV 111

Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADG 182
            E     +      +   L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++     
Sbjct: 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168

Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPPEVL-NSSPATFGNDLWA 240
            +++ D+G            L       +     V +  +  PE+L +     +  D+W+
Sbjct: 169 KLRLIDWG------------LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216

Query: 241 LGCTLYQMLSGTSPF-------------------KDTSEWLIFQRI-IARD--------- 271
           LGC L  M+    PF                   +D  +++    I +            
Sbjct: 217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276

Query: 272 -IRFPNYF--------SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
             R+  +         S  A D +D+LL  D   R  A       ++ HP+F  + 
Sbjct: 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR----EAME-HPYFYTVV 327

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  118 bits (298), Expect = 1e-30
 Identities = 81/325 (24%), Positives = 128/325 (39%), Gaps = 85/325 (26%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 95
             +E+ + Y      G G+Y  V  A    TG   A+K + + F +  + K  Y  ++L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL- 81

Query: 96  RIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFD----QITSKGHL 142
              L  + H  V+ L            F D   +Y+         L       I     L
Sbjct: 82  ---LKHMKHENVIGLLDVFTPARSLEEFND---VYLVTH------LMGADLNNIVKCQKL 129

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           ++D  +F   +++  L+YIHS  +IHRD+KP NL +  D  +KI DFG            
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG------------ 177

Query: 203 LPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 260
           L    +D+    +V T  Y  PE+ LN        D+W++GC + ++L+G + F  T   
Sbjct: 178 LARHTADEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

Query: 261 ---WLIFQ-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLL 290
               LI +           +I +   R             F N F  A   A DL++++L
Sbjct: 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFK 315
            +D   R  A       L  H +F 
Sbjct: 297 VLDSDKRITAA----QALA-HAYFA 316

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  115 bits (291), Expect = 3e-30
 Identities = 38/273 (13%), Positives = 93/273 (34%), Gaps = 33/273 (12%)

Query: 40  EHFSI--QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           +H  I  +              ++ + + +   G    +K++  +  +      + + E 
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 97  IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT--A 152
             L    HP V+ +             +       G L++ +    +   D+++      
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 153 EVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
           ++   + ++H++   +    +   ++++  D   +I+        Q              
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------ 166

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                +   A+V PE L   P        D+W+    L+++++   PF D S   I  ++
Sbjct: 167 ---GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

Query: 268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
               +R   P   S     L+   ++ DP+ RP
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (293), Expect = 3e-30
 Identities = 59/272 (21%), Positives = 109/272 (40%), Gaps = 17/272 (6%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P   F   D   G++ G G + + ++    +TG V  +K + +    +E +  ++K E  
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLK-EVK 59

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+  L+HP V++          L    E  +GG L   I +        +   +  ++  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG----SVKPMQDSRITVLPNAASDDKA 212
            + Y+HSM +IHRD+   N L+  + ++ +ADFG     V                  K 
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
            T VG   ++ PE++N        D+++ G  L +++   +   D   +L        ++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---YLPRTMDFGLNV 236

Query: 273 R------FPNYFSDAARDLIDRLLDVDPSGRP 298
           R       P     +   +  R  D+DP  RP
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  117 bits (295), Expect = 4e-30
 Identities = 81/326 (24%), Positives = 135/326 (41%), Gaps = 85/326 (26%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 95
             +E+  +Y      G G+Y  V  A    TG   A+K + + F ++   K AY  ++L 
Sbjct: 19  TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL- 77

Query: 96  RIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFD----QITSKGHL 142
              L  + H  V+ L            F D    Y+ +              ++     L
Sbjct: 78  ---LKHMRHENVIGLLDVFTPDETLDDFTD---FYLVMP------FMGTDLGKLMKHEKL 125

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
            ED  +F   +++  L YIH+ G+IHRD+KP NL +  D  +KI DFG  +   DS +T 
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMT- 183

Query: 203 LPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 260
                       +V T  Y  PEV LN    T   D+W++GC + +M++G + FK +   
Sbjct: 184 -----------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232

Query: 261 ---WLIFQ-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLL 290
                I +           R+ + + +             F +  ++A   A +L++++L
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 292

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKG 316
            +D   R  AG      L  HP+F+ 
Sbjct: 293 VLDAEQRVTAG----EALA-HPYFES 313

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  115 bits (291), Expect = 4e-30
 Identities = 56/268 (20%), Positives = 114/268 (42%), Gaps = 33/268 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
              +G+  G GS+  V + K     G V A+K+++    T +   A+   E  VL +  H
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWH---GDV-AVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 79

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
             ++    ++     ++    + CEG  L+  +  S+      +      +    ++Y+H
Sbjct: 80  VNILLFMGYSTAPQLAIVT--QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  N+ L  D  +KI DFG       +      + +   +  +  G+  ++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSRWSGSHQFEQLS--GSILWM 189

Query: 223 PPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---------R 270
            PEV+   +S+P +F +D++A G  LY++++G  P+ + +      +II           
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIEMVGRGSLSPD 246

Query: 271 DIRFPNYFSDAARDLIDRLLDVDPSGRP 298
             +  +      + L+   L      RP
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERP 274

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  117 bits (294), Expect = 1e-29
 Identities = 76/385 (19%), Positives = 137/385 (35%), Gaps = 111/385 (28%)

Query: 28  QRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
               + +   P   + I D +E+  + G GSY  V  A       V A+K + + F   E
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---E 91

Query: 87  N----KTAY--VKLERIVLDQLDHPGVVRLF--------FTFQDTFSLYMALESCEGGEL 132
           +    K     + +    L++L+H  VV++           F +   LY+ LE  +  + 
Sbjct: 92  DLIDCKRILREIAI----LNRLNHDHVVKVLDIVIPKDVEKFDE---LYVVLEIADS-DF 143

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-- 190
                +  +L+E   +     ++  ++Y+HS G++HRD+KP N L+  D  +K+ DFG  
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 191 -SVKPMQDSRITVLPNAASDDKACTFVGTAA--------YV------PPEV-LNSSPATF 234
            +V   ++    +  +   DD                  +V       PE+ L     T 
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263

Query: 235 GNDLWALGCTLYQMLS-----------------GTSPFKDTSEW---------------- 261
             D+W++GC   ++L+                 G+S F  + +                 
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323

Query: 262 --LIFQRI--------------IARD----------IRFPNYFSDA---ARDLIDRLLDV 292
             +IF  +               A+                 F  +   A  L+ R+L  
Sbjct: 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVF 383

Query: 293 DPSGRPGAGPGGYAVLKMHPFFKGI 317
           +P+ R          L  HPFFK +
Sbjct: 384 NPNKRITIN----ECLA-HPFFKEV 403

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  115 bits (289), Expect = 3e-29
 Identities = 78/345 (22%), Positives = 126/345 (36%), Gaps = 83/345 (24%)

Query: 28  QRSKSFAFRAPQEHFSI--QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALK--- 76
                 A  A      +  Q F++G  Y      G G+Y  V  A         A+K   
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61

Query: 77  ----IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFS-LYMALESC 127
                   +   +E     +K+    L +  H  ++ +    +    +    +Y+  +  
Sbjct: 62  PFEHQTYCQRTLRE-----IKI----LLRFRHENIIGINDIIRAPTIEQMKDVYIVQD-- 110

Query: 128 EGGELFD----QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
               L +    ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     
Sbjct: 111 ----LMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALG 242
           +KI DFG       +R+   P+         +V T  Y  PE+ LNS   T   D+W++G
Sbjct: 167 LKICDFGL------ARVAD-PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 243 CTLYQMLSGTSPFKDTSE----WLIF-----------QRIIARDIR-------------F 274
           C L +MLS    F           I              II    R             +
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279

Query: 275 PNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              F +A   A DL+D++L  +P  R          L  HP+ + 
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVE----QALA-HPYLEQ 319

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  114 bits (288), Expect = 4e-29
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 72/319 (22%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 95
             +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY  + L 
Sbjct: 18  TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL- 76

Query: 96  RIVLDQLDHPGVVRLFFTFQ-----DTFS-LYMALESCEGGELFDQITSKGHLSEDEARF 149
              L  + H  V+ L   F        F   Y+ +   +  +L   +  K   SE++ ++
Sbjct: 77  ---LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQY 130

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +   D+ +T        
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMT-------- 181

Query: 210 DKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIF 264
                +V T  Y  PEV L+        D+W++GC + +ML+G + FK          I 
Sbjct: 182 ----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 265 Q-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLLDVDPSGR 297
           +           ++  +  +             F   F  A   A DL++++L++D   R
Sbjct: 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297

Query: 298 PGAGPGGYAVLKMHPFFKG 316
             A       L  HPFF+ 
Sbjct: 298 LTAA----QALT-HPFFEP 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  111 bits (281), Expect = 2e-28
 Identities = 75/331 (22%), Positives = 120/331 (36%), Gaps = 77/331 (23%)

Query: 42  FSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKT 89
            +I  F+LG  Y      G G    V  A   D     A+K          K   +E   
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE--- 58

Query: 90  AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--------ELFD----QIT 137
             +K+    + +LDH  +V++F     + S                   E  +     + 
Sbjct: 59  --IKI----IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL 112

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQ 196
            +G L E+ AR +  +++  L+YIHS  ++HRD+KP NL +   D  +KI DFG      
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL----- 167

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +R  + P+ +        + T  Y  P + L+ +  T   D+WA GC   +ML+G + F
Sbjct: 168 -AR-IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

Query: 256 KDTSE----WLIFQRI----------IARDIR-------------FPNYFSDA---ARDL 285
               E     LI + I          +   I                         A D 
Sbjct: 226 AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
           ++++L   P  R  A       L  HP+   
Sbjct: 286 LEQILTFSPMDRLTAE----EALS-HPYMSI 311

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  112 bits (283), Expect = 2e-28
 Identities = 63/338 (18%), Positives = 117/338 (34%), Gaps = 68/338 (20%)

Query: 28  QRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
            + ++       E  ++Q  + + +    GSY  V      +   V A+K +        
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGR 62

Query: 87  NKTAYVKL--------ERIVLDQLDHPGVVRLFFTF----QDTFS-LYMALESCEGGELF 133
                           E  +L+   HP ++ L   F    +     LY+  E     +L 
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121

Query: 134 DQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
             I   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I DF   
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN-- 179

Query: 193 KPMQDSRITVLPNAASDDKACT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLS 250
                     L    + D   T +V    Y  PE+ +     T   D+W+ GC + +M +
Sbjct: 180 ----------LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 251 GTSPFKDTSE----WLIFQ-----------RIIARDIR--------------FPNYFSDA 281
             + F+ ++       I +              +   R              +      A
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA 289

Query: 282 ---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              A DLI ++L+ +P  R          L+ HP+F+ 
Sbjct: 290 DPVALDLIAKMLEFNPQRRISTE----QALR-HPYFES 322

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  113 bits (284), Expect = 3e-28
 Identities = 66/323 (20%), Positives = 117/323 (36%), Gaps = 55/323 (17%)

Query: 44  IQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY-- 91
           I++  +   Y      G GSY  V  A   +T    A+K +++ F   E+          
Sbjct: 19  IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILRE 75

Query: 92  VKLERIVLDQLDHPGVVRL--------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
           + +    L++L    ++RL           F +   LY+ LE  +  +L     +   L+
Sbjct: 76  ITI----LNRLKSDYIIRLYDLIIPDDLLKFDE---LYIVLEIADS-DLKKLFKTPIFLT 127

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRI 200
           E+  +     ++    +IH  G+IHRD+KP N LL  D  +K+ DFG   ++   +D+ I
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 201 TVLPNAASDDKACTFVGTAA---YV------PPEV-LNSSPATFGNDLWALGCTLYQMLS 250
                   +              +V       PE+ L     T   D+W+ GC   ++L+
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 251 GTSPFKDTSEWL--IFQ-RIIARDIRFPNYFSDAARDLIDRL-LDVDPSGRPGA------ 300
                 +       +F            N      +   D+L +  +  G P        
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 301 -GPGGYAVLKMHPFFKGIDWKNI 322
             P     +K+ P  K I+ K  
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQK 330

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  111 bits (279), Expect = 8e-28
 Identities = 72/330 (21%), Positives = 125/330 (37%), Gaps = 88/330 (26%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--VKLERIV 98
           + ++  K  G G+   V  A         A+K + + F   +N+T    AY  + L    
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVL---- 77

Query: 99  LDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF 149
           +  ++H  ++ L            FQD   +Y+ +E  +   L   I  +  L  +   +
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQD---VYIVMELMDA-NLCQVI--QMELDHERMSY 131

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG            L   A  
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------LARTAGT 179

Query: 210 DKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
               T +V T  Y  PEV+         D+W++GC + +M+ G   F  T     + ++I
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239

Query: 269 -----------------ARD----------IRFPNYFSDA---------------ARDLI 286
                             R             F   F D                ARDL+
Sbjct: 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            ++L +D S R          L+ HP+   
Sbjct: 300 SKMLVIDASKRISVD----EALQ-HPYINV 324

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  111 bits (279), Expect = 8e-28
 Identities = 76/342 (22%), Positives = 125/342 (36%), Gaps = 99/342 (28%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           + LGK  G GS+  V     I++G  +ALK  + D ++  +E           ++  LDH
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD---------IMKVLDH 59

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGG--------------------------------EL 132
             +++L   F  T                                             E 
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 133 FDQ---------ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DG 182
                       I S   +  +    Y  ++  A+ +IHS+G+ HRDIKP+NLL+ + D 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWAL 241
            +K+ DFGS K +  S  +V            ++ +  Y  PE+ L ++  T   DLW++
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV-----------AYICSRFYRAPELMLGATEYTPSIDLWSI 228

Query: 242 GCTLYQMLSGTSPFKDTSE----WLI-----------------------FQRIIARDIR- 273
           GC   +++ G   F   +       I                       F  + A+D R 
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288

Query: 274 -FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
             P      A DL++++L  +P  R       Y  +  HPFF
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINP----YEAMA-HPFF 325

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  110 bits (276), Expect = 2e-27
 Identities = 68/326 (20%), Positives = 123/326 (37%), Gaps = 80/326 (24%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             F++ ++ G G++  V   K+  TG   A+K   K       +   +++ +  L  L H
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQDPRFRNRELQIMQD-LAVLHH 78

Query: 105 PGVVRL---FFT-----FQDTFSLYMALESCEGGELFDQ---------ITSKGHLSEDEA 147
           P +V+L   F+T      +D + L + +E                      +        
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIY-LNVVME------YVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 148 RFYTAEVVDALEYIH--SMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLP 204
           + +  +++ ++  +H  S+ + HRDIKP N+L+  ADG +K+ DFGS K +  S   V  
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV-- 189

Query: 205 NAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
                     ++ +  Y  PE+   +   T   D+W++GC   +M+ G   F+  +    
Sbjct: 190 ---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240

Query: 264 FQRII-------ARDIR----------------------FPNYFSDA---ARDLIDRLLD 291
              I+          +R                      F ++       A DL+  LL 
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300

Query: 292 VDPSGRPGAGPGGYAVLKMHPFFKGI 317
             P  R       Y  L  HP+F  +
Sbjct: 301 YLPEERMKP----YEALC-HPYFDEL 321

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  110 bits (276), Expect = 5e-27
 Identities = 73/336 (21%), Positives = 128/336 (38%), Gaps = 94/336 (27%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--V 92
             F + K Y      G G+   V  A         A+K + + F   +N+T    AY  +
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYREL 112

Query: 93  KLERIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
            L    +  ++H  ++ L            FQD   +Y+ +E  +   L   I  +  L 
Sbjct: 113 VL----MKCVNHKNIISLLNVFTPQKTLEEFQD---VYLVMELMDA-NLCQVIQME--LD 162

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
            +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG            L
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------L 210

Query: 204 PNAASDDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 262
              A      T +V T  Y  PEV+         D+W++GC + +M+     F       
Sbjct: 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

Query: 263 IFQRII-----------------ARD----------IRFPNYFSDA-------------- 281
            + ++I                  R+          + FP  F D+              
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330

Query: 282 -ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            ARDL+ ++L +DP+ R          L+ HP+   
Sbjct: 331 QARDLLSKMLVIDPAKRISVD----DALQ-HPYINV 361

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  108 bits (271), Expect = 1e-26
 Identities = 77/349 (22%), Positives = 128/349 (36%), Gaps = 96/349 (27%)

Query: 46  DFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--VK 93
           D  + + Y      G G+Y  V ++    TG V A+K +   F   +N T     +  + 
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIM 60

Query: 94  LERIVLDQL-DHPGVVRLFFTFQ-DTFS-LYMALESCEGGELFD----QITSKGHLSEDE 146
           +    L +L  H  +V L    + D    +Y+  +        +     +     L    
Sbjct: 61  I----LTELSGHENIVNLLNVLRADNDRDVYLVFD------YMETDLHAVIRANILEPVH 110

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVL 203
            ++   +++  ++Y+HS GL+HRD+KP N+LL A+ H+K+ADFG   S   ++     + 
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 204 PNAASDDKACT--------FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSP 254
            +   + +           +V T  Y  PE+ L S+  T G D+W+LGC L ++L G   
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

Query: 255 F--KDT----------------------------------------SEWLIFQRIIARDI 272
           F    T                                         +            
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290

Query: 273 RFPNYFSDA-----ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
                   A     A DL+D+LL  +P+ R  A       LK HPF   
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISAN----DALK-HPFVSI 334

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (265), Expect = 1e-25
 Identities = 68/347 (19%), Positives = 117/347 (33%), Gaps = 102/347 (29%)

Query: 43  SIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            + ++E  K+ G G+Y  V +A  K       YALK      I     +     E  +L 
Sbjct: 20  DLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQ-----IEGTGISMSACREIALLR 73

Query: 101 QLDHPGVVRLF--FTFQDTFSLYMALESCE--------GGELFDQITSKGHLSEDEARFY 150
           +L HP V+ L   F       +++  +  E                     L     +  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFG-------SVKPMQDSR 199
             +++D + Y+H+  ++HRD+KP N+L+  +    G +KIAD G        +KP+ D  
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             V+              T  Y  PE+L    + + A    D+WA+GC   ++L+    F
Sbjct: 194 PVVV--------------TFWYRAPELLLGARHYTKAI---DIWAIGCIFAELLTSEPIF 236

Query: 256 KDTSEWLIFQRIIARD--------------------IRFPNY------------------ 277
               E +        D                     + P +                  
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296

Query: 278 ---------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                        A  L+ +LL +DP  R  +       ++  P+F 
Sbjct: 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS----EQAMQ-DPYFL 338

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  103 bits (260), Expect = 1e-25
 Identities = 62/315 (19%), Positives = 109/315 (34%), Gaps = 65/315 (20%)

Query: 26  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 85
           ++QR+ +            +D  L +  G G Y +V R      G   A+KI    F ++
Sbjct: 1   SMQRTVA------------RDITLLECVGKGRYGEVWRGSW--QGENVAVKI----FSSR 42

Query: 86  ENKTAYVKLERIVLDQLDHPGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGH 141
           + K+ + + E      L H  ++        +   +  L++     E G L+D +     
Sbjct: 43  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-T 101

Query: 142 LSEDEARFYTAEVVDALEYIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVK 193
           L           +   L ++H           + HRD+K +N+L+  +G   IAD G   
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-- 159

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQ 247
               + +        D      VGT  Y+ PEVL+ +            D+WA G  L++
Sbjct: 160 ----AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215

Query: 248 MLSGTSPFKDTSEWLI-FQRIIARDIRF-----------------PNYFSDAA----RDL 285
           +           ++   F  ++  D  F                   +FSD        L
Sbjct: 216 VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL 275

Query: 286 IDRLLDVDPSGRPGA 300
           +      +PS R  A
Sbjct: 276 MKECWYQNPSARLTA 290

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (256), Expect = 1e-24
 Identities = 74/354 (20%), Positives = 125/354 (35%), Gaps = 105/354 (29%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LER 96
           E +    + L +  G G +S V  AK +   T  A+KI+            Y +    E 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEAAEDEI 66

Query: 97  IVLDQL--------DHPG---VVRLF--FTFQDTFSLYMALESCE--GGELFDQITSKGH 141
            +L ++        D  G   +++L   F  +    +++ +   E  G  L   I    H
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM-VFEVLGENLLALIKKYEH 125

Query: 142 --LSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLL------TADGHIKIADFGSV 192
             +     +  + +++  L+Y+H   G+IH DIKPEN+L+           IKIAD G+ 
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN- 184

Query: 193 KPMQDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
                         A   D+     + T  Y  PEVL  +P   G D+W+  C ++++++
Sbjct: 185 --------------ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

Query: 251 GTSPF--KDTSEWLIFQRIIARDIR----FPNYFSDAAR--------------------- 283
           G   F   +   +      IA+ I      P+Y     +                     
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290

Query: 284 ---------------------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
                                D +  +L +DP  R  AG      L  HP+ K 
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG-----LVNHPWLKD 339

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 62/297 (20%), Positives = 107/297 (36%), Gaps = 55/297 (18%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ++ K  G G Y +V   K +   G   A+K+    F T E  + + + E      + 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKV----FFTTEEASWFRETEIYQTVLMR 89

Query: 104 HPGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
           H  ++               LY+  +  E G L+D + S   L            V  L 
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLC 148

Query: 160 YIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           ++H+          + HRD+K +N+L+  +G   IAD G       +   +      D  
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVKFISDTNEVDIP 202

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLI-- 263
             T VGT  Y+PPEVL+ S            D+++ G  L+++           E+ +  
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 264 ------------FQRIIARD-IR--FPNYFSDAA-----RDLIDRLLDVDPSGRPGA 300
                        + I+    +R  FPN +S          L+      +P+ R  A
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 53/296 (17%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +   L +  G G + +V R K    G   A+KI    F ++E ++ + + E      L H
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKI----FSSREERSWFREAEIYQTVMLRH 95

Query: 105 PGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             ++               L++  +  E G LFD +     ++ +            L +
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAH 154

Query: 161 IHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +H           + HRD+K +N+L+  +G   IAD G       +          D   
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVRHDSATDTIDIAP 208

Query: 213 CTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTS----------PFK 256
              VGT  Y+ PEVL+ S            D++A+G   +++    S          P+ 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 257 -----DTSEWLIFQRIIARDIR--FPNYFSD-----AARDLIDRLLDVDPSGRPGA 300
                D S   + + +  + +R   PN +           ++      + + R  A
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 40/254 (15%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQL- 102
           +E+  + G GS+ +VV+A         A+KI+       +NK A++    +E  +L+ + 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108

Query: 103 -----DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 155
                    +V L   F     L +  E      L+D + +     +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 156 DALEYIHS--MGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAAS--D 209
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS               +    
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS---------------SCQLG 212

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
            +   ++ +  Y  PEVL   P     D+W+LGC L +M +G   F   +E     +I+ 
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

Query: 270 RDIRFPNYFSDAAR 283
                P +  D A 
Sbjct: 273 VLGIPPAHILDQAP 286

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 52/259 (20%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQL- 102
           +E+ K+ G GS+ +VV+A         ALK++        N+  + +    E  +L+ L 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLR 151

Query: 103 -----DHPGVVRL--FFTFQD----TF-----SLYMALESCEGGELFDQITSKGHLSEDE 146
                +   V+ +   FTF++    TF     +LY         EL  +   +G  S   
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY---------ELIKKNKFQG-FSLPL 201

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLP 204
            R +   ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS------------- 248

Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           +     +  T++ +  Y  PEV+  +      D+W+LGC L ++L+G        E    
Sbjct: 249 SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308

Query: 265 QRIIARDIRFPNYFSDAAR 283
             +I           DA++
Sbjct: 309 ACMIELLGMPSQKLLDASK 327

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 46/233 (19%), Positives = 87/233 (37%), Gaps = 34/233 (14%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 103
           + +L ++ G G Y  V +          A+K+         N+  ++  E+ +  +  ++
Sbjct: 14  NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFIN-EKNIYRVPLME 65

Query: 104 HPGVVRLF-----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           H  + R        T        + +E    G L   ++         +      V   L
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGL 124

Query: 159 EYIHSM---------GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
            Y+H+           + HRD+   N+L+  DG   I+DFG    +  +R+        D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV--RPGEED 182

Query: 210 DKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLSGTSPF 255
           + A + VGT  Y+ PEVL  +        A    D++ALG   +++    +  
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 63/343 (18%), Positives = 113/343 (32%), Gaps = 93/343 (27%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK--------LERIV 98
           F + +  G G++ +V+  + ID    YA+K++        N   Y +        L++I 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQ 89

Query: 99  LDQLDHPGVVRLF--FTFQD----TFSLYMALESCEGGELFDQITSKGH--LSEDEARFY 150
            D +++  +V+    F + D     F          G  L++ IT   +     ++ + Y
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFEPL-------GPSLYEIITRNNYNGFHIEDIKLY 142

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS-- 208
             E++ AL Y+  M L H D+KPEN+LL      K                    +    
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 209 ----------DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
                      D   + + T  Y  PEV+ +      +D+W+ GC L ++ +G+  F+  
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 259 SEWLIFQRIIARDIRFPNYFSDAAR----------------------------------- 283
                   + +     P      A                                    
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 284 -----------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                      D +  +L +DP+ RP       A L  H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSP-----AELLKHKFLE 360

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 34/234 (14%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
             +L ++   G +  V +A+        A+KI       ++ ++   + E   L  + H 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP----IQDKQSWQNEYEVYSLPGMKHE 78

Query: 106 GVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            +++              L++     E G L D + +   +S +E       +   L Y+
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137

Query: 162 HSMGL----------IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           H               HRDIK +N+LL  +    IADFG     +  +     +      
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ---- 193

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
               VGT  Y+ PEVL  +     +     D++A+G  L+++ S  +      +
Sbjct: 194 ----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 25/262 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  LG+  G G++ +V   +     T+ A+K   ++ +  + K  +++ E  +L Q  HP
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQ-EARILKQYSHP 172

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSM 164
            +VRL         +Y+ +E  +GG+    + ++G  L          +    +EY+ S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP- 223
             IHRD+   N L+T    +KI+DFG  +   D                   G    VP 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-------------SGGLRQVPV 279

Query: 224 ----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR--FPN 276
               PE LN    +  +D+W+ G  L++  S G SP+ + S     + +  +  R   P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPE 338

Query: 277 YFSDAARDLIDRLLDVDPSGRP 298
              DA   L+++    +P  RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 72/354 (20%), Positives = 111/354 (31%), Gaps = 117/354 (33%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYV---KLERIVLDQL 102
           +E+    G G++ KVV         +  ALKI+        N   Y    +LE  VL ++
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKI 73

Query: 103 ------DHPGVVRLF--FTFQD----TFSLYMALESCEGGELFDQITSKGH--LSEDEAR 148
                 +    V +   F F       F L        G   F+ +             R
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-------GKNTFEFLKENNFQPYPLPHVR 126

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADF 189
               ++  AL ++H   L H D+KPEN+L                         I++ADF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 190 GSVKPMQDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           GS               A+   +   T V T  Y PPEV+         D+W++GC L++
Sbjct: 187 GS---------------ATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

Query: 248 MLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR------------------------ 283
              G + F+          +       P++     R                        
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291

Query: 284 --------------------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
                               DL+ R+L+ DP+ R          L  HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL----AEALL-HPFFAGL 340

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 20/216 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 102
            D  +    G G Y +V            A+K +      KE+     +   E  V+ ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI 273

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEY 160
            HP +V+L          Y+  E    G L D +       +S     +   ++  A+EY
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +     IHR++   N L+  +  +K+ADFG  + M     T     A          TA 
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-----AHAGAKFPIKWTA- 387

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 388 ---PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 73/348 (20%), Positives = 116/348 (33%), Gaps = 105/348 (30%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYV---KLERIVLDQL 102
           +E+    G G++ KVV       G  + A+KI+       +N   Y    + E  VL+ L
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68

Query: 103 ------DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEV 154
                      V++   F+    + +  E   G   +D I   G      D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADFGSVKPM 195
             ++ ++HS  L H D+KPEN+L     +                   IK+ DFGS    
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS---- 183

Query: 196 QDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 253
                      A+  D+   T V T  Y  PEV+ +   +   D+W++GC L +   G +
Sbjct: 184 -----------ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 254 PFKDTSEWLIFQRIIA----------RDIRFPNYFSD----------------------- 280
            F           +            +  R   YF                         
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 281 -----------AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
                         DLI ++L+ DP+ R          LK HPFF  +
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITL----REALK-HPFFDLL 335

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 28/244 (11%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYA 74
            +           +F  R P + F  +  +  +  G G++  V   +    + +TG V A
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74

Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGEL 132
           +K +  +  T+E+   + + E  +L  L H  +V+           +L + +E    G L
Sbjct: 75  VKKL--QHSTEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 133 FDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
            D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG 
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG- 190

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLY 246
                      L      DK    V      P     PE L  S  +  +D+W+ G  LY
Sbjct: 191 -----------LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239

Query: 247 QMLS 250
           ++ +
Sbjct: 240 ELFT 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 46/234 (19%), Positives = 96/234 (41%), Gaps = 29/234 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +F+  K+ G G++  V +     +   V    A+K + ++  + +     +  E  V+  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILD-EAYVMAS 73

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           +D+P V RL       T  + +  +    G L D +   K ++       +  ++   + 
Sbjct: 74  VDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+    L+HRD+   N+L+    H+KI DFG  K +             ++K   +    
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEK--EYHAEG 178

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
             VP      E +     T  +D+W+ G T++++++ G+ P+       I   +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 35/250 (14%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFIT 84
            ++ +A + P   F  +  +     G G++  V   +      +TG + A+K +      
Sbjct: 8   HAQLYACQDPTI-FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------ 60

Query: 85  KENKTAYVK---LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TS 138
           + +     +    E  +L  L    +V+           SL + +E    G L D +   
Sbjct: 61  QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 198
           +  L       Y++++   +EY+ S   +HRD+   N+L+ ++ H+KIADFG        
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG-------- 172

Query: 199 RITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GT 252
               L      DK    V      P     PE L+ +  +  +D+W+ G  LY++ +   
Sbjct: 173 ----LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228

Query: 253 SPFKDTSEWL 262
                ++E+L
Sbjct: 229 KSCSPSAEFL 238

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 27/222 (12%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
            F  +  +  +  G G++  V   +    + +TG V A+K +  +  T+E+   + + E 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER-EI 62

Query: 97  IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+           +L + +E    G L D +   K  +   +   YT++
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   +EY+ +   IHRD+   N+L+  +  +KI DFG            L      DK  
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG------------LTKVLPQDKEF 170

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS 250
             V      P     PE L  S  +  +D+W+ G  LY++ +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
              L    G G + +V       T  V A+K +      K    +      E  V+ +L 
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLR 237

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYI 161
           H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + Y+
Sbjct: 238 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             M  +HRD++  N+L+  +   K+ADFG  + ++D+  T     A          TA  
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-----ARQGAKFPIKWTA-- 349

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 350 --PEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
              L    G G + +V       T  V A+K +      K    +      E  V+ +L 
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLR 320

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYI 161
           H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + Y+
Sbjct: 321 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             M  +HRD++  N+L+  +   K+ADFG  + ++D+  T     A          TA  
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-----ARQGAKFPIKWTA-- 432

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 433 --PEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 27/238 (11%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           F  +  +  +  G G + KV           TG + A+K + K     ++++ + + E  
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQ-EID 85

Query: 98  VLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           +L  L H  +++           SL + +E    G L D +  +  +   +   +  ++ 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC 144

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + Y+H+   IHRD+   N+LL  D  +KI DFG            L  A  +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG------------LAKAVPEGHEYYR 192

Query: 216 VGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           V      P     PE L      + +D+W+ G TLY++L+   S     +++L    I
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 27/224 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQL 102
             ELG+  G G +  V +   +         A+K   K   +   +  +++ E + + Q 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQ-EALTMRQF 448

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
           DHP +V+L     +   +++ +E C  GEL   +   K  L       Y  ++  AL Y+
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS                +  +   
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------------TYYKASKGK 553

Query: 222 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +P     PE +N    T  +D+W  G  ++++L  G  PF+   
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 26/222 (11%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           HF  +  +  +  G G + KV   +      +TG   A+K + K      +     K E 
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKK-EI 74

Query: 97  IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG            L  A   DK  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG------------LTKAIETDKEY 182

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS 250
             V      P     PE L  S     +D+W+ G TL+++L+
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 31/235 (13%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLD 100
           +F+  K+ G G++  V +   I  G      V A+K + ++  + +     +  E  V+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKEL-REATSPKANKEILD-EAYVMA 72

Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 158
            +D+P V RL       T  + +  +    G L D +   K ++       +  ++   +
Sbjct: 73  SVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+    L+HRD+   N+L+    H+KI DFG  K +             ++K   +   
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEK--EYHAE 177

Query: 219 AAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
              VP      E +     T  +D+W+ G T++++++ G+ P+       I   +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 28/231 (12%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYVKLE 95
            +++  I D ELG     G++  V +   ++    +  A+K++ K+   K +    ++ E
Sbjct: 7   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMR-E 60

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEV 154
             ++ QLD+P +VRL    Q   +L + +E   GG L   +   +  +          +V
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG            L  A   D +  
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG------------LSKALGADDSYY 167

Query: 215 FVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
              +A   P     PE +N    +  +D+W+ G T+++ LS G  P+K   
Sbjct: 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 71/365 (19%), Positives = 111/365 (30%), Gaps = 117/365 (32%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPG-- 106
           G G +S V  +  I      A+K++  K      +TA    E  +L  +     + P   
Sbjct: 46  GWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETA--LDEIRLLKSVRNSDPNDPNRE 101

Query: 107 -VVRLFFTFQDTFSLY--------MALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 155
            VV+L     D F +         M  E   G  L   I    +  L     +    +V+
Sbjct: 102 MVVQLL----DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 156 DALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---------------- 198
             L+Y+H+   +IH DIKPEN+LL+ +              Q S                
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 199 -------------------RITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGNDL 238
                              +I  L NA    K  T  + T  Y   EVL  S      D+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276

Query: 239 WALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIR----FP-----------NYFSD- 280
           W+  C  +++ +G   F      E+   +  IA  I      P            +F+  
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336

Query: 281 ------------------------------AARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
                                            D +  +L++ P  R  A       L+ 
Sbjct: 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA----ECLR- 391

Query: 311 HPFFK 315
           HP+  
Sbjct: 392 HPWLN 396

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 28/232 (12%)

Query: 35  FRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYV 92
               +++  I D ELG     G++  V +   ++    +  A+K++ K+   K +    +
Sbjct: 330 LFLKRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM 384

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYT 151
           + E  ++ QLD+P +VRL    Q   +L + +E   GG L   +   +  +         
Sbjct: 385 R-EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +V   ++Y+     +HR++   N+LL    + KI+DFG            L  A   D 
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG------------LSKALGADD 490

Query: 212 ACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
           +     +A   P     PE +N    +  +D+W+ G T+++ LS G  P+K 
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 24/224 (10%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
              + KI G G   +V     +      V  A+K + K   T+  +  ++  E  ++ Q 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLS-EASIMGQF 107

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
           DHP ++RL           +  E  E G L   + T  G  +  +       V   + Y+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             +G +HRD+   N+L+ ++   K++DFG    +  SR+        DD    +  T   
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFG----L--SRVL------EDDPDAAYTTTGGK 215

Query: 222 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +P     PE +     +  +D+W+ G  ++++L+ G  P+ + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
             ELG+  G G +  V +      +   +  A+K   K   +   +  +++ E + + Q 
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQ-EALTMRQF 73

Query: 103 DHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           DHP +V+L    T      +++ +E C  GEL   +   K  L       Y  ++  AL 
Sbjct: 74  DHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ S   +HRDI   N+L++++  +K+ DFG  + M+DS                +  + 
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------------TYYKASK 176

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +P     PE +N    T  +D+W  G  ++++L  G  PF+   
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 47/225 (20%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQ 101
                K+ G G + +V +   K  +G      A+K + K   T++ +  ++  E  ++ Q
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLG-EAGIMGQ 102

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEY 160
             H  ++RL         + +  E  E G L   +    G  S  +       +   ++Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           + +M  +HRD+   N+L+ ++   K++DFG    +  SR+        DD   T+  +  
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFG----L--SRVL------EDDPEATYTTSGG 210

Query: 221 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +P     PE ++    T  +D+W+ G  ++++++ G  P+ + S
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 44/234 (18%), Positives = 93/234 (39%), Gaps = 29/234 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +    K+ G G +  V +   I  G        +K++ +    +++  A      + +  
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTD-HMLAIGS 71

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           LDH  +VRL       +  L +  +    G L D +   +G L       +  ++   + 
Sbjct: 72  LDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+   G++HR++   N+LL +   +++ADFG    +             DDK      + 
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP-----------DDKQLL--YSE 176

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           A  P      E ++    T  +D+W+ G T++++++ G  P+       +   +
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 58/245 (23%), Positives = 95/245 (38%), Gaps = 31/245 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +D  L +  G GS+  V R +    +G     A+K +    +++         E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 102 LDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 158
           LDH  ++RL+          + M  E    G L D++   +GH        Y  +V + +
Sbjct: 78  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG- 217
            Y+ S   IHRD+   NLLL     +KI DFG ++ +            +DD        
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----------NDDHYVMQEHR 184

Query: 218 ------TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
                  A    PE L +   +  +D W  G TL++M + G  P+   +   I  +I   
Sbjct: 185 KVPFAWCA----PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240

Query: 271 DIRFP 275
             R P
Sbjct: 241 GERLP 245

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 47/224 (20%), Positives = 96/224 (42%), Gaps = 24/224 (10%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +  + K+ G G + +V     K      +  A+K + K   T++ +  ++  E  ++ Q 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLG-EASIMGQF 103

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
           DHP ++RL      +  + +  E  E G L   +       +  +       +   ++Y+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             MG +HRD+   N+L+ ++   K++DFG    +   R+        DD    +      
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFG----L--GRVL------EDDPEAAYTTRGGK 211

Query: 222 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +P     PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 30/221 (13%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 102
            D  +    G G Y +V            A+K +      KE+     +   E  V+ ++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI 66

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEY 160
            HP +V+L          Y+  E    G L D  +  ++  +S     +   ++  A+EY
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +     IHRD+   N L+  +  +K+ADFG  + M     T                  A
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--------------AHAGA 172

Query: 221 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             P     PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.0 bits (180), Expect = 5e-15
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 102
            +    +  G G +  V     ++   V A+K +      +E   +      E  V+ +L
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI------REGAMSEEDFIEEAEVMMKL 60

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
            HP +V+L+    +   + +  E  E G L D + T +G  + +       +V + + Y+
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               +IHRD+   N L+  +  IK++DFG       +R         DD+  +  GT   
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGM------TRFV------LDDQYTSSTGTKFP 168

Query: 222 V---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           V    PEV + S  +  +D+W+ G  ++++ S G  P+
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 26/228 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYVKLE 95
            ++  +++D ELG     G++  V +   ++       A+KI+  +      K   +  E
Sbjct: 14  DRKLLTLEDKELGS----GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-E 68

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             V+ QLD+P +VR+    +   S  + +E  E G L   +    H+ +        +V 
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             ++Y+     +HRD+   N+LL    + KI+DFG            L  A   D+    
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG------------LSKALRADENYYK 175

Query: 216 VGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
             T    P     PE +N    +  +D+W+ G  +++  S G  P++ 
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 31/226 (13%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
           D  L +I G G + +V            +  A+K   KK  T +NK  ++  E +++  L
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMS-EAVIMKNL 70

Query: 103 DHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           DHP +V+L      +     ++ +E    GEL   +  +K  L       Y+ ++  A+ 
Sbjct: 71  DHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D                 +  + 
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------------DYYKASV 173

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +P     PE +N    T  +D+W     ++++LS G  PF    
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 22/218 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           F +GK  G G++ ++   K + T    A+K+   K     ++   + LE     QL    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGD 65

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+ ++++         M LE    S E  +LFD        S         +++  +EY+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLE--DLFDL--CDRTFSLKTVLMIAIQLISRMEYV 121

Query: 162 HSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           HS  LI+RD+KPEN L+   G+     I I DF   K   D   T       + K+    
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE-TKKHIPYREHKS--LT 178

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           GTA Y+          +  +DL ALG      L G+ P
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
           F LG+  G GS+ ++     I T    A+K+ + K      K   +  E  +   L    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQGGT 63

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+  + +   +     + ++    S E  +LF+       LS         ++++ +E++
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLE--DLFNFC--SRKLSLKTVLMLADQMINRVEFV 119

Query: 162 HSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           HS   +HRDIKP+N L+        + I DFG  K  +D+  T       ++K     GT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-THQHIPYRENKN--LTGT 176

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           A Y           +  +DL +LG  L   L G+ P
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 72.2 bits (178), Expect = 1e-14
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +  L K  G G +  V   K      V A+K++      KE   +  +   E   + +L 
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI------KEGSMSEDEFFQEAQTMMKLS 61

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP +V+ +      + +Y+  E    G L + + S G  L   +      +V + + ++ 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   IHRD+   N L+  D  +K++DFG    M  +R         DD+  + VGT   V
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFG----M--TRYV------LDDQYVSSVGTKFPV 169

Query: 223 ---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               PEV +    +  +D+WA G  ++++ S G  P+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 45/231 (19%), Positives = 93/231 (40%), Gaps = 24/231 (10%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
              ++ G G +  V     +D        A+K +  +       + ++  E I++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 149

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
           P V+ L     +   S  + L   + G+L + I     + +  +   +  +V   ++++ 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRD+   N +L     +K+ADFG  + M D            +       T A +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----------KEFDSVHNKTGAKL 258

Query: 223 P-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           P      E L +   T  +D+W+ G  L+++++ G  P+ D + + I   +
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 22/218 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           +++G+  G GS+  +     +      A+K   ++     +    ++ E      L    
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 66

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+  +++  Q+     + ++    S E  +L D        S         +++  ++ I
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDL--CGRKFSVKTVAMAAKQMLARVQSI 122

Query: 162 HSMGLIHRDIKPENLLL----TADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           H   L++RDIKP+N L+    + + + I + DFG VK  +D   T       + K     
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV-TKQHIPYREKKN--LS 179

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           GTA Y+          +  +DL ALG      L G+ P
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 22/217 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           + LG+  G GS+  +     I  G   A+K+   K      K   + +E  +   +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGV 65

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+  + +   +     M +E    S E  +LF+        S         +++  +EYI
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLE--DLFNF--CSRKFSLKTVLLLADQMISRIEYI 121

Query: 162 HSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRI-TVLPNAASDDKACTFVG 217
           HS   IHRD+KP+N L+        + I DFG  K  +D+R    +P      +     G
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY----RENKNLTG 177

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           TA Y           +  +DL +LG  L     G+ P
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 40/224 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
             +L K  G G + +V  A       V A+K M      K    +      E  V+  L 
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM------KPGSMSVEAFLAEANVMKTLQ 241

Query: 104 HPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 159
           H  +V+L    T +    +Y+  E    G L D + S         +   ++A++ + + 
Sbjct: 242 HDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG-- 217
           +I     IHRD++  N+L++A    KIADFG            L     D++     G  
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFG------------LARVIEDNEYTAREGAK 346

Query: 218 -----TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                TA    PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 347 FPIKWTA----PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 70.3 bits (173), Expect = 6e-14
 Identities = 37/157 (23%), Positives = 69/157 (43%), Gaps = 20/157 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI-----MDKKFITKENKTAYVKLER 96
            ++++ +L +  G G +  V+         V A+K        + F+           E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLA----------EA 65

Query: 97  IVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAE 153
            V+ QL H  +V+L     ++   LY+  E    G L D  +   +  L  D    ++ +
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           V +A+EY+     +HRD+   N+L++ D   K++DFG
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 45/231 (19%), Positives = 94/231 (40%), Gaps = 24/231 (10%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
              ++ G G +  V     +D        A+K +  +       + ++  E I++    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 85

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
           P V+ L     +   S  + L   + G+L + I     + +  +   +  +V   ++Y+ 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRD+   N +L     +K+ADFG    +  +R     +    +       T A +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFG----L--AR-----DMYDKEYYSVHNKTGAKL 194

Query: 223 P-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           P      E L +   T  +D+W+ G  L+++++ G  P+ D + + I   +
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 20/154 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK-----IMDKKFITKENKTAYVKLERIVL 99
           ++ +L +  G G +  V+         V A+K        + F+           E  V+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLA----------EASVM 240

Query: 100 DQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVD 156
            QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           A+EY+     +HRD+   N+L++ D   K++DFG
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 46/241 (19%), Positives = 96/241 (39%), Gaps = 27/241 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKL 94
           P E          ++ G G +  V   + ID        A+K +  +    +   A+++ 
Sbjct: 17  PHERVVTH---SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLR- 71

Query: 95  ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTA 152
           E +++  L+HP V+ L           ++ L     G+L   I + + + +  +   +  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +V   +EY+     +HRD+   N +L     +K+ADFG  + + D            +  
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----------REYY 180

Query: 213 CTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR 266
                  A +P      E L +   T  +D+W+ G  L+++L+ G  P++    + +   
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

Query: 267 I 267
           +
Sbjct: 241 L 241

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           D    K  G G +  V   K      V A+K++      KE   +  +   E  V+  L 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMI------KEGSMSEDEFIEEAKVMMNLS 77

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
           H  +V+L+        +++  E    G L + +   +      +      +V +A+EY+ 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRD+   N L+   G +K++DFG       SR         DD+  + VG+   V
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGL------SRY------VLDDEYTSSVGSKFPV 185

Query: 223 ---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              PPEVL  S  +  +D+WA G  ++++ S G  P+
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 40/224 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
             +L +  G G + +V          V A+K +      K+   +      E  ++ QL 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQ 66

Query: 104 HPGVVRLF--FTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALE 159
           H  +VRL+   T +    +Y+  E  E G L D  +  S   L+ ++     A++ + + 
Sbjct: 67  HQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG-- 217
           +I     IHRD++  N+L++     KIADFG            L     D++     G  
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG------------LARLIEDNEYTAREGAK 171

Query: 218 -----TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                TA    PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 172 FPIKWTA----PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 35/232 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           Q F LG++ G G +  V  A+           A+K++    I   +   +++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81

Query: 102 LDHPGVVRLF------FTFQDTFSLYMALESCEGGELFD------QITSKGHLSEDEARF 149
            DHP V +L                 + L   + G+L           +  +L       
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           +  ++   +EY+ S   IHRD+   N +L  D  + +ADFG  + +              
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR------- 194

Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                  G A+ +P      E L  +  T  +D+WA G T++++++ G +P+
Sbjct: 195 ------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 41/232 (17%), Positives = 80/232 (34%), Gaps = 32/232 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTV--------YALKI--------MDKKFITKENKTA 90
           ++L       +   +  A    T T         ++LK+         ++ F  +  K  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 91  YVKLERIVLDQLDHPGV--VRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSE 144
            V   +  L       +     F   QD +  ++ L     S +     D  + K  LSE
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQ--SALDV-SPKHVLSE 158

Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITV 202
                    ++DALE++H    +H ++  EN+ +       + +A +G       S   V
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
              A  +       G   ++  ++      +  +DL +LG  + + L G  P
Sbjct: 219 ---AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 42/236 (17%), Positives = 84/236 (35%), Gaps = 36/236 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
             + +   + +  G GS+  V         K +  T  A+K    +  +   +  ++  E
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLN-E 78

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------FDQITSKGHLSED 145
             V+ + +   VVRL           + +E    G+L                    S  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++       
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 195

Query: 206 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                      G    +P     PE L     T  +D+W+ G  L+++ +    P+
Sbjct: 196 ----------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            LGKI G G +  V+              A+K M     ++     ++  E   +    H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSH 95

Query: 105 PGVVRLF-----FTFQDTFSLYMALESCEGGELFD------QITSKGHLSEDEARFYTAE 153
           P V+RL       + Q      + L   + G+L          T   H+       +  +
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   +EY+ +   +HRD+   N +L  D  + +ADFG  K +                  
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----------- 204

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              G  A +P      E L     T  +D+WA G T++++ + G +P+
Sbjct: 205 --QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 29/104 (27%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
            ++D LEYIH    +H DIK  NLLL       + + D+G               AA   
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG-VHKAYAADPK 218

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           +     GT  +   +  N    +   DL  LG  + Q L+G  P
Sbjct: 219 RC--HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
            ++D LEYIH    +H DIK  NLLL       + +AD+G       +         +  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG-NHKQYQENPR 217

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           K     GT  +   +       +  +D+  LG  + + L G  P
Sbjct: 218 KG--HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 41/232 (17%), Positives = 85/232 (36%), Gaps = 35/232 (15%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY-------ALKIMDKKFITKENKTAYVKLERIV 98
           D    +  G G+++K+ +  + + G           LK++DK    +    ++ +    +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFE-AASM 65

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDA 157
           + +L H  +V  +          +  E  + G L   +  +K  ++         ++  A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAASD 209
           + ++    LIH ++  +N+LL  +          IK++D G    +    I         
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER----- 180

Query: 210 DKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                      +VPPE + N        D W+ G TL+++ S G  P     
Sbjct: 181 ---------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 44/236 (18%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
               ++  L +  G G++ +V   +        +    A+K    +  +++++  ++  E
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLM-E 83

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------QITSKGHLSEDEAR 148
            +++ + +H  +VR       +   ++ +E   GG+L         + +    L+  +  
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN 205
               ++    +Y+     IHRDI   N LLT  G     KI DFG  + +  +       
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------- 196

Query: 206 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                 +    G  A +P     PE       T   D W+ G  L+++ S G  P+
Sbjct: 197 ------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 47/236 (19%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
               ++  L +  G G++ +V   +        +    A+K    +  +++++  ++  E
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLM-E 124

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------QITSKGHLSEDEAR 148
            +++ + +H  +VR       +   ++ LE   GG+L         + +    L+  +  
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN 205
               ++    +Y+     IHRDI   N LLT  G     KI DFG    M  +R     +
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----M--AR-----D 233

Query: 206 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                      G  A +P     PE       T   D W+ G  L+++ S G  P+
Sbjct: 234 IYRAG--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 25/168 (14%)

Query: 46  DFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
             +LGK  G G++ +V+ A      K  T    A+K++ K+  T     A +  E  +L 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMS-ELKILI 85

Query: 101 QLD-HPGVVRLF-FTFQDTFSLYMALESCEGGELFD----------------QITSKGHL 142
            +  H  VV L     +    L + +E C+ G L                  +   K  L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           + +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI DFG
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 27/204 (13%)

Query: 12  LRIEGNNNSSTNCPTVQRSKSFAFRAPQE-HFSIQDFELGKIYGVGSYSKVVRAK----- 65
           +RI    +S+ + P +     +      +  F      LGK  G G + +VV A+     
Sbjct: 47  VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106

Query: 66  --KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM 122
             K       A+K++ K   T+++ +  V  E  ++  +  H  ++ L         LY+
Sbjct: 107 KDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYV 164

Query: 123 ALESCEGGELFD----------------QITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
            +E    G L +                    +  ++  +    T ++   +EY+ S   
Sbjct: 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224

Query: 167 IHRDIKPENLLLTADGHIKIADFG 190
           IHRD+   N+L+T +  +KIADFG
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFG 248

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 22/169 (13%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F   + + GK  G G++ KVV A      K D     A+K M K     + K A +  E 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMS-EL 100

Query: 97  IVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFD--------------QITSKGH 141
            ++  L  H  +V L         + +  E C  G+L +                 +   
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
            S  +   ++++V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 31/175 (17%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           ++  LGK  G G + KVV+A           T  A+K++ K+  +       +  E  VL
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVL 80

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD------------------------Q 135
            Q++HP V++L+        L + +E  + G L                           
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
              +  L+  +   +  ++   ++Y+  M L+HRD+   N+L+     +KI+DFG
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 21/174 (12%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVK 93
                     D +   + G G++ +V++A  KK       A+K M K++ +K++   +  
Sbjct: 16  PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAG 74

Query: 94  LERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QI 136
            E  VL +L  HP ++ L    +    LY+A+E    G L D                  
Sbjct: 75  -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           ++   LS  +   + A+V   ++Y+     IHRD+   N+L+  +   KIADFG
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 45/173 (26%), Positives = 63/173 (36%), Gaps = 26/173 (15%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F       GK  G G++ KVV A      K D     A+K M K       + A +  E 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMS-EL 77

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGEL----------FDQITSKGHLSED 145
            VL  L +H  +V L           +  E C  G+L          F    +   + ED
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 146 EARFYT--------AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           +              +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 42/201 (20%), Positives = 81/201 (40%), Gaps = 28/201 (13%)

Query: 15  EGNNNSSTNCPTVQRSKSFAFRAPQEH-FSIQDFELGKIYGVGSYSKVVRAK-------K 66
             +++ S + P +     +      +  F      LGK  G G++ +VV A+       K
Sbjct: 5   HHHHHHSQD-PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63

Query: 67  IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALE 125
                  A+K++ K   T+++ +  V  E  ++  +  H  ++ L         LY+ +E
Sbjct: 64  PKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121

Query: 126 SCEGGELFD----------------QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
               G L +                    +  ++  +    T ++   +EY+ S   IHR
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

Query: 170 DIKPENLLLTADGHIKIADFG 190
           D+   N+L+T +  +KIADFG
Sbjct: 182 DLAARNVLVTENNVMKIADFG 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 1e-09
 Identities = 39/213 (18%), Positives = 64/213 (30%), Gaps = 53/213 (24%)

Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 87
           +    F+   P E          KI G G + +V +   I   T  A+KI+  +     N
Sbjct: 8   KGPVPFSHCLPTEKLQR----CEKI-GEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVN 60

Query: 88  KTAYVKLERIV--------------LDQLDHPGVVRLF---------------------- 111
            +     E I+                     G + L                       
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 112 -----FTFQDTFS---LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH- 162
                    D F    L++ LE   GG   +Q+ +K   S   A+    ++  +L     
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEA 179

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
           S+   HRD+   N+LL      K+    + K  
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 39/211 (18%), Positives = 75/211 (35%), Gaps = 32/211 (15%)

Query: 10  SKLRIEGNNNSSTNCPTVQRSKSFAFRAPQE-HFSIQDFELGKIYGVGSYSKVVRAK--- 65
           + L  E   +     P  QR             +   + E  +  G G++ +V +A+   
Sbjct: 11  TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 66  --KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
               +  T+ A+K M K+  + + +  + + E  ++ + D+P +V+L         + + 
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKLLGVCAVGKPMCLL 128

Query: 124 LESCEGGEL------------------------FDQITSKGHLSEDEARFYTAEVVDALE 159
            E    G+L                                 LS  E      +V   + 
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           Y+     +HRD+   N L+  +  +KIADFG
Sbjct: 189 YLSERKFVHRDLATRNCLVGENMVVKIADFG 219

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 48/206 (23%), Positives = 71/206 (34%), Gaps = 54/206 (26%)

Query: 16  GNNNS-STNCPTVQRSKSFAFRAPQEHFSIQD-------FELGKIYGVGSYSKVVRAKKI 67
           G+  S +TN      S S+          + D       F+   + G G + KV +   +
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV-L 60

Query: 68  DTGTVYALKIMD-------KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFS 119
             G   ALK          ++F T          E   L    HP +V L  F  +    
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFET----------EIETLSFCRHPHLVSLIGFCDERNEM 110

Query: 120 L----YMA---LESCEGGELFDQITSKGHLS--------EDEARFYTAEVVDALEYIHSM 164
           +    YM    L+      L+        +S           AR         L Y+H+ 
Sbjct: 111 ILIYKYMENGNLKRH----LYGSDLPTMSMSWEQRLEICIGAAR--------GLHYLHTR 158

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG 190
            +IHRD+K  N+LL  +   KI DFG
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFG 184

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 42/241 (17%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           H   +D  L    G G++ KV  A+           + A+K +  K  ++  +  + + E
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQR-E 93

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL---------------FDQITSKG 140
             +L  L H  +VR F    +   L M  E    G+L                 +  + G
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            L   +     ++V   + Y+  +  +HRD+   N L+     +KI DFG  + +  +  
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213

Query: 201 TVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 254
                          VG    +P     PE +     T  +D+W+ G  L+++ + G  P
Sbjct: 214 YR-------------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

Query: 255 F 255
           +
Sbjct: 261 W 261

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 35/171 (20%), Positives = 62/171 (36%), Gaps = 23/171 (13%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
             S+      +  G   + KV +         +     A+K + K       +  +   E
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRH-E 62

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------------FDQITSK 139
            ++  +L HP VV L         L M    C  G+L                 D  T K
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
             L   +     A++   +EY+ S  ++H+D+   N+L+    ++KI+D G
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 43/242 (17%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           H   +D  L +  G G++ KV  A+           + A+K +  K  T   +  + + E
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQR-E 67

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QITSK 139
             +L  L H  +V+ +    D   L M  E  + G+L                     +K
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
           G L   +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  + 
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 200 ITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
                           VG    +P     PE +     T  +D+W+ G  L+++ + G  
Sbjct: 188 YYR-------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 254 PF 255
           P+
Sbjct: 235 PW 236

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 19/144 (13%)

Query: 158 LEYIH---SMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKA 212
           L Y+H      +IHRD+K  N+LL  +    + DFG  K    +D+ +T           
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT----------- 192

Query: 213 CTFV-GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
            T V GT  ++ PE L++  ++   D++  G  L ++++G   F D +       ++  D
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLD 250

Query: 272 IRFPNYFSDAARDLIDRLLDVDPS 295
                        L+D  L  +  
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYK 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 26/173 (15%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTAYVKL 94
                  LGK  G G++ +VV A+       K +  T  A+K++ K   T+++ +  +  
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS- 123

Query: 95  ERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QIT 137
           E  ++  +  H  ++ L         LY+ +E    G L +                   
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
            +  LS  +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 31/172 (18%)

Query: 48  ELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           E GK+ G G++ KV+ A      K       A+K M K+      + A +  E  ++ QL
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMS-ELKMMTQL 105

Query: 103 -DHPGVVRLFFTFQDTFSLYMALESCEGGEL-----------------------FDQITS 138
             H  +V L      +  +Y+  E C  G+L                        ++   
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
              L+ ++   +  +V   +E++     +HRD+   N+L+T    +KI DFG
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 21/181 (11%)

Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
           S    E   +   K  L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWA 240
           I DFG  + +      V                 A +P     PE +     T  +D+W+
Sbjct: 234 ICDFGLARDIYKDPDYV-------------RKGDARLPLKWMAPETIFDRVYTIQSDVWS 280

Query: 241 LGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGR 297
            G  L+++ S G SP+        F R +    R   P+Y +      +      +PS R
Sbjct: 281 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

Query: 298 P 298
           P
Sbjct: 341 P 341

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 13/176 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
             +LGK  G G++ +V+ A      K  T    A+K M K+  T     A +  E  +L 
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKILI 80

Query: 101 QLD-HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
            +  H  VV L     +    L + +E C+ G L   + SK +        Y  +     
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARFR 136

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +    +G I  D+K     +T+      + F   K + D      P     D    
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 50.6 bits (122), Expect = 3e-07
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 9/103 (8%)

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           + ++H    IHRDIK  N+LL      KI+DFG  +  +    TV+ +          VG
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR--------IVG 197

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           T AY+ PE L     T  +D+++ G  L ++++G     +  E
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 39/222 (17%), Positives = 62/222 (27%), Gaps = 67/222 (30%)

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
               ++DI         D  +   +F   K +QD   ++L     D              
Sbjct: 14  HQYQYKDILSVFE----DAFVD--NF-DCKDVQDMPKSILSKEEIDH------------- 53

Query: 224 PEVLNSSPATFGND--LWAL---GCTLYQMLSGTSPFKDTSEWL---------------- 262
             ++ S  A  G     W L      + Q        +   ++L                
Sbjct: 54  --IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-LRINYKFLMSPIKTEQRQPSMMTR 110

Query: 263 --IFQR-IIARDIR-FPNYF---SDAARDLIDRLLDVDPS------GRPGAGPG------ 303
             I QR  +  D + F  Y          L   LL++ P+      G  G+G        
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170

Query: 304 --GYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNFLLLIK 343
              Y V     F   I W N++    P+   E +   L  I 
Sbjct: 171 CLSYKVQCKMDF--KIFWLNLKNCNSPETVLEMLQKLLYQID 210

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	366
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.28
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.97
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.44
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.2
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.06
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.98
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.93
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.62
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.61
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.56
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.48
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.48
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.43
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.27
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.21
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.07
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.86
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.42
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.83
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	80.04

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-74  Score=521.99  Aligned_cols=283  Identities=48%  Similarity=0.851  Sum_probs=258.7

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      .....++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++|||||+++++|++++.
T Consensus        27 ~~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  106 (311)
T 4aw0_A           27 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK  106 (311)
T ss_dssp             CCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            34556899999999999999999999999999999999987655555566778899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998764321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s  279 (366)
                              ......+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.+|....+.+|..+|
T Consensus       187 --------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s  258 (311)
T 4aw0_A          187 --------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFF  258 (311)
T ss_dssp             --------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCC
T ss_pred             --------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Confidence                    122345678999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCccccccCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL  330 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~~~~~~~  330 (366)
                      +++++||.+||++||++|||+.| .....+++||||++++|+.+..++||.+
T Consensus       259 ~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l  310 (311)
T 4aw0_A          259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL  310 (311)
T ss_dssp             HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred             HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence            99999999999999999999965 2445689999999999999988777764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-70  Score=496.18  Aligned_cols=282  Identities=37%  Similarity=0.695  Sum_probs=246.6

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .+....++|++++.||+|+||+||+|++.   .+++.||+|++++........ ..+.+|+.+++.++|||||+++++++
T Consensus        18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~-~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-VRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC-C------CCCCCCCCTTEECEEEEEE
T ss_pred             cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH-HHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            34455689999999999999999999984   468899999998765433322 34667999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +++.+|+|||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999999999999899999999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ....          ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+......+|
T Consensus       177 ~~~~----------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p  246 (304)
T 3ubd_A          177 IDHE----------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP  246 (304)
T ss_dssp             --------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cCCC----------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence            3321          233467899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLA  331 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~  331 (366)
                      ..+|+++++||.+||++||++|||+...+++++++||||++++|+.+... .+|++.
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~  303 (304)
T 3ubd_A          247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFK  303 (304)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSC
T ss_pred             CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcC
Confidence            99999999999999999999999997767899999999999999988654 355554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-67  Score=470.65  Aligned_cols=255  Identities=35%  Similarity=0.556  Sum_probs=220.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.+++.++||||+++++++++.+.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999999887666666667788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||| +|+|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......    
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence            9999 56999999999999999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA  282 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  282 (366)
                             ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.....+.+..+...+|..+|+++
T Consensus       167 -------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  239 (275)
T 3hyh_A          167 -------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGA  239 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             -------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence                   2335689999999999998875 67999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ++||.+||++||++|||+     +++++||||+
T Consensus       240 ~~li~~~L~~dP~~R~s~-----~eil~hpw~k  267 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISI-----HEIMQDDWFK  267 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCH-----HHHHHCHHHH
T ss_pred             HHHHHHHccCChhHCcCH-----HHHHcCcccc
Confidence            999999999999999998     8999999996

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-66  Score=475.29  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=229.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .+.|++++.||+|+||+||+|+++.+|+.||||+++....   .....+.+|+.+++.++|||||+++++|.+.+.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4579999999999999999999999999999999976532   2234477899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....    
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----  224 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----  224 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC----
Confidence            999999999998876 469999999999999999999999999999999999999999999999999998764431    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~s~  280 (366)
                            ....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+....   ...+..+|+
T Consensus       225 ------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~  298 (346)
T 4fih_A          225 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP  298 (346)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCH
T ss_pred             ------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCH
Confidence                  23346789999999999999999999999999999999999999999999988888877653   334457899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ++++||.+||++||++|||+     +++++||||+..
T Consensus       299 ~~~dli~~~L~~dP~~R~ta-----~e~l~Hp~~~~~  330 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATA-----AELLKHPFLAKA  330 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             HHHHHHHHHcCCChhHCcCH-----HHHhcCHhhcCC
Confidence            99999999999999999999     999999999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.2e-67  Score=479.04  Aligned_cols=258  Identities=28%  Similarity=0.527  Sum_probs=228.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+++.++|||||++++++++++.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            4789999999999999999999999999999999998765443 345668889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||||+||+|.+++..+  ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999999765  357999999999999999999999999999999999999999999999999998765431 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFS  279 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s  279 (366)
                               ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++..+.. ..+..+|
T Consensus       180 ---------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s  250 (350)
T 4b9d_A          180 ---------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS  250 (350)
T ss_dssp             ---------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             ---------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCC
Confidence                     112356899999999999999999999999999999999999999999999999999888765 4667899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +++++||.+||++||++|||+     +++++||||+.
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~  282 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSV-----NSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHTSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCH-----HHHhcCHHhhc
Confidence            999999999999999999998     89999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-64  Score=475.73  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=229.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .+.|++++.||+|+||.||+|+++.+|+.||||++.....   .....+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            3579999999999999999999999999999999986532   2234577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....    
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----  301 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----  301 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC----
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC----
Confidence            999999999999876 469999999999999999999999999999999999999999999999999998764431    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~s~  280 (366)
                            ....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+....   ...+..+|+
T Consensus       302 ------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~  375 (423)
T 4fie_A          302 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP  375 (423)
T ss_dssp             ------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCH
T ss_pred             ------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCH
Confidence                  23346789999999999999999999999999999999999999999999988888876653   344567999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ++++||.+||++||++|||+     +++++||||+..
T Consensus       376 ~~~dli~~~L~~dP~~R~ta-----~ell~Hp~~~~~  407 (423)
T 4fie_A          376 SLKGFLDRLLVRDPAQRATA-----AELLKHPFLAKA  407 (423)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             HHHHHHHHHcCCChhHCcCH-----HHHhcCHHhcCC
Confidence            99999999999999999999     999999999853

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-64  Score=495.56  Aligned_cols=283  Identities=33%  Similarity=0.576  Sum_probs=249.1

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHH---HHHHHhCCCCCcceeEEEEe
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE---RIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~  115 (366)
                      ..++++++|+++++||+|+||.||+|+++.+|+.||+|++.+.............+|   +.+++.++|||||+++++|+
T Consensus       183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            347889999999999999999999999999999999999987654444444444444   45666779999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCC---CHHHHHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~  271 (366)
                      ...            ...+.+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.   +...+...+....
T Consensus       343 ~~~------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~  410 (689)
T 3v5w_A          343 SKK------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA  410 (689)
T ss_dssp             SSC------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC
T ss_pred             CCC------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Confidence            432            234678999999999996 467999999999999999999999999753   4456677788888


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      ..+|..+|+++++||.+||++||.+|++....+++++++||||++++|+.+... .+|++.|.
T Consensus       411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~  473 (689)
T 3v5w_A          411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP  473 (689)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence            999999999999999999999999999976667799999999999999998643 45666553

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-63  Score=447.55  Aligned_cols=251  Identities=21%  Similarity=0.378  Sum_probs=218.4

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee----CCeEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFSLYM  122 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~i  122 (366)
                      |++.++||+|+||+||+|.++.+|..||+|++....... .....+.+|+.+++.++|||||++++++++    ...+|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            478889999999999999999999999999998764433 344568889999999999999999999875    356899


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCC-CCCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~-~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++. +|.+||+|||+|+....  
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            9999999999999999889999999999999999999999999  999999999999984 79999999999975332  


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHhcCCC--CCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDI--RFPN  276 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~--~~~~  276 (366)
                                ....+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+ .......+.....  .++.
T Consensus       185 ----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  253 (290)
T 3fpq_A          185 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK  253 (290)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred             ----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence                      12346789999999999876 59999999999999999999999997654 4555555655432  3456


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..++++++||.+||++||++|||+     +++++||||+.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~-----~e~l~Hp~~~~  288 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             cCCHHHHHHHHHHccCChhHCcCH-----HHHhcCccccC
Confidence            789999999999999999999999     99999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.8e-64  Score=457.57  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=224.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..+.|++.++||+|+||.||+|+++.+|+.||||+++.+...        .+|+.+++.++|||||++++++++.+.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456899999999999999999999999999999999765322        358999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+| ++||+|||+|+.+......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999988999999999999999999999999999999999999999987 6999999999876543211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYF  278 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~  278 (366)
                      .     ........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.......+.....   .+|..+
T Consensus       208 ~-----~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          208 K-----SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             c-----ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence            0     01122346799999999999999999999999999999999999999998877777777776654   367789


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhh-------------hcCCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVL-------------KMHPFFKGID  318 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~-------------l~hp~f~~~~  318 (366)
                      ++++++||.+||++||++|||+     .++             +.|||+....
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa-----~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASA-----MELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCH-----HHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            9999999999999999999998     665             6899998653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-61  Score=455.59  Aligned_cols=264  Identities=27%  Similarity=0.392  Sum_probs=225.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------CC
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------TF  118 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~  118 (366)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++.... ......+.+|+.+|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999999999999999999765433 3334556789999999999999999999764      36


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999996 589999998889999999999999999999999999999999999999999999999999999876443


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC---
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF---  274 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---  274 (366)
                      ..      .......+.+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+..|.......   
T Consensus       212 ~~------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          212 PA------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             ----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cc------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            21      112234467899999999998775 47999999999999999999999999999988887775421110   


Q ss_pred             ----------------------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          275 ----------------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       275 ----------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                                  ...+++++++||.+||+.||++|||+     +++|+||||+......
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA-----AAALRHPFLAKYHDPD  355 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGTTTCCGG
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCHhhCcCCCCc
Confidence                                        12468999999999999999999999     8999999999876544

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-61  Score=438.88  Aligned_cols=268  Identities=25%  Similarity=0.427  Sum_probs=204.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++...  .+.....+.+|+.+++.++|||||+++++|.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            467999999999999999999999999999999997642  3344556788999999999999999999997644     


Q ss_pred             -------eEEEEEeecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEe
Q 017775          119 -------SLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (366)
Q Consensus       119 -------~~~iv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~D  188 (366)
                             .+|+|||||+||+|.+++...+.   .++..++.++.||++||+|||++||+||||||+|||++.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   37999999999999999988754   34567899999999999999999999999999999999999999999


Q ss_pred             cCCccccCCcccccc--CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHH
Q 017775          189 FGSVKPMQDSRITVL--PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQ  265 (366)
Q Consensus       189 fg~a~~~~~~~~~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~  265 (366)
                      ||+|+.+........  ............+||+.|||||++.+..|+.++|||||||++|||++   ||...... ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            999987765432211  11111223345689999999999999999999999999999999996   77653322 2233


Q ss_pred             HHhcCCCC-CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          266 RIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       266 ~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      .+.....+ .+...++.+.+||.+||++||++|||+     .++++||||++++|+.
T Consensus       239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGCCC----
T ss_pred             HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhCCCCCCC
Confidence            33333221 113456788999999999999999999     8999999999998854

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-58  Score=428.14  Aligned_cols=282  Identities=37%  Similarity=0.645  Sum_probs=252.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|..+++.++||||+++++++.+.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56889999999999999999999999999999999998764434444566778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....   
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---  158 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC---
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999754322   


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~  281 (366)
                             .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|..++++
T Consensus       159 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  231 (337)
T 1o6l_A          159 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE  231 (337)
T ss_dssp             -------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             -------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence                   1223456899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      +++||.+||+.||++||+....+++++++||||++++|+.+... ..|++.|.
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~  284 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ  284 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCC
Confidence            99999999999999999665556699999999999999987643 34555443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-59  Score=436.34  Aligned_cols=286  Identities=33%  Similarity=0.643  Sum_probs=246.7

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      .....+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+..|..+++.+ +||||+++++++.
T Consensus        15 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CCcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            344567899999999999999999999999999999999999876544555566677899999987 7999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999753


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ...          .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|
T Consensus       175 ~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  244 (353)
T 3txo_A          175 ICN----------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP  244 (353)
T ss_dssp             CC-------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ccC----------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            322          1233456899999999999988899999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCC-CCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~-~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      ..+++++.+||++||+.||.+||++ .+.+.+++++||||++++|+.+... ..|++.|
T Consensus       245 ~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p  303 (353)
T 3txo_A          245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP  303 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccC
Confidence            9999999999999999999999998 3345589999999999999987643 3455544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-59  Score=460.65  Aligned_cols=261  Identities=28%  Similarity=0.482  Sum_probs=236.8

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+++|++++.||+|+||.||+|+++.+|+.||+|++...   .......+.+|+.+|+.++||||++++++|++.+.+|+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            357999999999999999999999999999999999765   33345667889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC--CCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~--~~vkL~Dfg~a~~~~~~~  199 (366)
                      |||||+||+|.+++.+. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+  |.+||+|||+|+.+....
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999999999999654 679999999999999999999999999999999999999854  899999999998765432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  275 (366)
                                 .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++    
T Consensus       312 -----------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  380 (573)
T 3uto_A          312 -----------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF  380 (573)
T ss_dssp             -----------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred             -----------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence                       23356899999999999999999999999999999999999999999999999999988876665    


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                      ..+|+++++||.+||+.||.+|||+     +++++||||+..+|...
T Consensus       381 ~~~s~~~~dli~~~L~~dp~~R~t~-----~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          381 SGISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTSCCCCTTT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcCcCCCCCCCc
Confidence            4689999999999999999999999     89999999998887643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-59  Score=424.97  Aligned_cols=258  Identities=20%  Similarity=0.346  Sum_probs=223.3

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      +.+..++|.+.+.||+|+||+||+|++.     .+|..||||+++..   .......+.+|+.++++++|||||++++++
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            4566789999999999999999999875     46889999999754   344456688899999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC
Q 017775          115 QDTFSLYMALESCEGGELFDQITSK-------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~-------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~  181 (366)
                      .+.+.+|+|||||++|+|.+++.+.             ..+++.++..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence            9999999999999999999999764             359999999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCH
Q 017775          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (366)
Q Consensus       182 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  260 (366)
                      +.+||+|||+|+.........        ......||+.|+|||++.+..|+.++||||+||++|||+| |+.||.+.+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~--------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEE--------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CcEEECCcccceecCCCCcee--------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999998664432211        1223468999999999999999999999999999999998 9999999999


Q ss_pred             HHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          261 WLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       261 ~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      .+....+..+. ++.|..+|+++.+|+.+||+.||++|||+     +++  ++|++
T Consensus       237 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~~i--~~~L~  285 (299)
T 4asz_A          237 NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNI-----KGI--HTLLQ  285 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHH--HHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-----HHH--HHHHH
Confidence            98888887764 56788999999999999999999999999     666  34544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-59  Score=434.24  Aligned_cols=262  Identities=27%  Similarity=0.446  Sum_probs=211.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  119 (366)
                      .++|++++.||+|+||+||+|+++   .+++.||+|.+....     ....+.+|+.+++.+ +||||++++++|++.+.
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            467999999999999999999875   467899999886532     233467799999988 69999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~~~~  198 (366)
                      +|+||||++||+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999999999884   59999999999999999999999999999999999999877 89999999999876554


Q ss_pred             cccccCC------------------CCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCC-CC
Q 017775          199 RITVLPN------------------AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFK-DT  258 (366)
Q Consensus       199 ~~~~~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~-~~  258 (366)
                      .......                  ........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||. +.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            3221110                  0011223456899999999999776 48999999999999999999999985 44


Q ss_pred             CHHHHHHHHhc--------------------------------------C----------------CCCCCCCCCHHHHH
Q 017775          259 SEWLIFQRIIA--------------------------------------R----------------DIRFPNYFSDAARD  284 (366)
Q Consensus       259 ~~~~~~~~i~~--------------------------------------~----------------~~~~~~~~s~~~~~  284 (366)
                      ++.+.+..|..                                      .                .......+|++++|
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            44444443321                                      0                01112457899999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ||.+||+.||++|+|+     +++++||||++++
T Consensus       332 Ll~~lL~~dP~~R~ta-----~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          332 LLDKLLDLNPASRITA-----EEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHTCSCTTTSCCH-----HHHHTSGGGTTC-
T ss_pred             HHHHHCcCChhHCcCH-----HHHhcCcccCCCC
Confidence            9999999999999999     9999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.4e-59  Score=426.83  Aligned_cols=257  Identities=21%  Similarity=0.319  Sum_probs=218.0

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  112 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  112 (366)
                      ....+..++|.+.++||+|+||+||+|+..     .+++.||||+++..   .......+.+|+.++++++|||||++++
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g  110 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFG  110 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            344567789999999999999999999865     46889999999754   3444567889999999999999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSK---------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~---------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIl  177 (366)
                      ++.+.+.+|||||||++|+|.+++.+.               +++++.++..++.|++.||.|||+++|+||||||+|||
T Consensus       111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL  190 (329)
T 4aoj_A          111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL  190 (329)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence            999999999999999999999999753               35899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCC
Q 017775          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (366)
Q Consensus       178 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  256 (366)
                      ++.++++||+|||+|+........        .......||+.|||||++.+..++.++||||+||++|||+| |+.||.
T Consensus       191 l~~~~~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~  262 (329)
T 4aoj_A          191 VGQGLVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY  262 (329)
T ss_dssp             EETTTEEEECCCC------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             ECCCCcEEEcccccceeccCCCcc--------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence            999999999999999866443211        12234578999999999999999999999999999999999 999999


Q ss_pred             CCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          257 DTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       257 ~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +.+..+....+..+ .++.|..+++++.+|+.+||+.||++|||+     .+++.
T Consensus       263 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~ei~~  312 (329)
T 4aoj_A          263 QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSI-----KDVHA  312 (329)
T ss_dssp             SSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCH-----HHHHH
Confidence            99998888887765 467888999999999999999999999999     67765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.5e-59  Score=431.13  Aligned_cols=287  Identities=33%  Similarity=0.602  Sum_probs=252.7

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      .....+..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..+ +||+|+++++++.
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            345567899999999999999999999999999999999999876544444556677799999887 7999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999853


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ...          .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|
T Consensus       172 ~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  241 (353)
T 2i0e_A          172 IWD----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP  241 (353)
T ss_dssp             CCT----------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ccC----------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            221          1223456799999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      ..+++++++||.+||+.||.+||++.+.+++++++||||++++|+.+... .+|++.|.
T Consensus       242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~  300 (353)
T 2i0e_A          242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK  300 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCC
Confidence            99999999999999999999999987767799999999999999988643 45555554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-58  Score=421.78  Aligned_cols=280  Identities=35%  Similarity=0.689  Sum_probs=251.9

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.++||||+++++++.+...+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            35688999999999999999999999999999999999876444444556677899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||+++.....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            999999999999999998888999999999999999999999999999999999999999999999999999865332  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                                 .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|..+++
T Consensus       160 -----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  228 (318)
T 1fot_A          160 -----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE  228 (318)
T ss_dssp             -----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             -----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence                       224579999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      ++++||.+||+.||++||+..+.+++++++||||++++|+.+... ..|++.|.
T Consensus       229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~  282 (318)
T 1fot_A          229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP  282 (318)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred             HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence            999999999999999999665556699999999999999987643 34444443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.1e-58  Score=433.09  Aligned_cols=286  Identities=35%  Similarity=0.688  Sum_probs=247.3

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      ...+..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+..|..+++.+ +||||+++++++.+.
T Consensus        46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~  125 (396)
T 4dc2_A           46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE  125 (396)
T ss_dssp             ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence            4467889999999999999999999999999999999999887655555555677788888776 899999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999975322


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC---------CHHHHHHHHh
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---------SEWLIFQRII  268 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~  268 (366)
                      .          .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...         ......+.+.
T Consensus       206 ~----------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~  275 (396)
T 4dc2_A          206 P----------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  275 (396)
T ss_dssp             T----------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred             C----------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence            1          12334668999999999999999999999999999999999999999632         3445677788


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCccccccC-CCCCCCCCC
Q 017775          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (366)
Q Consensus       269 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~  334 (366)
                      .....+|..+++++++||++||+.||++||++.. .+++++++||||++++|+.+... ..|++.|..
T Consensus       276 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~  343 (396)
T 4dc2_A          276 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI  343 (396)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCC
T ss_pred             ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCC
Confidence            8899999999999999999999999999999842 35689999999999999988643 456655543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-58  Score=431.02  Aligned_cols=284  Identities=36%  Similarity=0.645  Sum_probs=244.7

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~  117 (366)
                      ......++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|..+ ++.++||||+++++++.+.
T Consensus        32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            446778999999999999999999999999999999999988755444444455556665 5678999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999985322


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .          .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++..
T Consensus       192 ~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  261 (373)
T 2r5t_A          192 H----------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN  261 (373)
T ss_dssp             C----------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSS
T ss_pred             C----------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence            2          123346689999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      +++++++||.+||+.||.+||++.+ .++++++||||++++|+.+... ..|++.|.
T Consensus       262 ~~~~~~~li~~lL~~dp~~R~~~~~-~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~  317 (373)
T 2r5t_A          262 ITNSARHLLEGLLQKDRTKRLGAKD-DFMEIKSHVFFSLINWDDLINKKITPPFNPN  317 (373)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTTTT-THHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred             CCHHHHHHHHHHcccCHHhCCCCCC-CHHHHhCCccccCCCHHHHHhCCCCCCCCCC
Confidence            9999999999999999999999863 5689999999999999988643 34555443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.9e-57  Score=421.53  Aligned_cols=284  Identities=36%  Similarity=0.699  Sum_probs=249.9

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  118 (366)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.+ +||||+++++++.+..
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            356789999999999999999999999999999999999887665666667788899999887 8999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||+++.....
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999753221


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC---------CCHHHHHHHHhc
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIA  269 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---------~~~~~~~~~i~~  269 (366)
                                .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..         .........+..
T Consensus       164 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          164 ----------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             ----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             ----------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence                      1223456899999999999999999999999999999999999999975         344556777888


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC-CChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       270 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~-~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      ....+|..+++++++||.+||+.||.+||++.. .+++++++||||++++|+.+... ..|++.|.
T Consensus       234 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~  299 (345)
T 3a8x_A          234 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN  299 (345)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCC
Confidence            888999999999999999999999999999842 34689999999999999987643 34555443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-58  Score=425.20  Aligned_cols=280  Identities=34%  Similarity=0.625  Sum_probs=244.4

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      ...+..++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+..|..+++.+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            3457789999999999999999999999999999999999876443344455667788888876 899999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||+++....
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .          .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|..
T Consensus       171 ~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~  240 (345)
T 1xjd_A          171 G----------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW  240 (345)
T ss_dssp             T----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             C----------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            2          122345689999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      +++++++||.+||+.||++||++.    .++++||||++++|+.+... ..|++.|
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~----~~i~~hp~f~~~~w~~l~~~~~~~p~~p  292 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPFRP  292 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTTCSCC----
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCCh----HHHHcCccccCCCHHHHhhCCCCCCcCC
Confidence            999999999999999999999993    27999999999999988643 3444444

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.9e-57  Score=422.18  Aligned_cols=281  Identities=35%  Similarity=0.627  Sum_probs=253.2

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ......++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus        35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            44577899999999999999999999999999999999998764444445566778999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  278 (366)
                                   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|..+
T Consensus       195 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~  261 (350)
T 1rdq_E          195 -------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF  261 (350)
T ss_dssp             -------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC
T ss_pred             -------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence                         2245799999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      ++++.+||.+||+.||.+||+....+++++++||||++++|..+... ..|++.|
T Consensus       262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p  316 (350)
T 1rdq_E          262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP  316 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCC
Confidence            99999999999999999999954445699999999999999987643 3444444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4e-58  Score=417.32  Aligned_cols=256  Identities=20%  Similarity=0.333  Sum_probs=222.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .+...++++.+.||+|+||+||+|...     .+++.||||+++...  .......+.+|+.++++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            466788999999999999999999853     467899999987542  2333456888999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC
Q 017775          116 DTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~  179 (366)
                      +.+.+++|||||++|+|.+++..+                +.+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999653                3589999999999999999999999999999999999999


Q ss_pred             CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCC
Q 017775          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (366)
Q Consensus       180 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  258 (366)
                      .++++||+|||+|+........        .......||+.|+|||++.+..++.++||||+||++|||+| |..||.+.
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYY--------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCB--------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             CCCCEEECCcccceeccCCCce--------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999876443211        12234578999999999999999999999999999999998 89999999


Q ss_pred             CHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          259 SEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       259 ~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      +..++...+..+. .+.|..+++++.+|+.+||+.||++|||+     .+|+.+
T Consensus       252 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-----~ei~~~  300 (308)
T 4gt4_A          252 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF-----KDIHSR  300 (308)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            9998888887654 56788999999999999999999999999     666654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-57  Score=411.55  Aligned_cols=247  Identities=20%  Similarity=0.328  Sum_probs=203.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..+++++++.||+|+||+||+|+..   ..||||+++.... .......+.+|+.++++++|||||++++++.+ +.+|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            55678999999999999999999864   3599999875432 33445678889999999999999999998765 5689


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||||||+||+|.+++... +.+++.++..++.||+.||.|||+++|+||||||+|||++.++++||+|||+|+.......
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999999765 5799999999999999999999999999999999999999999999999999986543211


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecC---CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----  272 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-----  272 (366)
                              .......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+.......+.....     
T Consensus       188 --------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          188 --------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             --------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence                    112335689999999999864   3588999999999999999999999988665544444433322     


Q ss_pred             -CCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       273 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                       ..+..+++++.+|+.+||+.||++|||+.
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  289 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFP  289 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHH
Confidence             23467899999999999999999999983

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-56  Score=418.50  Aligned_cols=281  Identities=30%  Similarity=0.573  Sum_probs=247.6

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +...+..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            45567889999999999999999999999999999999999876544445556778899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC---CCCCCCCCcccchhhhhhhhcCCCCCCC---CCHHHHHHHHhcCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARD  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~~i~~~~  271 (366)
                      .           .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||..   .........+....
T Consensus       168 ~-----------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~  236 (384)
T 4fr4_A          168 E-----------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV  236 (384)
T ss_dssp             T-----------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC
T ss_pred             C-----------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc
Confidence            2           22335679999999999864   4588999999999999999999999974   44556667777788


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      ..+|..+++++.+||.+||+.||.+||++    ++++++||||++++|+.+... ..|++.|.
T Consensus       237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~----~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~  295 (384)
T 4fr4_A          237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPN  295 (384)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCS----HHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred             cCCCCcCCHHHHHHHHHHhcCCHhHhccc----HHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence            88999999999999999999999999984    389999999999999987643 34555544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-56  Score=430.10  Aligned_cols=287  Identities=37%  Similarity=0.644  Sum_probs=242.4

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      .+...+..++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+
T Consensus       140 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             ----CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred             CcccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            34556778999999999999999999999999999999999987644444444556779999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      .+.+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999999999999988889999999999999999999998 99999999999999999999999999999754


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ....          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|
T Consensus       300 ~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p  369 (446)
T 4ejn_A          300 IKDG----------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  369 (446)
T ss_dssp             CC---------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cCCC----------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            3221          122356799999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~  333 (366)
                      ..+++++.+||.+||+.||.+||+....+++++++||||++++|+.+... .+|++.|.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~  428 (446)
T 4ejn_A          370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQ  428 (446)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred             ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCC
Confidence            99999999999999999999999444444599999999999999987643 45555554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.2e-56  Score=409.22  Aligned_cols=284  Identities=37%  Similarity=0.704  Sum_probs=240.9

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ...+..++|++++.||+|+||.||+|++.   .+|+.||+|++++..... ......+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            34567899999999999999999999985   689999999998754322 23344567799999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      .+.+.+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  274 (366)
                      .....          .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......+
T Consensus       171 ~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  240 (327)
T 3a62_A          171 SIHDG----------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL  240 (327)
T ss_dssp             ------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred             cccCC----------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            43221          12234578999999999999889999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      |..+++++.+||.+||+.||++||++...++++++.||||++++|+.+... ..|++.|
T Consensus       241 p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p  299 (327)
T 3a62_A          241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP  299 (327)
T ss_dssp             CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred             CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCC
Confidence            999999999999999999999999887777899999999999999987643 3444444

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-55  Score=405.66  Aligned_cols=262  Identities=32%  Similarity=0.535  Sum_probs=238.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            34578999999999999999999999999999999999876443 33445577899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999997654321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCC-CCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s  279 (366)
                                ......||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+..+...+|..++
T Consensus       169 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s  238 (328)
T 3fe3_A          169 ----------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS  238 (328)
T ss_dssp             ----------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             ----------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence                      22356799999999999887764 7899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      +++.+||++||+.||.+|||+     +++++||||+....
T Consensus       239 ~~~~~li~~~L~~dP~~R~t~-----~eil~h~~~~~~~~  273 (328)
T 3fe3_A          239 TDCENLLKRFLVLNPIKRGTL-----EQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHHHHHHCCSSTTTSCCH-----HHHTTCTTTTTTCT
T ss_pred             HHHHHHHHHHCCCChhHCcCH-----HHHhcCHhhcCCCc
Confidence            999999999999999999999     99999999987553

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.2e-56  Score=447.62  Aligned_cols=286  Identities=33%  Similarity=0.604  Sum_probs=254.1

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      ...+..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..+ +||+|+++++++++.
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            4456789999999999999999999999999999999999876444444455667788888877 799999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999985432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .          ........||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..+.++.|......+|..
T Consensus       495 ~----------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  564 (674)
T 3pfq_A          495 D----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS  564 (674)
T ss_dssp             T----------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT
T ss_pred             C----------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            2          123346689999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~  334 (366)
                      +++++++||++||+.||++||++...+++++++||||++++|+.+... ..|++.|..
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~  622 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA  622 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcC
Confidence            999999999999999999999986667799999999999999998754 456666644

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-55  Score=429.82  Aligned_cols=285  Identities=29%  Similarity=0.548  Sum_probs=252.9

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..+++.++||||+++++++.+...
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            55778999999999999999999999999999999999987654444455667789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          120 LYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +|+||||++||+|.+++.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999999764    36999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC----CHHHHHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~  271 (366)
                      ....          ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.    ........+....
T Consensus       340 ~~~~----------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~  409 (543)
T 3c4z_A          340 KAGQ----------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA  409 (543)
T ss_dssp             CTTC----------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred             cCCC----------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence            4331          1223457999999999999999999999999999999999999999875    4567777888888


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~  334 (366)
                      ..+|..+++++++||.+||+.||.+||++.+.+++++++||||++++|+.+... ..|++.|.+
T Consensus       410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~  473 (543)
T 3c4z_A          410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS  473 (543)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred             cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence            889999999999999999999999999987777799999999999999988653 456666654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.4e-56  Score=423.62  Aligned_cols=271  Identities=36%  Similarity=0.641  Sum_probs=237.1

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|+++++||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..++||||+++++++.+...+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            45678999999999999999999999999999999999764333333334477899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999997654332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--CC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DI  272 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~  272 (366)
                      .         ......+||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+..+....+...  ..
T Consensus       230 ~---------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          230 T---------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             C---------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             C---------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence            1         1122457999999999986     456899999999999999999999999999998888888653  34


Q ss_pred             CCCC---CCCHHHHHHHHHhhcCCCCC--CCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          273 RFPN---YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       273 ~~~~---~~s~~~~~li~~~L~~dP~~--Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      .+|.   .+++++++||++||+.+|++  |+++     +++++||||++++|+.+...
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~-----~eil~Hpff~~i~w~~l~~~  353 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGI-----EDFKKHPFFSGIDWDNIRNC  353 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTT-----HHHHTSGGGTTCCTTTGGGS
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCH-----HHHhCCCccCCCCHHHHhhC
Confidence            4554   48999999999999998888  8988     99999999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.3e-55  Score=407.76  Aligned_cols=263  Identities=29%  Similarity=0.522  Sum_probs=237.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+......   .....+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            5679999999999999999999999999999999987543221   2345688899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC----CEEEEecCCccccC
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  196 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~----~vkL~Dfg~a~~~~  196 (366)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998888899999999999999999999999999999999999998877    79999999998764


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  275 (366)
                      ...           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++ 
T Consensus       171 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          171 DGV-----------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             TTC-----------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CCC-----------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            421           22345799999999999998999999999999999999999999999999999999988877765 


Q ss_pred             ---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       276 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                         ..+++++++||.+||+.||.+|||+     +++++||||++++|...
T Consensus       240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~~~~~~  284 (361)
T 2yab_A          240 EFFSQTSELAKDFIRKLLVKETRKRLTI-----QEALRHPWITPVDTQQA  284 (361)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTSCSSHHHH
T ss_pred             hhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCcCcCCCchhhh
Confidence               5689999999999999999999999     89999999999988654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-55  Score=429.43  Aligned_cols=285  Identities=32%  Similarity=0.551  Sum_probs=251.2

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD  257 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence            45678899999999999999999999999999999999998765444445566788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          119 SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      .+|+||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999999999987643  9999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC----CHHHHHHHHhcCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDI  272 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~  272 (366)
                      ...           .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.    ........+.....
T Consensus       338 ~~~-----------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~  406 (576)
T 2acx_A          338 EGQ-----------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE  406 (576)
T ss_dssp             TTC-----------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC
T ss_pred             cCc-----------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc
Confidence            321           223457999999999999988999999999999999999999999875    34566677777778


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCCCC
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~~~  334 (366)
                      .+|..+++++++||.+||+.||.+||++...+++++++||||++++|+.+... ..|++.|.+
T Consensus       407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~  469 (576)
T 2acx_A          407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP  469 (576)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred             cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence            88999999999999999999999999765556699999999999999988653 456666654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.3e-56  Score=419.44  Aligned_cols=277  Identities=38%  Similarity=0.615  Sum_probs=238.6

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.++||||+++++++.+...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            45678999999999999999999999999999999999764333333334567799999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus       145 ~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            9999999999999998764 699999999999999999999999999999999999999999999999999987644321


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCC----CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRF  274 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~  274 (366)
                      .         .....+||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+......++....  ..+
T Consensus       224 ~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          224 V---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             E---------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             c---------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence            1         123567999999999997665    7889999999999999999999999999998888887642  344


Q ss_pred             C--CCCCHHHHHHHHHhhcCCCCC--CCCCCCCChHhhhcCCCCCCCCcccccc-CCCCCCCC
Q 017775          275 P--NYFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLAS  332 (366)
Q Consensus       275 ~--~~~s~~~~~li~~~L~~dP~~--Rps~~~~~~~~~l~hp~f~~~~~~~~~~-~~~~~~~~  332 (366)
                      |  ..+++++++||.+||+.+|.+  |+++     +++++||||++++|+.... ...|++.|
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~-----~ei~~Hp~f~~~~w~~~~~~~~~~p~~p  352 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGV-----EEIKRHLFFKNDQWAWETLRDTVAPVVP  352 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCH-----HHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCH-----HHHhcCccccCCCHHHHhhcccCCCCCC
Confidence            4  469999999999999999988  9988     9999999999999976542 23444444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.3e-56  Score=410.86  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=215.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||+||+|.+..+     ++.||+|.+....  .......+.+|+.+++++.| ||||++++++.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            4568999999999999999999998654     3579999987642  23334567889999999965 99999999987


Q ss_pred             e-CCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 017775          116 D-TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  178 (366)
Q Consensus       116 ~-~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli  178 (366)
                      + .+.+|+|||||++|+|.+++.+.                ..+++.++..++.||+.||.|||+++|+||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            6 45689999999999999999753                348999999999999999999999999999999999999


Q ss_pred             CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCC
Q 017775          179 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD  257 (366)
Q Consensus       179 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  257 (366)
                      +.++.+||+|||+|+.+......        .......||+.|||||++.+..|+.++||||+||++|||+| |..||.+
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTS--------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCCCCEEECcchhhhhcccCCCc--------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999866443211        12235578999999999999999999999999999999998 9999988


Q ss_pred             CCH-HHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          258 TSE-WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       258 ~~~-~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+. ......+..+ .+..|...++++.+|+.+||+.||++|||+     .++++|
T Consensus       291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-----~eil~~  341 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  341 (353)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH-----HHHHHH
Confidence            654 3444444443 567788999999999999999999999999     788876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=418.01  Aligned_cols=280  Identities=37%  Similarity=0.652  Sum_probs=238.9

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|..++..++||||+++++++.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            35678999999999999999999999999999999999976533333334457789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      +|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            999999999999999998754 7999999999999999999999999999999999999999999999999999876433


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeec-------CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN-------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      ..         ......+||+.|+|||++.       +..++.++|||||||++|+|++|..||.+.+..+.+.++....
T Consensus       216 ~~---------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  286 (412)
T 2vd5_A          216 GT---------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK  286 (412)
T ss_dssp             SC---------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             Cc---------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            21         1122457999999999986       3568999999999999999999999999999988888877532


Q ss_pred             --CCCC---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCCCCCCCC
Q 017775          272 --IRFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS  332 (366)
Q Consensus       272 --~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~~~~~~~  332 (366)
                        ..+|   ..+++++++||++||+ +|.+|++..  +++++++||||++++|+.+... .|++.|
T Consensus       287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~--~~~ei~~Hpff~~i~w~~l~~~-~~p~~p  348 (412)
T 2vd5_A          287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRG--GAGDFRTHPFFFGLDWDGLRDS-VPPFTP  348 (412)
T ss_dssp             HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTT--THHHHHTSGGGTTCCSTTSTTS-CCSCCC
T ss_pred             cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCC--CHHHHhcCCCcCCCCHHHHhhc-CCCCCC
Confidence              3334   5799999999999999 999996321  3499999999999999998754 444444

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-54  Score=401.32  Aligned_cols=258  Identities=33%  Similarity=0.534  Sum_probs=229.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+....+
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34689999999999999999999999999999999998754444444456788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            999999 56999999888889999999999999999999999999999999999999999999999999998654432  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                               ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|..+++
T Consensus       163 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  233 (336)
T 3h4j_B          163 ---------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP  233 (336)
T ss_dssp             ---------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCH
T ss_pred             ---------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCH
Confidence                     2234579999999999988775 789999999999999999999998876655555566666778889999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++.+||++||+.||.+|||+     +++++||||+.
T Consensus       234 ~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  264 (336)
T 3h4j_B          234 GAQSLIRRMIVADPMQRITI-----QEIRRDPWFNV  264 (336)
T ss_dssp             HHHHHHHTTSCSSGGGSCCH-----HHHTTCHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCH-----HHHHhChhhcc
Confidence            99999999999999999999     99999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-53  Score=390.42  Aligned_cols=264  Identities=30%  Similarity=0.517  Sum_probs=235.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++........   .....+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            35679999999999999999999999999999999987543221   235668889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC----CEEEEecCCcccc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPM  195 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~----~vkL~Dfg~a~~~  195 (366)
                      .++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999999998888899999999999999999999999999999999999999887    8999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ....           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++
T Consensus       169 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          169 DFGN-----------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             CTTS-----------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCCC-----------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            4321           12245789999999999988999999999999999999999999999998888888877666655


Q ss_pred             ----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          276 ----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       276 ----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                          ..+++++.+||.+||+.||++|||+     +++++||||++.++...
T Consensus       238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~~  283 (326)
T 2y0a_A          238 DEYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQA  283 (326)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSTTTSCCSHHHH
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCccCCcchhh
Confidence                4689999999999999999999999     99999999998876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.4e-53  Score=404.95  Aligned_cols=257  Identities=33%  Similarity=0.573  Sum_probs=230.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            56899999999999999999999999999999999876433 33345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC---CCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~---~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-  167 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-  167 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-
Confidence            99999999999999988999999999999999999999999999999999999998   45789999999998664432 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  276 (366)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..+...++.    
T Consensus       168 ---------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  238 (444)
T 3soa_A          168 ---------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD  238 (444)
T ss_dssp             ---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ---------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence                     1123457999999999999989999999999999999999999999999999999998888776653    


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+++++++||.+||+.||++|||+     .++++||||+.
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta-----~e~L~hp~~~~  273 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITA-----AEALKHPWISH  273 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSCTTHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCccccC
Confidence            689999999999999999999999     99999999974

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-53  Score=386.80  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=226.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            578999999999999999999999999999999997653   22345577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||++|++|.+++.+. .+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  170 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc----
Confidence            9999999999999875 69999999999999999999999999999999999999999999999999988664332    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc---CCCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---RDIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~s~  280 (366)
                            .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+..   .....+..+++
T Consensus       171 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T 3fxz_A          171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (297)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred             ------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence                  122345799999999999999999999999999999999999999998887766555443   23455678999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+.+||.+||+.||++|||+     +++++||||+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~  276 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSA-----KELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCH-----HHHhhChhhccc
Confidence            99999999999999999999     999999999854

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-53  Score=384.92  Aligned_cols=262  Identities=33%  Similarity=0.604  Sum_probs=236.5

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ..+..++|++++.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            35678999999999999999999999999999999999977544444455678889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      .++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999988654332 


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s  279 (366)
                                 ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......+|..++
T Consensus       163 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T 3fdn_A          163 -----------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT  231 (279)
T ss_dssp             ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred             -----------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCC
Confidence                       122456899999999999999999999999999999999999999999999998888888889999999


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +++.+||.+||+.||.+|||+     +++++||||+...
T Consensus       232 ~~~~~li~~~l~~~p~~Rps~-----~e~l~h~~~~~~~  265 (279)
T 3fdn_A          232 EGARDLISRLLKHNPSQRPML-----REVLEHPWITANS  265 (279)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCH-----HHHHHCHHHHHHC
T ss_pred             HHHHHHHHHHhccChhhCCCH-----HHHhhCccccCCc
Confidence            999999999999999999999     9999999997543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-53  Score=411.21  Aligned_cols=263  Identities=32%  Similarity=0.542  Sum_probs=239.0

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ....+..++|.+++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus         9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A            9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            34556789999999999999999999999999999999999875443444456788899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+||||++|++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999999999998888899999999999999999999999999999999999999999999999999986643


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  276 (366)
                      ..           .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|.
T Consensus       169 ~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~  237 (476)
T 2y94_A          169 GE-----------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ  237 (476)
T ss_dssp             TC-----------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT
T ss_pred             cc-----------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc
Confidence            21           2234579999999999988765 67899999999999999999999998888888999998888899


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+++++.+||.+||+.||.+|||+     +++++||||+.
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~-----~eil~hp~~~~  272 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATI-----KDIREHEWFKQ  272 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTCHHHHT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCH-----HHHHhCHHhhh
Confidence            999999999999999999999999     99999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.9e-53  Score=384.14  Aligned_cols=264  Identities=34%  Similarity=0.616  Sum_probs=238.1

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      .|...+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A            6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            45667889999999999999999999999999999999999976544444445668889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      .+..++||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999987543


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  276 (366)
                      ..            ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......+|.
T Consensus       166 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (284)
T 2vgo_A          166 SL------------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP  233 (284)
T ss_dssp             SS------------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred             cc------------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC
Confidence            32            122456899999999999988999999999999999999999999999988888888888888999


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .++.++.+||.+||+.||.+|||+     +++++||||+..
T Consensus       234 ~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~h~~~~~~  269 (284)
T 2vgo_A          234 FLSDGSKDLISKLLRYHPPQRLPL-----KGVMEHPWVKAN  269 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTCHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcCHhhCCCH-----HHHhhCHHHHhh
Confidence            999999999999999999999999     899999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.3e-53  Score=389.90  Aligned_cols=263  Identities=30%  Similarity=0.526  Sum_probs=239.7

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ....++|.+++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            44578999999999999999999999999999999999876655556667788899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998664321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                               .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+......+|..+++
T Consensus       196 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  266 (335)
T 2owb_A          196 ---------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP  266 (335)
T ss_dssp             ---------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred             ---------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCH
Confidence                     12234568999999999998889999999999999999999999999998888888888888888999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ++.+||.+||+.||++|||+     +++++||||+...
T Consensus       267 ~~~~li~~~l~~dp~~Rps~-----~ell~~~~~~~~~  299 (335)
T 2owb_A          267 VAASLIQKMLQTDPTARPTI-----NELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHTSC
T ss_pred             HHHHHHHHHccCChhHCcCH-----HHHhcCccccCCC
Confidence            99999999999999999999     8999999998644

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.4e-53  Score=394.84  Aligned_cols=256  Identities=32%  Similarity=0.574  Sum_probs=230.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            56899999999999999999999999999999999876443 23345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++....... 
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-  185 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  185 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence            99999999999998888899999999999999999999999999999999999998654   59999999998664321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  276 (366)
                                ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+...+|.    
T Consensus       186 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (362)
T 2bdw_A          186 ----------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  255 (362)
T ss_dssp             ----------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred             ----------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                      222457999999999999989999999999999999999999999999998888888887776653    


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+++++++||.+||+.||++|||+     .++++||||..
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~  290 (362)
T 2bdw_A          256 TVTPEAKSLIDSMLTVNPKKRITA-----DQALKVPWICN  290 (362)
T ss_dssp             GSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcccCC
Confidence            589999999999999999999999     99999999974

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-53  Score=391.04  Aligned_cols=254  Identities=27%  Similarity=0.462  Sum_probs=230.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...    ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            57899999999999999999999999999999998653    23345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--CCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||++|++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||+++.  ++.+||+|||++....... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999999775 46999999999999999999999999999999999999987  7899999999998764332 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~  276 (366)
                                ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......++    .
T Consensus       159 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T 1tki_A          159 ----------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             ----------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ----------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence                      22345789999999999988889999999999999999999999999999999999888877766    3


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+++++.+||.+||+.||.+|||+     .++++||||+..
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~  264 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQK  264 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHSC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhcChhhccC
Confidence            689999999999999999999999     899999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-52  Score=379.31  Aligned_cols=257  Identities=27%  Similarity=0.438  Sum_probs=217.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4689999999999999999999999999999999987643 333445677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+++ +|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......   
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence            999987 66565554 5789999999999999999999999999999999999999999999999999998664321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCC-CCCCCHHHHHHHHhcC----------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIAR----------  270 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~----------  270 (366)
                             .......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+...          
T Consensus       156 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          156 -------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             -------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             -------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence                   1222456899999999987766 89999999999999999987777 6666666666655321          


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 -------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                         .......+++++++||.+||+.||++|||+     +++++||||+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~  289 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTC
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH-----HHHhcCcccccC
Confidence                               001123578999999999999999999999     999999999865

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-53  Score=398.58  Aligned_cols=271  Identities=23%  Similarity=0.354  Sum_probs=223.1

Q ss_pred             CCcCCeeeeeeeeec--CceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           42 FSIQDFELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ...++|++++.||+|  +||.||+|+++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            357789999999999  9999999999999999999999876433 3445667889999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          120 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +|+||||+++++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999999876  6799999999999999999999999999999999999999999999999999875533


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  271 (366)
                      ......   ..........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.+.......+....    
T Consensus       181 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          181 HGQRQR---VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             TTEECS---CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             cccccc---ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            221110   01112234478999999999987  568999999999999999999999998765544443332211    


Q ss_pred             ------------------------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhh
Q 017775          272 ------------------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (366)
Q Consensus       272 ------------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l  309 (366)
                                                                ..++..+++++.+||.+||+.||++|||+     ++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~ell  332 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA-----STLL  332 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-----HHHT
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-----HHHh
Confidence                                                      12345689999999999999999999999     9999


Q ss_pred             cCCCCCCCCccc
Q 017775          310 MHPFFKGIDWKN  321 (366)
Q Consensus       310 ~hp~f~~~~~~~  321 (366)
                      +||||+.+.+..
T Consensus       333 ~hp~f~~~~~~~  344 (389)
T 3gni_B          333 NHSFFKQIKRRA  344 (389)
T ss_dssp             TSGGGGGC---C
T ss_pred             cCHHHHHHhhcc
Confidence            999999887654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-53  Score=392.84  Aligned_cols=286  Identities=37%  Similarity=0.683  Sum_probs=239.7

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFF  112 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  112 (366)
                      ....+..++|++++.||+|+||.||+|++.   .+|+.||+|+++..... .......+.+|+.+++.+ +||||+++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             ccccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            344567789999999999999999999984   58999999998764321 122223455688899988 6999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      ++.+...+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999999999998888999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCCCCC----CHHHHHHH
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQR  266 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~  266 (366)
                      +.+.....         .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||...    ........
T Consensus       207 ~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  277 (355)
T 1vzo_A          207 KEFVADET---------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR  277 (355)
T ss_dssp             EECCGGGG---------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH
T ss_pred             eecccCCC---------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH
Confidence            86543221         12234579999999999986  34788999999999999999999999643    34556666


Q ss_pred             HhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccCC-CCCCCC
Q 017775          267 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKLAS  332 (366)
Q Consensus       267 i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~~-~~~~~~  332 (366)
                      +......+|..++..+.+||.+||+.||++||++...+++++++||||+.++|+.+.... ++++.+
T Consensus       278 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p  344 (355)
T 1vzo_A          278 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP  344 (355)
T ss_dssp             HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCC
Confidence            777778888999999999999999999999996655566999999999999999887654 444433

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3e-52  Score=383.05  Aligned_cols=264  Identities=29%  Similarity=0.509  Sum_probs=236.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++........   .....+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            5689999999999999999999999999999999987543221   1355678899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC----CEEEEecCCccccC
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  196 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~----~vkL~Dfg~a~~~~  196 (366)
                      ++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999887    89999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  275 (366)
                      ...           ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++ 
T Consensus       171 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          171 DGV-----------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             TTC-----------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccc-----------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            321           12245689999999999998999999999999999999999999999999888888877766655 


Q ss_pred             ---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       276 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                         ..+++++.+||.+||+.||++|||+     +++++||||++++++...
T Consensus       240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~hp~~~~~~~~~~~  285 (321)
T 2a2a_A          240 EFFSHTSELAKDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQAM  285 (321)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSTTTSCCH-----HHHHHSTTTSCSSHHHHH
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCH-----HHHhcCccccCCCccccc
Confidence               5689999999999999999999999     999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=389.42  Aligned_cols=257  Identities=35%  Similarity=0.538  Sum_probs=211.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+.+++.++||||+++++++.+....+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34578999999999999999999999999999999987642     2345677999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CCCEEEEecCCccccCCc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~~vkL~Dfg~a~~~~~~  198 (366)
                      +||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++......
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999999999998888999999999999999999999999999999999999975   789999999999865432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCCCCCC--
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFP--  275 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~--  275 (366)
                      .           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+......++  
T Consensus       205 ~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          205 V-----------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred             c-----------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence            1           122457899999999999989999999999999999999999999765544 36666666654433  


Q ss_pred             --CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       276 --~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                        ..++.++.+||.+||+.||++|||+     .++++||||++...
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTT-----FQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTTSTTC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCH-----HHHhcCcccCCCcc
Confidence              4689999999999999999999999     89999999987543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-52  Score=383.28  Aligned_cols=260  Identities=26%  Similarity=0.418  Sum_probs=216.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            4789999999999999999999995 589999999976532 23334567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+++ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--  173 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--  173 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence            9999986 888888765 459999999999999999999999999999999999999999999999999998664321  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc---CCC-----
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---RDI-----  272 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~-----  272 (366)
                              .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+..   ...     
T Consensus       174 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          174 --------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             --------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             --------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence                    11223468999999999876 5589999999999999999999999988766655554432   000     


Q ss_pred             ----------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          273 ----------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       273 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                            .....+++++.+||.+||+.||++|||+     +++++||||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~  310 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-----RDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTSCTT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH-----HHHhcCcccccCCcc
Confidence                                  0123478899999999999999999999     999999999988753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7e-52  Score=375.75  Aligned_cols=263  Identities=30%  Similarity=0.526  Sum_probs=239.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            34578999999999999999999999999999999999876555556667788899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ++||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  169 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  169 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                               .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+......+|..+++
T Consensus       170 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T 2rku_A          170 ---------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP  240 (294)
T ss_dssp             ---------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred             ---------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCH
Confidence                     12224568999999999998889999999999999999999999999999888888888888888999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .+.++|.+||+.||++|||+     +++++||||....
T Consensus       241 ~~~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~~~  273 (294)
T 2rku_A          241 VAASLIQKMLQTDPTARPTI-----NELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHTSC
T ss_pred             HHHHHHHHHcccChhhCcCH-----HHHhhChheecCC
Confidence            99999999999999999999     8999999997543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-52  Score=390.21  Aligned_cols=263  Identities=32%  Similarity=0.499  Sum_probs=225.7

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      .....++|++.+.||+|+||.||+|.++.+|+.||+|++.......  ......+.+|+.+++.++||||+++++++.+.
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3444678999999999999999999999999999999997543211  12345678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC---EEEEecC
Q 017775          118 FSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFG  190 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~---vkL~Dfg  190 (366)
                      +.+|+||||++|++|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998887643    35899999999999999999999999999999999999987654   9999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ++.......          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. .......+...
T Consensus       179 ~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~  247 (351)
T 3c0i_A          179 VAIQLGESG----------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKG  247 (351)
T ss_dssp             TCEECCTTS----------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHT
T ss_pred             ceeEecCCC----------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcC
Confidence            998765432          1123457999999999999989999999999999999999999999875 44566667666


Q ss_pred             CCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          271 DIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       271 ~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ...++    ..+++++++||.+||+.||++|||+     .++++||||+..+
T Consensus       248 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~~~  294 (351)
T 3c0i_A          248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITV-----YEALNHPWLKERD  294 (351)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHTHH
T ss_pred             CCCCCccccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcChhhcCCc
Confidence            65554    4689999999999999999999999     8999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.6e-53  Score=388.39  Aligned_cols=265  Identities=25%  Similarity=0.370  Sum_probs=216.9

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ......++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            344568899999999999999999999999999999999976532 2223345667999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-----CCCCEEEEecCCcc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-----ADGHIKIADFGSVK  193 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-----~~~~vkL~Dfg~a~  193 (366)
                      .+++||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++     .++.+||+|||++.
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999986 9999999988899999999999999999999999999999999999994     44569999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      ......          .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus       186 ~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          186 AFGIPI----------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             HHC---------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ccCCcc----------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            654321          1222446799999999998754 89999999999999999999999999888777766543100


Q ss_pred             ------------------CC------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          273 ------------------RF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       273 ------------------~~------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                        .+            +..+++++.+||.+||+.||++|||+     +++++||||++.+|+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA-----KNALEHPYFSHNDFD  328 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSSCSC
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH-----HHHhCCcccCCCCCC
Confidence                              00            11278999999999999999999999     999999999999885

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=376.03  Aligned_cols=261  Identities=34%  Similarity=0.646  Sum_probs=206.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            35789999999999999999999999999999999976543334445667889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--  166 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--  166 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence            99999999999999876 679999999999999999999999999999999999999999999999999998654321  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~  281 (366)
                              .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.......|..++.+
T Consensus       167 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (278)
T 3cok_A          167 --------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE  238 (278)
T ss_dssp             ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHH
T ss_pred             --------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHH
Confidence                    112245689999999999988899999999999999999999999988776666666666677788889999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +.+||.+||+.||++|||+     +++++||||....
T Consensus       239 ~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~  270 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSL-----SSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCH-----HHHTTSTTTC---
T ss_pred             HHHHHHHHcccCHhhCCCH-----HHHhcCccccCCC
Confidence            9999999999999999999     9999999998543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-52  Score=392.09  Aligned_cols=271  Identities=29%  Similarity=0.459  Sum_probs=213.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCC--e
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF--S  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~  119 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++...... ........+|+.+++.+. ||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            367999999999999999999999999999999998765333 334455667999999997 999999999997544  7


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+||||+.+ +|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            9999999985 99998876 479999999999999999999999999999999999999999999999999998764321


Q ss_pred             cccc-----------CCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          200 ITVL-----------PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       200 ~~~~-----------~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      ....           ............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            1100           00011223345689999999999876 56899999999999999999999999999888777666


Q ss_pred             hcCCC-----------------------------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          268 IARDI-----------------------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       268 ~~~~~-----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      .....                                               ..+...++++.+||.+||+.||++|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            42100                                               0112678999999999999999999999


Q ss_pred             CCCChHhhhcCCCCCCCCccc
Q 017775          301 GPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       301 ~~~~~~~~l~hp~f~~~~~~~  321 (366)
                           +++++||||+.+....
T Consensus       324 -----~e~l~Hp~~~~~~~~~  339 (388)
T 3oz6_A          324 -----NDALKHPFVSIFHNPN  339 (388)
T ss_dssp             -----HHHTTSTTTTTTCCGG
T ss_pred             -----HHHhCCHHHHHhcCCc
Confidence                 9999999998776443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.5e-53  Score=383.95  Aligned_cols=248  Identities=22%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----eE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  120 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~  120 (366)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++..    .......+.|+..+..++||||+++++++.+.+    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            5799999999999999999988  6899999998653    222222344666667889999999999998654    58


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~--------~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      |||||||++|+|.+++.+. .++++.+..++.|++.||.|||++        +|+||||||+|||++.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999999775 599999999999999999999987        9999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCC------CCCCCCCcccchhhhhhhhcCCCCCCCC--------
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSGTSPFKDT--------  258 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~--------  258 (366)
                      +.........      .......+||+.|+|||++.+.      .++.++||||+||++|||+||.+||...        
T Consensus       156 ~~~~~~~~~~------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          156 VRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEEETTTTEE------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             ccccCCCCce------eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            8765432111      1122345799999999998764      3567899999999999999997765321        


Q ss_pred             -------CHHHHHHHHhcCCC--CCCCC-----CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          259 -------SEWLIFQRIIARDI--RFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       259 -------~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                             ........+.....  .+|..     .++.+.+|+.+||+.||++|||+     .+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~  290 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence                   22344444444332  33432     23568899999999999999999     66654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-52  Score=390.07  Aligned_cols=258  Identities=30%  Similarity=0.523  Sum_probs=228.9

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+...+++
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            3578999999999999999999999999999999997652   2334567889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--CCCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ||||+.|++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.......
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999999987653 6999999999999999999999999999999999999974  4789999999998764332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  275 (366)
                                 ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++    
T Consensus       206 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  274 (387)
T 1kob_A          206 -----------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF  274 (387)
T ss_dssp             -----------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred             -----------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence                       12244689999999999998999999999999999999999999999998888888877655443    


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ..+++++++||.+||+.||++|||+     .++++||||++..+
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~  313 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKGDHS  313 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSTTTSSCCT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCccccCCcc
Confidence            4689999999999999999999999     99999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-51  Score=371.24  Aligned_cols=261  Identities=31%  Similarity=0.562  Sum_probs=232.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            57899999999999999999999999999999999876433 33345677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC---EEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~---vkL~Dfg~a~~~~~~~~  200 (366)
                      |||++|++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++....... 
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-  162 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  162 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence            999999999999988888999999999999999999999999999999999999987655   9999999997654332 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~  276 (366)
                                ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+......++    .
T Consensus       163 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T 3kk8_A          163 ----------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  232 (284)
T ss_dssp             ----------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ----------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence                      12245689999999999999999999999999999999999999999999888888877766555    4


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      .+++++.+||.+||+.||++|||+     +++++||||++..+..
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITA-----DQALKVPWICNRERVA  272 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSHHHHSCCCGG
T ss_pred             ccCHHHHHHHHHHcccChhhCCCH-----HHHhcCccccCChhHH
Confidence            689999999999999999999999     9999999998765543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-52  Score=383.58  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=207.9

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            3578999999999999999999999999999999997653  22223456779999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          123 ALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      ||||++| +|.+++...      ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9999985 999988754      358999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  271 (366)
                      ...          .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....    
T Consensus       160 ~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          160 IPV----------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             SCC----------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCc----------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            321          112244689999999998764 58999999999999999999999999988877766654210    


Q ss_pred             ------------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          272 ------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       272 ------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                                    ...+..+++++.+||.+||+.||++|||+     +++++||||++..+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-----KQALHHPWFAEYYHHA  304 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCC--
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH-----HHHhCChhhhcccchh
Confidence                                          01123578999999999999999999999     8999999999877654


Q ss_pred             cc
Q 017775          322 IR  323 (366)
Q Consensus       322 ~~  323 (366)
                      ..
T Consensus       305 ~~  306 (317)
T 2pmi_A          305 SM  306 (317)
T ss_dssp             --
T ss_pred             hc
Confidence            43

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-52  Score=383.30  Aligned_cols=260  Identities=28%  Similarity=0.442  Sum_probs=219.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            6899999999999999999999999999999999976432  22234577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+......  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--  161 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--  161 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc--
Confidence            999999999999988888999999999999999999999999999999999999999999999999999865432211  


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCCCC--CCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIR--FPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~--~~~~~s  279 (366)
                            .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ............  ....++
T Consensus       162 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (323)
T 3tki_A          162 ------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  235 (323)
T ss_dssp             ------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             ------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCC
Confidence                  12234578999999999987764 77899999999999999999999875543 222333332222  235689


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +++.+||.+||+.||++|||+     +++++||||+..-
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~-----~eil~h~~~~~~~  269 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITI-----PDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCH-----HHHhhChhhcccc
Confidence            999999999999999999999     9999999998654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.6e-52  Score=398.18  Aligned_cols=275  Identities=24%  Similarity=0.332  Sum_probs=207.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-----CC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----TF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~  118 (366)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            5789999999999999999999999999999999976532 33444567789999999999999999999843     35


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999986 599999998888999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCC-----------------CCCCCCccccccCCCCCCceee-cCCCCCCCCCcccchhhhhhhhc----------
Q 017775          199 RITVLPN-----------------AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS----------  250 (366)
Q Consensus       199 ~~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~----------  250 (366)
                      .......                 ..........+||+.|+|||++ .+..++.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            2111000                 0001233456889999999986 56669999999999999999998          


Q ss_pred             -CCCCCCCCCH--------------------HHHHHHHhc---C-----------------------C-----CCCCCCC
Q 017775          251 -GTSPFKDTSE--------------------WLIFQRIIA---R-----------------------D-----IRFPNYF  278 (366)
Q Consensus       251 -g~~pf~~~~~--------------------~~~~~~i~~---~-----------------------~-----~~~~~~~  278 (366)
                       |.++|.+.+.                    ...+..+..   .                       .     .......
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7777866542                    111211110   0                       0     0011346


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~  325 (366)
                      ++++.+||.+||+.||++|||+     +++++||||+++.|......
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~-----~e~L~Hp~f~~~~~~~~e~~  411 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITI-----NECLAHPFFKEVRIAEVETN  411 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTCCGGGCCC
T ss_pred             CHHHHHHHHHHhccCccccCCH-----HHHhcCHhhhhcCCCccCCC
Confidence            9999999999999999999999     99999999999999877643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.8e-52  Score=389.29  Aligned_cols=255  Identities=33%  Similarity=0.509  Sum_probs=212.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++......    ...+.+|+.+++.++||||+++++++.+...++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            4578999999999999999999999999999999999764322    234678999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC--EEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~--vkL~Dfg~a~~~~~~~  199 (366)
                      +||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++..... 
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999988888999999999999999999999999999999999999987765  999999998743222 


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCC-CCcccchhhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRF  274 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~  274 (366)
                                .......||+.|+|||++.+..+..+ +|||||||++|+|++|..||.+...    ......+......+
T Consensus       172 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  241 (361)
T 3uc3_A          172 ----------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI  241 (361)
T ss_dssp             -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred             ----------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence                      12234579999999999988776555 8999999999999999999987443    45555666666666


Q ss_pred             CC--CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          275 PN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       275 ~~--~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      |.  .+++++.+||.+||+.||++|||+     +++++||||..
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~~  280 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISI-----PEIKTHSWFLK  280 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSHHHHT
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCH-----HHHHhCcchhc
Confidence            55  589999999999999999999999     99999999953

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-52  Score=378.52  Aligned_cols=258  Identities=36%  Similarity=0.620  Sum_probs=219.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHH
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------NKTAYVKLERIV   98 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~e~~~   98 (366)
                      +..++|++.+.||+|+||.||+|.+..+|+.||+|++........                       .....+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            557899999999999999999999999999999999976532211                       122457789999


Q ss_pred             HHhCCCCCcceeEEEEee--CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775           99 LDQLDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus        99 l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      ++.++||||+++++++.+  ...+|+||||+++++|.++.. .+.+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999987  668999999999999987653 35799999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC---CCCCCCcccchhhhhhhhcCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTS  253 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~  253 (366)
                      +++.++.+||+|||++........          ......||+.|+|||.+.+..   ++.++||||||+++|+|++|..
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA----------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC----------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             EECCCCCEEEecCCCccccccccc----------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            999999999999999987654321          122447899999999997765   3678999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          254 PFKDTSEWLIFQRIIARDIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       254 pf~~~~~~~~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ||...........+......+|  ..+++++.+||.+||+.||++|||+     .++++||||+
T Consensus       239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~-----~e~l~hp~~~  297 (298)
T 2zv2_A          239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV-----PEIKLHPWVT  297 (298)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTCHHHH
T ss_pred             CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH-----HHHhcCcccc
Confidence            9999888877777777666555  4689999999999999999999999     8999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.4e-52  Score=377.81  Aligned_cols=262  Identities=28%  Similarity=0.410  Sum_probs=218.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            578999999999999999999999999999999987653 2333445677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  156 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----  156 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----
Confidence            9999999999998888889999999999999999999999999999999999999999999999999998664322    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------------  270 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------  270 (366)
                            .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...            
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence                  11224468999999999876 56899999999999999999999999998877665544321            


Q ss_pred             -------CCCCC------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          271 -------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       271 -------~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                             ....+            ..+++++.+||.+||+.||++|||+     +++++||||+++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-----EQLLHHPYFENIREIE  295 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHTSGGGTTCC---
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH-----HHHhcChHHHhccCHH
Confidence                   00111            3578999999999999999999999     9999999999987654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-52  Score=406.18  Aligned_cols=262  Identities=33%  Similarity=0.549  Sum_probs=235.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44678999999999999999999999999999999998766555556677888999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---CCCCCEEEEecCCccccCCc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli---~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      +||||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..+...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999988899999999999999999999999999999999999999   46789999999999866433


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC---
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---  275 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  275 (366)
                      .           ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+..+...++   
T Consensus       183 ~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  250 (484)
T 3nyv_A          183 K-----------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ  250 (484)
T ss_dssp             C-----------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred             c-----------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            2           2234579999999999876 588999999999999999999999999999999998888766554   


Q ss_pred             -CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       276 -~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                       ..+++++++||.+||+.||.+|||+     +++++||||+...++
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~-----~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISA-----RDALDHEWIQTYTKE  291 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSHHHHHHTC-
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCH-----HHHhhChhhcccccc
Confidence             4689999999999999999999999     999999999865543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.5e-52  Score=374.58  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=215.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||.||+|.+ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999998 67999999999765322 22234567799999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......   
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence            999986 999988865 679999999999999999999999999999999999999999999999999997654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC--C--------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--D--------  271 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~--------  271 (366)
                             .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...  .        
T Consensus       155 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          155 -------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             -------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence                   112234689999999998764 4899999999999999999999999998887766655321  0        


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          272 -------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       272 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                         ..+...+++++.+||.+||+.||++|||+     +++++||||++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~  287 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKEN  287 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC-
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhc
Confidence                               01224579999999999999999999999     999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.8e-52  Score=372.69  Aligned_cols=262  Identities=32%  Similarity=0.543  Sum_probs=227.7

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34566889999999999999999999999999999999997654334444566788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..++||||+++++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998865432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .           ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+......+|..
T Consensus       165 ~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (276)
T 2h6d_A          165 E-----------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY  233 (276)
T ss_dssp             -----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             c-----------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchh
Confidence            2           1124468899999999987765 678999999999999999999999998888888888888888899


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++.++.++|.+||+.||++|||+     +++++||||++
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~-----~~~l~h~~~~~  267 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATI-----KDIREHEWFKQ  267 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             cCHHHHHHHHHHccCChhhCCCH-----HHHHhChhhcc
Confidence            99999999999999999999999     99999999974

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-52  Score=390.99  Aligned_cols=256  Identities=29%  Similarity=0.499  Sum_probs=221.4

Q ss_pred             Ceee--eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           46 DFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        46 ~y~~--~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3444  678999999999999999999999999997652   23445678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe--CCCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli--~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||++....... 
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            9999999999988765 469999999999999999999999999999999999999  567899999999998764432 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~  276 (366)
                                ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    .
T Consensus       244 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  313 (373)
T 2x4f_A          244 ----------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ  313 (373)
T ss_dssp             ----------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGT
T ss_pred             ----------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhc
Confidence                      12244689999999999988899999999999999999999999999999888888887766554    4


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      .+++++++||.+||+.||.+|||+     +++++||||+...+.
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~-----~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISA-----SEALKHPWLSDHKLH  352 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHCHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcCcCCCchh
Confidence            689999999999999999999999     999999999976654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-51  Score=369.73  Aligned_cols=253  Identities=32%  Similarity=0.547  Sum_probs=228.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            4689999999999999999999999999999999976532   2345677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---CCCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli---~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++....... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            9999999999999888889999999999999999999999999999999999999   778999999999998664332 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  276 (366)
                                ......||+.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....+......+|.    
T Consensus       164 ----------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          164 ----------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             ----------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             ----------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence                      22245689999999998765 888999999999999999999999999999988888888777775    


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+++++.+||.+||+.||++|||+     .++++||||++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~-----~~~l~h~~~~~  267 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITS-----LQALEHEWFEK  267 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHHHhc
Confidence            689999999999999999999999     89999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-51  Score=379.65  Aligned_cols=253  Identities=35%  Similarity=0.579  Sum_probs=203.6

Q ss_pred             cCCeeee---eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCe
Q 017775           44 IQDFELG---KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS  119 (366)
Q Consensus        44 ~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  119 (366)
                      .++|++.   +.||+|+||.||+|.++.+|+.||+|++...      ......+|+.+++.+. ||||+++++++.+...
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            3567775   8899999999999999999999999998653      2345667999999996 9999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEEEecCCccccC
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQ  196 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL~Dfg~a~~~~  196 (366)
                      .|+||||++|++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999999999988999999999999999999999999999999999999998766   89999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-------HHHHHHHHhc
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-------EWLIFQRIIA  269 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~  269 (366)
                      ...          .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+       ..+....+..
T Consensus       161 ~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          161 PDN----------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             C--------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             CCC----------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            321          12234568999999999999999999999999999999999999997643       3566777777


Q ss_pred             CCCCCCC----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          270 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       270 ~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +...++.    .+++++++||.+||+.||.+|||+     +++++||||++.
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~h~w~~~~  277 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKM-----SGLRYNEWLQDG  277 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCT-----TTSTTCGGGCTT
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCH-----HHHhcChhhccC
Confidence            7766653    589999999999999999999999     789999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.3e-52  Score=384.47  Aligned_cols=257  Identities=34%  Similarity=0.554  Sum_probs=222.8

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  121 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+....       ..+|+.++..+ +||||+++++++.+...+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            367899999999999999999999999999999999765321       23477777766 7999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC----CCEEEEecCCccccCC
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQD  197 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~----~~vkL~Dfg~a~~~~~  197 (366)
                      +||||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||++..+    +.+||+|||++.....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999999999988889999999999999999999999999999999999998543    3599999999986643


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC---CCHHHHHHHHhcCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRF  274 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~  274 (366)
                      ..          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+   .+..+....+..+...+
T Consensus       173 ~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          173 EN----------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL  242 (342)
T ss_dssp             TT----------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred             CC----------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence            31          122345789999999999887788999999999999999999999975   45677777887776665


Q ss_pred             C----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          275 P----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       275 ~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      +    ..+++++++||.+||+.||++|||+     .++++||||.  +|+.+.
T Consensus       243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~--~~~~~~  288 (342)
T 2qr7_A          243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTA-----ALVLRHPWIV--HWDQLP  288 (342)
T ss_dssp             CSTTTTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHTTSHHHH--TGGGSC
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCCeec--Cccccc
Confidence            4    5689999999999999999999999     8999999995  465543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=373.79  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=213.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhC---CCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~  116 (366)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.......  ........+|+.+++.+   +||||+++++++.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            45689999999999999999999999999999999997543211  11122345566666655   59999999999987


Q ss_pred             CC-----eEEEEEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          117 TF-----SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       117 ~~-----~~~iv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      ..     .+++||||+.+ +|.+++.....  +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     58999999975 99999987654  999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      |++.......           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       165 g~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          165 GLARIYSYQM-----------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCTTTSTTCC-----------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccCCCc-----------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9998654321           22356789999999999988999999999999999999999999999988887776643


Q ss_pred             CCC-----C----------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          270 RDI-----R----------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       270 ~~~-----~----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ...     .                      ....+++++.+||.+||+.||++|||+     +++++||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~h~~~~~~  303 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA-----FRALQHSYLHKD  303 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSTTC---
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH-----HHHhcCccccCC
Confidence            100     0                      113578999999999999999999999     899999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.2e-51  Score=398.63  Aligned_cols=258  Identities=30%  Similarity=0.479  Sum_probs=227.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch----------hhHHHHHHHHHHHHhCCCCCcceeEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE----------NKTAYVKLERIVLDQLDHPGVVRLFF  112 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~  112 (366)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++.+......          .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            46789999999999999999999999999999999987543321          33456788999999999999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEEEec
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADF  189 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL~Df  189 (366)
                      ++.+...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999998888899999999999999999999999999999999999999876   6999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      |++.......           ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus       194 g~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          194 GLSSFFSKDY-----------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             TTCEECCTTS-----------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCEEcCCCC-----------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            9998664431           2234579999999999874 588999999999999999999999999999999999988


Q ss_pred             CCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          270 RDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       270 ~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +...++    ..+++++++||.+||+.||.+|||+     +++++||||+..
T Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  308 (504)
T 3q5i_A          262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA-----EEALNSRWIKKY  308 (504)
T ss_dssp             CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHHT
T ss_pred             CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCHhhhhc
Confidence            877665    5789999999999999999999999     999999999754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.9e-51  Score=389.87  Aligned_cols=275  Identities=24%  Similarity=0.362  Sum_probs=217.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            36789999999999999999999999999999999976532 334455677899999999999999999999876     


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            579999999975 9999999888899999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCC------------CCCCCCccccccCCCCCCceee-cCCCCCCCCCcccchhhhhhhhc-----------CCC
Q 017775          198 SRITVLPN------------AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS-----------GTS  253 (366)
Q Consensus       198 ~~~~~~~~------------~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~-----------g~~  253 (366)
                      ........            ..........+||+.|+|||++ .+..++.++|||||||++|+|++           |.+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            32111000            0001123567899999999986 56669999999999999999998           445


Q ss_pred             CCCCCC-----------------HHHHHHHHhc------------------------CCCCC-------CCCCCHHHHHH
Q 017775          254 PFKDTS-----------------EWLIFQRIIA------------------------RDIRF-------PNYFSDAARDL  285 (366)
Q Consensus       254 pf~~~~-----------------~~~~~~~i~~------------------------~~~~~-------~~~~s~~~~~l  285 (366)
                      +|.+.+                 ....+..+..                        .....       ...+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            554433                 1111111111                        01111       13579999999


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                      |.+||+.||++|||+     +++++||||+++.|+....
T Consensus       342 l~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          342 LESMLKFNPNKRITI-----DQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HHHHSCSSTTTSCCH-----HHHHTCGGGTTTCCTTTC-
T ss_pred             HHHHhcCCcccCCCH-----HHHhcChhhhhccCcccCc
Confidence            999999999999999     9999999999999887653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.2e-51  Score=376.23  Aligned_cols=267  Identities=32%  Similarity=0.489  Sum_probs=216.4

Q ss_pred             cCCeeee-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 017775           44 IQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        44 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  121 (366)
                      .++|++. +.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++++ +||||+++++++.+.+.+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            5679985 78999999999999999999999999997652   23345577899999884 7999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC---EEEEecCCccccCCc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDS  198 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~---vkL~Dfg~a~~~~~~  198 (366)
                      +||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998888999999999999999999999999999999999999998775   999999998765432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC-----CCCCCCCCcccchhhhhhhhcCCCCCCCCC--------------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTS--------------  259 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------  259 (366)
                      .....   ..........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+..              
T Consensus       168 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          168 GDCSP---ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             Ccccc---ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            11100   00112224468999999999865     457889999999999999999999997754              


Q ss_pred             -HHHHHHHHhcCCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          260 -EWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       260 -~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                       .......+......+|    ..+++++++||.+||+.||++|||+     +++++||||++..++.
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~~  306 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-----AQVLQHPWVQGCAPEN  306 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSTTCC------
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH-----HHHhcChhhcCCCCcc
Confidence             2445666777777666    3689999999999999999999999     9999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-51  Score=396.33  Aligned_cols=255  Identities=23%  Similarity=0.409  Sum_probs=212.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            36899999999999999999999999999999999987633 333445677899999999999999999999654     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ..+|+||||+++ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             468999999987 67777654  49999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      ..           ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....     
T Consensus       216 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          216 TS-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             -C-----------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             CC-----------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            32           12335689999999999999999999999999999999999999999998877776654310     


Q ss_pred             ----------------------CC----CCCC-----------CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 ----------------------IR----FPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 ----------------------~~----~~~~-----------~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                            ..    +|..           .++++++||.+||+.||++|||+     +++++||||
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~~  359 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYI  359 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH-----HHHhcChhh
Confidence                                  00    0111           15679999999999999999999     999999999


Q ss_pred             CCC
Q 017775          315 KGI  317 (366)
Q Consensus       315 ~~~  317 (366)
                      +..
T Consensus       360 ~~~  362 (464)
T 3ttj_A          360 NVW  362 (464)
T ss_dssp             GGG
T ss_pred             hhc
Confidence            853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-51  Score=383.19  Aligned_cols=258  Identities=27%  Similarity=0.426  Sum_probs=215.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            36789999999999999999999999999999999976532 333445677899999999999999999999865     


Q ss_pred             -CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 -~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence             3469999999 7799999877 569999999999999999999999999999999999999999999999999998653


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC----
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  271 (366)
                      ..             .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+....    
T Consensus       180 ~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          180 SE-------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             SS-------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cc-------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            21             224578999999999877 679999999999999999999999999988877666654310    


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          272 ---------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       272 ---------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                                 .......++++.+||.+||+.||++|||+     +++++||||+.+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~-----~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHDTE  318 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC---
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH-----HHHhcChHHHhhcCCc
Confidence                                       01224579999999999999999999999     8999999999876554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-51  Score=399.17  Aligned_cols=258  Identities=35%  Similarity=0.577  Sum_probs=228.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            4679999999999999999999999999999999997653322 234567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC---CCCCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~---~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ||||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.......
T Consensus        99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            999999999999998888899999999999999999999999999999999999995   45689999999998654331


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  275 (366)
                                 ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+..+...++    
T Consensus       179 -----------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (486)
T 3mwu_A          179 -----------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW  246 (486)
T ss_dssp             --------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred             -----------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence                       2234579999999999876 488899999999999999999999999999999888887765543    


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..+++++++||.+||+.||.+|||+     .++++||||+...
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~~~~~~  284 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITA-----TQCLEHPWIQKYS  284 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHCHHHHHTC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCHhhccCc
Confidence            4689999999999999999999999     8999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.4e-51  Score=373.14  Aligned_cols=255  Identities=29%  Similarity=0.465  Sum_probs=224.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ..|...+.||+|+||.||+|++..+|+.||+|++....   ......+.+|+.+++.++||||+++++++......++||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            35888999999999999999999999999999997642   233455778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC
Q 017775          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (366)
Q Consensus       125 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~  204 (366)
                      ||++|++|.+++.+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......     
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----  195 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-----  195 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-----
Confidence            99999999998865 469999999999999999999999999999999999999999999999999998664321     


Q ss_pred             CCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHH
Q 017775          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYFSDA  281 (366)
Q Consensus       205 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~s~~  281 (366)
                           .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.....   ..+..++++
T Consensus       196 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2c30_A          196 -----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPV  270 (321)
T ss_dssp             -----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHH
T ss_pred             -----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHH
Confidence                 112345789999999999998899999999999999999999999999888877777665432   233468999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      +.+||.+||+.||++|||+     +++++||||....
T Consensus       271 l~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~  302 (321)
T 2c30_A          271 LRDFLERMLVRDPQERATA-----QELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHHHSCSSTTTSCCH-----HHHHTSGGGGGCC
T ss_pred             HHHHHHHHccCChhhCcCH-----HHHhcChhhccCC
Confidence            9999999999999999999     9999999998543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-51  Score=368.25  Aligned_cols=255  Identities=32%  Similarity=0.571  Sum_probs=219.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|+||.||+|.+..+|..||+|++....  .......+.+|+.+++.++||||+++++++.+....++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            3578999999999999999999999999999999997753  22334567889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC---CCCCEEEEecCCcccc
Q 017775          123 ALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPM  195 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~---~~~~vkL~Dfg~a~~~  195 (366)
                      ||||+++++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999999988543    6799999999999999999999999999999999999994   5578999999999765


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ....           ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+......++
T Consensus       178 ~~~~-----------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (285)
T 3is5_A          178 KSDE-----------HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA  245 (285)
T ss_dssp             --------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             CCcc-----------cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc
Confidence            4322           1224568999999999864 578899999999999999999999999888887777665544433


Q ss_pred             ---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       276 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                         ..+++++.+||.+||+.||++|||+     +++++||||++
T Consensus       246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~f~~  284 (285)
T 3is5_A          246 VECRPLTPQAVDLLKQMLTKDPERRPSA-----AQVLHHEWFKQ  284 (285)
T ss_dssp             C--CCCCHHHHHHHHHHTCSCTTTSCCH-----HHHHTSGGGGC
T ss_pred             cccCcCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHHhhc
Confidence               3479999999999999999999999     99999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.5e-51  Score=368.80  Aligned_cols=265  Identities=30%  Similarity=0.507  Sum_probs=229.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc------chhhHHHHHHHHHHHHhCC-CCCcceeEEEEe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT------KENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ  115 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~  115 (366)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++......      .......+.+|+.+++.+. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            378999999999999999999999999999999999765311      1223445678999999995 999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +....++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999866


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeec------CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      ....           ......|++.|+|||.+.      ...++.++||||||+++|+|++|..||...+.......+..
T Consensus       175 ~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          175 DPGE-----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             CTTC-----------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCc-----------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            4321           222456899999999874      45578899999999999999999999999888888888777


Q ss_pred             CCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          270 RDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       270 ~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ....++    ..+++++.+||.+||+.||++|||+     +++++||||++..++.++
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCTTC-----
T ss_pred             CCcccCcccccccCHHHHHHHHHHccCCcccCCCH-----HHHHhChHhhhccchhhc
Confidence            665544    3589999999999999999999999     999999999988776653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.6e-51  Score=371.68  Aligned_cols=254  Identities=33%  Similarity=0.569  Sum_probs=225.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            578999999999999999999999999999999997642   22334577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---CCCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli---~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++......  
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   67889999999998754322  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----CC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF----PN  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~~  276 (366)
                                ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......+    +.
T Consensus       163 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (304)
T 2jam_A          163 ----------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD  232 (304)
T ss_dssp             ----------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT
T ss_pred             ----------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc
Confidence                      1224568999999999999899999999999999999999999999998888888887765443    35


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+++++.+||.+||+.||++|||+     +++++||||++.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~  268 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTC-----EKALSHPWIDGN  268 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHHHHSS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhcCccccCC
Confidence            689999999999999999999999     899999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.8e-51  Score=379.41  Aligned_cols=255  Identities=25%  Similarity=0.446  Sum_probs=218.6

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceeEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGVVRLFF  112 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~  112 (366)
                      .......++|++++.||+|+||.||+|++..+|+.||+|++...    .........|..+++.+.     ||||+++++
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            44445578999999999999999999999999999999998642    233445667888998886     999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC----------
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA----------  180 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~----------  180 (366)
                      ++...+..++||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.          
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            999999999999999 789999998764  5999999999999999999999999999999999999975          


Q ss_pred             ---------------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhh
Q 017775          181 ---------------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL  245 (366)
Q Consensus       181 ---------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  245 (366)
                                     ++.+||+|||++......             .....||+.|+|||++.+..++.++|||||||++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC-------------CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                           789999999999754322             2245789999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----------------------------------------------CCCC
Q 017775          246 YQMLSGTSPFKDTSEWLIFQRIIARDIRFP----------------------------------------------NYFS  279 (366)
Q Consensus       246 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------------------------~~~s  279 (366)
                      |+|++|..||.+.+..+....+.......|                                              ...+
T Consensus       250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            999999999998887776665543222221                                              1124


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      +++.+||.+||+.||++|||+     +++++||||+
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~  360 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSP-----AELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGC
T ss_pred             HHHHHHHHHHhcCChhhCCCH-----HHHhcCcccC
Confidence            778899999999999999999     9999999995

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.8e-52  Score=382.88  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=220.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++........     .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35789999999999999999999999999999999987543221     1223456699999999999999999999999


Q ss_pred             CeEEEEEeecCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~-~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      +.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999998766 999999988889999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ...           ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....      .........|
T Consensus       182 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~  244 (335)
T 3dls_A          182 RGK-----------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPP  244 (335)
T ss_dssp             TTC-----------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCS
T ss_pred             CCC-----------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCC
Confidence            432           2234578999999999988776 788999999999999999999997632      2344555667


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..+++++.+||.+||+.||++|||+     +++++||||++
T Consensus       245 ~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~hp~~~~  280 (335)
T 3dls_A          245 YLVSKELMSLVSGLLQPVPERRTTL-----EKLVTDPWVTQ  280 (335)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHCTTTTC
T ss_pred             cccCHHHHHHHHHHccCChhhCcCH-----HHHhcCccccC
Confidence            7899999999999999999999999     99999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-51  Score=369.79  Aligned_cols=263  Identities=31%  Similarity=0.563  Sum_probs=230.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++........   .....+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            4679999999999999999999999999999999987543322   2356688899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC----CEEEEecCCccccC
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  196 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~----~vkL~Dfg~a~~~~  196 (366)
                      ++||||+++++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998888899999999999999999999999999999999999999877    89999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  275 (366)
                      ...           ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+......++ 
T Consensus       164 ~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T 3bhy_A          164 AGN-----------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE  232 (283)
T ss_dssp             -------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CCC-----------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence            321           12244689999999999988899999999999999999999999999988888888777665554 


Q ss_pred             ---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       276 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                         ..+++.+.+||.+||+.||++|||+     .++++||||+.+.+...
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          233 EYFSNTSELAKDFIRRLLVKDPKRRMTI-----AQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHHCHHHHHHHHCCC
T ss_pred             hhcccCCHHHHHHHHHHccCCHhHCcCH-----HHHHhCHHHHHHHHHhh
Confidence               5689999999999999999999999     89999999987765544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.5e-52  Score=380.27  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=213.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.......  ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            478999999999999999999999999999999987543111  111234589999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      |||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......   
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---  154 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---  154 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc---
Confidence            999986 999988875 459999999999999999999999999999999999999999999999999987554321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---------
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  272 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------  272 (366)
                             .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....         
T Consensus       155 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          155 -------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             -------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence                   12224468999999999876 5689999999999999999999999999888877666543100         


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          273 ---------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       273 ---------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                           ..+..+++++.+||.+||+.||++|||+     +++++||||.++...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-----EDAMKHPFFLSLGER  291 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCST
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH-----HHHhcChhhhhcccc
Confidence                                 0113478999999999999999999999     999999999976543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.8e-51  Score=396.48  Aligned_cols=257  Identities=32%  Similarity=0.551  Sum_probs=223.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|+++.++..||+|++.+....... ...+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            55899999999999999999999999999999999876433322 34577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++..   +.+||+|||++....... 
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-  193 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-  193 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence            9999999999999888889999999999999999999999999999999999999764   459999999998765432 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~  276 (366)
                                ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++    .
T Consensus       194 ----------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  262 (494)
T 3lij_A          194 ----------KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK  262 (494)
T ss_dssp             ----------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred             ----------cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence                      2234579999999999864 588999999999999999999999999999999998888776654    3


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .+++++++||.+||+.||.+|||+     +++++||||+...
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~  299 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISA-----QQALEHPWIKEMC  299 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTCHHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccH-----HHHhcCcccccCc
Confidence            689999999999999999999999     9999999997643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-51  Score=378.58  Aligned_cols=262  Identities=27%  Similarity=0.405  Sum_probs=220.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      -.+++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            358899999999999999999999999999999999876532 3334455678999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||||+++++|.++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  178 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  178 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence            999999998998888777889999999999999999999999999999999999999999999999999997654321  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC----------
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  270 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~----------  270 (366)
                              .......|++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+...          
T Consensus       179 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          179 --------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             --------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence                    112244689999999998775 6899999999999999999999999998877665554321          


Q ss_pred             ---------CCCC------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          271 ---------DIRF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       271 ---------~~~~------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                               ....            ...+++++.+||.+||+.||++|||+     +++++||||+..++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~  315 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC-----AELLHHDFFQMDGF  315 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHGGGH
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH-----HHHhcCchhccCCh
Confidence                     0111            12578999999999999999999999     89999999986544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.5e-51  Score=376.21  Aligned_cols=264  Identities=28%  Similarity=0.490  Sum_probs=227.2

Q ss_pred             cCCeeee-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 017775           44 IQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        44 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  121 (366)
                      .++|.+. +.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.+....+
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            4568887 89999999999999999999999999998764333 3345577799999988 5699999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CCCEEEEecCCccccC
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQ  196 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~~vkL~Dfg~a~~~~  196 (366)
                      +||||+.|++|.+++...  +.+++.+++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++....
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999988654  67999999999999999999999999999999999999997   7899999999998664


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  275 (366)
                      ...           ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++ 
T Consensus       186 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  254 (327)
T 3lm5_A          186 HAC-----------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE  254 (327)
T ss_dssp             -------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             Ccc-----------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence            332           12245789999999999999999999999999999999999999999988888777766554433 


Q ss_pred             ---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccccc
Q 017775          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (366)
Q Consensus       276 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~  324 (366)
                         ..+++.+.+||.+||+.||.+|||+     +++++||||++++|+.+..
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          255 ETFSSVSQLATDFIQSLLVKNPEKRPTA-----EICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTCGGGCCCCTTCC--
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCH-----HHHhCCHhhcccccccccC
Confidence               4689999999999999999999999     9999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-50  Score=367.28  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=221.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            44678999999999999999999999999999999997765555666677888999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||||++|++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999986643321 


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-----CCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----FPN  276 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~~  276 (366)
                              .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..............     .+.
T Consensus       167 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T 4eqm_A          167 --------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK  238 (294)
T ss_dssp             ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred             --------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence                    1223456899999999999999999999999999999999999999998887766555544322     346


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      .+++.+.++|.+||+.||.+||+.     .+.+.+.|..
T Consensus       239 ~~~~~l~~li~~~l~~dp~~R~~~-----~~~l~~~l~~  272 (294)
T 4eqm_A          239 DIPQSLSNVILRATEKDKANRYKT-----IQEMKDDLSS  272 (294)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCSS-----HHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHhcCCHhHcccc-----HHHHHHHHHH
Confidence            789999999999999999999966     4455555443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-50  Score=376.97  Aligned_cols=255  Identities=32%  Similarity=0.562  Sum_probs=225.5

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  118 (366)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++......     .......+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            5799999999999999999999999999999999765321     112244567899999998 7999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999866533


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC------CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      .           ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus       254 ~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          254 E-----------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             C-----------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             c-----------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            2           2234578999999999853      3578899999999999999999999999888888888877766


Q ss_pred             CCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       273 ~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      .++    ..+++++.+||.+||+.||++|||+     +++++||||+
T Consensus       323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~  364 (365)
T 2y7j_A          323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA-----EQALQHPFFE  364 (365)
T ss_dssp             CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGC
T ss_pred             CCCCcccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhcCcccC
Confidence            554    4689999999999999999999999     9999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-51  Score=385.11  Aligned_cols=251  Identities=30%  Similarity=0.513  Sum_probs=208.4

Q ss_pred             CCcCCeeee-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEee---
Q 017775           42 FSIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD---  116 (366)
Q Consensus        42 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~---  116 (366)
                      ...++|.+. +.||+|+||.||+|.++.+|+.||+|++...        ....+|+.++ +..+||||+++++++..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            346788887 7899999999999999999999999998642        2345677766 55689999999999876   


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CCCEEEEecC
Q 017775          117 -TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFG  190 (366)
Q Consensus       117 -~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~~vkL~Dfg  190 (366)
                       ...+|+||||++||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             667999999999999999998754  5999999999999999999999999999999999999997   7899999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH----HHHH
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQR  266 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~  266 (366)
                      +++......           .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....    ....
T Consensus       210 ~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  278 (400)
T 1nxk_A          210 FAKETTSHN-----------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  278 (400)
T ss_dssp             TCEECC----------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred             cccccCCCC-----------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence            998654321           2235578999999999999899999999999999999999999997654321    3444


Q ss_pred             HhcCCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          267 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       267 i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +..+...++    ..+++++++||++||+.||++|||+     .++++||||.+
T Consensus       279 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  327 (400)
T 1nxk_A          279 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  327 (400)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccC
Confidence            555555554    4689999999999999999999998     99999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-51  Score=380.23  Aligned_cols=266  Identities=30%  Similarity=0.473  Sum_probs=224.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      .++|++++.||+|+||.||+|.+..++..||+|++......  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            57899999999999999999999999999999999765321  2344566888999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 017775          122 MALESCEGGELFDQITS----------------------------------------KGHLSEDEARFYTAEVVDALEYI  161 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~----------------------------------------~~~l~~~~~~~~~~qil~aL~~L  161 (366)
                      +||||++|++|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998852                                        11246788999999999999999


Q ss_pred             HHCCceeccCCCCCeEeCCCC--CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCC
Q 017775          162 HSMGLIHRDIKPENLLLTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGND  237 (366)
Q Consensus       162 H~~~i~H~dlkp~NIli~~~~--~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  237 (366)
                      |++||+||||||+||+++.++  .+||+|||++..+......      .........||+.|+|||++.+  ..++.++|
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG------EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc------ccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999998776  8999999999865432111      0112234578999999999865  56889999


Q ss_pred             cccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          238 LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       238 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      |||||+++|+|++|..||.+.+..+....+......++.    .+++++.+||.+||+.||.+|||+     .++++|||
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~hp~  333 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA-----MRALQHPW  333 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHHHSHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH-----HHHhcChh
Confidence            999999999999999999999998888888777665543    479999999999999999999999     99999999


Q ss_pred             CCCCCcc
Q 017775          314 FKGIDWK  320 (366)
Q Consensus       314 f~~~~~~  320 (366)
                      |+++.++
T Consensus       334 ~~~~~~~  340 (345)
T 3hko_A          334 ISQFSDK  340 (345)
T ss_dssp             HHTTSSC
T ss_pred             hccChHh
Confidence            9987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=371.12  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=209.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||+||+|.+..+|+.||+|++.............+.++..+.+..+||||+++++++.+.+.++
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            34578999999999999999999999999999999987654444444444443444445559999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999999 55998888765 469999999999999999999999999999999999999999999999999988664332 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~  278 (366)
                                ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.+....   ..+....  ..++..+
T Consensus       212 ----------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~  277 (311)
T 3p1a_A          212 ----------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGL  277 (311)
T ss_dssp             -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTS
T ss_pred             ----------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCC
Confidence                      1223468999999999876 6889999999999999999997776554332   2333322  2234678


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++++.+||.+||+.||++|||+     +++++||||++
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  310 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATA-----EALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCH-----HHHHhCccccC
Confidence            9999999999999999999999     99999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-51  Score=376.74  Aligned_cols=262  Identities=26%  Similarity=0.428  Sum_probs=221.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  118 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            4678999999999999999999999999999999998765555555667888999999999999999999987644    


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+||||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            35999999999999999998888999999999999999999999999999999999999999999999999999866443


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC---
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---  275 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  275 (366)
                      ...       ........||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.......+   
T Consensus       170 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          170 GNS-------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             -------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             ccc-------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            211       1122345789999999999999999999999999999999999999999988877766665544332   


Q ss_pred             -CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       276 -~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                       ..+++++.+||.+||+.||++||++     .+++.|+|++.
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~~  279 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQT-----AAEMRADLVRV  279 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhh-----HHHHHHHHHHH
Confidence             4689999999999999999999999     88999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-50  Score=379.09  Aligned_cols=257  Identities=24%  Similarity=0.395  Sum_probs=211.0

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  118 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            46899999999999999999999999999999999976532 3334456778999999999999999999998655    


Q ss_pred             --eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          119 --SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       119 --~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                        .+|+||||+++ +|.+.+..  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              78999999986 88888863  59999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC---
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  273 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---  273 (366)
                      ...           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......   
T Consensus       179 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          179 TSF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             ccc-----------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            321           122457899999999999989999999999999999999999999998888777766543111   


Q ss_pred             ---------------------------------CCC------CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          274 ---------------------------------FPN------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       274 ---------------------------------~~~------~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                                                       +|.      ..++++++||.+||+.||++|||+     +++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~  322 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYI  322 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH-----HHHhCCcch
Confidence                                             000      015689999999999999999999     999999999


Q ss_pred             CCCCc
Q 017775          315 KGIDW  319 (366)
Q Consensus       315 ~~~~~  319 (366)
                      +....
T Consensus       323 ~~~~~  327 (371)
T 2xrw_A          323 NVWYD  327 (371)
T ss_dssp             HTTCC
T ss_pred             hhhcC
Confidence            86443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.5e-51  Score=379.23  Aligned_cols=265  Identities=26%  Similarity=0.429  Sum_probs=226.4

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++++.||+|+||.||+|.+..+|..||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            34566889999999999999999999999999999999997652  3344566788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||++|++|.+++.+.+.+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999999999999888899999999999999999999996 999999999999999999999999999875532


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH----------
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI----------  267 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----------  267 (366)
                      .            ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+          
T Consensus       185 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          185 S------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             H------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             c------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            2            112457899999999999999999999999999999999999999877665432221          


Q ss_pred             --------------------------------hcCC-CCC-CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          268 --------------------------------IARD-IRF-PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       268 --------------------------------~~~~-~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                                                      .... ... +..++.++.+||.+||+.||++|||+     +++++|||
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~  327 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAF  327 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHH
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH-----HHHhhChH
Confidence                                            1111 111 23479999999999999999999999     99999999


Q ss_pred             CCCCCcccc
Q 017775          314 FKGIDWKNI  322 (366)
Q Consensus       314 f~~~~~~~~  322 (366)
                      |+..+++.+
T Consensus       328 ~~~~~~~~~  336 (360)
T 3eqc_A          328 IKRSDAEEV  336 (360)
T ss_dssp             HHHHHHSCC
T ss_pred             hhcchHhhh
Confidence            987665544

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=368.25  Aligned_cols=264  Identities=31%  Similarity=0.545  Sum_probs=226.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEE--eeCCeE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTF--QDTFSL  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~  120 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999999999999997653222 23456688899999999999999999998  455679


Q ss_pred             EEEEeecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ++||||+.++ |.+++..  .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999875 7777765  356999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  276 (366)
                      ..        ........|++.|+|||++.+..  ++.++||||||+++|+|++|..||.+.+.......+......++.
T Consensus       163 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  234 (305)
T 2wtk_C          163 AA--------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG  234 (305)
T ss_dssp             CS--------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS
T ss_pred             cc--------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC
Confidence            11        11222446899999999987654  377899999999999999999999999998888888888888999


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      .+++++.+||.+||+.||.+|||+     +++++||||+......
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSI-----RQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHSHHHHSCCCC-
T ss_pred             ccCHHHHHHHHHHccCChhhCCCH-----HHHhcCcccccCCCCc
Confidence            999999999999999999999999     9999999998766544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-50  Score=374.60  Aligned_cols=253  Identities=27%  Similarity=0.398  Sum_probs=221.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            56999999999999999999999999999999998764444555566788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||+.| +|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......     
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----  207 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  207 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence            99985 88887754 467999999999999999999999999999999999999999999999999999765332     


Q ss_pred             CCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYF  278 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~  278 (366)
                               ....||+.|+|||++.   +..++.++|||||||++|+|++|..||.+.+.......+......  .+..+
T Consensus       208 ---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (348)
T 1u5q_A          208 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW  278 (348)
T ss_dssp             ---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             ---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence                     2457899999999984   566888999999999999999999999988887766666554332  34578


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ++.+.+||.+||+.||++|||+     +++++||||...
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~-----~~ll~h~~~~~~  312 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLRE  312 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHTTCHHHHSC
T ss_pred             CHHHHHHHHHHcccChhhCcCH-----HHHhhChhhhcc
Confidence            9999999999999999999999     999999999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-50  Score=375.75  Aligned_cols=264  Identities=26%  Similarity=0.349  Sum_probs=219.5

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------  116 (366)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            3689999999999999999999999999999999987654332 223345679999999999999999999987      


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          117 --TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       117 --~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                        .+.+|+||||+.+ +|.+.+... +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence              4568999999986 777777654 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      .+......      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus       173 ~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          173 AFSLAKNS------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             ECCCCSSS------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccccccc------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            76533211      1122335578999999999876 4589999999999999999999999999988877666543211


Q ss_pred             CCCCC--------------------------------CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          273 RFPNY--------------------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       273 ~~~~~--------------------------------~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ..+..                                .++++.+||.+||+.||++|||+     +++++||||+...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWSDPM  320 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGSSSC
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH-----HHHhCCCCcCCCCC
Confidence            11110                                27889999999999999999999     99999999986443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-50  Score=376.14  Aligned_cols=265  Identities=25%  Similarity=0.359  Sum_probs=217.2

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++........  .....+.+|+.+++.++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            36789999999999999999999999999999999876432221  1123466799999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999987 898888765 468999999999999999999999999999999999999999999999999998664321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----CC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IR  273 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----~~  273 (366)
                                .......||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....     ..
T Consensus       167 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          167 ----------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             ----------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ----------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence                      122345789999999998764 48889999999999999999999999998887777664310     00


Q ss_pred             -----------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          274 -----------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       274 -----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                                             ....+++++.+||.+||+.||++|||+     +++++||||++..+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~h~~f~~~~~~~~~  304 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNRPGPTPG  304 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSSSCCCCS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH-----HHHhcChhhhcCCCCCCc
Confidence                                   014567999999999999999999999     899999999987665543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.1e-50  Score=369.36  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=212.6

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEee--C
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD--T  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~  117 (366)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++...      ....+.+|+.+++.++ ||||+++++++.+  .
T Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            34578999999999999999999999999999999998643      2345778999999997 9999999999988  6


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~  196 (366)
                      ...++||||+.+++|.+++..   +++.+++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            779999999999999988753   89999999999999999999999999999999999999777 89999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHh------
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRII------  268 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~------  268 (366)
                      ...           ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.. ....+....+.      
T Consensus       183 ~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          183 PGQ-----------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             TTC-----------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             CCC-----------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            332           2224568899999999877 6689999999999999999999999943 33322222211      


Q ss_pred             -------cCCCC------------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          269 -------ARDIR------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       269 -------~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                             .....                        .+..+++++.+||.+||+.||++|||+     +++++||||+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~  326 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTV  326 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSGGGTTC
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCccHhhh
Confidence                   11111                        122379999999999999999999999     999999999988


Q ss_pred             Ccc
Q 017775          318 DWK  320 (366)
Q Consensus       318 ~~~  320 (366)
                      .++
T Consensus       327 ~~~  329 (330)
T 3nsz_A          327 VKD  329 (330)
T ss_dssp             C--
T ss_pred             ccC
Confidence            764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.8e-50  Score=361.29  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=212.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            5689999999999999999999999999999999987543333 344566688888888 89999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-----------------
Q 017775          123 ALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----------------  181 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-----------------  181 (366)
                      ||||++|++|.+++.+.    +.+++.+++.++.||+.||.|||++||+||||||+||+++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999765    669999999999999999999999999999999999999844                 


Q ss_pred             --CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCC
Q 017775          182 --GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT  258 (366)
Q Consensus       182 --~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  258 (366)
                        ..+||+|||.+.......              ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~--------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQ--------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSC--------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             CceEEEEcccccccccCCcc--------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence              479999999998664321              23589999999999766 5667999999999999999999887654


Q ss_pred             CHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          259 SEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       259 ~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ...   ..+... ...+|..+++++.+||.+||+.||++|||+     .++++||||.+.
T Consensus       235 ~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  286 (289)
T 1x8b_A          235 DQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSA-----MALVKHSVLLSA  286 (289)
T ss_dssp             HHH---HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTCTTC---
T ss_pred             hHH---HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCH-----HHHhhChHhhhh
Confidence            332   333333 345677899999999999999999999999     999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.5e-50  Score=359.69  Aligned_cols=259  Identities=29%  Similarity=0.449  Sum_probs=221.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            5789999999999999999999999999999999976432  23445678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.........  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  161 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--  161 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch--
Confidence            999999999999987778999999999999999999999999999999999999999999999999999865432211  


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCCCC--CCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIR--FPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~--~~~~~s  279 (366)
                            .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... .....+......  ....++
T Consensus       162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (276)
T 2yex_A          162 ------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  235 (276)
T ss_dssp             ------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             ------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence                  11224568999999999987664 77899999999999999999999875543 223333332222  234689


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +++.+||.+||+.||++|||+     +++++||||+..
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~  268 (276)
T 2yex_A          236 SAPLALLHKILVENPSARITI-----PDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHHHHHHHHHCCCCchhCCCH-----HHHhcCccccCh
Confidence            999999999999999999999     999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.7e-51  Score=377.98  Aligned_cols=267  Identities=23%  Similarity=0.434  Sum_probs=232.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhh--------------HHHHHHHHHHHHhCC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--------------TAYVKLERIVLDQLD  103 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~  103 (366)
                      .......++|++++.||+|+||.||+|.+  +|+.||+|++..........              ...+.+|+.+++.++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            34445678999999999999999999999  89999999997654332211              156788999999999


Q ss_pred             CCCcceeEEEEeeCCeEEEEEeecCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCC
Q 017775          104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQ------ITS--KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPE  174 (366)
Q Consensus       104 h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~------l~~--~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~  174 (366)
                      ||||+++++++.+.+..++||||+++++|.++      +..  .+.+++..++.++.|++.||.|||+ +||+||||||+
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            99999999999999999999999999999998      655  4679999999999999999999999 99999999999


Q ss_pred             CeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCC-CCCcccchhhhhhhhcCC
Q 017775          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATF-GNDLWALGCTLYQMLSGT  252 (366)
Q Consensus       175 NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~~ll~g~  252 (366)
                      ||+++.++.+||+|||.+......            ......|++.|+|||.+.+. .++. ++||||||+++|+|++|.
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             hEEEcCCCcEEEeccccccccccc------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999865433            12244689999999999877 5655 899999999999999999


Q ss_pred             CCCCCCCH-HHHHHHHhcCCCCCC-------------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCC
Q 017775          253 SPFKDTSE-WLIFQRIIARDIRFP-------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (366)
Q Consensus       253 ~pf~~~~~-~~~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp  312 (366)
                      .||..... .+....+......+|                   ..+++++.+||.+||+.||.+|||+     +++++||
T Consensus       250 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~e~l~hp  324 (348)
T 2pml_X          250 VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHE  324 (348)
T ss_dssp             CSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSG
T ss_pred             CCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH-----HHHhcCc
Confidence            99988776 777778877777776                   6789999999999999999999999     9999999


Q ss_pred             CCCCCCccccc
Q 017775          313 FFKGIDWKNIR  323 (366)
Q Consensus       313 ~f~~~~~~~~~  323 (366)
                      ||++.+|+.+.
T Consensus       325 ~f~~~~~~~~~  335 (348)
T 2pml_X          325 WLADTNIEDLR  335 (348)
T ss_dssp             GGTTCCHHHHH
T ss_pred             cccCCCHHHHH
Confidence            99998877654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-50  Score=372.24  Aligned_cols=265  Identities=25%  Similarity=0.405  Sum_probs=211.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            568999999999999999999999999999999997653  3344566888999999999999999999986543     


Q ss_pred             ----------------------------------------------------eEEEEEeecCCCchHHHHHhCCC---CC
Q 017775          119 ----------------------------------------------------SLYMALESCEGGELFDQITSKGH---LS  143 (366)
Q Consensus       119 ----------------------------------------------------~~~iv~e~~~g~~L~~~l~~~~~---l~  143 (366)
                                                                          ..++||||++|++|.+++.+...   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987643   56


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccC--CCCCCCCccccccCCCC
Q 017775          144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP--NAASDDKACTFVGTAAY  221 (366)
Q Consensus       144 ~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~--~~~~~~~~~~~~gt~~y  221 (366)
                      +..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++............  ............||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6679999999999999999999999999999999999999999999999877654211110  00001223345799999


Q ss_pred             CCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       222 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +|||++.+..++.++||||||+++|+|++|..|+..  .......+.....+ .+...++++.+||.+||+.||++|||+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            999999999999999999999999999998776522  12222333332221 123467889999999999999999999


Q ss_pred             CCCChHhhhcCCCCCCC
Q 017775          301 GPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       301 ~~~~~~~~l~hp~f~~~  317 (366)
                           +++++||||+++
T Consensus       321 -----~~~l~~~~f~~~  332 (332)
T 3qd2_B          321 -----TDIIENAIFENL  332 (332)
T ss_dssp             -----HHHHHSTTCCCC
T ss_pred             -----HHHhhchhhhcC
Confidence                 999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-49  Score=358.74  Aligned_cols=255  Identities=21%  Similarity=0.364  Sum_probs=218.3

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee----CC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TF  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~  118 (366)
                      ....|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.+    ..
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            455699999999999999999999999999999999865443 3345567789999999999999999999875    45


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeC-CCCCEEEEecCCcccc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLT-ADGHIKIADFGSVKPM  195 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~-~~~~vkL~Dfg~a~~~  195 (366)
                      .+++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            68999999999999999998888999999999999999999999999  99999999999998 7899999999998754


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHhcCC--C
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARD--I  272 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~--~  272 (366)
                      ...            ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+....  .
T Consensus       183 ~~~------------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (290)
T 1t4h_A          183 RAS------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA  249 (290)
T ss_dssp             CTT------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred             ccc------------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc
Confidence            332            2224568999999998875 48889999999999999999999998744 444444444432  2


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .++...++++.+||.+||+.||.+|||+     +++++||||++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~f~~  288 (290)
T 1t4h_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             ccCCCCCHHHHHHHHHHccCChhhCCCH-----HHHhhCccccc
Confidence            3456688999999999999999999999     99999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-50  Score=383.53  Aligned_cols=261  Identities=33%  Similarity=0.534  Sum_probs=212.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+.....     ......+.+|+.+++.++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            578999999999999999999999999999999998653221     1122246789999999999999999999754 4


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---CEEEEecCCcccc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPM  195 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~vkL~Dfg~a~~~  195 (366)
                      ..|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888899999999999999999999999999999999999997654   5999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecC---CCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~  271 (366)
                      ....           ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||...... .....+....
T Consensus       293 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          293 GETS-----------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             C----------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             CCCc-----------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            4321           2235679999999999853   55788999999999999999999999765432 3334444444


Q ss_pred             CCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       272 ~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      ..++    ..+++++.+||.+||+.||++|||+     +++++||||++.++..
T Consensus       362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKR  410 (419)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGCCHHHHH
T ss_pred             CCCCchhhcccCHHHHHHHHHHccCChhHCcCH-----HHHhCCcccCChhHHH
Confidence            4433    4689999999999999999999999     8999999999766543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.3e-50  Score=375.97  Aligned_cols=257  Identities=26%  Similarity=0.408  Sum_probs=203.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  117 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            5799999999999999999999999999999999976532 233445667899999999999999999999754      


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+|+|++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 5699998876 5799999999999999999999999999999999999999999999999999976432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      .             .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....     
T Consensus       185 ~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          185 E-------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             c-------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            1             224578999999999877 668999999999999999999999999988877666554310     


Q ss_pred             ------------------CC--------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          272 ------------------IR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       272 ------------------~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                        ..        .....++++.+||.+||+.||++|||+     ++++.||||+......
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~-----~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCCGG
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH-----HHHhcChhhhhccCCC
Confidence                              00        012468999999999999999999999     9999999999876544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.4e-50  Score=364.54  Aligned_cols=262  Identities=30%  Similarity=0.513  Sum_probs=222.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      -..++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            3467899999999999999999999999999999998764   2333456777999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999999999998876 4569999999999999999999999999999999999999999999999999875432211 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceee-----cCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---  272 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---  272 (366)
                               .......|++.|+|||.+     .+..++.++||||||+++|+|++|..||...+.......+.....   
T Consensus       172 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (302)
T 2j7t_A          172 ---------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL  242 (302)
T ss_dssp             ---------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             ---------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence                     011234689999999998     466788999999999999999999999999888777766655433   


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      ..+..++.++.+||.+||+.||++|||+     +++++||||+.+.+..
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVSSITSNK  286 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHTTSTTTTTCCCCH
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCH-----HHHhcChHHhhhccch
Confidence            2356789999999999999999999999     9999999999887643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-49  Score=371.06  Aligned_cols=260  Identities=24%  Similarity=0.358  Sum_probs=218.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----C
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  118 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            468999999999999999999999999999999987532  333445677899999999999999999999764     4


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+||||+.| +|.+++... .+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             eEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            69999999986 999988764 6999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  271 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------  271 (366)
                      ...       ........||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+....+....      
T Consensus       182 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          182 HDH-------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             GCB-------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             CCc-------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            211       11123457999999999865 4558999999999999999999999999887666555543210      


Q ss_pred             --------------------C-----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          272 --------------------I-----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       272 --------------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                          .     .....+++++.+||.+||+.||++|||+     +++++||||+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTTCC
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhhccC
Confidence                                0     0124578999999999999999999999     99999999998743

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5e-50  Score=362.36  Aligned_cols=259  Identities=34%  Similarity=0.569  Sum_probs=227.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+....++
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            367899999999999999999999999999999999765433 2334567789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~Dfg~a~~~~~~~  199 (366)
                      ||||+.+++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.......
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            99999999999999888889999999999999999999999999999999999999764   479999999988654321


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  275 (366)
                                 ......|++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+..+...++    
T Consensus       179 -----------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (287)
T 2wei_A          179 -----------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW  246 (287)
T ss_dssp             -----------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred             -----------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh
Confidence                       12234688999999998764 88899999999999999999999999998888888877665443    


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ..+++++.+||.+||+.||++|||+     .++++||||+...+
T Consensus       247 ~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~  285 (287)
T 2wei_A          247 RTISDDAKDLIRKMLTFHPSLRITA-----TQCLEHPWIQKYSS  285 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHSHHHHHHCC
T ss_pred             hhcCHHHHHHHHHHcccChhhCcCH-----HHHhcCHHHhcccc
Confidence            4689999999999999999999999     99999999986554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-49  Score=371.97  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=217.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE---
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL---  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---  120 (366)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++......   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4799999999999999999999999999999999976532 333445677899999999999999999999877654   


Q ss_pred             ---EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          121 ---YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       121 ---~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                         |+||||+.+ +|.+.+..  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       120 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          120 YDFYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCEEEEECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eeEEEEEccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence               999999985 88887743  499999999999999999999999999999999999999999999999999975533


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      .             .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+....     
T Consensus       197 ~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          197 E-------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  263 (371)
T ss_dssp             ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             C-------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence            2             224568999999999877 678999999999999999999999999988777666654310     


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          272 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       272 --------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                                                ...+..+++++.+||.+||+.||++|||+     +++++||||+.+..+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~~  336 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRDPEEE  336 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCCGGGC
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH-----HHHhcCcccccCCCcccc
Confidence                                      01123579999999999999999999999     999999999987765443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-49  Score=370.12  Aligned_cols=271  Identities=24%  Similarity=0.375  Sum_probs=219.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  117 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+|+.+++.++||||+++++++...     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            357999999999999999999999999999999998643  2333445567899999999999999999988754     


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ...++||||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            679999999985 99998876 4699999999999999999999999999999999999999999999999999987754


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  270 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------  270 (366)
                      ...................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            33221111111112234578999999998754 66899999999999999999999999988876655443210      


Q ss_pred             ------------------CCC--------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcccc
Q 017775          271 ------------------DIR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (366)
Q Consensus       271 ------------------~~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~  322 (366)
                                        ...        .+..+++++.+||.+||+.||++|||+     +++++||||+...+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~~  317 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA-----KEALEHPYLQTYHDPND  317 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCCTTS
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCccccccCCccc
Confidence                              000        123679999999999999999999999     99999999998876553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-49  Score=379.69  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=214.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC------CCCCcceeEEEEee
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL------DHPGVVRLFFTFQD  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~  116 (366)
                      ...+|++++.||+|+||.||+|.+..+|+.||+|++...    ........+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            456899999999999999999999999999999999753    23334456677777766      67899999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC--EEEEecCCc
Q 017775          117 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSV  192 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~--vkL~Dfg~a  192 (366)
                      ...+++||||+.+ +|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++
T Consensus       171 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999999999975 9999998764  4999999999999999999999999999999999999999987  999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      .....             ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus       250 ~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~  316 (429)
T 3kvw_A          250 CYEHQ-------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG  316 (429)
T ss_dssp             EETTC-------------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eecCC-------------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            75432             22245789999999999998999999999999999999999999999888776665542100


Q ss_pred             -----------------------------------------------------------CCCCCCCHHHHHHHHHhhcCC
Q 017775          273 -----------------------------------------------------------RFPNYFSDAARDLIDRLLDVD  293 (366)
Q Consensus       273 -----------------------------------------------------------~~~~~~s~~~~~li~~~L~~d  293 (366)
                                                                                 .++...++++.+||.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence                                                                       011234788999999999999


Q ss_pred             CCCCCCCCCCChHhhhcCCCCCCC
Q 017775          294 PSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       294 P~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      |++|||+     +++++||||+..
T Consensus       397 P~~Rpta-----~e~L~Hpw~~~~  415 (429)
T 3kvw_A          397 PAVRMTP-----GQALRHPWLRRR  415 (429)
T ss_dssp             TTTSCCH-----HHHHTSTTTC--
T ss_pred             hhhCCCH-----HHHhCChhhccC
Confidence            9999999     999999999853

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-49  Score=361.15  Aligned_cols=253  Identities=21%  Similarity=0.379  Sum_probs=213.6

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      -.+..++|++.+.||+|+||.||+|.+  +|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            345678999999999999999999987  6889999999765433 3334567789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          120 LYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      +++||||+++++|.+++.+.+.   +++..++.++.|++.||.|||++|  |+||||||+||+++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999999987653   999999999999999999999999  99999999999999999999999999975


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH--hcCCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI  272 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--~~~~~  272 (366)
                      .....          .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+  .....
T Consensus       189 ~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  258 (309)
T 3p86_A          189 KASTF----------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL  258 (309)
T ss_dssp             -----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             ccccc----------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            43321          1123457899999999999999999999999999999999999999998888777666  34456


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+|..+++++.+||.+||+.||.+|||+     ++++.
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~  291 (309)
T 3p86_A          259 EIPRNLNPQVAAIIEGCWTNEPWKRPSF-----ATIMD  291 (309)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            7788999999999999999999999999     66665

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-50  Score=375.85  Aligned_cols=252  Identities=28%  Similarity=0.479  Sum_probs=212.8

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------  116 (366)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++......       ..+|+.+++.++||||+++++++..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            457899999999999999999999999999999998654211       2358999999999999999999843      


Q ss_pred             --------------------------------CCeEEEEEeecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHH
Q 017775          117 --------------------------------TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEY  160 (366)
Q Consensus       117 --------------------------------~~~~~iv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qil~aL~~  160 (366)
                                                      ...+++||||++| +|.+.+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999986 7776665    34679999999999999999999


Q ss_pred             HHHCCceeccCCCCCeEeC-CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCc
Q 017775          161 IHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDL  238 (366)
Q Consensus       161 LH~~~i~H~dlkp~NIli~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  238 (366)
                      ||++||+||||||+||+++ .++.+||+|||+++......           ......||+.|+|||.+.+.. ++.++||
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----------PSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----------CCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----------CCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            9999999999999999997 68899999999998664332           223457899999999987754 8999999


Q ss_pred             ccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHh
Q 017775          239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------------DI------------RFPNYFSDAARDLIDRL  289 (366)
Q Consensus       239 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~li~~~  289 (366)
                      ||+||++|+|++|..||.+.+..+....+...                 ..            .++..+++++.+||.+|
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            99999999999999999998888777666431                 00            13556899999999999


Q ss_pred             hcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       290 L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      |+.||++|||+     .++++||||+.+.
T Consensus       306 L~~dP~~R~t~-----~e~l~hp~f~~~~  329 (383)
T 3eb0_A          306 LRYEPDLRINP-----YEAMAHPFFDHLR  329 (383)
T ss_dssp             CCSSGGGSCCH-----HHHHTSGGGHHHH
T ss_pred             ccCChhhCCCH-----HHHhcCHHHHHHH
Confidence            99999999999     9999999998654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.7e-50  Score=376.77  Aligned_cols=257  Identities=29%  Similarity=0.429  Sum_probs=212.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC---
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF---  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---  118 (366)
                      ....+|++++.||+|+||.||+|++..++. ||+|++......       ..+|+.+++.++||||+++++++....   
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            345689999999999999999999987766 888877553211       225899999999999999999986433   


Q ss_pred             ---eEEEEEeecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-CCCCEEEEecC
Q 017775          119 ---SLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFG  190 (366)
Q Consensus       119 ---~~~iv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-~~~~vkL~Dfg  190 (366)
                         .+++||||+++ ++...+.    ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus       109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence               38999999987 4444433    246799999999999999999999999999999999999999 78999999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      +++......           ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+..
T Consensus       188 ~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~  256 (394)
T 4e7w_A          188 SAKILIAGE-----------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK  256 (394)
T ss_dssp             TCEECCTTC-----------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CcccccCCC-----------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            998664322           22345789999999998765 489999999999999999999999999888776666543


Q ss_pred             C-----------------CC------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          270 R-----------------DI------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       270 ~-----------------~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      .                 ..            .++..+++++.+||.+||+.||.+|||+     .+++.||||+.+.+.
T Consensus       257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-----IEALCHPFFDELRTG  331 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGGSTTTSS
T ss_pred             HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH-----HHHhcChhhhhhccc
Confidence            1                 00            1234588999999999999999999999     999999999998876


Q ss_pred             ccc
Q 017775          321 NIR  323 (366)
Q Consensus       321 ~~~  323 (366)
                      ...
T Consensus       332 ~~~  334 (394)
T 4e7w_A          332 EAR  334 (394)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=365.37  Aligned_cols=259  Identities=19%  Similarity=0.295  Sum_probs=220.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ....+..++|++.+.||+|+||.||+|.+..+|+   .||+|++....  .......+.+|+.+++.++||||+++++++
T Consensus        42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  119 (325)
T 3kul_A           42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVV  119 (325)
T ss_dssp             -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3445678899999999999999999999986655   49999997642  333445678899999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+.+..|+||||++|++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            9999999999999999999999765 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-D  271 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~  271 (366)
                      .........       .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+... .
T Consensus       200 ~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  272 (325)
T 3kul_A          200 VLEDDPDAA-------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR  272 (325)
T ss_dssp             ECC----CC-------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ccccCccce-------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC
Confidence            765432111       01112345778999999988889999999999999999999 99999999988888777665 4


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ...+..+++++.+||.+||+.||++|||+     .+++.
T Consensus       273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~  306 (325)
T 3kul_A          273 LPAPMGCPHALHQLMLDCWHKDRAQRPRF-----SQIVS  306 (325)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            56677899999999999999999999998     56654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.2e-50  Score=359.60  Aligned_cols=258  Identities=29%  Similarity=0.509  Sum_probs=224.1

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe--eCCeE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSL  120 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~  120 (366)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            467999999999999999999999999999999999875433 334556788999999999999999999874  46789


Q ss_pred             EEEEeecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          121 YMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qil~aL~~LH~~~-----i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+||+++.++.+||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999999754    34999999999999999999999999     99999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      +........          ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus       163 ~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~  232 (279)
T 2w5a_A          163 ARILNHDTS----------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  232 (279)
T ss_dssp             HHHC---CH----------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             heeeccccc----------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence            876543211          1123468999999999998889999999999999999999999999988888877777665


Q ss_pred             C-CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          272 I-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       272 ~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      . .++..+++++.++|.+||+.||.+|||+     .+++.|+|+.+
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~  273 (279)
T 2w5a_A          233 FRRIPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPLILE  273 (279)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSTTCCG
T ss_pred             cccCCcccCHHHHHHHHHHcCCCcccCCCH-----HHHHhChhhhh
Confidence            4 5677899999999999999999999999     99999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=361.41  Aligned_cols=260  Identities=30%  Similarity=0.482  Sum_probs=220.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|.+....     ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            34678999999999999999999999999999999987642     2244677999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            99999999999999873 4679999999999999999999999999999999999999999999999999997654321 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNY  277 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~  277 (366)
                               .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...   ....+..
T Consensus       180 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T 3com_A          180 ---------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL  250 (314)
T ss_dssp             ---------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred             ---------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCccc
Confidence                     1122446899999999999988999999999999999999999999988776655554433   2334567


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      +++++.+||.+||+.||.+|||+     .++++||||++..+..
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATA-----TQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHTCCCGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHhcCCcch
Confidence            89999999999999999999999     9999999999776543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.6e-49  Score=376.46  Aligned_cols=255  Identities=29%  Similarity=0.457  Sum_probs=212.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------  116 (366)
                      ...+|++++.||+|+||.||+|++..+|+.||+|++.....       ...+|+.+++.++||||+++++++..      
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            45589999999999999999999999999999999865421       12358999999999999999998853      


Q ss_pred             CCeEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCC
Q 017775          117 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS  191 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~  191 (366)
                      ...+++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            2247899999986 77666542    4679999999999999999999999999999999999999965 5789999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ++.+....           ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       204 a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~  272 (420)
T 1j1b_A          204 AKQLVRGE-----------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV  272 (420)
T ss_dssp             CEECCTTC-----------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             hhhcccCC-----------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            98654321           12345789999999998765 6899999999999999999999999998877766655431


Q ss_pred             -----------------CCC------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          271 -----------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       271 -----------------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                                       ...            ++..+++++.+||.+||+.||.+|||+     .+++.||||+.+.+..
T Consensus       273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDELRDPN  347 (420)
T ss_dssp             HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGGGCTT
T ss_pred             hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH-----HHHhCCHhhccccccc
Confidence                             111            234578999999999999999999999     8999999998776544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=367.79  Aligned_cols=258  Identities=28%  Similarity=0.467  Sum_probs=213.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEeeCCe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFS  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~  119 (366)
                      +..++|++++.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++|  +||+++++++.+...
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4567899999999999999999988 4689999999976543 23344567889999999976  999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+|||+ .+++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9999995 5679999999988999999999999999999999999999999999999996 6899999999998664432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecC-----------CCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHH
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRI  267 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i  267 (366)
                      ..        .......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.... .......+
T Consensus       162 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          162 TS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cc--------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence            11        12234579999999999864           568889999999999999999999998643 33444444


Q ss_pred             hc--CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          268 IA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       268 ~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..  ....+|...+.++.+||.+||+.||.+|||+     .++++||||+.
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~  279 (343)
T 3dbq_A          234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  279 (343)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCH-----HHHHhCccccc
Confidence            43  3455677889999999999999999999999     99999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-49  Score=359.45  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=204.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.++...++.++||||+++++++.+.+..+
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            557899999999999999999999999999999999976532 2233344555666688889999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          122 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      +||||++| +|.+++..    .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999986 88777654    46799999999999999999999998 99999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceee----cCCCCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhc-C
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA-R  270 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~-~  270 (366)
                      ...           ......||+.|+|||.+    .+..++.++||||||+++|+|++|..||.. ............ .
T Consensus       162 ~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          162 DDV-----------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             ccc-----------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            432           11234689999999996    455688899999999999999999999985 344444444333 3


Q ss_pred             CCCCC-CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          271 DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       271 ~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ....+ ..+++++.+||.+||+.||++|||+     +++++||||+.
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~e~l~hp~f~~  272 (290)
T 3fme_A          231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTY-----PELMQHPFFTL  272 (290)
T ss_dssp             CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhcChhhCcCH-----HHHHhCccccc
Confidence            33333 4689999999999999999999999     99999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.3e-50  Score=366.89  Aligned_cols=260  Identities=33%  Similarity=0.538  Sum_probs=215.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++......     .......+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46899999999999999999999999999999999764321     1122334678999999999999999999987765


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC---EEEEecCCcccc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPM  195 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~---vkL~Dfg~a~~~  195 (366)
                       .|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++...
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999988888999999999999999999999999999999999999987664   999999999866


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhcCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD  271 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~  271 (366)
                      ....           ......|++.|+|||++.   ...++.++||||||+++|+|++|..||...... .....+....
T Consensus       168 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (322)
T 2ycf_A          168 GETS-----------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  236 (322)
T ss_dssp             CCCH-----------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred             cccc-----------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence            4321           112456899999999973   456889999999999999999999999765432 2333344444


Q ss_pred             CCC----CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          272 IRF----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       272 ~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      ..+    +..+++++.+||.+||+.||++|||+     +++++||||+..++.
T Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~~~l~h~~~~~~~~~  284 (322)
T 2ycf_A          237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK  284 (322)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGCCHHHH
T ss_pred             cccCchhhhhcCHHHHHHHHHHcccCHhhCCCH-----HHHhhCcCcCCHHHH
Confidence            333    24689999999999999999999999     899999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.6e-49  Score=357.70  Aligned_cols=255  Identities=30%  Similarity=0.475  Sum_probs=225.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .+.|++++.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            4679999999999999999999999999999999976532  23345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----  173 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----  173 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence            999999999998865 579999999999999999999999999999999999999999999999999998664432    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAA  282 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  282 (366)
                            .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+... ...++..++.++
T Consensus       174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  247 (303)
T 3a7i_A          174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL  247 (303)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHH
T ss_pred             ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHH
Confidence                  1123456899999999999988999999999999999999999999988887766665544 344667899999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+||.+||+.||++|||+     .++++||||..
T Consensus       248 ~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~  276 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTA-----KELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCH-----HHHTTCHHHHH
T ss_pred             HHHHHHHcCCChhhCcCH-----HHHhhChhhhc
Confidence            999999999999999999     99999999964

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-49  Score=365.10  Aligned_cols=277  Identities=20%  Similarity=0.335  Sum_probs=205.8

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      +...+..++|++++.||+|+||.||+|.+..++.   .||+|++....... .....+.+|+.+++.++||||+++++++
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            3344567899999999999999999999887765   89999997654333 3345677899999999999999999999


Q ss_pred             eeCCeE------EEEEeecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC
Q 017775          115 QDTFSL------YMALESCEGGELFDQITSKG------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  182 (366)
Q Consensus       115 ~~~~~~------~iv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~  182 (366)
                      .+....      ++||||+.+++|.+++....      .+++.+++.++.||+.||.|||++||+||||||+||+++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            876655      99999999999999996542      599999999999999999999999999999999999999999


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHH
Q 017775          183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEW  261 (366)
Q Consensus       183 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  261 (366)
                      .+||+|||++.........        .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  246 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYY--------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA  246 (323)
T ss_dssp             CEEECCCCC-------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             CEEEeeccccccccccccc--------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence            9999999999866443211        11123346778999999999899999999999999999999 99999988887


Q ss_pred             HHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCC--CChHhhhcCCCCCCCCccccc
Q 017775          262 LIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       262 ~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~--~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      +....+... ....+..+++++.+||.+||+.||++|||+.+  ..+++++.|||+.+...+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          247 EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            777776654 35667889999999999999999999999432  123889999999877655544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.4e-49  Score=365.20  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=216.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  119 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----  119 (366)
                      .++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            4789999999999999999999999999999999976532 33344567789999999999999999999987654    


Q ss_pred             --EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          120 --LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       120 --~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                        +|+||||+.+ +|.+++..  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              5999999985 88887643  599999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC------
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  270 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------  270 (366)
                      .             .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...      
T Consensus       179 ~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          179 E-------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  245 (353)
T ss_dssp             ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred             C-------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            1             124568999999999876 66899999999999999999999999988877665554321      


Q ss_pred             -------------------------CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          271 -------------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       271 -------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                                               -...+..+++++.+||.+||+.||++|||+     +++++||||+.+......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCCGGGC
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhccCcccc
Confidence                                     011234679999999999999999999999     899999999987765443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-49  Score=368.41  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=219.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  112 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  112 (366)
                      .+..++|++++.||+|+||.||+|.+.       .++..||+|+++...  .......+.+|+.+++.+ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            456789999999999999999999874       345679999997652  334455678899999999 8999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      ++.+.+.+|+||||++||+|.+++...+                .++..++..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                478999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  255 (366)
                      |++.+|.+||+|||+++........        .......+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTT--------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             EECCCCCEEEccccCCcccCcccce--------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999866443211        11223456788999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          256 KDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       256 ~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+....+....+... ....|..+++++.+||.+||+.||.+||++     .+++.
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~  357 (370)
T 2psq_A          307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  357 (370)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            988877777666554 355677899999999999999999999998     66765

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-49  Score=361.32  Aligned_cols=259  Identities=28%  Similarity=0.470  Sum_probs=216.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee----
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD----  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----  116 (366)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            34788999999999999999999999999999999987542    2234567799999988 79999999999987    


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          117 --TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       117 --~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                        ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999875  46999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      .......          .......|++.|+|||.+.     +..++.++||||||+++|+|++|..||...+.......+
T Consensus       177 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          177 AQLDRTV----------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             C-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             eecCcCc----------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            8654321          1122456899999999986     456889999999999999999999999988877766665


Q ss_pred             hcCCCC--CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       268 ~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ......  .+..+++.+.+||.+||+.||.+||++     +++++||||+...+
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIRDQPN  295 (326)
T ss_dssp             HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSHHHHCCTT
T ss_pred             hcCccccCCccccCHHHHHHHHHHhccChhhCCCH-----HHHhhChHHhhCcc
Confidence            544322  245689999999999999999999999     99999999987554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.2e-50  Score=365.14  Aligned_cols=269  Identities=28%  Similarity=0.462  Sum_probs=199.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            4667899999999999999999999999999999998865422  22334567799999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          121 YMALESCEGGELFDQITS--------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~--------~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      ++||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999999874        356999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  271 (366)
                      ..........     .........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||................
T Consensus       169 ~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          169 AFLATGGDIT-----RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             HHCC--------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             heeccCCCcc-----chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            7654321110     0112234578999999999865 568899999999999999999999998876655544443322


Q ss_pred             C----------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          272 I----------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       272 ~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      .          .....+++++.+||.+||+.||.+|||+     .++++||||+...++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA-----AELLRHKFFQKAKNKE  298 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSTTC-------
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH-----HHHhhChhhhcCCCCc
Confidence            1          1234678999999999999999999999     9999999999876554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-51  Score=385.01  Aligned_cols=250  Identities=17%  Similarity=0.229  Sum_probs=206.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHH---HHHhCCCCCcceeE-------EE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI---VLDQLDHPGVVRLF-------FT  113 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~  113 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            578999999999999999999999999999999998765555556677888994   45556899999988       77


Q ss_pred             EeeCCe-----------------EEEEEeecCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 017775          114 FQDTFS-----------------LYMALESCEGGELFDQITSKGHLSE-------DEARFYTAEVVDALEYIHSMGLIHR  169 (366)
Q Consensus       114 ~~~~~~-----------------~~iv~e~~~g~~L~~~l~~~~~l~~-------~~~~~~~~qil~aL~~LH~~~i~H~  169 (366)
                      +++.+.                 .|+||||+ +|+|.+++...+.+++       ..++.++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776543                 89999999 5699999987655555       7888899999999999999999999


Q ss_pred             cCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-----------CCCCCCCc
Q 017775          170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----------PATFGNDL  238 (366)
Q Consensus       170 dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di  238 (366)
                      ||||+|||++.+|.+||+|||+++....             ......| +.|+|||++.+.           .++.++||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC-------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC-------------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            9999999999999999999999985432             1224467 899999999877           79999999


Q ss_pred             ccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       239 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      |||||++|+|++|..||.+.+.......+.    ..+..+++++.+||.+||+.||++|||+     .++++||||+++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~  366 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCH-----HHHHTSHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCH-----HHHhhChHHHHH
Confidence            999999999999999998765544333332    2346789999999999999999999999     999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.2e-49  Score=371.54  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=215.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEeeCCe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDTFS  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~  119 (366)
                      +...+|++++.||+|+||.||+|.+.. |+.||+|++..... .......+.+|+.+++.+.  ||||+++++++.+...
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            334579999999999999999999865 89999999977543 3334566788999999996  5999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+||| +.+++|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 55779999999988899999999999999999999999999999999999995 6899999999998764332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecC-----------CCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHH
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRI  267 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i  267 (366)
                      ..        .......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.... .......+
T Consensus       209 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~  280 (390)
T 2zmd_A          209 TS--------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  280 (390)
T ss_dssp             -------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             cc--------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence            11        11234579999999999865           358889999999999999999999998753 33455555


Q ss_pred             hcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          268 IAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       268 ~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ...  ...+|...+.++.+||.+||+.||++|||+     .++++||||+..
T Consensus       281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~~~~~  327 (390)
T 2zmd_A          281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQIQ  327 (390)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHSC
T ss_pred             hCccccCCCCccchHHHHHHHHHHcccChhhCCCH-----HHHhhCcCcccc
Confidence            544  345677789999999999999999999999     999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4e-49  Score=364.08  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=215.4

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEE-CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC------CcceeE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKK-IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP------GVVRLF  111 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~  111 (366)
                      ......++|++++.||+|+||.||+|.+ ..+|+.||+|++...    ......+.+|+.+++.++|+      ++++++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            3344568999999999999999999999 568899999998653    23345577788888887654      599999


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---------
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---------  180 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---------  180 (366)
                      +++.+.+..++||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+||+++.         
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 779999998775  6899999999999999999999999999999999999987         


Q ss_pred             ----------CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc
Q 017775          181 ----------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS  250 (366)
Q Consensus       181 ----------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  250 (366)
                                ++.+||+|||++......             .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH-------------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC-------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCceEeeCcccccCccc-------------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence                      668999999999754321             224578999999999999899999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCC--------------------------------------------CCCCCCHHHHHHH
Q 017775          251 GTSPFKDTSEWLIFQRIIARDIR--------------------------------------------FPNYFSDAARDLI  286 (366)
Q Consensus       251 g~~pf~~~~~~~~~~~i~~~~~~--------------------------------------------~~~~~s~~~~~li  286 (366)
                      |..||...+..+....+......                                            .+...++++.+||
T Consensus       230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  309 (339)
T 1z57_A          230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI  309 (339)
T ss_dssp             SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence            99999988876654443221111                                            1122357799999


Q ss_pred             HHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .+||+.||.+|||+     +++++||||+.+.
T Consensus       310 ~~~L~~dP~~Rpt~-----~ell~hp~f~~~~  336 (339)
T 1z57_A          310 QKMLEYDPAKRITL-----REALKHPFFDLLK  336 (339)
T ss_dssp             HHHTCSSTTTSCCH-----HHHTTSGGGGGGG
T ss_pred             HHHhCcCcccccCH-----HHHhcCHHHHHHh
Confidence            99999999999999     9999999998654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-48  Score=358.59  Aligned_cols=259  Identities=27%  Similarity=0.431  Sum_probs=217.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEEC-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEe----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ----  115 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~----  115 (366)
                      .++|++++.||+|+||.||+|.+. .+|+.||+|++......... ...+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-CchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999995 67899999999765322211 12244566666555   8999999999987    


Q ss_pred             -eCCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          116 -DTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       116 -~~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                       .....++||||+.| +|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             56679999999985 9999998753  4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-  271 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-  271 (366)
                      .......           ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.... 
T Consensus       168 ~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (326)
T 1blx_A          168 RIYSFQM-----------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  236 (326)
T ss_dssp             CCCCGGG-----------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccCCC-----------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            8654321           1224568999999999998889999999999999999999999999988877766664210 


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          272 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       272 --------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                                ..++..+++++.+||.+||+.||++|||+     .++++||||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLERC  306 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCCC
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH-----HHHhcCccccccchh
Confidence                                      11235689999999999999999999999     899999999988764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-49  Score=361.03  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=212.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe--------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--------  115 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------  115 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            57899999999999999999999999999999998754   3344556778999999999999999999874        


Q ss_pred             ------eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-CCCCEEEEe
Q 017775          116 ------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIAD  188 (366)
Q Consensus       116 ------~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-~~~~vkL~D  188 (366)
                            +....++||||+.| +|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  44679999999985 99998865 5799999999999999999999999999999999999997 567999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      ||++.........       ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus       165 fg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          165 FGLARIMDPHYSH-------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             CTTCBCC---------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CccccccCCCccc-------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999876432111       112234467899999998765 66899999999999999999999999998887766655


Q ss_pred             hcCCC------------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          268 IARDI------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       268 ~~~~~------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .....                              ..+..+++++.+||.+||+.||++|||+     +++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA-----EEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH-----HHHhCCcccccc
Confidence            43211                              1124589999999999999999999999     999999999988


Q ss_pred             Cccc
Q 017775          318 DWKN  321 (366)
Q Consensus       318 ~~~~  321 (366)
                      +|+.
T Consensus       313 ~~p~  316 (320)
T 2i6l_A          313 SFPM  316 (320)
T ss_dssp             CC--
T ss_pred             cCcc
Confidence            7654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=363.81  Aligned_cols=255  Identities=31%  Similarity=0.547  Sum_probs=209.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhC----CCCCcceeEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQL----DHPGVVRLFFT  113 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~~iv~~~~~  113 (366)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++........   .....+.+|+.+++.+    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3447889999999999999999999999999999999976533221   1122344688888888    89999999999


Q ss_pred             EeeCCeEEEEEee-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-CCCCEEEEecCC
Q 017775          114 FQDTFSLYMALES-CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGS  191 (366)
Q Consensus       114 ~~~~~~~~iv~e~-~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-~~~~vkL~Dfg~  191 (366)
                      +.+.+..++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 78899999999888899999999999999999999999999999999999999 789999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      +.......            .....|+..|+|||.+.+..+ +.++||||||+++|+|++|..||....      .+...
T Consensus       187 ~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~  248 (312)
T 2iwi_A          187 GALLHDEP------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA  248 (312)
T ss_dssp             CEECCSSC------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT
T ss_pred             hhhcccCc------------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh
Confidence            98665432            224568999999999876665 458999999999999999999997632      34456


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ...++..+++++.+||.+||+.||++|||+     +++++||||+...
T Consensus       249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSL-----EEILLDPWMQTPA  291 (312)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHSTTTCC--
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhcCch
Confidence            677888999999999999999999999999     9999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=362.62  Aligned_cols=253  Identities=23%  Similarity=0.419  Sum_probs=210.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC--e
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--S  119 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~  119 (366)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+..  .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            346789999999999999999999999999999999976432  223445678999999999999999999998755  7


Q ss_pred             EEEEEeecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----CCCCCEEEEecCCc
Q 017775          120 LYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSV  192 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli----~~~~~vkL~Dfg~a  192 (366)
                      .++||||++|++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            8999999999999999987533   9999999999999999999999999999999999999    77788999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeec--------CCCCCCCCCcccchhhhhhhhcCCCCCCCCC----H
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--------SSPATFGNDLWALGCTLYQMLSGTSPFKDTS----E  260 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~  260 (366)
                      .......           ......||+.|+|||++.        +..++.++|||||||++|+|++|..||....    .
T Consensus       164 ~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          164 RELEDDE-----------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCTTC-----------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             eecCCCC-----------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            8764432           222456899999999975        5678899999999999999999999996422    2


Q ss_pred             HHHHHHHhcCCC-------------------------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCC
Q 017775          261 WLIFQRIIARDI-------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (366)
Q Consensus       261 ~~~~~~i~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp  312 (366)
                      ......+..+..                         .++..++..+.+||++||+.||++|||+     +++++||
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-----~ell~h~  304 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFAET  304 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-----HHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-----HHhhhcc
Confidence            334444433221                         1223356789999999999999999999     8999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-48  Score=349.63  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=219.4

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||.||+|.+. +++.||+|++......    ...+.+|+.+++.++||||+++++++.+....+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            45689999999999999999999986 4778999999765322    245778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999999764 5699999999999999999999999999999999999999999999999999986644321


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .         ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+... ....|..+
T Consensus       162 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T 4hcu_A          162 T---------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA  232 (269)
T ss_dssp             H---------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             c---------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence            1         1113346778999999998889999999999999999999 99999999998888887765 44566778


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ++++.+++.+||+.||++|||+     .++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~-----~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAF-----SRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCH-----HHHHHH
Confidence            9999999999999999999998     777764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=372.05  Aligned_cols=263  Identities=19%  Similarity=0.328  Sum_probs=223.8

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEE-----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      ...+..++|++++.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.+++.++||||++++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345667899999999999999999999     45578899999986532  33344457779999999999999999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC---C
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---H  183 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~~-------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~---~  183 (366)
                      +.+....++||||++||+|.+++...+       .+++.+++.++.||+.||.|||++||+||||||+|||++.+|   .
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999998643       489999999999999999999999999999999999999655   5


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  262 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  262 (366)
                      +||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       223 ~kL~DFG~a~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~  294 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGY--------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  294 (367)
T ss_dssp             EEECCCHHHHHHHHHSS--------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEECCCccccccccccc--------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999975533211        112234567889999999988889999999999999999998 999999999988


Q ss_pred             HHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          263 IFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       263 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ....+.... ...+..+++++.+|+.+||+.||++|||+     .+++++.++-.
T Consensus       295 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~l~~~~  344 (367)
T 3l9p_A          295 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYCT  344 (367)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCH-----HHHHHHHHHHh
Confidence            888777654 55677899999999999999999999999     88998877643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=354.84  Aligned_cols=260  Identities=27%  Similarity=0.487  Sum_probs=216.1

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|.....||+|+||.||+|.+..+++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            35556666677999999999999999999999999998764   233345677899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-CCCEEEEecCCccccC
Q 017775          121 YMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQ  196 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-~~~vkL~Dfg~a~~~~  196 (366)
                      ++||||+++++|.+++....   .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999999998752   4679999999999999999999999999999999999987 8999999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCCHH-H-HHH-HHhcCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEW-L-IFQ-RIIARD  271 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~-~~~-~i~~~~  271 (366)
                      ...          .......|++.|+|||.+.+..  ++.++||||||+++|+|++|..||...... . ... ......
T Consensus       175 ~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (295)
T 2clq_A          175 GIN----------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH  244 (295)
T ss_dssp             C---------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC
T ss_pred             CCC----------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc
Confidence            321          1122456899999999987643  788999999999999999999999754322 2 111 233445


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..++..+++++.+||.+||+.||++|||+     +++++||||+...
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~  286 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACA-----NDLLVDEFLKVSS  286 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCH-----HHHHTSGGGCC--
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCH-----HHHhcChhhhhcc
Confidence            56788899999999999999999999999     9999999998543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-49  Score=367.91  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=203.9

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe-
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS-  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  119 (366)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.......    ....+++..++.++||||+++++++.+... 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            355789999999999999999999999999999999886542221    224457777888899999999999975433 


Q ss_pred             ------EEEEEeecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCeEeCC-CCCEEE
Q 017775          120 ------LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLLTA-DGHIKI  186 (366)
Q Consensus       120 ------~~iv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qil~aL~~LH--~~~i~H~dlkp~NIli~~-~~~vkL  186 (366)
                            +++||||+.+ +|...+.    ....+++..++.++.|++.||.|||  ++||+||||||+||+++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                  8999999987 5554443    4567999999999999999999999  999999999999999996 899999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH
Q 017775          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  265 (366)
                      +|||++.......           ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+......
T Consensus       174 ~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          174 CDFGSAKKLSPSE-----------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH  242 (360)
T ss_dssp             CCCTTCBCCCTTS-----------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eeCCCceecCCCC-----------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence            9999998664432           222456899999999986654 8999999999999999999999999988877766


Q ss_pred             HHhcCC--------------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          266 RIIARD--------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       266 ~i~~~~--------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      .+....                                ...+...++++.+||.+||+.||.+|||+     .++++|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~  317 (360)
T 3e3p_A          243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP-----YEALCHPY  317 (360)
T ss_dssp             HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH-----HHHTTSGG
T ss_pred             HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH-----HHHhcCcc
Confidence            654310                                01112257899999999999999999999     89999999


Q ss_pred             CCCCCccc
Q 017775          314 FKGIDWKN  321 (366)
Q Consensus       314 f~~~~~~~  321 (366)
                      |+++..+.
T Consensus       318 f~~~~~~~  325 (360)
T 3e3p_A          318 FDELHDPA  325 (360)
T ss_dssp             GGGGGCTT
T ss_pred             ccccCCcc
Confidence            99876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.8e-48  Score=353.88  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ......++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            44556889999999999999999999999999999999998765555555677888999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+||||++|++|.+++.+.+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998765433


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFP  275 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~  275 (366)
                      ..         .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+....   ...+
T Consensus       188 ~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (309)
T 2h34_A          188 KL---------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR  258 (309)
T ss_dssp             ------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTS
T ss_pred             cc---------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccC
Confidence            21         11224468999999999998889999999999999999999999998877664444443322   1345


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCC-CC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRP-GA  300 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rp-s~  300 (366)
                      ..+++++.++|.+||+.||++|| ++
T Consensus       259 ~~~~~~l~~li~~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          259 PGIPVAFDAVIARGMAKNPEDRYVTC  284 (309)
T ss_dssp             TTCCTHHHHHHHHHTCSSGGGSCSSH
T ss_pred             CCCCHHHHHHHHHhccCCHHHHHHhH
Confidence            67899999999999999999999 55

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-49  Score=364.40  Aligned_cols=258  Identities=30%  Similarity=0.513  Sum_probs=221.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCC--CCCcceeEEEEe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLD--HPGVVRLFFTFQ  115 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~  115 (366)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++........   .....+.+|+.+++.+.  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3457889999999999999999999999999999999977543221   11123456888999885  599999999999


Q ss_pred             eCCeEEEEEeecCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC-CCCCEEEEecCCcc
Q 017775          116 DTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVK  193 (366)
Q Consensus       116 ~~~~~~iv~e~~~g-~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~-~~~~vkL~Dfg~a~  193 (366)
                      +.+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999976 89999999888899999999999999999999999999999999999999 77999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      ......            .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....      .+.....
T Consensus       199 ~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~  260 (320)
T 3a99_A          199 LLKDTV------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV  260 (320)
T ss_dssp             ECCSSC------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC
T ss_pred             cccccc------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc
Confidence            664321            123468999999999876664 678999999999999999999997642      2345566


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      .++..+++++.+||.+||+.||++|||+     +++++||||+++..+.
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSCCCHH
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHhhcCccCcc
Confidence            6778899999999999999999999999     9999999999876543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-50  Score=376.83  Aligned_cols=259  Identities=18%  Similarity=0.226  Sum_probs=199.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC--CCCCcceeE-------EEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLF-------FTF  114 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~  114 (366)
                      ..+|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|..+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            45699999999999999999999999999999999887554555566677785544444  699988755       555


Q ss_pred             eeC-----------------CeEEEEEeecCCCchHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 017775          115 QDT-----------------FSLYMALESCEGGELFDQITSK-GHLSEDEA------RFYTAEVVDALEYIHSMGLIHRD  170 (366)
Q Consensus       115 ~~~-----------------~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~------~~~~~qil~aL~~LH~~~i~H~d  170 (366)
                      ...                 ..+|+||||++ ++|.+++... ..+++...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 33899999999 6999999874 23444444      57779999999999999999999


Q ss_pred             CCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhh
Q 017775          171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQM  248 (366)
Q Consensus       171 lkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l  248 (366)
                      |||+|||++.+|.+||+|||+++......             ....+|+.|+|||++.+  ..++.++|||||||++|+|
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el  286 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG-------------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV  286 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE-------------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc-------------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence            99999999999999999999998654321             13456799999999987  6799999999999999999


Q ss_pred             hcCCCCCCCCCHHHH--HH-----HHhcCCCCCC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          249 LSGTSPFKDTSEWLI--FQ-----RIIARDIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       249 l~g~~pf~~~~~~~~--~~-----~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ++|..||.+......  ..     ........++  ..+++++.+||.+||+.||++|||+     +++++||||+++.|
T Consensus       287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~  361 (371)
T 3q60_A          287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP-----LEAMETPEFLQLQN  361 (371)
T ss_dssp             HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH-----HHHTTSHHHHHHHH
T ss_pred             HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCHHHHHHHH
Confidence            999999987643211  00     0011122222  4789999999999999999999999     99999999998766


Q ss_pred             cc
Q 017775          320 KN  321 (366)
Q Consensus       320 ~~  321 (366)
                      ..
T Consensus       362 ~~  363 (371)
T 3q60_A          362 EI  363 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-48  Score=363.36  Aligned_cols=260  Identities=26%  Similarity=0.387  Sum_probs=216.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC------cceeEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG------VVRLFFT  113 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~  113 (366)
                      ....++|++++.||+|+||.||+|.+..++ +.||+|++...    ......+.+|+.+++.++|++      ++.++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            345789999999999999999999998777 68999998653    233455677888888886655      8999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe-------------
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------  178 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli-------------  178 (366)
                      +...+..++||||+. ++|.+.+...  ..+++.+++.++.||+.||.|||++||+||||||+||++             
T Consensus        91 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           91 FNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            999999999999994 5777777665  369999999999999999999999999999999999999             


Q ss_pred             ------CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCC
Q 017775          179 ------TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT  252 (366)
Q Consensus       179 ------~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  252 (366)
                            +.++.+||+|||++......             .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-------------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccccCCCcEEEeecCcccccccc-------------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence                  56789999999999754322             12457899999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhcCCCCCC--------------------------------------------CCCCHHHHHHHHH
Q 017775          253 SPFKDTSEWLIFQRIIARDIRFP--------------------------------------------NYFSDAARDLIDR  288 (366)
Q Consensus       253 ~pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~~  288 (366)
                      .||...+..+....+.......|                                            ...+.++.+||.+
T Consensus       237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  316 (355)
T 2eu9_A          237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR  316 (355)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence            99998877665444322111111                                            1124578999999


Q ss_pred             hhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          289 LLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       289 ~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ||+.||++|||+     +++++||||++++++...
T Consensus       317 ~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~~~  346 (355)
T 2eu9_A          317 MLEFDPAQRITL-----AEALLHPFFAGLTPEERS  346 (355)
T ss_dssp             HTCSSTTTSCCH-----HHHTTSGGGGGCCHHHHC
T ss_pred             HhcCChhhCcCH-----HHHhcChhhcCCChhhcc
Confidence            999999999999     999999999999887654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7e-49  Score=358.76  Aligned_cols=262  Identities=23%  Similarity=0.361  Sum_probs=214.4

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            3456789999999999999999999999999999999988543   3445567888999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||+++++|.+++.. .+.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999999999987 46799999999999999999999999999999999999999999999999999987655


Q ss_pred             ccccccCC----CCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH-----HHHHHh
Q 017775          198 SRITVLPN----AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-----IFQRII  268 (366)
Q Consensus       198 ~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~  268 (366)
                      ........    ...........||+.|+|||.+.+..++.++||||||+++|+|++|..||.......     ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  240 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL  240 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence            43221100    001112235679999999999999999999999999999999999999986532210     000111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       269 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                        ....|..+++++.+++.+||+.||++|||+     ++++.
T Consensus       241 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~l~~  275 (310)
T 3s95_A          241 --DRYCPPNCPPSFFPITVRCCDLDPEKRPSF-----VKLEH  275 (310)
T ss_dssp             --HHTCCTTCCTTHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             --cccCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence              112456788999999999999999999998     66765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=361.60  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=223.2

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR  109 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~  109 (366)
                      +...+..++|++++.||+|+||.||+|.+..+       +..||+|++....  .......+.+|+.+++.+ +||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            44456778999999999999999999997543       3579999997652  334445677899999999 8999999


Q ss_pred             eEEEEeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 017775          110 LFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP  173 (366)
Q Consensus       110 ~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp  173 (366)
                      +++++.+.+..++||||+++++|.+++...+                .+++.+++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998754                499999999999999999999999999999999


Q ss_pred             CCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CC
Q 017775          174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GT  252 (366)
Q Consensus       174 ~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  252 (366)
                      +||+++.++.+||+|||++.........        .......+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTT--------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ceEEEcCCCcEEEcccCccccccccccc--------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999866543211        11223456788999999999999999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          253 SPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       253 ~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .||.+.+..+....+... ....+..+++++.+||.+||+.||++|||+     ++++++
T Consensus       292 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  346 (382)
T 3tt0_A          292 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVED  346 (382)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            999999888887777655 455678899999999999999999999999     667754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.3e-48  Score=364.69  Aligned_cols=253  Identities=28%  Similarity=0.424  Sum_probs=211.5

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CC-----CcceeEEEEee
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HP-----GVVRLFFTFQD  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~  116 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...    .........|+.+++.+. |+     +|+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            468999999999999999999999999999999999753    233445666888887774 44     49999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCeEeC--CCCCEEEEecC
Q 017775          117 TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLLT--ADGHIKIADFG  190 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH--~~~i~H~dlkp~NIli~--~~~~vkL~Dfg  190 (366)
                      .+..++||||+.+ +|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.+||+|||
T Consensus       128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999999975 999999875  45999999999999999999999  57999999999999995  46789999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ++......             .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus       207 ~a~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~  273 (382)
T 2vx3_A          207 SSCQLGQR-------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV  273 (382)
T ss_dssp             TCEETTCC-------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             Cceecccc-------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99865332             22457899999999999999999999999999999999999999998887776665431


Q ss_pred             CCCC------------------CC------------------C----------------------------CCHHHHHHH
Q 017775          271 DIRF------------------PN------------------Y----------------------------FSDAARDLI  286 (366)
Q Consensus       271 ~~~~------------------~~------------------~----------------------------~s~~~~~li  286 (366)
                      ....                  |.                  .                            .++++++||
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli  353 (382)
T 2vx3_A          274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI  353 (382)
T ss_dssp             HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred             hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence            1000                  00                  0                            014789999


Q ss_pred             HHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      .+||+.||++|||+     +++++||||+...
T Consensus       354 ~~mL~~dP~~Rpta-----~e~L~hp~f~~~~  380 (382)
T 2vx3_A          354 LRMLDYDPKTRIQP-----YYALQHSFFKKTA  380 (382)
T ss_dssp             HHHTCSCTTTSCCH-----HHHTTSGGGCC--
T ss_pred             HHhcCCChhhCCCH-----HHHhcCcccccCC
Confidence            99999999999999     9999999998654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-48  Score=361.87  Aligned_cols=254  Identities=31%  Similarity=0.492  Sum_probs=187.0

Q ss_pred             CCCCCcCCeeeee-eeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-
Q 017775           39 QEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-  116 (366)
Q Consensus        39 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-  116 (366)
                      ......++|++.+ .||+|+||.||+|.++.+|+.||+|++...    .   ....+....++.++||||+++++++.. 
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            3344578999965 699999999999999999999999998653    1   112223345677899999999999976 


Q ss_pred             ---CCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---CCEEEEe
Q 017775          117 ---TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIAD  188 (366)
Q Consensus       117 ---~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~~vkL~D  188 (366)
                         ...+++||||++|++|.+++.+.+  .+++.+++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence               556899999999999999998764  69999999999999999999999999999999999999864   5699999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH----H
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----F  264 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~  264 (366)
                      ||++......            ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........    .
T Consensus       175 fg~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (336)
T 3fhr_A          175 FGFAKETTQN------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK  242 (336)
T ss_dssp             CTTCEEC----------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             cccceecccc------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH
Confidence            9999765432            12244689999999999888889999999999999999999999977655433    2


Q ss_pred             HHHhcCCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          265 QRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       265 ~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..+......++    ..+++++.+||.+||+.||.+|||+     +++++||||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  293 (336)
T 3fhr_A          243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI-----TQFMNHPWINQ  293 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccc
Confidence            22222222222    4689999999999999999999999     99999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.6e-48  Score=349.36  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=216.9

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++++.||+|+||.||+|.+. ++..||+|++......    ...+.+|+.+++.++||||+++++++.+.+..
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            466889999999999999999999886 5778999999765322    24477899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++||||+++++|.+++.. .+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999998665432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ...         .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+... ....|..
T Consensus       175 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (283)
T 3gen_A          175 YTS---------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL  245 (283)
T ss_dssp             HHS---------TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccc---------ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCc
Confidence            111         112346778999999998889999999999999999998 99999999988888877765 3445677


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .++.+.++|.+||+.||.+|||+     ++++.|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTF-----KILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCH-----HHHHHH
Confidence            89999999999999999999999     777764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.1e-49  Score=369.71  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=207.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--------CCCcceeEEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--------HPGVVRLFFT  113 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~  113 (366)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+++.+.        |+||++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            3468999999999999999999999999999999999653    334455777999988884        7889999999


Q ss_pred             Ee----eCCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCC----
Q 017775          114 FQ----DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADG----  182 (366)
Q Consensus       114 ~~----~~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~----  182 (366)
                      +.    +...+++||||+. ++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++    
T Consensus       110 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            87    5667999999995 5777766654  4699999999999999999999998 999999999999999775    


Q ss_pred             ---------------------------------------------CEEEEecCCccccCCccccccCCCCCCCCcccccc
Q 017775          183 ---------------------------------------------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG  217 (366)
Q Consensus       183 ---------------------------------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~g  217 (366)
                                                                   .+||+|||++......             .....|
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------------~~~~~g  255 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------------FTEDIQ  255 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------------SCSCCS
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------------CccCCC
Confidence                                                         7999999999865432             123468


Q ss_pred             CCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC------HHHHHHHHhc---C------------------
Q 017775          218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS------EWLIFQRIIA---R------------------  270 (366)
Q Consensus       218 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~---~------------------  270 (366)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||...+      .......+..   .                  
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999899999999999999999999999997644      2222222211   0                  


Q ss_pred             ---------------------CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          271 ---------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       271 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                                           ....+...++++.+||.+||+.||++|||+     +++++||||++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~  397 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA-----AECLRHPWLNS  397 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH-----HHHHTSGGGGC
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH-----HHHhhCccccC
Confidence                                 111223345678999999999999999999     99999999973

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-48  Score=365.40  Aligned_cols=258  Identities=22%  Similarity=0.365  Sum_probs=209.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc--------chhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--------KENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .++|++++.||+|+||.||+|.+.. |..||+|++......        .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            5789999999999999999999865 999999998654322        1223356788999999999999999999984


Q ss_pred             e-----CCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          116 D-----TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       116 ~-----~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      .     ...+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            3     3468999999985 888888765 46999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHh
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  268 (366)
                      |++.......           ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       179 g~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          179 NLAREDTADA-----------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             TC--------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             Cccccccccc-----------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9997543321           2224568899999999877 668999999999999999999999999988777666653


Q ss_pred             cC------------------------CC--------CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          269 AR------------------------DI--------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       269 ~~------------------------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..                        ..        ..+...++.+.+||.+||+.||++|||+     +++++||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~  322 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST-----EQALRHPYFES  322 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGTT
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH-----HHHHcCchhhh
Confidence            21                        00        1123568999999999999999999999     99999999998


Q ss_pred             CCc
Q 017775          317 IDW  319 (366)
Q Consensus       317 ~~~  319 (366)
                      +..
T Consensus       323 ~~~  325 (362)
T 3pg1_A          323 LFD  325 (362)
T ss_dssp             TCC
T ss_pred             ccC
Confidence            743

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.5e-48  Score=351.47  Aligned_cols=266  Identities=31%  Similarity=0.523  Sum_probs=210.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------  116 (366)
                      .++|++++.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            46899999999999999999999999999999998642    3345567789999999999999999998865       


Q ss_pred             ------CCeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          117 ------TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       117 ------~~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                            ....|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  456899999999999999998653 5889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccC----CCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHH
Q 017775          190 GSVKPMQDSRITVLP----NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLI  263 (366)
Q Consensus       190 g~a~~~~~~~~~~~~----~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~  263 (366)
                      |++............    ............|++.|+|||.+.+. .++.++||||||+++|+|++   ||.. .+....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            999876533211000    00011223355789999999999765 68999999999999999998   5543 333445


Q ss_pred             HHHHhcCCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccc
Q 017775          264 FQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       264 ~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      ...+......+|    ...++.+.+||.+||+.||.+|||+     +++++||||+...++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~  294 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLPVKHQDE  294 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH-----HHHHHSSCSCCCCHHH
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH-----HHHhCCCCcCCCChHH
Confidence            555555444444    4567889999999999999999999     9999999998766543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-48  Score=361.46  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=221.0

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .+..++|++++.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            456789999999999999999999987     456899999997642  3344566888999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 017775          116 DTFSLYMALESCEGGELFDQITSK------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI  171 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~------------------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dl  171 (366)
                      +.+..++||||+++++|.+++...                        +.+++.+++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999874                        56899999999999999999999999999999


Q ss_pred             CCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-
Q 017775          172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-  250 (366)
Q Consensus       172 kp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-  250 (366)
                      ||+||+++.++.+||+|||++.........        .......+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccc--------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence            999999999999999999999865433211        11223457889999999988889999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          251 GTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       251 g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      |..||.+.+..+....+..... ..|..+++++.+||.+||+.||++|||+     .+++.
T Consensus       273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~  328 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-----CSIHR  328 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCH-----HHHHH
Confidence            9999999998888877776543 5678899999999999999999999998     66664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6e-48  Score=345.13  Aligned_cols=252  Identities=20%  Similarity=0.322  Sum_probs=218.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++++.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            356789999999999999999999875 567899999976432    234477899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998754 59999999999999999999999999999999999999999999999999998665432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~  277 (366)
                      ...         .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+.... ...|..
T Consensus       159 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (268)
T 3sxs_A          159 YVS---------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL  229 (268)
T ss_dssp             EEE---------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             hhc---------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCc
Confidence            211         112345678999999988889999999999999999999 999999988888777766554 445667


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .++++.++|.+||+.||++|||+     .+++.+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~  258 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTF-----QQLLSS  258 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             ChHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            89999999999999999999999     777764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-48  Score=353.13  Aligned_cols=248  Identities=19%  Similarity=0.301  Sum_probs=213.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTG-------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      .+..++|++.+.||+|+||.||+|.+..++       ..||+|++...   .......+.+|+.+++.++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            456789999999999999999999998877       46999998654   33445567889999999999999999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC--------E
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--------I  184 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~--------v  184 (366)
                      +.+.+..++||||++|++|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999998887        9


Q ss_pred             EEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcC-CCCCCCCCHHH
Q 017775          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWL  262 (366)
Q Consensus       185 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~  262 (366)
                      ||+|||++......              ....|++.|+|||.+.+ ..++.++||||||+++|+|++| .+||.......
T Consensus       161 kl~Dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~  226 (289)
T 4fvq_A          161 KLSDPGISITVLPK--------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR  226 (289)
T ss_dssp             EECCCCSCTTTSCH--------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eeccCcccccccCc--------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence            99999998755332              23457889999999987 6689999999999999999995 55565555544


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          263 IFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       263 ~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      . ..........|...++++.+||.+||+.||++|||+     .++++|
T Consensus       227 ~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  269 (289)
T 4fvq_A          227 K-LQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSF-----RAIIRD  269 (289)
T ss_dssp             H-HHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             H-HHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            3 344455667777889999999999999999999999     777765

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.9e-48  Score=354.90  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=222.2

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeE
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF  111 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  111 (366)
                      .+.-.+..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~   92 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY   92 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence            3455677899999999999999999999983     456899999987542  334445678899999999999999999


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCce
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSKGH------------------------LSEDEARFYTAEVVDALEYIHSMGLI  167 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~------------------------l~~~~~~~~~~qil~aL~~LH~~~i~  167 (366)
                      +++.+.+..++||||+++++|.+++...+.                        +++.+++.++.||+.||.|||++||+
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            999999999999999999999999987543                        89999999999999999999999999


Q ss_pred             eccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhh
Q 017775          168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (366)
Q Consensus       168 H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  247 (366)
                      ||||||+||+++.++.+||+|||++..........        ......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  244 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE  244 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE--------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccce--------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence            99999999999999999999999998664432111        1123356788999999988889999999999999999


Q ss_pred             hhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          248 MLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       248 ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      |++ |..||.+.........+... ....+..+++++.++|.+||+.||.+|||+     .+++.+
T Consensus       245 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~l~~~  305 (314)
T 2ivs_A          245 IVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF-----ADISKD  305 (314)
T ss_dssp             HHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            999 99999988877776666554 345677899999999999999999999998     677653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1e-48  Score=364.78  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=214.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEE-----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  114 (366)
                      .+..++|++++.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3567899999999999999999999     55677899999997642  233345678899999999 799999999999


Q ss_pred             eeCCe-EEEEEeecCCCchHHHHHhCCC----------------------------------------------------
Q 017775          115 QDTFS-LYMALESCEGGELFDQITSKGH----------------------------------------------------  141 (366)
Q Consensus       115 ~~~~~-~~iv~e~~~g~~L~~~l~~~~~----------------------------------------------------  141 (366)
                      .+.+. +++||||++||+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            87554 8999999999999999987543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          142 --------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       142 --------------l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                                    +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........      
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------  249 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------  249 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC------
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc------
Confidence                          899999999999999999999999999999999999999999999999999865433211      


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH-HHHHHhc-CCCCCCCCCCHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL-IFQRIIA-RDIRFPNYFSDAARD  284 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~-~~~~i~~-~~~~~~~~~s~~~~~  284 (366)
                        .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ....+.. .....|..+++++.+
T Consensus       250 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  327 (359)
T 3vhe_A          250 --VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  327 (359)
T ss_dssp             --EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             --hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence              12224567889999999998889999999999999999998 999998765433 3333332 345677889999999


Q ss_pred             HHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          285 LIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       285 li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ++.+||+.||.+|||+     ++++.|
T Consensus       328 li~~~l~~dP~~Rps~-----~ell~~  349 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTF-----SELVEH  349 (359)
T ss_dssp             HHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHccCChhhCCCH-----HHHHHH
Confidence            9999999999999998     777765

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.8e-48  Score=355.64  Aligned_cols=270  Identities=19%  Similarity=0.301  Sum_probs=228.1

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      .-.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            33456789999999999999999999876     467889999987542  23334457789999999999999999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~  183 (366)
                      +.+.+..++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence            99999999999999999999998753          35799999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHH
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  262 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  262 (366)
                      +||+|||++..........        ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEE--------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             EEECcCccccccccccccc--------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            9999999998654432111        1123456888999999988889999999999999999999 899999988888


Q ss_pred             HHHHHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC------CCCCCCCccccc
Q 017775          263 IFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH------PFFKGIDWKNIR  323 (366)
Q Consensus       263 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h------p~f~~~~~~~~~  323 (366)
                      ....+.... ...+..+++++.+||.+||+.||.+|||+     .+++.|      ++|+.++|....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~e~l~~L~~~~~~~~~~~~~~~~~  311 (322)
T 1p4o_A          249 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFREVSFYYSE  311 (322)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHHHCSTTST
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHHHHHhhccCCccccccccc
Confidence            877776654 45677899999999999999999999999     666665      777766655443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-47  Score=347.88  Aligned_cols=257  Identities=30%  Similarity=0.483  Sum_probs=207.7

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ......++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus        26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34456789999999999999999999999999999999998654445555667788999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          119 SLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ..++||||+++++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999999864    45699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC--CHHHHHHHHhcCCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--SEWLIFQRIIARDI  272 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~  272 (366)
                      .....          .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.  +.......+.....
T Consensus       186 ~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  255 (310)
T 2wqm_A          186 FSSKT----------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY  255 (310)
T ss_dssp             -----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS
T ss_pred             ecCCC----------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC
Confidence            54321          1122446899999999999988999999999999999999999999754  33444455544433


Q ss_pred             C--CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          273 R--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       273 ~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .  .+..+++++.+||.+||+.||++|||+     .+++.
T Consensus       256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~il~  290 (310)
T 2wqm_A          256 PPLPSDHYSEELRQLVNMCINPDPEKRPDV-----TYVYD  290 (310)
T ss_dssp             CCCCTTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcccccCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence            2  235689999999999999999999999     67765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-48  Score=364.52  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=219.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++++.||+|+||.||+|.++.+|+.||+|+++...  .......+.+|+.+++.++||||+++++++.+...+
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            456789999999999999999999999999999999987542  233334567799999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999999998653 59999999999999999999999999999999999999999999999999998654332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ...        ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..+ ..+.|..
T Consensus       268 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (377)
T 3cbl_A          268 YAA--------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL  339 (377)
T ss_dssp             EEC--------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             eee--------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            111        1112235678999999988889999999999999999998 99999998887777666544 4567788


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +++++.+|+.+||+.||++|||+     ++++.
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~-----~~i~~  367 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSF-----STIYQ  367 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCH-----HHHHH
Confidence            99999999999999999999998     66653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=368.06  Aligned_cols=260  Identities=26%  Similarity=0.379  Sum_probs=195.6

Q ss_pred             cCCeee-eeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CC
Q 017775           44 IQDFEL-GKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TF  118 (366)
Q Consensus        44 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~  118 (366)
                      .+.|++ +++||+|+||.||+|+++  .+++.||+|++......     ..+.+|+.+++.++||||+++++++.+  ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            345776 568999999999999976  57899999998754222     246679999999999999999999954  77


Q ss_pred             eEEEEEeecCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----CCCCCEE
Q 017775          119 SLYMALESCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIK  185 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~---------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli----~~~~~vk  185 (366)
                      .+|+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            89999999976 888887632         249999999999999999999999999999999999999    6778999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHH---
Q 017775          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW---  261 (366)
Q Consensus       186 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---  261 (366)
                      |+|||+++........       ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....   
T Consensus       173 l~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          173 IADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             ECCTTCCC-----------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             EEECCCceecCCCCcc-------cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            9999999876432111       1122356789999999998874 4899999999999999999999999766542   


Q ss_pred             ------HHHHHHhcCC-CC-------------------------------------CCCCCCHHHHHHHHHhhcCCCCCC
Q 017775          262 ------LIFQRIIARD-IR-------------------------------------FPNYFSDAARDLIDRLLDVDPSGR  297 (366)
Q Consensus       262 ------~~~~~i~~~~-~~-------------------------------------~~~~~s~~~~~li~~~L~~dP~~R  297 (366)
                            +.+..+.... .+                                     .....++++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                  2233322100 00                                     001127789999999999999999


Q ss_pred             CCCCCCChHhhhcCCCCCCCCccc
Q 017775          298 PGAGPGGYAVLKMHPFFKGIDWKN  321 (366)
Q Consensus       298 ps~~~~~~~~~l~hp~f~~~~~~~  321 (366)
                      ||+     +++++||||+...+..
T Consensus       326 ~ta-----~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          326 ITS-----EQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             CCH-----HHHHTSGGGTSSSCCC
T ss_pred             CCH-----HHHhcChhhccCCCCc
Confidence            999     9999999999766554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3e-48  Score=363.37  Aligned_cols=257  Identities=26%  Similarity=0.404  Sum_probs=210.8

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----------CCC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----------HPG  106 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~  106 (366)
                      ..+.+..++|++++.||+|+||.||+|.+..+|+.||+|++...    ......+.+|+.+++.+.           |+|
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence            34556778999999999999999999999999999999998753    233445677888888775           899


Q ss_pred             cceeEEEEeeCC----eEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeC
Q 017775          107 VVRLFFTFQDTF----SLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLT  179 (366)
Q Consensus       107 iv~~~~~~~~~~----~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~  179 (366)
                      |+++++++...+    .+++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            999999988654    799999999 77999999874  4599999999999999999999998 999999999999995


Q ss_pred             ------CCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCC
Q 017775          180 ------ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS  253 (366)
Q Consensus       180 ------~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  253 (366)
                            ..+.+||+|||++......             .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  233 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF  233 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCcCcceEEEcccccccccCCC-------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCC
Confidence                  3448999999999865432             123468999999999999999999999999999999999999


Q ss_pred             CCCCCCH------HHHHHHHh------------------------------------------cCCCCCCCCCCHHHHHH
Q 017775          254 PFKDTSE------WLIFQRII------------------------------------------ARDIRFPNYFSDAARDL  285 (366)
Q Consensus       254 pf~~~~~------~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~l  285 (366)
                      ||.+.+.      ......+.                                          .....++...++++.+|
T Consensus       234 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (373)
T 1q8y_A          234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  313 (373)
T ss_dssp             CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence            9986542      22222221                                          11223445567889999


Q ss_pred             HHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       286 i~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      |.+||+.||++|||+     +++++||||++.
T Consensus       314 i~~~L~~dP~~Rpt~-----~ell~hp~f~~~  340 (373)
T 1q8y_A          314 LSPMLQLDPRKRADA-----GGLVNHPWLKDT  340 (373)
T ss_dssp             HGGGGCSSTTTCBCH-----HHHHTCGGGTTC
T ss_pred             HHHHhccCccccCCH-----HHHhhChhhhcc
Confidence            999999999999999     999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-47  Score=352.73  Aligned_cols=265  Identities=24%  Similarity=0.312  Sum_probs=215.9

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  120 (366)
                      +..++|++++.||+|+||.||+|.+..+|+.||+|++......     ..+.+|+.+++.+ +||||+++++++.+....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            3457899999999999999999999999999999998764221     2366799999999 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC-----EEEEecCCccc
Q 017775          121 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKP  194 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~-----vkL~Dfg~a~~  194 (366)
                      ++||||+ +++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.     +||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 88999999874 67999999999999999999999999999999999999998887     99999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC---CHHHHHHHHhcCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARD  271 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~  271 (366)
                      +........   ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.   ...+....+....
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          160 YIDPETKKH---IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             SBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eecCCCCcc---ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            644321110   0011234567999999999999999999999999999999999999999873   3444445544333


Q ss_pred             CCCC-----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc----------CCCCCCCCccc
Q 017775          272 IRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM----------HPFFKGIDWKN  321 (366)
Q Consensus       272 ~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~----------hp~f~~~~~~~  321 (366)
                      ...+     ..++ ++.+++.+||+.||.+||++     +++..          ..+...++|..
T Consensus       237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~-----~~l~~~l~~~~~~~~~~~~~~~dw~~  295 (330)
T 2izr_A          237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDY-----DYLRKLFTDLFDRKGYMFDYEYDWIG  295 (330)
T ss_dssp             HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCH-----HHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred             ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCCCccCCC
Confidence            2222     2344 99999999999999999998     33332          34455678874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=350.93  Aligned_cols=263  Identities=28%  Similarity=0.443  Sum_probs=203.5

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      .+.-....++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.++..+++.++||||+++++++.+
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            34445668899999999999999999999999999999999976532 22233445555667888899999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          117 TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ....++||||+ ++.+..+... .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 4466555544 46799999999999999999999995 999999999999999999999999999876


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHh
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRII  268 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~  268 (366)
                      .....           ......|++.|+|||.+.     +..++.++||||||+++|+|++|..||.. ....+....+.
T Consensus       175 ~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          175 LVDDK-----------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             -----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccCCc-----------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            54321           112346899999999984     45688899999999999999999999986 44555555555


Q ss_pred             cCCCC-CC--CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          269 ARDIR-FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       269 ~~~~~-~~--~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ..... .+  ..+++++.+||.+||+.||.+||++     +++++||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  290 (318)
T 2dyl_A          244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKY-----NKLLEHSFIKRY  290 (318)
T ss_dssp             HSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHHH
T ss_pred             ccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCH-----HHHhhCHHHHhc
Confidence            54332 33  3589999999999999999999999     899999999754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-47  Score=343.32  Aligned_cols=250  Identities=24%  Similarity=0.444  Sum_probs=205.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      +..++|++.+.||+|+||.||+|.+.  |+.||+|++....... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            45789999999999999999999984  8899999987643222 22345677899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCeEeCC--------CCCEEEEec
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG---LIHRDIKPENLLLTA--------DGHIKIADF  189 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~---i~H~dlkp~NIli~~--------~~~vkL~Df  189 (366)
                      ++||||++|++|.+++.. +.+++..++.++.|++.||.|||++|   |+||||||+||+++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999988854 57999999999999999999999999   999999999999986        678999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhc
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  269 (366)
                      |++.......            .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus       161 g~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  228 (271)
T 3dtc_A          161 GLAREWHRTT------------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM  228 (271)
T ss_dssp             CC-------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred             Cccccccccc------------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence            9998654321            1234689999999999988899999999999999999999999999888777666655


Q ss_pred             CC--CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          270 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       270 ~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..  ...+..+++++.++|.+||+.||.+|||+     .+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  267 (271)
T 3dtc_A          229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF-----TNILDQ  267 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH-----HHHHHH
Confidence            43  45567899999999999999999999999     777653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.5e-47  Score=342.67  Aligned_cols=252  Identities=19%  Similarity=0.284  Sum_probs=210.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  119 (366)
                      .+..++|++++.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.+++.+ +|++++++++++.+...
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3456789999999999999999999999999999999865422     12366788899998 79999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC-----EEEEecCCcc
Q 017775          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVK  193 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~-----vkL~Dfg~a~  193 (366)
                      .++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.     +||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 889999998754 5999999999999999999999999999999999999987776     9999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC---CHHHHHHHHhcC
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIAR  270 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~  270 (366)
                      ..........   ..........||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.   ........+...
T Consensus       160 ~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          160 FYRDPVTKQH---IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             ESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccc---ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            7654322110   0112234567999999999999999999999999999999999999999873   344444444332


Q ss_pred             CC-----CCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          271 DI-----RFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       271 ~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ..     .....+++++.+|+.+||+.||++||++.
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~  272 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD  272 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence            21     22346899999999999999999999983

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-47  Score=352.11  Aligned_cols=259  Identities=22%  Similarity=0.370  Sum_probs=219.8

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEEC-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR  109 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~  109 (366)
                      +.-.+..++|++++.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++.+ +||||++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            344566789999999999999999999985       467789999997642  333445677899999999 8999999


Q ss_pred             eEEEEeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 017775          110 LFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP  173 (366)
Q Consensus       110 ~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp  173 (366)
                      +++++.+.+.+++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            9999999999999999999999999998754                389999999999999999999999999999999


Q ss_pred             CCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CC
Q 017775          174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GT  252 (366)
Q Consensus       174 ~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  252 (366)
                      +||+++.++.+||+|||++..........        ......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  257 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYK--------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  257 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEE--------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ceEEEcCCCCEEEcccccccccccccccc--------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999998665432111        1123346788999999988889999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          253 SPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       253 ~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .||.+.+..+....+... ....+..+++++.++|.+||+.||.+|||+     .+++.+
T Consensus       258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  312 (334)
T 2pvf_A          258 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVED  312 (334)
T ss_dssp             CSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            999998888877766654 355677899999999999999999999998     667654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.1e-48  Score=346.82  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=206.1

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      .+..++|++++.||+|+||.||+|.+..+   +..||+|++....  .......+.+|+.+++.++||||+++++++. .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            45678999999999999999999998654   4569999886532  3344556788999999999999999999985 4


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      +..++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            57899999999999999998764 69999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      .....         ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+... ....
T Consensus       168 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (281)
T 1mp8_A          168 DSTYY---------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM  238 (281)
T ss_dssp             --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred             ccccc---------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC
Confidence            43211         1123346778999999988889999999999999999996 99999988877777776654 3557


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +..+++++.++|.+||+.||++|||+     .+++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  269 (281)
T 1mp8_A          239 PPNCPPTLYSLMTKCWAYDPSRRPRF-----TELKA  269 (281)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            78899999999999999999999998     66664

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.4e-48  Score=356.88  Aligned_cols=262  Identities=24%  Similarity=0.365  Sum_probs=195.0

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++++.||+|+||.||+|.++.+|+.||+|++..... .........++..+++.++||||+++++++.+.+..
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            5678999999999999999999999999999999999976532 222223333333477788999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          121 YMALESCEGGELFDQITS-----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~~LH~~-~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ++||||+.+ +|.+++..     .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999999986 88887763     46799999999999999999999999 999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceee----cCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-HHHHHHhc
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIA  269 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~  269 (366)
                      .....           ......|++.|+|||.+    .+..++.++||||||+++|+|++|..||.+.... +....+..
T Consensus       176 ~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (327)
T 3aln_A          176 LVDSI-----------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK  244 (327)
T ss_dssp             -----------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred             ccccc-----------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence            54321           11233689999999998    4566889999999999999999999999875432 22222222


Q ss_pred             CCC-CCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          270 RDI-RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       270 ~~~-~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                      ... .++    ..+++++.+||.+||+.||++|||+     .++++||||...+++
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  295 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY-----KELLKHPFILMYEER  295 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHHHS
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH-----HHHHhChHHHHhHhh
Confidence            221 122    3589999999999999999999999     999999999765443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.1e-48  Score=348.87  Aligned_cols=256  Identities=20%  Similarity=0.318  Sum_probs=208.2

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      ..+..++|++++.||+|+||.||+|+    +..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45678999999999999999999998    5678999999998754   3444556788999999999999999999986


Q ss_pred             e--CCeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          116 D--TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       116 ~--~~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      .  ...+++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456899999999999999998764 4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH-----------
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------  261 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------  261 (366)
                      ..........       .......++..|+|||.+.+..++.++||||||+++|+|++|..||......           
T Consensus       162 ~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  234 (295)
T 3ugc_A          162 KVLPQDKEFF-------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG  234 (295)
T ss_dssp             C--------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT
T ss_pred             ccccCCccee-------eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc
Confidence            8764432111       1112334677899999999889999999999999999999999998653221           


Q ss_pred             -----HHHHHHh-cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          262 -----LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       262 -----~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                           .....+. ......|..+++++.+||.+||+.||++|||+     .+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~el~~  284 (295)
T 3ugc_A          235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-----RDLAL  284 (295)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence                 1112222 23455678899999999999999999999998     66653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-47  Score=353.32  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=216.8

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEE--EEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEee
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  116 (366)
                      ..+..++|++.+.||+|+||.||+|++..+|..+  |+|.+....  .......+.+|+.+++.+ +||||+++++++.+
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            3467889999999999999999999999888866  999886532  233344577899999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          117 TFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      .+..|+||||+++++|.+++...+                .+++.+++.++.||+.||.|||++||+||||||+||+++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            999999999999999999998754                6999999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      ++.+||+|||++.......           ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  246 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  246 (327)
T ss_dssp             GGCEEECCTTCEESSCEEC-----------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCeEEEcccCcCccccccc-----------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence            9999999999987432211           1123356788999999988888999999999999999998 999999999


Q ss_pred             HHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          260 EWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       260 ~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .......+... ....+..+++++.+||.+||+.||.+|||+     ++++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  294 (327)
T 1fvr_A          247 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  294 (327)
T ss_dssp             HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            88888777665 345677889999999999999999999998     667654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-47  Score=340.63  Aligned_cols=250  Identities=20%  Similarity=0.336  Sum_probs=218.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|++......    ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            45689999999999999999999986 5788999999765322    345778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999999875 5689999999999999999999999999999999999999999999999999986644321


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCC
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  278 (366)
                      .         ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+... ....|..+
T Consensus       160 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  230 (267)
T 3t9t_A          160 T---------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA  230 (267)
T ss_dssp             H---------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             c---------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccC
Confidence            1         1112346778999999988889999999999999999999 99999999888888777665 34456778


Q ss_pred             CHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       279 s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ++++.+++.+||+.||++|||+     .++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~-----~~ll~  257 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAF-----SRLLR  257 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999999999998     67765

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-47  Score=358.92  Aligned_cols=255  Identities=19%  Similarity=0.314  Sum_probs=206.8

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ....+..++|++.+.||+|+||.||+|+++   .++..||+|+++...  .......+.+|+.+++.++||||+++++++
T Consensus        38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            344567789999999999999999999886   567789999987642  334455678899999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+....++||||+++++|.+++.+.+ .+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            99999999999999999999998764 69999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-D  271 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~  271 (366)
                      .........       .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... .
T Consensus       196 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~  268 (373)
T 2qol_A          196 VLEDDPEAA-------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR  268 (373)
T ss_dssp             -------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred             ccccCCccc-------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            765432110       01112235678999999998889999999999999999998 99999998888877776554 3


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ...+..++.++.+|+.+||+.||++||++.
T Consensus       269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  298 (373)
T 2qol_A          269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFE  298 (373)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCccccHHHHHHHHHHhCcChhhCcCHH
Confidence            445667899999999999999999999983

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-48  Score=356.05  Aligned_cols=263  Identities=19%  Similarity=0.319  Sum_probs=218.9

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEE-----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  112 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  112 (366)
                      ....+..++|++++.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.+++.++||||+++++
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~  100 (327)
T 2yfx_A           23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIG  100 (327)
T ss_dssp             GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence            3445678899999999999999999998     56788999999986532  3334456778999999999999999999


Q ss_pred             EEeeCCeEEEEEeecCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC---C
Q 017775          113 TFQDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---G  182 (366)
Q Consensus       113 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~-------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~---~  182 (366)
                      ++.+....|+||||++|++|.+++...+       .+++..++.++.||+.||.|||++||+||||||+||+++.+   +
T Consensus       101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence            9999999999999999999999998753       48999999999999999999999999999999999999944   4


Q ss_pred             CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHH
Q 017775          183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEW  261 (366)
Q Consensus       183 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  261 (366)
                      .+||+|||++.........        .......|++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  252 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYY--------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ  252 (327)
T ss_dssp             CEEECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEECcccccccccccccc--------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence            6999999998755332211        12224567889999999988889999999999999999998 99999998888


Q ss_pred             HHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          262 LIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       262 ~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      .....+... ....+..+++.+.++|.+||+.||.+||++     .++++|.|+-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~l~~~  302 (327)
T 2yfx_A          253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYC  302 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHHHHHHH
Confidence            777776654 445667899999999999999999999999     8899988764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-47  Score=344.76  Aligned_cols=258  Identities=20%  Similarity=0.304  Sum_probs=216.3

Q ss_pred             CCCCCcCCeeeee-eeeecCceEEEEEEE--CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           39 QEHFSIQDFELGK-IYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        39 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .-.+..++|++.+ .||+|+||.||+|.+  ..+++.||+|++..... .......+.+|+.+++.++||||+++++++ 
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            3355678999999 999999999999954  56788999999976532 233355678899999999999999999999 


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      +....++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            56678999999999999999998888999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  273 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~  273 (366)
                      ........       ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+... ...
T Consensus       168 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  240 (291)
T 1xbb_A          168 RADENYYK-------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG  240 (291)
T ss_dssp             CTTCSEEE-------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccCCCccc-------ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            44321110       1112345678999999988888899999999999999999 99999998888877776654 355


Q ss_pred             CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       274 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .|..+++++.++|.+||+.||++|||+     .+++.
T Consensus       241 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  272 (291)
T 1xbb_A          241 CPAGCPREMYDLMNLCWTYDVENRPGF-----AAVEL  272 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            678899999999999999999999998     55553

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.6e-47  Score=340.70  Aligned_cols=253  Identities=21%  Similarity=0.352  Sum_probs=211.0

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhH----HHHHHHHHHHHhCCCCCcceeEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      ....+..++|++.+.||+|+||.||+|.+..+++.||+|++...........    ..+.+|+.+++.++||||++++++
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            3445667899999999999999999999999999999999876543322221    567789999999999999999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCC-----EE
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGH-----IK  185 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~-----vk  185 (366)
                      +.+..  ++||||+++++|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+||+++.++.     +|
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            98765  6999999999998888665 46999999999999999999999999  999999999999988876     99


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeec--CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH-
Q 017775          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-  262 (366)
Q Consensus       186 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  262 (366)
                      |+|||++......             .....||+.|+|||.+.  ...++.++||||||+++|+|++|..||...+... 
T Consensus       170 l~Dfg~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  236 (287)
T 4f0f_A          170 VADFGLSQQSVHS-------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI  236 (287)
T ss_dssp             ECCCTTCBCCSSC-------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred             eCCCCcccccccc-------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence            9999998744321             22456899999999984  4457889999999999999999999997654322 


Q ss_pred             -HHHHHhc--CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          263 -IFQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       263 -~~~~i~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                       ....+..  ....++..+++++.+||.+||+.||.+|||+     +++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  282 (287)
T 4f0f_A          237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF-----SYIVK  282 (287)
T ss_dssp             HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence             2333332  3445678899999999999999999999998     66654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-47  Score=346.27  Aligned_cols=252  Identities=21%  Similarity=0.352  Sum_probs=220.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|++...    ......+.+|+.+++.++||||+++++++.+....
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            45688999999999999999999999999999999998753    23345677899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ++||||++|++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999874  45999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ...         ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+... ....+.
T Consensus       165 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 3kfa_A          165 TYT---------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  235 (288)
T ss_dssp             SSE---------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             ccc---------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC
Confidence            211         1123456788999999998889999999999999999999 99999988777666665544 455677


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+++++.+||.+||+.||.+|||+     ++++.
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~-----~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSF-----AEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCH-----HHHHH
Confidence            899999999999999999999999     66654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-47  Score=353.37  Aligned_cols=258  Identities=18%  Similarity=0.298  Sum_probs=214.4

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      ....+..++|++++.||+|+||.||+|.+..+|+.    ||+|.+....  .......+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (325)
T 3kex_A            6 LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGL   83 (325)
T ss_dssp             CCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            34567788999999999999999999999988886    6666664332  11122235568889999999999999998


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      +. ....++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus        84 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           84 CP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             EC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             Ec-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence            86 45689999999999999999875 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-  270 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-  270 (366)
                      +........        .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+... 
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  234 (325)
T 3kex_A          163 DLLPPDDKQ--------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE  234 (325)
T ss_dssp             GGSCCCTTC--------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC
T ss_pred             cccCccccc--------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence            876443211        12234567889999999998889999999999999999999 99999988777776666554 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ....|..++.++.+++.+||+.||.+|||+     .+++++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~el~~~  270 (325)
T 3kex_A          235 RLAQPQICTIDVYMVMVKCWMIDENIRPTF-----KELANE  270 (325)
T ss_dssp             BCCCCTTBCTTTTHHHHHHTCSCTTTSCCH-----HHHHHH
T ss_pred             CCCCCCcCcHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            455667789999999999999999999998     666654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-47  Score=355.38  Aligned_cols=256  Identities=23%  Similarity=0.394  Sum_probs=213.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  114 (366)
                      .+..++|++++.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            45678999999999999999999997     3467789999997542  223345677899999999 899999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKG-----------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDI  171 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~-----------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dl  171 (366)
                      .+.+..++||||+++++|.+++...+                       .+++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999998653                       2799999999999999999999999999999


Q ss_pred             CCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-
Q 017775          172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-  250 (366)
Q Consensus       172 kp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-  250 (366)
                      ||+||+++.++.+||+|||++.........        .......||+.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNY--------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTS--------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccc--------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence            999999999999999999999866433211        11224457889999999988889999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          251 GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       251 g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      |..||.+.........+...  ....|..+++++.+||.+||+.||.+|||+     .+++.|
T Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~~  328 (344)
T 1rjb_A          271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  328 (344)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-----HHHHHH
Confidence            99999876654444444333  344567789999999999999999999999     777765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-47  Score=348.49  Aligned_cols=258  Identities=18%  Similarity=0.290  Sum_probs=213.2

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ...+..++|.+.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34566789999999999999999999986553    359999987542  233445677899999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+.+..++||||+++++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999999999875 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-D  271 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~  271 (366)
                      .........       .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+... .
T Consensus       196 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  268 (333)
T 1mqb_A          196 VLEDDPEAT-------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR  268 (333)
T ss_dssp             ----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             hhccccccc-------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence            765432110       11112345778999999998889999999999999999998 99999998888887777655 4


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ...+..+++++.++|.+||+.||++||++     .+++.
T Consensus       269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  302 (333)
T 1mqb_A          269 LPTPMDCPSAIYQLMMQCWQQERARRPKF-----ADIVS  302 (333)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            55667899999999999999999999998     56654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-47  Score=349.20  Aligned_cols=256  Identities=24%  Similarity=0.375  Sum_probs=215.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  114 (366)
                      .+..++|++++.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            45578999999999999999999985     4578899999997642  233446678899999999 899999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCe
Q 017775          115 QDTFSLYMALESCEGGELFDQITSKG------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~~------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NI  176 (366)
                      .+.+..++||||+++++|.+++...+                  .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998754                  489999999999999999999999999999999999


Q ss_pred             EeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCC
Q 017775          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (366)
Q Consensus       177 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  255 (366)
                      +++.++.+||+|||++..........        ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             EEcCCCCEEEccccccccccccccce--------eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999998765432111        1123457788999999988889999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          256 KDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       256 ~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+.............  ....+..+++++.++|.+||+.||.+|||+     .+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  301 (313)
T 1t46_A          249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIVQL  301 (313)
T ss_dssp             TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCH-----HHHHHH
Confidence            876654433333322  334467789999999999999999999998     677653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-47  Score=352.05  Aligned_cols=257  Identities=19%  Similarity=0.291  Sum_probs=209.9

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ...+..++|++.+.||+|+||.||+|++..+|+.+    |+|.+....  .......+.+|+.+++.++||||+++++++
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            44567889999999999999999999998888765    666664331  223345677899999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+.. .++++||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++++||+|||+++
T Consensus        87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence            8764 78899999999999999874 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-D  271 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~  271 (366)
                      ........        .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+... .
T Consensus       166 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  237 (327)
T 3poz_A          166 LLGAEEKE--------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  237 (327)
T ss_dssp             HHTTTCC---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EccCCccc--------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC
Confidence            76443211        11223356788999999999999999999999999999999 99999988777666655544 3


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ...+...+.++.+++.+||+.||.+||++     .+++.+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~  272 (327)
T 3poz_A          238 LPQPPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  272 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSCGGGSCCH-----HHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCCCH-----HHHHHH
Confidence            55677899999999999999999999999     667654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.4e-47  Score=339.55  Aligned_cols=248  Identities=15%  Similarity=0.256  Sum_probs=214.6

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC--
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--  117 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--  117 (366)
                      ..+..++|++.+.||+|+||.||+|.+.  |+.||+|++...... ......+.+|+.+++.++||||+++++++.+.  
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            3567889999999999999999999984  889999999875333 33345677899999999999999999999887  


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          118 FSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ...++||||+++++|.+++.+.+  .+++.+++.++.|++.||.|||++|  |+||||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78999999999999999998765  4899999999999999999999999  9999999999999999999999998876


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCC---CCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ....               ....||+.|+|||.+.+..++.   ++||||||+++|+|++|..||.+.+.......+...
T Consensus       162 ~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  226 (271)
T 3kmu_A          162 SFQS---------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE  226 (271)
T ss_dssp             TTSC---------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS
T ss_pred             eecc---------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc
Confidence            4322               1346789999999998766544   799999999999999999999998888776666544


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          271 --DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       271 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                        ....|..+++++.++|.+||+.||++|||+     ++++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~  263 (271)
T 3kmu_A          227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKF-----DMIVP  263 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence              455678899999999999999999999998     66664

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-47  Score=347.13  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=212.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEeeCC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDTF  118 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~  118 (366)
                      .+..++|++++.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++  |+||+++++++.+..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            345678999999999999999999885 589999999976533 2334456778999999996  599999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..++|||+ .+++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus       102 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          102 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            99999994 5679999999988899999999999999999999999999999999999995 589999999999866443


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecC-----------CCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHH
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQR  266 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~  266 (366)
                      ...        .......|++.|+|||.+.+           ..++.++||||||+++|+|++|..||.... .......
T Consensus       180 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (313)
T 3cek_A          180 TTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  251 (313)
T ss_dssp             ------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccc--------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence            211        11224468999999999875           467889999999999999999999997653 3334444


Q ss_pred             HhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          267 IIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       267 i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +...  ...++...+.++.+||.+||+.||++|||+     +++++||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~  299 (313)
T 3cek_A          252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQIQ  299 (313)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHCC
T ss_pred             HHhcccccCCcccchHHHHHHHHHHccCCcccCcCH-----HHHhcCccccCC
Confidence            4443  345677789999999999999999999999     999999999754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-47  Score=341.14  Aligned_cols=255  Identities=20%  Similarity=0.303  Sum_probs=217.3

Q ss_pred             CCcCCeeeee-eeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGK-IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .......+.+|+.+++.++||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            4567888887 9999999999999864  568889999997642  334456678899999999999999999999 455


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            799999999999999999754 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      .....       .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+... ...+|
T Consensus       163 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~  235 (287)
T 1u59_A          163 DDSYY-------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  235 (287)
T ss_dssp             CSCEE-------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC
T ss_pred             Cccee-------eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC
Confidence            32111       11123346788999999988889999999999999999998 99999988877777776654 35677


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..+++++.++|.+||+.||++||++     .+++.+
T Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~~  266 (287)
T 1u59_A          236 PECPPELYALMSDCWIYKWEDRPDF-----LTVEQR  266 (287)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             CCcCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            8899999999999999999999999     777765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-46  Score=341.82  Aligned_cols=260  Identities=20%  Similarity=0.308  Sum_probs=212.1

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  112 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  112 (366)
                      .....+..++|++++.||+|+||.||+|+    +..+|+.||+|++....  .......+.+|+.+++.++||||+++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            45556778889999999999999999999    56789999999997653  2334456788999999999999999999


Q ss_pred             EEeeC--CeEEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          113 TFQDT--FSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       113 ~~~~~--~~~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      ++.+.  ..+++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence            99876  679999999999999999954 467999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCC-----------
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----------  258 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----------  258 (366)
                      |++..........       .......||..|+|||.+.+..++.++||||||+++|+|++|..|+...           
T Consensus       171 g~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  243 (302)
T 4e5w_A          171 GLTKAIETDKEYY-------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT  243 (302)
T ss_dssp             TTCEECCTTCCEE-------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred             cccccccCCCcce-------eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence            9998765442111       1122345788899999998888899999999999999999999876422           


Q ss_pred             ---CHH-HHHHHHh-cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          259 ---SEW-LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       259 ---~~~-~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                         ... .....+. ......+..+++++.+||.+||+.||.+|||+     .++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  295 (302)
T 4e5w_A          244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF-----QNLIE  295 (302)
T ss_dssp             CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHH
T ss_pred             ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH-----HHHHH
Confidence               111 1222222 23455677899999999999999999999998     66653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.1e-47  Score=347.59  Aligned_cols=256  Identities=24%  Similarity=0.382  Sum_probs=214.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  114 (366)
                      .+..++|++++.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            35678999999999999999999985     4577899999997652  233445677899999999 799999999998


Q ss_pred             eeCC-eEEEEEeecCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 017775          115 QDTF-SLYMALESCEGGELFDQITSKGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (366)
Q Consensus       115 ~~~~-~~~iv~e~~~g~~L~~~l~~~~~----------------l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIl  177 (366)
                      .+.+ .+++||||+++++|.+++...+.                +++..++.++.||+.||.|||++||+||||||+||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            8754 59999999999999999987644                899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCC
Q 017775          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (366)
Q Consensus       178 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  256 (366)
                      ++.++.+||+|||++.........        .......|++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTS--------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ECCCCCEEECCCccccccccCccc--------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999865433211        11224467889999999998889999999999999999998 999998


Q ss_pred             CCCHH-HHHHHHhc-CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          257 DTSEW-LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       257 ~~~~~-~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      +.... .....+.. .....+..+++++.++|.+||+.||.+|||+     .+++.|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  304 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  304 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            76533 33333333 3455677899999999999999999999998     777765

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-47  Score=347.68  Aligned_cols=256  Identities=19%  Similarity=0.295  Sum_probs=209.5

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ...+..++|++++.||+|+||.||+|.+..+|+.+    |+|.+....  .......+.+|+.+++.++||||+++++++
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (327)
T 3lzb_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred             hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            33466889999999999999999999999888876    555554321  233455677899999999999999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          115 QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .+.. .++++||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            8765 78899999999999999874 569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-D  271 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~  271 (366)
                      ........        .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+... .
T Consensus       166 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  237 (327)
T 3lzb_A          166 LLGAEEKE--------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  237 (327)
T ss_dssp             ----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EccCcccc--------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            76443211        11123346778999999999999999999999999999999 99999988877766666544 3


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ...+..++.++.+||.+||+.||.+|||+     .+++.
T Consensus       238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  271 (327)
T 3lzb_A          238 LPQPPICTIDVYMIMRKCWMIDADSRPKF-----RELII  271 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            55677899999999999999999999999     56654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=352.10  Aligned_cols=255  Identities=17%  Similarity=0.182  Sum_probs=199.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchh--------hHHHHHHHHHHHHhCCCCCccee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKEN--------KTAYVKLERIVLDQLDHPGVVRL  110 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~  110 (366)
                      +..++|++++.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            446789999999999999999999987   8889999998765321111        11224467788899999999999


Q ss_pred             EEEEee----CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC--CE
Q 017775          111 FFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--HI  184 (366)
Q Consensus       111 ~~~~~~----~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~--~v  184 (366)
                      ++++.+    ....|+||||+ |++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    77899999999 889999998877899999999999999999999999999999999999999887  99


Q ss_pred             EEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC--CCHHH
Q 017775          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD--TSEWL  262 (366)
Q Consensus       185 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~  262 (366)
                      ||+|||+++.+.......   ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+  .+...
T Consensus       193 kL~Dfg~a~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHK---QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             EECCCTTCEESSGGGCCC---CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             EEEeCCCceecccccccc---cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            999999998765432111   0111222455799999999999998999999999999999999999999965  23322


Q ss_pred             HHHHHhcCCCCCC---------CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          263 IFQRIIARDIRFP---------NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       263 ~~~~i~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ............|         ..+++++.++|.+||+.||++|||+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  316 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY  316 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH
Confidence            2221111111122         2789999999999999999999999

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.9e-47  Score=341.15  Aligned_cols=263  Identities=20%  Similarity=0.332  Sum_probs=198.9

Q ss_pred             CccccccCCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce
Q 017775           30 SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR  109 (366)
Q Consensus        30 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~  109 (366)
                      ........+...+..++|++.+.||+|+||.||+|.+.   ..||+|+++.... .......+.+|+.+++.++||||++
T Consensus         9 ~~~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~   84 (289)
T 3og7_A            9 HHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILL   84 (289)
T ss_dssp             ---------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEE
Confidence            33333444555677889999999999999999999764   3599999976533 3344566788999999999999999


Q ss_pred             eEEEEeeCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEe
Q 017775          110 LFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (366)
Q Consensus       110 ~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~D  188 (366)
                      ++++. .....++||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus        85 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           85 FMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             EEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             EEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcc
Confidence            99954 556789999999999999999654 5699999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCccccccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH-H
Q 017775          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI-F  264 (366)
Q Consensus       189 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~  264 (366)
                      ||++........        ........||+.|+|||.+.   +..++.++||||||+++|+|++|..||.+...... .
T Consensus       164 fg~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  235 (289)
T 3og7_A          164 FGLATEKSRWSG--------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII  235 (289)
T ss_dssp             CC--------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH
T ss_pred             ceeccccccccc--------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            999975543211        11223456899999999986   56678899999999999999999999987554443 3


Q ss_pred             HHHhcCCC-----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          265 QRIIARDI-----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       265 ~~i~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+.....     ..+..+++++.+||.+||+.||.+|||+     .+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~  281 (289)
T 3og7_A          236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF-----PRILA  281 (289)
T ss_dssp             HHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCH-----HHHHH
Confidence            33333322     1234689999999999999999999998     66654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-46  Score=359.98  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=212.9

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      -.+..++|++.+.||+|+||.||+|.+. ++..||+|+++...    .....+.+|+.+++.++||||+++++++. ...
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            3566789999999999999999999985 46789999997642    23456778999999999999999999986 567


Q ss_pred             EEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          120 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            89999999999999999754  3689999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      .....         .....++..|+|||.+....++.++||||||+++|+|++ |..||.+.+..+....+..+ ....|
T Consensus       337 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~  407 (454)
T 1qcf_A          337 NEYTA---------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP  407 (454)
T ss_dssp             HHHHT---------TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC
T ss_pred             Cceec---------cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            32111         112245778999999988889999999999999999999 99999998888877776654 45567


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..+++++.+||.+||+.||++|||+
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~  432 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTF  432 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCH
Confidence            7899999999999999999999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-46  Score=359.04  Aligned_cols=240  Identities=24%  Similarity=0.407  Sum_probs=209.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-e
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-S  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~  119 (366)
                      .+..++|++.+.||+|+||.||+|.+.  |+.||+|+++...     ....+.+|+.+++.++||||+++++++.+.. .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            467889999999999999999999884  7799999997642     2345778999999999999999999987655 7


Q ss_pred             EEEEEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          120 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      +|+||||+++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987643  79999999999999999999999999999999999999999999999999985432


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      .             .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+ ....|
T Consensus       342 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p  408 (450)
T 1k9a_A          342 T-------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  408 (450)
T ss_dssp             ------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             c-------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            1             112256788999999999899999999999999999998 99999987777776666554 45677


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..+++++.+||.+||+.||.+|||+
T Consensus       409 ~~~~~~l~~li~~cl~~dp~~Rpt~  433 (450)
T 1k9a_A          409 DGCPPAVYDVMKNCWHLDAATRPTF  433 (450)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCH
Confidence            8899999999999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-46  Score=344.20  Aligned_cols=259  Identities=20%  Similarity=0.339  Sum_probs=208.3

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .-.+..++|.+++.||+|+||.||+|.+..   ++..||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            334567899999999999999999998765   5568999998765332 333456778999999999999999999998


Q ss_pred             eCC-----eEEEEEeecCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCE
Q 017775          116 DTF-----SLYMALESCEGGELFDQITS------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI  184 (366)
Q Consensus       116 ~~~-----~~~iv~e~~~g~~L~~~l~~------~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~v  184 (366)
                      +..     ..++||||+.+++|.+++..      .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence            754     35999999999999999843      3569999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHH
Q 017775          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLI  263 (366)
Q Consensus       185 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  263 (366)
                      ||+|||++.........        .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+......
T Consensus       187 kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             EECSCSCC------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEeecCcceeccccccc--------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            99999999866443211        11123356788999999999899999999999999999999 9999998887777


Q ss_pred             HHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          264 FQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       264 ~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ...+... ....+..+++++.++|.+||+.||.+|||+     .+++.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~~  302 (313)
T 3brb_A          259 YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF-----SVLRLQ  302 (313)
T ss_dssp             HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            7766655 455677899999999999999999999998     677653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.8e-47  Score=347.82  Aligned_cols=265  Identities=19%  Similarity=0.279  Sum_probs=215.7

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEE
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  112 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  112 (366)
                      .....+..++|++++.||+|+||.||+|+    +..+++.||+|++...   .......+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~   91 (327)
T 3lxl_A           15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRG   91 (327)
T ss_dssp             --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence            34556788999999999999999999999    5678999999998764   3444556788999999999999999999


Q ss_pred             EEe--eCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          113 TFQ--DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       113 ~~~--~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                      ++.  +...+++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A           92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred             EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence            886  566799999999999999999874 56999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH--------
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--------  261 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------  261 (366)
                      |++..........       .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......        
T Consensus       172 g~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  244 (327)
T 3lxl_A          172 GLAKLLPLDKDYY-------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE  244 (327)
T ss_dssp             GGCEECCTTCSEE-------ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred             ccceecccCCccc-------eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence            9998765432111       1112345788899999998888899999999999999999999998654332        


Q ss_pred             -------HHHHHHh-cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhh---cCCCCCC
Q 017775          262 -------LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK---MHPFFKG  316 (366)
Q Consensus       262 -------~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l---~hp~f~~  316 (366)
                             .....+. ......+..+++++.+||.+||+.||++|||+     .+++   ...|...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~L~~~~~~~  305 (327)
T 3lxl_A          245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF-----SALGPQLDMLWSGS  305 (327)
T ss_dssp             --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHC----
T ss_pred             cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH-----HHHHHHHHHHHhhh
Confidence                   1122222 22345677899999999999999999999999     5664   4455443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-46  Score=338.42  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=213.0

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      .-.+..++|++.+.||+|+||.||+|.+..   ++..||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            345678899999999999999999998754   34469999987652  3334566788999999999999999999987


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      +. ..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 568999999999999999765 4599999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  272 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~  272 (366)
                      .......         ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ..
T Consensus       163 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~  233 (281)
T 3cc6_A          163 IEDEDYY---------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL  233 (281)
T ss_dssp             C------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC
T ss_pred             ccccccc---------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC
Confidence            6443211         1123346778999999988889999999999999999998 99999877666665555443 45


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..+..+++.+.++|.+||+.||++|||+     .+++.+
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~~  267 (281)
T 3cc6_A          234 PKPDLCPPVLYTLMTRCWDYDPSDRPRF-----TELVCS  267 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCCchhCcCH-----HHHHHH
Confidence            5677899999999999999999999998     677653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-46  Score=347.19  Aligned_cols=255  Identities=21%  Similarity=0.383  Sum_probs=214.8

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  114 (366)
                      .+..++|++.+.||+|+||.||+|.+..++.     .||+|.+....  .......+.+|+.+++.+ +||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4567899999999999999999999987665     79999987642  233455678899999999 899999999999


Q ss_pred             eeCCeEEEEEeecCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC
Q 017775          115 QDTFSLYMALESCEGGELFDQITSK--------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (366)
Q Consensus       115 ~~~~~~~iv~e~~~g~~L~~~l~~~--------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~  180 (366)
                      .+.+.+++||||+++++|.+++...              ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            9999999999999999999998753              35799999999999999999999999999999999999999


Q ss_pred             CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCC
Q 017775          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (366)
Q Consensus       181 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  259 (366)
                      ++.+||+|||++.........        .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNY--------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTS--------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCeEEECccccccccccccce--------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            999999999999865433211        11123456788999999988889999999999999999998 999998765


Q ss_pred             HHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          260 EWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       260 ~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .......+...  ....|...++++.+||.+||+.||.+|||+     .+++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  319 (333)
T 2i1m_A          272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF-----QQICS  319 (333)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             hhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCH-----HHHHH
Confidence            54444443332  334567789999999999999999999998     67765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.9e-47  Score=347.55  Aligned_cols=255  Identities=21%  Similarity=0.285  Sum_probs=203.3

Q ss_pred             cCCCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 017775           36 RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (366)
Q Consensus        36 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  115 (366)
                      ..+--.+..++|++++.||+|+||.||+|++.  |+.||+|++...    .........|+.+++.++||||+++++++.
T Consensus        15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             CCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            34444577889999999999999999999885  789999998653    222334455888899999999999999998


Q ss_pred             eCC----eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCeEeCCC
Q 017775          116 DTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM----------GLIHRDIKPENLLLTAD  181 (366)
Q Consensus       116 ~~~----~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~----------~i~H~dlkp~NIli~~~  181 (366)
                      +..    .+++||||+++|+|.+++... .+++..++.++.|++.||.|||+.          ||+||||||+||+++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence            744    479999999999999999775 599999999999999999999999          99999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC-----CCCCCCCcccchhhhhhhhcCCCCCC
Q 017775          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGTSPFK  256 (366)
Q Consensus       182 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~  256 (366)
                      +.+||+|||+++.......        ........||+.|+|||++.+.     .++.++|||||||++|+|++|..||.
T Consensus       168 ~~~kL~DFg~a~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~  239 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKS--------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD  239 (322)
T ss_dssp             CCEEECCCTTCEEECTTSC--------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred             CeEEEccCCcccccccccC--------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence            9999999999986654321        1122345789999999998763     35567899999999999999999997


Q ss_pred             CCC----------------HHHHHHHHhcCCCC--CCC-----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          257 DTS----------------EWLIFQRIIARDIR--FPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       257 ~~~----------------~~~~~~~i~~~~~~--~~~-----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +..                .......+......  .+.     ..++++.+||.+||+.||++|||+     .+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~  311 (322)
T 3soc_A          240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA-----GCVGE  311 (322)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            532                22233333222211  111     124569999999999999999999     66654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.1e-46  Score=337.68  Aligned_cols=265  Identities=21%  Similarity=0.300  Sum_probs=208.2

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE-EeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT-FQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~i  122 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++......     ..+.+|..+++.++|++++..+.. +.+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            47899999999999999999999999999999987654322     235668999999988777666554 467888999


Q ss_pred             EEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---CCCCCEEEEecCCccccCCc
Q 017775          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli---~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8899999985 3579999999999999999999999999999999999999   78899999999999876554


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH---HHHHHHhcCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRIIARDIRFP  275 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~  275 (366)
                      .....   ..........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..   .....+.......+
T Consensus       162 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          162 RTHQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTCCB---CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccCcc---CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            32110   0012233567899999999999999999999999999999999999999764321   22222222222222


Q ss_pred             -----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc----------CCCCCCCCcccc
Q 017775          276 -----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM----------HPFFKGIDWKNI  322 (366)
Q Consensus       276 -----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~----------hp~f~~~~~~~~  322 (366)
                           ..+++++.+||.+||+.||++|||+     +++++          ..|-..++|+.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDY-----SYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCH-----HHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCH-----HHHHHHHHHHHHHhCCCccCccchhhc
Confidence                 6689999999999999999999998     44443          455556666654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-47  Score=361.24  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=202.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  120 (366)
                      +...+|++.+.||+|+||+|+. ....+|+.||||++.......      ..+|+.+++.+ +||||+++++++.+....
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~------~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEE------CHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHH------HHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            4456799999999999999764 445689999999986643221      34688999998 799999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-----CCEEEEecCCccc
Q 017775          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----GHIKIADFGSVKP  194 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-----~~vkL~Dfg~a~~  194 (366)
                      |+||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+     ..+||+|||+++.
T Consensus        94 ~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            999999975 9999998763 46666788999999999999999999999999999999532     3688999999987


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeec---CCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  270 (366)
                      .......       ........||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........+...
T Consensus       173 ~~~~~~~-------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~  245 (432)
T 3p23_A          173 LAVGRHS-------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC  245 (432)
T ss_dssp             C-------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC
T ss_pred             ccCCCcc-------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC
Confidence            6543211       11223457999999999987   3557789999999999999999 99999766554433322222


Q ss_pred             CCC---CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          271 DIR---FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       271 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ...   .+...+..+.+||.+||+.||.+|||+     +++++||||..++|
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~evl~hp~f~~~~~  292 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA-----KHVLKHPFFWSLEK  292 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHTSTTTCCHHH
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCCH-----HHHHhCccccChHH
Confidence            221   123346678999999999999999999     99999999998877

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-46  Score=364.81  Aligned_cols=252  Identities=21%  Similarity=0.346  Sum_probs=218.6

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+...+|++.+.||+|+||.||+|.++.++..||+|+++...    .....+.+|+.+++.++||||+++++++.+...+
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            456779999999999999999999999999999999987642    2245577899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999999864  45899999999999999999999999999999999999999999999999999876443


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....         .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+... ....|.
T Consensus       372 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  442 (495)
T 1opk_A          372 TYTA---------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  442 (495)
T ss_dssp             CEEC---------CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             ceee---------cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            2111         112345678999999988889999999999999999999 99999988877666665543 455678


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+++++.+||.+||+.||++|||+     .+++.
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~-----~el~~  471 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSF-----AEIHQ  471 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCH-----HHHHH
Confidence            899999999999999999999999     56653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.6e-46  Score=335.58  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=213.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.+++.++||||+++++++.+ +..+
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            44679999999999999999999975 567899999876422    23457789999999999999999999874 4689


Q ss_pred             EEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999999987543  69999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ...         .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+... ....+..
T Consensus       164 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T 1qpc_A          164 YTA---------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN  234 (279)
T ss_dssp             EEC---------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccc---------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccc
Confidence            211         113346778999999988888999999999999999999 99999998888877776654 3456678


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +++++.+++.+||+.||++|||+     .+++.
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  262 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTF-----DYLRS  262 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             ccHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            99999999999999999999998     55553

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-47  Score=351.26  Aligned_cols=252  Identities=20%  Similarity=0.259  Sum_probs=206.9

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            468999999999999999999986 46899999988664   23345567889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          123 ALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ||||+++++|.+++....    .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999886543    4899999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH------H-HHHhcCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI------F-QRIIARD  271 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~-~~i~~~~  271 (366)
                      ..        ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+......      . .......
T Consensus       193 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          193 DQ--------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             SC--------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cc--------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            11        1122344689999999999888899999999999999999999999976433211      0 1111111


Q ss_pred             ------C----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          272 ------I----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       272 ------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                            .    ..+...+.++.+++.+||+.||++|||+     .+++.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  309 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-----GDVLWK  309 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence                  0    1122345679999999999999999999     777765

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.3e-47  Score=342.32  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=208.8

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKID-TGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      ..+..++|++++.||+|+||.||+|.+.. ++.  .||+|+++............+.+|+.+++.++||||+++++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34667899999999999999999998643 333  689999877654455556678889999999999999999999987


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                      .. .++||||+.+++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 88999999999999999764 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC--C
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD--I  272 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~--~  272 (366)
                      .......       .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+....  .
T Consensus       172 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDHY-------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             CC-CCEE-------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             cccccch-------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            5432111       11123356778999999988888999999999999999999 999999999888887776553  3


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       273 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+..+++++.++|.+||+.||.+|||+     .+++.
T Consensus       245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  277 (291)
T 1u46_A          245 PRPEDCPQDIYNVMVQCWAHKPEDRPTF-----VALRD  277 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcCcCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            4556799999999999999999999999     67775

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.5e-47  Score=352.78  Aligned_cols=278  Identities=17%  Similarity=0.162  Sum_probs=207.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccchhhH--------HHHHHHHHHHHhCCCCCcc
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKT--------AYVKLERIVLDQLDHPGVV  108 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv  108 (366)
                      ...++|++++.||+|+||.||+|.+..+     ++.||+|++...........        .....|...++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456999999999999999999998764     58899999876431111101        1122355567778899999


Q ss_pred             eeEEEEeeC----CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC--CC
Q 017775          109 RLFFTFQDT----FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--AD  181 (366)
Q Consensus       109 ~~~~~~~~~----~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~--~~  181 (366)
                      ++++++.+.    ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5589999999 88999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH
Q 017775          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW  261 (366)
Q Consensus       182 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  261 (366)
                      +.+||+|||+++.+........   ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            9999999999987754432111   1112223556999999999999999999999999999999999999999853221


Q ss_pred             HHHHHHhc----CC-------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCC--ChH---hhhcCCCCCCCCccccc
Q 017775          262 LIFQRIIA----RD-------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG--GYA---VLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       262 ~~~~~i~~----~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~--~~~---~~l~hp~f~~~~~~~~~  323 (366)
                      ........    ..       ...+..+++++.+++..||+.||.+||++.+.  .++   +-+..++-..++|....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~  345 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE  345 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence            11111000    00       00125679999999999999999999998431  001   11134666777887654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-46  Score=337.45  Aligned_cols=245  Identities=23%  Similarity=0.401  Sum_probs=206.0

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-Ce
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-FS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~  119 (366)
                      .+..++|++.+.||+|+||.||+|.+  +|+.||+|++....     ....+.+|+.+++.++||||+++++++.+. +.
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            46788999999999999999999988  48899999986542     344577899999999999999999987554 57


Q ss_pred             EEEEEeecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          120 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .++||||+++++|.+++.+.+.  +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999987543  89999999999999999999999999999999999999999999999999875433


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      ..             ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... ....+
T Consensus       170 ~~-------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (278)
T 1byg_A          170 TQ-------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  236 (278)
T ss_dssp             -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred             cc-------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence            21             12356788999999988889999999999999999998 99999988777776666554 45567


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+++++.++|.+||+.||++|||+     .+++.
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  266 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSF-----LQLRE  266 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCH-----HHHHH
Confidence            7899999999999999999999998     55553

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.5e-46  Score=335.75  Aligned_cols=249  Identities=20%  Similarity=0.283  Sum_probs=203.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-eeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF-QDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~i  122 (366)
                      .++|++++.||+|+||.||+|++..+|+.||+|++......     ..+.+|+.+++.++|++++..+..+ .+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            57899999999999999999999999999999998764322     2367799999999988766655544 67788999


Q ss_pred             EEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC---CCCCEEEEecCCccccCCc
Q 017775          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~---~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ||||+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899999974 45799999999999999999999999999999999999994   7889999999999876554


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCH---HHHHHHHhcCCCCC-
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRF-  274 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~-  274 (366)
                      .....   ..........||+.|+|||.+.+..++.++||||||+++|+|++|..||.+...   ......+....... 
T Consensus       162 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          162 RTHQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTCCB---CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccc---cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            32110   001123456799999999999999999999999999999999999999976332   22233333222222 


Q ss_pred             ----CCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          275 ----PNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       275 ----~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                          +..+++++.+||.+||+.||++|||+.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  269 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence                367899999999999999999999983

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=335.32  Aligned_cols=254  Identities=21%  Similarity=0.341  Sum_probs=211.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .-.|.+.+.||+|+||.||+|.+..++.   .||+|++...  ........+.+|+.+++.++||||+++++++.+.+..
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            3357788999999999999999765554   7999998653  2334455677899999999999999999999876665


Q ss_pred             -EEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 -YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 -~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                       +++|||+.+++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             9999999999999999874 56899999999999999999999999999999999999999999999999999866543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....      ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+.......+... ....+.
T Consensus       178 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 3pls_A          178 EYYS------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE  251 (298)
T ss_dssp             GGGC------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT
T ss_pred             cccc------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc
Confidence            2211      112234467889999999999999999999999999999999 56667766666666555544 355677


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+++++.+|+.+||+.||.+|||+     ++++.
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~  280 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTF-----RVLVG  280 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            899999999999999999999998     66654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-46  Score=337.37  Aligned_cols=244  Identities=27%  Similarity=0.411  Sum_probs=209.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------  116 (366)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....       ..+.+|+.+++.++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            468999999999999999999999999999999987642       124569999999999999999998864       


Q ss_pred             ---------CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEE
Q 017775          117 ---------TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (366)
Q Consensus       117 ---------~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vk  185 (366)
                               ...+++||||+++++|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45589999999999999999764  5799999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH
Q 017775          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (366)
Q Consensus       186 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  265 (366)
                      |+|||++.......           ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...  .....
T Consensus       163 l~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~  229 (284)
T 2a19_B          163 IGDFGLVTSLKNDG-----------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT  229 (284)
T ss_dssp             ECCCTTCEESSCCS-----------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred             ECcchhheeccccc-----------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence            99999998664432           122346899999999999888999999999999999999999887532  22333


Q ss_pred             HHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       266 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      .+...  .++..++.++.+||.+||+.||.+|||+     .++++|.+.
T Consensus       230 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~l~~  271 (284)
T 2a19_B          230 DLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNT-----SEILRTLTV  271 (284)
T ss_dssp             HHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHH
T ss_pred             Hhhcc--cccccCCHHHHHHHHHHccCChhhCcCH-----HHHHHHHHH
Confidence            33332  3567789999999999999999999999     889988654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6e-46  Score=337.28  Aligned_cols=255  Identities=20%  Similarity=0.332  Sum_probs=209.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE-eeCC
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF-QDTF  118 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~  118 (366)
                      ...+|++.+.||+|+||.||+|.+..++   ..+|+|.+...  ........+.+|+.+++.++||||+++++++ .+++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            3567999999999999999999975433   35899988653  2334455677899999999999999999985 4566


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            789999999999999999764 4689999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~  275 (366)
                      .....      ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+.......+.... ...|
T Consensus       181 ~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3f66_A          181 KEYYS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP  254 (298)
T ss_dssp             GGGCB------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             cchhc------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            43211      112224457888999999998889999999999999999999 777887777666666655544 3456


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+++++.+++.+||+.||++|||+     .++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSF-----SELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            7789999999999999999999998     66654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-47  Score=356.84  Aligned_cols=246  Identities=24%  Similarity=0.436  Sum_probs=203.5

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC--eE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SL  120 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~  120 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+..  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            46789999999999999999999999999999999976432  223445667999999999999999999998755  78


Q ss_pred             EEEEeecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe----CCCCCEEEEecCCcc
Q 017775          121 YMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSVK  193 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli----~~~~~vkL~Dfg~a~  193 (366)
                      ++||||++|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999997653   39999999999999999999999999999999999999    777889999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecC--------CCCCCCCCcccchhhhhhhhcCCCCCCC----CCHH
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--------SPATFGNDLWALGCTLYQMLSGTSPFKD----TSEW  261 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~----~~~~  261 (366)
                      ......           ......||+.|+|||++.+        ..++.++|||||||++|+|++|..||..    ....
T Consensus       165 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          165 ELEDDE-----------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             ECCCGG-----------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             EccCCC-----------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            765432           1224568999999999864        4567889999999999999999999963    2233


Q ss_pred             HHHHHHhcCCCC-------------------------CCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          262 LIFQRIIARDIR-------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       262 ~~~~~i~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      +....+..+...                         ++..++..+.++|++||+.||++||++.
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence            444444443221                         1123456789999999999999999993

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=343.67  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=190.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEe----
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ----  115 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----  115 (366)
                      .+...+|++.+.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.+++.+. ||||+++++++.    
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            34456899999999999999999999999999999998554   3344556778999999995 999999999983    


Q ss_pred             ----eCCeEEEEEeecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeCCCCCEEE
Q 017775          116 ----DTFSLYMALESCEGGELFDQITS---KGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKI  186 (366)
Q Consensus       116 ----~~~~~~iv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~~~~~vkL  186 (366)
                          ....++++|||+. |+|.+++..   .+.+++.+++.++.||+.||.|||++|  |+||||||+||+++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                4455899999997 599888865   467999999999999999999999999  999999999999999999999


Q ss_pred             EecCCccccCCccccccCCC--CCCCCccccccCCCCCCceee---cCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH
Q 017775          187 ADFGSVKPMQDSRITVLPNA--ASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW  261 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  261 (366)
                      +|||++..............  ..........||+.|+|||++   .+..++.++||||||+++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99999987654322110000  001112245689999999998   5666888999999999999999999999876554


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          262 LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       262 ~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .......  ....+...+..+.+||.+||+.||.+|||+     .+++.|
T Consensus       260 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  302 (337)
T 3ll6_A          260 RIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSI-----AEVVHQ  302 (337)
T ss_dssp             ------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             HhhcCcc--cCCcccccchHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            4333221  223345678889999999999999999998     778876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.7e-46  Score=339.16  Aligned_cols=261  Identities=24%  Similarity=0.373  Sum_probs=205.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe----eC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~  117 (366)
                      +..++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            4567899999999999999999999999999999998653   3444566788999999999999999999987    34


Q ss_pred             CeEEEEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          118 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ...++||||+.+++|.+++..    .+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            478999999999999999876    4679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCC---CCCCCCcccchhhhhhhhcCCCCCCCCCH--HHHHHHHh
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRII  268 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~  268 (366)
                      ............ ..........|++.|+|||.+.+..   ++.++||||||+++|+|++|..||.....  ......+.
T Consensus       183 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          183 QACIHVEGSRQA-LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             ESCEEEESHHHH-HHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hccccccccccc-ccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            653221000000 0000011335789999999987654   68899999999999999999999953111  01111111


Q ss_pred             -cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          269 -ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       269 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                       ....+.+..+++++.+||.+||+.||.+|||+     ++++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  300 (317)
T 2buj_A          262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-----PLLLSQ  300 (317)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccCCCCccccCCHHHHHHHHHHhhcChhhCCCH-----HHHHHH
Confidence             12233445789999999999999999999999     778765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.2e-46  Score=341.07  Aligned_cols=258  Identities=21%  Similarity=0.289  Sum_probs=209.5

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEE----CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEE
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      +...+..+.|++++.||+|+||.||+|..    ..+|+.||+|++....  .......+.+|+.+++.++||||++++++
T Consensus        24 ~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (318)
T 3lxp_A           24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGC  101 (318)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence            33445555569999999999999988754    4578999999997652  33445667889999999999999999999


Q ss_pred             Eee--CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          114 FQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       114 ~~~--~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      +.+  ...+++||||+++++|.+++.+. .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence            987  46799999999999999999775 499999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH----------
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----------  261 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------  261 (366)
                      +..........       .......++..|+|||.+.+..++.++||||||+++|+|++|..||......          
T Consensus       181 a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          181 AKAVPEGHEYY-------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             CEECCTTCSEE-------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             ccccccccccc-------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence            98765432111       1122345778899999999888899999999999999999999999754321          


Q ss_pred             -----HHHHHHh-cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          262 -----LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       262 -----~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                           .....+. ......+..+++++.+||.+||+.||++|||+     .+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  303 (318)
T 3lxp_A          254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF-----ENLIP  303 (318)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence                 1111111 22445677899999999999999999999999     66663

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-45  Score=352.81  Aligned_cols=255  Identities=30%  Similarity=0.431  Sum_probs=196.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  120 (366)
                      ...+.|.+.+.||+|+||+||.+ ...+|+.||||++..+.      .....+|+.+++.+ +||||+++++++.+...+
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            34556777899999999999875 45679999999986532      23456789988876 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC------------
Q 017775          121 YMALESCEGGELFDQITSKGHL-------SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD------------  181 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l-------~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~------------  181 (366)
                      |+||||+.| +|.+++...+..       ++..++.++.||+.||.|||++||+||||||+|||++.+            
T Consensus        85 ~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           85 YIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            999999975 999999876432       233457899999999999999999999999999999754            


Q ss_pred             -CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-------CCCCCCCCcccchhhhhhhhc-CC
Q 017775          182 -GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GT  252 (366)
Q Consensus       182 -~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~  252 (366)
                       +.+||+|||++..........      ........||+.|+|||++.+       ..++.++|||||||++|+|++ |.
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSF------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             ceEEEEcccccceecCCCCccc------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence             489999999998765432110      011234579999999999865       568899999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHhcCCCCCC-------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          253 SPFKDTSEWLIFQRIIARDIRFP-------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       253 ~pf~~~~~~~~~~~i~~~~~~~~-------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .||.......  ..+.......+       ..+++++.+||.+||+.||.+|||+     .++++||||.+.
T Consensus       238 ~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~hp~f~~~  302 (434)
T 2rio_A          238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHPLFWPK  302 (434)
T ss_dssp             CTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSCH
T ss_pred             CCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH-----HHHHhCCccCCc
Confidence            9997654433  23333332222       1346889999999999999999999     899999999754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.4e-45  Score=352.60  Aligned_cols=273  Identities=19%  Similarity=0.285  Sum_probs=218.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEeeCCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~  120 (366)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.......     .+..|..+++.+.| +++..+..++.+....
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            34678999999999999999999999999999999887653222     25678999999976 5556666677788899


Q ss_pred             EEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe---CCCCCEEEEecCCccccC
Q 017775          121 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli---~~~~~vkL~Dfg~a~~~~  196 (366)
                      ++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8899999985 4579999999999999999999999999999999999999   578999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC---HHHHHHHHhcCCC-
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDI-  272 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~-  272 (366)
                      .......   ..........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+..   ....+..+..... 
T Consensus       158 ~~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          158 DTSTHQH---IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             CTTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             CCccccc---cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            4321110   00112235679999999999999999999999999999999999999997643   2333333332221 


Q ss_pred             ----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCC-----ChHhhhcCCCCCCCCccccc
Q 017775          273 ----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPG-----GYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       273 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~-----~~~~~l~hp~f~~~~~~~~~  323 (366)
                          .++..+++++.+||.+||+.||++||++.+.     .+.....++|+..++|+.+.
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~  294 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILK  294 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHT
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhc
Confidence                2335789999999999999999999998431     01122358999999998764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-45  Score=334.63  Aligned_cols=231  Identities=29%  Similarity=0.513  Sum_probs=192.2

Q ss_pred             CCcCCeeee-eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEee---
Q 017775           42 FSIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD---  116 (366)
Q Consensus        42 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~---  116 (366)
                      ...++|.+. +.||+|+||.||+|.++.+|+.||+|++...        ....+|+.++ +..+||||+++++++.+   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            346788888 7899999999999999999999999998542        2345677776 66799999999999987   


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CCCEEEEecC
Q 017775          117 -TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFG  190 (366)
Q Consensus       117 -~~~~~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~~vkL~Dfg  190 (366)
                       ...+++||||++|++|.+++...+  .+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998764  6999999999999999999999999999999999999998   7899999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHH----
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR----  266 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----  266 (366)
                      ++....                                +..++.++|||||||++|+|++|..||.+.........    
T Consensus       166 ~a~~~~--------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          166 FAKETT--------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             TCEECT--------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             cccccc--------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence            986432                                23366789999999999999999999987655443222    


Q ss_pred             HhcCCCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          267 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       267 i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      +......++    ..+++++.+||.+||+.||.+|||+     +++++||||++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~e~l~hp~~~~~  263 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQS  263 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHTG
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH-----HHHhcChhhccc
Confidence            122223333    4689999999999999999999999     999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.4e-46  Score=355.24  Aligned_cols=255  Identities=20%  Similarity=0.343  Sum_probs=212.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++.+.||+|+||.||+|.+.. +..||+|+++....    ....+.+|+.+++.++||||+++++++.+ ...
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            3567889999999999999999999865 46799999876432    23457789999999999999999999876 678


Q ss_pred             EEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ++||||+++|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999999753  46999999999999999999999999999999999999999999999999999866433


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ...         ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+ ..+.|.
T Consensus       334 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  404 (452)
T 1fmk_A          334 EYT---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  404 (452)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cee---------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211         1112346778999999988889999999999999999999 99999999888887777654 455678


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc--CCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK  315 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~--hp~f~  315 (366)
                      .+++++.+||.+||+.||++|||+     ++++.  ..++.
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~-----~~l~~~L~~~~~  440 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTF-----EYLQAFLEDYFT  440 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHTTTS
T ss_pred             CCCHHHHHHHHHHccCChhhCcCH-----HHHHHHHHHHhc
Confidence            899999999999999999999999     55654  24544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-45  Score=364.64  Aligned_cols=247  Identities=21%  Similarity=0.314  Sum_probs=207.9

Q ss_pred             CCeeee-eeeeecCceEEEEEEE--CCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           45 QDFELG-KIYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        45 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ..+.+. +.||+|+||.||+|.+  +.+++.||||+++.... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  445 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM  445 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence            334443 4899999999999954  56678999999976532 33345668889999999999999999999875 4588


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999876543211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                      .       .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..++
T Consensus       526 ~-------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  598 (635)
T 4fl3_A          526 Y-------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP  598 (635)
T ss_dssp             ----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             c-------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            1       11122346778999999999899999999999999999998 99999999988888777665 355778899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~  300 (366)
                      +++.+||.+||+.||++||++
T Consensus       599 ~~l~~li~~cl~~dP~~RPs~  619 (635)
T 4fl3_A          599 REMYDLMNLCWTYDVENRPGF  619 (635)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHHcCCCHhHCcCH
Confidence            999999999999999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-46  Score=349.07  Aligned_cols=254  Identities=19%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEe-eCCe
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFS  119 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~  119 (366)
                      ...|++.+.||+|+||.||+|.+..++   ..||+|.++..  ........+.+|+.+++.++||||+++++++. ..+.
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            346899999999999999999875433   46899988653  23344566788999999999999999999865 4567


Q ss_pred             EEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999865 45899999999999999999999999999999999999999999999999999866443


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....      ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+..+ ....|.
T Consensus       246 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~  319 (373)
T 3c1x_A          246 EFDS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  319 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT
T ss_pred             cccc------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            2111      111223456788999999998899999999999999999999 78889877665555555544 344567


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+++++.+++.+||+.||++|||+     .+++.
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~-----~ell~  348 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSF-----SELVS  348 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            899999999999999999999999     66664

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=343.49  Aligned_cols=245  Identities=16%  Similarity=0.212  Sum_probs=200.8

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCC--------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDT--------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR------  109 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~------  109 (366)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|++...        ..+.+|+.+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            47999999999999999999999874        889999998654        23667999999999999887      


Q ss_pred             ---------eEEEEee-CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 017775          110 ---------LFFTFQD-TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (366)
Q Consensus       110 ---------~~~~~~~-~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIl  177 (366)
                               +++++.. ....|+||||+ +++|.+++...  +.+++.+++.++.||+.||.|||++||+||||||+||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5677765 78899999999 88999999886  67999999999999999999999999999999999999


Q ss_pred             eCCCC--CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCC
Q 017775          178 LTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  255 (366)
Q Consensus       178 i~~~~--~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  255 (366)
                      ++.++  .+||+|||++..+........   ..........||+.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA---YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCC---CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EcCCCCceEEEecCcceeeccCCCcccc---ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99998  999999999987654422111   1112223457999999999999989999999999999999999999999


Q ss_pred             CCCC--HHHHHHHH---hcCCCCCC------CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          256 KDTS--EWLIFQRI---IARDIRFP------NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       256 ~~~~--~~~~~~~i---~~~~~~~~------~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ....  ........   ......++      ..+++++.+||.+||+.||++|||+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  324 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY  324 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence            8753  33332222   22222222      2579999999999999999999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=334.40  Aligned_cols=243  Identities=26%  Similarity=0.463  Sum_probs=200.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||+|.+...     .....+.+|+.+++.++||||+++++++.+  ..
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            456789999999999999999999884  788999998542     334567789999999999999999998874  47


Q ss_pred             EEEEeecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCeEeCCCCC-EEEEecCCcc
Q 017775          121 YMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHS---MGLIHRDIKPENLLLTADGH-IKIADFGSVK  193 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qil~aL~~LH~---~~i~H~dlkp~NIli~~~~~-vkL~Dfg~a~  193 (366)
                      ++||||++|++|.+++...+   .+++..+..++.|+++||.|||+   +||+||||||+||+++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            89999999999999998764   37899999999999999999999   89999999999999998886 7999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC--HHHHHHHHhc-C
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIA-R  270 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~-~  270 (366)
                      .....             .....||+.|+|||.+.+..++.++||||||+++|+|++|..||....  .......+.. .
T Consensus       155 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  221 (307)
T 2eva_A          155 DIQTH-------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT  221 (307)
T ss_dssp             -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred             ccccc-------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence            55322             113358999999999999899999999999999999999999997533  3333333333 3


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       271 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ....+..+++.+.+++.+||+.||++|||+     +++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  256 (307)
T 2eva_A          222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSM-----EEIVK  256 (307)
T ss_dssp             CCCCBTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcccccCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            445667899999999999999999999998     66665

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-45  Score=333.55  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceeEEEEee--
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQD--  116 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~--  116 (366)
                      ....++|++++.||+|+||.||+|.+  +|+.||+|++...      .......|.+++..  ++||||+++++++.+  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            34578999999999999999999988  6899999998543      22334446666655  799999999998654  


Q ss_pred             --CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCeEeCCCCCEEE
Q 017775          117 --TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH--------SMGLIHRDIKPENLLLTADGHIKI  186 (366)
Q Consensus       117 --~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH--------~~~i~H~dlkp~NIli~~~~~vkL  186 (366)
                        ...+++||||+++++|.+++.. +.+++..++.++.|++.||.|||        ++||+||||||+||+++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999955 46999999999999999999999        999999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCC------CCCCCCCcccchhhhhhhhcC---------
Q 017775          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSG---------  251 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g---------  251 (366)
                      +|||++...........      .......||+.|+|||++.+.      .++.++||||||+++|+|++|         
T Consensus       155 ~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLD------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             CCCTTCEEEETTTTEEE------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             eeCCCeeeccccccccc------ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            99999976544321110      112244789999999999876      344689999999999999999         


Q ss_pred             -CCCCCCCC----HHHHHHHHhcC---CCCCC-----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          252 -TSPFKDTS----EWLIFQRIIAR---DIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       252 -~~pf~~~~----~~~~~~~i~~~---~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                       ..||....    ...........   ....|     ...++++.+|+.+||+.||++|||+     .++++
T Consensus       229 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~i~~  295 (301)
T 3q4u_A          229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-----LRIKK  295 (301)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHH
T ss_pred             ccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-----HHHHH
Confidence             88885422    12222222221   22222     2245789999999999999999998     66664

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-45  Score=360.15  Aligned_cols=250  Identities=20%  Similarity=0.299  Sum_probs=208.2

Q ss_pred             CCcCCeeeee-eeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGK-IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..+++.+.+ .||+|+||.||+|.++  .++..||+|+++...  .......+.+|+.+++.++||||+++++++.+ +
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            3455667666 8999999999999875  456679999997652  23345567889999999999999999999976 5


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            699999999999999999754 4599999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      .....       .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+ ....|
T Consensus       489 ~~~~~-------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  561 (613)
T 2ozo_A          489 DDSYY-------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  561 (613)
T ss_dssp             --------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC
T ss_pred             CCcee-------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            32110       01112245678999999998889999999999999999998 99999998888877777655 35677


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAG  301 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~  301 (366)
                      ..+++++.+||.+||+.||++||++.
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~  587 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFL  587 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            88999999999999999999999983

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=337.85  Aligned_cols=257  Identities=20%  Similarity=0.311  Sum_probs=210.1

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEE----ECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEE
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  114 (366)
                      ...+..++|++++.||+|+||.||+|+    +..+|+.||+|++...   .......+.+|+.+++.++||||+++++++
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            345678899999999999999999998    4668999999998764   334455678899999999999999999998


Q ss_pred             eeCC--eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          115 QDTF--SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       115 ~~~~--~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      ....  .+++||||+++++|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            7644  689999999999999999876 4599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHH----------
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----------  261 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------  261 (366)
                      +...........       ......++..|+|||.+.+..++.++||||||+++|+|++|..||......          
T Consensus       192 ~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~  264 (326)
T 2w1i_A          192 TKVLPQDKEYYK-------VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ  264 (326)
T ss_dssp             CEECCSSCSEEE-------CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred             hhhccccccccc-------cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence            987654321110       111234677899999998888899999999999999999999998643111          


Q ss_pred             ------HHHHHHh-cCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          262 ------LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       262 ------~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                            .....+. ......+..+++++.+||.+||+.||++|||+     .+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~el~~  315 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-----RDLAL  315 (326)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence                  1111121 22355677899999999999999999999998     66653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.1e-46  Score=343.55  Aligned_cols=256  Identities=18%  Similarity=0.242  Sum_probs=205.6

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      ....++|++.+.||+|+||.||+|.+ .+|+.||+|++........  ...+.+|+.+++.++||||+++++++.+....
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            34578999999999999999999975 4689999999876532222  22477899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          121 YMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSM---GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qil~aL~~LH~~---~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ++||||+.+++|.+++....    .+++..++.++.|++.||.|||++   ||+||||||+||+++.++.+||+|||++.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999998653    499999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC--------HHHHHH
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--------EWLIFQ  265 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~  265 (366)
                      .......         .......||+.|+|||.+.+..++.++||||||+++|+|++|..||....        ......
T Consensus       183 ~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          183 LMDYKDT---------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCSSSS---------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             ccCcccc---------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            6643321         12224458999999999988889999999999999999999999995211        111111


Q ss_pred             HHhcC-C----------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCC
Q 017775          266 RIIAR-D----------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (366)
Q Consensus       266 ~i~~~-~----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~  313 (366)
                      ..... .          ..++...+.++.+++.+||+.||.+|||+     .++++|-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~L~  307 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-----SEVVRMLE  307 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-----HHHHHHHH
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-----HHHHHHhc
Confidence            11111 0          01122234779999999999999999999     77887643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=357.86  Aligned_cols=256  Identities=20%  Similarity=0.342  Sum_probs=217.4

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+..++|++.+.||+|+||.||+|.+.. +..||||+++....    ....+.+|+.+++.++|+||+++++++.+ ..+
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            4567889999999999999999999865 46799999976432    23457789999999999999999999876 678


Q ss_pred             EEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      |+||||+.+|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999999753  46999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  276 (366)
                      ....         .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+ ....+.
T Consensus       417 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          417 EYTA---------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  487 (535)
T ss_dssp             HHHT---------TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             ceec---------ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            2111         112345778999999988889999999999999999999 99999999888887777654 345677


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC--CCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH--PFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h--p~f~~  316 (366)
                      .+++++.+||.+||+.||++|||+     ++++..  .+|..
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~-----~~l~~~L~~~~~~  524 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTF-----EYLQAFLEDYFTS  524 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHTSSCC
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCH-----HHHHHHHHHHhhc
Confidence            899999999999999999999999     555542  45543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.8e-46  Score=366.88  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=208.7

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------  116 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++++..      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3589999999999999999999999999999999987642  33445567889999999999999999998765      


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCC---EEEEecC
Q 017775          117 TFSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFG  190 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~---vkL~Dfg  190 (366)
                      .+..++||||++|++|.+++...+   .+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999998754   5999999999999999999999999999999999999997765   9999999


Q ss_pred             CccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHH----
Q 017775          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR----  266 (366)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----  266 (366)
                      ++.......           ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.........    
T Consensus       170 ~a~~~~~~~-----------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~  238 (676)
T 3qa8_A          170 YAKELDQGE-----------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE  238 (676)
T ss_dssp             CCCBTTSCC-----------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred             ccccccccc-----------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence            998764432           22345789999999999999999999999999999999999999976543322100    


Q ss_pred             -----H-----hcCCCC----------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          267 -----I-----IARDIR----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       267 -----i-----~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                           +     ..+...          ++..+++.+.+||.+||+.||++|||+     .++++||||+.+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa-----~elL~hp~F~~l  304 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD-----PQNPNVGCFQAL  304 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC-----TTCCCCTTHHHH
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH-----HHHhcCHHHHHH
Confidence                 0     111111          122367889999999999999999999     789999999753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=341.61  Aligned_cols=241  Identities=16%  Similarity=0.205  Sum_probs=195.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEE-----EECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRA-----KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFT  113 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~  113 (366)
                      +..++|++.+.||+|+||.||+|     .+..+++.||+|++...      ....+..|..+++.++   |+||++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            45678999999999999999999     46778999999998653      1234566777777776   9999999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--------
Q 017775          114 FQDTFSLYMALESCEGGELFDQITS-----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--------  180 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--------  180 (366)
                      +...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||.|||++||+||||||+|||++.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999999974     456999999999999999999999999999999999999998        


Q ss_pred             ---CCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC
Q 017775          181 ---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD  257 (366)
Q Consensus       181 ---~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  257 (366)
                         ++.+||+|||+|+.+.....        ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPK--------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCT--------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccCCEEEeeCchhhhhhccCC--------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence               89999999999975532210        1122345799999999999999999999999999999999999999964


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       258 ~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ......   ....... ....++.+.+++.+||+.+|.+|++.
T Consensus       288 ~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          288 NEGGEC---KPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             EETTEE---EECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             CCCCce---eechhcc-ccCcHHHHHHHHHHHcCCCCCCcchH
Confidence            322100   0001111 11346789999999999999999766

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=334.36  Aligned_cols=250  Identities=25%  Similarity=0.329  Sum_probs=195.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceeEEEEeeC--
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQDT--  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~--  117 (366)
                      ...++|++++.||+|+||.||+|.+.  |+.||+|++...    .  ......|.+++..  ++||||+++++++.+.  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----E--EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG----G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc----c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34579999999999999999999884  899999998543    1  1223334555544  4899999999999887  


Q ss_pred             --CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCeEeCCCCCEEEE
Q 017775          118 --FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIA  187 (366)
Q Consensus       118 --~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~--------~i~H~dlkp~NIli~~~~~vkL~  187 (366)
                        ..+++||||+++++|.+++... .+++..++.++.|++.||.|||++        ||+||||||+||+++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              7899999999999999999765 699999999999999999999999        99999999999999999999999


Q ss_pred             ecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCC------CCcccchhhhhhhhcC----------
Q 017775          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG------NDLWALGCTLYQMLSG----------  251 (366)
Q Consensus       188 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~~ll~g----------  251 (366)
                      |||++..+.......      ........||+.|+|||++.+..+...      +|||||||++|+|++|          
T Consensus       185 Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          185 DLGLAVKFISDTNEV------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             CCTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             eCCCceeeccccccc------cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999997664432111      111224579999999999988776665      8999999999999999          


Q ss_pred             CCCCCCC-----CHHHHHHHHhcC--CCCCCC-----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          252 TSPFKDT-----SEWLIFQRIIAR--DIRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       252 ~~pf~~~-----~~~~~~~~i~~~--~~~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..||...     ........+...  ...+|.     .+++++.+||.+||+.||++|||+     .++++|
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  325 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-----LRVKKT  325 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-----HHHHHH
Confidence            7777542     122222222222  223332     456779999999999999999999     777764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=337.43  Aligned_cols=258  Identities=20%  Similarity=0.318  Sum_probs=208.6

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      ..-.+..++|++++.||+|+||.||+|.+..   .+|+|++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            3445678899999999999999999998854   49999987653222 2223355688899999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      ..+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++....
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999999998764 699999999999999999999999999999999999997 7899999999987653


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecC---------CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS---------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  267 (366)
                      .....     ..........|++.|+|||.+.+         ..++.++||||||+++|+|++|..||...........+
T Consensus       181 ~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          181 VLQAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            32111     11122234468899999999864         34788999999999999999999999998888877776


Q ss_pred             hcCCCCC--CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          268 IARDIRF--PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       268 ~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .......  +..++.++.++|.+||+.||++|||+     .+++.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~l~~  295 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTF-----TKLMD  295 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCH-----HHHHH
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            6554332  23588999999999999999999998     66665

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=337.33  Aligned_cols=265  Identities=20%  Similarity=0.318  Sum_probs=195.1

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-  116 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-  116 (366)
                      ....+..++|++++.||+|+||.||+|++  +|+.||+|++....    ........|+..+..++||||+++++.+.. 
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            34457899999999999999999999977  68999999986532    111112233334456899999999976542 


Q ss_pred             ----CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCeEeCCCCC
Q 017775          117 ----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------GLIHRDIKPENLLLTADGH  183 (366)
Q Consensus       117 ----~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~---------~i~H~dlkp~NIli~~~~~  183 (366)
                          ...+++||||+++|+|.+++...+ .++..++.++.||+.||.|||++         ||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence                336799999999999999997764 69999999999999999999999         9999999999999999999


Q ss_pred             EEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecC-------CCCCCCCCcccchhhhhhhhcCCCCCC
Q 017775          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLSGTSPFK  256 (366)
Q Consensus       184 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~  256 (366)
                      +||+|||++..+.........  ..........||+.|+|||++.+       ..++.++|||||||++|+|++|..||.
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPG--EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             EEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             EEEeeccceeecccccccCcc--ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            999999999876543221110  11122334579999999999977       345678999999999999999977653


Q ss_pred             CCCH-----------------HHHHHHHhc---CCCCCCCC------CCHHHHHHHHHhhcCCCCCCCCCCCCChHhh--
Q 017775          257 DTSE-----------------WLIFQRIIA---RDIRFPNY------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVL--  308 (366)
Q Consensus       257 ~~~~-----------------~~~~~~i~~---~~~~~~~~------~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~--  308 (366)
                      ....                 .........   ....+|..      .++++.+||.+||+.||++|||+     .++  
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~e~l~  311 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA-----QXAEE  311 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch-----HHHHH
Confidence            2111                 111111111   12333333      34589999999999999999999     666  


Q ss_pred             ----hcCCCCCC
Q 017775          309 ----KMHPFFKG  316 (366)
Q Consensus       309 ----l~hp~f~~  316 (366)
                          +.++|-++
T Consensus       312 ~L~~ll~~~~~~  323 (336)
T 3g2f_A          312 RMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHCCCC-
T ss_pred             HHHHHHHHHHhc
Confidence                44677553

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.3e-45  Score=333.06  Aligned_cols=250  Identities=23%  Similarity=0.282  Sum_probs=202.9

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..|..++.||+|+||.||+|.+  +++.||+|++..... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence            3466679999999999999986  688999999876432 2344556788899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITS---KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence            999999999999874   34699999999999999999999999999999999999999999999999999986543221


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHH----HHHHHhcCC-----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARD-----  271 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~-----  271 (366)
                      .        .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.......    ....+....     
T Consensus       189 ~--------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (307)
T 2nru_A          189 T--------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED  259 (307)
T ss_dssp             C--------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred             c--------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence            1        11223468999999999875 47889999999999999999999997644321    112211111     


Q ss_pred             ------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          272 ------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       272 ------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                            ...+...+..+.+++.+||+.||.+|||+     .++++
T Consensus       260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~l~~  299 (307)
T 2nru_A          260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-----KKVQQ  299 (307)
T ss_dssp             HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             hccccccccchHHHHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence                  11233456789999999999999999998     66664

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.2e-44  Score=358.46  Aligned_cols=252  Identities=25%  Similarity=0.432  Sum_probs=213.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..++|++++.||+|+||.||+|.+..+   +..||+|.+...  ........+.+|+.+++.++||||+++++++.+ +
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence            4567899999999999999999998654   457999987653  233444567889999999999999999999854 5


Q ss_pred             eEEEEEeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999999999999998654 699999999999999999999999999999999999999999999999999987644


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      ....         ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+... ....|
T Consensus       544 ~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~  614 (656)
T 2j0j_A          544 STYY---------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  614 (656)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred             Ccce---------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            3211         1123346778999999988889999999999999999997 99999999888887777654 45678


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      ..+++++.+||.+||+.||.+|||+     .+++.
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~-----~el~~  644 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRF-----TELKA  644 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            8899999999999999999999998     66654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.4e-46  Score=344.17  Aligned_cols=245  Identities=17%  Similarity=0.223  Sum_probs=195.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCC---------CCCc
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLD---------HPGV  107 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~i  107 (366)
                      +..++|++++.||+|+||.||+|++  +|+.||+|++......     .......+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            5578999999999999999999998  7899999999875432     2223356777888888875         7777


Q ss_pred             ceeEEEEe------------------------------eCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHH
Q 017775          108 VRLFFTFQ------------------------------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA  157 (366)
Q Consensus       108 v~~~~~~~------------------------------~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~a  157 (366)
                      +++.+++.                              +...+|+||||+++|++.+.+.+ +.+++.+++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            77766642                              26789999999999977776644 568999999999999999


Q ss_pred             HHHHH-HCCceeccCCCCCeEeCCCC--------------------CEEEEecCCccccCCccccccCCCCCCCCccccc
Q 017775          158 LEYIH-SMGLIHRDIKPENLLLTADG--------------------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFV  216 (366)
Q Consensus       158 L~~LH-~~~i~H~dlkp~NIli~~~~--------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~  216 (366)
                      |.||| ++||+||||||+|||++.++                    .+||+|||+|+.....               ...
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------------~~~  238 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------------IVV  238 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------------EEE
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------------cEE
Confidence            99999 99999999999999999887                    8999999999865432               347


Q ss_pred             cCCCCCCceeecCCCCCCCCCcccchhh-hhhhhcCCCCCCCCCH-HHHHHHHhcC---CCC----CCCCCCHHHHHHHH
Q 017775          217 GTAAYVPPEVLNSSPATFGNDLWALGCT-LYQMLSGTSPFKDTSE-WLIFQRIIAR---DIR----FPNYFSDAARDLID  287 (366)
Q Consensus       217 gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~~~i~~~---~~~----~~~~~s~~~~~li~  287 (366)
                      ||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+... ......+...   ...    .+..+++++++||+
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            999999999998776 889999998777 8889999999854321 1122233211   111    12347889999999


Q ss_pred             HhhcCCCCCCCCCCCCChHhhh-cCCCCC
Q 017775          288 RLLDVDPSGRPGAGPGGYAVLK-MHPFFK  315 (366)
Q Consensus       288 ~~L~~dP~~Rps~~~~~~~~~l-~hp~f~  315 (366)
                      +||+.|     |+     ++++ +||||+
T Consensus       318 ~~L~~d-----sa-----~e~l~~Hp~f~  336 (336)
T 2vuw_A          318 TMLNFS-----SA-----TDLLCQHSLFK  336 (336)
T ss_dssp             HGGGSS-----SH-----HHHHHHCGGGC
T ss_pred             HHhccC-----CH-----HHHHhcCCCcC
Confidence            999976     66     8999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-44  Score=325.59  Aligned_cols=227  Identities=18%  Similarity=0.168  Sum_probs=190.2

Q ss_pred             CCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        39 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      ...+..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|...++.++||||+++++++.+.+
T Consensus        25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            33355688999999999999999999999999999999998775555555667888999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..|+||||++|++|.+++.+.  ....++..++.|++.||.|||++||+||||||+||+++.+|.+||+++|.       
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-------  175 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------  175 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred             cEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------
Confidence            999999999999999998543  46678899999999999999999999999999999999999999985542       


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHH---HHhcCCC---
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RIIARDI---  272 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~---  272 (366)
                                             ++       .++.++|||||||++|+|++|+.||.+.+......   .......   
T Consensus       176 -----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T 3uqc_A          176 -----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP  225 (286)
T ss_dssp             -----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred             -----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence                                   22       26779999999999999999999998765432110   1111111   


Q ss_pred             -CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       273 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                       ..+..+++++.+||.+||+.||++| |+     .++++
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~-----~el~~  258 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SA-----STLLN  258 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CH-----HHHHH
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CH-----HHHHH
Confidence             1235689999999999999999999 88     56664

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-45  Score=346.46  Aligned_cols=251  Identities=18%  Similarity=0.242  Sum_probs=196.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcc----------e---
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVV----------R---  109 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv----------~---  109 (366)
                      ...|..++.||+|+||.||+|.+..+|+.||||++.............+.+|..+++.+.| .+..          .   
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            4568999999999999999999999999999999885433333345567889999988876 2211          1   


Q ss_pred             --------eEEEEee-----CCeEEEEEeecCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 017775          110 --------LFFTFQD-----TFSLYMALESCEGGELFDQITS-------KGHLSEDEARFYTAEVVDALEYIHSMGLIHR  169 (366)
Q Consensus       110 --------~~~~~~~-----~~~~~iv~e~~~g~~L~~~l~~-------~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~  169 (366)
                              +..++..     ...++++|+++. ++|.+++..       .+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    1111111     234678888775 599988851       2347888999999999999999999999999


Q ss_pred             cCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceee----------cCCCCCCCCCcc
Q 017775          170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL----------NSSPATFGNDLW  239 (366)
Q Consensus       170 dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diw  239 (366)
                      ||||+|||++.++.+||+|||+++.....             .....| +.|+|||++          .+..++.++|||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-------------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            99999999999999999999998865432             224467 899999998          555588899999


Q ss_pred             cchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       240 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ||||++|+|++|+.||...+.......+..    ....+++++.+||.+||+.||++||++     .++++||||+.+.
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~~l~~~~~~~~~  371 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHHHHH
Confidence            999999999999999987665443333332    224678999999999999999999999     8999999998654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-43  Score=328.59  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=200.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceeEEEEeeCC---
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQDTF---  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~---  118 (366)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++...      ....+.+|..+++.  ++||||+++++++.+..   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            57899999999999999999988  5899999998543      22345668888877  78999999999998876   


Q ss_pred             -eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCeEeCCCCCEEEEec
Q 017775          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH--------SMGLIHRDIKPENLLLTADGHIKIADF  189 (366)
Q Consensus       119 -~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH--------~~~i~H~dlkp~NIli~~~~~vkL~Df  189 (366)
                       .+++||||+++++|.+++.+. .+++.+++.++.|++.||.|||        ++||+||||||+||+++.++.+||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             799999999999999999764 6999999999999999999999        899999999999999999999999999


Q ss_pred             CCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC------CCCCCCcccchhhhhhhhcC----------CC
Q 017775          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSG----------TS  253 (366)
Q Consensus       190 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g----------~~  253 (366)
                      |++..........      ........||+.|+|||++.+..      ++.++||||||+++|+|++|          ..
T Consensus       192 g~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          192 GLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             TTCEEEETTTTEE------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             CCceecccccccc------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9997664432111      00123457899999999987753      23679999999999999999          78


Q ss_pred             CCCCC-----CHHHHHHHHhcCC--CCCCC-----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          254 PFKDT-----SEWLIFQRIIARD--IRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       254 pf~~~-----~~~~~~~~i~~~~--~~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ||...     ........+....  ..++.     ..++.+.+|+.+||+.||++|||+     ++++.|
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~i~~~  330 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKKT  330 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-----HHHHHH
Confidence            88654     2344444444332  22332     234679999999999999999999     777764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.2e-43  Score=352.39  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  119 (366)
                      ....++|++.+.||+|+||.||+|.+.. +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            3445899999999999999999999976 78999999886532  33444567789999999999999999999987665


Q ss_pred             -----EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          120 -----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       120 -----~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                           .|+||||++|++|.+++..  .+++.+++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||+++.
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999987765  69999999999999999999999999999999999999875 999999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  274 (366)
                      ....              ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....    +.  ....
T Consensus       231 ~~~~--------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----~~--~~~~  289 (681)
T 2pzi_A          231 INSF--------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----LP--EDDP  289 (681)
T ss_dssp             TTCC--------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----CC--TTCH
T ss_pred             cccC--------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----cc--cccc
Confidence            5432              2456899999999987654 789999999999999999999886521100    00  0000


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ....++.+.+||.+||+.||++||++     .+.+.|+|+.
T Consensus       290 ~~~~~~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~  325 (681)
T 2pzi_A          290 VLKTYDSYGRLLRRAIDPDPRQRFTT-----AEEMSAQLTG  325 (681)
T ss_dssp             HHHHCHHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHH
T ss_pred             ccccCHHHHHHHhhhccCChhhCCCH-----HHHHHHHHHH
Confidence            01246789999999999999999998     7778888764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.8e-36  Score=295.15  Aligned_cols=189  Identities=15%  Similarity=0.165  Sum_probs=138.3

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeeccccc-------chhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEE
Q 017775           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-------KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        52 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      ..+.|+.|.+..++....|+.|++|++.+....       .+.....+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            355677777777777778999999999865322       123345688899999999 699999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||++|++|.+++.+.+++++.   .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......    
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~----  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC----  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC----
Confidence            9999999999999999888875   478999999999999999999999999999999999999999998664331    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP  254 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  254 (366)
                            ....+.+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus       394 ------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 ------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence                  233467899999999999875 55689999999999999876544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.5e-29  Score=243.60  Aligned_cols=193  Identities=15%  Similarity=0.085  Sum_probs=143.5

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ...+.||+|+||.||+|.  ..+..+++|..........     .....+.+|+.++++++||||+++..++.+....|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            456799999999999994  4678899998755332221     123457889999999999999965555556677799


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  ++||+|||+++.........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999998865        5689999999999999999999999999999998  99999999999775432110


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecC--CCCCCCCCcccchhhhhhhhcCCCCC
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPF  255 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf  255 (366)
                      ...   ........||+.|+|||++.+  ..|+..+|+|+.++-..+-..++.+|
T Consensus       487 ~~~---~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          487 VDL---IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHH---HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cch---hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            000   001135679999999999976  55777889999888777776665554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=3.9e-27  Score=211.56  Aligned_cols=132  Identities=17%  Similarity=0.196  Sum_probs=106.8

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch---------------hhHHHHHHHHHHHHhCCCCCcceeEEE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---------------NKTAYVKLERIVLDQLDHPGVVRLFFT  113 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~~~~~  113 (366)
                      +++.||+|+||.||+|.+ .+|+.||+|+++.......               .....+.+|+.+++.++|   +++.++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence            339999999999999999 8899999999965321111               134557789999999984   555555


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      +.. +..|+||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|.
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            444 45699999999999987 32      234567999999999999999999999999999999 9999999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=1.2e-22  Score=180.11  Aligned_cols=140  Identities=18%  Similarity=0.221  Sum_probs=109.0

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcE--EEEEEeecccccc---------------------hhhHHHHHHHHHHHHhCC
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITK---------------------ENKTAYVKLERIVLDQLD  103 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~  103 (366)
                      |++.+.||+|+||.||+|.+..+|+.  ||+|+++......                     ......+.+|..+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999888999  9999976532110                     111235677999999998


Q ss_pred             CCCc--ceeEEEEeeCCeEEEEEeecCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCC
Q 017775          104 HPGV--VRLFFTFQDTFSLYMALESCEG-G----ELFDQITSKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPEN  175 (366)
Q Consensus       104 h~~i--v~~~~~~~~~~~~~iv~e~~~g-~----~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH-~~~i~H~dlkp~N  175 (366)
                      |+++  ..++..    ...++||||+.+ |    +|.+....   .++..+..++.|++.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7764  334432    246899999942 3    67665432   345678899999999999999 9999999999999


Q ss_pred             eEeCCCCCEEEEecCCcccc
Q 017775          176 LLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       176 Ili~~~~~vkL~Dfg~a~~~  195 (366)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=1.6e-19  Score=166.68  Aligned_cols=141  Identities=18%  Similarity=0.184  Sum_probs=101.4

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc------------chhh-------HHHHHHHHHHHHhCCCCCc
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT------------KENK-------TAYVKLERIVLDQLDHPGV  107 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~-------~~~~~~e~~~l~~l~h~~i  107 (366)
                      |++++.||.|++|.||+|.+. +|+.||||+++.....            ....       ......|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999884 6999999998643211            0000       0112346666777654443


Q ss_pred             ceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-----
Q 017775          108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----  182 (366)
Q Consensus       108 v~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-----  182 (366)
                      .-..-+....  .++||||++|++|..+.      ..+....++.||+.+|.+||++||+||||||.|||++++|     
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            2211111222  36999999998886532      2234567889999999999999999999999999998876     


Q ss_pred             -----CEEEEecCCccccC
Q 017775          183 -----HIKIADFGSVKPMQ  196 (366)
Q Consensus       183 -----~vkL~Dfg~a~~~~  196 (366)
                           .+.++||+-+....
T Consensus       248 ~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECCCTTCEETT
T ss_pred             cccccceEEEEeCCcccCC
Confidence                 38999999876443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=1.1e-13  Score=122.35  Aligned_cols=140  Identities=16%  Similarity=0.134  Sum_probs=111.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  122 (366)
                      +..|++...++.|+.+.||++..  .|+.+++|+........   ...+.+|..+++.+. +..+.+++++..+.+..|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            45799999999999999999975  36899999986532111   123677888888884 6778889999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS---------------------------------------  163 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~---------------------------------------  163 (366)
                      |||+++|.+|.+.+     .+......++.++.++|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999999987652     1223345788999999999998                                       


Q ss_pred             --------------------CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 --------------------MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 --------------------~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                                          ..++|||++|.||+++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                458999999999999765556799999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=3.1e-12  Score=112.58  Aligned_cols=135  Identities=16%  Similarity=0.171  Sum_probs=99.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceeEEEEeeCCeEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDTFSLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~  121 (366)
                      ..+|.+....+.|..+.||++.. .+|..+++|+.....      ...+..|..+++.+.+.+  +.+++.+..+.+..+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            44567655555667799999954 567889999875431      123566888888875434  456888888888899


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG------------------------------------  165 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~------------------------------------  165 (366)
                      +||||++|.+|.  ..   ..+   ...++.++...|..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998884  11   122   2356677777788888653                                    


Q ss_pred             ----------------------ceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          166 ----------------------LIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       166 ----------------------i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                                            ++|+|++|.||+++.++.+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  9999999999999776666799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.28  E-value=1.5e-11  Score=113.73  Aligned_cols=142  Identities=18%  Similarity=0.238  Sum_probs=106.1

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEee--cccccchhhHHHHHHHHHHHHhCC--CCCcceeEEEEeeC---Ce
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD--KKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDT---FS  119 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~  119 (366)
                      ...++.|+.|.++.||++...  +..+++|+..  ....  ......+.+|..+++.+.  +..+.+++.++.+.   +.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            345788999999999998763  4688999775  3211  112335677999998886  44577888888776   45


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS------------------------------------  163 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~------------------------------------  163 (366)
                      .|+||||++|..+.+.  ....++..+...++.++..+|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            8999999999777431  12347888899999999999999997                                    


Q ss_pred             ----------------------CCceeccCCCCCeEeCCCCC--EEEEecCCccc
Q 017775          164 ----------------------MGLIHRDIKPENLLLTADGH--IKIADFGSVKP  194 (366)
Q Consensus       164 ----------------------~~i~H~dlkp~NIli~~~~~--vkL~Dfg~a~~  194 (366)
                                            ..++|||++|.||+++.++.  +.++||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  35899999999999997753  68999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=4.4e-11  Score=108.03  Aligned_cols=133  Identities=17%  Similarity=0.232  Sum_probs=98.9

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCC--cceeEEEEeeCC---eEEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPG--VVRLFFTFQDTF---SLYMA  123 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~iv  123 (366)
                      ++.++.|....||++.     ..+++|+....     .....+.+|..+++.+ .+..  +.+++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4558999999999873     56899986432     3345677899999887 3333  334444433333   34889


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS----------------------------------------  163 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~----------------------------------------  163 (366)
                      ||+++|.+|......  .++.++...++.|+...|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999999888754332  47888888999999999999996                                        


Q ss_pred             ------------------CCceeccCCCCCeEeCC--CCCEEEEecCCccc
Q 017775          164 ------------------MGLIHRDIKPENLLLTA--DGHIKIADFGSVKP  194 (366)
Q Consensus       164 ------------------~~i~H~dlkp~NIli~~--~~~vkL~Dfg~a~~  194 (366)
                                        ..++|+|++|.||+++.  .+.+.++||+.+..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                              13699999999999998  45688999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.81  E-value=1.3e-07  Score=85.28  Aligned_cols=133  Identities=14%  Similarity=0.213  Sum_probs=95.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC---CcceeEEEEe-eCCeEEEEEe
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP---GVVRLFFTFQ-DTFSLYMALE  125 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~iv~e  125 (366)
                      ++.++.|....||++     |..+++|+...     ......+..|..+++.+.+.   .+.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456789999999988     57789998532     23345678899999988642   2455666654 4556789999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-----------------------------------------  164 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~-----------------------------------------  164 (366)
                      +++|.++....-  ..++..+...++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988876322  2355666666666666666666643                                         


Q ss_pred             -------------------CceeccCCCCCeEeCC---CCCE-EEEecCCccc
Q 017775          165 -------------------GLIHRDIKPENLLLTA---DGHI-KIADFGSVKP  194 (366)
Q Consensus       165 -------------------~i~H~dlkp~NIli~~---~~~v-kL~Dfg~a~~  194 (366)
                                         .++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               2499999999999987   4554 8999998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.77  E-value=1.8e-07  Score=82.54  Aligned_cols=133  Identities=17%  Similarity=0.153  Sum_probs=96.6

Q ss_pred             eeeeecCce-EEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVGSYS-KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      +.+..|..| .||+......+..+++|+-..      .....+.+|...++.+. +--+.+++.+..+.+..++|||+++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            344556555 699988877788899997643      23445777888888774 3346778888999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q 017775          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------------------------------------------  164 (366)
Q Consensus       129 g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~--------------------------------------------  164 (366)
                      |.++.+.....    ......+..++...|..||+.                                            
T Consensus       104 G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          104 GKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             SEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             CccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            98887665432    122334555666666666631                                            


Q ss_pred             --------------CceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          165 --------------GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       165 --------------~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                                    .++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                          15899999999999877767799999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.52  E-value=3.2e-07  Score=85.72  Aligned_cols=81  Identities=16%  Similarity=0.129  Sum_probs=49.1

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCCC--CCc-ceeEEEEeeCCeEE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKE---NKTAYVKLERIVLDQLDH--PGV-VRLFFTFQDTFSLY  121 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~h--~~i-v~~~~~~~~~~~~~  121 (366)
                      -.+.||.|..+.||++....+++.+++|....... ...   ........|..+++.+..  +.. .+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46789999999999997666678999998653211 000   112335568888877632  333 355543  344568


Q ss_pred             EEEeecCCCc
Q 017775          122 MALESCEGGE  131 (366)
Q Consensus       122 iv~e~~~g~~  131 (366)
                      +|||+++|..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999998743

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=8.5e-06  Score=74.10  Aligned_cols=30  Identities=30%  Similarity=0.415  Sum_probs=27.4

Q ss_pred             CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ..++|||+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.20  E-value=3.8e-06  Score=77.11  Aligned_cols=85  Identities=9%  Similarity=-0.037  Sum_probs=53.8

Q ss_pred             eeeeee-eecCceEEEEEEEC--C----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-C--CCcceeEEEEeeC
Q 017775           48 ELGKIY-GVGSYSKVVRAKKI--D----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H--PGVVRLFFTFQDT  117 (366)
Q Consensus        48 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~  117 (366)
                      ...+.| +.|....+|++...  .    ++..+++|+..............+..|..+++.+. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            445777 88888999988653  1    26689999865432000000123566777777763 2  3466777776655


Q ss_pred             ---CeEEEEEeecCCCch
Q 017775          118 ---FSLYMALESCEGGEL  132 (366)
Q Consensus       118 ---~~~~iv~e~~~g~~L  132 (366)
                         +..++|||+++|.++
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.06  E-value=2.5e-05  Score=73.48  Aligned_cols=31  Identities=23%  Similarity=0.311  Sum_probs=27.3

Q ss_pred             HCCceeccCCCCCeEeCCCCCEEEEecCCccc
Q 017775          163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (366)
Q Consensus       163 ~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~  194 (366)
                      ...++|||++|.||+++.++ +.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            46799999999999998776 99999998763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.02  E-value=1.2e-05  Score=67.40  Aligned_cols=122  Identities=16%  Similarity=0.123  Sum_probs=81.8

Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCC
Q 017775          130 GELFDQITSK-GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (366)
Q Consensus       130 ~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~  207 (366)
                      -+|.+++... .+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+ +.+.              
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence            3788888765 689999999999999999877632 2222333457899999999988774 2111              


Q ss_pred             CCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 017775          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID  287 (366)
Q Consensus       208 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  287 (366)
                              .....+.|||... ...+.+.-|||||+++|..+--..|                 ..-+..+|+.+.+||.
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~  151 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLID  151 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHH
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHH
Confidence                    1123567888763 3345567899999999999963322                 1123468999999999


Q ss_pred             HhhcC
Q 017775          288 RLLDV  292 (366)
Q Consensus       288 ~~L~~  292 (366)
                      .|...
T Consensus       152 ~Mt~~  156 (229)
T 2yle_A          152 HMANT  156 (229)
T ss_dssp             HHTTC
T ss_pred             HHHhc
Confidence            99876

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.98  E-value=9.2e-05  Score=66.54  Aligned_cols=77  Identities=12%  Similarity=0.037  Sum_probs=59.3

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceeEEEEeeCCeEEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      .-.+.|+.|....+|++..  ++..+++|+....      ....+..|...|+.+.   ...+.+++.+....+..++||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            3467789999999999875  4678999986532      2455777888887773   356778888888888899999


Q ss_pred             eecCCCch
Q 017775          125 ESCEGGEL  132 (366)
Q Consensus       125 e~~~g~~L  132 (366)
                      |+++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.93  E-value=2.2e-05  Score=70.28  Aligned_cols=131  Identities=18%  Similarity=0.075  Sum_probs=73.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEeeCCeEEEEEeec-
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC-  127 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~-  127 (366)
                      ++.|+.|....+|++      ..+++|+........    .....|..+++.+...++ .+++..  +...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            788999999999999      568999876431110    112346666666532223 455544  333456899999 


Q ss_pred             CCCchHHH--------H----------HhCC-CC----C-HHHHHHHHHH--------------HHHHHHHHH-------
Q 017775          128 EGGELFDQ--------I----------TSKG-HL----S-EDEARFYTAE--------------VVDALEYIH-------  162 (366)
Q Consensus       128 ~g~~L~~~--------l----------~~~~-~l----~-~~~~~~~~~q--------------il~aL~~LH-------  162 (366)
                      +|.++...        .          +..+ .+    . ...+..+..+              +...+..+.       
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            76555321        0          0111 01    0 1111111111              111111111       


Q ss_pred             -HCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          163 -SMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       163 -~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                       ...++|+|+.+.||+ ..++.+.++||..+.
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence             113799999999999 567789999999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=0.00017  Score=64.88  Aligned_cols=142  Identities=16%  Similarity=0.116  Sum_probs=77.2

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceeE-E--EEee
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGVVRLF-F--TFQD  116 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~-~--~~~~  116 (366)
                      ++..-.+.|+.|....+|++...  +..+++|+.....  .   ...+..|..+++.+.     .|.++... +  +...
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            33445677788888999998763  3378899886521  1   112344666665552     23333210 0  1123


Q ss_pred             CCeEEEEEeecCCCchH----HH----------HHhC--C---C----CCHHHHHH---------------HHHHHHHHH
Q 017775          117 TFSLYMALESCEGGELF----DQ----------ITSK--G---H----LSEDEARF---------------YTAEVVDAL  158 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~----~~----------l~~~--~---~----l~~~~~~~---------------~~~qil~aL  158 (366)
                      .+..+++|++++|..+.    ..          ++..  +   +    .....-..               +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            45679999999985431    00          1110  0   0    11100000               001134445


Q ss_pred             HHHHH-------CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          159 EYIHS-------MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       159 ~~LH~-------~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ..++.       .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            55553       369999999999999877666899999775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.62  E-value=0.00013  Score=67.27  Aligned_cols=136  Identities=16%  Similarity=0.148  Sum_probs=80.6

Q ss_pred             eeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEeeCCeEE
Q 017775           50 GKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLY  121 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~  121 (366)
                      ++.|..|....+|++....       ++..|++|+....    ......+.+|..+++.+...+ ..+++..+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            4567778888999997642       4578999986332    112334557888887774222 3556665543    2


Q ss_pred             EEEeecCCCchHH----------HH-------HhC----C-CC--CHHHHHHHHHHHHH-------------------HH
Q 017775          122 MALESCEGGELFD----------QI-------TSK----G-HL--SEDEARFYTAEVVD-------------------AL  158 (366)
Q Consensus       122 iv~e~~~g~~L~~----------~l-------~~~----~-~l--~~~~~~~~~~qil~-------------------aL  158 (366)
                      +||||++|.+|..          .+       ..-    + ..  -..++..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            9999999865421          11       111    1 11  13455666554422                   23


Q ss_pred             HHHH----H----CCceeccCCCCCeEeCCC----CCEEEEecCCcc
Q 017775          159 EYIH----S----MGLIHRDIKPENLLLTAD----GHIKIADFGSVK  193 (366)
Q Consensus       159 ~~LH----~----~~i~H~dlkp~NIli~~~----~~vkL~Dfg~a~  193 (366)
                      ..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3333    2    248999999999999876    789999999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.61  E-value=0.00039  Score=61.62  Aligned_cols=79  Identities=16%  Similarity=0.087  Sum_probs=54.0

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC---CCcceeEEEEeeCCeEEE
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH---PGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~i  122 (366)
                      ...-++.+|.|..+.||++.. .+|+.|++|+.....   ......+..|...|+.+..   --+.+++.+  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            456688999999999999975 578999999865432   1223356778888887742   123445544  22  368


Q ss_pred             EEeecCCCch
Q 017775          123 ALESCEGGEL  132 (366)
Q Consensus       123 v~e~~~g~~L  132 (366)
                      |||++.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            8999987543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.56  E-value=0.00021  Score=67.28  Aligned_cols=75  Identities=11%  Similarity=0.018  Sum_probs=48.7

Q ss_pred             eeeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEeeCCeE
Q 017775           49 LGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSL  120 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~  120 (366)
                      -++.|+.|....||++....       ++..+++|+.....  .   ...+..|..+++.+...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35678888889999998643       35789999884321  1   1223358888777743333 566665542    


Q ss_pred             EEEEeecCCCch
Q 017775          121 YMALESCEGGEL  132 (366)
Q Consensus       121 ~iv~e~~~g~~L  132 (366)
                      .+|+||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            289999987443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.48  E-value=0.00035  Score=63.27  Aligned_cols=30  Identities=33%  Similarity=0.643  Sum_probs=26.5

Q ss_pred             CCceeccCCCCCeEeCCC----CCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTAD----GHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~----~~vkL~Dfg~a~  193 (366)
                      ..++|||+.+.||+++.+    +.+.++||+.+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            469999999999999875    689999999876

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.48  E-value=0.00061  Score=61.42  Aligned_cols=135  Identities=16%  Similarity=0.128  Sum_probs=75.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceeEEE-----EeeCCeEEEE
Q 017775           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFT-----FQDTFSLYMA  123 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~iv  123 (366)
                      ..++ |....||++.. .+|+.+++|.......    ....+..|..+++.+....  +.+++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 77889998754 3567899999863311    1234555777666653111  3333332     2235567899


Q ss_pred             EeecCCCchH----HHH----------Hh---C-C-----CCCHHHH----------------------HHHHHHHHHHH
Q 017775          124 LESCEGGELF----DQI----------TS---K-G-----HLSEDEA----------------------RFYTAEVVDAL  158 (366)
Q Consensus       124 ~e~~~g~~L~----~~l----------~~---~-~-----~l~~~~~----------------------~~~~~qil~aL  158 (366)
                      |++++|.++.    +.+          ++   . .     ..+....                      ...+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999885431    111          10   0 0     1111110                      11111222222


Q ss_pred             HHH----HHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          159 EYI----HSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       159 ~~L----H~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .-+    ....++|||+++.||+++ + .+.++||+.+.
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            221    123589999999999998 4 89999998765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.43  E-value=0.00029  Score=64.84  Aligned_cols=75  Identities=17%  Similarity=0.026  Sum_probs=43.2

Q ss_pred             eeeeeecCceEEEEEEECC--------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEeeCCeE
Q 017775           50 GKIYGVGSYSKVVRAKKID--------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSL  120 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~  120 (366)
                      .+.|+.|....+|++....        .+..+++|+.....   ... .....|..+++.+...+ ..+++...  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DEL-YNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cce-ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            5677888888999997643        13689999875431   110 11345777777664333 34566544  22  


Q ss_pred             EEEEeecCCCch
Q 017775          121 YMALESCEGGEL  132 (366)
Q Consensus       121 ~iv~e~~~g~~L  132 (366)
                      ++|||+++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999998543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.27  E-value=0.0017  Score=58.91  Aligned_cols=30  Identities=30%  Similarity=0.403  Sum_probs=27.0

Q ss_pred             CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      ..++|+|+.+.||+++.++.+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            358999999999999988899999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.21  E-value=0.0028  Score=59.97  Aligned_cols=76  Identities=14%  Similarity=0.165  Sum_probs=48.4

Q ss_pred             eeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEeeCCeEEEEEeec
Q 017775           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC  127 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~  127 (366)
                      -++.|+.|-...+|++.....+..+++|+..... ....+   ...|..+++.+...++ .++++.+.  +.  +||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIIN---REREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence            3567888888999999875545789999875421 11101   2458888888865444 46666653  22  599999


Q ss_pred             CCCch
Q 017775          128 EGGEL  132 (366)
Q Consensus       128 ~g~~L  132 (366)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            88544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.44  E-value=0.0053  Score=57.42  Aligned_cols=76  Identities=16%  Similarity=0.045  Sum_probs=46.9

Q ss_pred             eeeeeeecCceEEEEEEECCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEeeCCeE
Q 017775           49 LGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSL  120 (366)
Q Consensus        49 ~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~  120 (366)
                      -++.+..|....+|++.....       +..|++|+.....   ... ....+|..+++.+...+ ..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            356677788889999987521       5789999875421   111 11345777777664223 34555533  22  


Q ss_pred             EEEEeecCCCch
Q 017775          121 YMALESCEGGEL  132 (366)
Q Consensus       121 ~iv~e~~~g~~L  132 (366)
                      +.|+||++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            688999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.86  E-value=0.037  Score=51.32  Aligned_cols=28  Identities=25%  Similarity=0.462  Sum_probs=24.5

Q ss_pred             ceeccCCCCCeEe------CCCCCEEEEecCCcc
Q 017775          166 LIHRDIKPENLLL------TADGHIKIADFGSVK  193 (366)
Q Consensus       166 i~H~dlkp~NIli------~~~~~vkL~Dfg~a~  193 (366)
                      ++|+|+.+.||++      +.++.+.++||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999      345789999999876

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.42  E-value=0.94  Score=37.80  Aligned_cols=83  Identities=11%  Similarity=-0.029  Sum_probs=61.7

Q ss_pred             CCCCcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCCeEeCCC
Q 017775          103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE-YIHSMGLIHRDIKPENLLLTAD  181 (366)
Q Consensus       103 ~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~-~LH~~~i~H~dlkp~NIli~~~  181 (366)
                      .||++  -..+-.+++.+.+.++.-+++.=+..+.   .++..+.++++.+|+.... ++  ..-+|--|+|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            67888  3444477778888777764444444443   3788999999999888665 33  445788899999999999


Q ss_pred             CCEEEEecCCc
Q 017775          182 GHIKIADFGSV  192 (366)
Q Consensus       182 ~~vkL~Dfg~a  192 (366)
                      +.+++.-.|+-
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999988763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.83  E-value=1.2  Score=37.11  Aligned_cols=84  Identities=17%  Similarity=0.140  Sum_probs=61.2

Q ss_pred             CCCCcceeEEEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC
Q 017775          103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  182 (366)
Q Consensus       103 ~h~~iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~  182 (366)
                      .||++++. .+-++.+.+.+.++.-+.+.=+..+.   .++....++++.+|+....++  ..=+|--|+|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            68988876 56666777777766654222222232   378899999999999877444  3347778999999999999


Q ss_pred             CEEEEecCCc
Q 017775          183 HIKIADFGSV  192 (366)
Q Consensus       183 ~vkL~Dfg~a  192 (366)
                      .+++.-.|+-
T Consensus       117 ~p~i~~RGik  126 (215)
T 4ann_A          117 LPIAKTRGLQ  126 (215)
T ss_dssp             CEEESCCEET
T ss_pred             CEEEEEccCc
Confidence            9999877763

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=80.04  E-value=39  Score=33.33  Aligned_cols=25  Identities=40%  Similarity=0.594  Sum_probs=23.2

Q ss_pred             ccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          169 RDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       169 ~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      +|=+++||||+.+|++.=+|||.+-
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhh
Confidence            6999999999999999999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	366
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-98
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-87
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-85
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-82
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-82
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-80
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-78
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-76
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-76
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-74
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-74
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-74
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-73
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-73
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-71
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-70
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-67
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-65
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-59
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-56
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-55
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-54
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-53
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-53
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-52
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-49
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-47
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-38
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  290 bits (743), Expect = 7e-98
 Identities = 138/288 (47%), Positives = 183/288 (63%), Gaps = 9/288 (3%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
             V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +IHRD+KPEN+LL  D HI+I DFG+ K +               +A +FVGTA YV PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--------KQARANSFVGTAQYVSPE 180

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL 285
           +L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARDL
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240

Query: 286 IDRLLDVDPSGRPGAG-PGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           +++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (673), Expect = 1e-87
 Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 17/276 (6%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            HS  +IHRDIKPENLLL + G +KIADFG                A   +  T  GT  
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------HAPSSRRTTLCGTLD 169

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ ++
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            ARDLI RLL  +PS RP         +  HP+   
Sbjct: 230 GARDLISRLLKHNPSQRPML-----REVLEHPWITA 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  258 bits (660), Expect = 5e-85
 Identities = 101/289 (34%), Positives = 165/289 (57%), Gaps = 15/289 (5%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K +              D   T  GT  Y
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-------------PDVTYTLCGTPDY 167

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F++ 
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 227

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +DL+ RL+  D S R G    G   +K HP+FK + W+ +  R    P
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (644), Expect = 1e-82
 Identities = 96/288 (33%), Positives = 145/288 (50%), Gaps = 17/288 (5%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQL 102
           I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ VL    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  L+++H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S G+++RD+K +N+LL  DGHIKIADFG  K               D K  TF GT  Y+
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----------GDAKTNTFCGTPDYI 170

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 282
            PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +    A
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           +DL+ +L   +P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 231 KDLLVKLFVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPP 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (641), Expect = 6e-82
 Identities = 105/288 (36%), Positives = 153/288 (53%), Gaps = 12/288 (4%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  +++RDIK ENL+L  DGHIKI DFG  K                    TF GT  Y+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----------DGATMKTFCGTPEYL 172

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 282
            PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           + L+  LL  DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  248 bits (634), Expect = 2e-80
 Identities = 93/293 (31%), Positives = 146/293 (49%), Gaps = 19/293 (6%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV---L 99
           ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+   +
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
              D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  LE
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           ++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VGT 
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTH 169

Query: 220 AYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP 275
            Y+ PEVL          D ++LGC L+++L G SPF+         I +  +   +  P
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           + FS   R L++ LL  D + R G    G   +K  PFF+ +DW+ +  Q  P
Sbjct: 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 282

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  242 bits (618), Expect = 3e-78
 Identities = 81/297 (27%), Positives = 136/297 (45%), Gaps = 27/297 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +++ +  G G++  V R  +  TG V+  K ++  +   +     VK E  +++QL HP
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 86

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            ++ L   F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H  
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 165 GLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            ++H DIKPEN++        +KI DFG    +             D+       TA + 
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----------DEIVKVTTATAEFA 195

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 278
            PE+++  P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F     +  
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPM 335
           S  A+D I  LL  +P  R             HP+ KG D  N+  + P    ++  
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKG-DHSNLTSRIPSSRYNKIR 306

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  236 bits (604), Expect = 4e-76
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 26/293 (8%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR 81

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIH 162
           HP +V L   F+D   + M  E   GGELF+++  +   +SEDEA  Y  +V   L ++H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 163 SMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
               +H D+KPEN++ T      +K+ DFG    +                     GTA 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-----------KQSVKVTTGTAE 190

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---- 276
           +  PEV    P  +  D+W++G   Y +LSG SPF   ++    + + + D    +    
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK 329
             S+  +D I +LL  DP+ R             HP+    +      Q P  
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRDSQIPSS 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  236 bits (603), Expect = 5e-76
 Identities = 101/293 (34%), Positives = 157/293 (53%), Gaps = 15/293 (5%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
            Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ 
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++                 T  G
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------------WTLCG 200

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T   + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           FS   +DL+  LL VD + R G    G   +K H +F   DW  I  R    P
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 9e-76
 Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 27/287 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +E+    G G++ KV +A+  +T  + A K++D K    E +     +E  +L   DHP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            +V+L   F    +L++ +E C GG +   +      L+E + +    + +DAL Y+H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRD+K  N+L T DG IK+ADFG                 +  +  +F+GT  ++ P
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------TIQRRDSFIGTPYWMAP 179

Query: 225 EVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPN 276
           EV+        P  +  D+W+LG TL +M     P  + +   +  +I   +   +  P+
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
            +S   +D + + L+ +   R        + L  HPF      K IR
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTT-----SQLLQHPFVTVDSNKPIR 281

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  229 bits (585), Expect = 3e-74
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 33/288 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIV 98
           +++E  +I G G  S V R     T   YA+KI+D       +     +L      E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 99  LDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L ++  HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K     G
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------GEKLREVCG 171

Query: 218 TAAYVPPEVL------NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           T +Y+ PE++      N        D+W+ G  +Y +L+G+ PF    + L+ + I++ +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +F     + +SD  +DL+ R L V P  R  A          HPFF+
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 4e-74
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 19/276 (6%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 61

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG           V      +       GT  YV 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLAT--------VFRYNNRERLLNKMCGTLPYVA 173

Query: 224 PEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF---S 279
           PE+L          D+W+ G  L  ML+G  P+   S+             + N +    
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            A   L+ ++L  +PS R          +K   ++ 
Sbjct: 234 SAPLALLHKILVENPSARITI-----PDIKKDRWYN 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  229 bits (586), Expect = 5e-74
 Identities = 91/295 (30%), Positives = 145/295 (49%), Gaps = 27/295 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             ++   + G G++S+V+ A+   T  + A+K + KK +  E K   ++ E  VL ++ H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLL      D  I I+DFG  K                    T  GT  Y
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----------GSVLSTACGTPGY 175

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 277
           V PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F     + 
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW--KNIRGQTPPKL 330
            SD+A+D I  L++ DP  R             HP+  G     KNI      ++
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTC-----EQALQHPWIAGDTALDKNIHQSVSEQI 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  228 bits (582), Expect = 2e-73
 Identities = 71/285 (24%), Positives = 112/285 (39%), Gaps = 28/285 (9%)

Query: 40  EHFSIQD----FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           E F   D    F   +  G GS+  V  A+ +    V A+K M         K   +  E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
              L +L HP  ++    +    + ++ +E C G         K  L E E    T   +
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL 125

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L Y+HS  +IHRD+K  N+LL+  G +K+ DFGS   M  +               +F
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--------------SF 171

Query: 216 VGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           VGT  ++ PEV+   +        D+W+LG T  ++     P  + +       I   + 
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231

Query: 273 RF--PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 ++S+  R+ +D  L   P  RP +      VL  H F  
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVL 271

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 8e-73
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 22/274 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + +   +  G G+   V  A  + TG   A++ M+ +   ++ K   +  E +V+ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKN 76

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V    ++     L++ +E   GG L D +T      E +      E + ALE++HS 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRDIK +N+LL  DG +K+ DFG    +               K  T VGT  ++ P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------EQSKRSTMVGTPYWMAP 185

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA 281
           EV+         D+W+LG    +M+ G  P+ + +       I      +++ P   S  
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            RD ++R LD+D   R  A       L  H F K
Sbjct: 246 FRDFLNRCLDMDVEKRGSA-----KELLQHQFLK 274

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 1e-72
 Identities = 106/312 (33%), Positives = 166/312 (53%), Gaps = 20/312 (6%)

Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT 84
              ++       E   I++FEL K+ G G+Y KV   +KI   DTG +YA+K++ K  I 
Sbjct: 7   HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66

Query: 85  KENK-TAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
           ++ K T + + ER VL+ +   P +V L + FQ    L++ L+   GGELF  ++ +   
Sbjct: 67  QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           +E E + Y  E+V ALE++H +G+I+RDIK EN+LL ++GH+ + DFG  K         
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE- 185

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSE 260
                   +A  F GT  Y+ P+++    +      D W+LG  +Y++L+G SPF    E
Sbjct: 186 --------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 261 ----WLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
                 I +RI+  +  +P   S  A+DLI RLL  DP  R G GP     +K H FF+ 
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

Query: 317 IDWKNIRGQTPP 328
           I+W ++  +  P
Sbjct: 298 INWDDLAAKKVP 309

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 2e-72
 Identities = 67/322 (20%), Positives = 117/322 (36%), Gaps = 64/322 (19%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE     G G+   V +     +G V A K++  +   K      +  E  VL + + P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM- 164
            +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+    
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP N+L+ + G IK+ DFG    + DS               +FVGT +Y+ P
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN------------SFVGTRSYMSP 172

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------- 270
           E L  +  +  +D+W++G +L +M  G  P        +      +              
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 271 ------------------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
                                                FS   +D +++ L  +P+ R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 301 GPGGYAVLKMHPFFKGIDWKNI 322
                  L +H F K  D + +
Sbjct: 293 -----KQLMVHAFIKRSDAEEV 309

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 8e-71
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 30/305 (9%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---E 95
           QE+     ++ G+  G G ++ V + ++  TG  YA K + K+      +    +    E
Sbjct: 5   QENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             +L ++ HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  +++
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDK 211
           + + Y+HS+ + H D+KPEN++L         IKI DFG    +              ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNE 172

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
                GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232

Query: 272 IRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQ 325
             F +      S  A+D I RLL  DP  R             HP+ K  D +       
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSSAW 287

Query: 326 TPPKL 330
           + P+ 
Sbjct: 288 SHPQF 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 1e-70
 Identities = 77/324 (23%), Positives = 133/324 (41%), Gaps = 28/324 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            + + +  G G +  V R  +  +   Y  K +  K   +      VK E  +L+   H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIARHR 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSM 164
            ++ L  +F+    L M  E   G ++F++I +    L+E E   Y  +V +AL+++HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 165 GLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            + H DI+PEN++        IKI +FG  + ++             D          Y 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-----------GDNFRLLFTAPEYY 170

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 278
            PEV      +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F        
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNF 338
           S  A D +DRLL  +   R  A     +    HP+ K    + +  +    L      + 
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQ-KIERVSTKVIRTLKHRRYYHT 284

Query: 339 LLLIKLLSVVKSNLLPCLALVKSS 362
           L+   L  VV +  + C   ++S 
Sbjct: 285 LIKKDLNMVVSAARISCGGAIRSQ 308

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 3e-70
 Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 28/280 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHP 63

Query: 106 GVVRLFFTFQDTFS--LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALE 159
            +VR +    D  +  LY+ +E CEGG+L   IT     + +L E+       ++  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 160 YIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
             H        ++HRD+KP N+ L    ++K+ DFG  + +                A  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----------TSFAKA 173

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R 273
           FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+  +  +I      R
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            P  +SD   ++I R+L++    RP         +  +P 
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 6e-69
 Identities = 52/279 (18%), Positives = 108/279 (38%), Gaps = 29/279 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
            +     G GS+  V +    +T    A   +  + +TK  +  + + E  +L  L HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE-EAEMLKGLQHPN 69

Query: 107 VVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +VR + +++ T      + +  E    G L   +     +     R +  +++  L+++H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 163 SMG--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +    +IHRD+K +N+ +T   G +KI D G     + S                 +GT 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK------------AVIGTP 177

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPN 276
            ++ PE+          D++A G  + +M +   P+ +        R +   ++   F  
Sbjct: 178 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 +++I+  +  +   R          L  H FF+
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  212 bits (541), Expect = 1e-67
 Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 15/263 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +ELG+I G G  S+V  A+ +      A+K++        +     + E      L+HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 106 GVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H  G+IHRD+KP N++++A   +K+ DFG  + + DS         S  +    +GTA Y
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-------GNSVTQTAAVIGTAQY 180

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY---- 277
           + PE          +D+++LGC LY++L+G  PF   S   +  + +  D   P+     
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 278 FSDAARDLIDRLLDVDPSGRPGA 300
            S     ++ + L  +P  R   
Sbjct: 241 LSADLDAVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-67
 Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 31/280 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
            +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 103 D--HPGVVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALE 159
                GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 160 YIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           + H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGT 172

Query: 219 AAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
             Y PPE +           +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
            S   + LI   L + PS RP         ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDV 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 5e-65
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 41/290 (14%)

Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D++   ++ G+G   KV++     T   +ALK++      +           +     
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV-------ELHWRAS 62

Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------SHNSLT 171

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIA 269
           T   T  YV PEVL         D+W+LG  +Y +L G  PF           +  RI  
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231

Query: 270 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
               FPN      S+  + LI  LL  +P+ R             HP+  
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIM 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 23/263 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
              +G+  G GS+  V + K        A+K+++    T +   A+   E  VL +  H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHV 64

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
            ++  F  +     L +  + CEG  L+  +   +      +      +    ++Y+H+ 
Sbjct: 65  NILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRD+K  N+ L  D  +KI DFG           V    +   +     G+  ++ P
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLAT--------VKSRWSGSHQFEQLSGSILWMAP 175

Query: 225 EVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY---- 277
           EV+   + +P +F +D++A G  LY++++G  P+ + +       ++ R    P+     
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 278 --FSDAARDLIDRLLDVDPSGRP 298
                A + L+   L      RP
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERP 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-60
 Identities = 56/264 (21%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
            ++++ +L +  G G +  V+       G   A+K +      +         E  V+ Q
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDAL 158
           L H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+     +HRD+   N+L++ D   K++DFG  K    ++              T    
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-------------DTGKLP 163

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRFPN 276
             +  PE L     +  +D+W+ G  L+++ S G  P+       +  R+     +  P+
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

Query: 277 YFSDAARDLIDRLLDVDPSGRPGA 300
               A  +++     +D + RP  
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSF 247

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-60
 Identities = 56/288 (19%), Positives = 112/288 (38%), Gaps = 23/288 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
            ++  +++D ELG     G++  V +   +        A+KI+  +      K   +  E
Sbjct: 4   DRKLLTLEDKELGS----GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-E 58

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             V+ QLD+P +VR+    +   S  + +E  E G L   +    H+ +        +V 
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             ++Y+     +HRD+   N+LL    + KI+DFG  K ++                   
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-------KAQTHG 170

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IR 273
                +  PE +N    +  +D+W+ G  +++  S G  P++      +   +   + + 
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKGIDW 319
            P        DL++     D   RPG      AV     + ++  ++ 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFA----AVELRLRNYYYDVVNE 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 67/314 (21%), Positives = 128/314 (40%), Gaps = 52/314 (16%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIV--L 99
           + Q +E     G G+Y KV +A+ + + G   ALK +  +   +    + ++   ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 100 DQLDHPGVVRLFFTFQDTFS-----LYMALESCEGGEL-FDQITSKGHLSEDEARFYTAE 153
           +  +HP VVRLF     + +     L +  E  +     +     +  +  +  +    +
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG  +                    
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-----------QMALT 173

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---- 269
           + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+     +I+     
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 270 -----------------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYA 306
                                     +F     +  +DL+ + L  +P+ R  A      
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----Y 288

Query: 307 VLKMHPFFKGIDWK 320
               HP+F+ ++  
Sbjct: 289 SALSHPYFQDLERC 302

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-59
 Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 25/285 (8%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
            +++  I D ELG     G++  V +   +        A+K++ +   T++  T  +  E
Sbjct: 6   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMRE 59

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEV 154
             ++ QLD+P +VRL    Q   +L + +E   GG L   +  K   +          +V
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K +         + +       
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG-------ADDSYYTARSA 171

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDI 272
                 +  PE +N    +  +D+W+ G T+++ LS G  P+K      +   I   + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK 315
             P         L+          RP        V +     ++ 
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFL----TVEQRMRACYYS 272

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 7e-58
 Identities = 79/333 (23%), Positives = 127/333 (38%), Gaps = 65/333 (19%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +   K+ G GS+  V +AK  D+G + A+K + +    K         E  ++ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 106 GVVRLFFTF------QDTFSLYMALESCEGG---ELFDQITSKGHLSEDEARFYTAEVVD 156
            +VRL + F      +D   L + L+               +K  L     + Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +L YIHS G+ HRDIKP+NLLL  D   +K+ DFGS K +              +   ++
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----------GEPNVSY 182

Query: 216 VGTAAYVPP-EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII------ 268
           + +  Y  P  +  ++  T   D+W+ GC L ++L G   F   S       II      
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 269 -----------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGY 305
                        + +FP                  A  L  RLL+  P+ R        
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP----- 297

Query: 306 AVLKMHPFFKGIDWKNIRGQTPPKLASEPMVNF 338
                H FF  +   N++   P    +  + NF
Sbjct: 298 LEACAHSFFDELRDPNVK--LPNGRDTPALFNF 328

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-57
 Identities = 59/263 (22%), Positives = 98/263 (37%), Gaps = 15/263 (5%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVL 99
             +D  L +  G GS+  V R +           A+K +    +++         E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDAL 158
             LDH  ++RL+        + M  E    G L D++    GH        Y  +V + +
Sbjct: 66  HSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+ S   IHRD+   NLLL     +KI DFG ++ +         N             
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-------NDDHYVMQEHRKVP 177

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--P 275
            A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R   P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 276 NYFSDAARDLIDRLLDVDPSGRP 298
                   +++ +     P  RP
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRP 260

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (474), Expect = 4e-57
 Identities = 71/314 (22%), Positives = 115/314 (36%), Gaps = 53/314 (16%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  +E     G G++ +V +A+   TG   ALK +  +   KE        E  +L  L
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66

Query: 103 DHPGVVRLFFTFQDTFS--------LYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
            H  VV L    +   S        +Y+  + CE              +  E +     +
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG  +    ++ +        ++   
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------PNRYTN 180

Query: 215 FVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---- 269
            V T  Y PPE+L          DLW  GC + +M + +   +  +E      I      
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 270 ----------------------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
                                       +D          A DLID+LL +DP+ R  + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS- 299

Query: 302 PGGYAVLKMHPFFK 315
                    H FF 
Sbjct: 300 ----DDALNHDFFW 309

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 5e-57
 Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 42/289 (14%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F  ++ E GK+ G G++ KV+ A      K       A+K++ +K  + E +   +  E 
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA--LMSEL 91

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 141
            ++ QL  H  +V L      +  +Y+  E C  G+L + + SK                
Sbjct: 92  KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 142 ---------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
                    L+ ++   +  +V   +E++     +HRD+   N+L+T    +KI DFG  
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
           + +      V+                 ++ PE L     T  +D+W+ G  L+++ S G
Sbjct: 212 RDIMSDSNYVVR--------GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263

Query: 252 TSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
            +P+        F ++I    +   P Y ++    ++      D   RP
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (467), Expect = 2e-56
 Identities = 52/263 (19%), Positives = 94/263 (35%), Gaps = 17/263 (6%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
               D  +    G G Y +V            A+K + +  +  E        E  V+ +
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALE 159
           + HP +V+L          Y+  E    G L D +       +S     +   ++  A+E
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+     IHRD+   N L+  +  +K+ADFG  + M     T                  
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH---------AGAKFPI 180

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 277
            +  PE L  +  +  +D+WA G  L+++ +         +      ++ +D R   P  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

Query: 278 FSDAARDLIDRLLDVDPSGRPGA 300
             +   +L+      +PS RP  
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSF 263

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 64/299 (21%), Positives = 102/299 (34%), Gaps = 46/299 (15%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHP 105
           E     G G ++ V +A+  +T  + A+K +     ++           E  +L +L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            ++ L   F    ++ +  +  E         +   L+    + Y    +  LEY+H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+KP NLLL  +G +K+ADFG  K                      V T  Y  PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----------RAYTHQVVTRWYRAPE 170

Query: 226 VLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--------- 275
           +L        G D+WA+GC L ++L         S+     RI                 
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 276 -------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                              +   D   DLI  L   +P  R  A            +F 
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFS 284

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 7e-56
 Identities = 51/258 (19%), Positives = 109/258 (42%), Gaps = 17/258 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +    +  G G +  V     ++     A+K + +  +++E+       E  V+ +L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEED----FIEEAEVMMKLSHP 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
            +V+L+    +   + +  E  E G L D + ++  L + +       +V + + Y+   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRD+   N L+  +  IK++DFG  + + D + T          +        +  P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASP 171

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDAA 282
           EV + S  +  +D+W+ G  ++++ S G  P+++ S   + + I     +  P   S   
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

Query: 283 RDLIDRLLDVDPSGRPGA 300
             +++      P  RP  
Sbjct: 232 YQIMNHCWKERPEDRPAF 249

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 7e-56
 Identities = 52/257 (20%), Positives = 103/257 (40%), Gaps = 17/257 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D    K  G G +  V   K        A+K++ +  ++++        E  V+  L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHS 163
             +V+L+        +++  E    G L + +   +      +      +V +A+EY+ S
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              +HRD+   N L+   G +K++DFG  + + D   T          +        + P
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSP 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 281
           PEVL  S  +  +D+WA G  ++++ S G  P++  +     + I     +  P+  S+ 
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 282 ARDLIDRLLDVDPSGRP 298
              ++          RP
Sbjct: 230 VYTIMYSCWHEKADERP 246

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  180 bits (458), Expect = 3e-55
 Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +   +  G G+Y  V +A+  + G  +ALK +  +   +   +  ++ E  +L +L H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+L+        L +  E  +          +G L    A+ +  ++++ + Y H   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+KP+NLL+  +G +KIADFG  +                 K    + T  Y  P+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI----------PVRKYTHEIVTLWYRAPD 170

Query: 226 VL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------------- 269
           VL  S   +   D+W++GC   +M++GT  F   SE     RI                 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 270 --------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                             F     ++  DL+ ++L +DP+ R  A          H +FK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFK 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 5e-55
 Identities = 54/278 (19%), Positives = 110/278 (39%), Gaps = 24/278 (8%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
              +  +L +  G G + +V      +  T  A+K + +  ++ +        E  ++ Q
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA----FLAEANLMKQ 64

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 159
           L H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ + + 
Sbjct: 65  LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +I     IHRD++  N+L++     KIADFG  + ++D+                     
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---------EYTAREGAKFPI 174

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
            +  PE +N    T  +D+W+ G  L ++++ G  P+   +   + Q +     +  P+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-HPFF 314
             +    L+       P  RP        +  +   FF
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFD----YLRSVLEDFF 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-54
 Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 47/305 (15%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 104 HPGVVRLFFTFQDTFSLYMALESCE-GGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E      + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G IK+ADFG  +                      V T  Y 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------PVRTYTHEVVTLWYR 169

Query: 223 PPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-----------AR 270
            PE+L      +   D+W+LGC   +M++  + F   SE     RI              
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 271 DIRFPNY------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
               P+Y                    +  R L+ ++L  DP+ R  A          HP
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHP 284

Query: 313 FFKGI 317
           FF+ +
Sbjct: 285 FFQDV 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 2e-54
 Identities = 51/288 (17%), Positives = 106/288 (36%), Gaps = 41/288 (14%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           +   + E  +  G G++ +V +A+       +  T+ A+K++ ++           + E 
Sbjct: 10  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREA 67

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--------------- 141
            ++ + D+P +V+L         + +  E    G+L + + S                  
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 142 ---------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
                    LS  E      +V   + Y+     +HRD+   N L+  +  +KIADFG  
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
           + +  +                      ++PPE +  +  T  +D+WA G  L+++ S G
Sbjct: 188 RNIYSADYY--------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 252 TSPFKDTSEWLIFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRP 298
             P+   +   +   +   +I   P        +L+       P+ RP
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-54
 Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 30/275 (10%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
              D +   + G G++ +V++A+    G      I   K    ++       E  VL +L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 103 -DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSED 145
             HP ++ L    +    LY+A+E    G L D +                ++   LS  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +   + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +         
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------- 179

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF 264
                K         ++  E LN S  T  +D+W+ G  L++++S G +P+   +   ++
Sbjct: 180 ---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 265 QRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           +++     +  P    D   DL+ +     P  RP
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 52/282 (18%), Positives = 106/282 (37%), Gaps = 24/282 (8%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
              +   L    G G + +V       T  V A+K +    ++ E        E  V+ +
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA----FLQEAQVMKK 68

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 159
           L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + 
Sbjct: 69  LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T                  
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---------ARQGAKFPI 178

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
            +  PE       T  +D+W+ G  L ++ + G  P+       +  ++     +  P  
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-HPFFKGID 318
             ++  DL+ +    +P  RP        +      +F   +
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFE----YLQAFLEDYFTSTE 276

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 14/260 (5%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L     +   +++ +E C  GEL   +  +   L       Y  ++  AL Y+ 
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRDI   N+L++++  +K+ DFG  + M+DS            KA        ++
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWM 176

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII-ARDIRFPNYFSD 280
            PE +N    T  +D+W  G  ++++L  G  PF+      +  RI     +  P     
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236

Query: 281 AARDLIDRLLDVDPSGRPGA 300
               L+ +    DPS RP  
Sbjct: 237 TLYSLMTKCWAYDPSRRPRF 256

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-53
 Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 54/314 (17%)

Query: 40  EHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           + F +   +      G G+Y  V  A         A+K +       +        E  +
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKI 59

Query: 99  LDQLDHPGVVRLF-----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           L +  H  ++ +       T +    +Y+            ++    HLS D   ++  +
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQ 117

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +          P+        
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-------PDHDHTGFLT 170

Query: 214 TFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
            +V T  Y  PE++ NS   T   D+W++GC L +MLS    F           I+    
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230

Query: 273 -------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
                                          R        A DL+D++L  +P  R    
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV- 289

Query: 302 PGGYAVLKMHPFFK 315
                    HP+ +
Sbjct: 290 ----EQALAHPYLE 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 47/259 (18%), Positives = 98/259 (37%), Gaps = 12/259 (4%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+    T       +  E  V+  +D
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           +P V RL      +    +      G  L      K ++       +  ++   + Y+  
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             L+HRD+   N+L+    H+KI DFG  K +             +  A        ++ 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVPIKWMA 181

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDA 281
            E +     T  +D+W+ G T++++++ G+ P+       I   +   + +  P   +  
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241

Query: 282 ARDLIDRLLDVDPSGRPGA 300
              ++ +   +D   RP  
Sbjct: 242 VYMIMVKCWMIDADSRPKF 260

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 2e-53
 Identities = 74/326 (22%), Positives = 125/326 (38%), Gaps = 60/326 (18%)

Query: 42  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           + ++  +   +  G G+Y  V  A    TG   A+K + + F ++       + E  +L 
Sbjct: 14  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLK 72

Query: 101 QLDHPGVVRLFFTFQ------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
            + H  V+ L   F       D    Y+ +     G    ++     L ED  +F   ++
Sbjct: 73  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L YIH+ G+IHRD+KP NL +  D  +KI DFG  +               D +   
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-------------DSEMTG 177

Query: 215 FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +V T  Y  PEV LN    T   D+W++GC + +M++G + FK +      + I+     
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 274 FPNYF-------------------------------SDAARDLIDRLLDVDPSGRPGAGP 302
            P  F                               S  A +L++++L +D   R  A  
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-- 295

Query: 303 GGYAVLKMHPFFKGIDWKNIRGQTPP 328
                   HP+F+ +       Q   
Sbjct: 296 ---GEALAHPYFESLHDTEDEPQVQK 318

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (446), Expect = 3e-53
 Identities = 51/268 (19%), Positives = 105/268 (39%), Gaps = 13/268 (4%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLER 96
           +   I   ++ ++ G G + +V        G      A+K +   +  K+ +      E 
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEA 78

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-QITSKGHLSEDEARFYTAEVV 155
            ++ Q DHP V+ L      +  + +  E  E G L      + G  +  +       + 
Sbjct: 79  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             ++Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D       +  +   A   
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-----SDPTYTSALGG 193

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR 273
                +  PE +     T  +D+W+ G  +++++S G  P+ D +   +   I     + 
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAG 301
            P     A   L+      D + RP  G
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFG 281

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 33/298 (11%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP- 105
           + LG+  G GS+  +     I  G   A+K+   K    +     + +E  +   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
           G+  + +   +     M +E                 S         +++  +EYIHS  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 166 LIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            IHRD+KP+N L+        + I DFG  K  +D+R           +     GTA Y 
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---YRENKNLTGTARYA 180

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--------F 274
                     +  +DL +LG  L     G+ P++        Q+      +         
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK-------GIDWKNIR 323
              +       ++    +    +P        + ++  + F +         DW  ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYS----YLRQLFRNLFHRQGFSYDYVFDWNMLK 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 9e-52
 Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 47/302 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q +E  +  G G+Y  V +AK  +T  + ALK +      +   ++ ++ E  +L +L H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             +VRL         L +  E C+        +  G L  +  + +  +++  L + HS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP+NLL+  +G +K+A+FG  +                      V T  Y PP
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGI----------PVRCYSAEVVTLWYRPP 170

Query: 225 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIARDIRFPNY----- 277
           +VL  +   +   D+W+ GC   ++ +   P F         +RI               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 278 ------------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
                                    +   RDL+  LL  +P  R  A          HP+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPY 285

Query: 314 FK 315
           F 
Sbjct: 286 FS 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-51
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 37/286 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F       GK  G G++ KVV A      K D     A+K++       E +   +  E 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSEL 77

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 141
            VL  L +H  +V L           +  E C  G+L + +  K                
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 142 ----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
               L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG  + +++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FK 256
               V+                 ++ PE + +   TF +D+W+ G  L+++ S  S  + 
Sbjct: 198 DSNYVVKG--------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 257 DTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 300
                  F ++I    R   P +      D++    D DP  RP  
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  171 bits (433), Expect = 5e-51
 Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 68/320 (21%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +  D++L +  G G YS+V  A  I       +KI+      K      +K E  +L+ L
Sbjct: 33  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENL 86

Query: 103 -DHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
              P ++ L    +D  S    +  E     +          L++ + RFY  E++ AL+
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 143

Query: 160 YIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           Y HSMG++HRD+KP N+++  +   +++ D+G  +                 +    V +
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-----------GQEYNVRVAS 192

Query: 219 AAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
             +  PE+ ++     +  D+W+LGC L  M+    PF    +       IA+ +   + 
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 278 F--------------------------------------SDAARDLIDRLLDVDPSGRPG 299
           +                                      S  A D +D+LL  D   R  
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 300 AGPGGYAVLKMHPFFKGIDW 319
           A          HP+F  +  
Sbjct: 313 A-----REAMEHPYFYTVVK 327

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-50
 Identities = 52/299 (17%), Positives = 110/299 (36%), Gaps = 36/299 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
            + +   + +  G GS+  V         K +  T  A+K +++    +E        E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEA 74

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----------LSEDE 146
            V+ + +   VVRL           + +E    G+L   + S              S  +
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
                 E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++        
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----- 189

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDTSEWLIFQ 265
               K    +    ++ PE L     T  +D+W+ G  L+++ +    P++  S   + +
Sbjct: 190 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 266 RIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-----HPFFKGID 318
            ++   +   P+   D   +L+      +P  RP        ++        P F+ + 
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL----EIISSIKEEMEPGFREVS 301

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-49
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 34/284 (11%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F     +LGK  G G++ +V+ A      K  T    A+K++ +     E++ A +   +
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELK 68

Query: 97  IVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 141
           I++    H  VV L     +    L + +E C+ G L   + SK +              
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 142 --LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
             L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI DFG  + +    
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187

Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDT 258
                      +         ++ PE +     T  +D+W+ G  L+++ S   SP+   
Sbjct: 188 -------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 259 SEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 300
                F R +    R   P+Y +      +      +PS RP  
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  166 bits (420), Expect = 2e-49
 Identities = 45/266 (16%), Positives = 91/266 (34%), Gaps = 22/266 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           +++G+  G GS+  +     +      A+K   ++    +     ++ E      L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCT 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
           G+  +++  Q+     + ++                 S         +++  ++ IH   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 166 LIHRDIKPENLLLTA-----DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           L++RDIKP+N L+          I + DFG VK  +D             +     GTA 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK---QHIPYREKKNLSGTAR 178

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP-- 275
           Y+          +  +DL ALG      L G+ P++          ++RI  +    P  
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRP 298
                F +     +    ++     P
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATP 264

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-49
 Identities = 59/282 (20%), Positives = 109/282 (38%), Gaps = 34/282 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKL 94
                  LGK  G G++ +VV A+ I          T  A+K++ K   T+++ +  +  
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISE 68

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TS 138
             ++     H  ++ L         LY+ +E    G L + +                  
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 198
           +  LS  +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +   
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
                       K         ++ PE L     T  +D+W+ G  L+++ + G SP+  
Sbjct: 189 D--------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

Query: 258 TSEWLIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                +F+ +     +  P+  ++    ++       PS RP
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-48
 Identities = 71/311 (22%), Positives = 121/311 (38%), Gaps = 56/311 (18%)

Query: 42  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           + + + ++     G G+Y  V  A    TG   A+K + + F +  +     + E  +L 
Sbjct: 14  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLK 72

Query: 101 QLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            + H  V+ L   F    SL     + L +   G   + I     L++D  +F   +++ 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            L+YIHS  +IHRD+KP NL +  D  +KI DFG  +               DD+   +V
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-------------DDEMTGYV 179

Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            T  Y  PE+ LN        D+W++GC + ++L+G + F  T      + I+       
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 276 NYF-------------------------------SDAARDLIDRLLDVDPSGRPGAGPGG 304
                                             +  A DL++++L +D   R  A    
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---- 295

Query: 305 YAVLKMHPFFK 315
            A    H +F 
Sbjct: 296 -AQALAHAYFA 305

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 44/261 (16%), Positives = 96/261 (36%), Gaps = 16/261 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLD 100
                 K+ G G + +V +     +        A+K +   +  K+        E  ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 64

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALE 159
           Q  H  ++RL         + +  E  E G L   +  K G  S  +       +   ++
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ +M  +HRD+   N+L+ ++   K++DFG  + ++D       +  +           
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-------DPEATYTTSGGKIPI 177

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 277
            +  PE ++    T  +D+W+ G  ++++++               + I    R   P  
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 278 FSDAARDLIDRLLDVDPSGRP 298
              A   L+ +    + + RP
Sbjct: 238 CPSAIYQLMMQCWQQERARRP 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-47
 Identities = 52/257 (20%), Positives = 107/257 (41%), Gaps = 15/257 (5%)

Query: 49  LGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
             ++ G G +  V     +D        A+K +++  IT   + +    E I++    HP
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 88

Query: 106 GVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS 163
            V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              +HRD+   N +L     +K+ADFG  + M D          S            ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK------EFDSVHNKTGAKLPVKWMA 202

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 281
            E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y  D 
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262

Query: 282 ARDLIDRLLDVDPSGRP 298
             +++ +        RP
Sbjct: 263 LYEVMLKCWHPKAEMRP 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 7e-47
 Identities = 57/320 (17%), Positives = 118/320 (36%), Gaps = 68/320 (21%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++ ++  K  G G+   V  A         A+K + + F  + +     + E +++  ++
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 74

Query: 104 HPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           H  ++ L   F      ++   +Y+ +E  +          +  L  +   +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++++HS G+IHRD+KP N+++ +D  +KI DFG  +                     +V 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----------SFMMTPYVV 180

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-------- 269
           T  Y  PEV+         D+W++GC + +M+     F        + ++I         
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

Query: 270 -------------------RDIRFPNYF---------------SDAARDLIDRLLDVDPS 295
                                + FP  F               +  ARDL+ ++L +DP+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300

Query: 296 GRPGAGPGGYAVLKMHPFFK 315
            R             HP+  
Sbjct: 301 KRISV-----DDALQHPYIN 315

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-45
 Identities = 53/295 (17%), Positives = 104/295 (35%), Gaps = 53/295 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
              L +  G G + +V R K    G   A+KI   +    E ++ + + E      L H 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHE 57

Query: 106 GVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            ++               L++  +  E G LFD + ++  ++ +            L ++
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116

Query: 162 HS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           H           + HRD+K +N+L+  +G   IAD G       +  T+      D    
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------DIAPN 170

Query: 214 TFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSGTSPFKDTSEW------ 261
             VGT  Y+ PEVL+ S       +    D++A+G   +++    S      ++      
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 262 ---------LIFQRIIARDIR--FPNYFS-----DAARDLIDRLLDVDPSGRPGA 300
                     + + +  + +R   PN +           ++      + + R  A
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 58/350 (16%), Positives = 117/350 (33%), Gaps = 75/350 (21%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--- 96
           E +    + L +  G G +S V  AK +   T  A+KI+    +  E     +KL +   
Sbjct: 8   EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 97  ----IVLDQLDHPGVVRLFFTFQDTFS--LYMALESCEGG---ELFDQITSKGHLSEDEA 147
                  D +    +++L   F       +++ +     G       +      +     
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 148 RFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
           +  + +++  L+Y+    G+IH DIKPEN+L+      +      +  + ++        
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY----- 182

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS------- 259
             D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+          
Sbjct: 183 --DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 260 -----------------------------------------EWLIFQRIIARDIRFPNYF 278
                                                    ++   + ++    +F    
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           +    D +  +L +DP  R  A       L  HP+ K  D   +     P
Sbjct: 301 AKEISDFLSPMLQLDPRKRADA-----GGLVNHPWLK--DTLGMEEIRVP 343

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 1e-15
 Identities = 21/159 (13%), Positives = 48/159 (30%), Gaps = 28/159 (17%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---------------V 92
            +GK+ G G  S V      +      +K       + +                     
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
           + E   L +L    V +++          + +E                +  +       
Sbjct: 62  RNEFRALQKLQGLAVPKVY----AWEGNAVLME-------LIDAKELYRVRVENPDEVLD 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
            +++ +   +  G++H D+   N+L++ +  I I DF  
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	366
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.3
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.49
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.39
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.07

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-69  Score=483.62  Aligned_cols=282  Identities=49%  Similarity=0.860  Sum_probs=252.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.++++++||||+++++++.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            44578999999999999999999999999999999998765545555667888999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..... 
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~-  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc-
Confidence            9999999999999999989999999999999999999999999999999999999999999999999999987653321 


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~  281 (366)
                             .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++......+|..++++
T Consensus       164 -------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  236 (288)
T d1uu3a_         164 -------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK  236 (288)
T ss_dssp             -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHH
T ss_pred             -------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHH
Confidence                   1123356799999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCC-ChHhhhcCCCCCCCCccccccCCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPG-GYAVLKMHPFFKGIDWKNIRGQTPPKLA  331 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~-~~~~~l~hp~f~~~~~~~~~~~~~~~~~  331 (366)
                      +++||.+||++||++|||++|+ ....+++||||++++|+.+..++||++.
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~  287 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT  287 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence            9999999999999999999652 3345799999999999999988887754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-67  Score=480.65  Aligned_cols=281  Identities=37%  Similarity=0.644  Sum_probs=256.3

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +++++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+++.++||||+++++++++.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            67899999999999999999999999999999999998765545555667788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......  
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--  159 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998654321  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~  281 (366)
                              ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+..+.+......+|..+|++
T Consensus       160 --------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~  231 (337)
T d1o6la_         160 --------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE  231 (337)
T ss_dssp             --------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             --------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHH
Confidence                    233467899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      +++||.+||++||++|++....+++++++||||++++|+.+... ..|++.|
T Consensus       232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P  283 (337)
T d1o6la_         232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP  283 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCC
Confidence            99999999999999999876666799999999999999987643 3444433

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-67  Score=463.54  Aligned_cols=258  Identities=34%  Similarity=0.618  Sum_probs=240.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .+++++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            35688999999999999999999999999999999999876555555667788899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      |+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......  
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~  280 (366)
                                ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|+.+|+
T Consensus       160 ----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  229 (263)
T d2j4za1         160 ----------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE  229 (263)
T ss_dssp             ----------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred             ----------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCH
Confidence                      2235679999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ++++||.+||++||++|||+     +++++||||+
T Consensus       230 ~~~~li~~~L~~dp~~R~t~-----~eil~hp~~~  259 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPML-----REVLEHPWIT  259 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHHTCHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCH-----HHHHcCcCcC
Confidence            99999999999999999999     9999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-66  Score=468.52  Aligned_cols=278  Identities=36%  Similarity=0.694  Sum_probs=253.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +++++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            46789999999999999999999999999999999998765555555677888999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      +|||||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....   
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876432   


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~  281 (366)
                                ..+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++......+|..++++
T Consensus       158 ----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  227 (316)
T d1fota_         158 ----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED  227 (316)
T ss_dssp             ----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHH
Confidence                      2246799999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       282 ~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      ++++|.+||++||.+|++..+.+++++++||||++++|+.+... ..|++.|
T Consensus       228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p  279 (316)
T d1fota_         228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP  279 (316)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred             HHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCC
Confidence            99999999999999998655556699999999999999987533 3344433

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-64  Score=465.27  Aligned_cols=282  Identities=35%  Similarity=0.625  Sum_probs=252.7

Q ss_pred             CCCCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        38 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +.....+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus        34 ~~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  113 (350)
T d1rdqe_          34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             CCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ccCCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence            34456689999999999999999999999999999999999876544445556678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+++||||+.||+|..++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+..
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  277 (366)
                      .             .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..
T Consensus       194 ~-------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  260 (350)
T d1rdqe_         194 R-------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH  260 (350)
T ss_dssp             C-------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred             c-------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc
Confidence            2             224679999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      +++++.+||++||++||.+|+.....+++++++||||++++|+.+... .+|++.|
T Consensus       261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p  316 (350)
T d1rdqe_         261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP  316 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccC
Confidence            999999999999999999996322234499999999999999987643 3444444

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-64  Score=457.31  Aligned_cols=274  Identities=34%  Similarity=0.625  Sum_probs=241.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++..............|..++ +.++||||+++++++.+.+.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            47899999999999999999999999999999999875443334444444455554 57899999999999999999999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......   
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc---
Confidence            99999999999999998899999999999999999999999999999999999999999999999999998654321   


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA  282 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  282 (366)
                             .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+....+.+|..+|+++
T Consensus       158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  230 (320)
T d1xjda_         158 -------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA  230 (320)
T ss_dssp             -------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             -------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence                   2223457999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCC
Q 017775          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLA  331 (366)
Q Consensus       283 ~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~  331 (366)
                      ++||++||+.||++|||+.    .+++.||||++++|+.+... .+|+..
T Consensus       231 ~dli~~~L~~dP~~R~s~~----~~l~~hpff~~~~~~~l~~~~~~pp~~  276 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPFR  276 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTTCSCC---
T ss_pred             HHHHHHhcccCCCCCcCHH----HHHHhCchhccCCHHHHHhcCCCCCCC
Confidence            9999999999999999983    36999999999999887543 344443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-63  Score=462.89  Aligned_cols=279  Identities=33%  Similarity=0.580  Sum_probs=240.8

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHH---HHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE---RIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +++++|++++.||+|+||.||+|+++.+|+.||+|++.+.............+|   +.+++.++||||+++++++.+.+
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            468999999999999999999999999999999999986544433333334334   56677778999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999866543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRF  274 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~  274 (366)
                                  ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+   .......+......+
T Consensus       161 ------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  228 (364)
T d1omwa3         161 ------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  228 (364)
T ss_dssp             ------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC
T ss_pred             ------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence                        223457999999999986 4568999999999999999999999997644   334555666677788


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      |..+|+++++||.+||++||++|||..+..++++++||||++++|+.+..+ .+|++.|
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p  287 (364)
T d1omwa3         229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP  287 (364)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCC
Confidence            899999999999999999999999976656799999999999999987643 3444444

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-63  Score=448.60  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=226.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            357999999999999999999999999999999997653   22345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||||+||+|.+++.+. .+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+....    
T Consensus        96 mEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~----  170 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (293)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred             EEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc----
Confidence            9999999999987664 69999999999999999999999999999999999999999999999999998764432    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCH
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~  280 (366)
                            ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...   ....|..+|+
T Consensus       171 ------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  244 (293)
T d1yhwa1         171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (293)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCH
T ss_pred             ------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCH
Confidence                  2233567999999999999999999999999999999999999999998887776665543   3455678999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++++||.+||++||++|||+     +++++||||+.
T Consensus       245 ~~~~li~~~L~~dP~~R~s~-----~eil~Hp~~~~  275 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSA-----KELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHHccCChhHCcCH-----HHHhcCHhhCC
Confidence            99999999999999999999     89999999973

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-64  Score=447.81  Aligned_cols=258  Identities=29%  Similarity=0.458  Sum_probs=220.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.....  .+....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            5789999999999999999999999999999999976532  22334577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........  
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~--  159 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--  159 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc--
Confidence            999999999999988888999999999999999999999999999999999999999999999999999876443211  


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCCC-CCCCCcccchhhhhhhhcCCCCCCCCCHHHH-HHHHhcCCC--CCCCCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLI-FQRIIARDI--RFPNYFS  279 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~--~~~~~~s  279 (366)
                            ......+||+.|+|||++.+..+ +.++||||+||++|+|++|++||...+.... ...+.....  ..+..+|
T Consensus       160 ------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  233 (271)
T d1nvra_         160 ------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  233 (271)
T ss_dssp             ------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             ------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCC
Confidence                  12335689999999999988775 6789999999999999999999976554332 223333222  2235689


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +++++||.+||+.||++|||+     +++++||||+.
T Consensus       234 ~~~~~li~~~L~~dP~~R~t~-----~eil~hpwf~~  265 (271)
T d1nvra_         234 SAPLALLHKILVENPSARITI-----PDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhCc
Confidence            999999999999999999999     89999999973

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=444.37  Aligned_cols=264  Identities=30%  Similarity=0.514  Sum_probs=233.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc---hhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK---ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  120 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.....   ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999999999999999998754332   22356788899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC----CEEEEecCCccccC
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  196 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~----~vkL~Dfg~a~~~~  196 (366)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+|    .+||+|||+|....
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999999888999999999999999999999999999999999999998776    59999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  275 (366)
                      ...           ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+......++ 
T Consensus       169 ~~~-----------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         169 FGN-----------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             TSC-----------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CCc-----------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            432           22345789999999999999999999999999999999999999999999999999888877665 


Q ss_pred             ---CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       276 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                         ..+|+++++||.+||+.||++|||+     +++++||||++.+|+...
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~~~~~~~l  283 (293)
T d1jksa_         238 EYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQAL  283 (293)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTCC-------
T ss_pred             hhcCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCChhHhh
Confidence               5689999999999999999999999     899999999999887653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-62  Score=452.83  Aligned_cols=262  Identities=28%  Similarity=0.479  Sum_probs=235.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+++|++++.||+|+||.||+|+++.+|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467999999999999999999999999999999999765   23345668889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC--CCCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~--~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.  +|.+||+|||+|+.+....
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999999854 467999999999999999999999999999999999999964  5799999999998765432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  275 (366)
                                 ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++    
T Consensus       181 -----------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  249 (350)
T d1koaa2         181 -----------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF  249 (350)
T ss_dssp             -----------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred             -----------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence                       23356899999999999999999999999999999999999999999999999999888776655    


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccc
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~  323 (366)
                      ..+|+++++||.+||+.||++|||+     +++++||||+..++....
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~-----~eil~hp~~~~~~~~~~~  292 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRD  292 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCH-----HHHHHSTTTSCTTCCSCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCCCCch
Confidence            4689999999999999999999999     999999999988765543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-63  Score=446.35  Aligned_cols=255  Identities=34%  Similarity=0.600  Sum_probs=215.4

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.....  ....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            567999999999999999999999999999999998764332  234577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC---CCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~---~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||++.   .+|.+||+|||+|+...... 
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            99999999999999988999999999999999999999999999999999999995   47899999999998654332 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~  276 (366)
                                ...+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    .
T Consensus       165 ----------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (307)
T d1a06a_         165 ----------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD  234 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred             ----------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence                      22356799999999999999999999999999999999999999999999998888888766544    5


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+|+++++||.+||++||++|||+     +++++||||++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  269 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTC-----EQALQHPWIAG  269 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSTTTTS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCH-----HHHhcCHhhCC
Confidence            789999999999999999999999     99999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=437.40  Aligned_cols=255  Identities=29%  Similarity=0.531  Sum_probs=217.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLY  121 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~  121 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... +.....+.+|+.++++++||||+++++++.+  .+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            47899999999999999999999999999999999876543 3345567889999999999999999999865  56699


Q ss_pred             EEEeecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCeEeCCCCCEEEEecCCc
Q 017775          122 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSV  192 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qil~aL~~LH~~~-----i~H~dlkp~NIli~~~~~vkL~Dfg~a  192 (366)
                      +|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||++|     |+||||||+|||++.+|.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999999864    357999999999999999999999976     999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Q 017775          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (366)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  272 (366)
                      +.+....          .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..+..
T Consensus       162 ~~~~~~~----------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~  231 (269)
T d2java1         162 RILNHDT----------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF  231 (269)
T ss_dssp             HHC---------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             eecccCC----------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            8765432          122356799999999999999999999999999999999999999999999998888877765


Q ss_pred             -CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       273 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                       .+|..+|+++++||.+||+.||++|||+     +++++|||+
T Consensus       232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~-----~ell~hp~i  269 (269)
T d2java1         232 RRIPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPLI  269 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSTTC
T ss_pred             CCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHHhCCcC
Confidence             4678899999999999999999999999     999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-62  Score=441.51  Aligned_cols=254  Identities=29%  Similarity=0.499  Sum_probs=224.4

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  124 (366)
                      +.|++++.||+|+||.||+|+++.+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999997652   223345678999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       125 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      |||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......   
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~---  165 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---  165 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH---
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc---
Confidence            99999999998765 45799999999999999999999999999999999999999999999999999976543211   


Q ss_pred             CCCCCCCCccccccCCCCCCceeec-----CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCC
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFP  275 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~  275 (366)
                             ......||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.+.+..+.+.++....   ...|
T Consensus       166 -------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (288)
T d2jfla1         166 -------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP  238 (288)
T ss_dssp             -------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG
T ss_pred             -------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                   122457999999999984     4558899999999999999999999999988888888877664   3345


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ..+|+++++||.+||+.||++|||+     +++++||||+.
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~-----~ell~hp~~~~  274 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTT-----SQLLQHPFVTV  274 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGCC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCC
Confidence            6799999999999999999999999     89999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.4e-61  Score=446.45  Aligned_cols=255  Identities=30%  Similarity=0.533  Sum_probs=231.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||.||+|+++.+|+.||+|+++...   ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            568999999999999999999999999999999997753   23345677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeC--CCCCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~--~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||||+||+|.+.+.+.+ ++++.+++.++.||+.||.|||++||+||||||+|||++  .+|.+||+|||+|..+.... 
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            99999999998877654 699999999999999999999999999999999999998  56899999999998765432 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~  276 (366)
                                ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++    .
T Consensus       184 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  253 (352)
T d1koba_         184 ----------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS  253 (352)
T ss_dssp             ----------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred             ----------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                      23356789999999999999999999999999999999999999999999999999888776655    4


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      .+|+++++||.+||++||.+|||+     +++++||||++.
T Consensus       254 ~~s~~~~~li~~~L~~dp~~R~s~-----~eil~Hp~~~~~  289 (352)
T d1koba_         254 SVSPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKGD  289 (352)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSTTTSSC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhCCC
Confidence            689999999999999999999999     899999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-63  Score=450.38  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=223.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +.-++|++++.||+|+||+||+|+++.+|+.||+|+++...  .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34678999999999999999999999999999999997653  3344566788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.....  
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999999999988899999999999999999999997 59999999999999999999999999999865432  


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHH----------------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----------------  264 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------  264 (366)
                                ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.....                
T Consensus       159 ----------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         159 ----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             ----------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             ----------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence                      223568999999999999999999999999999999999999999765432211                


Q ss_pred             --------------------------HHHhcC-CCCCC-CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          265 --------------------------QRIIAR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       265 --------------------------~~i~~~-~~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                                                ..+... ....+ ..+|.++++||.+||+.||++|||+     +++++||||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta-----~e~L~Hpf~~~  303 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFIKR  303 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHH
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCHhhCc
Confidence                                      011111 11112 2468999999999999999999999     99999999987


Q ss_pred             CCcccc
Q 017775          317 IDWKNI  322 (366)
Q Consensus       317 ~~~~~~  322 (366)
                      .+++.+
T Consensus       304 ~~~~~~  309 (322)
T d1s9ja_         304 SDAEEV  309 (322)
T ss_dssp             HHHSCC
T ss_pred             CCcccc
Confidence            665543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-62  Score=440.05  Aligned_cols=252  Identities=27%  Similarity=0.382  Sum_probs=227.1

Q ss_pred             CeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        46 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      .|+.++.||+|+||+||+|+++.+|+.||||++.............+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999987655555566678889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      ||.||+|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|......       
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-------  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------  168 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence            9999999888888888999999999999999999999999999999999999999999999999999865432       


Q ss_pred             CCCCCCccccccCCCCCCceeecC---CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCH
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYFSD  280 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~s~  280 (366)
                             ....||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.+.+..+....+......  .+..+|+
T Consensus       169 -------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~  241 (309)
T d1u5ra_         169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE  241 (309)
T ss_dssp             -------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred             -------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH
Confidence                   24579999999999864   35888999999999999999999999999888888777665443  2456899


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ++++||.+||+.||++|||+     +++++||||..
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~-----~ell~Hp~~~~  272 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHTTCHHHHS
T ss_pred             HHHHHHHHHCcCChhHCcCH-----HHHHhCHHhcC
Confidence            99999999999999999999     89999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-61  Score=426.41  Aligned_cols=250  Identities=22%  Similarity=0.385  Sum_probs=217.5

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee----CCeEEE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFSLYM  122 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~i  122 (366)
                      |++.+.||+|+||+||+|+++.+++.||+|++....... .....+.+|+.++++++||||+++++++++    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            478889999999999999999999999999998764433 334567889999999999999999999875    456899


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCeEeC-CCCCEEEEecCCccccCCcc
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~--i~H~dlkp~NIli~-~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      ||||++||+|.+++.+.+.+++.+++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+..... 
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            9999999999999998889999999999999999999999999  99999999999997 5789999999999754322 


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC-HHHHHHHHhcCC--CCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARD--IRFPN  276 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~--~~~~~  276 (366)
                                 .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .....+.+..+.  ..++.
T Consensus       169 -----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  236 (270)
T d1t4ha_         169 -----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK  236 (270)
T ss_dssp             -----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred             -----------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence                       2335689999999999876 58999999999999999999999997654 455556665543  23456


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ..++++++||.+||++||++|||+     +++++||||+
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~-----~ell~Hp~fk  270 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ  270 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCH-----HHHhCCcccC
Confidence            789999999999999999999999     9999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-60  Score=426.18  Aligned_cols=258  Identities=30%  Similarity=0.521  Sum_probs=229.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhCC-CCCcceeEEEEee
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK------ENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  116 (366)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.....      ......+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999998754332      122345678999999996 9999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      ++.+|+||||++||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeec------CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  270 (366)
                      ...           ......||+.|+|||.+.      ...++.++||||+||++|+|++|+.||.+.+.......+..+
T Consensus       162 ~~~-----------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         162 PGE-----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             TTC-----------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CCC-----------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            432           223567999999999975      334688999999999999999999999999999988888887


Q ss_pred             CCCCC----CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 DIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 ~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                      ...++    ..+|+++++||.+||++||++|||+     +++++||||+..
T Consensus       231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~-----~eil~h~~~~~~  276 (277)
T d1phka_         231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQY  276 (277)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCTT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHHHHh
Confidence            66544    3799999999999999999999999     999999999853

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-61  Score=438.81  Aligned_cols=253  Identities=27%  Similarity=0.468  Sum_probs=230.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      .++|++++.||+|+||+||+|.++.+|+.||+|+++...    .....+.+|+.+++.++||||+++++++++.+.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            678999999999999999999999999999999997642    2334577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC--CCEEEEecCCccccCCccc
Q 017775          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~--~~vkL~Dfg~a~~~~~~~~  200 (366)
                      ||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||++....... 
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            99999999999998765 79999999999999999999999999999999999999854  489999999998764432 


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  276 (366)
                                ......+++.|+|||...+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.    
T Consensus       159 ----------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T d1tkia_         159 ----------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             ----------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ----------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence                      223557899999999999999999999999999999999999999999999999999988877764    


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      .+|+++++||.+||++||++|||+     +++++||||++
T Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~-----~eil~hp~~~~  263 (321)
T d1tkia_         229 EISIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhcc
Confidence            689999999999999999999999     89999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=424.46  Aligned_cols=256  Identities=25%  Similarity=0.350  Sum_probs=214.5

Q ss_pred             eeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  125 (366)
                      +.+++||+|+||+||+|+++.+|+.||||+++.......  .....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999976533221  122457789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCC
Q 017775          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (366)
Q Consensus       126 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~  205 (366)
                      |+.|+++..+....+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......      
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------  154 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------  154 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence            99998777776666789999999999999999999999999999999999999999999999999998654432      


Q ss_pred             CCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----C-------
Q 017775          206 AASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----I-------  272 (366)
Q Consensus       206 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----~-------  272 (366)
                          ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+.+..+....     .       
T Consensus       155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence                12234579999999999865 458999999999999999999999999999888777764310     0       


Q ss_pred             --------C--------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          273 --------R--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       273 --------~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                              .        ....+++++++||.+||+.||++||||     +++++||||++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa-----~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNRP  287 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH-----HHHhCCHhhCCCC
Confidence                    0        012468999999999999999999999     8999999998643

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-59  Score=423.11  Aligned_cols=287  Identities=37%  Similarity=0.677  Sum_probs=243.2

Q ss_pred             CCCCCCCcCCeeeeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCC-CCcceeE
Q 017775           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQLDH-PGVVRLF  111 (366)
Q Consensus        37 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~  111 (366)
                      ...+..++++|++++.||+|+||+||+|.+.   .+|+.||+|++++.... .......+.+|+.++++++| |||++++
T Consensus        16 ~~~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~   95 (322)
T d1vzoa_          16 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH   95 (322)
T ss_dssp             SCCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             CCCcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEee
Confidence            3444567899999999999999999999874   47899999999765432 22233456779999999966 8999999


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      +++.+...++++|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+
T Consensus        96 ~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_          96 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence            99999999999999999999999999988999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC--CCCCCCcccchhhhhhhhcCCCCCCCCCH----HHHHH
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ  265 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~  265 (366)
                      ++.+......         ......|++.|+|||.+.+..  ++.++|||||||++|+|++|..||.+.+.    .....
T Consensus       176 a~~~~~~~~~---------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~  246 (322)
T d1vzoa_         176 SKEFVADETE---------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  246 (322)
T ss_dssp             EEECCGGGGG---------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             hhhhcccccc---------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9876543221         223567999999999987643  67899999999999999999999976543    34445


Q ss_pred             HHhcCCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCccccccC-CCCCCCC
Q 017775          266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (366)
Q Consensus       266 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~~~~~~-~~~~~~~  332 (366)
                      ........+|..+++++.+||.+||++||++|||+...+++++++||||++++|+.+..+ .+|++.|
T Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p  314 (322)
T d1vzoa_         247 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP  314 (322)
T ss_dssp             HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             hcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCC
Confidence            555667788889999999999999999999999876556799999999999999988764 4555544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=419.02  Aligned_cols=252  Identities=31%  Similarity=0.542  Sum_probs=219.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchh---hHHHHHHHHHHHHhCC--CCCcceeEEEEeeCC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---KTAYVKLERIVLDQLD--HPGVVRLFFTFQDTF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~  118 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.......   ....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46899999999999999999999999999999999875433221   1122456999999886  899999999999999


Q ss_pred             eEEEEEeecCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC-CCEEEEecCCccccC
Q 017775          119 SLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQ  196 (366)
Q Consensus       119 ~~~iv~e~~~g-~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~-~~vkL~Dfg~a~~~~  196 (366)
                      .+|+||||+.+ +++.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 6888888888889999999999999999999999999999999999999854 799999999998654


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  275 (366)
                      ..            ...+..||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.      ..+......++
T Consensus       163 ~~------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~  224 (273)
T d1xwsa_         163 DT------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR  224 (273)
T ss_dssp             SS------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS
T ss_pred             cc------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC
Confidence            32            223567999999999987665 467799999999999999999999763      24566778888


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                      ..+|+++++||.+||+.||++|||+     +++++||||+++.
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~s~-----~eil~hp~~~~~~  262 (273)
T d1xwsa_         225 QRVSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVL  262 (273)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSCC
T ss_pred             CCCCHHHHHHHHHHccCCHhHCcCH-----HHHhcCHhhCCCC
Confidence            9999999999999999999999999     8999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=416.34  Aligned_cols=258  Identities=29%  Similarity=0.447  Sum_probs=215.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||+||+|.++.+|+.||+|++...... +.....+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            47999999999999999999999999999999999765332 22345577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          124 LESCEGGELFDQIT-S-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       124 ~e~~~g~~L~~~l~-~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      |||+.+ .+.+++. . .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.|+......  
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            999987 4444443 3 3569999999999999999999999999999999999999999999999999997654321  


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---------  271 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------  271 (366)
                              .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.+..+...++....         
T Consensus       157 --------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         157 --------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             --------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             --------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence                    2233557999999999977665 5789999999999999999999999988877766653210         


Q ss_pred             ---------CCC-----------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          272 ---------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       272 ---------~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                               ..+           ...+++++++||.+||+.||++|||+     +++++||||+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~-----~ell~H~ff~~~~  290 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPFFQDVT  290 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTCC
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH-----HHHhCCHhhccCC
Confidence                     000           12468999999999999999999999     8999999999774

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-58  Score=423.04  Aligned_cols=250  Identities=30%  Similarity=0.505  Sum_probs=212.5

Q ss_pred             CcCCeeeee-eeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceeEEEEee----
Q 017775           43 SIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVRLFFTFQD----  116 (366)
Q Consensus        43 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----  116 (366)
                      ..++|++.+ .||+|+||.||+|+++.+|+.||||+++..        ..+.+|+.++. ..+||||++++++|++    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            367999875 699999999999999999999999998642        23566888754 5589999999999976    


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CCCEEEEecCC
Q 017775          117 TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGS  191 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~~vkL~Dfg~  191 (366)
                      ...+|+|||||+||+|.+++.++  ..+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            46799999999999999999875  36999999999999999999999999999999999999985   46799999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHH----HHHH
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRI  267 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i  267 (366)
                      |+......           ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+....    ...+
T Consensus       161 a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i  229 (335)
T d2ozaa1         161 AKETTSHN-----------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  229 (335)
T ss_dssp             CEECCCCC-----------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred             eeeccCCC-----------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence            98664432           22355799999999999999999999999999999999999999977654333    3334


Q ss_pred             hcCCCCCCC----CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          268 IARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       268 ~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      ......+|.    .+|+++++||++||+.||++|||+     +++++||||.+
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  277 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  277 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSHHHHT
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHhhC
Confidence            445555553    589999999999999999999998     89999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-57  Score=408.17  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=214.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----e
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----S  119 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~  119 (366)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+++.++||||+++++++.+.+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999999999999999998876656666677889999999999999999999998644    4


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+.......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999988899999999999999999999999999999999999999999999999999987554332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----C
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF----P  275 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~  275 (366)
                      .       .........||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+..+...++.......    +
T Consensus       166 ~-------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         166 N-------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             --------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             c-------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            1       1123345689999999999999999999999999999999999999999999888887777665443    3


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                      ..+|+++.+||.+||++||++||+.
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~s  263 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQT  263 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhH
Confidence            5789999999999999999999954

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=412.28  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=215.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceeEEEEee---
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD---  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---  116 (366)
                      -++|++++.||+|+||+||+|++..+ ++.||||+++......... ....+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~-~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB-CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH-HHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47899999999999999999999765 6679999997654332222 2234566666554   89999999999853   


Q ss_pred             --CCeEEEEEeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          117 --TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       117 --~~~~~iv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                        ...++++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              3568999999998766544443 3569999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---
Q 017775          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  270 (366)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---  270 (366)
                      ......           ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+..+.+..+...   
T Consensus       165 ~~~~~~-----------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         165 IYSFQM-----------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             CCCGGG-----------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hhcccc-----------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            654332           223567999999999999999999999999999999999999999999988877766431   


Q ss_pred             ------------------------CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          271 ------------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       271 ------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                              ...++..+++++++||.+||+.||++|||+     +++++||||+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa-----~e~L~Hpff~~i~~  301 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLER  301 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCC
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhcCchh
Confidence                                    011345679999999999999999999999     89999999998864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-57  Score=405.61  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=217.5

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++..... +.....+.+|+.+++.++||||+++++++.+.+..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            479999999999999999999985 7899999999776432 33345677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      ||++.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.......    
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~----  154 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----  154 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc----
Confidence            9999987777776767889999999999999999999999999999999999999999999999999998764432    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------  271 (366)
                            .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+...++....           
T Consensus       155 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         155 ------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence                  122345689999999998754 47899999999999999999999999988877766653200           


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          272 ------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       272 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                                        ..++..+++++.+||++||+.||++|||+     ++++.||||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~-----~ell~Hp~f~~  286 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKE  286 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCc
Confidence                              11234678999999999999999999999     89999999973

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-57  Score=403.47  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=217.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++.+.||+|+||+||+|+++.+|+.||||+++.+..    ..+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            456799999999999999999999999999999999876422    2345778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +|||||++|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999999764  568999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCC-CCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ..         ......|++.|+|||.+.+..++.++||||+||++|||++|..| |.+.+.....+.+..+ ..+.|..
T Consensus       170 ~~---------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         170 YT---------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             SE---------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ce---------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence            21         11234578899999999999999999999999999999996554 5666666665555443 4567888


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +++++++||.+||+.||++|||+     ++++.
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~-----~ei~~  268 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSF-----AEIHQ  268 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCH-----HHHHH
Confidence            99999999999999999999999     67754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=395.01  Aligned_cols=250  Identities=20%  Similarity=0.339  Sum_probs=209.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||.||+|.++ +++.||||+++....    ....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            4578999999999999999999986 567899999876432    23457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999998765 56899999999999999999999999999999999999999999999999999866443211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                               ......||+.|+|||++.+..++.++||||+||++|||+| |.+||...+..+....+..+ ....|...+
T Consensus       158 ---------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~  228 (263)
T d1sm2a_         158 ---------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS  228 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             ---------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccC
Confidence                     1224568999999999999999999999999999999999 68888888888888777665 455678899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      +++.+|+.+||+.||++|||+     +++++|
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~-----~~il~~  255 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAF-----SRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCH-----HHHHHH
Confidence            999999999999999999999     778765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-56  Score=400.41  Aligned_cols=258  Identities=19%  Similarity=0.314  Sum_probs=209.2

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      .+..++|++.+.||+|+||+||+|.++.+|+   .||+|.+....  .......+.+|+.++++++||||+++++++.+.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            3557889999999999999999999987765   58888876542  333445678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      +.+|+|||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999999988875 569999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      .......     ........||+.|+|||.+.+..++.++|||||||++|||+| |..||.+.+..+....+..+ .++.
T Consensus       180 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~  254 (299)
T d1jpaa_         180 DDTSDPT-----YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP  254 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCCcce-----eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            4321110     111223457889999999999999999999999999999998 89999999998888877654 4567


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      |..+++++.+|+.+||+.||++|||+     .++++
T Consensus       255 ~~~~~~~l~~li~~cl~~~P~~RPs~-----~ei~~  285 (299)
T d1jpaa_         255 PMDCPSALHQLMLDCWQKDRNHRPKF-----GQIVN  285 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCH-----HHHHH
Confidence            78899999999999999999999998     55554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-56  Score=392.50  Aligned_cols=250  Identities=21%  Similarity=0.329  Sum_probs=221.4

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  122 (366)
                      ..++|++++.||+|+||+||+|+++ +++.||||++++....    ...+.+|+.++++++||||+++++++.+++.+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            4578999999999999999999984 7889999999875332    3457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccc
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~  201 (366)
                      ||||+++|+|.+++... ..+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            99999999999986654 57999999999999999999999999999999999999999999999999999866543211


Q ss_pred             ccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCC
Q 017775          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (366)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s  279 (366)
                               ......||+.|+|||.+.+..++.++||||+||++|||+| |+.||.+.+..+....+..+ ....|...+
T Consensus       157 ---------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  227 (258)
T d1k2pa_         157 ---------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS  227 (258)
T ss_dssp             ---------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             ---------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     2223568999999999999999999999999999999998 89999999999888888775 456778899


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       280 ~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      +++.+||.+||+.||++|||+     +++++|
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~-----~eil~~  254 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTF-----KILLSN  254 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCH-----HHHHHH
Confidence            999999999999999999998     788876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=398.87  Aligned_cols=251  Identities=21%  Similarity=0.323  Sum_probs=212.4

Q ss_pred             eeeeecCceEEEEEEEC--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeecC
Q 017775           51 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        51 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      +.||+|+||+||+|.+.  .+++.||||+++.... .......+.+|+.++++++||||+++++++.++ ..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            47999999999999864  4567899999976533 333455678899999999999999999998654 5789999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccccCCCCC
Q 017775          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (366)
Q Consensus       129 g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~  208 (366)
                      +|+|.+++.+.+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.......      
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------  164 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------  164 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence            99999999998899999999999999999999999999999999999999999999999999998765432111      


Q ss_pred             CCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHH
Q 017775          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLI  286 (366)
Q Consensus       209 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  286 (366)
                       .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+..+ .++.|..+|+++.+||
T Consensus       165 -~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         165 -KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             -EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             -ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence             11224468899999999998889999999999999999997 99999999988888877664 4677889999999999


Q ss_pred             HHhhcCCCCCCCCCCCCChHhh---hcCCCCC
Q 017775          287 DRLLDVDPSGRPGAGPGGYAVL---KMHPFFK  315 (366)
Q Consensus       287 ~~~L~~dP~~Rps~~~~~~~~~---l~hp~f~  315 (366)
                      .+||+.||++|||+     +++   |+|+|++
T Consensus       244 ~~cl~~dp~~RPs~-----~~i~~~L~~~~~~  270 (277)
T d1xbba_         244 NLCWTYDVENRPGF-----AAVELRLRNYYYD  270 (277)
T ss_dssp             HHHTCSSTTTSCCH-----HHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCH-----HHHHHHhhCHHhh
Confidence            99999999999998     555   5666654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=408.39  Aligned_cols=255  Identities=23%  Similarity=0.397  Sum_probs=214.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||+||+|++..+++     .||+|.+....  .......+.+|+.+++++ +|||||++++++.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            456799999999999999999999876554     69999886543  222334567799999887 8999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 017775          116 DTFSLYMALESCEGGELFDQITSK-----------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK  172 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~-----------------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlk  172 (366)
                      +.+.+|+|||||++|+|.+++.+.                       +.+++..++.++.||+.||+|||++||+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999999999999764                       248999999999999999999999999999999


Q ss_pred             CCCeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-C
Q 017775          173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G  251 (366)
Q Consensus       173 p~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  251 (366)
                      |+||+++.++++||+|||+|+........        .......||+.|+|||++.+..++.++||||+||++|||+| |
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNY--------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTS--------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             hhccccccCCeEEEeeccccccccCCCce--------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence            99999999999999999999865443211        11224568999999999999999999999999999999997 8


Q ss_pred             CCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          252 TSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       252 ~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..||.+.+....+.++...  .++.|..+|+++++||.+||+.||++|||+     ++|++|
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~~  320 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  320 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            9999887665555555554  455678899999999999999999999999     778765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=394.59  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=221.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  123 (366)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++.+....+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4789999999999999999999999999999999977643 344556778899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcccccc
Q 017775          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~~  203 (366)
                      +|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......    
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----  155 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----  155 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC----
Confidence            9999999999888888899999999999999999999999999999999999999999999999999998765432    


Q ss_pred             CCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCC-CCCCHHHHHHHHhcC-----------
Q 017775          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIAR-----------  270 (366)
Q Consensus       204 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~-----------  270 (366)
                            .......+++.|+|||.+.+.. ++.++||||+||++|+|++|..|| .+.+..+....+...           
T Consensus       156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence                  1122345678899999987665 689999999999999999999885 555555555554220           


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCC
Q 017775          271 ------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (366)
Q Consensus       271 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~  317 (366)
                                        ....+..+++++.+||.+||+.||++||||     +++++||||+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa-----~e~L~Hp~f~~~  289 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGSSC
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcChhhcCC
Confidence                              111234578999999999999999999999     999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=398.05  Aligned_cols=262  Identities=20%  Similarity=0.296  Sum_probs=221.4

Q ss_pred             CCcCCeeeeee-eeecCceEEEEEEECC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKI-YGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..++|.+.+. ||+|+||+||+|.++.  ++..||||+++...  .......+.+|+.++++++||||+++++++.++ 
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-   81 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-   81 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence            34567888885 9999999999998754  45579999997642  334455678899999999999999999998754 


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .+|+||||++||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            689999999999999987654 5799999999999999999999999999999999999999999999999999987755


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~  275 (366)
                      .....       .......||+.|+|||++.+..++.++||||+||++|||+| |..||.+.+..+....+..+ .++.|
T Consensus       162 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  234 (285)
T d1u59a_         162 DDSYY-------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  234 (285)
T ss_dssp             CSCEE-------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC
T ss_pred             ccccc-------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            43221       12224468899999999998889999999999999999998 99999998888887777665 46778


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                      ..+++++.+||.+||+.||++|||+.+  +.+.|+|+|++
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~--i~~~L~~~~~~  272 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLT--VEQRMRACYYS  272 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHH--HHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHH--HHHHHHHHHHH
Confidence            899999999999999999999999842  24447777763

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=402.35  Aligned_cols=261  Identities=26%  Similarity=0.327  Sum_probs=213.0

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-------
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------  116 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..+.... .....+.+|+.+++.++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            689999999999999999999999999999999987764332 333456679999999999999999998854       


Q ss_pred             -CCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCcccc
Q 017775          117 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (366)
Q Consensus       117 -~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~  195 (366)
                       .+.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             4568999999988666655555677999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 017775          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (366)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  274 (366)
                      .......      .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+......+
T Consensus       168 ~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         168 SLAKNSQ------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             CC-----------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccc------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            5432211      1223345799999999998765 58999999999999999999999999988877666553311111


Q ss_pred             C--------------------------------CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCC
Q 017775          275 P--------------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (366)
Q Consensus       275 ~--------------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~  316 (366)
                      +                                ...++++++||.+||+.||++|||+     +++++||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa-----~elL~Hpff~~  310 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWS  310 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHHcChhhcc
Confidence            0                                0137789999999999999999999     99999999984

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-56  Score=396.37  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=217.5

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||.||+|.++ ++..||||+++....    ....+.+|+.++++++||||+++++++.+ +.+|
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            34579999999999999999999985 578899999976432    23457889999999999999999998765 5679


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +||||+++|+|.+++...  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            999999999999877544  359999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ..         ......||+.|+|||.+.+..++.++||||+||++|||+| |.+||...+..+....+..+ ....|..
T Consensus       164 ~~---------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~  234 (272)
T d1qpca_         164 YT---------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN  234 (272)
T ss_dssp             EE---------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             cc---------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence            21         1224468899999999988889999999999999999999 56677788888887777664 4567788


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc--CCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK  315 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~--hp~f~  315 (366)
                      +++++.+|+.+||+.||++|||+     +++++  |+||+
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~-----~ei~~~L~~~ft  269 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTF-----DYLRSVLEDFFT  269 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCH-----HHHHHHhhhhhh
Confidence            99999999999999999999998     77776  67764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=406.00  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=211.9

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  118 (366)
                      .++|++++.||+|+||+||+|.++.+|+.||||++++... .......+.+|+.+|+.++||||++++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            6799999999999999999999999999999999986543 3344556778999999999999999999997654     


Q ss_pred             -eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 -~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                       .+|+||||+ |.+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 5577776654 5799999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCC-CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----  271 (366)
                      .             .....||+.|+|||.+.+. .++.++||||+||++|+|++|.+||.+.+....+..+....     
T Consensus       174 ~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         174 E-------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             S-------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             c-------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence            2             2345789999999998764 57899999999999999999999999888766554432210     


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          272 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       272 --------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                                ......+++++++||.+||+.||++|||+     +++++||||+++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC--
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhCcCCCc
Confidence                                      11234679999999999999999999999     999999999987644

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-56  Score=395.07  Aligned_cols=252  Identities=21%  Similarity=0.326  Sum_probs=205.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||+||+|+..   ..||||+++..... ......+.+|+.++++++||||+++++++.+ ..++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            45678999999999999999999753   46999999765433 3445668889999999999999999998654 5689


Q ss_pred             EEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999765 5699999999999999999999999999999999999999999999999999986643221


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeecCC---CCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHh-cCC-----
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARD-----  271 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~-----  271 (366)
                              ........||+.|+|||++.+.   .++.++||||+||++|||+||+.||.+.+.......+. .+.     
T Consensus       160 --------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         160 --------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             --------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence                    1122356799999999998643   47889999999999999999999998866554443333 322     


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ...+..+++++.+|+.+||+.||++|||+     ++++.+
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~~il~~  266 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLF-----PQILAS  266 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            12456789999999999999999999999     777765

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-55  Score=403.99  Aligned_cols=253  Identities=29%  Similarity=0.430  Sum_probs=210.7

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------CC
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------TF  118 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~  118 (366)
                      -+|..+++||+|+||+||+|+++.+|+.||||++.++...       ..+|+.+++.++||||+++++++..      ..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            3799999999999999999999999999999999765321       2359999999999999999999853      34


Q ss_pred             eEEEEEeecCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccc
Q 017775          119 SLYMALESCEGGELFDQ---ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKP  194 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~---l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~  194 (366)
                      ++|+||||++++.+..+   ......+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            58999999987533332   23345799999999999999999999999999999999999999775 899999999986


Q ss_pred             cCCccccccCCCCCCCCccccccCCCCCCceeecC-CCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---
Q 017775          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  270 (366)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---  270 (366)
                      +....           ...+..|++.|+|||.+.+ ..++.++||||+||++|||++|..||...+..+.+..+...   
T Consensus       173 ~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         173 LVRGE-----------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCTTS-----------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccCCc-----------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            64432           2235679999999998765 46899999999999999999999999998887776665420   


Q ss_pred             --------------CCC------------CCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCcc
Q 017775          271 --------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (366)
Q Consensus       271 --------------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~~  320 (366)
                                    ...            ....+++++.+||.+||+.||++|||+     +++++||||+++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDELRDP  312 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGGGCT
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccccCC
Confidence                          111            123478999999999999999999999     899999999876443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.4e-55  Score=399.38  Aligned_cols=253  Identities=26%  Similarity=0.459  Sum_probs=210.6

Q ss_pred             CcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEee--CCe
Q 017775           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD--TFS  119 (366)
Q Consensus        43 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~  119 (366)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|+++..      ....+.+|+.+++.+. ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            467899999999999999999999999999999998653      2345678999999985 9999999999974  456


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCC-CEEEEecCCccccCCc
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDS  198 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~-~vkL~Dfg~a~~~~~~  198 (366)
                      +++||||+.+++|..+.   +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999997653   4699999999999999999999999999999999999998665 6999999999866543


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCH-HHHHHHHhc-------
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIA-------  269 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~-------  269 (366)
                      .           ......+|+.|+|||.+.+.. ++.++||||+||++|+|++|..||..... ......+..       
T Consensus       184 ~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~  252 (328)
T d3bqca1         184 Q-----------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  252 (328)
T ss_dssp             C-----------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             C-----------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence            2           223557899999999987654 79999999999999999999999965443 222211110       


Q ss_pred             ------CC------------------------CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          270 ------RD------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       270 ------~~------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                            ..                        ......+++++++||++||+.||++|||+     +++|+||||+++.|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTSCC
T ss_pred             hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCC
Confidence                  00                        00113478999999999999999999999     99999999999988


Q ss_pred             c
Q 017775          320 K  320 (366)
Q Consensus       320 ~  320 (366)
                      +
T Consensus       328 ~  328 (328)
T d3bqca1         328 D  328 (328)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=398.08  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=212.0

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----eE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  120 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~  120 (366)
                      .+|++++.||+|+||+||+|.++.+|+.||||++++..  .......+.+|+.+++.++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            57999999999999999999999999999999997642  3344456778999999999999999999997643    23


Q ss_pred             EEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccc
Q 017775          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~  200 (366)
                      +++++|+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus        86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            4444566688999999765 699999999999999999999999999999999999999999999999999987654422


Q ss_pred             cccCCCCCCCCccccccCCCCCCceeec-CCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC---------
Q 017775          201 TVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  270 (366)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---------  270 (366)
                      .       .......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+..+........         
T Consensus       165 ~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         165 H-------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             B-------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             c-------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            1       12233567999999999984 456788999999999999999999999988776554443210         


Q ss_pred             -----------------CC-----CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          271 -----------------DI-----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       271 -----------------~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                                       ..     .....+++++++||.+||+.||++|||+     +++++||||+...-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta-----~e~L~hpf~~~~~~  303 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQYYD  303 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccCCC
Confidence                             00     0123578999999999999999999999     99999999986643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=389.87  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=207.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..++|++++.||+|+||.||+|++..++   ..||+|.++..  ........+.+|+.++++++||||+++++++.+ +
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~   80 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   80 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            34578999999999999999999987543   46888887543  234445668889999999999999999999864 6


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      .+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            789999999999999987654 5799999999999999999999999999999999999999999999999999987644


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  275 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~  275 (366)
                      ...         .......||+.|+|||.+.+..++.++||||+||++|||++ |.+||.+.+..+....+..+. .++|
T Consensus       161 ~~~---------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~  231 (273)
T d1mp8a_         161 STY---------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  231 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             Ccc---------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            321         12234468899999999999999999999999999999998 899999988888888877654 5678


Q ss_pred             CCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       276 ~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ..+|+++.+||.+||+.||++|||+     ++++.|
T Consensus       232 ~~~~~~~~~li~~cl~~dp~~Rps~-----~ei~~~  262 (273)
T d1mp8a_         232 PNCPPTLYSLMTKCWAYDPSRRPRF-----TELKAQ  262 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            8999999999999999999999999     777764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=387.85  Aligned_cols=256  Identities=20%  Similarity=0.345  Sum_probs=214.3

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  121 (366)
                      +..++|++++.||+|+||+||+|+++.+ +.||||+++....    ....+.+|+.++++++||||+++++++.+ +.++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            4568999999999999999999998765 5799999976432    23457889999999999999999999865 5678


Q ss_pred             EEEeecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCcc
Q 017775          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       122 iv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~  199 (366)
                      +||||+++|+|..++...  +.+++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999999999888653  569999999999999999999999999999999999999999999999999998664332


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  277 (366)
                      ..         ......||+.|+|||.+.+..++.++||||+||++|||++ |.+|+.+....+.+..+... ..+.+..
T Consensus       168 ~~---------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  238 (285)
T d1fmka3         168 YT---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  238 (285)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ce---------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence            11         1223468999999999999999999999999999999999 56667777887777777654 4567888


Q ss_pred             CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc--CCCCCCC
Q 017775          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKGI  317 (366)
Q Consensus       278 ~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~--hp~f~~~  317 (366)
                      +++++++||.+||+.||++|||+     ++++.  ++||+..
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~-----~~i~~~L~~~~~~~  275 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTF-----EYLQAFLEDYFTST  275 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHTTTSCS
T ss_pred             cCHHHHHHHHHHcccCHhHCcCH-----HHHHHHHhhhhcCC
Confidence            99999999999999999999999     77776  7888754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=382.94  Aligned_cols=255  Identities=18%  Similarity=0.293  Sum_probs=208.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +..++|+..++||+|+||.||+|.++.++    ..||||++....  .......+.+|+.++++++||||+++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            44578999999999999999999987654    469999987543  233344577899999999999999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                      +..++||||+.++++.+++... +.+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999999887765 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      .....       ........||+.|+|||.+.+..++.++||||+||++|||++ |.+|+.+.+..+....+..+ ..+.
T Consensus       162 ~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         162 DDPEA-------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  234 (283)
T ss_dssp             -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCcc-------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC
Confidence            43211       112223468899999999999999999999999999999998 56667777777777776654 4567


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      |..+++++.+||.+||+.||++|||+     .+++.
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~  265 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKF-----ADIVS  265 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCH-----HHHHH
Confidence            78899999999999999999999998     66654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=400.29  Aligned_cols=257  Identities=22%  Similarity=0.380  Sum_probs=207.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee------C
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------T  117 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~  117 (366)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.++++++||||++++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            57899999999999999999999999999999999876543 3444567789999999999999999999963      4


Q ss_pred             CeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..+|+||||+.| ++.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            689999999987 5555553  4599999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcC-------
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------  270 (366)
                      ..           ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+...       
T Consensus       172 ~~-----------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         172 SF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cc-----------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            32           233557899999999999999999999999999999999999999988877665554321       


Q ss_pred             ---------------CCCC--------------------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCC
Q 017775          271 ---------------DIRF--------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (366)
Q Consensus       271 ---------------~~~~--------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~  315 (366)
                                     ....                    +...++++++||++||+.||++||||     +++|+||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta-----~elL~Hpw~~  315 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYIN  315 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTG
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCcccC
Confidence                           0000                    01246789999999999999999999     9999999998


Q ss_pred             CCCcc
Q 017775          316 GIDWK  320 (366)
Q Consensus       316 ~~~~~  320 (366)
                      ...+.
T Consensus       316 ~~~~~  320 (355)
T d2b1pa1         316 VWYDP  320 (355)
T ss_dssp             GGCCH
T ss_pred             CCCCc
Confidence            75443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=400.07  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=212.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----C
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  118 (366)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+++.++||||+++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            46899999999999999999999999999999999876433 33344577899999999999999999998632     3


Q ss_pred             eEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      ..+++|+|+.||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||.+......
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            34666777889999998865 46999999999999999999999999999999999999999999999999998755332


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCC-CCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC----
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  273 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----  273 (366)
                                   .....|++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+.......+......    
T Consensus       175 -------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         175 -------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             -------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             -------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence                         23457899999999876654 688999999999999999999999998887766665432111    


Q ss_pred             -------------------C--------CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCCCCCC
Q 017775          274 -------------------F--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (366)
Q Consensus       274 -------------------~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~  318 (366)
                                         .        ...+++++++||.+||+.||++|||+     +++++||||+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~elL~Hp~f~~~~  308 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQYH  308 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTC
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH-----HHHhcCHhhCCCC
Confidence                               1        13578999999999999999999999     9999999999764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=385.67  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-CCC--cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-DTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      +..+||++.+.||+|+||.||+|+.. .++  ..||+|++++...........+.+|+.+++.++||||+++++++.+. 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            45789999999999999999999864 333  36899999876655556666788999999999999999999999764 


Q ss_pred             eEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCC
Q 017775          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~  197 (366)
                      ..++||||+++|++.+.+..+ +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            678999999999999877654 5799999999999999999999999999999999999999999999999999997655


Q ss_pred             ccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcCCC--CC
Q 017775          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI--RF  274 (366)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~--~~  274 (366)
                      .....       .......|+..|+|||.+.+..++.++||||||+++|||+| |..||.+.+..+....+.....  +.
T Consensus       164 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (273)
T d1u46a_         164 NDDHY-------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  236 (273)
T ss_dssp             -CCEE-------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             CCCcc-------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC
Confidence            43221       12224457889999999999899999999999999999998 8999999999998888876643  55


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhh
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l  309 (366)
                      +..+|+++.+||.+||+.||++|||+     ++++
T Consensus       237 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~ei~  266 (273)
T d1u46a_         237 PEDCPQDIYNVMVQCWAHKPEDRPTF-----VALR  266 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             cccccHHHHHHHHHHcCCChhHCcCH-----HHHH
Confidence            67899999999999999999999998     6664

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-54  Score=390.28  Aligned_cols=254  Identities=19%  Similarity=0.303  Sum_probs=211.0

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  117 (366)
                      +...+|++++.||+|+||+||+|.+..+|+    .||+|.++...  .......+.+|+.++++++||||+++++++.++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            345689999999999999999999988877    47777775432  233445678899999999999999999999875


Q ss_pred             CeEEEEEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccC
Q 017775          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~  196 (366)
                       ..++++|++.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+...
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             567788999899999888765 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCC
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~  274 (366)
                      .....        .......||+.|+|||.+.+..++.++||||+||++|||+| |.+||.+.+..+....+..+ .++.
T Consensus       163 ~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~  234 (317)
T d1xkka_         163 AEEKE--------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  234 (317)
T ss_dssp             TTCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred             ccccc--------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            43211        12234468999999999999999999999999999999998 89999988877777766654 3667


Q ss_pred             CCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       275 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      |..+++++.+|+.+||+.||++|||+     .+++.|
T Consensus       235 p~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  266 (317)
T d1xkka_         235 PPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  266 (317)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CcccCHHHHHHHHHhCCCChhhCcCH-----HHHHHH
Confidence            88899999999999999999999999     778776

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=385.97  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=216.5

Q ss_pred             CCCcCCeeeeeeeeecCceEEEEEEECCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 017775           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (366)
Q Consensus        41 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  117 (366)
                      .+..++|++.++||+|+||+||+|.++.+|..  ||||.+....  .......+.+|+.+++++ +||||+++++++.+.
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            45678999999999999999999999888875  5677665432  233345578899999998 799999999999999


Q ss_pred             CeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCC
Q 017775          118 FSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (366)
Q Consensus       118 ~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~  181 (366)
                      +.+++||||++||+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999999653                468999999999999999999999999999999999999999


Q ss_pred             CCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcC-CCCCCCCCH
Q 017775          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSE  260 (366)
Q Consensus       182 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~  260 (366)
                      +.+||+|||+++......           ......||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+.
T Consensus       164 ~~~kl~DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~  232 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  232 (309)
T ss_dssp             GCEEECCTTCEESSCEEC-----------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CceEEccccccccccccc-----------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence            999999999997554321           12244689999999999998999999999999999999996 568999999


Q ss_pred             HHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       261 ~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+....+..+ .++.|..+++++++||.+||+.||++|||+     .++++|
T Consensus       233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  279 (309)
T d1fvra_         233 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  279 (309)
T ss_dssp             HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            8888887764 566778899999999999999999999999     778876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-54  Score=378.44  Aligned_cols=244  Identities=23%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-CCeE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSL  120 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~  120 (366)
                      +.+++|++++.||+|+||.||+|+.  +|..||||+++++     ...+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            5688999999999999999999998  4789999998654     233457889999999999999999998854 5668


Q ss_pred             EEEEeecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCc
Q 017775          121 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (366)
Q Consensus       121 ~iv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~  198 (366)
                      |+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+++|+||||||+||+++.+|.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999999997643  4899999999999999999999999999999999999999999999999999865332


Q ss_pred             cccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCCCCCHHHHHHHHhc-CCCCCCC
Q 017775          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRFPN  276 (366)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~  276 (366)
                                   .....++..|+|||.+.+..++.++|||||||++|||+| |.+||...+..+....+.. ...++|.
T Consensus       157 -------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~  223 (262)
T d1byga_         157 -------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  223 (262)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred             -------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence                         123457889999999988899999999999999999998 8999999888888888765 3567888


Q ss_pred             CCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       277 ~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      .+++++.+||.+||+.||++|||+     .++++
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~  252 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSF-----LQLRE  252 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence            899999999999999999999999     66665

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-53  Score=381.34  Aligned_cols=251  Identities=20%  Similarity=0.316  Sum_probs=217.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  118 (366)
                      .++|++++.||+|+||+||+|+.+     .+++.||||+++...  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            568999999999999999999975     356789999987642  3344566888999999999999999999999999


Q ss_pred             eEEEEEeecCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 017775          119 SLYMALESCEGGELFDQITSKG------------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  174 (366)
Q Consensus       119 ~~~iv~e~~~g~~L~~~l~~~~------------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~  174 (366)
                      ..+++|||+.+|+|.+++....                        .+++..+..++.|++.||+|||+++|+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999986532                        3789999999999999999999999999999999


Q ss_pred             CeEeCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcC-CC
Q 017775          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TS  253 (366)
Q Consensus       175 NIli~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~  253 (366)
                      |||++.++.+||+|||+|+.+......        .......|++.|+|||.+.+..++.++||||+||++|||++| .+
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ceEECCCCcEEEccchhheeccCCccc--------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999866443211        122345688999999999999999999999999999999997 57


Q ss_pred             CCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhh
Q 017775          254 PFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (366)
Q Consensus       254 pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l  309 (366)
                      ||.+.+..+....+..+.. ..|..+++++.+||.+||+.||++|||+     .+++
T Consensus       242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~-----~ev~  293 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-----CSIH  293 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-----HHHH
Confidence            8999999998888877654 4678899999999999999999999999     6664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=382.44  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|.+..     +++.||+|+++...  .......+.+|...+.++ +|+||+.+++++.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            445789999999999999999999754     45689999987543  222233455566666555 7999999999876


Q ss_pred             e-CCeEEEEEeecCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEe
Q 017775          116 D-TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  178 (366)
Q Consensus       116 ~-~~~~~iv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli  178 (366)
                      + ...+++|||||++|+|.+++...                ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 45689999999999999999753                248999999999999999999999999999999999999


Q ss_pred             CCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcC-CCCCCC
Q 017775          179 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKD  257 (366)
Q Consensus       179 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~  257 (366)
                      +.++++||+|||+|+.......        ........||+.|+|||++.+..++.++||||+||++|||++| .+||.+
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~--------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPD--------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGCEEECC------CCSCTT--------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCCcEEEccCcchhhcccccc--------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999986543321        1223355799999999999999999999999999999999986 568877


Q ss_pred             CCHHHHH-HHHhc-CCCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          258 TSEWLIF-QRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       258 ~~~~~~~-~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      .+..+.+ ..+.. ..+..|..+++++.+||.+||+.||++|||+     +++++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~eil~~  290 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  290 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            6543333 33333 3466788899999999999999999999999     788876

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=379.39  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=213.3

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEE
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-------TVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  113 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~  113 (366)
                      +..++|++++.||+|+||.||+|+...++       ..||+|+++.+.  .......+.+|...+.++ +||||++++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            56789999999999999999999976554       479999997653  223344566677777776 89999999999


Q ss_pred             EeeCCeEEEEEeecCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 017775          114 FQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (366)
Q Consensus       114 ~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIl  177 (366)
                      +.+++.+++||||+++|+|.+++..+.                .+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            999999999999999999999997542                4899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCC
Q 017775          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (366)
Q Consensus       178 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  256 (366)
                      ++.++.+||+|||+++.......        ........|++.|+|||.+.+..++.++||||||+++|+|++ |.+||.
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDY--------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCT--------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecCCCCeEeccchhhcccccccc--------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            99999999999999987654321        122335578899999999999999999999999999999998 799999


Q ss_pred             CCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          257 DTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       257 ~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +.+.......+..+ .+..|..+++++.+||.+||+.||++|||+     .++++
T Consensus       240 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-----~eil~  289 (299)
T d1fgka_         240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  289 (299)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-----HHHHH
Confidence            99988887776554 466788899999999999999999999999     66764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=376.88  Aligned_cols=260  Identities=19%  Similarity=0.305  Sum_probs=223.6

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  116 (366)
                      +..++|++++.||+|+||.||+|.++.     +++.||||+++...  .......+.+|+.++++++||||+++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            456899999999999999999998752     46789999997542  33344567889999999999999999999999


Q ss_pred             CCeEEEEEeecCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEE
Q 017775          117 TFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  186 (366)
Q Consensus       117 ~~~~~iv~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL  186 (366)
                      ....++||||+++|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999988642          24789999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcC-CCCCCCCCHHHHHH
Q 017775          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQ  265 (366)
Q Consensus       187 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~  265 (366)
                      +|||+++.+......        .......|++.|+|||.+.+..++.++||||+|+++|||+|| .+||.+.+..+.+.
T Consensus       175 ~DFGla~~~~~~~~~--------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         175 GDFGMTRDIYETDYY--------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             CCTTCCCGGGGGGCE--------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             eecccceeccCCcce--------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999876544321        122344689999999999999999999999999999999997 68899999988888


Q ss_pred             HHhcCC-CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc------CCCCCC
Q 017775          266 RIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM------HPFFKG  316 (366)
Q Consensus       266 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~------hp~f~~  316 (366)
                      .+..+. ...|..+++.+.+||.+||+.||++|||+     +++++      +|+|++
T Consensus       247 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHH
T ss_pred             HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHHHHHHhcCCCCcC
Confidence            877654 45678899999999999999999999998     67765      566653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=373.12  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=215.1

Q ss_pred             CCcCCeeeeeeeeecCceEEEEEEEC-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 017775           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (366)
Q Consensus        42 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  115 (366)
                      +..++|++++.||+|+||.||+|+..     .++..||||+++...  .......+.+|+.+++.+ +||||+++++++.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            45689999999999999999999863     467789999997653  333445677899999988 6999999999999


Q ss_pred             eCCeEEEEEeecCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeE
Q 017775          116 DTFSLYMALESCEGGELFDQITSKG------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L~~~l~~~~------------------~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIl  177 (366)
                      +...+++|||||++|+|.+++.+..                  .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999987543                  5899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhc-CCCCCC
Q 017775          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (366)
Q Consensus       178 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  256 (366)
                      ++.++.+|++|||.++.........        ......||+.|+|||.+.+..++.++|||||||++|||+| |.+||.
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccCcccccccchheeccCCCcce--------EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            9999999999999998765432211        2224578999999999999999999999999999999998 777777


Q ss_pred             CCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          257 DTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       257 ~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                      +.+....+.++...  ....|...++++.+||.+||+.||++|||+     ++++.
T Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~~il~  300 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIVQ  300 (311)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            76665555554433  345567899999999999999999999999     66664

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=363.27  Aligned_cols=251  Identities=19%  Similarity=0.308  Sum_probs=205.5

Q ss_pred             eeeeeeeecCceEEEEEEECCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEee-CCeEEEE
Q 017775           48 ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLYMA  123 (366)
Q Consensus        48 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv  123 (366)
                      .+.++||+|+||+||+|++..++   ..||||.++..  ........+.+|+.++++++||||+++++++.+ ++..++|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            44789999999999999986643   36899998653  244455678889999999999999999999765 5689999


Q ss_pred             EeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCCccccCCccccc
Q 017775          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~~~~~~~~~~  202 (366)
                      ||||++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999999988865 457888999999999999999999999999999999999999999999999998765442211


Q ss_pred             cCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCC-CCHHHHHHHHhcC-CCCCCCCCCH
Q 017775          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR-DIRFPNYFSD  280 (366)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~-~~~~~~~~s~  280 (366)
                            ........||+.|+|||.+.+..++.++||||+|+++|||++|..||.. .+..+....+..+ ....|..+++
T Consensus       188 ------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~  261 (311)
T d1r0pa_         188 ------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  261 (311)
T ss_dssp             ------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCH
T ss_pred             ------ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcH
Confidence                  1122345689999999999988999999999999999999997666654 3444445555443 4556788999


Q ss_pred             HHHHHHHHhhcCCCCCCCCCCCCChHhhhcC
Q 017775          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (366)
Q Consensus       281 ~~~~li~~~L~~dP~~Rps~~~~~~~~~l~h  311 (366)
                      ++.+||.+||+.||++|||+     .++++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~-----~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSF-----SELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            99999999999999999999     778776

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-49  Score=358.26  Aligned_cols=259  Identities=20%  Similarity=0.242  Sum_probs=203.6

Q ss_pred             CCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceeEEEEeeCCeEEEE
Q 017775           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYMA  123 (366)
Q Consensus        45 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv  123 (366)
                      ++|++++.||+|+||.||+|++..+|+.||||++..+...     ..+..|..+++.++|++ |+.+..++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4799999999999999999999999999999998764322     23567999999998766 45556667888899999


Q ss_pred             EeecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC---CCCEEEEecCCccccCCcc
Q 017775          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSR  199 (366)
Q Consensus       124 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~---~~~vkL~Dfg~a~~~~~~~  199 (366)
                      |||+.+ +|...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+....
T Consensus        82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            999965 66666554 467999999999999999999999999999999999999864   4579999999999876543


Q ss_pred             ccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCCHHHHHHHH---hc-----CC
Q 017775          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IA-----RD  271 (366)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~-----~~  271 (366)
                      ....   ..........||+.|+|||.+.+..++.++|||||||++|||++|..||...........+   ..     ..
T Consensus       161 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         161 THQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TCCB---CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccc---eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            2211   1112334568999999999999999999999999999999999999999876554332221   11     11


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhcCCCC
Q 017775          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (366)
Q Consensus       272 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~hp~f  314 (366)
                      ...+..+|+++.+|+.+||+.||++||++.+  +.++++|+|.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~--i~~~l~~~~~  278 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY--LRQLFRNLFH  278 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH--HHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHH--HHHHHHHHHH
Confidence            1234578999999999999999999999842  2466777654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-48  Score=352.10  Aligned_cols=248  Identities=19%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~i  122 (366)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++.....     ...+.+|...++.+.| +|++.+++++.+....++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            4689999999999999999999999999999999865421     1235668888888865 899999999999999999


Q ss_pred             EEeecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCC-----CCCEEEEecCCccccC
Q 017775          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----DGHIKIADFGSVKPMQ  196 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~-----~~~vkL~Dfg~a~~~~  196 (366)
                      ||||+ |++|.+++... ..+++.++..++.|++.||.|||++||+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 56999998775 46999999999999999999999999999999999999974     5789999999998775


Q ss_pred             CccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCCCCC---HHHHHHHHhcCC--
Q 017775          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARD--  271 (366)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~--  271 (366)
                      .......   ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   .......+....  
T Consensus       158 ~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         158 DPVTKQH---IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             CTTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cCccccc---eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            4321111   11123345689999999999999999999999999999999999999997543   333333332221  


Q ss_pred             ---CCCCCCCCHHHHHHHHHhhcCCCCCCCCC
Q 017775          272 ---IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (366)
Q Consensus       272 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~  300 (366)
                         ...+..+|+++.+++..|+..+|++||+.
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y  266 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDY  266 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence               12345689999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=353.78  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=193.6

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----e
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----S  119 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~  119 (366)
                      .++|.+.+.||+|+||.||+|+.  +|+.||||+++..    .......+.|+..+..++||||+++++++.+.+    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            36899999999999999999987  6899999998653    122222334555566789999999999997654    5


Q ss_pred             EEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS--------MGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       120 ~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~--------~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      +|+||||+++|+|.+++.+. .++..+...++.|++.||.|||+        +||+||||||+||||+.++++||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            89999999999999999875 59999999999999999999996        5999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccccccCCCCCCceeecCCC------CCCCCCcccchhhhhhhhcCCCCCCC--------
Q 017775          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKD--------  257 (366)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~--------  257 (366)
                      ++.........      ........||+.|+|||++.+..      ++.++|||||||++|||+||..||..        
T Consensus       155 ~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         155 AVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CEEEETTTTEE------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             cccccCCCcce------eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            98765432111      11233567999999999987653      46688999999999999999887632        


Q ss_pred             -------CCHHHHHHHHhcCCC--CCCCC-----CCHHHHHHHHHhhcCCCCCCCCCCCCChHhhhc
Q 017775          258 -------TSEWLIFQRIIARDI--RFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (366)
Q Consensus       258 -------~~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~Rps~~~~~~~~~l~  310 (366)
                             .........+.....  .+|..     ....+.+|+.+||+.||++|||+     .+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ei~~  290 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence                   122333333333332  23322     23458999999999999999998     66664

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-47  Score=355.34  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=198.6

Q ss_pred             CCCCcCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----------CCCcc
Q 017775           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----------HPGVV  108 (366)
Q Consensus        40 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv  108 (366)
                      +.+.-++|++++.||+|+||+||+|+++.+|+.||||+++++.    .......+|+.+++.++           |+||+
T Consensus         8 ~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv   83 (362)
T d1q8ya_           8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   83 (362)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence            3444467999999999999999999999999999999997642    22345566888777664           57899


Q ss_pred             eeEEEEee--CCeEEEEEeecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCeEeCCCC
Q 017775          109 RLFFTFQD--TFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADG  182 (366)
Q Consensus       109 ~~~~~~~~--~~~~~iv~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qil~aL~~LH~-~~i~H~dlkp~NIli~~~~  182 (366)
                      ++++++..  ....+++++++..+.......   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence            99888754  466777777776544333322   23569999999999999999999998 8999999999999998765


Q ss_pred             ------CEEEEecCCccccCCccccccCCCCCCCCccccccCCCCCCceeecCCCCCCCCCcccchhhhhhhhcCCCCCC
Q 017775          183 ------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  256 (366)
Q Consensus       183 ------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  256 (366)
                            .++++|||.+......             .....||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             cccccceeeEeecccccccccc-------------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence                  4999999998755332             124579999999999999999999999999999999999999997


Q ss_pred             CCCHH------HHHHHH---hc---------------------------------------CCCCCCCCCCHHHHHHHHH
Q 017775          257 DTSEW------LIFQRI---IA---------------------------------------RDIRFPNYFSDAARDLIDR  288 (366)
Q Consensus       257 ~~~~~------~~~~~i---~~---------------------------------------~~~~~~~~~s~~~~~li~~  288 (366)
                      ..+..      ......   +.                                       ....++...++++++||.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            54321      111110   00                                       0111223356789999999


Q ss_pred             hhcCCCCCCCCCCCCChHhhhcCCCCCCCCc
Q 017775          289 LLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (366)
Q Consensus       289 ~L~~dP~~Rps~~~~~~~~~l~hp~f~~~~~  319 (366)
                      ||+.||.+||||     +++|+||||++...
T Consensus       311 mL~~dP~~Rpta-----~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         311 MLQLDPRKRADA-----GGLVNHPWLKDTLG  336 (362)
T ss_dssp             GGCSSTTTCBCH-----HHHHTCGGGTTCTT
T ss_pred             HCCCChhHCcCH-----HHHhcCcccCCCCC
Confidence            999999999999     89999999996543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=3.5e-27  Score=197.75  Aligned_cols=138  Identities=17%  Similarity=0.185  Sum_probs=108.6

Q ss_pred             eeeeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---------------chhhHHHHHHHHHHHHhCCCCCcceeE
Q 017775           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---------------KENKTAYVKLERIVLDQLDHPGVVRLF  111 (366)
Q Consensus        47 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~~  111 (366)
                      |.+++.||+|+||+||+|.+. +|+.||+|+++.....               ..........|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468999999999999999984 6899999987642211               011122345678888999999999887


Q ss_pred             EEEeeCCeEEEEEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCeEeCCCCCEEEEecCC
Q 017775          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (366)
Q Consensus       112 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~~~i~H~dlkp~NIli~~~~~vkL~Dfg~  191 (366)
                      ++..    .+++|||+++..+.+       +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    269999999865532       5666778899999999999999999999999999999865 589999999


Q ss_pred             ccccCC
Q 017775          192 VKPMQD  197 (366)
Q Consensus       192 a~~~~~  197 (366)
                      |.....
T Consensus       149 a~~~~~  154 (191)
T d1zara2         149 SVEVGE  154 (191)
T ss_dssp             CEETTS
T ss_pred             cccCCC
Confidence            876543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.71  E-value=3.9e-08  Score=84.26  Aligned_cols=140  Identities=15%  Similarity=0.126  Sum_probs=91.1

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEE
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  122 (366)
                      .+.|+.++..+.++.+.||++.  .++..+++|.........   ...+.+|...++.+. +--+.+++.+..+++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            3567777776666667999875  356678888876542221   223556777776663 3335677888888899999


Q ss_pred             EEeecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 017775          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS---------------------------------------  163 (366)
Q Consensus       123 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qil~aL~~LH~---------------------------------------  163 (366)
                      ||++++|.++.+.....     .....++.++...+..||+                                       
T Consensus        88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            99999997775433111     1112223333333333332                                       


Q ss_pred             --------------C------CceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 --------------M------GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 --------------~------~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                                    .      .++|+|+.|.||++++++.+-|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                          1      26899999999999876666799999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.30  E-value=1.4e-06  Score=78.98  Aligned_cols=81  Identities=16%  Similarity=0.113  Sum_probs=47.8

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cc---hhhHHHHHHHHHHHHhCC--CC-CcceeEEEEeeCCeEEE
Q 017775           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TK---ENKTAYVKLERIVLDQLD--HP-GVVRLFFTFQDTFSLYM  122 (366)
Q Consensus        50 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~i  122 (366)
                      .+.||.|....||++.+..+|+.+++|....... ..   .........|...++.+.  .| .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5678999999999998877888999996542111 01   111223445777776552  23 34455544  4445678


Q ss_pred             EEeecCCCch
Q 017775          123 ALESCEGGEL  132 (366)
Q Consensus       123 v~e~~~g~~L  132 (366)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.08  E-value=6.1e-06  Score=69.69  Aligned_cols=135  Identities=12%  Similarity=0.092  Sum_probs=80.0

Q ss_pred             eeeecC-ceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceeEEEEeeCCeEEEEEeecC
Q 017775           52 IYGVGS-YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALESCE  128 (366)
Q Consensus        52 ~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~iv~e~~~  128 (366)
                      .+..|. -+.||++.. ..+..+++|......      ...+..|...++.+..  -.+.+++.+..+.+..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            344454 367898865 457778999764432      1225567777766632  235667888888889999999999


Q ss_pred             CCchHHH-------H-------Hh-C------CCC--CHHH-HH----HH---------------HHHHHHHHHHHHHC-
Q 017775          129 GGELFDQ-------I-------TS-K------GHL--SEDE-AR----FY---------------TAEVVDALEYIHSM-  164 (366)
Q Consensus       129 g~~L~~~-------l-------~~-~------~~l--~~~~-~~----~~---------------~~qil~aL~~LH~~-  164 (366)
                      |.++.+.       .       .+ +      .++  .... ..    .+               .......+..+.+. 
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  169 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  169 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence            8665221       1       00 0      000  0000 00    00               00012223333332 


Q ss_pred             ------CceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          165 ------GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       165 ------~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                            .++|+|+.|.||+++.++.+-|+||+.+.
T Consensus       170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  27999999999999877667799999865

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.49  E-value=0.00022  Score=64.11  Aligned_cols=79  Identities=11%  Similarity=0.091  Sum_probs=51.3

Q ss_pred             cCCeeeeeeeeecCceEEEEEEECC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceeEEEEe
Q 017775           44 IQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQ  115 (366)
Q Consensus        44 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~  115 (366)
                      .++.+ ++.|+.|-.-.+|++....       .+..|.+++....    .. .....+|..+++.+.-.++ .++++++.
T Consensus        42 ~~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          42 LEHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET-ESHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             GGGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC-HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             ccceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            34444 4678888888999998653       3467888887532    11 1234568888887743344 46777665


Q ss_pred             eCCeEEEEEeecCCCch
Q 017775          116 DTFSLYMALESCEGGEL  132 (366)
Q Consensus       116 ~~~~~~iv~e~~~g~~L  132 (366)
                      +    .+|+||++|.+|
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            3    588999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.39  E-value=0.00029  Score=61.57  Aligned_cols=69  Identities=13%  Similarity=0.097  Sum_probs=42.6

Q ss_pred             ceEEEEEEECCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-----cee--EEEEeeCCeEEEEEeecCCC
Q 017775           58 YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-----VRL--FFTFQDTFSLYMALESCEGG  130 (366)
Q Consensus        58 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~--~~~~~~~~~~~iv~e~~~g~  130 (366)
                      .-.||++.. ++|+.|++|+.+....    ....+..|...+..+...++     +..  -..+......+.+++++.|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            358999866 5788999999865422    23446667777666532111     111  12234567789999999874


Q ss_pred             c
Q 017775          131 E  131 (366)
Q Consensus       131 ~  131 (366)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.07  E-value=0.0018  Score=55.90  Aligned_cols=30  Identities=27%  Similarity=0.400  Sum_probs=26.8

Q ss_pred             CCceeccCCCCCeEeCCCCCEEEEecCCcc
Q 017775          164 MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (366)
Q Consensus       164 ~~i~H~dlkp~NIli~~~~~vkL~Dfg~a~  193 (366)
                      .|+||+|+.++||+++.++..-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            469999999999999988777899999875